Citrus Sinensis ID: 044497

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340
Protein Sequence
MGNGISFLVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG
Secondary Structure (PSIPRED)
ccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHcccccccccEEEEcccccEEEEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccccccccccccccccccccccccccccEEEEcccccccccccHHccccccccccccccHHHHHHHHHHHccccccccccccccccccHHHHHHHHHccccEEEccccHHHHHHHHHHHHHHHccccccccccccHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccHHHEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHccccccccccEEcHHHHHHHHHcHHHcccccccccEEEcEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHHHHHHHEEEEcccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEEccccccEEEcccccccHcHHcHHHHccccccEEEEEEEEEccccccHHHHHHHcccccEccHHHHHHEEEEHHHcccccccccccccccccHHHHHHHHHHcccccHccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcc
Coil and Loop (DISEMBL)
mgngisflvdvpiigrfILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNqqswmpkrysypeiiAVTNhfthklgqggfgsvykgqlhtGGLIAVKMLAnskfsgeefinevstigrIHHVNVVQLLGFCSEGSKRALVYeympngsldrhifpkesrgqsfcwEKLHEVALGTARGIEylhngcdvcilhfdikphnilldhnfipkvsdfglakfhpkendfvsisatrgtigyiapelisrnfgtvscksdvYGFGMVLLEMaggrrnsnmhatrsskayfpswvydqlnkggdlelrnVTEIESMIARKLCMIGLWCiqvkaadrpsMTKVLEMLEG
Flexible Loop (DISEMBL)
MGNGISFLVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLhnqqswmpkrYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIApelisrnfgtvSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQvkaadrpsMTKVLEMLEG
Low Complexity Region (SEG)
MGNGISFLVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG
Disordered region (IsUnstruct)
****ISFLVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG************KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAA**************
Disordered Region (DISOPRED)
***GISFLVDVPIIGRFILAPIVFLVFLIQRYRKSLK**********NQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANS****EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS******SS*AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG
Disordered Region (DISEMBL)
MGNGISFLVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG
Disordered Region (DISPRO)
*GNGISFLVDVPIIGRFILAPIVFLVFLIQRYRKS*****NVE***HNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE*LE*
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNGISFLVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	340	2.2.26 [Sep-21-2011]
Q3ECH2	892	Probable receptor-like pr	no	no	0.932	0.355	0.488	3e-82
Q9FID6	813	Probable receptor-like pr	no	no	0.938	0.392	0.456	5e-80
Q9FID5	806	Probable receptor-like pr	no	no	0.902	0.380	0.480	1e-79
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.920	0.381	0.454	6e-71
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.935	0.364	0.432	8e-69
O64477	828	G-type lectin S-receptor-	no	no	0.814	0.334	0.464	2e-66
Q9XID3	829	G-type lectin S-receptor-	no	no	0.829	0.340	0.440	2e-64
Q39203	797	G-type lectin S-receptor-	no	no	0.823	0.351	0.442	4e-60
O65238	872	G-type lectin S-receptor-	no	no	0.832	0.324	0.409	2e-58
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.935	0.307	0.399	2e-57

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  305 bits (782), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 164/336 (48%), Positives = 218/336 (64%), Gaps = 19/336 (5%)

Query: 22  IVFLVFLIQRYRKSL--KRVDNVEKFLHNQQSWMP-KRYSYPEIIAVTNHFTHKLGQGGF 78
           IVFLV L   +R  +  KR  + E  L   ++ +P K Y+Y E+  +T  FT  +G+GGF
Sbjct: 508 IVFLVLLCPCFRVQIFRKRKTSDEVRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGF 567

Query: 79  GSVYKGQLHTGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL 137
           G VY G L    ++AVK+L +SK + GE+FINEV+++ +  HVN+V LLGFC EGS+RA+
Sbjct: 568 GIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAI 627

Query: 138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN 197
           +YE++ NGSLD+ I  K S       + L+ +ALG ARG+EYLH GC   I+HFDIKP N
Sbjct: 628 IYEFLGNGSLDKFISDKSSVNLDL--KTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQN 685

Query: 198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 257
           +LLD N  PKVSDFGLAK   K+   +S+  TRGTIGYIAPE+ISR +G+VS KSDVY +
Sbjct: 686 VLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSY 745

Query: 258 GMVLLEMAGGRRNSNM-HATRS--SKAYFPSWVYDQLNKG----------GDLELRNVTE 304
           GM++LEM G R+       +RS  S  YFP W+Y  L K           G L    ++ 
Sbjct: 746 GMLVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISS 805

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
            E  IARK+ ++GLWCIQ   +DRP M KV+EM+EG
Sbjct: 806 EEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEG 841

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  298 bits (762), Expect = 5e-80,   Method: Compositional matrix adjust.
 Identities = 153/335 (45%), Positives = 217/335 (64%), Gaps = 16/335 (4%)

Query: 13  IIGRFI-LAPIVFLVFLI--QRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHF 69
           ++G  I LA  + ++ L+  Q  RK  K+ ++V  F       + K+Y Y E+  +T  F
Sbjct: 444 VVGSVIGLATFIVIIMLLIRQMKRKKNKKENSVIMF-----KLLLKQYIYAELKKITKSF 498

Query: 70  THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           +H +G+GGFG+VY+G L  G  +AVK+L + K +G++FINEV+++ +  HVN+V LLGFC
Sbjct: 499 SHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFC 558

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFC--WEKLHEVALGTARGIEYLHNGCDVC 187
            EGSKRA++ E++ +GSLD+ I    SR +S       L+ +ALG ARG+EYLH GC   
Sbjct: 559 YEGSKRAIISEFLEHGSLDQFI----SRNKSLTPNVTTLYGIALGIARGLEYLHYGCKTR 614

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+HFDIKP NILLD NF PKV+DFGLAK   K    +S+  TRGTIGYIAPE++SR +G 
Sbjct: 615 IVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGG 674

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL--RNVTEI 305
           +S KSDVY +GM++L+M G R          S AYFP W+Y  L  G    +    + E 
Sbjct: 675 ISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEE 734

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           ++ I +K+ ++ LWCI+   +DRP M KV+EM+EG
Sbjct: 735 DNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEG 769

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  296 bits (759), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 157/327 (48%), Positives = 214/327 (65%), Gaps = 20/327 (6%)

Query: 22  IVFLVFLIQRYRKSLK--RVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFG 79
           +V ++++ Q  RK+ K  RV   +K L+         Y+Y E+  +T  F++ +G+GGFG
Sbjct: 459 VVLMLWMRQMKRKNRKEERVVMFKKLLN--------MYTYAELKKITKSFSYIIGKGGFG 510

Query: 80  SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY 139
           +VY G L  G  +AVK+L + K S E+FINEV+++ +  HVN+V LLGFC EGSKRA+VY
Sbjct: 511 TVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQTSHVNIVSLLGFCFEGSKRAIVY 570

Query: 140 EYMPNGSLDRHIFPKESRGQSFCWE--KLHEVALGTARGIEYLHNGCDVCILHFDIKPHN 197
           E++ NGSLD+ +    SR +S   +   L+ +ALG ARG+EYLH GC   I+HFDIKP N
Sbjct: 571 EFLENGSLDQFM----SRNKSLTQDVTTLYGIALGIARGLEYLHYGCKTRIVHFDIKPQN 626

Query: 198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 257
           ILLD N  PKVSDFGLAK   K    +S+  TRGTIGYIAPE+ SR +G VS KSDVY F
Sbjct: 627 ILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSHKSDVYSF 686

Query: 258 GMVLLEMAGGRRNSNMHATRS--SKAYFPSWVYDQLNKGGDLEL--RNVTEIESMIARKL 313
           GM++++M G R    +    S  S  YFP W+Y  L  G    +    +T+ E  IA+K+
Sbjct: 687 GMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTWIFGDEITKEEKEIAKKM 746

Query: 314 CMIGLWCIQVKAADRPSMTKVLEMLEG 340
            ++GLWCIQ   +DRPSM +V+EM+EG
Sbjct: 747 IVVGLWCIQPCPSDRPSMNRVVEMMEG 773

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  268 bits (684), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 149/328 (45%), Positives = 207/328 (63%), Gaps = 15/328 (4%)

Query: 22  IVFLVFLIQRYRKSL----KRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGG 77
           ++F+ F I + +K +    +     + FL N  S MP R++Y ++ + TN+F+ KLGQGG
Sbjct: 445 LIFVAFRIHKRKKMILEAPQESSEEDNFLENL-SGMPIRFAYKDLQSATNNFSVKLGQGG 503

Query: 78  FGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL 137
           FGSVY+G L  G  +AVK L       +EF  EVS IG IHH+++V+L GFC+EG+ R L
Sbjct: 504 FGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLL 563

Query: 138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN 197
            YE++  GSL+R IF K+       W+    +ALGTA+G+ YLH  CD  I+H DIKP N
Sbjct: 564 AYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPEN 623

Query: 198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 257
           ILLD NF  KVSDFGLAK   +E   V  +  RGT GY+APE I+ N+  +S KSDVY +
Sbjct: 624 ILLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWIT-NYA-ISEKSDVYSY 680

Query: 258 GMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG-----DLELRNVTEIESMIARK 312
           GMVLLE+ GGR+N +   T S K +FPS+ + ++ +G      D +++NV   +  + R 
Sbjct: 681 GMVLLELIGGRKNYDPSET-SEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRA 739

Query: 313 LCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           +    LWCIQ     RPSM+KV++MLEG
Sbjct: 740 M-KTALWCIQEDMQTRPSMSKVVQMLEG 766

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  261 bits (666), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 145/335 (43%), Positives = 204/335 (60%), Gaps = 17/335 (5%)

Query: 13  IIGRFILAPIVFLVFLIQRYRK-SLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTH 71
           ++G  +L  ++ ++      RK +LKR       L +     P  ++Y ++   TN+F+ 
Sbjct: 479 VVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDS----PVSFTYRDLQNCTNNFSQ 534

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE-EFINEVSTIGRIHHVNVVQLLGFCS 130
            LG GGFG+VYKG +    L+AVK L  +   GE EFI EV+TIG +HH+N+V+L G+CS
Sbjct: 535 LLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCS 594

Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
           E S R LVYEYM NGSLD+ IF  E       W    E+A+ TA+GI Y H  C   I+H
Sbjct: 595 EDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIH 654

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            DIKP NILLD NF PKVSDFGLAK   +E+  V ++  RGT GY+APE +S     ++ 
Sbjct: 655 CDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMIRGTRGYLAPEWVSNR--PITV 711

Query: 251 KSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE-----LRNVTEI 305
           K+DVY +GM+LLE+ GGRRN +M +  +   ++P W Y +L  G  L+     L+ V E 
Sbjct: 712 KADVYSYGMLLLEIVGGRRNLDM-SYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEE 770

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           E ++  K   +  WCIQ + + RPSM +V+++LEG
Sbjct: 771 EEVV--KALKVAFWCIQDEVSMRPSMGEVVKLLEG 803

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  252 bits (644), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 136/293 (46%), Positives = 183/293 (62%), Gaps = 16/293 (5%)

Query: 57  YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGR 116
           +SY E+   T +F+ KLG GGFGSV+KG L     IAVK L       ++F  EV TIG 
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542

Query: 117 IHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ-SFCWEKLHEVALGTAR 175
           I HVN+V+L GFCSEGSK+ LVY+YMPNGSLD H+F  +   +    W+   ++ALGTAR
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIG 234
           G+ YLH+ C  CI+H DIKP NILLD  F PKV+DFGLAK   +  DF  +  T RGT G
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGR--DFSRVLTTMRGTRG 660

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG 294
           Y+APE IS     ++ K+DVY +GM+L E+  GRRN+        + +FPSW    L K 
Sbjct: 661 YLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTEQSENEKVR-FFPSWAATILTKD 717

Query: 295 GDLELR-------NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           GD+          +  +IE +   + C +  WCIQ + + RP+M++V+++LEG
Sbjct: 718 GDIRSLVDPRLEGDAVDIEEVT--RACKVACWCIQDEESHRPAMSQVVQILEG 768

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  246 bits (627), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 129/293 (44%), Positives = 184/293 (62%), Gaps = 11/293 (3%)

Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVST 113
           P +++Y E+   T  F  KLG GGFG+VY+G L    ++AVK L   +   ++F  EV+T
Sbjct: 471 PVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVAT 530

Query: 114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
           I   HH+N+V+L+GFCS+G  R LVYE+M NGSLD  +F  +S  +   WE    +ALGT
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDS-AKFLTWEYRFNIALGT 589

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGT 232
           A+GI YLH  C  CI+H DIKP NIL+D NF  KVSDFGLAK  +PK+N + ++S+ RGT
Sbjct: 590 AKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY-NMSSVRGT 648

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN 292
            GY+APE ++     ++ KSDVY +GMVLLE+  G+RN ++ + +++   F  W Y++  
Sbjct: 649 RGYLAPEWLANL--PITSKSDVYSYGMVLLELVSGKRNFDV-SEKTNHKKFSIWAYEEFE 705

Query: 293 KGG-----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           KG      D  L     ++     ++     WCIQ +   RP+M KV++MLEG
Sbjct: 706 KGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  232 bits (591), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 132/298 (44%), Positives = 178/298 (59%), Gaps = 18/298 (6%)

Query: 55  KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVST 113
           K +S+ E+ + TN F+ K+G GGFG+V+KG L  +   +AVK L        EF  EV T
Sbjct: 449 KVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCT 508

Query: 114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
           IG I HVN+V+L GFCSE   R LVY+YMP GSL  ++    +  +   WE    +ALGT
Sbjct: 509 IGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL--SRTSPKLLSWETRFRIALGT 566

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGT 232
           A+GI YLH GC  CI+H DIKP NILLD ++  KVSDFGLAK   +  DF  + AT RGT
Sbjct: 567 AKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGR--DFSRVLATMRGT 624

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHA-------TRSSKAYFPS 285
            GY+APE IS     ++ K+DVY FGM LLE+ GGRRN  +++       T   K +FP 
Sbjct: 625 WGYVAPEWISGL--PITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPP 682

Query: 286 WVYDQLNKG---GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           W   ++ +G     ++ R   E  +    ++  + +WCIQ     RP+M  V++MLEG
Sbjct: 683 WAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  226 bits (576), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 127/310 (40%), Positives = 180/310 (58%), Gaps = 27/310 (8%)

Query: 53  MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG-EEFINEV 111
           +P+++ + E+   T +F  ++G GGFGSVYKG L    LIAVK + N    G +EF  E+
Sbjct: 501 LPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEI 560

Query: 112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVAL 171
           + IG I H N+V+L GFC+ G +  LVYEYM +GSL++ +F     G    W++  ++AL
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF--SGNGPVLEWQERFDIAL 618

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
           GTARG+ YLH+GCD  I+H D+KP NILL  +F PK+SDFGL+K   +E   +  +  RG
Sbjct: 619 GTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL-FTTMRG 677

Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA---------- 281
           T GY+APE I+     +S K+DVY +GMVLLE+  GR+N +  +  +S            
Sbjct: 678 TRGYLAPEWITN--AAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSST 735

Query: 282 --------YFPSWVYDQLNKGGDLEL---RNVTEIESMIARKLCMIGLWCIQVKAADRPS 330
                   YFP +  D   +G  +EL   R    + S  A KL  I L C+  + A RP+
Sbjct: 736 TTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPT 795

Query: 331 MTKVLEMLEG 340
           M  V+ M EG
Sbjct: 796 MAAVVGMFEG 805

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  223 bits (568), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 133/333 (39%), Positives = 195/333 (58%), Gaps = 15/333 (4%)

Query: 13  IIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHF--T 70
           I+G  +L+ I  +V  I R R+  KR  + E+ L       P  ++Y E+ + T  F  +
Sbjct: 641 IVGVGLLSIISGVVIFIIRKRR--KRYTDDEEIL--SMDVKPYTFTYSELKSATQDFDPS 696

Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE-EFINEVSTIGRIHHVNVVQLLGFC 129
           +KLG+GGFG VYKG+L+ G  +AVK+L+     G+ +F+ E+  I  + H N+V+L G C
Sbjct: 697 NKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCC 756

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            EG  R LVYEY+PNGSLD+ +F +++      W   +E+ LG ARG+ YLH    + I+
Sbjct: 757 YEGEHRLLVYEYLPNGSLDQALFGEKT--LHLDWSTRYEICLGVARGLVYLHEEARLRIV 814

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+K  NILLD   +PKVSDFGLAK +  +   +S +   GTIGY+APE   R  G ++
Sbjct: 815 HRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVAGTIGYLAPEYAMR--GHLT 871

Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL--RNVTEIES 307
            K+DVY FG+V LE+  GR NS+ +     K Y   W ++   KG ++EL    +TE   
Sbjct: 872 EKTDVYAFGVVALELVSGRPNSDEN-LEDEKRYLLEWAWNLHEKGREVELIDHQLTEFNM 930

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
              +++  I L C Q   A RP M++V+ ML G
Sbjct: 931 EEGKRMIGIALLCTQTSHALRPPMSRVVAMLSG 963

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	340
255570697	631	kinase, putative [Ricinus communis] gi|2	0.979	0.527	0.660	1e-132
224101781	348	predicted protein [Populus trichocarpa]	0.888	0.867	0.705	1e-124
224108395	348	predicted protein [Populus trichocarpa]	0.894	0.873	0.690	1e-123
326508416	666	predicted protein [Hordeum vulgare subsp	0.970	0.495	0.613	1e-117
414876616	668	TPA: putative protein kinase superfamily	0.944	0.480	0.619	1e-117
357135051	680	PREDICTED: probable receptor-like protei	0.982	0.491	0.611	1e-117
357130561	663	PREDICTED: probable receptor-like protei	0.961	0.493	0.615	1e-117
326509433	685	predicted protein [Hordeum vulgare subsp	0.958	0.475	0.607	1e-115
13377503	708	TAK33 [Triticum aestivum]	0.955	0.459	0.618	1e-115
115434136	659	Os01g0114100 [Oryza sativa Japonica Grou	0.952	0.491	0.611	1e-115

>gi|255570697|ref|XP_002526303.1| kinase, putative [Ricinus communis] gi|223534384|gb|EEF36092.1| kinase, putative [Ricinus communis]

 Score =  476 bits (1224), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 220/333 (66%), Positives = 273/333 (81%)

Query: 8   LVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTN 67
           L+ + +I RF++APIV + FLI +YR   K  ++ E  L N+ S MP+RYSY +IIA+TN
Sbjct: 258 LLAINLIARFVVAPIVIVGFLIHKYRTQKKTEESKENLLPNEPSMMPRRYSYSDIIAITN 317

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           +F  K+G+GGFG+VYKGQL  G L+AVKML +SKFS ++FI+EVSTIG+IHH NVVQL+G
Sbjct: 318 NFKDKIGKGGFGTVYKGQLPDGFLVAVKMLGDSKFSDKDFIDEVSTIGKIHHANVVQLVG 377

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           FCSEGS  AL++EY+  GSLD+HIF +E+  Q F WEK  ++A+GTARGIE+LH GCDVC
Sbjct: 378 FCSEGSYHALLFEYIARGSLDKHIFSREAEFQPFSWEKRLQIAIGTARGIEHLHVGCDVC 437

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ILHFDIKPHN+LL HNFIPKVSDFGLAKF+PKENDFVS+S  RGTIGYIAPELIS+N G+
Sbjct: 438 ILHFDIKPHNVLLHHNFIPKVSDFGLAKFYPKENDFVSVSTARGTIGYIAPELISKNLGS 497

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 307
           VSCKSDVY +G++LLEM GGRRN N +   S K +F SWVYD LN+GGDLEL +V E E+
Sbjct: 498 VSCKSDVYSYGILLLEMVGGRRNINPNGNSSGKVHFASWVYDHLNEGGDLELESVNEAEA 557

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
            IA+KLC++GLWCI   ++DRPSMTKV+EMLEG
Sbjct: 558 AIAKKLCIVGLWCINKNSSDRPSMTKVVEMLEG 590

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224101781|ref|XP_002312418.1| predicted protein [Populus trichocarpa] gi|222852238|gb|EEE89785.1| predicted protein [Populus trichocarpa]

 Score =  451 bits (1161), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 213/302 (70%), Positives = 246/302 (81%)

Query: 37  KRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKM 96
           K   N E FL NQQ  MPKRY++ +IIA+TN+F  KLGQGGFG+VYKGQL    L+AVKM
Sbjct: 5   KASGNEEIFLVNQQHLMPKRYTFSDIIAITNNFKDKLGQGGFGNVYKGQLRDAFLVAVKM 64

Query: 97  LANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKES 156
           L N+K + E+FINEVS IGRIHHVN+V+L+GFCSEGS RALV+EYM NGSLD+ +F +E+
Sbjct: 65  LGNAKCNDEDFINEVSIIGRIHHVNIVRLVGFCSEGSYRALVFEYMANGSLDKLLFSRET 124

Query: 157 RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
                 WEKL ++A+GTARGIE+LH GC VCILH DIKPHN+LLD NFIPKVSDFGLAKF
Sbjct: 125 ELLLVSWEKLLQIAVGTARGIEHLHGGCSVCILHLDIKPHNVLLDSNFIPKVSDFGLAKF 184

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT 276
           +P E DFVSIS TRGTIGY APE+ISRN G VSCKSDVY FGM+LLEMAG RR SN    
Sbjct: 185 YPSEKDFVSISTTRGTIGYFAPEMISRNLGAVSCKSDVYSFGMLLLEMAGRRRKSNSKGN 244

Query: 277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            SS  YFPSWVYD L++GGDLEL NVTEIE+ IARKLC+ GLWCIQ  A+DRP+MTKV+E
Sbjct: 245 CSSDVYFPSWVYDHLSEGGDLELENVTEIEAAIARKLCIAGLWCIQKAASDRPTMTKVVE 304

Query: 337 ML 338
           ML
Sbjct: 305 ML 306

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108395|ref|XP_002314832.1| predicted protein [Populus trichocarpa] gi|222863872|gb|EEF01003.1| predicted protein [Populus trichocarpa]

 Score =  446 bits (1147), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 210/304 (69%), Positives = 248/304 (81%)

Query: 37  KRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKM 96
           K +DN ++FL  QQ  MP+RYSY +IIA+TN+F +KLGQGGFG+VYKGQL  G  +AVKM
Sbjct: 5   KAIDNEQRFLRRQQHSMPRRYSYSDIIAITNNFENKLGQGGFGTVYKGQLRDGFSVAVKM 64

Query: 97  LANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKES 156
           L N K + E+FINEVS IGRIH VN+V L+GFCSEG  RALV+EYM NGSLD+ +F +E+
Sbjct: 65  LDNPKCNDEDFINEVSIIGRIHQVNIVWLMGFCSEGCHRALVFEYMANGSLDKLLFSREA 124

Query: 157 RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
                 WEKL ++ALGTARGIE+LH GC+VCILH DIKP N+LLD+NFIPKVSDFGL+KF
Sbjct: 125 ERHLVGWEKLLQIALGTARGIEHLHGGCNVCILHSDIKPQNVLLDNNFIPKVSDFGLSKF 184

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT 276
           +P+E DFVSIS TRGTIGYIAPE+ISRN G VSCKSDVY FGM+LLEMAG RRNSN    
Sbjct: 185 YPEEKDFVSISTTRGTIGYIAPEMISRNLGAVSCKSDVYSFGMLLLEMAGRRRNSNSKGN 244

Query: 277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            SS+ YFPSWVYD L +  DL+L NVTEIE+ I RKLC++GLWCIQ  A+DRPSMTKV+E
Sbjct: 245 CSSEVYFPSWVYDHLIERADLQLENVTEIEAGIPRKLCLVGLWCIQKAASDRPSMTKVVE 304

Query: 337 MLEG 340
           MLE 
Sbjct: 305 MLEA 308

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326508416|dbj|BAJ99475.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  429 bits (1103), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 208/339 (61%), Positives = 267/339 (78%), Gaps = 9/339 (2%)

Query: 7   FLVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVT 66
           F+  + ++ RF+LAP+V L+FL  +Y K+   +D VEKFL  QQ   P RY+Y +I A+T
Sbjct: 288 FVKWIAVLCRFVLAPLVVLIFLAHKYWKTRITIDAVEKFLRMQQMLGPMRYAYTDITAIT 347

Query: 67  NHFTHKLGQGGFGSVYKGQLHTGGL-IAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQ 124
           +HF  KLGQGG+GSV+KG L  G + +AVKML  N   +GE+FINEVSTIGRIHHVNVV+
Sbjct: 348 SHFRDKLGQGGYGSVFKGVLLPGNVHVAVKMLEGNPNCNGEDFINEVSTIGRIHHVNVVR 407

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L+GFCSE  +RALVYEYMP GSLD++IF   S G+SFCW+KL E+ALG ARGI+YLH GC
Sbjct: 408 LMGFCSEEMRRALVYEYMPQGSLDKYIF---SSGKSFCWDKLAEIALGIARGIDYLHQGC 464

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D+ ILHFDIKPHNILLD+NF+PKV+DFGLAK +P++N FV   A RGTIGYIAPE+ISR+
Sbjct: 465 DMQILHFDIKPHNILLDNNFVPKVADFGLAKLYPRDNSFVPSRALRGTIGYIAPEMISRS 524

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG---GDLELRN 301
           FG +S KSDVY FGM+LLEMAGGRRN++ +A  +S+AY+PSWVYD+L +    G++    
Sbjct: 525 FGAISSKSDVYSFGMLLLEMAGGRRNADPNAANTSQAYYPSWVYDRLTQQDHVGEIFAHV 584

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
            TE+  +  RKLC++GLWCIQ++  DRP+M+ V+EMLEG
Sbjct: 585 YTEMHEL-ERKLCIVGLWCIQMRCQDRPTMSDVIEMLEG 622

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|414876616|tpg|DAA53747.1| TPA: putative protein kinase superfamily protein [Zea mays]

 Score =  428 bits (1100), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 205/331 (61%), Positives = 254/331 (76%), Gaps = 10/331 (3%)

Query: 13  IIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHK 72
           I+ RF+ AP+  L FL  +Y K+   +D VEKFL  QQ+  P RY+Y +I A+T HF  K
Sbjct: 309 ILSRFVFAPLTVLTFLAYKYWKTRISIDAVEKFLQMQQALSPARYAYTDITAITGHFREK 368

Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           LGQGG+GSVY+G L     +AVKML+NS  +G+EFI+EVSTIG IHHVNVV+L+GFCSE 
Sbjct: 369 LGQGGYGSVYRGVLPGDVSVAVKMLSNSLCNGDEFISEVSTIGSIHHVNVVRLVGFCSEE 428

Query: 133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFD 192
           +KRAL+YEYMP GSLD+HIF  E   QSF W+KL+ +ALG ARGI YLH GC++ ILHFD
Sbjct: 429 TKRALIYEYMPRGSLDKHIFSSE---QSFSWDKLNGIALGIARGINYLHQGCEMQILHFD 485

Query: 193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 252
           IKPHNILLD++F PKV+DFGLAK +P++N FV +SA RGTIGYIAPE+ISRNFG VSCKS
Sbjct: 486 IKPHNILLDNSFTPKVADFGLAKLYPRDNSFVPVSAARGTIGYIAPEMISRNFGVVSCKS 545

Query: 253 DVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK---GGDLELRNVTEIESMI 309
           DVY FGM+LLEMAGGRRN + HA R S+ Y+P+WVY  L +   G   E  +V E+E   
Sbjct: 546 DVYSFGMLLLEMAGGRRNLDQHAERRSQTYYPAWVYSHLTRQEVGEICEAFDVHEVE--- 602

Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
            RKLC++GLWCIQ+K  DRP+M +V+ MLE 
Sbjct: 603 -RKLCVVGLWCIQMKPHDRPTMAEVVGMLEA 632

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357135051|ref|XP_003569125.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon]

 Score =  427 bits (1097), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 208/340 (61%), Positives = 268/340 (78%), Gaps = 6/340 (1%)

Query: 3   NGISFLVDVPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEI 62
           + I+ L  + ++ RF+LAP+V  +FL  +Y K+   +D VEKFL  QQ   P RY+Y +I
Sbjct: 304 SSIAILKFIFVLCRFVLAPMVVWIFLAYKYWKTRITIDVVEKFLRIQQMIGPTRYAYTDI 363

Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGL-IAVKML-ANSKFSGEEFINEVSTIGRIHHV 120
            A+T HF  KLGQGG+GSVYKG L  G + +AVKML  NS  +GE+FI+EVSTIGRIHHV
Sbjct: 364 TAITGHFRDKLGQGGYGSVYKGVLLPGDVHVAVKMLEGNSSCNGEDFISEVSTIGRIHHV 423

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           NVV+L+GFCSE  KRALVYEYMP+GSLD++IF  E   +SF W+KL+E+ALG ARGI YL
Sbjct: 424 NVVRLVGFCSEEMKRALVYEYMPHGSLDKYIFSAE---KSFSWDKLNEIALGIARGINYL 480

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H GCD+ ILHFDIKPHNILLD NF+PKV+DFGLAK +P++N FV +SA RGTIGYIAPE+
Sbjct: 481 HQGCDMQILHFDIKPHNILLDSNFVPKVADFGLAKLYPRDNSFVPLSALRGTIGYIAPEM 540

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR 300
           ISR+FG +S KSDVY FGM+LLEMAGGRRN++ +A RSS+AY+PSWVYDQL +    E+ 
Sbjct: 541 ISRSFGVISSKSDVYSFGMLLLEMAGGRRNADPNAARSSQAYYPSWVYDQLTQQEAGEIS 600

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
              ++  +  +KLC++GLWCIQ+K+ DRP+M++V+E+LE 
Sbjct: 601 PAADMHEL-EKKLCVVGLWCIQMKSHDRPTMSEVIEVLEA 639

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357130561|ref|XP_003566916.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon]

 Score =  426 bits (1096), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 205/333 (61%), Positives = 268/333 (80%), Gaps = 6/333 (1%)

Query: 11  VPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFT 70
           + ++ RF+LAP++ L+FL  +Y K+   +D VEKFL  QQ   P RY+Y +I+AVT+HF 
Sbjct: 294 IAVLCRFVLAPLMVLLFLAHKYWKTRITIDAVEKFLRMQQMIGPTRYTYTDIVAVTSHFR 353

Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
            KLGQGG+GSV+KG LH G + +AVKML + S  +GE+FI+EVSTIGRIHHVNVV L+GF
Sbjct: 354 DKLGQGGYGSVFKGVLHPGDVHVAVKMLDSKSNCNGEDFISEVSTIGRIHHVNVVCLIGF 413

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           CSE  +RALVYEYMP+GSLD++IF  E   +SF W+KL+E+ALG ARGI YLH GC++ I
Sbjct: 414 CSEEMRRALVYEYMPHGSLDKYIFSAE---KSFSWDKLNEIALGIARGINYLHQGCEMQI 470

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +HFDIKPHNILLD NF+PKV+DFGLAK +P++N FV +SA RGTIGYIAPE+ISR+FG +
Sbjct: 471 VHFDIKPHNILLDSNFVPKVADFGLAKLYPRDNSFVPLSALRGTIGYIAPEMISRSFGAI 530

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE-S 307
           S KSDVY FGM+LLEMAGGRRN + +A  SS++Y+PSWVYDQL +  +L   +V+  E  
Sbjct: 531 SSKSDVYSFGMLLLEMAGGRRNVDANAVNSSQSYYPSWVYDQLTRQEELGEISVSVAEMH 590

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
            + RKLC++GLWCIQ+++ DRP+M++V+EMLEG
Sbjct: 591 ELERKLCIVGLWCIQMRSQDRPTMSEVIEMLEG 623

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326509433|dbj|BAJ91633.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  422 bits (1085), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 203/334 (60%), Positives = 265/334 (79%), Gaps = 8/334 (2%)

Query: 11  VPIIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFT 70
           + ++ RF+LAP+  L+FL  +Y K+   +D VEKFL  QQ   P RY+Y +I A+T+HF 
Sbjct: 317 IAVLCRFVLAPMAVLIFLGYKYLKTRVTIDAVEKFLRLQQMLGPTRYAYTDITAITSHFR 376

Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
             LGQGG+GSV+KG L  G + +AVKML  NS  +GE+FI+EVSTIGRIHHVNVV+L+GF
Sbjct: 377 DMLGQGGYGSVFKGVLLPGNVHVAVKMLEGNSSCNGEDFISEVSTIGRIHHVNVVRLMGF 436

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           CSE  +RALVYEYMP GSLD++IF  E   + F W+KL+E+ALG ARGI YLH GCD+ I
Sbjct: 437 CSEEMRRALVYEYMPRGSLDKYIFSTE---KCFSWDKLNEIALGIARGINYLHQGCDMQI 493

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LHFDIKPHNILLD+NFIP+V+DFGLAK +P++N FV +SA RGTIGYIAPE+ISR+FG +
Sbjct: 494 LHFDIKPHNILLDNNFIPRVADFGLAKLYPRDNSFVPLSALRGTIGYIAPEMISRSFGAI 553

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG--GDLELRNVTEIE 306
           S KSDVY FGM+LLEM+GGRRN++ +A  SS+AY+PSWVYD+L +   G++     TE+ 
Sbjct: 554 SSKSDVYSFGMLLLEMSGGRRNADSNAATSSQAYYPSWVYDRLTQQDVGEISAPIATEMH 613

Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
            +  RKLC++GLWCIQ+++ DRP+M++V+EMLEG
Sbjct: 614 EL-ERKLCIVGLWCIQMRSHDRPTMSEVIEMLEG 646

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|13377503|gb|AAK20741.1| TAK33 [Triticum aestivum]

 Score =  422 bits (1084), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 204/330 (61%), Positives = 261/330 (79%), Gaps = 5/330 (1%)

Query: 13  IIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHK 72
           ++ RF+LAP+   +FL  +Y K+   +D VEKFL  QQ   P RYSY +I+AVT+HF  K
Sbjct: 334 VLCRFLLAPLAVWIFLAYKYMKTRIIIDAVEKFLRIQQMIGPARYSYTDIVAVTSHFRDK 393

Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           LGQGG+GSVYKG L  GG+ +AVKML  NS  +GE+FI+EVSTIGRIHHVNVV+L+GFCS
Sbjct: 394 LGQGGYGSVYKGVLLPGGVHVAVKMLEGNSNCNGEDFISEVSTIGRIHHVNVVRLVGFCS 453

Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
           E   RALVYEYMPNGSLD++IF  E   +SF WEKL+E+ALG ARGI YLH GCD+ ILH
Sbjct: 454 EEMLRALVYEYMPNGSLDKYIFSTE---KSFSWEKLNEIALGIARGINYLHQGCDMQILH 510

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
           FDIKPHNILLD NF+PKV+DFGLAK +P+ + FV +SA RGT+GYIAPE+ISR+FG +S 
Sbjct: 511 FDIKPHNILLDSNFVPKVADFGLAKLYPRGDSFVPLSAMRGTVGYIAPEMISRSFGVISS 570

Query: 251 KSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIA 310
           KSDVY FGM+LLEMAGGRRN++ +   SS+AY+PSWVYD+L +    E+ +V      + 
Sbjct: 571 KSDVYSFGMLLLEMAGGRRNADPNMGSSSQAYYPSWVYDRLTQEEAGEISDVAADMHELE 630

Query: 311 RKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           +KLC++GLWCIQ+++ DRP+M++V+E+LE 
Sbjct: 631 KKLCVVGLWCIQMRSRDRPTMSEVIEILEA 660

Source: Triticum aestivum

Species: Triticum aestivum

Genus: Triticum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434136|ref|NP_001041826.1| Os01g0114100 [Oryza sativa Japonica Group] gi|52076330|dbj|BAD45151.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|113531357|dbj|BAF03740.1| Os01g0114100 [Oryza sativa Japonica Group] gi|215687145|dbj|BAG90915.1| unnamed protein product [Oryza sativa Japonica Group]

 Score =  421 bits (1082), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 203/332 (61%), Positives = 260/332 (78%), Gaps = 8/332 (2%)

Query: 13  IIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHK 72
           ++ RF+LAP+   +FL  +Y ++   +D VEKFL  Q +  P RY+Y ++ A+T HF  K
Sbjct: 292 VLCRFVLAPLAVFIFLAHKYWRNKITIDAVEKFLQMQLTLGPTRYAYTDLTAITGHFGEK 351

Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           LGQGG+GSVYKG L     +AVK+L N+  +GEEFI+EVSTIGRIHHVNVV+L+GFCSE 
Sbjct: 352 LGQGGYGSVYKGVLPGYVNVAVKVLENANCNGEEFISEVSTIGRIHHVNVVRLVGFCSEE 411

Query: 133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFD 192
            +RALVYEYMP GSLD++IF   S  +SF W+KL+E+ALG ARGI YLH GCD+ ILHFD
Sbjct: 412 LRRALVYEYMPRGSLDKYIF---SSKRSFSWDKLNEIALGIARGINYLHQGCDMQILHFD 468

Query: 193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 252
           IKPHNILLD NF+PKV+DFGLAK +P++N FV ++A RGTIGYIAPE+ISR+FG +S KS
Sbjct: 469 IKPHNILLDDNFVPKVADFGLAKLYPRDNSFVPLNALRGTIGYIAPEMISRSFGVISSKS 528

Query: 253 DVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG----GDLELRNVTEIESM 308
           DVY FGM+LLEMAGGRRNS+MHA  SS+AY+PSWVYD+L +     G++    V  +  +
Sbjct: 529 DVYSFGMLLLEMAGGRRNSDMHAGNSSQAYYPSWVYDRLIEQQVGVGEISAATVANMHEL 588

Query: 309 IARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
             RKLC+IGL CIQ+K+ DRP+M++V+EMLEG
Sbjct: 589 -ERKLCIIGLHCIQMKSHDRPTMSEVIEMLEG 619

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	340
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.952	0.487	0.482	3.3e-79
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.941	0.480	0.475	1.1e-78
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.944	0.376	0.470	6.2e-78
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.932	0.355	0.491	2.7e-77
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.970	0.489	0.471	2.1e-75
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.970	0.517	0.462	3.5e-75
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.944	0.394	0.453	1.2e-74
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.935	0.397	0.463	6.5e-74
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.908	0.383	0.48	6.5e-74
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.979	0.405	0.442	4.3e-70

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 796 (285.3 bits), Expect = 3.3e-79, P = 3.3e-79
 Identities = 161/334 (48%), Positives = 220/334 (65%)

Query:    13 IIGRFILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSW-MPKRYSYPEIIAVTNHFTH 71
             I+G  + A +  ++ ++       K + N E    N ++  M KRYSY  +  +TN F H
Sbjct:   278 IVG--VSAALTLMILIVVVIIVRTKNMRNSEWNDQNVEAVAMLKRYSYTRVKKMTNSFAH 335

Query:    72 KLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
              LG+GGFG+VYKG+L   G  +AVK+L  S+ +GEEFINEV+++ R  HVN+V LLGFC 
Sbjct:   336 VLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFCY 395

Query:   131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
             E +KRA++YE+MPNGSLD++I    S      WE+L++VA+G +RG+EYLHN C   I+H
Sbjct:   396 EKNKRAIIYEFMPNGSLDKYISANMSTKME--WERLYDVAVGISRGLEYLHNRCVTRIVH 453

Query:   191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
             FDIKP NIL+D N  PK+SDFGLAK    +   +S+   RGT GYIAPE+ S+NFG VS 
Sbjct:   454 FDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSH 513

Query:   251 KSDVYGFGMVLLEMAGGRRNSNMHATRSSKA--YFPSWVYDQLNKGGDLEL--RNVTEIE 306
             KSDVY +GMV+LEM G +    +  + S+    YFP WVY    KG    +   ++T+ E
Sbjct:   514 KSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEE 573

Query:   307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
               IA+KL ++ LWCIQ+  +DRP M KV+EMLEG
Sbjct:   574 EKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEG 607

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
 Identities = 158/332 (47%), Positives = 227/332 (68%)

Query:    18 ILAPIVFLVFLIQRYRKSLK--RV-DNVEKFLHNQQSWMP-KRYSYPEIIAVTNHFTHKL 73
             ++  +  L  LI+R RK+L   R+  + +    N ++ +P K YSY ++ ++T  F   +
Sbjct:   295 VILVVTCLNCLIRRQRKTLNDPRMRTSDDSRQQNLKALIPLKHYSYAQVTSITKSFAEVI 354

Query:    74 GQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS 133
             G+GGFG+VY+G L+ G  +AVK+L  S+ +GE+FINEV+++ +  HVN+V LLGFCSEG 
Sbjct:   355 GKGGFGTVYRGTLYDGRSVAVKVLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGY 414

Query:   134 KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDI 193
             KRA++YE+M NGSLD+ I  K+S   +  W +L+ +ALG ARG+EYLH+GC   I+HFDI
Sbjct:   415 KRAIIYEFMENGSLDKFISSKKS--STMDWRELYGIALGVARGLEYLHHGCRTRIVHFDI 472

Query:   194 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSD 253
             KP N+LLD N  PKVSDFGLAK   ++   +S+  TRGTIGYIAPE+ SR +G VS KSD
Sbjct:   473 KPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSD 532

Query:   254 VYGFGMVLLEMAGGRRNSNMHATRSSKA--YFPSWVYDQLNK---GGDLELRNVTEIESM 308
             VY +GM++L++ G R  ++   T SS +  YFP W+Y  L K   G  +E   ++  E  
Sbjct:   533 VYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRDLEKAHNGKSIETA-ISNEEDE 591

Query:   309 IARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
             IA+K+ ++GLWCIQ    DRP+M +V+EM+EG
Sbjct:   592 IAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEG 623

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 6.2e-78, P = 6.2e-78
 Identities = 162/344 (47%), Positives = 224/344 (65%)

Query:    12 PIIGR----FILAPIVFLVFLIQ-RY--RKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIA 64
             PI+G      +L  IV +  +++ R+  RKS    +N+E  +      M KRYS+ ++  
Sbjct:   463 PILGGSAALIVLISIVVIALVVRARHAKRKSELNDENIEAVV------MLKRYSFEKVKK 516

Query:    65 VTNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV 122
             +TN F H +G+GGFG+VYKG+L   +G  IA+K+L  SK +GEEFINE+ ++ R  HVN+
Sbjct:   517 MTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINELVSMSRASHVNI 576

Query:   123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
             V L GFC EGS+RA++YE+MPNGSLD+ I   E+      W+ L+ +A+G ARG+EYLHN
Sbjct:   577 VSLFGFCYEGSQRAIIYEFMPNGSLDKFI--SENMSTKIEWKTLYNIAVGVARGLEYLHN 634

Query:   183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              C   I+HFDIKP NIL+D +  PK+SDFGLAK   K+   +S+   RGT+GYIAPE+ S
Sbjct:   635 SCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFS 694

Query:   243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMH--ATRSSKAYFPSWVYDQLNKGGDLELR 300
             +N+G VS KSDVY +GMV+LEM G  +   +   AT  S  YFP WVY+ L +   + L 
Sbjct:   695 KNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVYEDLERKETMRLL 754

Query:   301 N----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
                    E E  I +++ ++GLWCIQ   +DRP M KV+EMLEG
Sbjct:   755 EDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEG 798

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 778 (278.9 bits), Expect = 2.7e-77, P = 2.7e-77
 Identities = 165/336 (49%), Positives = 221/336 (65%)

Query:    22 IVFLVFLIQRYRKSL--KRVDNVEKFLHNQQSWMP-KRYSYPEIIAVTNHFTHKLGQGGF 78
             IVFLV L   +R  +  KR  + E  L   ++ +P K Y+Y E+  +T  FT  +G+GGF
Sbjct:   508 IVFLVLLCPCFRVQIFRKRKTSDEVRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGF 567

Query:    79 GSVYKGQLHTGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL 137
             G VY G L    ++AVK+L +SK + GE+FINEV+++ +  HVN+V LLGFC EGS+RA+
Sbjct:   568 GIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAI 627

Query:   138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN 197
             +YE++ NGSLD+ I  K S       + L+ +ALG ARG+EYLH GC   I+HFDIKP N
Sbjct:   628 IYEFLGNGSLDKFISDKSSVNLDL--KTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQN 685

Query:   198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 257
             +LLD N  PKVSDFGLAK   K+   +S+  TRGTIGYIAPE+ISR +G+VS KSDVY +
Sbjct:   686 VLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSY 745

Query:   258 GMVLLEMAGGRRNSNMHA-TRS--SKAYFPSWVYDQLNKGG--DLE-------LRN-VTE 304
             GM++LEM G R+       +RS  S  YFP W+Y  L K    D+E       + N ++ 
Sbjct:   746 GMLVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISS 805

Query:   305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
              E  IARK+ ++GLWCIQ   +DRP M KV+EM+EG
Sbjct:   806 EEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEG 841

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 760 (272.6 bits), Expect = 2.1e-75, P = 2.1e-75
 Identities = 163/346 (47%), Positives = 221/346 (63%)

Query:     5 ISFLVDVPIIGRFILAPIVFLVFLIQ--RYRKSLKRVDNVEKFLHNQQSWMP-KRYSYPE 61
             I   V +  IG FI     FLV L    + R    R  + ++     ++ +P K Y+Y +
Sbjct:   285 IGIFVALCTIGGFI----AFLVLLCPCCKVRIFRNRKTSDDRRQEKLKALIPLKHYTYAQ 340

Query:    62 IIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHV 120
             +  +T  F   +G+GGFG VY+G L  G ++AVK+L  SK +  E+FINEVS++ +  HV
Sbjct:   341 VKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINEVSSMSQTSHV 400

Query:   121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
             N+V LLGFCSEGS+RA++YE++ NGSLD+ I  K S         L+ +ALG ARG+EYL
Sbjct:   401 NIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVILDLT--ALYGIALGVARGLEYL 458

Query:   181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
             H GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+  TRGTIGYIAPE+
Sbjct:   459 HYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTIGYIAPEM 518

Query:   241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM--HATRSSKAYFPSWVYDQLNKG--GD 296
             ISR +G+VS KSDVY +GM++ EM G R+      ++   S  YFP W+Y  L K   GD
Sbjct:   519 ISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKDLEKADNGD 578

Query:   297 LE-LR-NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
             LE +   ++  E  IA+K+ ++GLWCIQ   +DRP M KV+EM+EG
Sbjct:   579 LEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEG 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 758 (271.9 bits), Expect = 3.5e-75, P = 3.5e-75
 Identities = 160/346 (46%), Positives = 218/346 (63%)

Query:     1 MGNGISFLVDVPIIGRFILAPIVFLVFLIQRYRKS--LKRVDNVEKFLHNQQSWMPKRYS 58
             MG GI   +    +G  ++  +  L F  Q+ R S  L+  DN  K L        K+YS
Sbjct:   261 MGIGIG--LGCGFLGATLIT-VCLLCFFFQKRRTSHHLRPRDNNLKGLVQL-----KQYS 312

Query:    59 YPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH 118
             Y E+  +T  F+H LG+GGFG+VY G L  G  +AVK+L + K +GE+FINEV+++ +  
Sbjct:   313 YAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFINEVASMSQTS 372

Query:   119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
             HVN+V LLGFC EGSKRA+VYE++ NGSLD+ +  K+S         L+ +ALG ARG++
Sbjct:   373 HVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKKSLNLDV--STLYRIALGVARGLD 430

Query:   179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
             YLH+GC   I+HFDIKP NILLD  F PKVSDFGLAK   K    +S+   RGTIGYIAP
Sbjct:   431 YLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGYIAP 490

Query:   239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMHATRSSKAYFPSWVYDQLNKGGD 296
             E+ S  +G VS KSDVY +GM++LEM G +        A+ SS AYFP W+Y  L  G D
Sbjct:   491 EVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFPDWIYKNLENGED 550

Query:   297 LEL--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
                    ++  +  +A+K+ ++GLWCIQ    +RP M +++EM+EG
Sbjct:   551 TWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEG 596

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
 Identities = 151/333 (45%), Positives = 216/333 (64%)

Query:    13 IIGRFI-LAPIVFLVFLI--QRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHF 69
             ++G  I LA  + ++ L+  Q  RK  K+ ++V  F       + K+Y Y E+  +T  F
Sbjct:   444 VVGSVIGLATFIVIIMLLIRQMKRKKNKKENSVIMF-----KLLLKQYIYAELKKITKSF 498

Query:    70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
             +H +G+GGFG+VY+G L  G  +AVK+L + K +G++FINEV+++ +  HVN+V LLGFC
Sbjct:   499 SHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFC 558

Query:   130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
              EGSKRA++ E++ +GSLD+ I   +S   +     L+ +ALG ARG+EYLH GC   I+
Sbjct:   559 YEGSKRAIISEFLEHGSLDQFISRNKSLTPNVT--TLYGIALGIARGLEYLHYGCKTRIV 616

Query:   190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
             HFDIKP NILLD NF PKV+DFGLAK   K    +S+  TRGTIGYIAPE++SR +G +S
Sbjct:   617 HFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGIS 676

Query:   250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL--RNVTEIES 307
              KSDVY +GM++L+M G R          S AYFP W+Y  L  G    +    + E ++
Sbjct:   677 HKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDN 736

Query:   308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
              I +K+ ++ LWCI+   +DRP M KV+EM+EG
Sbjct:   737 KIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEG 769

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 746 (267.7 bits), Expect = 6.5e-74, P = 6.5e-74
 Identities = 153/330 (46%), Positives = 214/330 (64%)

Query:    18 ILAPIVFLVFLIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGG 77
             +LA ++ +V + +    ++++ D  EK +  +   M KR+SY ++  +T  F + LG+GG
Sbjct:   412 VLATMIIIVIVGKVRANNMRKSDLNEKNM--EAVVMLKRFSYVQVKKMTKSFENVLGKGG 469

Query:    78 FGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA 136
             FG+VYKG+L  G   +AVK+L  S   GE+FINE++++ R  H N+V LLGFC EG K+A
Sbjct:   470 FGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGFCYEGRKKA 529

Query:   137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH 196
             ++YE MPNGSLD+ I    S      W+ L+ +A+G + G+EYLH+ C   I+HFDIKP 
Sbjct:   530 IIYELMPNGSLDKFISKNMSAKME--WKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQ 587

Query:   197 NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG 256
             NIL+D +  PK+SDFGLAK        +S+   RGTIGYIAPE+ S+NFG VS KSDVY 
Sbjct:   588 NILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSDVYS 647

Query:   257 FGMVLLEMAGGR---RNSNMHATRSSKAYFPSWVYDQLNKGGDLELR--NVTEIES-MIA 310
             +GMV+LEM G R   R  N  ++ +S  YFP W+Y  L KG  +      +TE E   I 
Sbjct:   648 YGMVVLEMIGARNIGRAQNAGSSNTSM-YFPDWIYKDLEKGEIMSFLADQITEEEDEKIV 706

Query:   311 RKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
             +K+ ++GLWCIQ    DRP M+KV+EMLEG
Sbjct:   707 KKMVLVGLWCIQTNPYDRPPMSKVVEMLEG 736

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 746 (267.7 bits), Expect = 6.5e-74, P = 6.5e-74
 Identities = 156/325 (48%), Positives = 212/325 (65%)

Query:    22 IVFLVFLIQRYRKSLK--RVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFG 79
             +V ++++ Q  RK+ K  RV   +K L+         Y+Y E+  +T  F++ +G+GGFG
Sbjct:   459 VVLMLWMRQMKRKNRKEERVVMFKKLLN--------MYTYAELKKITKSFSYIIGKGGFG 510

Query:    80 SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY 139
             +VY G L  G  +AVK+L + K S E+FINEV+++ +  HVN+V LLGFC EGSKRA+VY
Sbjct:   511 TVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQTSHVNIVSLLGFCFEGSKRAIVY 570

Query:   140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL 199
             E++ NGSLD+ +   +S  Q      L+ +ALG ARG+EYLH GC   I+HFDIKP NIL
Sbjct:   571 EFLENGSLDQFMSRNKSLTQDVT--TLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNIL 628

Query:   200 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 259
             LD N  PKVSDFGLAK   K    +S+  TRGTIGYIAPE+ SR +G VS KSDVY FGM
Sbjct:   629 LDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSHKSDVYSFGM 688

Query:   260 VLLEMAGGRRNSNMHATRS--SKAYFPSWVYDQLNKGGDLEL--RNVTEIESMIARKLCM 315
             ++++M G R    +    S  S  YFP W+Y  L  G    +    +T+ E  IA+K+ +
Sbjct:   689 LVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTWIFGDEITKEEKEIAKKMIV 748

Query:   316 IGLWCIQVKAADRPSMTKVLEMLEG 340
             +GLWCIQ   +DRPSM +V+EM+EG
Sbjct:   749 VGLWCIQPCPSDRPSMNRVVEMMEG 773

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 710 (255.0 bits), Expect = 4.3e-70, P = 4.3e-70
 Identities = 154/348 (44%), Positives = 218/348 (62%)

Query:     2 GNGISFLVDVPIIGRFILAPIVFLVFLIQRYRKSL----KRVDNVEKFLHNQQSWMPKRY 57
             G    ++V + ++  FI+A ++F+ F I + +K +    +     + FL N  S MP R+
Sbjct:   425 GKHFPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENL-SGMPIRF 483

Query:    58 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI 117
             +Y ++ + TN+F+ KLGQGGFGSVY+G L  G  +AVK L       +EF  EVS IG I
Sbjct:   484 AYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSI 543

Query:   118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
             HH+++V+L GFC+EG+ R L YE++  GSL+R IF K+       W+    +ALGTA+G+
Sbjct:   544 HHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGL 603

Query:   178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
              YLH  CD  I+H DIKP NILLD NF  KVSDFGLAK   +E   V  +  RGT GY+A
Sbjct:   604 AYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLA 662

Query:   238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG-- 295
             PE I+ N+  +S KSDVY +GMVLLE+ GGR+N +   T S K +FPS+ + ++ +G   
Sbjct:   663 PEWIT-NYA-ISEKSDVYSYGMVLLELIGGRKNYDPSET-SEKCHFPSFAFKKMEEGKLM 719

Query:   296 ---DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
                D +++NV   +  + R +    LWCIQ     RPSM+KV++MLEG
Sbjct:   720 DIVDGKMKNVDVTDERVQRAM-KTALWCIQEDMQTRPSMSKVVQMLEG 766

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	340
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-32
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	8e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  166 bits (422), Expect = 1e-49
 Identities = 85/281 (30%), Positives = 131/281 (46%), Gaps = 36/281 (12%)

Query: 69  FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVN 121
              KLG+G FG VYKG L          +AVK L         EEF+ E   + ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +V+LLG C+E     +V EYMP G L  ++  +++R +      L   AL  ARG+EYL 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                  +H D+   N L+  N + K+SDFGL++    ++D+  +   +  I ++APE  
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPE-- 174

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
           S   G  + KSDV+ FG++L E+   G      M             V + L KG  L  
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---------VLEYLKKGYRLPK 225

Query: 300 RNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                 E+  ++        L C      DRP+ ++++E+L
Sbjct: 226 PPNCPPELYKLM--------LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (416), Expect = 9e-49
 Identities = 84/279 (30%), Positives = 128/279 (45%), Gaps = 33/279 (11%)

Query: 69  FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVN 121
              KLG+G FG VYKG+L          +AVK L         EEF+ E   + ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           VV+LLG C+E     +V EYM  G L  ++  +++R +      L   AL  ARG+EYL 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPK-LSLSDLLSFALQIARGMEYLE 119

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                  +H D+   N L+  N + K+SDFGL++    + D+      +  I ++APE  
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPE-- 173

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
           S   G  + KSDV+ FG++L E+   G +    M             V + L  G  L  
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLEYLKNGYRL-- 222

Query: 300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                       +L  + L C      DRP+ ++++E+L
Sbjct: 223 ----PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  160 bits (408), Expect = 2e-47
 Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 38/283 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHV 120
               KLG+G FG VYKG L      T   +AVK L         EEF+ E S + ++ H 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           N+V+LLG C++G    +V EYMP G L   +      G+    + L ++AL  A+G+EYL
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                   +H D+   N L+  N + K+SDFGL++   +++ +      +  I ++APE 
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           +    G  + KSDV+ FG++L E+   G +    M             V + L  G  L 
Sbjct: 176 L--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLELLEDGYRLP 224

Query: 299 LRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
            R      E+  ++ +        C      DRP+ ++++E L
Sbjct: 225 -RPENCPDELYELMLQ--------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (403), Expect = 8e-47
 Identities = 83/278 (29%), Positives = 130/278 (46%), Gaps = 32/278 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFI---NEVSTIGRIHHVNVV 123
               KLG G FG+VYK +   TG ++AVK+L       ++      E+  + R+ H N+V
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-N 182
           +L+    +     LV EY   G L  ++    SRG     ++  ++AL   RG+EYLH N
Sbjct: 62  RLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
           G    I+H D+KP NILLD N + K++DFGLAK   K +  ++     GT  Y+APE++ 
Sbjct: 118 G----IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMAPEVLL 171

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
              G    K DV+  G++L E+  G+      N+             +  +   G  LE 
Sbjct: 172 GGNG-YGPKVDVWSLGVILYELLTGKPPFSGENILD--------QLQLIRR-ILGPPLEF 221

Query: 300 RNVTEIESMI-ARKLCMIGLWCIQVKAADRPSMTKVLE 336
                      A+ L      C+    + RP+  ++L+
Sbjct: 222 DEPKWSSGSEEAKDLI---KKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  155 bits (395), Expect = 3e-46
 Identities = 65/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+GGFG+VY  +   TG  +A+K++   +S    EE + E+  + +++H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            + +   LV EY   GSL   +   +        +++  + L    G+EYLH+     I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHS---NGII 114

Query: 190 HFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           H D+KP NILLD  N   K++DFGL+K    +   +      GT  Y+APE++    G  
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGK-GYY 171

Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++  G++L E+
Sbjct: 172 SEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  150 bits (382), Expect = 1e-43
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 21/203 (10%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGF 128
           KLG+G FG VY  +   TG L+A+K++   K     E  + E+  + ++ H N+V+L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
             +  K  LV EY   G L   +     +      ++           +EYLH      I
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLH---SKGI 118

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELISRNF 245
           +H D+KP NILLD +   K++DFGLA+      K   FV      GT  Y+APE++    
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV------GTPEYMAPEVLLGK- 171

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                  D++  G++L E+  G+
Sbjct: 172 -GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  147 bits (373), Expect = 2e-42
 Identities = 83/284 (29%), Positives = 133/284 (46%), Gaps = 39/284 (13%)

Query: 72  KLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQL 125
           KLG+G FG VYKG+L         +AVK L       E  +F+ E   + ++ H NVV+L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 126 LGFCSEGSKRALVYEYMPNGSLD------RHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           LG C+E     LV EYM  G L       R +FP   +  +   + L   A+  A+G+EY
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEK-STLSLKDLLSFAIQIAKGMEY 120

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           L +      +H D+   N L+  + + K+SDFGL++    ++ +   +  +  I ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL 297
            +    G  + KSDV+ FG++L E+   G      +             V + L KG  L
Sbjct: 178 SL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---------VLEYLRKGYRL 226

Query: 298 EL-RNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                   E+  ++        L C Q+   DRP+ ++++E LE
Sbjct: 227 PKPEYCPDELYELM--------LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  132 bits (335), Expect = 9e-37
 Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 27/211 (12%)

Query: 71  HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLL 126
             LG+G FGSVY      TG L+AVK +  S  S EE      E+  +  + H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 127 GFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHE--VALGTA---RGIEY 179
           G   +  K  L    EY+  GSL   +   +  G      KL E  +   T     G+ Y
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFG------KLPEPVIRKYTRQILEGLAY 116

Query: 180 LH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           LH NG    I+H DIK  NIL+D + + K++DFG AK            + RGT  ++AP
Sbjct: 117 LHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           E+I          +D++  G  ++EMA G+ 
Sbjct: 173 EVIRG--EEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  119 bits (301), Expect = 6e-32
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLA-NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
            K+G+GGFG VYK     TG  +A+K++   SK   E+ INE+  + +  H N+V+  G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDVC 187
             +  +  +V E+   GSL   +   +S  Q+    ++  V     +G+EYLH NG    
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSNG---- 118

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H DIK  NILL  +   K+ DFGL+          ++    GT  ++APE+I+     
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING--KP 173

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K+D++  G+  +E+A G+
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 3e-30
 Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 15/204 (7%)

Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQLL 126
           +G G FG V +G+L   G     +A+K L       +  +F+ E S +G+  H N+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     ++ EYM NGSLD+  F +E+ G+ F   +L  +  G A G++YL    ++
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDK--FLRENDGK-FTVGQLVGMLRGIASGMKYL---SEM 125

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   NIL++ N + KVSDFGL++         +    +  I + APE I+  + 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA--YR 183

Query: 247 TVSCKSDVYGFGMVLLE-MAGGRR 269
             +  SDV+ FG+V+ E M+ G R
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  115 bits (288), Expect = 4e-30
 Identities = 78/275 (28%), Positives = 132/275 (48%), Gaps = 32/275 (11%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
              ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C+E S   LV+E+M +G L  ++  +  RG  F  E L  + L    G+ YL +     +
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRG-KFSQETLLGMCLDVCEGMAYLESS---NV 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFS--FSKY 178

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG-----GDLELRNVT 303
           S KSDV+ FG+++ E+    +    +  RS+     S V + +N G       L  ++V 
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTP--YENRSN-----SEVVETINAGFRLYKPRLASQSVY 231

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
           E+              C + +  DRPS + +L  L
Sbjct: 232 ELMQ-----------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (283), Expect = 3e-29
 Identities = 66/194 (34%), Positives = 99/194 (51%), Gaps = 10/194 (5%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           KLG G FG V++G       +A+K+L ++     ++F  EV  + R+ H +++ L   CS
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
            G    ++ E M  GSL    F +   GQ      L ++A   A G+ YL    +   +H
Sbjct: 73  VGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            D+   NIL+  + + KV+DFGLA+   KE D    S  +    + APE  S   GT S 
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARL-IKE-DVYLSSDKKIPYKWTAPEAASH--GTFST 183

Query: 251 KSDVYGFGMVLLEM 264
           KSDV+ FG++L EM
Sbjct: 184 KSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  113 bits (282), Expect = 2e-28
 Identities = 78/276 (28%), Positives = 117/276 (42%), Gaps = 19/276 (6%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS----GEEFINEVSTIGRI-HHVNVVQLL 126
           KLG+G FG VY  +     L+A+K+LA    S     E F+ E+  +  + H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV EY+  GSL   +  K  R       +   +       +EYLH     
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120

Query: 187 CILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELI 241
            I+H DIKP NILLD +  + K+ DFGLAK  P      SI A      GT GY+APE++
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 242 SR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR 300
              +    S  SD++  G+ L E+  G         ++S A   +           L   
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPF--EGEKNSSATSQTLKIILELPTPSLASP 238

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                  +I++    +    +     +R S +  L 
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 3e-28
 Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 9/196 (4%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V+ G+      +A+KM+     S ++FI E   + ++ H N+VQL G 
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V EYM NG L  ++  ++ +  +   E L ++       +EYL +      
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESN---GF 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  + + KVSDFGLA++   ++ + S   T+  + +  PE+   ++   
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPEVF--DYSRF 178

Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (275), Expect = 6e-28
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 26/210 (12%)

Query: 69  FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIH 118
           F  +LG+G FG V   +      +TG  +AVK L     SGEE     F  E+  +  + 
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSGEEQHRSDFEREIEILRTLD 64

Query: 119 HVNVVQLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           H N+V+  G C +   R+  L+ EY+P+GSL R    +     +   ++L   +    +G
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQINL--KRLLLFSSQICKG 121

Query: 177 IEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IG 234
           ++YL +       +H D+   NIL++   + K+SDFGLAK  P++ D+  +     + I 
Sbjct: 122 MDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + APE +  +    S  SDV+ FG+ L E+
Sbjct: 178 WYAPECLRTS--KFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 3e-27
 Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 8/193 (4%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+ G  +    +AVK L     S E F+ E   + ++ H  +VQL   CSE
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ YL +      +H 
Sbjct: 73  EEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D+   NIL+  N + K++DFGLA+   +++++ +    +  I + APE    N+G  + K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEAA--NYGRFTIK 184

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 185 SDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  107 bits (268), Expect = 3e-27
 Identities = 82/274 (29%), Positives = 126/274 (45%), Gaps = 30/274 (10%)

Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++     + + + +  +  I + APE  S  +   S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 183

Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP----SWVYDQLNKGGDLELRNVTEI 305
            KSDV+ FG++L E+          AT     Y P    S VY+ L KG  +E       
Sbjct: 184 IKSDVWAFGVLLWEI----------ATYGMSPY-PGIDLSQVYELLEKGYRMER------ 226

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 K+  +   C Q   +DRPS  ++ +  E
Sbjct: 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  105 bits (264), Expect = 2e-26
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLG 127
           ++G+G FG VY  +    G L  +K +  S  S +E    +NEV  + +++H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              E  K  +V EY   G L + I  ++  G+ F  E++ +  +     ++YLH      
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---N 244
           ILH DIKP NI L  N + K+ DFG++K     +         GT  Y++PEL      N
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELCQNKPYN 181

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRR---NSNMHATRSSKAYFPSWVYDQLNKGGDLELRN 301
           +     KSD++  G VL E+   +      N+             +  ++ KG       
Sbjct: 182 Y-----KSDIWSLGCVLYELCTLKHPFEGENLLE-----------LALKILKG------Q 219

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
              I S  + +L  +    +Q    +RPS+ ++L+ 
Sbjct: 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 2e-26
 Identities = 76/282 (26%), Positives = 131/282 (46%), Gaps = 47/282 (16%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFC 129
           K+G+G FG VYKG L     +AVK   ++       +F+ E   + +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            +     +V E +P GSL   +  K++R      +KL +++L  A G+EYL +    CI 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKN--CI- 115

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTI--GYIAPELISRNFG 246
           H D+   N L+  N + K+SDFG+++   +E   + ++S     I   + APE +  N+G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEAL--NYG 170

Query: 247 TVSCKSDVYGFGMVLLEM----AGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             + +SDV+ +G++L E            +   TR           +++  G        
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------ERIESGY------- 212

Query: 303 TEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
                M A +LC      + L C      +RPS +++   L+
Sbjct: 213 ----RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 5e-26
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 12/206 (5%)

Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           EI   +     KLG G FG V++G  +    +AVK L       ++F+ E   + ++ H 
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            ++QL   C+      +V E M  GSL  ++  +   G++    +L ++A   A G+ YL
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 181 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              N      +H D+   N+L+  N I KV+DFGLA+   KE+ + +    +  I + AP
Sbjct: 120 EAQN-----YIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAP 173

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E     +   S KSDV+ FG++L E+
Sbjct: 174 EAA--LYNRFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 1e-25
 Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 15/198 (7%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G FG V  G  + G  +AVK L +   + + F+ E S +  + H N+VQLLG
Sbjct: 9   KLGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQS-FCWEKLHEVALGTARGIEYLHNGCDV 186
              +G+   +V EYM  GSL  ++    SRG++     +    AL    G+EYL      
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK--- 121

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   N+L+  + + KVSDFGLAK   +  D     + +  + + APE +     
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALRE--K 174

Query: 247 TVSCKSDVYGFGMVLLEM 264
             S KSDV+ FG++L E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (255), Expect = 3e-25
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 37/213 (17%)

Query: 71  HKLGQGGFGSVYKGQLH--TGGLIAVKMLA-NSKFSGEEFI-NEVSTIGRIHHVNVVQLL 126
             LGQG  G VYK + H  TG + A+K +  +      + +  E+ T+       VV+  
Sbjct: 7   KVLGQGSSGVVYKVR-HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 127 G-FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA-----RGIEYL 180
           G F  EG    +V EYM  GSL   +             K+ E  L        +G++YL
Sbjct: 66  GAFYKEGEIS-IVLEYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYL 115

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISATRGTIGYI 236
           H      I+H DIKP N+L++     K++DFG++K       + N FV      GT+ Y+
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYM 167

Query: 237 APELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +PE I   ++      +D++  G+ LLE A G+
Sbjct: 168 SPERIQGESYSY---AADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  101 bits (254), Expect = 8e-25
 Identities = 67/210 (31%), Positives = 95/210 (45%), Gaps = 31/210 (14%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
              K+G+G  G VYK     TG  +A+K +   K + E  INE+  +    H N+V    
Sbjct: 23  NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 128 FCSEGSKRALVYEYMPNGSL----DRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLH- 181
               G +  +V EYM  GSL     ++     E +    C E L        +G+EYLH 
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL--------QGLEYLHS 134

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIA 237
                  +H DIK  NILL  +   K++DFG A    K   K N  V      GT  ++A
Sbjct: 135 QNV----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWMA 184

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           PE+I R       K D++  G++ +EMA G
Sbjct: 185 PEVIKRK--DYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 8e-25
 Identities = 82/279 (29%), Positives = 129/279 (46%), Gaps = 47/279 (16%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVK--MLANSKFSGEEFIN----EVSTIGRIHHVNVVQL 125
           LG G FGSVY+G  L  G   AVK   LA+   +G+E +     E++ + ++ H N+VQ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR---GIEYLHN 182
           LG   E     +  E +P GSL           + +       + L T +   G+EYLH+
Sbjct: 68  LGTEREEDNLYIFLELVPGGSL-------AKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                 +H DIK  NIL+D N + K++DFG+AK    E  F    + +G+  ++APE+I+
Sbjct: 121 RN---TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSF--AKSFKGSPYWMAPEVIA 174

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW-----VYDQLNKGGDL 297
           +  G     +D++  G  +LEMA G+               P W     V      G   
Sbjct: 175 QQ-GGYGLAADIWSLGCTVLEMATGK---------------PPWSQLEGVAAVFKIGRSK 218

Query: 298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           EL  + +  S  A+   +    C+Q   + RP+  ++LE
Sbjct: 219 ELPPIPDHLSDEAKDFILK---CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 72/260 (27%), Positives = 115/260 (44%), Gaps = 36/260 (13%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE-----------FINEVSTIGRIHHV 120
           +G+G +G VY    + TG ++AVK +                      +E+ T+  + H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGS----LDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           N+VQ LGF +     ++  EY+P GS    L  +   +E   + F  + L         G
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL--------EG 120

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YLH+     ILH D+K  N+L+D + I K+SDFG++K      D     + +G++ ++
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMHA--------TRSSKAYFPSWV 287
           APE+I       S K D++  G V+LEM  GRR  S+  A         + S    P  V
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237

Query: 288 YDQLNKGGDLELRNVTEIES 307
              L+      L     I  
Sbjct: 238 SMNLSPVALDFLNACFTINP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 78/291 (26%), Positives = 126/291 (43%), Gaps = 51/291 (17%)

Query: 73  LGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQL 125
           LG+G FGSV +GQL     +   +AVK +     +    EEF++E + +    H NV++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 126 LGFCSEGSKRA------LVYEYMPNGSLDRHIFPKESRGQS--FCWEKLHEVALGTARGI 177
           +G C E S         ++  +M +G L   +      G       + L +  +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           EYL N      +H D+   N +L  +    V+DFGL+K     + +      +  + +IA
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP----SWVYDQLNK 293
            E ++    T   KSDV+ FG+ + E+          ATR    Y P      +YD L  
Sbjct: 184 IESLADRVYTS--KSDVWAFGVTMWEI----------ATRGQTPY-PGVENHEIYDYLRH 230

Query: 294 GGDLELRNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
           G  L+             + C+  L+     C +    DRP+ TK+ E+LE
Sbjct: 231 GNRLK-----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.9 bits (247), Expect = 4e-24
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +K+G G FG VY    L TG L+AVK +    N   + +E  +E+  +  + H N+V+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV-ALGTARGIEYLH-NGC 184
           G      K  +  EY   G+L+     +  R      E +  V  L    G+ YLH +G 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEE--LLEHGRILD---EHVIRVYTLQLLEGLAYLHSHG- 119

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRGTIGYIAPELIS 242
              I+H DIKP NI LDHN + K+ DFG A    +        + +  GT  Y+APE+I+
Sbjct: 120 ---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 243 RN-----FGTVSCKSDVYGFGMVLLEMAGGRR 269
                          D++  G V+LEMA G+R
Sbjct: 177 GGKGKGHGRAA----DIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.5 bits (245), Expect = 5e-24
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 9/193 (4%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+ G  +    +AVK L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K+  G++     L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+    + K++DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.4 bits (245), Expect = 7e-24
 Identities = 66/208 (31%), Positives = 114/208 (54%), Gaps = 20/208 (9%)

Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V +G+L   G     +A+K L +  ++    +F++E S +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     ++ E+M NG+LD   F +++ GQ F   +L  +  G A G++YL    ++
Sbjct: 72  GVVTKSRPVMIITEFMENGALDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---SEM 125

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFGL++F      +  + S    +  I + APE I+ 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
           R F   +  SDV+ +G+V+ E M+ G R
Sbjct: 186 RKF---TSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 98.3 bits (245), Expect = 9e-24
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 27/217 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML--ANSKFSGEEFINEVSTIGRIHH 119
               +LG+G FG V+ G+ +         L+AVK L    S  + ++F  E   +    H
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRH-----------IFPKESRGQSFCWEKLHE 168
            N+V+  G C+EG    +V+EYM +G L++              P    G+     +L +
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQ 126

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A+  A G+ YL +   V   H D+   N L+ ++ + K+ DFG+++      D+  +  
Sbjct: 127 IAVQIASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYYRVGG 182

Query: 229 TRG-TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
                I ++ PE I   +   + +SDV+ FG+VL E+
Sbjct: 183 HTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.4 bits (242), Expect = 2e-23
 Identities = 70/216 (32%), Positives = 117/216 (54%), Gaps = 24/216 (11%)

Query: 67  NHFTHK--LGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIH 118
           +H T +  +G G FG V++G L   G     +A+K L    ++   ++F++E S +G+  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H N+++L G  ++     ++ EYM NG+LD+++   +    S+   +L  +  G A G++
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMK 121

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGY 235
           YL    D+  +H D+   NIL++ N   KVSDFGL++    E+D      T G    I +
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPIRW 176

Query: 236 IAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            APE I+ R F +    SDV+ FG+V+ E M+ G R
Sbjct: 177 TAPEAIAYRKFTSA---SDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 97.0 bits (241), Expect = 2e-23
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 184 SDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 96.5 bits (241), Expect = 2e-23
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 25/202 (12%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGE---EFINEVSTIGRIHHVNVVQLLG 127
            +G+G FG VYKG  L TG  +A+K ++  K   E     + E+  +  + H N+V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDV 186
                    ++ EY  NGSL + I       +S     +++V     +G+ YLH  G   
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV----LQGLAYLHEQG--- 119

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELIS 242
            ++H DIK  NIL   + + K++DFG+A         +   V      GT  ++APE+I 
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV------GTPYWMAPEVI- 171

Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
                 S  SD++  G  ++E+
Sbjct: 172 -EMSGASTASDIWSLGCTVIEL 192

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 96.5 bits (240), Expect = 3e-23
 Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 9/196 (4%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+      +A+KM+     S +EFI E   + ++ H  +VQL G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V EYM NG L  ++      G+ F   +L E+      G+ YL +      
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+D     KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL--LYSKF 178

Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 96.5 bits (240), Expect = 4e-23
 Identities = 86/283 (30%), Positives = 139/283 (49%), Gaps = 46/283 (16%)

Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L   G     +A+K L    ++    +F++E S +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD   F ++  GQ F   +L  +  G A G++YL    D+
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDM 125

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + APE I+ 
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN 301
           R F   +  SDV+ +G+V+ E M+ G R              P W  +  N+  D+ ++ 
Sbjct: 184 RKF---TSASDVWSYGIVMWEVMSYGER--------------PYW--EMSNQ--DV-IKA 221

Query: 302 VTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
           + E   + A   C   L      C Q    +RP   +++ +L+
Sbjct: 222 IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 4e-23
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 21/212 (9%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           KLG+G +GSVYK     TG ++A+K++   +   +E I E+S + +     +V+  G   
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
           + +   +V EY   GS+   +   +   ++   E++  +   T +G+EYLH+      +H
Sbjct: 69  KNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIH 122

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IG---YIAPELISRNFG 246
            DIK  NILL+     K++DFG++             A R T IG   ++APE+I     
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSG------QLTDTMAKRNTVIGTPFWMAPEVIQEI-- 174

Query: 247 TVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
             + K+D++  G+  +EMA G+   S++H  R
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 94.9 bits (236), Expect = 1e-22
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 11/194 (5%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+ G  +    +A+K L     S E F+ E + + ++ H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 132 GSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
                ++ EYM NGSL D   F K   G      KL ++A   A G+ ++        +H
Sbjct: 73  -EPIYIITEYMENGSLVD---FLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+GT + 
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI--NYGTFTI 182

Query: 251 KSDVYGFGMVLLEM 264
           KSDV+ FG++L E+
Sbjct: 183 KSDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 93.9 bits (233), Expect = 2e-22
 Identities = 59/193 (30%), Positives = 100/193 (51%), Gaps = 8/193 (4%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+ G  +    +AVK L     S + F+ E + +  + H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                ++ EYM  GSL    F K   G      KL + +   A G+ Y+        +H 
Sbjct: 73  EEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 184

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 185 SDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.8 bits (233), Expect = 3e-22
 Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 26/210 (12%)

Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLA---NSKFSGE----EFINEVSTIGRIHHVNVVQL 125
           LG+G +G+VY G  + G LIAVK +    ++  + E    +   EV  +  + HVN+VQ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           LG C + +  ++  E++P GS+   +    +R          +       G+ YLHN C 
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNC- 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK------FHPKENDFVSISATRGTIGYIAPE 239
             ++H DIK +N++L  N I K+ DFG A+       H   ++   + +  GT  ++APE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM--LKSMHGTPYWMAPE 178

Query: 240 LISRN-FGTVSCKSDVYGFGMVLLEMAGGR 268
           +I+ + +G    KSD++  G  + EMA G+
Sbjct: 179 VINESGYGR---KSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 93.7 bits (233), Expect = 4e-22
 Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 46/286 (16%)

Query: 73  LGQGGFGSVYKGQLHTGG--LIAVK--MLANSKF---------SGEEFINEVSTIG-RIH 118
           LG G FG VYK +    G  L+A+K   + N  F         S  + ++EV+ I  ++ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H N+V+      E  +  +V + +    L  H    + + Q F  E++  + +     + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YLH   +  I+H D+ P+NI+L  +    ++DFGLAK    E+   S+    GTI Y  P
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSCP 182

Query: 239 ELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNM--HATRSSKAYFPSWVYDQLN 292
           E++ +  +G    K+DV+ FG +L +M   +    ++NM   AT+  +A     VY+ L 
Sbjct: 183 EIVKNEPYGE---KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA-----VYEPLP 234

Query: 293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                        E M +  +  +   C+   A  RP + +V  M+
Sbjct: 235 -------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 5e-22
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 71  HKLGQGGFGSVYKGQLHTGGL----IAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQ 124
            +LG G FGSV KG           +AVK L     +   +EF+ E S + ++ H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L+G C +G    LV E  P G L +++  +    +      L E+A   A G+ YL    
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLE--- 112

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISR 243
               +H D+   N+LL +    K+SDFG+++      + + + +A R  + + APE I  
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI-- 170

Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
           N+G  S KSDV+ +G+ L E 
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 93.3 bits (233), Expect = 5e-22
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 32/210 (15%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLL 126
           KLG+G +G VYK +   TG ++A+K +       E      + E+S +  + H N+V+LL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 127 GFCSEGSKRALVYEYMPN---GSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHN 182
                  K  LV+EY        LD+   P   +  +S  ++ L        RG+ Y H 
Sbjct: 65  DVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLL--------RGLAYCH- 115

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI 241
                ILH D+KP NIL++ + + K++DFGLA+ F      +        T+ Y APE++
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWYRAPEIL 170

Query: 242 --SRNFGT-VSCKSDVYGFGMVLLEMAGGR 268
             S+++ T V    D++  G +  EM  G+
Sbjct: 171 LGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 92.5 bits (230), Expect = 7e-22
 Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 45/277 (16%)

Query: 72  KLGQGGFGSVYK------GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           KLG+G +GSVYK       Q +   L  V + + S+   E+ +NE+  +  ++H N++  
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFY--ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
                +G+K  +V EY P G L + I  ++ + +    +++  + +   RG++ LH   +
Sbjct: 65  KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---E 121

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ILH D+K  NILL  N + K+ D G++K   K      I    GT  Y+APE+     
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR- 176

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR-----RNSNMHATRSSKAYFP--SWVYDQLNKGGDLE 298
              S KSD++  G +L EMA        R+      +  +  +P    +Y Q     DL+
Sbjct: 177 -PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ-----DLQ 230

Query: 299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
                                 +QVK   RP+  K+L
Sbjct: 231 -------------NFIR---SMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.8 bits (228), Expect = 1e-21
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 9/196 (4%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V+ G+      +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V E+M NG L  ++  ++ +G+    + L  +      G+EYL        
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYL--RQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SF 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+    + KVSDFG+ ++   ++++ S S  +  + +  PE+   NF   
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVF--NFSKY 178

Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.6 bits (227), Expect = 2e-21
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 27/201 (13%)

Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG-FC 129
             +G+G FG V  G  + G  +AVK + N   + + F+ E S + ++ H N+VQLLG   
Sbjct: 12  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFC-WEKLHEVALGTARGIEYLHNGCDVCI 188
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT----IGYIAPE-LISR 243
           +H D+   N+L+  + + KVSDFGL K           S+T+ T    + + APE L  +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREK 174

Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
            F T   KSDV+ FG++L E+
Sbjct: 175 KFST---KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.3 bits (226), Expect = 3e-21
 Identities = 61/193 (31%), Positives = 101/193 (52%), Gaps = 9/193 (4%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L       E F+ E   + ++ H  +V L    SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V E+M  GSL    F KE  G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + K++DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 73  LGQGGFGSVYKGQLHT------GGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQ 124
           LGQG FG VY+G             +A+K +  +    E  EF+NE S +   +  +VV+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKE---SRGQSFCWEKLHEVALGTARGIE 178
           LLG  S G    +V E M  G L    R   P+            +K  ++A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YL        +H D+   N ++  +   K+ DFG+ +   + + +         + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMA 265
           E  S   G  + KSDV+ FG+VL EMA
Sbjct: 191 E--SLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.0 bits (226), Expect = 5e-21
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 17/205 (8%)

Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   LV EY+P GSL  ++     R       KL   A    +G+EYL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL 124

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    + H D+   NIL++     K+ DFGL K  P++ ++  +       I + APE
Sbjct: 125 --GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 182 SLTES--KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 35/229 (15%)

Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGG------LIAVKML--ANSKFSGEEFINEVS 112
           EI      F  +LG+G FG VYKG+L           +A+K L         +EF  E  
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF-----PKESRGQSF------ 161
            +  + H N+V LLG C++     +++EY+ +G L  H F     P    G         
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL--HEFLVRNSPHSDVGAESGDETVK 118

Query: 162 ----CWEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
               C + LH +A+  A G+EYL  H+      +H D+   N L+      K+SDFGL++
Sbjct: 119 SSLDCSDFLH-IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR 172

Query: 216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
                + +   S +   + ++ PE I   +G  + +SD++ FG+VL E+
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 45/273 (16%)

Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L    S  + +E ++E   +  + H +VV+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ-------SFCWEKLHEVALGTARGIE 178
           LG C   S+  L+ + MP G L  ++  +  +         ++C        +  A+G+ 
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWC--------VQIAKGMS 123

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YL    +  ++H D+   N+L+      K++DFGLAK    +         +  I ++A 
Sbjct: 124 YLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL 297
           E I       + KSDV+ +G+ + E M  G +                 + D L KG  L
Sbjct: 181 ESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------IPDLLEKGERL 230

Query: 298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPS 330
               +  I+      + M+ + C  + A  RP+
Sbjct: 231 PQPPICTID------VYMVLVKCWMIDAESRPT 257

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 6e-21
 Identities = 68/216 (31%), Positives = 111/216 (51%), Gaps = 39/216 (18%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNVV 123
            ++G+G +G VYK +   TG L+A+K +   +   E+       I E+  + ++ H N+V
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIV 61

Query: 124 QLLGFCSEGSKRA--LVYEYMP---NGSLDRHIFPKESRGQSFCWEK-LHEVALGTARGI 177
           +L    +   K +  +V+EYM     G LD     K +  Q  C+ K L E       G+
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQLLE-------GL 113

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TIG 234
           +YLH NG    ILH DIK  NIL++++ + K++DFGLA+ + K N   S   T    T+ 
Sbjct: 114 QYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---SADYTNRVITLW 166

Query: 235 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           Y  PEL+  +  +G    + D++  G +L E+  G+
Sbjct: 167 YRPPELLLGATRYGP---EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.6 bits (222), Expect = 8e-21
 Identities = 59/194 (30%), Positives = 104/194 (53%), Gaps = 17/194 (8%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
            +G+G FG+V +G+ +TG  +AVK +     + + F+ E + + ++HH N+V+LLG    
Sbjct: 13  IIGEGEFGAVLQGE-YTGQKVAVKNI-KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFC-WEKLHEVALGTARGIEYLHNGCDVCILH 190
                +V E M  G+L   +    +RG++     +L + +L  A G+EYL +     ++H
Sbjct: 71  NGLY-IVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            D+   NIL+  + + KVSDFGLA+      D      ++  + + APE +       S 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHK--KFSS 176

Query: 251 KSDVYGFGMVLLEM 264
           KSDV+ +G++L E+
Sbjct: 177 KSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 72  KLGQGGFGSVYKGQLHTGGL----IAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQL 125
           KLG G FG V +G+  T G     +AVK L + K S   ++F+ E + +  + H N+++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 126 LGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            G         +V E  P GSL DR    ++     F    L + A+  A G+ YL +  
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELISR 243
               +H D+   NILL  +   K+ DFGL +  P+  D   +         + APE  S 
Sbjct: 118 ---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--SL 172

Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
              T S  SDV+ FG+ L EM
Sbjct: 173 RTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 72  KLGQGGFGSVYKGQLHTGGLI-AVK--MLANSKFSGEEFINEVSTIGRIHHVNVVQLLG- 127
           +LG+G  GSV K +L   G+I A+K      +    ++ + E+          +V+  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 128 FCSEGSKR-ALVYEYMPNGSLDRHIFPKESRGQSFCWEK-LHEVALGTARGIEYLHNGCD 185
           F  E S    +  EY   GSLD  I+ K  +      EK L ++A    +G+ YLH    
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---S 123

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISAT-RGTIGYIAPELISR 243
             I+H DIKP NILL      K+ DFG++       + V S++ T  GT  Y+APE I  
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLAGTFTGTSFYMAPERIQG 177

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                S  SDV+  G+ LLE+A  R
Sbjct: 178 --KPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 3e-20
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 24/206 (11%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN--EVSTIGRI-HHVNVVQLLG 127
           +LG G FGSVY  +   TG L+A+K +    +S EE +N  EV ++ ++  H N+V+L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDV 186
              E  +   V+EYM  G+L  +   K+ +G+ F    +  +     +G+ ++H +G   
Sbjct: 66  VFRENDELYFVFEYM-EGNL--YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--- 119

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN----DFVSISATRGTIGYIAPELIS 242
              H D+KP N+L+    + K++DFGLA+   +      D+VS   TR    Y APE++ 
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDYVS---TR---WYRAPEILL 171

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR 268
           R+  + S   D++  G ++ E+   R
Sbjct: 172 RS-TSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 30/198 (15%)

Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS-GEEFIN-----EVSTIGRIHHVNVV 123
            KLG+G +  VYK     TG ++A+K +   +    ++ IN     E+  +  + H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESR---GQSFCWEKLHEVALGTARGIEYL 180
            LL      S   LV+E+M    L++ I  K           +       L T RG+EYL
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSY------MLMTLRGLEYL 118

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H+     ILH D+KP+N+L+  + + K++DFGLA+     N  ++      T  Y APEL
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPEL 173

Query: 241 ISRNFGTVSCKSDVYGFG 258
           +   FG    +   YG G
Sbjct: 174 L---FG---ARH--YGVG 183

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 87.8 bits (218), Expect = 4e-20
 Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 26/206 (12%)

Query: 72  KLGQGGFGSVYKGQLH--TGGLIAVK-MLANSKFSGEEFIN----EVSTIGRIHHVNVVQ 124
           +LG G  G V K   H  TG ++AVK +        E        E+  + + +   +V 
Sbjct: 8   ELGAGNSGVVSKVL-HRPTGKIMAVKTIRLEIN---EAIQKQILRELDILHKCNSPYIVG 63

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
             G        ++  EYM  GSLD+    KE +G+      L ++A+   +G+ YLH   
Sbjct: 64  FYGAFYNNGDISICMEYMDGGSLDK--ILKEVQGR-IPERILGKIAVAVLKGLTYLHE-- 118

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELIS 242
              I+H D+KP NIL++     K+ DFG++    +     FV      GT  Y+APE I 
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPERIQ 172

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR 268
            N  +V  KSD++  G+ L+E+A GR
Sbjct: 173 GNDYSV--KSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.8 bits (215), Expect = 1e-19
 Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 39/214 (18%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIHHVNVVQL 125
           KLG+G + +VYKG+   TG ++A+K +       EE      I E+S +  + H N+V+L
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG-------QSFCWEKLHEVALGTARGIE 178
                  +K  LV+EYM +  L +++     RG       +SF ++ L        +GI 
Sbjct: 64  HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL--------KGIA 114

Query: 179 YLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYI 236
           + H N     +LH D+KP N+L++     K++DFGLA+ F    N F   S    T+ Y 
Sbjct: 115 FCHENR----VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLWYR 167

Query: 237 APELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           AP+++  SR   T S   D++  G ++ EM  GR
Sbjct: 168 APDVLLGSR---TYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 85.6 bits (213), Expect = 2e-19
 Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 37/234 (15%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+G FG V   +   TG L A+K+L      K    E  + E + + RI+H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARGIEYL 180
             +  ++  L  V EY P G L  H+     F  E R + F      E+ L     +EYL
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-EERAR-FY---AAEIVLA----LEYL 109

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H+   + I++ D+KP NILLD +   K++DFGLAK     ++    +   GT  Y+APE+
Sbjct: 110 HS---LGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEV 164

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHAT----RSSKAYFPSWV 287
           +       +   D +  G++L EM  G+      +              FP ++
Sbjct: 165 LLGKGYGKAV--DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL 216

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 47/219 (21%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--------FINEVSTIGRIHHVN 121
             +G+G +G V K +   TG ++A+K     KF   E         + EV  + ++ H N
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG-------QSFCWEKLHEVALGTA 174
           +V L        +  LV+EY+    L+     + S G       +S+ W+ L        
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLLE---LLEASPGGLPPDAVRSYIWQLL-------- 110

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRG 231
           + I Y H +     I+H DIKP NIL+  + + K+ DFG A+       +      ATR 
Sbjct: 111 QAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR- 165

Query: 232 TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
              Y APEL+    N+G      DV+  G ++ E+  G 
Sbjct: 166 --WYRAPELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.4 bits (211), Expect = 6e-19
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 34/223 (15%)

Query: 69  FTHKLGQGGFGSVY---------------KGQLHTGGLIAVKMLAN--SKFSGEEFINEV 111
              KLG+G FG V+                       L+AVKML    +K +  +F+ E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ--------SFCW 163
             + R+ + N+++LLG C       ++ EYM NG L++ +  +E            S   
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
             L  +A+  A G++YL     +  +H D+   N L+ +++  K++DFG+++ +    D+
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NLYSGDY 184

Query: 224 VSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             I   R    I ++A E I    G  +  SDV+ FG+ L EM
Sbjct: 185 YRIQG-RAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.9 bits (210), Expect = 6e-19
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 33/211 (15%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLA--NSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G VY  + L T   IA+K +   +S++  +    E++    + H N+VQ LG  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE--KLHEVALG-----TARGIEYLHN 182
           SE     +  E +P GSL   +  K        W   K +E  +         G++YLH 
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIIFYTKQILEGLKYLH- 125

Query: 183 GCDVCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIA 237
             D  I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+A
Sbjct: 126 --DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMA 177

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I +        +D++  G  ++EMA G+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 87.2 bits (216), Expect = 9e-19
 Identities = 66/264 (25%), Positives = 127/264 (48%), Gaps = 23/264 (8%)

Query: 13  IIGRFILAPIVFLVFLIQRYRK--SLKRVDNVEKFLHNQ--QSWMPKRYSYPEIIAVTNH 68
            +G F++  +V   F+  R R    LKRV+N +     Q   S + K  +  +I++    
Sbjct: 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKE 694

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
             + + +G  G+ YKG+    G+  V    N   S     +E++ +G++ H N+V+L+G 
Sbjct: 695 -ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS--SEIADMGKLQHPNIVKLIGL 751

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C       L++EY+   +L   +       ++  WE+  ++A+G A+ + +LH  C   +
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +  ++ P  I++D    P +    L      +      SA      Y+APE  +R    +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPE--TRETKDI 855

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSN 272
           + KSD+YGFG++L+E+  G+  ++
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 81/307 (26%), Positives = 136/307 (44%), Gaps = 51/307 (16%)

Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLAN--SKFSGEEFINEVST 113
           YP +      F   +G+G FG V K ++   GL    A+K +    SK    +F  E+  
Sbjct: 1   YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 114 IGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHIFPKESRGQS 160
           + ++ HH N++ LLG C       L  EY P+G+L            D       S   +
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 161 FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
              ++L   A   ARG++YL        +H D+   NIL+  N++ K++DFGL++    +
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQ 174

Query: 221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRS 278
             +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M     
Sbjct: 175 EVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 231

Query: 279 SKAYFPSWVYDQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL- 335
                   +Y++L +G  LE  L    E+  ++ +        C + K  +RPS  ++L 
Sbjct: 232 --------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSFAQILV 275

Query: 336 ---EMLE 339
               MLE
Sbjct: 276 SLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 84.2 bits (208), Expect = 1e-18
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 16/204 (7%)

Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQLL 126
           LG G FG + +G L         +A+  L       +   F+ E  T+G+  H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  + G+   +V EYM NG+LD   F ++  GQ     +L  +  G A G++YL    ++
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEM 126

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H  +  H +L++ + + K+S F   +    E  + ++S  +  + + APE I   + 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG-KSPVLWAAPEAI--QYH 183

Query: 247 TVSCKSDVYGFGMVLLE-MAGGRR 269
             S  SDV+ FG+V+ E M+ G R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.5 bits (206), Expect = 1e-18
 Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 17/196 (8%)

Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE---EFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G FG V+KG L     +AVK         E   +F++E   + +  H N+V+L+G C
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           ++     +V E +P G     +  K+   ++   ++L + AL  A G+ YL +    CI 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKT---KQLVKFALDAAAGMAYLES--KNCI- 115

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA--TRGTIGYIAPELISRNFGT 247
           H D+   N L+  N + K+SDFG+++   +E+D +  S+   +  I + APE +  N+G 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEAL--NYGR 170

Query: 248 VSCKSDVYGFGMVLLE 263
            S +SDV+ +G++L E
Sbjct: 171 YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+    +    +AVK +     S E F+ E + +  + H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                ++ E+M  GSL    F K   G      KL + +   A G+ ++        +H 
Sbjct: 73  -EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 183

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L+E+
Sbjct: 184 SDVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 72/263 (27%), Positives = 123/263 (46%), Gaps = 42/263 (15%)

Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLANSKFSGEEFINEVS----TIGRIHHVNVV 123
           LG G FG+V+KG     G      +A+K + +   SG +   E++     +G + H  +V
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +LLG C  G+   LV +  P GSL  H+  ++ R  S   ++L    +  A+G+ YL   
Sbjct: 73  RLLGICP-GASLQLVTQLSPLGSLLDHV--RQHRD-SLDPQRLLNWCVQIAKGMYYLE-- 126

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            +  ++H ++   NILL  + I +++DFG+A     ++     S  +  I ++A E I  
Sbjct: 127 -EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI-- 183

Query: 244 NFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN 301
            FG  + +SDV+ +G+ + EM   G    + M          P  V D L KG       
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR---------PHEVPDLLEKG------- 227

Query: 302 VTEIESMIARKLCMIGLWCIQVK 324
               E +   ++C I ++ + VK
Sbjct: 228 ----ERLAQPQICTIDVYMVMVK 246

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 37/222 (16%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVS----TIGRI-HHVNVVQLL 126
           +G+G F +V   +   T    A+K+L   +   E+ +  V      + R+  H  +++L 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 127 G-FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGC 184
             F  E      V EY PNG L ++I    S  +        E+ L     +EYLH  G 
Sbjct: 69  YTFQDE-ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA----LEYLHSKG- 122

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----HPKENDFVSISATR--------- 230
              I+H D+KP NILLD +   K++DFG AK       P+ N   + +            
Sbjct: 123 ---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 231 ----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
               GT  Y++PEL++         SD++  G ++ +M  G+
Sbjct: 180 ASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 27/217 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGG-----LIAVKMLA--NSKFSGEEFINEVSTIGRIHHVN 121
           F  +LG+  FG +YKG L+  G     L+A+K L   N+     EF  E S +  +HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK--------------LH 167
           +V LLG  ++     +++EY+  G L   +  +       C                 LH
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
            +A+  A G+EYL +      +H D+   NIL+      K+SD GL++     + +    
Sbjct: 129 -IAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +   I ++ PE I   +G  S  SD++ FG+VL E+
Sbjct: 185 KSLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLG 127
            +G+G FG+V K +    G ++  K +     + +E    ++EV+ +  + H N+V+   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHI--FPKESR--GQSFCWEKLHEVALGTARGIEYLH 181
              + S + L  V EY   G L + I    KE +   + F W  L ++ L     +   H
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LYECH 122

Query: 182 NGCDV--CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           N  D    +LH D+KP NI LD N   K+ DFGLAK    ++ F       GT  Y++PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--GTPYYMSPE 180

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            ++    +   KSD++  G ++ E+    
Sbjct: 181 QLNHM--SYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 82.3 bits (203), Expect = 6e-18
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 20/202 (9%)

Query: 73  LGQGGFGSVY-----KGQLHTGGLIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG+G FG V           TG ++AVK L     + +   +  E++ +  ++H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 126 LGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            G CSE   +   L+ EY+P GSL R   PK     +    +L   A     G+ YLH+ 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL-RDYLPKHKLNLA----QLLLFAQQICEGMAYLHSQ 126

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELIS 242
                +H D+   N+LLD++ + K+ DFGLAK  P+ +++  +       + + A E + 
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
            N    S  SDV+ FG+ L E+
Sbjct: 184 EN--KFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 6e-18
 Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 43/235 (18%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFS-GEEFIN--EVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     S G       E+  +  ++H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 128 FCSEGSKRALVYEYMPNG---SLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLH-N 182
                    LV+E+M       +        ES  +S+ ++ L        +G+ + H +
Sbjct: 66  VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLL--------QGLAFCHSH 117

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI 241
           G    ILH D+KP N+L++   + K++DFGLA+ F      +     TR    Y APEL+
Sbjct: 118 G----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR---WYRAPELL 170

Query: 242 --SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY-DQLNK 293
              + + T     D++  G +  E+   R              FP     DQL K
Sbjct: 171 LGDKGYST---PVDIWSVGCIFAELLSRR------------PLFPGKSEIDQLFK 210

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGL--------IAVKMLANSKFSGEE--FINEVSTIGRI- 117
           F   LG G FG V +   +  GL        +AVKML  +  S E    ++E+  +  + 
Sbjct: 39  FGKTLGAGAFGKVVEATAY--GLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96

Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           +H N+V LLG C+ G    ++ EY   G L   +  K     +   + L   +   A+G+
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL-EDLLS-FSYQVAKGM 154

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            +L +    CI H D+   N+LL H  I K+ DFGLA+    ++++V     R  + ++A
Sbjct: 155 AFLAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE I     T   +SDV+ +G++L E+
Sbjct: 212 PESIFNCVYTF--ESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 33/271 (12%)

Query: 72  KLGQGGFGSVYK----GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G FG V+K           +  + +   ++   EE I+E   + ++    +++   
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K  +V EY  NG L  H   K  RG+    +++    +    G+ +LH+     
Sbjct: 67  SFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--- 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ILH DIK  N+ LD     K+ D G+AK      +F   +   GT  Y++PEL       
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDK--P 177

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE--LRNVTE- 304
            + KSDV+  G+VL E   G+               P   +D  N+G  +   +R V   
Sbjct: 178 YNEKSDVWALGVVLYECCTGK--------------HP---FDANNQGALILKIIRGVFPP 220

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
           +  M +++L  +   C+      RP   ++L
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 82/293 (27%), Positives = 128/293 (43%), Gaps = 56/293 (19%)

Query: 73  LGQGGFGSVYKGQLHTGGLI---AVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FGSV +GQL+    I   AVK +     ++   E+F++E   +    H NV++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 127 GFCSEGSKR------ALVYEYMPNGSLDRHIFPKESR----GQSFCWEKLHEVALGTARG 176
           G C +  +        ++  +M +G L  H F   SR     Q    + L +     A G
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDL--HSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +EYL +      +H D+   N +L+ N    V+DFGL+K     + +      +  + +I
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP----SWVYDQL 291
           A E L  R + T   KSDV+ FG+ + E+          ATR    Y P    S +YD L
Sbjct: 182 AIESLADRVYTT---KSDVWSFGVTMWEI----------ATRGQTPY-PGVENSEIYDYL 227

Query: 292 NKGGDLELRNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
            +G  L+               C+ GL+     C  +   DRPS   +   LE
Sbjct: 228 RQGNRLK-----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.4 bits (202), Expect = 1e-17
 Identities = 70/236 (29%), Positives = 108/236 (45%), Gaps = 44/236 (18%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLG 127
           LG G FG V   +   +G   A+K+L+ +K       E  +NE   +  I H  +V L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLH--EVALGTARGIEYL 180
              + S   LV EY+P G L  H+     FP+          + +  +V L     +EYL
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP-------VARFYAAQVVLA----LEYL 117

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H+  D  I++ D+KP N+LLD +   K++DFG AK               GT  Y+APE+
Sbjct: 118 HS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEI 169

Query: 241 I-SRNFGTVSCKS-DVYGFGMVLLEMAGG----RRNSNM---HATRSSKAYFPSWV 287
           I S+ +G    K+ D +  G+++ EM  G      ++ +         K  FPS+ 
Sbjct: 170 ILSKGYG----KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF 221

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 29/209 (13%)

Query: 72  KLGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG 127
           ++G+G  G V+K     TG  +A+K +A  +  G    + + E+  +    H  VV+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 128 FCSEGSKRALVYEYMPNGSLD-----RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH- 181
               GS   LV EYMP+   +         P E++ +S+    L        +G+ Y+H 
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLP-EAQVKSYMRMLL--------KGVAYMHA 117

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           NG    I+H D+KP N+L+  + + K++DFGLA+   +E      S    T  Y APEL+
Sbjct: 118 NG----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELL 172

Query: 242 --SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             +R +       D++  G +  E+  G 
Sbjct: 173 YGARKYDP---GVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 38/218 (17%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----------EEFINEVSTIGRIHHVN 121
           +G G FGSVY G    +G L+AVK +     S           +    E++ +  + H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGS----LDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           +VQ LG   +     +  EY+P GS    L+ +   +E+  ++F  + L        +G+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL--------KGL 119

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR------- 230
            YLHN     I+H DIK  NIL+D+    K+SDFG++K   K       + T        
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQ 173

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           G++ ++APE++ +   T   K+D++  G +++EM  G+
Sbjct: 174 GSVFWMAPEVVKQTSYTR--KADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 48/226 (21%)

Query: 71  HKLGQGGFGSVYKGQL-----HTGGL-IAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
             LG+G FG V K +            +AVKML +     +  + ++E+  +  I  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSL-------------DRHIFPKESRGQ-------SF 161
           ++ LLG C++     +V EY  +G+L                  P+            SF
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 162 CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKE 220
            ++         ARG+E+L +    CI H D+   N+L+  + + K++DFGLA+  H   
Sbjct: 138 AYQ--------VARGMEFLAS--KKCI-HRDLAARNVLVTEDHVMKIADFGLARDIH--H 184

Query: 221 NDFVSISATRG--TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            D+     T G   + ++APE +     T   +SDV+ FG++L E+
Sbjct: 185 IDYYR-KTTNGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.4 bits (196), Expect = 4e-17
 Identities = 71/205 (34%), Positives = 103/205 (50%), Gaps = 25/205 (12%)

Query: 73  LGQGGFGSVYKGQLHTGGLI----AVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQLL 126
           +G+G FG VY G L          AVK L       E  +F+ E   +    H NV+ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 127 GFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           G C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G+EYL +  
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDL-RNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASKK 118

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGT---IGYIAPE- 239
            V   H D+   N +LD +F  KV+DFGLA+  + KE  + S+    G    + ++A E 
Sbjct: 119 FV---HRDLAARNCMLDESFTVKVADFGLARDIYDKE--YYSVHNHTGAKLPVKWMALES 173

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
           L ++ F T   KSDV+ FG++L E+
Sbjct: 174 LQTQKFTT---KSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.3 bits (196), Expect = 5e-17
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 30/212 (14%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGF 128
            +G G    VY    L     +A+K +   K   S +E   EV  + + +H NVV+    
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 129 CSEGSKRALVYEYMPNGS-LD--RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGC 184
              G +  LV  Y+  GS LD  +  +P+    ++     L EV     +G+EYLH NG 
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL----KGLEYLHSNG- 122

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--------HPKENDFVSISATRGTIGYI 236
               +H DIK  NILL  +   K++DFG++                FV      GT  ++
Sbjct: 123 ---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV------GTPCWM 173

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           APE++ +  G    K+D++ FG+  +E+A G 
Sbjct: 174 APEVMEQVHGYDF-KADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 73/234 (31%), Positives = 106/234 (45%), Gaps = 53/234 (22%)

Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVK--MLANSKFSGEEF----INEVSTIGRIHHV 120
               KLG+G FG VYK  Q+ TG ++A+K  ++ N K   + F    + E+  + ++ H 
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILKKLKHP 67

Query: 121 NVVQLLGFCSEGS-----KRALVYEYMP------NGSLDRHIFPKESRGQSFCW-EKLHE 168
           NVV L+    E       KR  VY   P      +G L+     K +  Q  C+  +L E
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV-KLTESQIKCYMLQLLE 126

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----------- 217
                  GI YLH   +  ILH DIK  NIL+D+  I K++DFGLA+ +           
Sbjct: 127 -------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 218 -PKENDFVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                 + ++  TR    Y  PEL+   R + T     D++G G V  EM   R
Sbjct: 177 GGGTRKYTNLVVTR---WYRPPELLLGERRYTT---AVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.4 bits (196), Expect = 6e-17
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V       TG  +AVK +   K    E + NEV  +    H N+V++    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  +V E++  G+L   +    +R      E++  V L   + + +LH      ++
Sbjct: 86  LVGDELWVVMEFLEGGALTDIV--THTRMNE---EQIATVCLAVLKALSFLHAQG---VI 137

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRN- 244
           H DIK  +ILL  +   K+SDFG    ++K  P+    V      GT  ++APE+ISR  
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISRLP 191

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +GT   + D++  G++++EM  G
Sbjct: 192 YGT---EVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGL---IAVKMLAN--SKFSGEEFINEVSTIGRI-HHVNV 122
           F   +G+G FG V +  +   GL    A+KML    S+    +F  E+  + ++ HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHI-----------FPKE-SRGQSFCWEKLHEVA 170
           + LLG C       +  EY P G+L   +           F KE     +   ++L + A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A G++YL    +   +H D+   N+L+  N   K++DFGL++    E  +V  +  R
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++A E  S N+   + KSDV+ FG++L E+
Sbjct: 180 LPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 79.2 bits (195), Expect = 7e-17
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 53/230 (23%)

Query: 73  LGQGGFGSVYKG-QLHTGGL-----IAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQ 124
           LG+G FG V K       G      +AVKML  +  S E  + ++E + + +++H +V++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ------------------------- 159
           L G CS+     L+ EY   GSL    F +ESR                           
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRS--FLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 160 -----SFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
                SF W+         +RG++YL    ++ ++H D+   N+L+      K+SDFGL+
Sbjct: 126 MGDLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +   +E+ +V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT--QSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.5 bits (196), Expect = 8e-17
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVK-MLANSKFSGEEF---INEVSTIGRIHHVNVVQL 125
            ++G G FG+VY  + + T  ++A+K M  + K S E++   I EV  + ++ H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 126 LGFCSEGSKRALVYEYMPNGS----LDRHIFPKESRGQSFCWEKLHEVAL-----GTARG 176
            G         LV EY   GS    L+ H  P            L EV +     G  +G
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDILEVHKKP------------LQEVEIAAICHGALQG 127

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YLH+      +H DIK  NILL      K++DFG A      N FV      GT  ++
Sbjct: 128 LAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWM 178

Query: 237 APELI-SRNFGTVSCKSDVYGFGMVLLEMA 265
           APE+I + + G    K DV+  G+  +E+A
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.1 bits (195), Expect = 8e-17
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 51/228 (22%)

Query: 73  LGQGGFGSVYK--------GQLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNV 122
           +GQG FG V++         +  T  ++AVKML    S     +F  E + +    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPK----------------ESRGQSFCW 163
           V+LLG C+ G    L++EYM  G L+   RH  P+                 +     C 
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-------F 216
           E+L  +A   A G+ YL    +   +H D+   N L+  N + K++DFGL++       +
Sbjct: 131 EQL-CIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              END + I        ++ PE I   +   + +SDV+ +G+VL E+
Sbjct: 187 KASENDAIPIR-------WMPPESIF--YNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.4 bits (193), Expect = 1e-16
 Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 36/218 (16%)

Query: 69  FTHKLGQGGFGSVYKGQLH--TGGLIAVK----MLANSKFSGEEFINEVSTIGRIHHVNV 122
              +LG+G +GSVYK  LH  TG  +A+K     L  SKF+    I E+  + +     +
Sbjct: 5   VLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQ--IIMELDILHKAVSPYI 61

Query: 123 VQLLG-FCSEGSKRALVY---EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           V   G F  EG+    VY   EYM  GSLD+ ++      +    + L  +     +G++
Sbjct: 62  VDFYGAFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 179 YL---HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIG 234
           +L   HN     I+H D+KP N+L++ N   K+ DFG++      N   S++ T  G   
Sbjct: 117 FLKEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSG-----NLVASLAKTNIGCQS 166

Query: 235 YIAPELIS----RNFGTVSCKSDVYGFGMVLLEMAGGR 268
           Y+APE I         T + +SDV+  G+ +LEMA GR
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 64/218 (29%), Positives = 93/218 (42%), Gaps = 25/218 (11%)

Query: 74  GQGGFGSVYKGQL-HTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQL-LG 127
           G+G FG V   Q   T  + A+K +   K     S    +NE   +  ++H  +V L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE--KLHEVALGTARGIEYLHNGCD 185
           F  E     LV + +  G L  H+    S+   F  E  K     +  A  +EYLH+   
Sbjct: 69  FQDE-ENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLA--LEYLHSKG- 120

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELISRN 244
             I+H DIKP NILLD      ++DF +A K  P        ++T GT GY+APE++ R 
Sbjct: 121 --IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----TTSTSGTPGYMAPEVLCRQ 174

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY 282
               S   D +  G+   E   G+R    H+       
Sbjct: 175 --GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.4 bits (190), Expect = 2e-16
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 19/199 (9%)

Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANS--KFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG V+ G+L      +AVK    +       +F+ E   + +  H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V E +  G     +    + G     ++L ++    A G+EYL +    CI
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESKH--CI 116

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT----IGYIAPELISRN 244
            H D+   N L+    + K+SDFG+++   +E D V  ++T G     + + APE +  N
Sbjct: 117 -HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGV-YASTGGMKQIPVKWTAPEAL--N 169

Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +G  S +SDV+ FG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 79/295 (26%), Positives = 118/295 (40%), Gaps = 60/295 (20%)

Query: 73  LGQGGFGSVYKGQ-LHTGGL-----IAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+G      G      +AVK L    S+    +F+ E   + + +H N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           L+G   E   R ++ E M  G L    R   P+  R  S   + L   A   A+G +YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 182 -NGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRG------ 231
            N      +H DI   N LL       + K++DFG+A+      D    S  R       
Sbjct: 134 ENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMAR------DIYRASYYRKGGRAML 183

Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMHATRSSKAYFP 284
            I ++ PE      G  + K+DV+ FG++L E+         GR N              
Sbjct: 184 PIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------------ 229

Query: 285 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             V + +  GG L+          + R    I   C Q    DRP+   +LE ++
Sbjct: 230 --VMEFVTGGGRLD--PPKGCPGPVYR----IMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 29/214 (13%)

Query: 72  KLGQGGFGSVYKGQLHT------GGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  + H         L+AVK L  +  S  ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDR---------HIFPKESRGQS---FCWEKLHEVALG 172
             G C+EG    +V+EYM +G L+R          I        +       ++  +A  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKIL-AGGEDVAPGQLTLGQMLAIASQ 130

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TRG 231
            A G+ YL     +  +H D+   N L+    + K+ DFG+++      D+  +   T  
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYRVGGRTML 186

Query: 232 TIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            I ++ PE ++ R F T   +SD++ FG+VL E+
Sbjct: 187 PIRWMPPESILYRKFTT---ESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 5e-16
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 73  LGQGGFGSVYKGQLHTGGL---IAVKMLAN--SKFSGEEFINEVSTIGRI-HHVNVVQLL 126
           +G+G FG V K ++   GL    A+K +    SK    +F  E+  + ++ HH N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 127 GFCSEGSKRALVYEYMPNGSL------------DRHIFPKESRGQSFCWEKLHEVALGTA 174
           G C       L  EY P+G+L            D       S   +   ++L   A   A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           RG++YL        +H D+   NIL+  N++ K++DFGL++    +  +V  +  R  + 
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           ++A E  S N+   +  SDV+ +G++L E+
Sbjct: 177 WMAIE--SLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 76.5 bits (188), Expect = 5e-16
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)

Query: 73  LGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQL 125
           LG+G FGSV + QL     +   +AVKML    FS    EEF+ E + +    H NV++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 126 LGFC--SEGSKR----ALVYEYMPNGSLDRHIFPKESR-GQ---SFCWEKLHEVALGTAR 175
           +G    S    R     ++  +M +G L  H F   SR G+   +   + L    +  A 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G+EYL +      +H D+   N +L+ N    V+DFGL+K     + +    A++  + +
Sbjct: 125 GMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           +A E ++ N  T    SDV+ FG+ + E+ 
Sbjct: 182 LALESLADNVYTT--HSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 7e-16
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 32/224 (14%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQL 125
               ++G G +G VYK + + TG L+A+K++        E I  E+S +    H N+V  
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 126 LGFCSEGSKRALVYEYMPNGSLD------RHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            G      K  +V EY   GSL       R     E +    C E L        +G+ Y
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-ELQIAYVCRETL--------KGLAY 116

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGY 235
           LH       +H DIK  NILL  +   K++DFG++        K   F+      GT  +
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYW 167

Query: 236 IAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           +APE+ +    G    K D++  G+  +E+A  +    ++H  R
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.1 bits (187), Expect = 7e-16
 Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 70/294 (23%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG-------EEFINEVSTIGRIHHVNVVQ 124
           LG G F S Y+ + + TG L+AVK +   + +        E    E+  + R++H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 125 LLGFCSEGSKRALVYEYMPNGS----LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           +LG   E S   L  E+M  GS    L ++   KE+   ++  + L        RG+ YL
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL--------RGLSYL 119

Query: 181 HNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR--------- 230
           H   +  I+H D+K  N+L+D      +++DFG A         ++   T          
Sbjct: 120 H---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA-------RLAAKGTGAGEFQGQLL 169

Query: 231 GTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS--------SKA 281
           GTI ++APE++    +G  SC  DV+  G V++EMA  +   N     +        + A
Sbjct: 170 GTIAFMAPEVLRGEQYGR-SC--DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226

Query: 282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
                + + L+ G    LR+VT              L C++++  DRP   ++L
Sbjct: 227 TTAPSIPEHLSPG----LRDVT--------------LRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.1 bits (188), Expect = 7e-16
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 32/218 (14%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
            +G+G FG VYK     T  ++A+K+  L  ++   E+   E+  + +     + +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 129 CSEGSKRALVYEYMPNGS----LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
             +GSK  ++ EY   GS    L      +           L EV      G+EYLH   
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA-----FILREV----LLGLEYLHEEG 118

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  NILL      K++DFG    L     K N FV      GT  ++APE+
Sbjct: 119 KI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFWMAPEV 169

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
           I +       K+D++  G+  +E+A G    S++H  R
Sbjct: 170 IKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 32/220 (14%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           LG G FG VYK Q   TG   A K++   S+   E+F+ E+  +    H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 131 EGSKRALVYEYMPNGSLDRHIFP-----KESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
             +K  ++ E+   G+LD  +        E + +  C + L          + +LH+   
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML--------EALNFLHSHK- 123

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELI 241
             ++H D+K  NILL  +   K++DFG          K + F+      GT  ++APE++
Sbjct: 124 --VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEVV 175

Query: 242 S-RNFGT--VSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           +   F       K+D++  G+ L+E+A     +  ++  R
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 51/284 (17%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVK-------MLANSKFSGEEFINEVSTIGRIHHVNVV 123
           K+G+G F  VYK   L  G ++A+K       M A ++   ++ + E+  + ++ H NV+
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR---QDCLKEIDLLKQLDHPNVI 65

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHI--FPKESR--GQSFCWEKLHEVALGTARGIEY 179
           + L    E ++  +V E    G L R I  F K+ R   +   W+   ++       +E+
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEH 121

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           +H+     I+H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE
Sbjct: 122 MHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPE 176

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMA-------GGRRNSNMHATRSSKAYFPSWVYDQLN 292
            I  N    + KSD++  G +L EMA       G + N      +  K  +P    D  +
Sbjct: 177 RIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234

Query: 293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           +    ELR++                 CI      RP ++ VL+
Sbjct: 235 E----ELRDLVSR--------------CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 1e-15
 Identities = 62/204 (30%), Positives = 84/204 (41%), Gaps = 27/204 (13%)

Query: 75  QGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV-----NVVQLLGF 128
           +G FGSVY  +   TG   A+K+L  S    +  +  V     I  +      V +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK--LHEVALGTARGIEYLH-NGCD 185
                   LV EY+  G     I  K   G    W K  + EV LG    +E LH  G  
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLG----VEDLHQRG-- 117

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I+H DIKP N+L+D     K++DFGL++   +   FV      GT  Y+APE I    
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETILGVG 169

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRR 269
                  D +  G V+ E   G  
Sbjct: 170 DDKMS--DWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 57/215 (26%), Positives = 107/215 (49%), Gaps = 30/215 (13%)

Query: 72  KLGQGGFGSVYKGQLHTGG------LIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  + +         L+AVK L +   +  ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIF-------------PKESRGQSFCWEKLHEVAL 171
             G C +G    +V+EYM +G L++ +              P++++G+    + LH +A 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IAS 130

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TR 230
             A G+ YL +      +H D+   N L+  N + K+ DFG+++      D+  +   T 
Sbjct: 131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRVGGHTM 186

Query: 231 GTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
             I ++ PE ++ R F T   +SDV+ FG++L E+
Sbjct: 187 LPIRWMPPESIMYRKFTT---ESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 34/210 (16%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVVQLLG 127
            +G+G +G V K +   TG ++A+K    S   K   +  + E+  + ++ H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 128 FCSEGSKRALVYEYMPNGSLDR-HIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNG 183
                 +  LV+E++ +  LD    +P    ESR + + ++ L        RGIE+ H+ 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL--------RGIEFCHSH 119

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKE--NDFVSISATRGTIGYIAPE 239
               I+H DIKP NIL+  + + K+ DFG A+    P E   D+V   ATR    Y APE
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV---ATR---WYRAPE 170

Query: 240 LISRN--FGTVSCKSDVYGFGMVLLEMAGG 267
           L+  +  +G      D++  G ++ EM  G
Sbjct: 171 LLVGDTKYGR---AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 49/289 (16%)

Query: 73  LGQGGFGSVY----KGQLHTGG--LIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQ 124
           LG+G FG V+    KG    GG  L+ VK L  +K      EF  E+    ++ H NVV+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKL---HEVALGT--ARGIEY 179
           LLG C E     ++ EY   G L + +   +S+ +      L    +VAL T  A G+++
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK------FHPKENDFVSISATRGTI 233
           L N      +H D+   N L+      KVS   L+K      ++   N  + +       
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------ 183

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ-LN 292
            ++APE +  +    S KSDV+ FG+++ E+               +  F     ++ LN
Sbjct: 184 -WLAPEAVQED--DFSTKSDVWSFGVLMWEV-----------FTQGELPFYGLSDEEVLN 229

Query: 293 --KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             + G LEL     +      +L  +   C  V   DRPS ++++  L 
Sbjct: 230 RLQAGKLELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 37/275 (13%)

Query: 73  LGQGGFGS--VYKGQLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLG 127
           LG+G FG   +Y+ +     L+  K +  ++ S +E    +NE+  +  + H N++    
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              + +   +  EY   G+L   I     +GQ F  E +          + Y+H      
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL---ISR 243
           ILH DIK  NI L    + K+ DFG++K         S++ T  GT  Y++PEL   +  
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISK---ILGSEYSMAETVVGTPYYMSPELCQGVKY 178

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT 303
           NF     KSD++  G VL E+        +   R+  A  P  +  ++ +G      N T
Sbjct: 179 NF-----KSDIWALGCVLYEL--------LTLKRTFDATNPLNLVVKIVQG------NYT 219

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
            + S+ + +L  +    +Q     RP+  +VL+  
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML-ANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGF 128
           ++G G  G+VYK     TG L A+K++  N + +    I  E+  +  ++H NVV+    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                +  ++ E+M  GSL+      E        + L +VA     GI YLH      I
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADE--------QFLADVARQILSGIAYLHRRH---I 189

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--NFG 246
           +H DIKP N+L++     K++DFG+++   +  D  + S   GTI Y++PE I+   N G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHG 247

Query: 247 TVS-CKSDVYGFGMVLLEMAGGR 268
                  D++  G+ +LE   GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 4e-15
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKML----ANSKFSGE--EFINEVSTIGRIHHVNVVQL 125
           LGQG FG VY    + TG  +AVK +     + +   E      E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP----KESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   +    ++  EYMP GS+   +       E+  + +  + L         G+EYLH
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE--------GVEYLH 121

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIA 237
                 I+H DIK  NIL D     K+ DFG +K             S++   GT  +++
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWMS 175

Query: 238 PELIS-RNFGTVSCKSDVYGFGMVLLEM 264
           PE+IS   +G    K+DV+  G  ++EM
Sbjct: 176 PEVISGEGYGR---KADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.8 bits (181), Expect = 5e-15
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 14/204 (6%)

Query: 72  KLGQGGFGSVYKGQLHTG---GLIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQLL 126
           ++G G FG V  G+ H G     + VK L  S    E+  F+ EV     ++H NV+Q L
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           G C E     LV E+ P G L  ++   +    Q    + L  +A   A G+ +LH    
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS--- 242
              +H D+   N  L  +   K+ D+GLA     E+ +++       + ++APEL+    
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 243 RNFGTV--SCKSDVYGFGMVLLEM 264
           ++      + KS+++  G+ + E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + HTG  +AVK +   K    E + NEV  +   HH NVV +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  +V E++  G+L   +    +R      E++  V L   R + YLHN     ++
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV--THTRMNE---EQIATVCLSVLRALSYLHNQG---VI 140

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 244
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR  
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVISRLP 194

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +GT   + D++  G++++EM  G
Sbjct: 195 YGT---EVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 24/214 (11%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG VYKG    T  ++A+K+  L  ++   E+   E++ + +     + +  G 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
             +G+K  ++ EY+  GS    + P     +++    L E+     +G++YLH+   +  
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGPLE-ETYIATILREIL----KGLDYLHSERKI-- 123

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELISRN 244
            H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I ++
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQS 176

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
                 K+D++  G+  +E+A G   NS++H  R
Sbjct: 177 --AYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.1 bits (179), Expect = 8e-15
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 21/201 (10%)

Query: 72  KLGQGGFGSVYKG---QLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      +   +AVK+L    N     +E + E + + ++ +  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNG 183
           +G C E     LV E    G L++ +   +   +    E +H+V++G    ++YL   N 
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN- 115

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELIS 242
                +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE + 
Sbjct: 116 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM- 170

Query: 243 RNFGTVSCKSDVYGFGMVLLE 263
            N+   S KSDV+ FG+++ E
Sbjct: 171 -NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K L      K  GE   +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV   M  G L  HI+   + G  F  E+    A     G+E LH      
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLHREN--- 122

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            ++ D+KP NILLD     ++SD GLA   P+     SI    GT+GY+APE+++    T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYT 179

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
           +S   D +G G ++ EM  G+
Sbjct: 180 LS--PDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 32/209 (15%)

Query: 73  LGQGGFGSVY------KGQLHTGGLIAVKMLANSKFSGEEFIN----EVSTIGRIHHVNV 122
           LG+G FG V       +G  +TG  +AVK L     SG   I     E+  +  ++H N+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENI 68

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C+E       L+ E++P+GSL  ++ P+     +   ++  + A+   +G++YL
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINL--KQQLKYAVQICKGMDYL 125

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE 239
            +   V   H D+   N+L++     K+ DFGL K    + ++ ++     + + + APE
Sbjct: 126 GSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 240 LISRNFGTVSCK----SDVYGFGMVLLEM 264
            +      +  K    SDV+ FG+ L E+
Sbjct: 183 CL------IQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+VY    + TG  +A+K +   +   +E I NE+  +    H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 130 SEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V EY+  GSL   +      E +  + C E L        + +E+LH+    
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ-- 135

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN- 244
            ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA 191

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +G    K D++  G++ +EM  G
Sbjct: 192 YGP---KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 43/232 (18%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGG-----------------LIAVKMLA--NSKFSGEEFIN 109
           F  KLG+G FG V+  ++                     L+AVK+L    +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD-----RHIFPKESRGQ----- 159
           EV  + R+   N+++LLG C +     ++ EYM NG L+      H+  KE  G      
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 160 -----SFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
                +  +  L  VAL  A G++YL +   +  +H D+   N L+  N   K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 215 KFHPKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + +    D+  I   R    I ++A E I    G  +  SDV+ FG+ L E+
Sbjct: 186 R-NLYAGDYYRIQG-RAVLPIRWMAWECIL--MGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 63/213 (29%), Positives = 88/213 (41%), Gaps = 15/213 (7%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K L      K  GE+  +NE   + ++    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV   M  G L  HI+     G  F   +    A     G+E+LH      
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQ---RR 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I++ D+KP N+LLD +   ++SD GLA           I    GT GY+APE++      
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG--EV 170

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK 280
                D +  G  L EM  GR        +  K
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 70/203 (34%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K L      K  GE   +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +  E +K AL  V   M  G L  HI+   + G  F  E+    A     G+E LH    
Sbjct: 67  YAYE-TKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLHRER- 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I++ D+KP NILLD     ++SD GLA     E +  +I    GT+GY+APE++    
Sbjct: 123 --IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE--TIRGRVGTVGYMAPEVVKNER 177

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
            T S   D +G G ++ EM  G+
Sbjct: 178 YTFS--PDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)

Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  +C+                  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 146 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 203 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 26/215 (12%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG V+KG    T  ++A+K+  L  ++   E+   E++ + +     V +  G 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 129 CSEGSKRALVYEYMPNGS-LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             +G+K  ++ EY+  GS LD        R   F   ++  +     +G++YLH+   + 
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDL------LRAGPFDEFQIATMLKEILKGLDYLHSEKKI- 123

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELISR 243
             H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIQQ 175

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           +      K+D++  G+  +E+A G   NS+MH  R
Sbjct: 176 S--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 143 TYQVARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 200 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)

Query: 71  HKLGQGGFGSVY-KGQLHTGGLIAVKMLANSKFSG-------EEFINEVSTIGRIHHVNV 122
           H++G G FG+VY     HT  ++AVK ++   +SG       ++ I EV  + ++ H N 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEKWQDIIKEVKFLQQLKHPNT 83

Query: 123 VQLLGFCSEGSKRALVYEYMPNGS---LDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           ++  G   +     LV EY    +   L+ H  P +         ++  +  G  +G+ Y
Sbjct: 84  IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE-------VEIAAITHGALQGLAY 136

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           LH+     ++H DIK  NILL      K++DFG A      N FV      GT  ++APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPE 187

Query: 240 LI-SRNFGTVSCKSDVYGFGMVLLEMA 265
           +I + + G    K DV+  G+  +E+A
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELA 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 31/208 (14%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK +   TG L A K++   S+   E+++ E+  +   +H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 130 SEGSKRALVYEYMPNGSLDRHIFP-----KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
               K  ++ E+ P G++D  +        E + Q  C + L          ++YLH+  
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML--------EALQYLHS-- 128

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            + I+H D+K  N+LL  +   K++DFG++    K   + + F+      GT  ++APE+
Sbjct: 129 -MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEV 181

Query: 241 I---SRNFGTVSCKSDVYGFGMVLLEMA 265
           +   +        K+D++  G+ L+EMA
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 36/210 (17%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNVVQ 124
           K+G+G +G VYKG+   TG ++A+K +   +   EE       I E+S +  + H N+V 
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHI--FPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           L     + S+  L++E++ +  L +++   PK   GQ    E +        +GI + H+
Sbjct: 64  LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHS 119

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGYIA 237
                +LH D+KP N+L+D+  + K++DFGLA+          ++ V       T+ Y A
Sbjct: 120 RR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-------TLWYRA 169

Query: 238 PELISRNFGTV--SCKSDVYGFGMVLLEMA 265
           PE++    G+   S   D++  G +  EMA
Sbjct: 170 PEVL---LGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.7 bits (174), Expect = 6e-14
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 38/211 (18%)

Query: 73  LGQGGFGSVY---KGQLHTGGLIAVKMLANSKFSGEEFINEVST----IGRIHHVNVVQL 125
           + +G +G V+   K    TG + A+K++  +    +  +++V T    + +     VV+L
Sbjct: 1   ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 126 LGFCSEGSKRAL--VYEYMPNG---SLDRHI--FPKESRGQSFCWEKLHEVALGTARGIE 178
             + S   K+ L  V EY+P G   SL  ++    ++            E+ L     +E
Sbjct: 59  --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LE 107

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------HPKENDFVSISATRGT 232
           YLH+     I+H D+KP NIL+D N   K++DFGL+K           +D        GT
Sbjct: 108 YLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLE 263
             YIAPE+I    G  S   D +  G +L E
Sbjct: 165 PDYIAPEVI-LGQGH-SKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 70.7 bits (173), Expect = 6e-14
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 30/213 (14%)

Query: 73  LGQGGFGSVYKGQL------HTGGL-IAVKMLANSKFSGE--EFINEVSTIGRIHHVNVV 123
           LG G FG VY+G         +G + +AVK L       E  EF+ E   +   +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSF-----CWEKLHEVALGTARGIE 178
           +LLG C     + ++ E M  G L  ++  +++R + F       ++L ++ L  A+G  
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 179 YLHNGCDVCILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRG-T 232
           YL     +  +H D+   N L+     D + + K+ DFGLA+   K +D+          
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-SDYYRKEGEGLLP 176

Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE L+   F T   +SDV+ FG+++ E+
Sbjct: 177 VRWMAPESLLDGKFTT---QSDVWSFGVLMWEI 206

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 6e-14
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 27/222 (12%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLG-FC 129
           +G G +G VYKG+ + TG L A+K++  +    EE   E++ + +  HH N+    G F 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 130 SEG-----SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +       +  LV E+   GS+   I  K ++G +   E +  +     RG+ +LH   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 132 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 182

Query: 241 ISRNF---GTVSCKSDVYGFGMVLLEMA-GGRRNSNMHATRS 278
           I+ +     T   KSD++  G+  +EMA G     +MH  R+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.8 bits (173), Expect = 6e-14
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 15/201 (7%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K L      K  GE   +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV   M  G L  HI+     G  F   +    A     G+E LH      
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLHQER--- 122

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+APE++     T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 179

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D +  G +L EM  G+
Sbjct: 180 FS--PDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 70.7 bits (173), Expect = 6e-14
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 37/225 (16%)

Query: 69  FTHKLGQGGFGSVY----KGQL-------------HTGGLIAVKML---ANSKFSGEEFI 108
           F  KLG+G FG V+    +G               +   L+AVKML   AN K +  +F+
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFL 67

Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD----RHIFPK---ESRGQSF 161
            E+  + R+   N+++LL  C       ++ EYM NG L+    RH   +   ++   + 
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 162 CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 221
            +  L  +A   A G++YL +   +  +H D+   N L+  N+  K++DFG+++ +    
Sbjct: 128 SYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSG 183

Query: 222 DFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           D+  I   R    I +++ E I    G  +  SDV+ FG+ L E+
Sbjct: 184 DYYRIQG-RAVLPIRWMSWESIL--LGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.3 bits (172), Expect = 7e-14
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 33/211 (15%)

Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLGF 128
           +G+G FG V+   +     L+ +K +   + + +E     NE   +  + H N+++    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK--LH---EVALGTARGIEYLHNG 183
             E     +V EY P G+L  +I   + R  S   E   LH   ++ L     + ++H  
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLA----LHHVHTK 120

Query: 184 CDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG---YIAPE 239
               ILH D+K  NILLD H  + K+ DFG++K         S S     +G   YI+PE
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKI------LSSKSKAYTVVGTPCYISPE 171

Query: 240 LI-SRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           L   + +     KSD++  G VL E+A  +R
Sbjct: 172 LCEGKPYNQ---KSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 72/241 (29%), Positives = 103/241 (42%), Gaps = 53/241 (21%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF--INEVSTIGRIHHVNVVQLLG 127
            KLG+G + +VYKG+   TG L+A+K +      G  F  I E S +  + H N+V L  
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 128 FCSEGSKRALVYEYMPNG---SLDRHIFPKESRGQSFCWEKLHEVALGT---ARGIEYLH 181
                    LV+EY+       +D         G S     +H V L      RG+ Y H
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYMDDC-----GGGLS-----MHNVRLFLFQLLRGLAYCH 120

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGYI 236
                 +LH D+KP N+L+      K++DFGLA+          N+ V       T+ Y 
Sbjct: 121 ---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-------TLWYR 170

Query: 237 APE--LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP--SWVYDQLN 292
            P+  L S  + T     D++G G +  EMA GR              FP  + V DQL+
Sbjct: 171 PPDVLLGSTEYST---SLDMWGVGCIFYEMATGR------------PLFPGSTDVEDQLH 215

Query: 293 K 293
           K
Sbjct: 216 K 216

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 27/222 (12%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCS 130
           +G G +G VYKG+ + TG L A+K++  ++   EE   E++ + +  HH N+    G   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 131 EGSKRA------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           + S         LV E+   GS+   +  K ++G +   + +  +     RG+ +LH   
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGLAHLHAHK 141

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 142 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 192

Query: 241 ISRNF---GTVSCKSDVYGFGMVLLEMA-GGRRNSNMHATRS 278
           I+ +     T   +SD++  G+  +EMA G     +MH  R+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 30/216 (13%)

Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + ++E+  +  I  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK------------LHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 140 AYQVARGMEYL--ASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 54/207 (26%), Positives = 106/207 (51%), Gaps = 27/207 (13%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIH---HVNV 122
           ++G G +G+VYK +  H+G  +A+K +     + E+      + EV+ + R+    H N+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQ--TNEDGLPLSTVREVALLKRLEAFDHPNI 64

Query: 123 VQLLGFCS-----EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           V+L+  C+       +K  LV+E++     D   +  +        E + ++     RG+
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y A
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRA 175

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE++ ++  T +   D++  G +  EM
Sbjct: 176 PEVLLQS--TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 70.1 bits (171), Expect = 9e-14
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 72  KLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVV 123
           +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  +VV
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKE--SRGQSF-CWEKLHEVALGTARGI 177
           +LLG  S+G    ++ E M  G L    R + P+   +  Q+    +K+ ++A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TIGY 235
            YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   + +
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPVRW 187

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           ++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 188 MSPE--SLKDGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 70.4 bits (173), Expect = 9e-14
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 44/213 (20%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQL 125
            K+G+G F  V K Q   TG   A+K +    F   E +N +  I  +     H N+++L
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 126 LG--FCSEGSKRALV--------YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
           +   F  +  + ALV        YE +      +   P E R +S+ ++ L         
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKG---RKRPLP-EKRVKSYMYQLLK-------- 111

Query: 176 GIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRG 231
            ++++H NG    I H DIKP NIL+  + + K++DFG  +     P   +++S   TR 
Sbjct: 112 SLDHMHRNG----IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYIS---TR- 162

Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              Y APE +  + G    K D++  G V  E+
Sbjct: 163 --WYRAPECLLTD-GYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 17/199 (8%)

Query: 72  KLGQGGFGSVYKG--QLHTGGL-IAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FG V KG  ++    + +A+K+L   N K   +E + E   + ++ +  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPK-ESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           G C E     LV E    G L++ +  K +    S   E +H+V++G    ++YL     
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEGKNF 116

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
           V   H D+   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  N
Sbjct: 117 V---HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--N 171

Query: 245 FGTVSCKSDVYGFGMVLLE 263
           F   S +SDV+ +G+ + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 14/204 (6%)

Query: 72  KLGQGGFGSVYKGQLHTG---GLIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQLL 126
           ++G G FG V  G++++G     + VK L  S    E+  F+ E      + H N++Q L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFC-WEKLHEVALGTARGIEYLHNGCD 185
           G C+E +   LV E+ P G L  ++               L  +A   A G+ +LH    
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
              +H D+   N LL  +   K+ D+GL+    KE+ +V+       + +IAPEL+    
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 246 GTV-----SCKSDVYGFGMVLLEM 264
           G +     + +S+V+  G+ + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 72/285 (25%), Positives = 129/285 (45%), Gaps = 50/285 (17%)

Query: 68  HFTHKLGQGGFGSVY--KGQLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNV 122
               K+G+G FG +Y  K +  +   + +K +  +K   +E      EV  + ++ H N+
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           V       E  +  +V EY   G L + I     RG  F  +++    +  + G++++H 
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIH- 118

Query: 183 GCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL 240
             D  ILH DIK  NI L  N  + K+ DFG+A+   + ND + ++ T  GT  Y++PE+
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLSPEI 173

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMH--ATRSSKAYF----PSWVYDQL 291
                   + K+D++  G VL E+   +     +N+H    +  + YF    P++  D  
Sbjct: 174 CQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD-- 229

Query: 292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                        + S+I++          +V   DRPS+T +L+
Sbjct: 230 -------------LRSLISQ--------LFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 70/260 (26%), Positives = 106/260 (40%), Gaps = 74/260 (28%)

Query: 73  LGQGGFGSVYK------GQLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  +   +AVKML     + E    + E+  +  I HH+NVV
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLD------RHIF-----PKESRGQ------------ 159
            LLG C++ G    ++ EY   G+L       R  F         + +            
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 160 -----------SFCWEK-----------------------LHEVALGTARGIEYLHNGCD 185
                       F  +K                       L   +   ARG+E+L     
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--ASR 192

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
            CI H D+   NILL  N + K+ DFGLA+   K+ D+V     R  + ++APE I   F
Sbjct: 193 KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI---F 248

Query: 246 GTV-SCKSDVYGFGMVLLEM 264
             V + +SDV+ FG++L E+
Sbjct: 249 DKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 44/215 (20%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--------FINEVSTIGRIHHVNV 122
           K+G+G +G V+K +   TG ++A+K     KF   E         + E+  + ++ H N+
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 123 VQLLGFCSEGSKRALVYEYMPN---GSLDRHIFPK---ESRGQSFCWEKLHEVALGTARG 176
           V L+       K  LV+EY  +     L+++  P+   E   +   W+        T + 
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQ--------TLQA 112

Query: 177 IEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG 234
           + + H + C    +H D+KP NIL+      K+ DFG A+      +D+    ATR    
Sbjct: 113 VNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---W 165

Query: 235 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           Y APEL+     +G      DV+  G V  E+  G
Sbjct: 166 YRAPELLVGDTQYGP---PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 25/221 (11%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGF-- 128
           +G+G +G VYK     TG L+A+K++   +   EE   E + + +  +H N+    G   
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73

Query: 129 ----CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
                    +  LV E    GS+   +     +G+    E +  +   T RG+ YLH   
Sbjct: 74  KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H DIK  NILL  N   K+ DFG    L     + N F+      GT  ++APE+
Sbjct: 134 ---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------GTPYWMAPEV 184

Query: 241 ISRNFG---TVSCKSDVYGFGMVLLEMAGGRRN-SNMHATR 277
           I+ +     +   +SDV+  G+  +E+A G+    +MH  R
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 32/217 (14%)

Query: 73  LGQGGFGSVYKGQLH--------TGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V + + +            +AVKML ++    +  + I+E+  +  I  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHI-------------FPKESRGQSFCWEKLHE 168
           ++ LLG C++     ++ EY   G+L   +               K    Q   ++ L  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ-LSFKDLVS 138

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
            A   ARG+EYL +    CI H D+   N+L+  + + K++DFGLA+     + +   S 
Sbjct: 139 CAYQVARGMEYLES--RRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 229 TRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 196 GRLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)

Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + + G L+AVK +   K    E + NEV  +    H NVV++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 130 SEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  + C   L  +++  A+G+         
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGV--------- 137

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 138 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELIS 189

Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 190 RLPYGP---EVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 43/228 (18%)

Query: 69  FTHKLGQGGFGSV----------YKGQLHTGG-------LIAVKMLA--NSKFSGEEFIN 109
           F  KLG+G FG V          +  +            L+AVK+L    S  + E+F+ 
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68

Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD----RHIFPKESR---GQSFC 162
           EV  + R+   N+ +LLG C+      ++ EYM NG L+    +H+          +S  
Sbjct: 69  EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 163 WEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
           +  L  +A   A G+ YL   N      +H D+   N L+  N+  K++DFG+++ +   
Sbjct: 129 FSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSR-NLYS 182

Query: 221 NDFVSISATRGT----IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +D+  +   +G     I ++A E +    G  + KSDV+ FG+ L E+
Sbjct: 183 SDYYRV---QGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)

Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE-----FINEVSTIGRIHHVNVVQL 125
           KLG+G + +V+KG+   T  L+A+K +   +   EE      I EVS +  + H N+V L
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
                      LV+EY+ +  L +++   ++ G       +        RG+ Y H    
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK- 123

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ILH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++    
Sbjct: 124 --ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVL---L 176

Query: 246 GTV--SCKSDVYGFGMVLLEMAGGR 268
           G+   S   D++G G +L EMA GR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 4e-13
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 35/210 (16%)

Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEF--INEVSTIGRIHHVNVVQLLGF 128
           KLG+G + +VYKG+    G L+A+K++   +  G  F  I E S +  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 129 CSEGSKRALVYEYMPNG---SLDRH---IFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
                   LV+EY+       +D+H   + P+  +   F ++ L        RG+ Y+H 
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK--LFLFQLL--------RGLSYIHQ 121

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----HPKENDFVSISATRGTIGYIA 237
                ILH D+KP N+L+      K++DFGLA+      H   N+ V       T+ Y  
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-------TLWYRP 171

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           P+++  +    +C  D++G G + +EM  G
Sbjct: 172 PDVLLGSTEYSTC-LDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + H+G  +AVKM+   K    E + NEV  +    H NVV++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  ++ E++  G+L   +   ++R      E++  V     + + YLH+     ++
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV--SQTRLNE---EQIATVCESVLQALCYLHSQG---VI 139

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRN- 244
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR  
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTP 193

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +GT   + D++  G++++EM  G
Sbjct: 194 YGT---EVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 30/208 (14%)

Query: 73  LGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEEFI---NEVSTIGRIHHVNVVQ 124
           LGQG FG V+      G    G L A+K+L  +     + +    E   +  ++H  +V+
Sbjct: 4   LGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 125 L-LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK----LHEVALGTARGIEY 179
           L   F +EG K  L+ +++  G L    F + S+   F  E     L E+AL     +++
Sbjct: 63  LHYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALA----LDH 113

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           LH+   + I++ D+KP NILLD     K++DFGL+K    +++  + S   GT+ Y+APE
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC-GTVEYMAPE 168

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +++R   T S  +D + FG+++ EM  G
Sbjct: 169 VVNRRGHTQS--ADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 16/199 (8%)

Query: 72  KLGQGGFGSVYKG--QLHTGGLI--AVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQL 125
            +G+G FG VY+G         I  AVK   N  S    E+F+ E   + +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G  +E +   +V E  P G L  ++   +    S     L   +   +  + YL +   
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLESKRF 128

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           V   H DI   N+L+      K+ DFGL+++  ++  +   S  +  I ++APE I  NF
Sbjct: 129 V---HRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESI--NF 182

Query: 246 GTVSCKSDVYGFGMVLLEM 264
              +  SDV+ FG+ + E+
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 15/213 (7%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKF---SGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+ +TG + A K L   +    SGE+  + E   + +++   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G L  HI+    RG     E++   +     GI +LH    + 
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM--ERVIHYSAQITCGILHLH---SMD 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I++ D+KP N+LLD     ++SD GLA       D  +I+   GT GY+APE++      
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKEE--P 170

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK 280
            S   D +  G  + EM  GR     H  + +K
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 36/214 (16%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +   T  ++A+K   + N K   E F    + E+  +  + H NVV 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 75

Query: 125 LLGFCS-----EGSKRA---LVYEYMPN--GSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           L+  C          +    LV+E+  +    L  +   K      F   ++ +V     
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK------FTLSEIKKVMKMLL 129

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  NIL+  + I K++DFGLA+ F   +N   +    R  T
Sbjct: 130 NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 187 LWYRPPELLLGERDYGP---PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.9 bits (166), Expect = 6e-13
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 38/216 (17%)

Query: 70  THKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNV 122
             K+G+G +G VYK +   T   IA+K +   +   E+       I E+S +  + H N+
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHI-----FPKESRG-QSFCWEKLHEVALGTARG 176
           V+L        +  LV+EY+ +  L +H+     F K  R  +++ ++ L        RG
Sbjct: 64  VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL--------RG 114

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAK-FHPKENDFVSISATRGTIG 234
           I Y H+     +LH D+KP N+L+D      K++DFGLA+ F      F        T+ 
Sbjct: 115 IAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---TLW 168

Query: 235 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           Y APE++  SR++ T     D++  G +  EM   +
Sbjct: 169 YRAPEILLGSRHYST---PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 35/267 (13%)

Query: 73  LGQGGFGSVYKGQLHTGGL-----IAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   S   L+ + MP G L  ++   +        + L    +  A+G+ YL    +
Sbjct: 75  LGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE---E 127

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    +         +  I ++A E I    
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR- 186

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY--FP-SWVYDQLNKGGDLELRNV 302
              + +SDV+ +G+ + E+           T  SK Y   P S +   L KG  L    +
Sbjct: 187 -IYTHQSDVWSYGVTVWEL----------MTFGSKPYDGIPASEISSILEKGERLPQPPI 235

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRP 329
             I+      + MI + C  + A  RP
Sbjct: 236 CTID------VYMIMVKCWMIDADSRP 256

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 38/162 (23%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNVVQ 124
           K+G+G +G VYK +   TG ++A+K +   +   E+       I E+S +  ++H N+V+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI---RLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 125 LLGFCSEGSKRALVYEYM-----------PNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
           LL      +K  LV+E++           P   LD  +       +S+ ++ L       
Sbjct: 63  LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI------KSYLYQLL------- 109

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
            +GI Y H+     +LH D+KP N+L+D     K++DFGLA+
Sbjct: 110 -QGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.4 bits (164), Expect = 8e-13
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 33/215 (15%)

Query: 72  KLGQGGFGSVYKGQLHT------GGLIAVKMLAN-SKFSGEEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  + +         L+AVK L + S  + ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIF-------------PKESRGQSFCWEKLHEVAL 171
             G C EG    +V+EYM +G L++ +                    QS   + LH +A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS---QMLH-IAQ 127

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TR 230
             A G+ YL +      +H D+   N L+  N + K+ DFG+++      D+  +   T 
Sbjct: 128 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR-DVYSTDYYRVGGHTM 183

Query: 231 GTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
             I ++ PE ++ R F T   +SDV+  G+VL E+
Sbjct: 184 LPIRWMPPESIMYRKFTT---ESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 67.3 bits (164), Expect = 8e-13
 Identities = 68/203 (33%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K L      K  GE   +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +  E +K AL  V   M  G L  HI+   + G  F  ++    A     G+E L     
Sbjct: 67  YAYE-TKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQRER- 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I++ D+KP NILLD     ++SD GLA   P+     ++    GT+GY+APE+I+   
Sbjct: 123 --IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEK 177

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
            T S   D +G G ++ EM  G+
Sbjct: 178 YTFS--PDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 38/233 (16%)

Query: 73  LGQGGFGSVYKGQLH--TGGLIAVKM--LANSKFSGEEFINEVSTIGRIHH-VNVVQLLG 127
           +G+G FG+V K  LH  +G ++AVK       +   +  + ++  + R      +V+  G
Sbjct: 12  IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 128 --FCSEGSKRALV-YEYMPNGSLDR-HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
             F  EG     +  E M + SLD+ + +  E        E L ++A+ T + + YL   
Sbjct: 71  ALF-REGD--CWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE- 125

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELI 241
            ++ I+H D+KP NILLD N   K+ DFG++     +    SI+ TR  G   Y+APE I
Sbjct: 126 -ELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVD----SIAKTRDAGCRPYMAPERI 179

Query: 242 SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW--VYDQL 291
             +       +SDV+  G+ L E+A G            K  +P W  V+DQL
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATG------------KFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 25/203 (12%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANS-KFSGEEF---INEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + + T  ++A+K ++ S K S E++   I EV  + RI H N ++  
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 127 GFCSEGSKRALVYEYMPNGS---LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           G         LV EY    +   L+ H  P +         ++  +  G  +G+ YLH+ 
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-------EIAAITHGALQGLAYLHSH 144

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-S 242
               ++H DIK  NILL      K++DFG A      N FV      GT  ++APE+I +
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILA 195

Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
            + G    K DV+  G+  +E+A
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELA 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 72  KLGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           +LGQG FG VY        KG+  T   +AVK +  S    E  EF+NE S +      +
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAET--RVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEV---ALGTAR 175
           VV+LLG  S+G    +V E M +G L    R + P+           L E+   A   A 
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TI 233
           G+ YL+    V   H D+   N ++ H+F  K+ DFG+ +    E D+      +G   +
Sbjct: 131 GMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPV 185

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 186 RWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 23/204 (11%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG- 127
           +LG G  G V K Q    GLI  + L + +       + I E+  +   +   +V   G 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F S+G + ++  E+M  GSLD+ +  KE++      E L +V++   RG+ YL       
Sbjct: 72  FYSDG-EISICMEHMDGGSLDQVL--KEAK--RIPEEILGKVSIAVLRGLAYLREKHQ-- 124

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 245
           I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +    
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ--- 175

Query: 246 GT-VSCKSDVYGFGMVLLEMAGGR 268
           GT  S +SD++  G+ L+E+A GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 29/208 (13%)

Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE-----FINEVSTIGRIHHVNVVQL 125
           KLG+G + +VYKG+   T  L+A+K +   +   EE      I EVS +  + H N+V L
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVAL---GTARGIEYLHN 182
                      LV+EY+ +  L +++   +  G S     +H V L      RG+ Y H 
Sbjct: 70  HDIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSI---NMHNVKLFLFQLLRGLNYCHR 122

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI- 241
                +LH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++ 
Sbjct: 123 RK---VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 242 -SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            S ++ T   + D++G G +  EM+ GR
Sbjct: 178 GSTDYST---QIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 67.1 bits (163), Expect = 1e-12
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+VY    + TG  +A+K +   +   +E I NE+  +    + N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPK---ESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V EY+  GSL   +      E +  + C E L        + +++LH+    
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALDFLHSNQ-- 135

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN- 244
            ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA 191

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +G    K D++  G++ +EM  G
Sbjct: 192 YGP---KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE-----FINEVSTIGRIHHVNVVQL 125
           KLG+G + +V+KG+   T  L+A+K +   +   EE      I EVS +  + H N+V L
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVAL---GTARGIEYLHN 182
                      LV+EY     LD+ +  K+          +H V +      RG+ Y H 
Sbjct: 70  HDIVHTDKSLTLVFEY-----LDKDL--KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI- 241
                +LH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++ 
Sbjct: 123 RK---VLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLL 177

Query: 242 -SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            S  + T   + D++G G +  EMA GR
Sbjct: 178 GSSEYST---QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 33/185 (17%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE------FINEVSTIGRI---HHVNV 122
           +G+G +G+VYK + L+TG  +A+K +   +    E       + E++ + ++    H N+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 123 VQLLGFC-----SEGSKRALVYEYMP---NGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           V+LL  C         K  LV+E++       L +   PK         E + ++     
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PKPGLPP----ETIKDLMRQLL 117

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           RG+++LH+     I+H D+KP NIL+  +   K++DFGLA+ +  E    S+     T+ 
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV---TLW 171

Query: 235 YIAPE 239
           Y APE
Sbjct: 172 YRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 66.7 bits (162), Expect = 2e-12
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+V+    + TG  +A+K +   K   +E I NE+  +  + + N+V  L   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPK---ESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V EY+  GSL   +      E++  + C E L        + +E+LH     
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL--------QALEFLHAN--- 134

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN- 244
            ++H DIK  N+LL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA 191

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +G    K D++  G++ +EM  G
Sbjct: 192 YGP---KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 14/203 (6%)

Query: 73  LGQGGFGSVYKGQLH--TGGLIAVKMLANSKFSGEE--FINEVSTIGR-IHHVNVVQLLG 127
           LG+G +G V K + H  TG ++AVK +  +  S E+   + ++    R +     V   G
Sbjct: 9   LGRGAYGVVDKMR-HVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    +  E M + SLD+       +G +   + L ++A+   + +EYLH+   V 
Sbjct: 68  ALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV- 125

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS--RNF 245
            +H D+KP N+L++ N   K+ DFG++ +     D V+ +   G   Y+APE I+   N 
Sbjct: 126 -IHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQ 181

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                KSDV+  G+ ++E+A GR
Sbjct: 182 KGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 25/204 (12%)

Query: 73  LGQGGFGSVYK-GQLHTGGLIAVK-MLANSKFSGEEFINEVSTIGRIHHVN---VVQLLG 127
           LG G  GSV K   + TG ++A K +   +K S  + I  +  +  +H      +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70

Query: 128 -FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            F +E +   +  E+M  GSLDR I+ K   G     E L ++A+    G+ YL+N    
Sbjct: 71  AFLNENNI-CMCMEFMDCGSLDR-IYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VH 123

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRN 244
            I+H DIKP NIL++     K+ DFG++    +   + FV      GT  Y++PE I   
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV------GTSTYMSPERIQG- 176

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
            G  + KSDV+  G+ ++E+A G+
Sbjct: 177 -GKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 47/283 (16%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM-----LANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           K+G+G F  VY+   L  G  +A+K      L ++K +  + I E+  + +++H NV++ 
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKY 67

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHI--FPKESR--GQSFCWEKLHEVALGTARGIEYLH 181
                E ++  +V E    G L R I  F K+ R   +   W+    V L +A  +E++H
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF--VQLCSA--LEHMH 123

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERI 178

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA-------GGRRNSNMHATRSSKAYFPSWVYDQLNKG 294
             N    + KSD++  G +L EMA       G + N      +  +  +P    D  ++ 
Sbjct: 179 HEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE- 235

Query: 295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
              ELR +  +              CI      RP +T V ++
Sbjct: 236 ---ELRQLVNM--------------CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 42/216 (19%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLA-NSKFSG--EEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G+V+K +   T  ++A+K +  +    G     + E+  +  + H N+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 128 FCSEGSKRALVYEYMP----------NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
                 K  LV+EY            NG +D  I       +SF ++ L        +G+
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV------KSFMFQLL--------KGL 112

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGY 235
            + H+     +LH D+KP N+L++ N   K++DFGLA+    P        SA   T+ Y
Sbjct: 113 AFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR----CYSAEVVTLWY 165

Query: 236 IAPELISRNFGT--VSCKSDVYGFGMVLLEMAGGRR 269
             P+++   FG    S   D++  G +  E+A   R
Sbjct: 166 RPPDVL---FGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPK---ESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V EY+  GSL   +      E +  + C E L        + +E+LH+    
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ-- 136

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN- 244
            ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA 192

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +G    K D++  G++ +EM  G
Sbjct: 193 YGP---KVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLL-GF 128
           +LG G FG VYK Q    G++A   + ++K     E+++ E+  +    H N+V+LL  F
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
             E +   L+ E+   G++D  +   E   +     ++  V   T   + YLH   +  I
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH---ENKI 124

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISATRGTIGYIAPELI--- 241
           +H D+K  NIL   +   K++DFG++  +     + + F+      GT  ++APE++   
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCE 178

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA 265
           +        K+DV+  G+ L+EMA
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 25/203 (12%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANS-KFSGEEF---INEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + +    ++A+K ++ S K S E++   I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 127 GFCSEGSKRALVYEYMPNGS---LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           G         LV EY    +   L+ H  P +         ++  V  G  +G+ YLH+ 
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-------EIAAVTHGALQGLAYLHSH 134

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-S 242
               ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I +
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 185

Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
            + G    K DV+  G+  +E+A
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 64.3 bits (156), Expect = 9e-12
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 34/219 (15%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           K+G+G FG V+KG    T  ++A+K+  L  ++   E+   E++ + +     V +  G 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA-----RGIEYLHNG 183
             + +K  ++ EY+  GS    + P            L E  + T      +G++YLH+ 
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLHSE 120

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPE 239
             +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE
Sbjct: 121 KKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPE 171

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           +I ++      K+D++  G+  +E+A G   +S +H  +
Sbjct: 172 VIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPMK 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 22/204 (10%)

Query: 72  KLGQGGFGSVYKGQLH----TGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           K+G+G F  VY+           L  V++  + ++K + ++ + E+  + +++H NV++ 
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK-ARQDCVKEIDLLKQLNHPNVIKY 67

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHI--FPKESR--GQSFCWEKLHEVALGTARGIEYLH 181
           L    E ++  +V E    G L + I  F K+ R   +   W+    V L +A  +E++H
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF--VQLCSA--VEHMH 123

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERI 178

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA 265
             N    + KSD++  G +L EMA
Sbjct: 179 HEN--GYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEF--INEVSTIGRIHHVNVVQLLGF 128
           KLG+G + +VYKG     G L+A+K+++     G  F  I E S +  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                    V+EYM +  L +++  +   G      +L    L   RG+ Y+H      I
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRLFMFQL--LRGLAYIHGQH---I 124

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+KP N+L+ +    K++DFGLA+   K     + S+   T+ Y  P+++    G  
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVL---LGAT 179

Query: 249 --SCKSDVYGFGMVLLEMAGGR 268
             S   D++G G + +EM  G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 33/271 (12%)

Query: 73  LGQGGFGSVYKGQLHTGGL-----IAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L  +    +  EF++E   +  + H ++V+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + LV + MP+G L  ++   K++ G       L    +  A+G+ YL    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 126

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 184

Query: 245 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT 303
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 236

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
            I+      + M+ + C  + A  RP   ++
Sbjct: 237 TID------VYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 59/190 (31%), Positives = 91/190 (47%), Gaps = 38/190 (20%)

Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLANSKF----------SGEEFINEVSTIGRIH 118
           LG+GG+G V++ +  TG     + A+K+L  +              E  I E      + 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA-----VK 58

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG----QSFCWEKLHEVALGTA 174
           H  +V L+     G K  L+ EY+  G L  H+   E  G     + C+  L E++L   
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACF-YLSEISLA-- 112

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTI 233
             +E+LH      I++ D+KP NILLD     K++DFGL K    E    +++ T  GTI
Sbjct: 113 --LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTI 164

Query: 234 GYIAPELISR 243
            Y+APE++ R
Sbjct: 165 EYMAPEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 43/226 (19%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRH--IFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
                +K  LV+E++ +  L +     P            L ++     +G+ + H+   
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLAFCHSHR- 120

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGYIAPEL 240
             +LH D+KP N+L++     K++DFGLA+          ++ V       T+ Y APE+
Sbjct: 121 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYRAPEI 171

Query: 241 I--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP 284
           +   + + T     D++  G +  EM           TR  +A FP
Sbjct: 172 LLGCKYYSTA---VDIWSLGCIFAEM----------VTR--RALFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 33/228 (14%)

Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSG---EEFINEV 111
           EI   T  F  +LG+  FG VYKG L           +A+K L + K  G   EEF +E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD-KAEGPLREEFKHEA 59

Query: 112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK------ 165
               R+ H N+V LLG  ++    ++++ Y  +  L   +  +         +       
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 166 -------LHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
                  +H V    A G+E+L  H+       H D+   N+L+      K+SD GL + 
Sbjct: 120 TLEPADFVHIVT-QIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
               + +  +  +   I +++PE I   +G  S  SD++ +G+VL E+
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 52/216 (24%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---NEVS----------TIGRIH 118
           LG+G FG V   +   TG L A+K L       +  I   +EV           T     
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALK------KGDIIARDEVESLMCEKRIFETANSER 60

Query: 119 HVNVVQLLGFCSEGSKRA-LVYEYMPNGSLDRHI----FPKESRGQSFCWEKLHEVALGT 173
           H  +V L   C +       V EY   G L  HI    F  E R   +       V LG 
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYA----ACVVLG- 113

Query: 174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISA 228
              ++YLH N     I++ D+K  N+LLD     K++DFGL K    F  + + F     
Sbjct: 114 ---LQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---- 162

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             GT  ++APE+++    T +   D +G G+++ EM
Sbjct: 163 --GTPEFLAPEVLTETSYTRAV--DWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 71/275 (25%), Positives = 125/275 (45%), Gaps = 37/275 (13%)

Query: 73  LGQGGFGSVYKGQLHTGGL-----IAVKMLA--NSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L    S  + +E ++E   +  +    V +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   S   LV + MP G L  ++   + R  S   + L    +  A+G+ YL    +
Sbjct: 75  LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGS---QDLLNWCVQIAKGMSYLE---E 127

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE-LISRN 244
           V ++H D+   N+L+      K++DFGLA+    +         +  I ++A E ++ R 
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY--FPSW-VYDQLNKGGDLELRN 301
           F   + +SDV+ +G+ + E+           T  +K Y   P+  + D L KG  L    
Sbjct: 188 F---THQSDVWSYGVTVWEL----------MTFGAKPYDGIPAREIPDLLEKGERLPQPP 234

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           +  I+      + MI + C  + +  RP   ++++
Sbjct: 235 ICTID------VYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHV---NVVQLL 126
           +G+G +G+VY+G  + TG ++A+K+  L        +   EV+ + ++      N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G   +G +  ++ EY   GS+ R +       + +    + EV +     ++Y+H    V
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLV----ALKYIHK---V 120

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELIS 242
            ++H DIK  NIL+ +    K+ DFG+A            S+ R    GT  ++APE+I 
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVGTPYWMAPEVI- 173

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
                   K+D++  G+ + EMA G
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 44/131 (33%), Positives = 66/131 (50%), Gaps = 16/131 (12%)

Query: 140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL 199
           E+M  GSLD+ +  K  R        L ++++   RG+ YL       I+H D+KP NIL
Sbjct: 79  EHMDGGSLDQ-VLKKAGRIPE---NILGKISIAVLRGLTYLREKHK--IMHRDVKPSNIL 132

Query: 200 LDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 257
           ++     K+ DFG++        N FV      GT  Y++PE +     TV   SD++  
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYTVQ--SDIWSL 184

Query: 258 GMVLLEMAGGR 268
           G+ L+EMA GR
Sbjct: 185 GLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 53/223 (23%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLL 126
            +G+G +G V       TG  +A+K +  S F  + F    + E+  + R  H N++ +L
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRRFKHENIIGIL 69

Query: 127 GFCSEGSKRA-----LVYEYMPNG--------SL-DRHIFPKESRGQSFCWEKLHEVALG 172
                 S  +     +V E M            L + HI       Q F ++ L      
Sbjct: 70  DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI-------QYFLYQIL------ 116

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-------FVS 225
             RG++Y+H   +V  LH D+KP N+LL+ N   K+ DFGLA+    E+D       +V 
Sbjct: 117 --RGLKYIH-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV- 170

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             ATR    Y APE I  N    +   D++  G +L EM   R
Sbjct: 171 --ATR---WYRAPE-IMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 64/257 (24%), Positives = 100/257 (38%), Gaps = 76/257 (29%)

Query: 73  LGQGGFGSVYKGQL----HTGGLIAVKMLANSKF----SGEE--FINEVSTIGRIHHVNV 122
           +G+G FG V    L     TG + A+K+L   K       +      E   +       +
Sbjct: 9   IGRGAFGEV---WLVRDKDTGQVYAMKVL--RKSDMIKRNQIAHVRAERDILADADSPWI 63

Query: 123 VQLLGFCSEGSKRAL--VYEYMPNGSL-----DRHIFPKESRGQSFCWEKLH--EVALGT 173
           V+L  + S   +  L  V EYMP G L      + +FP+E         + +  E+ L  
Sbjct: 64  VKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-------TARFYIAELVLA- 113

Query: 174 ARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK----------------- 215
              ++ +H  G     +H DIKP NIL+D +   K++DFGL K                 
Sbjct: 114 ---LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 216 ----------FHPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
                         +   V  ++T GT  YIAPE L    +G    + D +  G++L EM
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEM 223

Query: 265 AGGR---RNSNMHATRS 278
             G     +  +  T +
Sbjct: 224 LYGFPPFYSDTLQETYN 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 67/266 (25%), Positives = 99/266 (37%), Gaps = 75/266 (28%)

Query: 68  HFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-H 118
                LG G FG V +          +   +AVKML     + E    ++E+  +  I +
Sbjct: 10  RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69

Query: 119 HVNVVQLLG--------------FCSEG-------SKRALVYEY---------------- 141
           H+NVV LLG              FC  G       +KR     Y                
Sbjct: 70  HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVE 129

Query: 142 ------MPNGSLDRHIFPKESRGQSFCWEKLHEV----------------ALGTARGIEY 179
                          +F +     S       E                 +   ARG+E+
Sbjct: 130 QSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEF 189

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V   + R  + ++APE
Sbjct: 190 L--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246

Query: 240 LISRNFGTV-SCKSDVYGFGMVLLEM 264
            I   F  V + +SDV+ FG++L E+
Sbjct: 247 SI---FDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)

Query: 48  NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGE 105
           N+  W +P+RY+             ++G G +GSV       TG  +A+K L+   F  E
Sbjct: 7   NKTVWELPERYTSL----------KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSE 55

Query: 106 EF----INEVSTIGRIHHVNVVQLLG-FCSEGSKRAL--VYEYMPNGSLDRHIFPKESRG 158
            F      E++ +  + H NV+ LL  F S  S       Y  MP    D     ++  G
Sbjct: 56  IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL----QKIMG 111

Query: 159 QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
                +K+  +      G++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+   
Sbjct: 112 HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168

Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            E        TR    Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 169 AE--MTGYVVTR---WYRAPEVI-LNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)

Query: 108 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH 167
             E   +  I+H +++QL G  +      L+   +P    D + +    R  + C   + 
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAIC--DIL 185

Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
            +     R I+YLH      I+H DIK  NI ++H     + DFG A F       V I+
Sbjct: 186 AIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP------VDIN 236

Query: 228 ATR-----GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 268
           A +     GTI   APEL++R+ +G      D++  G+VL EMA   
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.2 bits (152), Expect = 6e-11
 Identities = 62/256 (24%), Positives = 96/256 (37%), Gaps = 72/256 (28%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLAN---SKFSGEEFINEVSTIGRIHHVNVVQ 124
               +G G +G V       TG  +A+K ++N        +  + E+  +  + H N++ 
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63

Query: 125 LLG-FCSEGSKR----ALVYEYMP---------NGSL-DRHIFPKESRGQSFCWEKLHEV 169
           LL        +      +V E M             L D HI       Q F ++ L   
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHI-------QYFLYQIL--- 113

Query: 170 ALGTARGIEYLH--NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF----HPKENDF 223
                RG++YLH  N     ++H D+KP NIL++ N   K+ DFGLA+       ++   
Sbjct: 114 -----RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKS-----DVYGFGMVLLEMAGGRRNSNMHATRS 278
                TR    Y APEL+      +S        D++  G +  E+              
Sbjct: 164 TEYVVTR---WYRAPELL------LSSSRYTKAIDIWSVGCIFAELLTR----------- 203

Query: 279 SKAYFP-SWVYDQLNK 293
            K  FP     DQLN 
Sbjct: 204 -KPLFPGRDYIDQLNL 218

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG- 127
           +LG G  G V+K      GLI  + L + +       + I E+  +   +   +V   G 
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F S+G + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       
Sbjct: 72  FYSDG-EISICMEHMDGGSLDQ-VLKKAGRIPE---QILGKVSIAVIKGLTYLREKHK-- 124

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 245
           I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +    
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ--- 175

Query: 246 GT-VSCKSDVYGFGMVLLEMAGGR 268
           GT  S +SD++  G+ L+EMA GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 26/202 (12%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG G  G+VYK   L T  ++AVK+  L  +    ++ ++E+  + +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 130 SEGSKRALVYEYMPNGSLDRH-IFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
              ++ ++  E+M  GSLD +   P+   G+         +A+   +G+ YL +   + I
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLGR---------IAVAVVKGLTYLWS---LKI 116

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATR-GTIGYIAPELISRNFG 246
           LH D+KP N+L++     K+ DFG++         V SI+ T  GT  Y+APE IS    
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST------QLVNSIAKTYVGTNAYMAPERISGE-- 168

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                SDV+  G+  +E+A GR
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 61.4 bits (149), Expect = 9e-11
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 71  HKLGQGGFGSVYKGQLHTGGLIA---VKML---ANSKFSGEEFINEVSTIGRIHHVNVVQ 124
            ++G G FG V   +++T   +A   VK L   A+SK    EF+ +      + H N++Q
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK-EQNEFLQQGDPYRILQHPNILQ 59

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKE-SRGQSFCWEKLHEVALGTARGIEYLHNG 183
            LG C E     LV+EY   G L  ++  ++  R  S     L  +A   A G+ ++H  
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL-LQRMACEIAAGVTHMHK- 117

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-S 242
                LH D+   N  L  +   KV D+G+     KE+   +       + ++APEL+  
Sbjct: 118 --HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 243 RNFGTVSCK----SDVYGFGMVLLEM 264
            + G ++ +    S+V+  G+ L E+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 34/201 (16%)

Query: 88  TGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVVQLL--GFCSEGSKRALVYEY 141
           TG  +A+K+L       E     F  E +   R++H N+V LL  G    G   A V+EY
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEY 60

Query: 142 MPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH 196
           +P  +L   +      P    G+    + L  +A    +G           I+H D+KP 
Sbjct: 61  VPGRTLREVLAADGALPAGETGR-LMLQVLDALACAHNQG-----------IVHRDLKPQ 108

Query: 197 NILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELISRNFGTV 248
           NI++         KV DFG+    P   D    + TR     GT  Y APE + R    V
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RG-EPV 166

Query: 249 SCKSDVYGFGMVLLEMAGGRR 269
           +  SD+Y +G++ LE   G+R
Sbjct: 167 TPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 49/198 (24%), Positives = 83/198 (41%), Gaps = 37/198 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQL---HTGGLIAVKMLANSKFSGEEF----INEVSTIGRIHHV 120
                +G+G +G VYK +      G   A+K     K            E++ +  + H 
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62

Query: 121 NVVQLLGFCSEGSKRA--LVYEYMPNGSLDRHI--FPKESRG--------QSFCWEKLHE 168
           NVV L+    E + ++  L+++Y  +      I  F ++++         +S  W+ L+ 
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLWQILN- 119

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLA-KFHPKENDF 223
                  G+ YLH+     +LH D+KP NIL+        + K+ D GLA  F+      
Sbjct: 120 -------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 224 VSISATRGTIGYIAPELI 241
             +     TI Y APEL+
Sbjct: 170 ADLDPVVVTIWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 36/214 (16%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSK----FSGEEFINEVSTIGRIHHVNVV 123
           +++G+G +G VY+ +   +G ++A+K   + N +     S    + E++ +  + H N+V
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLRHPNIV 69

Query: 124 QLLGFCSEGSKRA----LVYEYMPN--GSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           +L        K      LV EY      SL  ++    S  Q  C      + L   RG+
Sbjct: 70  ELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC------LMLQLLRGL 121

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYI 236
           +YLH   +  I+H D+K  N+LL      K++DFGLA+ +         ++    T+ Y 
Sbjct: 122 QYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVVTLWYR 175

Query: 237 APELISRNFG-TVSCKS-DVYGFGMVLLEMAGGR 268
           APEL+    G T    + D++  G +L E+   +
Sbjct: 176 APELL---LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 72  KLGQGGFG-SVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G FG ++       G    +K +  SK S    EE   EV+ +  + H N+VQ   
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              E     +V +Y   G L + I     RG  F  +++ +  +     ++++H   D  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVH---DRK 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELI-SRNF 245
           ILH DIK  NI L  +   K+ DFG+A+     N  V ++ T  GT  Y++PE+  +R +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICENRPY 178

Query: 246 GTVSCKSDVYGFGMVLLEM 264
                KSD++  G VL EM
Sbjct: 179 NN---KSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKF---SGEEF-INE------VSTIGRIHHVN 121
           +G+GGFG VY   +  TG + A+K L   +     GE   +NE      VST G    + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST-GDCPFI- 59

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           V     F +   K + + + M  G L  H+    S+   F   ++   A     G+E++H
Sbjct: 60  VCMSYAFHTP-DKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           N     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+APE++
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 167

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS 279
            +     S  +D +  G +L ++  G      H T+  
Sbjct: 168 QKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 20/205 (9%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG L A K L   +       E  + E   + ++H   +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR---GIEYLHNGC 184
                +   LV   M  G L  HI+  +     F           TA+   G+E+LH   
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGF---PEPRACFYTAQIISGLEHLHQRR 117

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELISR 243
              I++ D+KP N+LLD++   ++SD GLA +    ++         GT G++APEL+  
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQG 171

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                S   D +  G+ L EM   R
Sbjct: 172 EEYDFSV--DYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 21/203 (10%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFIN------EVSTIGRIHHVNVVQL 125
           LGQG FG VY    + TG  +A K +     S E          E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 126 LGFCSEGSKRALV--YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            G   + +++ L    EYMP GS+   +    +  +S   +   ++      G+ YLH+ 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHSN 125

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELIS 242
               I+H DIK  NIL D     K+ DFG +K           I +  GT  +++PE+IS
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 243 -RNFGTVSCKSDVYGFGMVLLEM 264
              +G    K+DV+  G  ++EM
Sbjct: 183 GEGYGR---KADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 52/209 (24%), Positives = 104/209 (49%), Gaps = 30/209 (14%)

Query: 72  KLGQGGFGSVYKGQ-LHTGG-LIAVKMLANSKFSGEEFINEVSTIGRI---------HHV 120
           ++G+G +G V+K + L  GG  +A+K +   +    E    +STI  +          H 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 121 NVVQLLGFCS-----EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
           NVV+L   C+       +K  LV+E++     D   +  +        E + ++     R
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G+++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +   +++++   T+ Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWY 175

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            APE++ ++  + +   D++  G +  EM
Sbjct: 176 RAPEVLLQS--SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 38/222 (17%)

Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G+GGFG VY   +  TG + A+K L   +   ++        G    +N   +L   S 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 53

Query: 132 GS---------------KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           G                K   + + M  G L  H+    S+   F  +++   A     G
Sbjct: 54  GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILG 109

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 162

Query: 237 APELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMHATR 277
           APE++ +  GT     +D +  G +L ++  G      H T+
Sbjct: 163 APEVLQK--GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 36/210 (17%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFI---NEVSTIGRIHHVNVVQLL 126
            ++G G +G VYK + LHTG L AVK++      G++F     E+  +    H N+V   
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 127 GFCSEGSKRALVYEYMPNGSLDR--HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           G      K  +  EY   GSL    H+    S  Q      +  V   T +G+ YLH+  
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ------IAYVCRETLQGLAYLHSKG 126

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIA 237
               +H DIK  NILL  N   K++DFG+A           I+AT        GT  ++A
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA---------AKITATIAKRKSFIGTPYWMA 174

Query: 238 PEL--ISRNFGTVSCKSDVYGFGMVLLEMA 265
           PE+  + +N G  +   D++  G+  +E+A
Sbjct: 175 PEVAAVEKN-GGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 58/252 (23%), Positives = 98/252 (38%), Gaps = 62/252 (24%)

Query: 53  MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF---- 107
           + +RY     I    H    LG+G +G V K     TG ++A+K +   + S +      
Sbjct: 6   ISERY-----IQKGAH----LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQ 56

Query: 108 -----------INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL----DRHIF 152
                      + E+  +  I H N++ L+    EG    LV + M    L    DR I 
Sbjct: 57  LVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR 115

Query: 153 PKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
             ES+ +    + L         G+  LH       +H D+ P NI ++   I K++DFG
Sbjct: 116 LTESQVKCILLQIL--------NGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFG 164

Query: 213 LAK------FHPKENDFVSISATRG------TIGYIAPELISRNFG----TVSCKSDVYG 256
           LA+      +    +   ++           T+ Y APEL+    G      +   D++ 
Sbjct: 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL---MGAEKYHFAV--DMWS 219

Query: 257 FGMVLLEMAGGR 268
            G +  E+  G+
Sbjct: 220 VGCIFAELLTGK 231

Length = 335

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 75  QGGFGSVYKGQLHTGGL-----IAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           +G FG ++ G L          + VK + +  S+      + E   +  + H N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 128 FCSEGSKRALV-YEYMPNGSLDRHIFPKESR------GQSFCWEKLHEVALGTARGIEYL 180
            C E  +   V Y YM  G+L   +F ++ R       Q+   ++L  +A+  A G+ YL
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 239
           H      ++H DI   N ++D     K++D  L++   P +   +  +  R  + ++A E
Sbjct: 134 HK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALE 189

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMA 265
            +       S  SDV+ FG++L E+ 
Sbjct: 190 SLVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 22/154 (14%)

Query: 116 RIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF-PKESR----GQSFCWEKLHEVA 170
            ++H +V+++      G+   +V   +P+ S D + +  K SR     Q+   EK     
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEK----- 164

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
                G+ YLH      I+H D+K  NI ++      + D G A+F      F+ ++   
Sbjct: 165 -QILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--- 217

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           GT+   APE+++R+    + K+D++  G+VL EM
Sbjct: 218 GTVETNAPEVLARD--KYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 53/169 (31%), Positives = 77/169 (45%), Gaps = 33/169 (19%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEF----INEVSTIGRIHHVNVVQL 125
           +G+G +G VYK +   TG L+A+K   L N K   E F    I E+  + +++H N+V L
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNL 71

Query: 126 ----------LGFCSEGSKRALVYEYMPN---GSLDRHIFPKESRGQSFCWEKLHEVALG 172
                     L F  +     LV+EYM +   G L       ES    F  + +      
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-------ESGLVHFSEDHIKSFMKQ 124

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 221
              G+ Y H       LH DIK  NILL++    K++DFGLA+ +  E 
Sbjct: 125 LLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGE--EFIN----EVSTIGRIHHVNVVQL 125
           LGQG FG VY      TG  +AVK +     S E  + +N    E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 126 LGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            G   +  +R L    E+MP GS+   +    +  ++   +   ++      G+ YLH+ 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHSN 125

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELIS 242
               I+H DIK  NIL D     K+ DFG +K           + +  GT  +++PE+IS
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 243 -RNFGTVSCKSDVYGFGMVLLEM 264
              +G    K+D++  G  ++EM
Sbjct: 183 GEGYGR---KADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)

Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  +G   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY+  G L  H+    SR + F  ++           ++YLH+G    
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSGK--- 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           I++ D+K  N++LD +   K++DFGL K      D  ++    GT  Y+APE++  N +G
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 174 RA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 43/226 (19%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKM----LANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
            +G+GG G VY          +A+K     L+ +    + F+ E      + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 127 GFCSEGSKRALVYEYMP--NGSLDRHIFPKESRGQSFCWEKLHE-VALGT--------AR 175
             CS+G     VY  MP   G   + +  K    +    ++L E  ++G           
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLL-KSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATR---- 230
            IEY+H+     +LH D+KP NILL       + D+G A F   +E D + I        
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 231 -----------GTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEM 264
                      GT  Y+APE   R  G   S  +D+Y  G++L +M
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 34/209 (16%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFI---NEVSTIGRIHHVNVVQLL 126
            ++G G +G VYK + ++TG L A+K++      GE+F     E+  +    H N+V   
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 127 GFCSEGSKRALVYEYMPNGSLDR--HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           G      K  +  E+   GSL    H+    S  Q      +  V+  T +G+ YLH+  
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ------IAYVSRETLQGLYYLHSKG 126

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIA 237
            +   H DIK  NILL  N   K++DFG++           I+AT        GT  ++A
Sbjct: 127 KM---HRDIKGANILLTDNGHVKLADFGVS---------AQITATIAKRKSFIGTPYWMA 174

Query: 238 PELIS-RNFGTVSCKSDVYGFGMVLLEMA 265
           PE+ +    G  +   D++  G+  +E+A
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 41/214 (19%)

Query: 73  LGQGGFGSV----YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVV 123
           LG+G FG V     KG   T  L AVK+L       ++ +    T  R+      H  + 
Sbjct: 3   LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 124 QLLGFCSEGSKRAL--VYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARG 176
           QL       +K  L  V EY+  G L  HI     F  E R + +      E+ LG    
Sbjct: 60  QL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD-EPRARFYA----AEIVLG---- 108

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIG 234
           +++LH   +  I++ D+K  N+LLD     K++DFG+     KE     V+ S   GT  
Sbjct: 109 LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC----KEGILGGVTTSTFCGTPD 161

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           YIAPE++S      +   D +  G++L EM  G+
Sbjct: 162 YIAPEILSYQPYGPAV--DWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 10/157 (6%)

Query: 110 EVSTIGRIHHVNVVQLL-GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
           E   + ++ H N+V     +  E     +V  +   G L   +  KE +G+     ++ E
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVE 106

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
             +  A  ++YLH   +  ILH D+K  N+ L    I KV D G+A+    + D    S 
Sbjct: 107 WFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--ST 161

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
             GT  Y++PEL S      + KSDV+  G  + EMA
Sbjct: 162 LIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMA 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           RG++YLH+     ILH DIKP N+L++ N + K+ DFGLA+   + ++   ++    T  
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQY 169

Query: 235 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           Y APE++  SR++ +     D++  G +  E+ G R
Sbjct: 170 YRAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 19/202 (9%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           LG+G FG V   +L  +G L AVK+L       ++ +    T  RI     +H  + QL 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 127 GFCSEGSKRAL-VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
             C +   R   V E++  G L  HI  ++SR   F   +    A      + +LH   D
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHI--QKSR--RFDEARARFYAAEITSALMFLH---D 114

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I++ D+K  N+LLDH    K++DFG+ K         + S   GT  YIAPE++    
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEML 172

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
              S   D +  G++L EM  G
Sbjct: 173 YGPSV--DWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 34/214 (15%)

Query: 73  LGQGGFGSVYKG---------QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVV 123
           LGQG F  ++KG         +LH   ++   +  + +   E F    S + ++ H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
              G C  G +  +V EY+  GSLD ++  K     +  W KL EVA   A  + +L   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW-KL-EVAKQLAWALHFLE-- 117

Query: 184 CDVCILHFDIKPHNILLDHN---------FIPKVSDFGLA-KFHPKENDFVSISATRGTI 233
            D  + H ++   N+LL            FI K+SD G++    PKE     I   R  I
Sbjct: 118 -DKGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKE-----ILLER--I 168

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            ++ PE I  N   +S  +D + FG  L E+  G
Sbjct: 169 PWVPPECI-ENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCS 130
           +G+G +G VYK      G L AVK+L       EE   E + +  + +H NVV+  G   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 131 E-----GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +     G +  LV E    GS+   +      GQ      +  +  G   G+++LHN   
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR- 148

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAP 238
             I+H D+K +NILL      K+ DFG++           +++TR       GT  ++AP
Sbjct: 149 --IIHRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLRRNTSVGTPFWMAP 197

Query: 239 ELIS---RNFGTVSCKSDVYGFGMVLLEMAGG 267
           E+I+   +   +   + DV+  G+  +E+  G
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 71  HKLGQGGFGSVY----KGQLHTGGLIAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVV 123
            +LG+G FG+VY    K  +    L  +K +   + +  E +    E   + ++ H  +V
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +      E     ++ EY     LD  +   +  G++    ++ E  +    G+ Y+H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ILH D+K  NI L +N + K+ DFG+++      D    +   GT  Y++PE +  
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKH 179

Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
                  KSD++  G +L EM
Sbjct: 180 Q--GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 66/217 (30%), Positives = 91/217 (41%), Gaps = 49/217 (22%)

Query: 73  LGQGGFGSVY----KGQLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLG 127
           LG GGFG V     K +  T  L  VK     +   +E I +E   +   +H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVAL---GTAR------- 175
           + +   K+ +  + EY   G L               W  L +  L    TAR       
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGEL---------------WTILRDRGLFDEYTARFYIACVV 103

Query: 176 -GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRG 231
              EYLHN     I++ D+KP N+LLD N   K+ DFG AK      K   F       G
Sbjct: 104 LAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------G 154

Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           T  Y+APE+I  N G      D +  G++L E+  GR
Sbjct: 155 TPEYVAPEIIL-NKGY-DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)

Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  ++           ++YLH+  +V 
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 117

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 118 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 175 RA---VDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A+G+E+L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V     R  +
Sbjct: 189 AKGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++APE I     T+  +SDV+ FG++L E+
Sbjct: 246 KWMAPETIFDRVYTI--QSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 65/245 (26%), Positives = 97/245 (39%), Gaps = 52/245 (21%)

Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVST----IGRIHHVNVVQLL 126
            LG+G  G V+  +L  TG L A+K+L   +      +  V T    +  + H  +  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK----LHEVALGTARGIEYLH- 181
                 +   LV +Y P G L      +   G+    E       EV L     +EYLH 
Sbjct: 68  ASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLHL 121

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---------------------FHPKE 220
            G    I++ D+KP NILL  +    +SDF L+K                      +   
Sbjct: 122 LG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 221 NDFVS-ISATR-----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNS 271
           ++  S   + R     GT  YIAPE+IS +    +   D +  G++L EM  G    + S
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYGTTPFKGS 235

Query: 272 NMHAT 276
           N   T
Sbjct: 236 NRDET 240

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 31/206 (15%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFIN-EVSTIGRIHHVNVVQLLG 127
           LG G FG V   +   TG   A+K L      K    + +  E S +  + H  +V ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 128 FCSEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
              + ++   + E++  G L  H+     FP +   + +      E+ L      EYLH+
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV-AKFYH----AELVLA----FEYLHS 136

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI- 241
             D  I++ D+KP N+LLD+    KV+DFG AK  P +  F       GT  Y+APE+I 
Sbjct: 137 -KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFTLC----GTPEYLAPEVIQ 188

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           S+  G      D +  G++L E   G
Sbjct: 189 SKGHGKA---VDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFIN----EVSTIGRIHHVNVVQ 124
           LG+G FG VY      TG  +AVK +    +S+ + +E +N    E+  +  + H  +VQ
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68

Query: 125 LLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
             G   +  ++ L    EYMP GS+   +    +  ++       ++     +G+ YLH+
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLHS 124

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI 241
                I+H DIK  NIL D     K+ DFG +K           I +  GT  +++PE+I
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 242 S-RNFGTVSCKSDVYGFGMVLLEM 264
           S   +G    K+DV+     ++EM
Sbjct: 182 SGEGYGR---KADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 26/209 (12%)

Query: 73  LGQGGFGSVY----KGQLHTGGLIAVKMLANSKF-----SGEEFINEVSTIGRIHHVNVV 123
           LG G +G V+     G    G L A+K+L  +       + E    E   +  +     +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 124 QLL--GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR---GIE 178
             L   F ++ +K  L+ +Y+  G L  H++ +E     F      EV +  A     ++
Sbjct: 68  VTLHYAFQTD-TKLHLILDYVNGGELFTHLYQREH----F---TESEVRVYIAEIVLALD 119

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           +LH    + I++ DIK  NILLD      ++DFGL+K    E +  + S   GTI Y+AP
Sbjct: 120 HLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAP 175

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E+I    G      D +  G++  E+  G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 42/214 (19%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V K +   T  ++A+K   +S+ +    E  + E+  +  +   N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 129 CSEGSKRALVYEY-----------MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
                K  LV+EY           MPNG       P++ R  S+ ++ +        + I
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVP-----PEKVR--SYIYQLI--------KAI 113

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND--FVSISATRGTIGY 235
            + H      I+H DIKP N+L+ HN + K+ DFG A+   + ++  +    ATR    Y
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR---WY 167

Query: 236 IAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR 268
            +PEL+    G    K+ D++  G +L E++ G+
Sbjct: 168 RSPELL---LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 38/235 (16%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           LG+G FG V+  +L  T    A+K L       ++ +       R+      H  +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61

Query: 127 GFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +C+  +K  L  V EY+  G L  HI         F   +    A     G+++LH+  
Sbjct: 62  -YCTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISATRGTIGYIAPE- 239
              I++ D+K  NILLD +   K++DFG+ K +     K   F       GT  YIAPE 
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC------GTPDYIAPEI 167

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMHATRSSKAYFPSWV 287
           L+ + + T     D + FG++L EM  G+             + R     +P W+
Sbjct: 168 LLGQKYNT---SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 49/221 (22%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFI-----NEVSTIGRIHHVN-VVQ 124
           K+G+G +G VYK +  +TG L+A+K         EE I      E+S +  +     +V+
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLE--MDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 125 LLGFCSEGSKRA-----LVYEYMP---------NGSLDRHIFPKESRGQSFCWEKLHEVA 170
           LL       K       LV+EY+          NG       P ++  +SF ++ L    
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKT-IKSFMYQLL---- 120

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISAT 229
               +G+ + H      ++H D+KP N+L+D    + K++D GL +        + + + 
Sbjct: 121 ----KGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-----AFSIPVKSY 168

Query: 230 RG---TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMA 265
                T+ Y APE++  S ++ T     D++  G +  EM+
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYST---PVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           ARG+E+L      C+ H D+   N+LL    I K+ DFGLA+    ++++VS  +T   +
Sbjct: 247 ARGMEFL--ASKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++APE I  N  T    SDV+ +G++L E+
Sbjct: 304 KWMAPESIFDNLYTT--LSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 44/217 (20%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH------HVNVVQL 125
           +G+G +G V       T   +A+K +AN+ F  +  I+   T+  I       H NV+ +
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-F--DNRIDAKRTLREIKLLRHLDHENVIAI 69

Query: 126 LGFCSEGSKRA-----LVYEYMPNGSLDRHIFPKESRG------QSFCWEKLHEVALGTA 174
                   + A     +VYE M     D H   + S+       Q F ++ L        
Sbjct: 70  KDIMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHCQYFLYQLL-------- 118

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTI 233
           RG++Y+H+     +LH D+KP N+LL+ N   K+ DFGLA+   ++ DF++    TR   
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR--- 172

Query: 234 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            Y APEL+     + T     DV+  G +  E+ G +
Sbjct: 173 WYRAPELLLNCSEYTTA---IDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 54/236 (22%)

Query: 56  RYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS----GEEFINE 110
           RY   E+I          G+G +G V      HTG  +A+K + N  F         + E
Sbjct: 1   RYKIQEVI----------GKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILRE 49

Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEYMPNGSLDRHIFPKES------RGQ 159
           +  +  + H ++V++       S+R      +V+E M +   D H   K +        Q
Sbjct: 50  IKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQ 106

Query: 160 SFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
            F ++ L        R ++Y+H      + H D+KP NIL + +   K+ DFGLA+    
Sbjct: 107 FFLYQLL--------RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155

Query: 220 E-------NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +        D+V   ATR    Y APEL    F   +   D++  G +  E+  G+
Sbjct: 156 DTPTAIFWTDYV---ATR---WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  E+           +EYLH+     
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 174 RA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 27/204 (13%)

Query: 73  LGQGGFGSVYKGQLHTGG-LIAVKMLANS---KFSGEEFI-NEVSTIGRIHHVNVVQLLG 127
           +G G FG V+  +        A+K++A     +   E+ + NE   +  + H  +++L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           F +E  +R L  + EY+P G L  ++  + S   S      +   +  A  +EYLH+   
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA--LEYLHS--- 119

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELI-SR 243
             I++ D+KP NILLD     K++DFG AK           + T  GT  Y+APE+I S+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPEVIQSK 173

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
                    D +  G+++ EM  G
Sbjct: 174 GHNKA---VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 38/219 (17%)

Query: 65  VTNHFT--HKLGQGGFGSV--YKGQLHTGGLIAVKMLANSKFS----GEEFINEVSTIGR 116
           +TN +     +G G FG V   + QL TG  +A+K +    FS     +    E+  +  
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKH 65

Query: 117 IHHVNVVQLLG-FCSEGSKRALVYEYMPNGSLDRHIF----PKESR-GQSFCWEKLHEVA 170
           + H N++ L   F S       V E +     D H      P E +  Q F ++ L    
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFLYQIL---- 118

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH-PKENDFVSISAT 229
               RG++Y+H+     ++H D+KP NIL++ N   K+ DFGLA+   P+   +VS    
Sbjct: 119 ----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---- 167

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             T  Y APE I   +     + D++  G +  EM  G+
Sbjct: 168 --TRYYRAPE-IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 73  LGQGGFGSVYKGQLHTGG-----------LIAVKMLANSKFSGEEFINEVSTIGRIHHVN 121
           LGQG F ++YKG L                + +K+L +       F    S + ++ H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +V+L G C    +  +V EY+  G LD  +  +E    S  W KL +VA   A  + YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLHW-KL-DVAKQLASALHYLE 118

Query: 182 NGCDVCILHFDIKPHNILL-----DHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIG 234
              D  ++H ++   NIL+     +  ++P  K+SD G+        + V        I 
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIP 169

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +IAPE I     +++  +D + FG  LLE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 46/214 (21%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQL- 125
           ++ +G +G VY+ +   TG ++A+K L   K   E F    + E++ + ++ H N+V + 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 126 ---LGFCSEGSKRALVYEYMPN---GSLDRHIFPKESRGQSFCWEKLHEVA---LGTARG 176
              +G  S   K  +V EY+ +     ++     K+   QS       EV    L    G
Sbjct: 71  EVVVG--SNLDKIYMVMEYVEHDLKSLMETM---KQPFLQS-------EVKCLMLQLLSG 118

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KF-HPKENDFVSISATRG--T 232
           + +LH   D  ILH D+K  N+LL++  I K+ DFGLA ++  P +        T+   T
Sbjct: 119 VAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP------YTQLVVT 169

Query: 233 IGYIAPELISRNFGT--VSCKSDVYGFGMVLLEM 264
           + Y APEL+    G    S   D++  G +  E+
Sbjct: 170 LWYRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 22/221 (9%)

Query: 73  LGQGGFGSVY---KGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGR--IHHVNVVQLL 126
           LG G +G V+   K   H +G L A+K+L  +    +    E +   R  + H+     L
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 127 -----GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
                 F ++ +K  L+ +Y+  G L  H+  +E   +        E+ L     +E+LH
Sbjct: 68  VTLHYAFQTD-TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA----LEHLH 122

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 240
               + I++ DIK  NILLD N    ++DFGL+K FH  E +     +  GTI Y+AP++
Sbjct: 123 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE--RAYSFCGTIEYMAPDI 177

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA 281
           +    G      D +  G+++ E+  G     +   ++S+A
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  ++           + YLH+ CD  
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALGYLHS-CD-- 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ D+K  N++LD +   K++DFGL K    +    ++    GT  Y+APE++  N +G
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYG 173

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 174 RA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 38/178 (21%)

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
           FC+  +K  L  V EY+  G L  HI       E+R + +  E +         G+++LH
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII--------CGLQFLH 113

Query: 182 -NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISATRGTIGYI 236
             G    I++ D+K  N+LLD +   K++DFG+ K +     K + F       GT  YI
Sbjct: 114 KKG----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------GTPDYI 163

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMHATRSSKAYFPSWV 287
           APE++       S   D + FG++L EM  G+        +    +  + + +FP W+
Sbjct: 164 APEILKGQKYNESV--DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 34/227 (14%)

Query: 73  LGQGGFGSVYKGQL----HTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN----VVQ 124
           +G+G FG V   Q+     TG + A+K++  S    +E ++       I  ++    + Q
Sbjct: 9   VGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65

Query: 125 LLGFCSEGSKRALVYEYMPNGSL----DRHIFP-KESRGQSFCWEKLHEVALGTARGIEY 179
           L     +     LV EY P G L    +R+     E   Q +  E +  +A+ +   + Y
Sbjct: 66  LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV--LAIHSVHQMGY 123

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           +H          DIKP N+L+D     K++DFG A          S     GT  YIAPE
Sbjct: 124 VHR---------DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPE 173

Query: 240 LISRNFGTVSCKSDV----YGFGMVLLEMAGGRRNSNMHATRSSKAY 282
           +++   G       V    +  G++  EM  GR  S  H   S+K Y
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR--SPFHEGTSAKTY 218

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 64/243 (26%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVST----IGRIHHVNVVQLLG 127
           +G+G FG V   Q   TG + A+K L  S+   +E +  V      +    +  VV+L  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL-- 66

Query: 128 FCSEGSKRAL--VYEYMPNGSL-----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           + S   +  L  + EY+P G +      +  F  E   + +  E        T   I+ +
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF-TEEETRFYIAE--------TILAIDSI 117

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK--------------FHPKENDFVSI 226
           H    +  +H DIKP N+LLD     K+SDFGL                 H   ++F+  
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 227 SA----------------------TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +                      T GT  YIAPE+  +      C  D +  G+++ EM
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWSLGVIMYEM 232

Query: 265 AGG 267
             G
Sbjct: 233 LVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 70/263 (26%), Positives = 108/263 (41%), Gaps = 63/263 (23%)

Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTN--------HFTHKLGQGGFGSVYKGQL 86
           +L++  N++ FL         RY       +T              +G+G FG V   QL
Sbjct: 14  ALRKNKNIDNFL--------SRYE-KAAEKITKLRMKAEDFDVIKVIGRGAFGEV---QL 61

Query: 87  ----HTGGLIAVKMLANSKF-----SGEEFINEVSTIGRIHHVN---VVQLLGFCSEGSK 134
                +  + A+K+L  SKF     S   F  E   I  + H N   +VQL    +    
Sbjct: 62  VRHKSSKQVYAMKLL--SKFEMIKRSDSAFFWEERDI--MAHANSEWIVQL--HYAFQDD 115

Query: 135 RAL--VYEYMPNGSL----DRHIFPKESRGQSFCWEKLH--EVALGTARGIEYLHNGCDV 186
           + L  V EYMP G L      +  P++       W + +  EV L     ++ +H+   +
Sbjct: 116 KYLYMVMEYMPGGDLVNLMSNYDIPEK-------WARFYTAEVVLA----LDAIHS---M 161

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRN 244
             +H D+KP N+LLD +   K++DFG        N  V      GT  YI+PE++     
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
            G    + D +  G+ L EM  G
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 11/159 (6%)

Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
           +E+  +    H  +V+         K  L+ EY   G L++ I  +      F   + +E
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF---QEYE 170

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-- 226
           V L   + +  L       ++H D+K  NI L    I K+ DFG +K   + +D VS+  
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSLDV 227

Query: 227 -SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            S+  GT  Y+APEL  R     S K+D++  G++L E+
Sbjct: 228 ASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYEL 264

Length = 478

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 12/99 (12%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSIS--AT 229
           RG++Y+H+     ++H D+KP N+L++ +   ++ DFG+A+     P E+ +      AT
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           R    Y APEL+  +    +   D++  G +  EM G R
Sbjct: 175 R---WYRAPELL-LSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 31/225 (13%)

Query: 73  LGQGGFGSVY---KGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGR--IHHVNVVQLL 126
           LG G +G V+   K   H TG L A+K+L  +    +    E +   R  + HV     L
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 127 -----GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
                 F +E +K  L+ +Y+  G +  H++ +++  +        E+ L     +E+LH
Sbjct: 68  VTLHYAFQTE-AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLH 122

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYI 236
               + I++ DIK  NILLD      ++DFGL+K      +F+S    R     GTI Y+
Sbjct: 123 K---LGIVYRDIKLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFCGTIEYM 173

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA 281
           APE+I R  G      D +  G+++ E+  G     +   R++++
Sbjct: 174 APEII-RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 5/83 (6%)

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--F 245
           ++H D+KP NILLD +   K+ DFG++       D  + + + G   Y+APE I      
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPDPN 192

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                ++DV+  G+ L+E+A G+
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 36/212 (16%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVS-TIGRIHHVNVVQLLGFC- 129
           +G+G FG VY+ +   T  + A+K+L+  +   ++   EV+ TIG   ++ V  LL    
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK---EVAHTIGE-RNILVRTLLDESP 56

Query: 130 ---------SEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTAR 175
                       S   LV +YM  G L  H+     F  E R + +    + E+ L    
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-EDRAKFY----IAELVLA--- 108

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
            +E+LH      I++ D+KP NILLD      + DFGL+K +  +N   +     GT  Y
Sbjct: 109 -LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEY 162

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +APE++    G      D +  G+++ EM  G
Sbjct: 163 LAPEVLLDEKGYTK-HVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 42/235 (17%)

Query: 48  NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGE 105
           N+  W +P RY   ++  V        G G +G+V       TG  +A+K L    F  E
Sbjct: 7   NKTIWEVPDRYR--DLKQV--------GSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSE 55

Query: 106 EFIN----EVSTIGRIHHVNVVQLLG-FCSEGS--KRALVYEYMPN-----GSLDRHIFP 153
            F      E+  +  + H NV+ LL  F  + S  +    Y  MP      G L +H   
Sbjct: 56  LFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115

Query: 154 KESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 213
            E R Q   ++ L        +G++Y+H      I+H D+KP N+ ++ +   K+ DFGL
Sbjct: 116 SEDRIQFLVYQML--------KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164

Query: 214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           A+    +++      TR    Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 165 AR--QTDSEMTGYVVTR---WYRAPEVI-LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 76/326 (23%), Positives = 127/326 (38%), Gaps = 76/326 (23%)

Query: 53  MPKRYSYPEIIAVTNHFTHKLGQGGFGSVY------KGQLHTGGLIAVKMLANSKFSGEE 106
           MP +Y   E          K+G G FG V+        +      I+ + L   + S  +
Sbjct: 1   MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS--Q 58

Query: 107 FINEVSTIGRIHHVNVVQ---------------LLGFCSEGS-KRALVYEYMPNGSLDRH 150
            + EV+ +  + H N+V+               L+ FC  G   R +   Y   G ++ H
Sbjct: 59  LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118

Query: 151 IFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD----VCILHFDIKPHNILLDHNF-- 204
                +R      + LH +A        Y HN  D      +LH D+KP NI L      
Sbjct: 119 AIVDITR------QLLHALA--------YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164

Query: 205 ---------------IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
                          I K+ DFGL+K    E+      +  GT  Y +PEL+     +  
Sbjct: 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYD 221

Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSD++  G ++ E+  G+       T   KA   S +  +L +G DL ++  ++  +++
Sbjct: 222 DKSDMWALGCIIYELCSGK-------TPFHKANNFSQLISELKRGPDLPIKGKSKELNIL 274

Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVL 335
            + L       + + A +RPS  + L
Sbjct: 275 IKNL-------LNLSAKERPSALQCL 293

Length = 1021

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)

Query: 136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP 195
           ALV +Y   G L + I  +    ++F   + HE  L   + +  +H+     ++H DIK 
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTF---REHEAGLLFIQVLLAVHHVHSKHMIHRDIKS 171

Query: 196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKS 252
            NILL  N + K+ DFG +K +      VS    R   GT  Y+APE+  R     S K+
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTPYYVAPEIWRRK--PYSKKA 226

Query: 253 DVYGFGMVLLEMAGGRR---NSNMH 274
           D++  G++L E+   +R     NM 
Sbjct: 227 DMFSLGVLLYELLTLKRPFDGENME 251

Length = 496

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 68/251 (27%), Positives = 107/251 (42%), Gaps = 39/251 (15%)

Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGGLI 92
           +L++  N++ FL N+   + ++    ++ A        +G+G FG V   QL  H     
Sbjct: 14  ALRKNKNIDNFL-NRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEV---QLVRHKSSQK 69

Query: 93  AVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPN 144
              M   SKF          F  E   +   +   VVQL  FC+    + L  V EYMP 
Sbjct: 70  VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPG 127

Query: 145 GSL----DRHIFPKESRGQSFCWEKLH--EVALGTARGIEYLHNGCDVCILHFDIKPHNI 198
           G L      +  P++       W K +  EV L     ++ +H+   + ++H D+KP N+
Sbjct: 128 GDLVNLMSNYDVPEK-------WAKFYTAEVVLA----LDAIHS---MGLIHRDVKPDNM 173

Query: 199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYG 256
           LLD +   K++DFG       E   V      GT  YI+PE++    G      + D + 
Sbjct: 174 LLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232

Query: 257 FGMVLLEMAGG 267
            G+ L EM  G
Sbjct: 233 VGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 28/230 (12%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV---NVVQLLGF 128
           LG+G FG V   +L   G   AVK L       ++ +       R+  +   N      +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 129 CSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           C+  +K  L  V E++  G L  HI   + +G+ F   +    A     G+++LH+    
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHI---QDKGR-FDLYRATFYAAEIVCGLQFLHSKG-- 116

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELISRN 244
            I++ D+K  N++LD +   K++DFG+     KEN F    A+   GT  YIAPE++   
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMC----KENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMHATRSSKAYFPSWV 287
             T S   D + FG++L EM  G+        +    + R    ++P W+
Sbjct: 172 KYTFSV--DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 33/209 (15%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTI--------GRIHHVNVV 123
           +G+G FG V   +    G   AVK+L       +    E   I          + H  +V
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK---KEQKHIMAERNVLLKNVKHPFLV 59

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARGIE 178
            L        K   V +Y+  G L  H+     FP E R + +  E         A  + 
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP-EPRARFYAAE--------IASALG 110

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YLH+   + I++ D+KP NILLD      ++DFGL K   + +   + S   GT  Y+AP
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAP 165

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++ +     +   D +  G VL EM  G
Sbjct: 166 EVLRKQPYDRTV--DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 7/102 (6%)

Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
           E L   +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 214 EDLLSFSYQVAKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270

Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G++L E+
Sbjct: 271 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 38/208 (18%)

Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVST------------IGRIHHV 120
           +G+G FG           L+   + ++ K++ +E     S+            + ++ H 
Sbjct: 8   VGEGSFGR---------ALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP 58

Query: 121 NVVQLL-GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           N+V     F ++G    +V EY   G L + I  K  RG+ F  + + +  +    G+++
Sbjct: 59  NIVAFKESFEADG-HLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATR-GTIGYI 236
           +H   +  +LH DIK  NI L  N   K+ DFG A+    P      + + T  GT  Y+
Sbjct: 116 IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-----GAYACTYVGTPYYV 167

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
            PE I  N    + KSD++  G +L E+
Sbjct: 168 PPE-IWENM-PYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 40/216 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL--IAVKMLANSKFSGEEFINEV----STIGRIHHVN 121
           +F   LG G FG V            +A+K    SK   ++ ++ V      +  I+H  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSF-----CWEKLHEVALGTARG 176
            V L G   + S   LV E++  G      F    R + F     C+     V +     
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEF----FTFLRRNKRFPNDVGCFYAAQIVLI----- 143

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----G 231
            EYL +   + I++ D+KP N+LLD +   K++DFG AK          +  TR     G
Sbjct: 144 FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK----------VVDTRTYTLCG 190

Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           T  YIAPE++  N G     +D +  G+ + E+  G
Sbjct: 191 TPEYIAPEIL-LNVGHGKA-ADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 54/229 (23%)

Query: 73  LGQGGFGSVYKGQLHTGG--------LIAVKMLANSKFSGEE------------------ 106
           LGQG   ++Y G+L   G        +     L     +G E                  
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ-SFCWEK 165
           F    S + ++ H+++  + G C  GS+  +V E++ +G LD  +  ++ +G+    W+ 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD--VCLRKEKGRVPVAWKI 120

Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN--------FIPKVSDFGLAKFH 217
              VA   A  + YL    D  ++H ++   NILL           FI K+SD G++   
Sbjct: 121 T--VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFI-KLSDPGVS--- 171

Query: 218 PKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
                F ++S       I +IAPE +     ++S  +D + FG  LLE+
Sbjct: 172 -----FTALSREERVERIPWIAPECV-PGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 31/209 (14%)

Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L     I A+K++     + +E I+ V T   +     +H  +V L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V E++  G L  H+     R +    E     +   +  + +LH     
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHM----QRQRKLPEEHARFYSAEISLALNFLHERG-- 116

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+K  N+LLD     K++D+G+ K   +  D  S     GT  YIAPE++     
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYIAPEIL----- 168

Query: 247 TVSCKSDVYGF-------GMVLLEMAGGR 268
               + + YGF       G+++ EM  GR
Sbjct: 169 ----RGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +     A   E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 85  FTP----ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 191

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 17/201 (8%)

Query: 73  LGQGGFGSVYKGQLHT-GGLIAVKMLANSKFSGEEFINEVST-----IGRIHHVNVVQLL 126
           +G+G FG V   +  + G   AVK+L       ++  N +       +  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                  K   V +Y+  G L  H+     R + F   +    A   A  I YLH+   +
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS---L 115

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+KP NILLD      ++DFGL K   +  +  + S   GT  Y+APE++ +   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE-- 171

Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
                 D +  G VL EM  G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 25/106 (23%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---------FHPKENDFVS 225
           + ++Y+H+G    ++H D+KP NILL+ +   K++DFGLA+          +P   D+V 
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV- 173

Query: 226 ISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGR 268
             ATR    Y APE++  S  +   V    D++  G +L EM  G+
Sbjct: 174 --ATR---WYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 45/177 (25%), Positives = 70/177 (39%), Gaps = 60/177 (33%)

Query: 138 VYEYMPNGSL-----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFD 192
           V +Y+P G +        IF  E   + +    + E+       IE +H    +  +H D
Sbjct: 79  VMDYIPGGDMMSLLIRLGIFE-EDLARFY----IAELTCA----IESVHK---MGFIHRD 126

Query: 193 IKPHNILLDHNFIPKVSDFGL---------AKF-----HPKENDF------VSISATR-- 230
           IKP NIL+D +   K++DFGL         +K+     H +++          I   R  
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 231 -------------------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                              GT  YIAPE++ R   T  C  D +  G++L EM  G+
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 30/209 (14%)

Query: 73  LGQGGFGSVYKGQL----HTGGLIAVKMLANSKF-----SGEEFINEVSTIGRIHHVN-V 122
           +G+G FG V   QL     T  + A+K+L  SKF     S   F  E   I    +   V
Sbjct: 51  IGRGAFGEV---QLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWV 105

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH--EVALGTARGIEYL 180
           VQL     +     +V EYMP G L   +   +   +   W + +  EV L     ++ +
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLA----LDAI 158

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H+   +  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+PE+
Sbjct: 159 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEV 214

Query: 241 ISRNFGT--VSCKSDVYGFGMVLLEMAGG 267
           +    G      + D +  G+ L EM  G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 43/219 (19%)

Query: 67  NHFT--HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI----HH 119
             F    ++GQGG+G V+  +   TG ++A+K +  S       +  V T   I      
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR---- 175
             +V+LL    +     L  EY+P G     +              L E     AR    
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV---------LSE---DHARFYMA 108

Query: 176 ----GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-ATR 230
                ++ LH   ++  +H D+KP N L+D +   K++DFGL+K        V+ + +  
Sbjct: 109 EMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSVV 159

Query: 231 GTIGYIAPELI-SRNFG-TVSCKSDVYGFGMVLLEMAGG 267
           G+  Y+APE++  + +  TV    D +  G +L E   G
Sbjct: 160 GSPDYMAPEVLRGKGYDFTV----DYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L  T  + A+K++     + +E I+ V T   +     +H  +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R +    E     +   +  + YLH   + 
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 115

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDY 173

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 174 GF---SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 26/205 (12%)

Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQL-L 126
           +G+G FG V +  +  T  + A+K +      S+      + E + + +++   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLHN 182
            F S   K  LV  ++  G L  H+  +     SR + +  E L   AL      E LH 
Sbjct: 61  SFQSPE-KLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELL--CAL------ENLH- 110

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                +++ D+KP NILLD+     + DFGL K + K++D    +   GT  Y+APEL+ 
Sbjct: 111 --KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLL 166

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
              G      D +  G++L EM  G
Sbjct: 167 -GHGYTKA-VDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 16/113 (14%)

Query: 159 QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FH 217
           QSF ++ L         G++Y+H+  +V  LH D+KP N+L++ +   K+ DFGLA+ F 
Sbjct: 108 QSFIYQIL--------CGLKYIHSA-NV--LHRDLKPGNLLVNADCELKICDFGLARGFS 156

Query: 218 --PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             P EN    ++    T  Y APE I  +F + +   DV+  G +L E+ G +
Sbjct: 157 ENPGENA-GFMTEYVATRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN----- 121
           +F   LG+G FG V   +   T  L A+K+L       ++ +       R+  ++     
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV--ALGTARGIEY 179
           + QL        +   V EY+  G L   I   +  G+   +++ H V  A   A G+ +
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI---QQVGR---FKEPHAVFYAAEIAIGLFF 116

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIA 237
           LH+     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  YIA
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENMWDGVTTKTFCGTPDYIA 169

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I+  +       D + FG++L EM  G+
Sbjct: 170 PEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 34/231 (14%)

Query: 48  NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGE 105
           N+  W +P RY     +          G G +G V       TG  +A+K L+   F   
Sbjct: 7   NKTVWEVPDRYQNLSPV----------GSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSA 55

Query: 106 EF----INEVSTIGRIHHVNVVQLLG-FCSEGSKRAL--VYEYMPNGSLDRHIFPKESRG 158
                   E+  +  + H NV+ LL  F    S      VY        D +      + 
Sbjct: 56  IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLN---NIVKC 112

Query: 159 QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           Q    + +  +     RG++Y+H+     I+H D+KP NI ++ +   K+ DFGLA+   
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169

Query: 219 KE-NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            E   +V   ATR    Y APE++  N+   +   D++  G ++ E+  G+
Sbjct: 170 DEMTGYV---ATR---WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 31/198 (15%)

Query: 88  TGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP 143
           TG L+ V+ + + +   EE +    NEV       H N++      + GS   ++  +M 
Sbjct: 24  TGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82

Query: 144 NGS---LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNIL 199
            GS   L +  FP E   ++     +  +  G  RG+ YLH NG     +H +IK  +IL
Sbjct: 83  YGSANSLLKTYFP-EGMSEAL----IGNILFGALRGLNYLHQNGY----IHRNIKASHIL 133

Query: 200 LDHNFIPKVSDFGLAKFHPKEN---------DFVSISATRGTIGYIAPELISRNFGTVSC 250
           +  + +  +S  GL+  +             DF   S +   + +++PEL+ ++    + 
Sbjct: 134 ISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS--VLPWLSPELLRQDLYGYNV 189

Query: 251 KSDVYGFGMVLLEMAGGR 268
           KSD+Y  G+   E+A GR
Sbjct: 190 KSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 31/210 (14%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVK-MLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           +G G FG VY+   + T   +A+K +L + ++   E +     +  ++H+N++ L  +  
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYY 129

Query: 131 EGSKRA--------LVYEYMPNGSLDRHI--FPKESRGQSFCWEKLHEVALGTARGIEYL 180
               +         +V E++P  ++ +++  + + +        KL+   L   R + Y+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186

Query: 181 HNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           H+     I H D+KP N+L+D N    K+ DFG AK        VS   +R    Y APE
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAPE 240

Query: 240 LI--SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           L+  + N+ T     D++  G ++ EM  G
Sbjct: 241 LMLGATNYTT---HIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A+G+++L      CI H D+   N+LL    + K+ DFGLA+    ++++V     R  +
Sbjct: 222 AQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++APE I     TV  +SDV+ +G++L E+
Sbjct: 279 KWMAPESIFDCVYTV--QSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 17/201 (8%)

Query: 73  LGQGGFGSVYKGQLHTG-GLIAVKMLANS----KFSGEEFINEVSTIGR-IHHVNVVQLL 126
           +G+G FG V   +        AVK+L       K   +  ++E + + + + H  +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                  K   V +Y+  G L  H+     R + F   +    A   A  + YLH+   +
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHS---L 115

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+KP NILLD      ++DFGL K + + N   + S   GT  Y+APE++ +   
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ-- 171

Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
                 D +  G VL EM  G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 17/206 (8%)

Query: 69  FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFIN----EVSTIGRIHHVNVV 123
           F   LG+G FG V   +   T  L A+K+L       ++ +     E   +        +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 124 QLLGFCSEGSKRA-LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
             L  C +   R   V EY+  G L  HI     +   F   +    A   + G+ +LH 
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLHR 119

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I++ D+K  N++LD     K++DFG+ K H  +   V+     GT  YIAPE+I+
Sbjct: 120 RG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIA 174

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR 268
             +       D + +G++L EM  G+
Sbjct: 175 --YQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 47/233 (20%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           +G+G FG V   Q   TG + A+K+L  +    +E +  +     I      + VV++  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +     L+ E++P G +   +  K++  +      + E  L     I+ +H    + 
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA----IDSIHQ---LG 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLA----KFH------------PKENDFVSISATR- 230
            +H DIKP N+LLD     K+SDFGL     K H            P +  F ++++ R 
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 231 ----------------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
                           GT  YIAPE+  +      C  D +  G+++ EM  G
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+E+L      C+ H D+   N+L+    + K+ DFGLA+   ++++++S  +T   +
Sbjct: 249 ANGMEFL--ASKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++APE I  N  T    SDV+ FG++L E+
Sbjct: 306 KWMAPESIFNNLYTTL--SDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 55/237 (23%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG---- 127
           +G+G FG V   Q   TG + A+K+L  +    +E +  +    R     +V+  G    
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILVEADGAWVV 64

Query: 128 --FCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
             F S   KR L  + E++P G +   +  K++  +      + E  L     I+ +H  
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA----IDAIHQ- 119

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFH------------PKENDFVSIS 227
             +  +H DIKP N+LLD     K+SDFGL     K H            P +  F +++
Sbjct: 120 --LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 228 ATR-----------------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           + R                 GT  YIAPE+  +      C  D +  G+++ EM  G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 55/277 (19%), Positives = 112/277 (40%), Gaps = 51/277 (18%)

Query: 80  SVYKGQLHTGGLIAVKMLA----NSKFSGEEFINEVSTIGRIHHVNVVQLLGF----CSE 131
           S+YKG  +    + ++         K   +   NE+  + RI   N++++ GF      +
Sbjct: 35  SIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
             + +L+ EY   G L R +  KE   +   ++   ++A+   +G+  L+         +
Sbjct: 94  LPRLSLILEYCTRGYL-REVLDKE---KDLSFKTKLDMAIDCCKGLYNLYK--------Y 141

Query: 192 DIKPH------NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             KP+      + L+  N+  K+   GL K       F +++     + Y + ++++  F
Sbjct: 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-PFKNVN----FMVYFSYKMLNDIF 196

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL---NKGGDLELRNV 302
              + K D+Y  G+VL E+  G+       T+         +YD +   N    L L   
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--------IYDLIINKNNSLKLPLDCP 248

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            EI+ ++          C    +  RP++ ++L  L 
Sbjct: 249 LEIKCIVEA--------CTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 25/138 (18%)

Query: 138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV--ALGTARGIEYLHNGCDVCILHFDIKP 195
           V EY+  G L  HI   +  G+   +++ H V  A   A G+ +LH+     I++ D+K 
Sbjct: 79  VMEYVNGGDLMYHI---QQVGK---FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKL 129

Query: 196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELIS-RNFGTVSCK 251
            N++LD     K++DFG+ K +           TR   GT  YIAPE+I+ + +G    K
Sbjct: 130 DNVMLDAEGHIKIADFGMCKENIFGGK-----TTRTFCGTPDYIAPEIIAYQPYG----K 180

Query: 252 S-DVYGFGMVLLEMAGGR 268
           S D + FG++L EM  G+
Sbjct: 181 SVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 25/205 (12%)

Query: 73  LGQGGFGSVY------KGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V        G+ +   ++  K++ N K            +  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                  K   V +++  G L  H+     R +SF   +    A   A  + YLH+   +
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS---I 115

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELIS 242
            I++ D+KP NILLD      ++DFGL K      + ++ S T     GT  Y+APE+I 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLAPEVIR 169

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           +         D +  G VL EM  G
Sbjct: 170 KQ--PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 13/137 (9%)

Query: 133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFD 192
           S+  LV EY+  G L  H+     R +    E     A      + +LH   +  I++ D
Sbjct: 69  SRLFLVIEYVNGGDLMFHM----QRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRD 121

Query: 193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCK 251
           +K  N+LLD +   K++D+G+ K      D  + S   GT  YIAPE++    +G     
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGF---S 176

Query: 252 SDVYGFGMVLLEMAGGR 268
            D +  G+++ EM  GR
Sbjct: 177 VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 37/223 (16%)

Query: 66  TNHFTHKLGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVV 123
           T      +G+G +G V+K      G   AVK+L       EE   E + +  +  H NVV
Sbjct: 19  TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVV 78

Query: 124 QLLGF-----CSEGSKRALVYEYMPNGSLDRHIFPKESRG----QSFCWEKLHEVALGTA 174
           +  G         G +  LV E    GS+   +     RG    +      LHE  +G  
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG-- 136

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---- 230
             +++LH    +   H D+K +NILL      K+ DFG++           +++TR    
Sbjct: 137 --LQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLRRN 182

Query: 231 ---GTIGYIAPELIS---RNFGTVSCKSDVYGFGMVLLEMAGG 267
              GT  ++APE+I+   +   T   + DV+  G+  +E+  G
Sbjct: 183 TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 27/207 (13%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           LG+G FG V   +L  T  + A+K+L       ++ ++   T  RI      H  +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL- 61

Query: 127 GFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NG 183
             C   +K  L  V EY+  G L   I     R + F   +    A      + +LH +G
Sbjct: 62  -HCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELI 241
               +++ D+K  NILLD     K++DFG+     KE     ++ T   GT  YIAPE++
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMC----KEGILNGVTTTTFCGTPDYIAPEIL 168

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                  S   D +  G+++ EM  G+
Sbjct: 169 QELEYGPSV--DWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 49/157 (31%), Positives = 69/157 (43%), Gaps = 36/157 (22%)

Query: 128 FCSEGSKRAL--VYEYMPNG---SLDRHI--FPKESRGQSFCWEKLHEVALGTARGIEYL 180
           FCS  +KR L  V EY+  G   +L ++I   P +     F           T   +EYL
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA---------ETVLALEYL 117

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----------HPKENDFVSISAT 229
           HN     I+H D+KP N+L+      K++DFGL+K               E D       
Sbjct: 118 HN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 230 R--GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLE 263
           +  GT  YIAPE+I R  +G      D +  G++L E
Sbjct: 175 QVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 36/120 (30%), Positives = 60/120 (50%), Gaps = 22/120 (18%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           RG++Y+H+     I+H D+KP N+ ++ +   ++ DFGLA+    +++     ATR    
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVATR---W 180

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY-DQLNK 293
           Y APE I  N+   +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLKG------------KALFPGNDYIDQLKR 227

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 46/219 (21%)

Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI---NEVSTIGRIHHVNVVQLLGFC 129
                   + K +  T  L+AVK +     S E+      E+ T  ++ H N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 130 SEGSKRALVYEYMPNGS----LDRHIFPKESRGQSFCWEKLHEVAL-----GTARGIEYL 180
              S+  +V   M  GS    L  H FP          E L E+A+          ++Y+
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTH-FP----------EGLPELAIAFILKDVLNALDYI 117

Query: 181 H-NGCDVCILHFDIKPHNILLD----------HNFIPKVS-DFGLAKFHPKENDFVSISA 228
           H  G     +H  +K  +ILL              +  +         H    DF   S+
Sbjct: 118 HSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH----DF-PKSS 168

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            +  + +++PE++ +N    + KSD+Y  G+   E+A G
Sbjct: 169 VK-NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 36/116 (31%), Positives = 51/116 (43%), Gaps = 17/116 (14%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGL--------IAVKMLANSKFSGEE--FINEVSTIGRI- 117
           F   LG G FG V +   +  GL        +AVKML  S    E    ++E+  +  + 
Sbjct: 39  FGKTLGAGAFGKVVEATAY--GLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 96

Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFC--WEKLHEVAL 171
           +H+N+V LLG C+ G    ++ EY   G L    F +  R    C   E   E AL
Sbjct: 97  NHINIVNLLGACTVGGPTLVITEYCCYGDLLN--FLRRKRDSFICPKHEDHAEAAL 150

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           GI++LH+     I+H D+KP NI++  +   K+ DFGLA+          ++    T  Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183

Query: 236 IAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 268
            APE+I    G       D++  G ++ EM  G 
Sbjct: 184 RAPEVI---LGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 245
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           G    + D +  G+ + EM  G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 19/97 (19%)

Query: 73  LGQGGFGSVYKGQLHTGGL--------IAVKMLANSKFSGEE--FINEVSTIGRIH-HVN 121
           LG G FG V +   H  GL        +AVKML ++  S E+   ++E+  +  +  H+N
Sbjct: 45  LGSGAFGRVVEATAH--GLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLN 102

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSL------DRHIF 152
           +V LLG C++G    ++ EY   G L      ++H F
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 245
           +H DIKP NIL+D N   +++DFG +     E+  V  S   GT  YI+PE++       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           G    + D +  G+ + EM  G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 18/149 (12%)

Query: 75  QGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEFINEVST----IGRIHHVNVVQLLGFC 129
           +G FG VY G+      L AVK++  +    +  +++V      +       +V L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 130 SEGSKRALVYEYMPNGSLDR--HIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDV 186
              +   LV EY+  G +    HI+       +  +  + EVAL     ++YLH +G   
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALA----LDYLHRHG--- 124

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAK 215
            I+H D+KP N+L+ +    K++DFGL+K
Sbjct: 125 -IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 37/203 (18%)

Query: 77  GFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKR 135
           G  S  +G+     LIA K +     +  +  NE+  +GR++H N++++     SE +  
Sbjct: 181 GVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTY 239

Query: 136 AL-------VYEYMPNGSLDRHIFP--KESRG---QSFCWEKLHEVALGTARGIEYLHNG 183
            +       +Y +M + + D    P  K++R    Q  C              +EY+H  
Sbjct: 240 MITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLC-------------AVEYIH-- 284

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-ATRGTIGYIAPELIS 242
            D  ++H DIK  NI L+ +    + DFG A   P E +  +      GT+   +PE+++
Sbjct: 285 -DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM--PFEKEREAFDYGWVGTVATNSPEILA 341

Query: 243 RNFGTVSCK-SDVYGFGMVLLEM 264
            +     C+ +D++  G++LL+M
Sbjct: 342 GD---GYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 62/246 (25%), Positives = 95/246 (38%), Gaps = 59/246 (23%)

Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVST----IGRIHHVNVVQLLG 127
           LG G FG V    ++ T  L A+K L          +  V      +    +  VV+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +      V +Y+P G +   +   E   +      + E+ L     IE +H    + 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLA----IESVHK---MG 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGL---------AKFHPKEN-------------DFVS 225
            +H DIKP NIL+D +   K++DFGL         +K++ K +             D VS
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 226 ------------ISATR-----------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 262
                         AT+           GT  YIAPE++ R   T  C  D +  G++L 
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC--DWWSVGVILF 239

Query: 263 EMAGGR 268
           EM  G+
Sbjct: 240 EMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 14/100 (14%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKF---HPKENDFVSISATR 230
           RG++Y+H+     +LH D+KP N+ ++  + + K+ DFGLA+    H     ++S     
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 231 GTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            T  Y +P L+    N+       D++  G +  EM  G+
Sbjct: 181 -TKWYRSPRLLLSPNNYTKA---IDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 72  KLGQGGFGSVYKGQLHTGGL---IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG- 127
           K+G+G +G VYK +   G      A+K +  +  S      E++ +  + H NV+ L   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKV 66

Query: 128 FCSEGSKRA-LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIE 178
           F S   ++  L+++Y  +       F + S+      +K  ++  G  +        GI 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILDGIH 122

Query: 179 YLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTI 233
           YLH      +LH D+KP NIL+          K++D G A+ F+        +     T 
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 234 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
            Y APEL+  +R++   +   D++  G +  E+
Sbjct: 180 WYRAPELLLGARHY---TKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.4 bits (94), Expect = 8e-04
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 72  KLGQGGFGSVYKGQLHTGG---LIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG- 127
           K+G+G +G VYK +   G      A+K +  +  S      E++ +  + H NV+ L   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-CREIALLRELKHPNVIALQKV 66

Query: 128 FCSEGSKRA-LVYEYMPNGSLDRHIFPKESRG--------QSFCWEKLHEVALGTARGIE 178
           F S   ++  L+++Y  +       F + S+         +S     L+++      GI 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL----DGIH 122

Query: 179 YLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTI 233
           YLH      +LH D+KP NIL+          K++D G A+ F+        +     T 
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 234 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
            Y APEL+  +R++   +   D++  G +  E+
Sbjct: 180 WYRAPELLLGARHY---TKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.4 bits (94), Expect = 9e-04
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHIFPKES 156
            LLG C++ G    ++ E+   G+L  ++  K  
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRG 108

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 9/88 (10%)

Query: 69  FTHKLGQGGFGSVYK------GQLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HH 119
           F   LG G FG V +      G+      +AVKML  S  + E    ++E+  +  +  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSL 147
            N+V LLG C+ G    ++ EY   G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 33/218 (15%)

Query: 73  LGQGGFGSVYKGQ------LHTGGLIAVKMLANSKFSGEEF-------INEVSTIGRIH- 118
           +G GGFG VY+ Q      ++   +  ++ L N     E         I++++    IH 
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79

Query: 119 --HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF-PKESRGQSFCWEK--LHEVALGT 173
             H+ + +  G C    +  + Y ++    L++ +   KE   +  C  K  +  +    
Sbjct: 80  IDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIMKDM 135

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISAT- 229
              +EY+H   +  I H DIKP NI++D N    + D+G+A     H K  ++       
Sbjct: 136 LTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL 192

Query: 230 -RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG 266
            RGT+ Y    L + N   V+ + D+   G  +L+ AG
Sbjct: 193 HRGTLYYAG--LDAHNGACVTRRGDLESLGYCMLKWAG 228

Length = 294

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 37/127 (29%)

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           GI++LH+     I+H D+KP NI++  +   K+ DFGLA+             T GT   
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------------TAGTSFM 181

Query: 236 IAPELISRNFGTVSC--------KSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWV 287
           + P +++R +               D++  G ++ EM  G               FP   
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG------------GVLFPGTD 229

Query: 288 Y-DQLNK 293
           + DQ NK
Sbjct: 230 HIDQWNK 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 63/251 (25%), Positives = 95/251 (37%), Gaps = 69/251 (27%)

Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVST----IGRIHHVNVVQLLG 127
           LG G FG V    ++ T  L A+K L          +  V      +    +  VV+L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 128 FCSEGSKRALVYEYMPNGSL-----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
              +      V +Y+P G +        IFP E   + +  E    V        E +H 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFP-EDLARFYIAELTCAV--------ESVHK 119

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGL---------AKF-----HPKEN--DF--- 223
              +  +H DIKP NIL+D +   K++DFGL         +K+     H +++  DF   
Sbjct: 120 ---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 224 ---------------VSISATR-----------GTIGYIAPELISRNFGTVSCKSDVYGF 257
                          +   A R           GT  YIAPE++ R   T  C  D +  
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWWSV 234

Query: 258 GMVLLEMAGGR 268
           G++L EM  G+
Sbjct: 235 GVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 32/165 (19%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN---------- 121
           +G+G FG V   Q   TG + A+K L  S         E+    ++ HV           
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKS---------EMFKKDQLAHVKAERDVLAESD 59

Query: 122 ---VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
              VV L     +     L+ E++P G L   +   ++  +      + E  L     IE
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLA----IE 115

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKEND 222
            +H    +  +H DIKP NIL+D     K+SDFGL+  FH K++D
Sbjct: 116 AVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH-KQHD 156

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 26/114 (22%), Positives = 39/114 (34%), Gaps = 20/114 (17%)

Query: 155 ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
           E RG+    E++  V L     +  LH            K  NILL  + +  +   G  
Sbjct: 8   EVRGRPLNEEEIWAVCLQCLGALRELHRQ---------AKSGNILLTWDGL--LKLDGSV 56

Query: 215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            F   E                APE+I     + + K+D+Y  G+ L E     
Sbjct: 57  AFKTPEQSRPDPYFM-------APEVIQG--QSYTEKADIYSLGITLYEALDYE 101

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 20/53 (37%), Positives = 31/53 (58%), Gaps = 1/53 (1%)

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +H DIKP N+LLD N   +++DFG +      +  V  +   GT  YI+PE++
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEIL 175

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	340
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
smart00090	237	RIO RIO-like kinase.	99.83
PRK10345	210	hypothetical protein; Provisional	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.45
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.24
COG4248	637	Uncharacterized protein with protein kinase and he	99.24
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.2
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.15
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.95
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.79
PRK09902	216	hypothetical protein; Provisional	98.74
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.74
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.63
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.57
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.56
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
PLN02876	822	acyl-CoA dehydrogenase	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.37
PRK10593	297	hypothetical protein; Provisional	98.32
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.31
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.28
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.26
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.25
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.2
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.1
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.02
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.97
PRK05231	319	homoserine kinase; Provisional	97.92
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.92
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.82
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.81
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.74
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.67
KOG2270	520	consensus Serine/threonine protein kinase involved	97.57
PLN02236	344	choline kinase	97.45
COG2334	331	Putative homoserine kinase type II (protein kinase	97.42
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.36
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.16
PRK11768	325	serine/threonine protein kinase; Provisional	97.15
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.15
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.01
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.99
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.95
PLN02756	418	S-methyl-5-thioribose kinase	96.88
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.82
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.8
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.68
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.61
PRK06148	1013	hypothetical protein; Provisional	96.59
PTZ00384	383	choline kinase; Provisional	95.88
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.87
PTZ00296	442	choline kinase; Provisional	95.85
PRK12396	409	5-methylribose kinase; Reviewed	95.75
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.36

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-54  Score=383.65  Aligned_cols=279  Identities=44%  Similarity=0.784  Sum_probs=235.7

Q ss_pred             CCCCCCHHHHHHHHhhhh--hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEE
Q 044497           53 MPKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFC  129 (340)
Q Consensus        53 ~~~~~~~~~~~~~~~~~~--~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~  129 (340)
                      ....|++.++..+|++|.  ..||+|+||.||+|...+++.||||.+...... ..+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999998  699999999999999998899999998876655 66799999999999999999999999


Q ss_pred             EcCC-eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          130 SEGS-KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       130 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                      .+.+ ..++|+|||++|+|.+++......  +++|.++.+|+.++|.||+|||+.+++.|+||||||+|||+|+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9988 499999999999999999654433  8899999999999999999999988888999999999999999999999


Q ss_pred             ecccCCccCCC-CCCceeeecc-ccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHH
Q 044497          209 SDFGLAKFHPK-ENDFVSISAT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       209 ~Dfg~~~~~~~-~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~  286 (340)
                      +|||+|+.... ...   .... .||.+|+|||++..  +..+.|+||||||++++|++||+++.+.... .....+..|
T Consensus       219 sDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~~w  292 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLVEW  292 (361)
T ss_pred             cCccCcccCCccccc---eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHHHH
Confidence            99999976544 222   1122 79999999999976  4789999999999999999999988776542 223336788


Q ss_pred             HHHHhhcCCCccccccc----hhhH-HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          287 VYDQLNKGGDLELRNVT----EIES-MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~----~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....+.++...++.+..    ..+. .....+..++.+|++.+|++||+|.||++.|+
T Consensus       293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            77777776444433322    2222 45567899999999999999999999999885

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-53  Score=378.24  Aligned_cols=246  Identities=25%  Similarity=0.414  Sum_probs=214.7

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccC----CCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .+|...+.||+|||+.||.+++ .+|+.||+|++.+    .....+...+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4567778999999999999987 7999999999976    4455678999999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      |+|..++|..++    ++..++.+.+++.+..||+.||.|||++   +|+|||||..|+|++++.++||+|||+|.....
T Consensus        98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999998    3567899999999999999999999999   999999999999999999999999999997765


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...  ...+.+|||.|.|||++.+.  .++..+||||+||++|.||+|++||......+        ....+....    
T Consensus       171 ~~E--rk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------ty~~Ik~~~----  234 (592)
T KOG0575|consen  171 DGE--RKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------TYNKIKLNE----  234 (592)
T ss_pred             ccc--ccceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------HHHHHHhcC----
Confidence            433  23567899999999999865  78999999999999999999999998765322        222222211    


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ...+..++.++.+||.++|+.||.+|||+++|+.
T Consensus       235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               2344567889999999999999999999999985

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-54  Score=365.48  Aligned_cols=256  Identities=26%  Similarity=0.371  Sum_probs=210.9

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCCh--------HHHHHHHHHhcccCCCceeeEeeEEEc
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSG--------EEFINEVSTIGRIHHVNVVQLLGFCSE  131 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~  131 (340)
                      +.....|.+.+.+|+|+||.|-+|.. ++++.||||++++.....        ....+|+++|++++|||||+++++|..
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            34455667789999999999999975 489999999997643221        235799999999999999999999999


Q ss_pred             CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC---CceEE
Q 044497          132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKV  208 (340)
Q Consensus       132 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~---~~~kl  208 (340)
                      .+..||||||++||+|.+.+..    .+.+.+..-..+++|++.|+.|||++   ||+||||||+|||++.+   ..+||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEe
Confidence            9999999999999999999944    34556666688999999999999999   99999999999999766   78999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccc-cccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHH
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~  287 (340)
                      +|||+|+..+..+   .+.+.+||+.|.|||++.+....+. .++|+||+||+||-+++|.+||.......       ..
T Consensus       321 tDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------sl  390 (475)
T KOG0615|consen  321 TDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------SL  390 (475)
T ss_pred             cccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------cH
Confidence            9999999876433   5678899999999999976533333 48999999999999999999998655432       13


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+.+..+...   .....+..++.+..+|+.+||..||++|||+.|+|+
T Consensus       391 ~eQI~~G~y~---f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  391 KEQILKGRYA---FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHhcCccc---ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            3444444322   223456678899999999999999999999999985

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-52  Score=354.25  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=206.4

Q ss_pred             hhhhcCCCCCeEEEEEEEc-CCcEEEEEEccC--CCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCe-eEEEEEccCC
Q 044497           69 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-RALVYEYMPN  144 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~  144 (340)
                      ..+.||+|+.|+||++.++ ++..+|+|++..  +....+++.+|+++++..+||+||.++|.|..... .+++||||++
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            4578999999999999876 788999999933  34445789999999999999999999999999885 9999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      |+|.+.+    ...+.+++..+-.++.++++||.|||+ .   +|+||||||+|+|+++.|++||||||.+....+.   
T Consensus       163 GSLd~~~----k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  163 GSLDDIL----KRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            9999998    334679999999999999999999996 6   9999999999999999999999999999866444   


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                       ...+..||..|||||.+.+.  .|+.++||||||++++|+.+|+-|+......  ... .......+..+..+.+... 
T Consensus       233 -~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~--~~~-~~~Ll~~Iv~~ppP~lP~~-  305 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPP--YLD-IFELLCAIVDEPPPRLPEG-  305 (364)
T ss_pred             -hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCC--CCC-HHHHHHHHhcCCCCCCCcc-
Confidence             34667899999999999986  8889999999999999999999999875211  111 1112333333333332221 


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          .++++++.++..||+.||.+|||++|+++
T Consensus       306 ----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  306 ----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                37789999999999999999999999975

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-52  Score=369.99  Aligned_cols=258  Identities=29%  Similarity=0.478  Sum_probs=225.0

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .++......+.+.||+|.||.||.|.++...+||+|.++......++|.+|+++|+.|+|+|||+++++|..+..+||||
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            45666777888999999999999999998889999999998888899999999999999999999999999988999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      |||+.|+|.+++..  ..+..+.....+.++.||++|++||+++   ++|||||.++||||+++..+||+|||+|+...+
T Consensus       281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence            99999999999954  3456788999999999999999999999   999999999999999999999999999994433


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                       +.+.......-+..|.|||.+...  .++.+|||||||++||||+| |+.||+.+...+        +.+.+.+|.+..
T Consensus       356 -~~Y~~~~~~kfPIkWtAPEa~~~~--~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~~le~GyRlp  424 (468)
T KOG0197|consen  356 -DEYTASEGGKFPIKWTAPEALNYG--KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLELLERGYRLP  424 (468)
T ss_pred             -CceeecCCCCCCceecCHHHHhhC--CcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHHHHhccCcCC
Confidence             333334455567899999999865  88999999999999999999 888988776533        556666666554


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      -+      ..++.++.+++..||+.+|++|||++.+...|+
T Consensus       425 ~P------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  425 RP------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             CC------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence            33      346789999999999999999999999988775

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-51  Score=360.41  Aligned_cols=256  Identities=32%  Similarity=0.500  Sum_probs=211.7

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCC-eeEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVY  139 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  139 (340)
                      .....+.+.||+|+||+||+|.+++...||+|++......   .++|.+|+.+|..++|||||+++|+|.+.. .+++||
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            3334456779999999999999985555999999875544   348999999999999999999999999887 799999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeecCCCCCCeeEcCCC-ceEEecccCCccC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC-ILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  217 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~  217 (340)
                      ||+++|+|.+++...  ....+++..+..++.||+.||.|||++   + ||||||||+|+|++.++ ++||+|||+++..
T Consensus       120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            999999999999553  467899999999999999999999999   7 99999999999999997 9999999999865


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ....  .......||+.|||||++.+....++.|+||||||+++|||+||+.||.......       ........+..+
T Consensus       195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-------~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-------VASAVVVGGLRP  265 (362)
T ss_pred             cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcCCCC
Confidence            4432  2234467999999999998432478999999999999999999999998765411       122222233333


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .+.      ..+++.+..++.+||+.||..||++.+++..|+
T Consensus       266 ~~p------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  266 PIP------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             CCC------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence            222      235688999999999999999999999999885

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-52  Score=341.61  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=213.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEee-EEEcCCe-eEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG-FCSEGSK-RAL  137 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~l  137 (340)
                      -+.|.+.+.||.|+||+||++. ..+|..+|.|.+..+..+.   ++...|+.+|++|+|||||+.++ .+.+.+. +++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            3456788999999999999996 5589999999998654443   57899999999999999999998 4554444 899


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV-CILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      |||+|..|+|.+.+..-......+++.++++++.|++.||..+|++.+. .+.||||||.||+++.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999876666778899999999999999999999995443 389999999999999999999999999998


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      +.+...+  ....+|||.||+||.+.+.  .|++++||||+||++|||+..++||....-        ......+..+..
T Consensus       178 l~s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~KI~qgd~  245 (375)
T KOG0591|consen  178 LSSKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCKKIEQGDY  245 (375)
T ss_pred             hcchhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHHHHHcCCC
Confidence            8765543  3567899999999999886  899999999999999999999999987532        113344444432


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      +++.     ...++.++..|+..|+.+||..||+.-.+++.
T Consensus       246 ~~~p-----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  246 PPLP-----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             CCCc-----HHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence            2221     25788999999999999999999986555543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-50  Score=340.36  Aligned_cols=243  Identities=26%  Similarity=0.435  Sum_probs=193.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||.|+||+||+|+.+ ++..||||.+.....   ..+-+..|+.+|+.++|||||.+++++...+.+|+|||||
T Consensus        12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC   91 (429)
T KOG0595|consen   12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC   91 (429)
T ss_pred             ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence            445678999999999999865 678999999976543   3356789999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC------CceEEecccCCcc
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN------FIPKVSDFGLAKF  216 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~------~~~kl~Dfg~~~~  216 (340)
                      .||+|.+++.    ..+.+++.++..++.|++.||++||++   +|+||||||.|||++..      -.+||+|||+|+.
T Consensus        92 ~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   92 NGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             CCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999994    345789999999999999999999999   99999999999999764      4689999999998


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .....-   ..+.+|++.|||||++..+  .|+.|+|+||+|+++|+|++|+.||+.....+        .....+.+..
T Consensus       165 L~~~~~---a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e--------L~~~~~k~~~  231 (429)
T KOG0595|consen  165 LQPGSM---AETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKE--------LLLYIKKGNE  231 (429)
T ss_pred             CCchhH---HHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhcccc
Confidence            875442   3567899999999999764  89999999999999999999999998655432        1112222211


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK  333 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~e  333 (340)
                      ..    ...+...+....+++...++.+|++|.+..+
T Consensus       232 ~~----~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~  264 (429)
T KOG0595|consen  232 IV----PVLPAELSNPLRELLISLLQRNPKDRISFED  264 (429)
T ss_pred             cc----CchhhhccCchhhhhhHHHhcCccccCchHH
Confidence            11    1222233344455666666666666665544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=335.71  Aligned_cols=239  Identities=26%  Similarity=0.369  Sum_probs=202.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .+.+.+.||+|+||+|+.++.+ +++.+|+|++++...    ..+....|..+|..++||.||+++-.|++.+++|+|+|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld  105 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD  105 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence            3456789999999999999754 789999999987433    34678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+.||.|..++    ++.+.+++..+.-++..|+.||.|||++   +|+|||+||+|||+|.+|+++|+|||+++.....
T Consensus       106 ~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  106 YLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             ccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999999    4567899999999999999999999999   9999999999999999999999999999865444


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ...+.+||+.|||||++.+.  .++..+|.||||+++|||++|.+||...+...        ..+.+..+..    
T Consensus       179 ~~--~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k~----  242 (357)
T KOG0598|consen  179 GD--ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGKL----  242 (357)
T ss_pred             CC--ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCcC----
Confidence            33  33557899999999999886  88999999999999999999999998766432        2222333221    


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCC
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRP  329 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  329 (340)
                        ...+...+.++++++.++|+.||++|.
T Consensus       243 --~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 --PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              122223567899999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.1e-49  Score=323.27  Aligned_cols=261  Identities=23%  Similarity=0.311  Sum_probs=205.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|+...++|+|+||.||+|+.+ +|+.||||++..++.+.   +-..+|+++|++++|||+|.++.+|....++++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            3455678999999999999866 89999999998766543   4578999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      |+..-|++ +   +......+.+.+.++++|++.|+.|+|++   +++||||||+|||++.++.+||||||+|+......
T Consensus        83 ~dhTvL~e-L---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   83 CDHTVLHE-L---ERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             cchHHHHH-H---HhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            97644443 3   23456788999999999999999999999   99999999999999999999999999999876433


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHH-------HHHHhhc-
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW-------VYDQLNK-  293 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~-  293 (340)
                      .  ..+..+.|.+|+|||++.+. ..|+..+||||+||++.||++|.+.|+..+.-+.-..+...       -.+.+.. 
T Consensus       156 d--~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  156 D--NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             c--hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence            3  23556789999999999885 47889999999999999999999998876643211000000       0111111 


Q ss_pred             ----C-CCccccccc---hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 ----G-GDLELRNVT---EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ----~-~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          | ..++.....   ...+.++.-+.+++..||+.||.+|+|-+|++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                1 111222222   223445678899999999999999999999874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.4e-49  Score=363.08  Aligned_cols=260  Identities=27%  Similarity=0.457  Sum_probs=218.4

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcC
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  132 (340)
                      ++......+.+.||+|+||+||+|...      +...||||.++.....  ..+|.+|++++..++|||||+++|+|..+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            444455566789999999999999632      3457999999876554  47899999999999999999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKES------R----GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~------~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~  202 (340)
                      +..|||+|||..|+|.+++..+..      .    ..+++..+.+.|+.|||.|+.||-++   .+|||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            999999999999999999865332      1    23488999999999999999999999   9999999999999999


Q ss_pred             CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccccccc
Q 044497          203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKA  281 (340)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~  281 (340)
                      +..+||+|||+++.....+.+.......-+.+|||||.|...  .++.+||||||||+|||++| |+.||...+..+   
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~--kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---  713 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG--KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---  713 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC--cccchhhhhhhhhhhhhhhccccCcccccchHH---
Confidence            999999999999866555544433344567899999999764  89999999999999999999 999988766543   


Q ss_pred             chhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           +.+.+..+...      +.+..++.++.+|+..||+.+|++|||++||-..|+
T Consensus       714 -----VIe~i~~g~lL------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  714 -----VIECIRAGQLL------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             -----HHHHHHcCCcc------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence                 55566666543      234467789999999999999999999999998885

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=329.17  Aligned_cols=253  Identities=30%  Similarity=0.386  Sum_probs=201.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCC--eeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~  141 (340)
                      ++...+.||+|+||+||++... +|...|||.+..... ..+.+.+|+.+|.+++|||||+.+|......  .++++|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            4556789999999999999865 588999999865421 1466899999999999999999999754444  68999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~~~  220 (340)
                      +++|+|.+++...   +..+++..+..+..|+++||+|||++   |++||||||+|||++. ++.+||+|||++......
T Consensus        98 ~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   98 APGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999432   22799999999999999999999999   9999999999999999 799999999999866531


Q ss_pred             CC-ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          221 ND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       221 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      .. ........||+.|||||++... ....+++|||||||++.||+||++||... .     ....+..........   
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~-----~~~~~~~~ig~~~~~---  241 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF-F-----EEAEALLLIGREDSL---  241 (313)
T ss_pred             cccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh-c-----chHHHHHHHhccCCC---
Confidence            11 1122345699999999999852 23345899999999999999999999764 0     111222222222211   


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                         ..++..++.++++++.+|++.||++||||.++|+-
T Consensus       242 ---P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  242 ---PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ---CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence               24555678899999999999999999999999863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=337.25  Aligned_cols=247  Identities=25%  Similarity=0.342  Sum_probs=204.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .+.|.+.||.|+|++|++|+.. +++.||+|++.+.-..    .+-+..|-++|.+| .||.|++++..|++...+|+|+
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            3457889999999999999754 8899999999764322    24467888999999 8999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++|+|.++|    .+-+.|++...+.++.+|+.||+|||++   |||||||||+|||+|++++++|+|||.|+.+..
T Consensus       154 e~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  154 EYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            999999999999    4457899999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCc-----------eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHH
Q 044497          220 ENDF-----------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY  288 (340)
Q Consensus       220 ~~~~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  288 (340)
                      ....           .....++||..|.+||++...  ..++.+|+|+|||++|+|+.|++||.....-.        +.
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--------iF  296 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEYL--------IF  296 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHHH--------HH
Confidence            3221           111447899999999999875  77889999999999999999999998755311        11


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+.   ..+    -.+++..++.+.+|+.+.|..||.+|+|++||-+
T Consensus       297 qkI~---~l~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  297 QKIQ---ALD----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHH---Hhc----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            1111   111    2344455688999999999999999999988864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-47  Score=337.72  Aligned_cols=248  Identities=26%  Similarity=0.371  Sum_probs=205.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CC--ChHHHHHHHHHhcccC-CCceeeEeeEEEcCCee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KF--SGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  135 (340)
                      ...|.+.+.||+|+||+|+.|... ++..||+|++...    ..  ..+.+.+|+.+++.++ ||||+++++++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            345667889999999999999754 7899999987653    11  2356778999999998 99999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-CceEEecccCC
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLA  214 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-~~~kl~Dfg~~  214 (340)
                      ++||||+.+|+|.+++.    ..+++.+..+..++.|+++|++|||++   ||+||||||+|+|++.+ +++||+|||++
T Consensus        96 ~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999994    356788899999999999999999999   99999999999999999 99999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ....  .......+.+||+.|+|||++.+.....+.++||||+||+||.|++|+.||+.....       . ....+..+
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~-l~~ki~~~  238 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------N-LYRKIRKG  238 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------H-HHHHHhcC
Confidence            8774  122245677899999999999986323467999999999999999999999873321       1 11122222


Q ss_pred             CCccccccchhhHHH-HHHHHHHHhhcccCCCCCCCCHHHHH
Q 044497          295 GDLELRNVTEIESMI-ARKLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                      .       ..++..+ +++++.|+.+||..||.+|+|+.+++
T Consensus       239 ~-------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 E-------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             C-------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1       2233334 78999999999999999999999997

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-47  Score=324.60  Aligned_cols=261  Identities=22%  Similarity=0.314  Sum_probs=212.0

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCCCh--HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...|++.+.||.|..++||+|. ...+..||||++.-+..+.  +.+.+|+..|+.++||||++.+..|...+.+++||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3456778899999999999996 5578999999998765543  688999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      ||.+|++.+.+..  .....+.+..+..|++++++||.|||.+   |.+|||||+.|||++++|.+||+|||.+-.+-..
T Consensus       105 fMa~GS~ldIik~--~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  105 FMAGGSLLDIIKT--YYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhcCCcHHHHHHH--HccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999998843  2345589999999999999999999999   9999999999999999999999999987654433


Q ss_pred             CCce--eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC-c
Q 044497          221 NDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD-L  297 (340)
Q Consensus       221 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~  297 (340)
                      ....  ...+..||++|||||++..+...|+.|+||||||++..||.+|..||....+-.      . ....+++... .
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------v-Ll~tLqn~pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------V-LLLTLQNDPPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------H-HHHHhcCCCCCc
Confidence            3221  125668999999999977766789999999999999999999999998654311      1 1112222111 1


Q ss_pred             cc-cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 EL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .. ....+.....+..+++++..||+.||++|||++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            10 1112334456779999999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-48  Score=333.91  Aligned_cols=264  Identities=23%  Similarity=0.358  Sum_probs=211.1

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHH--HHHHHHHhcccC-CCceeeEeeEEEcCC-eeEE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE--FINEVSTIGRIH-HVNVVQLLGFCSEGS-KRAL  137 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~--~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~l  137 (340)
                      ...+|...++||.|.||.||+|+.. +++.||||.+++.-...++  -.+|++.|++++ ||||+++.+++.+.+ .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            3467888899999999999999754 8899999999876555554  468999999998 999999999998887 8999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||| ..+|.+++..   ++..|++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+|+..
T Consensus        88 VfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            99999 6699999843   367899999999999999999999999   9999999999999998999999999999976


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc---------cchhHHHH
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK---------AYFPSWVY  288 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~---------~~~~~~~~  288 (340)
                      .....   .+..+.|.+|+|||++.+. +.|+.+.|+||+||+++|+.+.++.|+..+..+.-         .....|..
T Consensus       161 ~SkpP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  161 RSKPP---YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccCCC---cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            55543   3456789999999999875 68999999999999999999999999876542110         00011111


Q ss_pred             -HHhhcCCCccc-----cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          289 -DQLNKGGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       289 -~~~~~~~~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                       ..+.......+     ......-+..+.++.+++.+|++.||.+||||.|+++.
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             11111111111     11122333477899999999999999999999999863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=308.51  Aligned_cols=239  Identities=28%  Similarity=0.360  Sum_probs=205.5

Q ss_pred             CCHHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEc
Q 044497           57 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSE  131 (340)
Q Consensus        57 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~  131 (340)
                      +++.+     +++.+.||.|+||.|.+++.+ ++..+|+|++++...-    .+...+|..+|+.+.||+++++.+.|.+
T Consensus        41 ~~l~d-----fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQD-----FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhh-----hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            55555     346789999999999999866 7889999999875432    3567899999999999999999999999


Q ss_pred             CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecc
Q 044497          132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (340)
Q Consensus       132 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Df  211 (340)
                      .+.+||||||.+||.|..++    .+.+++++...+-++.||+.||+|||+.   +|++||+||+|||+|.+|.+||+||
T Consensus       116 ~~~lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             CCeEEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence            99999999999999999999    4567899999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      |+|+.....     ..+.+|||.|+|||++...  .++.++|.||||+++|||+.|.+||.....        ..+.+.+
T Consensus       189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI  253 (355)
T KOG0616|consen  189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKI  253 (355)
T ss_pred             cceEEecCc-----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHH
Confidence            999876543     3566799999999999886  788899999999999999999999987664        2234444


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCC
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP  329 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  329 (340)
                      ..+.       -.+++..+.++++|+.+.|+.|-.+|.
T Consensus       254 ~~~~-------v~fP~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  254 LEGK-------VKFPSYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             HhCc-------ccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence            4332       245556778999999999999999983

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-47  Score=339.11  Aligned_cols=243  Identities=25%  Similarity=0.356  Sum_probs=208.9

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+++.||+|+.|.|-+|++. +|+.+|||++.+..    .....+.+|+-+|+.+.|||++++++++++..++|+|.||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            45789999999999999754 89999999997642    22356889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++|.|.+++    ...+++++.+..+++.||+.|+.|||..   +|+|||+||+|+|+|..+++||+|||+|..-..+. 
T Consensus        95 ~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   95 PGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             CCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            999999999    4567899999999999999999999999   99999999999999999999999999998644433 


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                        -..+.+|+++|.+||++.+. ...+.++||||.||+||.||||+.||++.....        +......|.       
T Consensus       167 --lLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--------LLlKV~~G~-------  228 (786)
T KOG0588|consen  167 --LLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--------LLLKVQRGV-------  228 (786)
T ss_pred             --cccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCc-------
Confidence              34667899999999999986 456789999999999999999999998543221        223333332       


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+.+..++.++++|+.+|+..||++|.|++||++
T Consensus       229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            3445677899999999999999999999999986

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6e-46  Score=332.86  Aligned_cols=258  Identities=28%  Similarity=0.436  Sum_probs=201.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE------cCCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcC-C
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEG-S  133 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~  133 (340)
                      ...+++.+.||+|+||.||+|..      .++..||+|++......  .+.+.+|+.++..+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            34567789999999999999963      23467999998754322  35688999999999 899999999988654 4


Q ss_pred             eeEEEEEccCCCCcccccccCCCC--------------------------------------------------------
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESR--------------------------------------------------------  157 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------------  157 (340)
                      ..+++|||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            578999999999999888542210                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCccc
Q 044497          158 --GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY  235 (340)
Q Consensus       158 --~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y  235 (340)
                        ..++++..+..++.|+++||+|||++   +++||||||+||+++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              13478889999999999999999999   9999999999999999999999999999765433222222233466789


Q ss_pred             cccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHH
Q 044497          236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLC  314 (340)
Q Consensus       236 ~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  314 (340)
                      +|||.+.+.  .++.++||||||+++|||++ |..||.......       .....+..+.....      +...++.+.
T Consensus       243 ~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGTRMRA------PENATPEIY  307 (338)
T ss_pred             cCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCCCCCC------CCCCCHHHH
Confidence            999998764  67889999999999999997 999987543211       12222222222111      223456789


Q ss_pred             HHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          315 MIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       315 ~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      +++.+||+.||.+|||+.++++.|+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~  332 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILG  332 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-47  Score=335.99  Aligned_cols=263  Identities=27%  Similarity=0.472  Sum_probs=213.3

Q ss_pred             CHHHHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           58 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      ...|+......+..+||+|+||+||+|.|+  +.||||+++-+.-+.   +.|++|+.++++-+|.||+-+.|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            334555555567789999999999999997  579999998755544   679999999999999999999999988876


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                       .+|+.+|+|.+|..++...+   ..|...+...|+.|+++|+.|||.+   +|+|||||..|||+.++++|||+|||++
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence             99999999999999995443   6788999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      ..-.............|...|||||++..+ ..++++.+||||||+++|||+||..||.....+.  ..        +.-
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--Ii--------fmV  605 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--II--------FMV  605 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--eE--------EEe
Confidence            754444333344555688899999999643 2378899999999999999999999998333221  10        111


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ++.....+......++++++++|+..||..++++||++.+|+..|+
T Consensus       606 GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  606 GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence            1111122233445567789999999999999999999999999765

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-46  Score=325.46  Aligned_cols=264  Identities=24%  Similarity=0.336  Sum_probs=207.4

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcC--CeeEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAL  137 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l  137 (340)
                      ...|+..++||+|.||.||+|++ .+|+.||+|++..+...   ..-..+|+.+|++|+||||+++.+...+.  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            45566678999999999999974 58999999999765433   35678999999999999999999998766  68999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      |+|||+. +|.-++.   ..+-.|++.++..++.|+++||+|||++   |+.|||||.+|||+|.+|.+||+|||+|+++
T Consensus       196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999965 7777662   3456799999999999999999999999   9999999999999999999999999999976


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc---------cchhHHHH
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK---------AYFPSWVY  288 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~---------~~~~~~~~  288 (340)
                      ...... ..+..+.|.+|+|||++.+. ..|+..+|+||.||++.||++|++.+......+.-         ..-..|..
T Consensus       269 ~~~~~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  269 TPSGSA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             cCCCCc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence            555432 24566789999999999986 57899999999999999999999998765532110         00011211


Q ss_pred             HHhhcCCCcc-----ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 DQLNKGGDLE-----LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ~~~~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+.......     .....+....++....+|+..+|..||.+|.|+.++|+
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1111100000     01112334456788999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.6e-46  Score=301.33  Aligned_cols=258  Identities=22%  Similarity=0.317  Sum_probs=205.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +|...+++|+|.||.||+|++ .+|+.||+|+++..+..   .-...+|++.|+.++|+||+.++++|...+...+|+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            456678999999999999975 48999999999876544   35688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      + ..+|+..+.   .+...++...+..++.++++|++|||++   .|.|||+||.|+|++++|.+||+|||+++......
T Consensus        83 m-~tdLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   83 M-PTDLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             c-cccHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9 559998883   3456789999999999999999999999   99999999999999999999999999999877655


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC-------
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG-------  294 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  294 (340)
                      ...  ...+.|..|+|||++.|. ..|+..+|+||.||++.||+-|.+-|...+.-+.    ...+...+...       
T Consensus       156 ~~~--~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ----L~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  156 RIQ--THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ----LSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             ccc--ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH----HHHHHHHcCCCCcccCcc
Confidence            432  223678999999999886 5788999999999999999999877765443210    00011100000       


Q ss_pred             ----------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          295 ----------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       295 ----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                                ...+........+..+.++.+|+.+||..||.+|+|++|+++.
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                      0001111112334556788999999999999999999999863

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-46  Score=328.71  Aligned_cols=244  Identities=27%  Similarity=0.408  Sum_probs=206.2

Q ss_pred             hhhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCCCh-HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           69 FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      -.++||+|+.|.||.|. ..+++.||+|.+....... +-+.+|+.+|+..+|+|||.+++.|...+.+++||||++||+
T Consensus       277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs  356 (550)
T KOG0578|consen  277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS  356 (550)
T ss_pred             chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence            34689999999999996 4578899999998766554 567899999999999999999999988899999999999999


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceee
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  226 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (340)
                      |.+.+     ....+++.++..|+..+++||+|||.+   +|+|||||.+|||++.+|.+||+|||++........  .-
T Consensus       357 LTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR  426 (550)
T KOG0578|consen  357 LTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR  426 (550)
T ss_pred             hhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence            99988     345589999999999999999999999   999999999999999999999999999987665543  22


Q ss_pred             eccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhh
Q 044497          227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  306 (340)
Q Consensus       227 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (340)
                      .+..||++|||||+....  .|+++.||||||++++||+-|++||-...+..       .++- +.....+.+.    .+
T Consensus       427 ~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyL-Ia~ng~P~lk----~~  492 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYL-IATNGTPKLK----NP  492 (550)
T ss_pred             ccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHH-HhhcCCCCcC----Cc
Confidence            456799999999999886  88999999999999999999999997533211       1111 2222233333    23


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          307 SMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       307 ~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+++.+++++.+||+.|+.+|+|++|+|+
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            456789999999999999999999999986

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-45  Score=314.73  Aligned_cols=255  Identities=21%  Similarity=0.342  Sum_probs=216.5

Q ss_pred             CCCHHHHHHHHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCChH----HHHHHHHHhcccCCCceeeEeeEEE
Q 044497           56 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGE----EFINEVSTIGRIHHVNVVQLLGFCS  130 (340)
Q Consensus        56 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~  130 (340)
                      +-....-...+|++.+.||+|.||+|-+|+. ..|+.||||.++++....+    .+.+|+++|..|+||||++++.+|+
T Consensus        44 rhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE  123 (668)
T KOG0611|consen   44 RHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE  123 (668)
T ss_pred             ccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence            3334445577889999999999999999975 5899999999988765443    4789999999999999999999999


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEec
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~D  210 (340)
                      ..++..+||||..+|.|.+|+    +..+.+++.....++.||.+|+.|+|.+   +++|||||.+|||+|.++++||+|
T Consensus       124 NkdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  124 NKDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             CCceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeec
Confidence            999999999999999999999    5667899999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      ||++..+....   ..++++|++-|.+||++.+. +.-++.+|.||||++||.|+.|..||+..+-.        .....
T Consensus       197 FGLSNly~~~k---fLqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk--------~lvrQ  264 (668)
T KOG0611|consen  197 FGLSNLYADKK---FLQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK--------RLVRQ  264 (668)
T ss_pred             cchhhhhcccc---HHHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHH--------HHHHH
Confidence            99998765544   34678899999999999986 44578999999999999999999999875532        23334


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      +.++..-+..        .+.++.-||.+||-.||.+|.|+.++..-
T Consensus       265 Is~GaYrEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  265 ISRGAYREPE--------TPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             hhcccccCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            4444332222        23567889999999999999999998754

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.9e-45  Score=320.55  Aligned_cols=265  Identities=24%  Similarity=0.353  Sum_probs=200.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcC-----------------CcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHT-----------------GGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQ  124 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~  124 (340)
                      ...|.+.+.||+|+||.||+|.+++                 +..||+|.+......  ..++.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3456677899999999999997532                 336999998764332  356889999999999999999


Q ss_pred             EeeEEEcCCeeEEEEEccCCCCcccccccCC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCee
Q 044497          125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKE---------------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL  189 (340)
Q Consensus       125 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~iv  189 (340)
                      +++++.+.+..+++|||+++++|.+++....               .....+++..+..++.|++.||+|||+.   +++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            9999999999999999999999998874321               1123578889999999999999999999   999


Q ss_pred             ecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcC--
Q 044497          190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG--  267 (340)
Q Consensus       190 H~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg--  267 (340)
                      ||||||+|||+++++.+||+|||+++...............++..|+|||.+...  .++.++||||||+++|+|+++  
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999765443322222333467889999998764  678899999999999999874  


Q ss_pred             CCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          268 RRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       268 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..||.......    .................   ...++.++..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       239 ~~p~~~~~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         239 EQPYGELTDEQ----VIENAGEFFRDQGRQVY---LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCcCCHHH----HHHHHHHHhhhcccccc---ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            45665432211    11111111111110000   01112345688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-44  Score=314.17  Aligned_cols=244  Identities=18%  Similarity=0.280  Sum_probs=197.4

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh----HHHHHHHHHhcccCCCceeeEeeEEEc----CCeeEEEEEcc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEYM  142 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~  142 (340)
                      ..||+|++|.||+|.. +|+.||+|.++......    +.+.+|+.++.+++||||+++++++.+    ....+++|||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4799999999999988 58899999998654433    567799999999999999999999876    45688999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++|+|.+++..    ...+++.....++.|++.|++|||+.  .+++||||||+||++++++.+||+|||++....... 
T Consensus       105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999843    34688899999999999999999972  178899999999999999999999999987543321 


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                          ....++..|+|||.+.+....++.++|||||||++|||++|+.||......       ..............    
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~----  242 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYDLIINKNNSLK----  242 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCCC----
Confidence                233578899999999764347889999999999999999999999754321       11222222222211    


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        .+...+..+.+++.+||+.||.+|||++++++.|+
T Consensus       243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~  277 (283)
T PHA02988        243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS  277 (283)
T ss_pred             --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence              12235678999999999999999999999999886

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=341.66  Aligned_cols=257  Identities=28%  Similarity=0.454  Sum_probs=214.9

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-C---CcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-T---GGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      ||..+-..+.+.||.|.||.||+|.++ .   ...||||.++....  ...+|+.|+.+|.+++||||+++.|+.+....
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            344444455689999999999999876 2   34799999987543  44689999999999999999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      ..+|.|||++|+|..++..+.   +.|.+.++..+++.|+.|++||.+.   ++|||||.++|||++++..+|++|||++
T Consensus       705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999996544   5588999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCC-ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhh
Q 044497          215 KFHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       215 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      +...++.. ........-+.+|.|||.|...  +++.++||||||+++||.++ |.+||..++..+        +.+.++
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~R--KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------VIkaIe  848 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIE  848 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhc--ccCchhhccccceEEEEecccCCCcccccchHH--------HHHHHH
Confidence            97765542 2222233346799999999764  88999999999999999887 999998877643        445555


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .+.+..      .+.+++..+.+|+..||+.|-.+||.+.|++..|+
T Consensus       849 ~gyRLP------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD  889 (996)
T KOG0196|consen  849 QGYRLP------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD  889 (996)
T ss_pred             hccCCC------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence            554433      23467789999999999999999999999999875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-45  Score=321.45  Aligned_cols=266  Identities=24%  Similarity=0.348  Sum_probs=215.6

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh--HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      +|.......+.++||+|-||.|.+|....+..||||+++.+....  .+|.+|+++|.+++||||++++|+|...+.+++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            456667777889999999999999998888999999998765443  689999999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ++|||++|+|.+++..++...  .....-.+|+.||+.|++||.+.   ++||||+.++|+|++.++++||+|||+++.+
T Consensus       613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence            999999999999997664332  34455667999999999999998   9999999999999999999999999999976


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc--CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .....+.......-+.+|||||.+.-.  +++.++|+|+||+++||+++  ...||.....+..    .+-....+..+.
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillg--kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----ven~~~~~~~~~  761 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----VENAGEFFRDQG  761 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhc--cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----HHhhhhhcCCCC
Confidence            666555544455678899999988764  88999999999999999876  6778775544321    111111222221


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...   ....+..++..+.+++.+||..+-++|||++++...|+
T Consensus       762 ~~~---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  762 RQV---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             cce---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence            111   12344556788999999999999999999999988775

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-44  Score=325.44  Aligned_cols=258  Identities=26%  Similarity=0.440  Sum_probs=202.6

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE------cCCcEEEEEEccCCCC--ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCe
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  134 (340)
                      ...+.+.+.||+|+||.||+|++      .++..||+|+++....  ..+.+.+|+.++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            44567889999999999999963      2456899999975433  235688999999999 89999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCC----------------------------------------------------------
Q 044497          135 RALVYEYMPNGSLDRHIFPKES----------------------------------------------------------  156 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  156 (340)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999988853221                                                          


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          157 -------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       157 -------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                                   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         112578899999999999999999999   9999999999999999999999999999765443322


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      .......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......       .....+..+.....   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~~---  338 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------KFYKMIKEGYRMLS---  338 (375)
T ss_pred             cccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------HHHHHHHhCccCCC---
Confidence            222223456789999999765  77889999999999999998 888886533211       12222222221111   


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         +...+.++.+++.+||+.||++|||+.++++.|+
T Consensus       339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~  372 (375)
T cd05104         339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE  372 (375)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence               1123467899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.7e-45  Score=319.06  Aligned_cols=243  Identities=25%  Similarity=0.323  Sum_probs=196.7

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +++.++||+|+||.||+|+.+ +|..+|+|+++++..    ..+....|-.+|....+|.||+++-.|++.+++|+||||
T Consensus       143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy  222 (550)
T KOG0605|consen  143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY  222 (550)
T ss_pred             chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence            345589999999999999755 899999999988543    335688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC--
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK--  219 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~--  219 (340)
                      ++||++..+|    .+...+++.....++.+++.|+..+|+.   |++||||||+|+|||..|++||+|||++.-...  
T Consensus       223 lPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  223 LPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             cCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            9999999999    4567899999999999999999999999   999999999999999999999999999842211  


Q ss_pred             -------------------CCCce-----e-------------------eeccccCccccccccccccccccccccchhh
Q 044497          220 -------------------ENDFV-----S-------------------ISATRGTIGYIAPELISRNFGTVSCKSDVYG  256 (340)
Q Consensus       220 -------------------~~~~~-----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  256 (340)
                                         .....     .                   ....+|||.|+|||++.+.  .++..+|.||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWS  373 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWS  373 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHH
Confidence                               00000     0                   0122499999999999987  6889999999


Q ss_pred             HHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 044497          257 FGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (340)
Q Consensus       257 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  330 (340)
                      |||++||||.|.+||....+.+.-..+..|.       .....+.    ...+++++.+||.+|+. ||.+|..
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-------~~l~fP~----~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWR-------ETLKFPE----EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-------hhccCCC----cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999998776544222222221       1111111    12344889999999999 9999975

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=308.94  Aligned_cols=258  Identities=21%  Similarity=0.286  Sum_probs=204.7

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccC---CCCChHHHHHHHHHhcccCCCceeeEeeEEEc-----CCeeEEEEE
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLAN---SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRALVYE  140 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e  140 (340)
                      .+.||+|+||.|+.+... +|+.||+|++..   .....++..+|+++|+.++|+||+.+.+.+..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            468999999999999765 889999999873   34455788999999999999999999998854     556899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      +| +.+|++.+    ..+..++......+.+|++.||+|+|+.   +++|||+||+|+|++.+..+|++|||+|+.....
T Consensus       107 lM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  107 LM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             HH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence            99 77999988    3445589999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch-------hHHH------
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF-------PSWV------  287 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~~------  287 (340)
                      .....++....|.+|+|||++... ..|+...||||.||++.||++|++.|.+.+.-..-..+       .+..      
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            333445677789999999998654 58899999999999999999999999876532100000       0011      


Q ss_pred             ---HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          288 ---YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       288 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ...+..-.......-....+..++.+.+|+.+||..||.+|+|++|.|+
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence               1111111111111112333466789999999999999999999999885

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-45  Score=324.39  Aligned_cols=244  Identities=26%  Similarity=0.391  Sum_probs=208.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.....   +.+.+|+++++.++||||+.++++|+...+.++|.||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            4566789999999999999755 78899999998766554   4578999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +.| +|..++    ...+.++++.+..++.+++.||.|||+.   +|.|||+||.|||++.++.+|+||||+|+......
T Consensus        83 a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   83 AVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            966 999999    4567899999999999999999999999   99999999999999999999999999999765533


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ..+...|||.|||||+..+.  .++..+|.||+||++||+.+|++||...+       +...+.....+.       
T Consensus       155 ~--vltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d~-------  216 (808)
T KOG0597|consen  155 S--VLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKDP-------  216 (808)
T ss_pred             e--eeeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcCC-------
Confidence            2  34556799999999999875  88999999999999999999999997543       233333333322       


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ...+...+..+.+++...|..||.+|.|..+++.
T Consensus       217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence             2233467789999999999999999999988864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.3e-44  Score=316.59  Aligned_cols=249  Identities=26%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |...+.||+|+||.||+|.. .+++.||+|.+.....    ....+.+|+.++..++|+|++++++.+.+.+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            45567899999999999976 4789999999865332    224578899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998877432  234688999999999999999999999   99999999999999999999999999997653322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   .....||..|+|||.+.+.  .++.++|||||||++|+|++|+.||........    ...........       
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~-------  220 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKED-------  220 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcc-------
Confidence            1   2344689999999999865  778899999999999999999999986543211    11111111111       


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                      ....+...+.++.+|+.+||+.||.+|||     ++++++
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11223345678999999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=311.93  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=197.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---------------hHHHHHHHHHhcccCCCceeeEeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---------------GEEFINEVSTIGRIHHVNVVQLLGF  128 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~iv~~~~~  128 (340)
                      ..|++.+.||+|.||.|-+|+.. +++.||+|++.+....               .+...+|+.+|++++|||||+++.+
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            34667789999999999999865 7889999999653221               2478899999999999999999999


Q ss_pred             EEc--CCeeEEEEEccCCCCcccccccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc
Q 044497          129 CSE--GSKRALVYEYMPNGSLDRHIFPKESRGQS-FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  205 (340)
Q Consensus       129 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~  205 (340)
                      ..+  .+++|||+|||..|.+...-     ...+ +++.+.++++.+++.||+|||.+   ||+||||||+|+|++++|+
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            865  56799999999988875433     2333 89999999999999999999999   9999999999999999999


Q ss_pred             eEEecccCCccCCCCC---CceeeeccccCccccccccccccc--cccccccchhhHHHHHHHHHcCCCCCCCCcccccc
Q 044497          206 PKVSDFGLAKFHPKEN---DFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK  280 (340)
Q Consensus       206 ~kl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~  280 (340)
                      +||+|||.+.......   .........|||.|+|||.+.+..  ...+.+.||||+||+||+|+.|+.||......   
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---  325 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---  325 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence            9999999998653321   112234467999999999987632  24567899999999999999999999754321   


Q ss_pred             cchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          281 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          .......+..  ..+.+    .+++.+++++|+.+||..||+.|.++.+|..
T Consensus       326 ----~l~~KIvn~p--L~fP~----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  326 ----ELFDKIVNDP--LEFPE----NPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             ----HHHHHHhcCc--ccCCC----cccccHHHHHHHHHHhhcChhheeehhhhee
Confidence                1122222221  11111    1245678999999999999999999998753

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-43  Score=305.40  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=204.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ..+++.+.||+|+||.||++.++++..+|+|.+.......+.+.+|+.+++.++||||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            34566789999999999999988888999999887776778899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||.+......... 
T Consensus        84 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          84 GCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            9999988432   23588999999999999999999999   9999999999999999999999999998755332211 


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      ......++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||......       . ....+..+.....    
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~-~~~~i~~~~~~~~----  222 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------E-VVEMISRGFRLYR----  222 (256)
T ss_pred             ccCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHHCCCCCCC----
Confidence            11222356689999998764  67889999999999999999 88898654321       1 1112222211111    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1123467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-46  Score=319.01  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +-.+.||+|+||.||+|.+. +++.||+|++.-+..  ..+++..|+.++.+++++||.+.++.+..+..++++||||.|
T Consensus        16 ~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g   95 (467)
T KOG0201|consen   16 TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG   95 (467)
T ss_pred             ccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence            33468999999999999765 889999999976543  346889999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |++.+.+    ..+..+.+..+..++.++..|+.|||..   +.+|||||+.|||+..+|.+||+|||.+......... 
T Consensus        96 Gsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-  167 (467)
T KOG0201|consen   96 GSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-  167 (467)
T ss_pred             cchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence            9999998    3444558888889999999999999999   9999999999999999999999999999765544332 


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                       ..+.+||+.|||||++.+.  .|+.|+||||||++.+||++|.+|+....+...-..+        .      ...+..
T Consensus       168 -r~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--------p------k~~PP~  230 (467)
T KOG0201|consen  168 -RKTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--------P------KSAPPR  230 (467)
T ss_pred             -cccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec--------c------CCCCCc
Confidence             2677899999999999865  8899999999999999999999999876552211111        1      111123


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .....++.+++++..||+.||+.||||.++++
T Consensus       231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            33366788999999999999999999999986

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-44  Score=321.57  Aligned_cols=240  Identities=22%  Similarity=0.305  Sum_probs=195.0

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.||+|+||.||+|... +++.+|+|+++...    .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999765 78899999987532    12246778999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  151 (323)
T cd05571          81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence            9998883    345789999999999999999999999   999999999999999999999999999874322211  1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.......        .........       ..+
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~-------~~~  214 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEE-------IRF  214 (323)
T ss_pred             ccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcCC-------CCC
Confidence            2344699999999999765  67889999999999999999999996533211        111111111       112


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                      +...+.++.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            234567899999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-44  Score=307.26  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=208.1

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +...++++.+.||.|++|.||+|..++++.+|+|.++......+++.+|+++++.++|||++++++++...+..+++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            34456777899999999999999887788999999987766677899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++....  +..+++..+..++.|++.|+.+||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            99999999984432  35689999999999999999999999   99999999999999999999999999998654321


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      . ........+..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||......        .............  
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~--  224 (261)
T cd05068         158 Y-EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------EVLQQVDQGYRMP--  224 (261)
T ss_pred             c-cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC--
Confidence            1 111122234579999998764  67889999999999999999 99888643321        1112222211111  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                          .+...+..+.+++.+|++.+|.+||++.++++.|++
T Consensus       225 ----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 ----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                112345789999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=325.79  Aligned_cols=239  Identities=24%  Similarity=0.341  Sum_probs=202.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .+.+.++||+|+||+|+++..+ +++.+|||+++++..    ..+....|.+++... +||.+++++..|+..+++|+||
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm  448 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM  448 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence            3456789999999999999866 788999999998544    345678888888877 5999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+.||++..+.     ....+++..+.-++..++.||+|||++   +||+||||.+|||+|.+|++||+|||+++....
T Consensus       449 ey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  449 EYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence            999999965544     456799999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...  ..++.+||+.|+|||++.+.  .|+..+|.|||||+||||+.|..||...+.++.       ..+.+++      
T Consensus       521 ~g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------FdsI~~d------  583 (694)
T KOG0694|consen  521 QGD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------FDSIVND------  583 (694)
T ss_pred             CCC--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcC------
Confidence            322  45788999999999999986  899999999999999999999999987665431       1122221      


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                        ...++..++.++.+++.++|..||++|...
T Consensus       584 --~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 --EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              234555678899999999999999999865

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-44  Score=322.69  Aligned_cols=243  Identities=24%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..|.+.+.||+|+||.||+|... +++.+|+|++....    ...+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            34667789999999999999875 68899999987532    22356889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++.....
T Consensus        98 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999999883    345688999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ..     ....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......        .....+..+. .  
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~-~--  232 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAGR-L--  232 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCC-c--
Confidence            22     234589999999999775  6788999999999999999999999653321        1122222221 1  


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                          ..+..++..+.+|+.+||+.||.+||+     ++++++
T Consensus       233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                112224567899999999999999997     677663

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-43  Score=310.10  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=206.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      ..++.+.+.||+|+||.||+|...      ++..+|+|.++.....  .+.+.+|+++++.++|||++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            456778899999999999999753      3478999998765443  36789999999999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKE----------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  205 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~  205 (340)
                      +++|||+++++|.+++....          .....+++..+..++.|++.|++|||++   +++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999985432          2234578899999999999999999999   9999999999999999999


Q ss_pred             eEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchh
Q 044497          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFP  284 (340)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~  284 (340)
                      ++|+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......      
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------  232 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------  232 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            999999998754332221112233457889999998764  68889999999999999998 999986543321      


Q ss_pred             HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          285 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                        .......+....      .+...+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus       233 --~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 --VIECITQGRLLQ------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              112222221111      112345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=317.84  Aligned_cols=241  Identities=23%  Similarity=0.263  Sum_probs=197.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |++.+.||+|+||.||+|... +++.+|+|++.....    ..+.+.+|+++++.++||||+++++++.+.+..+++|||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            556789999999999999865 788999999865322    235678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++.......
T Consensus        83 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          83 VPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            99999999983    335688999999999999999999999   99999999999999999999999999987653321


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                           ....|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ....+..+.      
T Consensus       156 -----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~------  214 (291)
T cd05612         156 -----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--------IYEKILAGK------  214 (291)
T ss_pred             -----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC------
Confidence                 234589999999998765  67889999999999999999999997543211        112222111      


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                       ...+...+..+.+++.+||+.||.+||+     ++++++
T Consensus       215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence             1122234578899999999999999995     888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-44  Score=310.33  Aligned_cols=249  Identities=32%  Similarity=0.559  Sum_probs=194.9

Q ss_pred             hhhhcCCCCCeEEEEEEEc-----CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           69 FTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.+.||.|+||.||+|.++     .+..|+||.++.....  .+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999876     3568999999664332  46899999999999999999999999988889999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+++||++++++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999544  246789999999999999999999999   99999999999999999999999999998663333


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .............|+|||.+.+.  .++.++||||||+++|||++ |+.|+......       . +...+.++....  
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-------~-~~~~~~~~~~~~--  225 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-------E-IIEKLKQGQRLP--  225 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-------H-HHHHHHTTEETT--
T ss_pred             ccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc-------c-ccccccccccce--
Confidence            33333344577899999999775  67889999999999999999 67887654321       1 222333332222  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                          .+..++..+.+++.+||+.+|.+|||+.++++.|
T Consensus       226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                1223457788999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.4e-44  Score=308.37  Aligned_cols=254  Identities=25%  Similarity=0.401  Sum_probs=202.1

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ....+.+.+.||+|+||.||+|.++    .+..+|+|.++.....  ...+.+|+..+..++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3456778899999999999999753    3568999998765332  256889999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.++++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999988432   34688999999999999999999999   999999999999999999999999998764


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ....... ......++..|+|||.+.+.  .++.++|||||||++||+++ |+.||.......        ....+.++.
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~  225 (266)
T cd05064         157 DKSEAIY-TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------VIKAVEDGF  225 (266)
T ss_pred             ccccchh-cccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCC
Confidence            3222111 11123356789999998764  77889999999999999775 999987543221        122222221


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...      .+..++..+.+++.+||+.+|.+|||++++++.|+
T Consensus       226 ~~~------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         226 RLP------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS  263 (266)
T ss_pred             CCC------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence            111      12345678899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-44  Score=317.74  Aligned_cols=237  Identities=22%  Similarity=0.277  Sum_probs=192.1

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ||+|+||.||+|... +++.+|+|++...    ......+.+|+.++..++||||+++++++...+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999865 6789999998653    22335678899999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  151 (312)
T cd05585          81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN  151 (312)
T ss_pred             HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence            99883    235688999999999999999999999   999999999999999999999999999875433221  123


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......       .........        ....+.
T Consensus       152 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~~--------~~~~~~  214 (312)
T cd05585         152 TFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQE--------PLRFPD  214 (312)
T ss_pred             cccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcC--------CCCCCC
Confidence            45689999999999775  6788999999999999999999999754321       111111111        112223


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCC---HHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPS---MTKVL  335 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps---~~evl  335 (340)
                      .+++.+.+++.+||+.||.+||+   +.+++
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            45678899999999999999986   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-43  Score=320.71  Aligned_cols=259  Identities=24%  Similarity=0.435  Sum_probs=202.1

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcCC
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  133 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  133 (340)
                      ....+.+.+.||+|+||.||+|...      ++..||+|+++.....  .+.+.+|+.+++.+ +|+||++++++|....
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3456677899999999999998742      2357999999764332  35688999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCCcccccccCC----------------------------------------------------------
Q 044497          134 KRALVYEYMPNGSLDRHIFPKE----------------------------------------------------------  155 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------  155 (340)
                      ..+++|||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999998874321                                                          


Q ss_pred             --------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          156 --------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       156 --------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                              ....++++..+.+++.|+++||+|||++   +++||||||+||++++++.++|+|||++.............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                    0123578889999999999999999999   99999999999999999999999999997654433222222


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhh
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  306 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (340)
                      ...++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......       ........+.....      +
T Consensus       273 ~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~~~~~------~  337 (374)
T cd05106         273 NARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGYQMSR------P  337 (374)
T ss_pred             CCCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcccCccC------C
Confidence            33456789999998764  68889999999999999997 999987543211       11122222211111      1


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       307 ~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...++++.+++.+||+.||++|||+.++++.|+
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~  370 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ  370 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            123578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-43  Score=306.60  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=207.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...+.+.++||+|++|.||+|...++..+|+|.+.......+.+.+|+.+++.++|+|++++++.+...+..+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            34566778999999999999998888899999988766667889999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.........
T Consensus        85 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          85 KGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            99999988432  245678899999999999999999998   9999999999999999999999999999865433211


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                       ......++..|+|||.+.+.  .++.++||||||+++|+|+| |+.||.......        ....+.......    
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~----  224 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSALQRGYRMP----  224 (261)
T ss_pred             -ccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCC----
Confidence             11223356789999998764  67889999999999999998 999986533211        122222221111    


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                        ....++.++.+++.+||+.+|++|||++++.+.|+.
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 --RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              111245678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-43  Score=308.53  Aligned_cols=256  Identities=25%  Similarity=0.442  Sum_probs=203.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcC-C-----cEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHT-G-----GLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~-~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      .+.+.+.||+|+||.||+|.... +     ..+++|.+......  .+.+.+|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            45677899999999999997542 2     57999998754332  3568899999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc
Q 044497          138 VYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  205 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~  205 (340)
                      +|||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence            9999999999998854321            114688899999999999999999999   9999999999999999999


Q ss_pred             eEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchh
Q 044497          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFP  284 (340)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~  284 (340)
                      ++|+|||++................+++.|+|||.+.+.  .++.++|||||||++|||++ |..||......+      
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------  234 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------  234 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence            999999998755433322222334467889999988764  67889999999999999998 999987543211      


Q ss_pred             HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          285 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                        ....+..+...      ..+..++.++.+|+.+||+.||.+|||+.++++.|++
T Consensus       235 --~~~~i~~~~~~------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 --VIEMIRSRQLL------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHcCCcC------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              22222222211      1233566889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=319.82  Aligned_cols=248  Identities=20%  Similarity=0.260  Sum_probs=200.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||.||+|... +++.||+|++.....    ....+.+|++++..++||||+++++++...+..|+||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            556789999999999999876 688999999875422    235678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++.....  
T Consensus        83 ~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          83 VPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            99999999983    345688999999999999999999999   999999999999999999999999999975543  


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC-CCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG-GDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  300 (340)
                         ......||+.|+|||.+.+.  .++.++|||||||++|||++|..||.......        ....+... ......
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~  220 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQRP  220 (333)
T ss_pred             ---ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhccccccCC
Confidence               12344689999999999875  77889999999999999999999997544321        11111110 000001


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ........++.++.+++.+||+.+|.+|||++++++
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            001111235678999999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-43  Score=306.13  Aligned_cols=254  Identities=30%  Similarity=0.443  Sum_probs=205.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ..+.+.+.||.|++|.||+|.+. +++.+|+|.+..+....+++.+|+++++.++|||++++++++...+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            44566789999999999999765 68899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...  ....+++..+..++.|+++||+|||++   +++|+||||+||++++++.++|+|||++.........
T Consensus        86 ~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          86 YGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999988432  234688999999999999999999998   9999999999999999999999999999765433211


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                       ......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ....+......     
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~-----  224 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKGYRM-----  224 (263)
T ss_pred             -ccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCCC-----
Confidence             11122345689999988764  67889999999999999998 888886543211        12222222111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       ..+...+.++.+++.+||+.+|++|||+.++++.|+.
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence             1122345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.2e-43  Score=302.29  Aligned_cols=252  Identities=28%  Similarity=0.465  Sum_probs=204.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ..+.+.+.||+|+||.||.|...++..+|+|.+.......+.+.+|+.+++.++||||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            34567789999999999999887777899999987766678899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||.+........ .
T Consensus        84 ~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          84 GCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            9999988432   23689999999999999999999999   999999999999999999999999999875543321 1


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        .......+......   
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~---  223 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------TVEKVSQGLRLYRP---  223 (256)
T ss_pred             ecCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCCCCC---
Confidence            11223356789999998764  67889999999999999999 998886433211        11222222111111   


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         ...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 ---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               123578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.5e-44  Score=314.87  Aligned_cols=258  Identities=23%  Similarity=0.330  Sum_probs=195.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|++.+.||+|+||.||+|... +++.+|+|++.....  ....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV   85 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence            4667789999999999999876 788999999875432  2346788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      + ++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++........
T Consensus        86 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          86 H-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             C-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            4 678777733   235688899999999999999999999   999999999999999999999999999874432221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC--------
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG--------  294 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  294 (340)
                        ......+++.|+|||.+.+. ..++.++||||+||++|+|++|+.||.........  + ..........        
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--L-ERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             --cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--H-HHHHHHhCCCChhhccch
Confidence              12334588999999998653 35678899999999999999999999754321100  0 0000000000        


Q ss_pred             --------CCccccccchhhH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 --------GDLELRNVTEIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 --------~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                              .............     ..+.++.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                    0000000000000     12357889999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-43  Score=311.22  Aligned_cols=261  Identities=24%  Similarity=0.309  Sum_probs=196.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|.+.+.||.|+||.||+|... +++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            3566789999999999999865 788999999865332  2356789999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      + ++|.+++..   .+..+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++........
T Consensus        86 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          86 D-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             C-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            6 488888732   234578899999999999999999999   999999999999999999999999999875433221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHhhcC-
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQLNKG-  294 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~-  294 (340)
                        ......+++.|+|||.+.+. ..++.++||||+||++|+|++|+.||......+.-....       ...+...... 
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             --cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence              12334578999999998653 357889999999999999999999997544321100000       0000000000 


Q ss_pred             -----CCcccc--ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 -----GDLELR--NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 -----~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           ......  .........+.++.+|+.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 000000  000111234567899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-43  Score=302.60  Aligned_cols=251  Identities=28%  Similarity=0.456  Sum_probs=203.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      .+++.+.||+|+||.||++.++++..+|+|++.......+.+.+|+++++.++|||++++++++...+..+++|||++++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            45678899999999999998887789999998876666778899999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+||+|||+++........ .
T Consensus        85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~  157 (256)
T cd05059          85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S  157 (256)
T ss_pred             CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence            999988432   23688999999999999999999999   9999999999999999999999999998755432211 1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      .....++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||.......        .......+....      
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------  221 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------VVESVSAGYRLY------  221 (256)
T ss_pred             cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------HHHHHHcCCcCC------
Confidence            1122245579999998764  67889999999999999999 788886543211        112222221111      


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            11234678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-43  Score=330.41  Aligned_cols=251  Identities=20%  Similarity=0.222  Sum_probs=201.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-C-CcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-T-GGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~-~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      |.+.+.||+|++|.||+|... + ++.+|+|.+...... ...+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            667789999999999999754 3 577888877544322 2457789999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +|+|.+++........++++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||++.........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999988755444456789999999999999999999999   9999999999999999999999999999865443322


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      .......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......       ..... ...+...      
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-------~~~~~-~~~~~~~------  289 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQR-------EIMQQ-VLYGKYD------  289 (478)
T ss_pred             ccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH-HHhCCCC------
Confidence            223345699999999998764  6788999999999999999999998653321       11111 1111111      


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..++.++.+++.+||+.||++|||+.+++.
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            112234578999999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=323.11  Aligned_cols=249  Identities=29%  Similarity=0.451  Sum_probs=202.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcC--C---cEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHT--G---GLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~--~---~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ...+.++||+|+||.||+|....  +   ..||+|..+.+.    ....++.+|+++|++++|||||+++|++.....++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            33456899999999999997552  2   238999987522    22367899999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +|||+|+||+|.+++...   ...++..+...++.+.+.||+|||++   +++||||..+|+|++.++.+||+|||+++.
T Consensus       238 ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999433   23689999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCceeee-ccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHh-hc
Q 044497          217 HPKENDFVSIS-ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQL-NK  293 (340)
Q Consensus       217 ~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~~  293 (340)
                      ...   +.... ...-+..|+|||.+...  .++.++|||||||++||+++ |..||......+        +...+ .+
T Consensus       312 ~~~---~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--------v~~kI~~~  378 (474)
T KOG0194|consen  312 GSQ---YVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--------VKAKIVKN  378 (474)
T ss_pred             Ccc---eeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHH--------HHHHHHhc
Confidence            431   11111 22467899999999864  88999999999999999999 788988765432        22222 33


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      +.......      ..+.++..++.+||..+|++||||.++.+.|+
T Consensus       379 ~~r~~~~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  379 GYRMPIPS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             CccCCCCC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence            33333222      44578888999999999999999999999875

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.2e-43  Score=301.89  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=208.7

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ++...++++.++||+|+||.||+|..++++.+|+|.+.......+++.+|+.+++.++|||++++++++. .+..+++||
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            3456778889999999999999999888899999999887777788999999999999999999999874 456899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            99999999988432  245688999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ... ......++..|+|||.+...  .++.++|+||||+++|+|++ |+.||.......        ....+..+.... 
T Consensus       156 ~~~-~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~-  223 (260)
T cd05067         156 EYT-AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--------VIQNLERGYRMP-  223 (260)
T ss_pred             Ccc-cccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHHcCCCCC-
Confidence            211 11223456789999998764  67889999999999999999 999987543211        112222221111 


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                           .+...+.++.+++.+||+.+|++|||++++++.|+.
T Consensus       224 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 -----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 112345689999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.7e-43  Score=313.72  Aligned_cols=256  Identities=23%  Similarity=0.312  Sum_probs=198.9

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...|++.+.||+|+||.||++... ++..+|+|.+.....  ..+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            345566789999999999999876 678899999875432  23578999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+.  .+++||||||+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999883    234688999999999999999999985  15999999999999999999999999998755332


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh----------------
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP----------------  284 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~----------------  284 (340)
                      .    .....|+..|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+.                
T Consensus       158 ~----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 M----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             c----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence            2    1334589999999999765  67889999999999999999999996543211000000                


Q ss_pred             ----------------------HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 ----------------------SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                            ......+........     .....+.++.+|+.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL-----PNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCC-----CCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                  000000000000000     01124578999999999999999999999986

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.7e-44  Score=311.65  Aligned_cols=261  Identities=21%  Similarity=0.262  Sum_probs=198.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +|++.+.||+|+||.||+|..+ +++.+|+|++.....   ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            3567789999999999999876 678999999875432   235678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      ++++.+..+.    .....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          82 VEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             CCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9887766543    2235688999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc-------hh-HHHHHHhhc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-------FP-SWVYDQLNK  293 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~~-~~~~~~~~~  293 (340)
                      .. ......|+..|+|||.+.+.  .++.++|+|||||++|+|++|+.||...........       .+ .........
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN  231 (287)
T ss_pred             cc-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence            11 12234589999999999765  678899999999999999999999976442110000       00 000000000


Q ss_pred             C-----CCcccccc----chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 G-----GDLELRNV----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ~-----~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .     ........    ......++.++.+|+.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0     00000000    1112235678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-44  Score=317.40  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=211.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCe-eEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-RALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e  140 (340)
                      .|...+++|+|+||.+++.+.+ ++..+++|.+.-...+   .+....|+.++++++|||||.+.+.|...+. .+++|+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            4667889999999999999755 6779999998754433   3467899999999999999999999988887 999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      ||+||++.+.+....  +..++++.+..++.|++.|+.|||++   .|.|||||+.|||++.++.++|+|||+|+.....
T Consensus        85 Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             ecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999995433  67899999999999999999999998   9999999999999999999999999999987665


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ...+..||+.|+.||++.+.  +|+.|+|||||||++|||++-+++|...+...       .+.. +..+.     
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-------Li~k-i~~~~-----  222 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-------LILK-INRGL-----  222 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchHH-------HHHH-Hhhcc-----
Confidence            42  23556799999999999986  88999999999999999999999998765422       2222 22222     


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                       ....+..++.++..++..||+.+|..||++.++|..
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             134556778899999999999999999999999864

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.4e-44  Score=316.37  Aligned_cols=240  Identities=24%  Similarity=0.315  Sum_probs=193.8

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.||+|+||.||++... ++..||+|++....    .....+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999865 78899999987532    22345678999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|..++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  151 (323)
T cd05595          81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence            9988873    345689999999999999999999999   999999999999999999999999999874322211  1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        .........       ...
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~~~-------~~~  214 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-------IRF  214 (323)
T ss_pred             cccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCC-------CCC
Confidence            2334689999999999764  67889999999999999999999997543211        111111110       112


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                      +..+++++.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            223567889999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-43  Score=316.39  Aligned_cols=240  Identities=22%  Similarity=0.316  Sum_probs=194.6

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.||+|+||.||++... +++.+|+|++....    .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 78899999997532    22356788999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  151 (328)
T cd05593          81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T  151 (328)
T ss_pred             CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence            9988873    335688999999999999999999999   999999999999999999999999999875322211  1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        .........       ...
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~~~~~-------~~~  214 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMED-------IKF  214 (328)
T ss_pred             cccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHhccCC-------ccC
Confidence            2344689999999999765  67889999999999999999999996543211        111111110       112


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                      +..++.++.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            234567889999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=342.38  Aligned_cols=261  Identities=28%  Similarity=0.474  Sum_probs=213.2

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEc--CCc----EEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEc
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLH--TGG----LIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSE  131 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  131 (340)
                      +++...+.++.+.||+|+||.||.|...  .+.    .||+|.++....  ...+|.+|..+|+.++|||||+++|+|.+
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            3455566677789999999999999744  333    489999887533  44689999999999999999999999999


Q ss_pred             CCeeEEEEEccCCCCcccccccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          132 GSKRALVYEYMPNGSLDRHIFPKE---SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       132 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                      ....++++|||++|+|..+|...+   .....++...++.++.|+|+|+.||+++   +.|||||..+|+|++....+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence            999999999999999999996542   2245688999999999999999999999   9999999999999999999999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHH
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  287 (340)
                      +|||+|+.......+.......-+..|||||.+..  +.++.|+|||||||++||++| |..||...+..+        +
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v  913 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------V  913 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------H
Confidence            99999995544443332222345679999999987  489999999999999999999 889998766543        3


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .....++.+.+.      +..++..+.+++.+||+.+|++||++..+++.++
T Consensus       914 ~~~~~~ggRL~~------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  914 LLDVLEGGRLDP------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             HHHHHhCCccCC------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence            333333333332      3356678889999999999999999999998764

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-43  Score=293.68  Aligned_cols=257  Identities=21%  Similarity=0.286  Sum_probs=200.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEE--cCCeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~  139 (340)
                      .|+..++|++|+||.||+|+++ +++.||+|+++-+....   -...+|+.+|.+.+|||||.+-.+..  +-+..|+||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            3445579999999999999865 88999999998655332   24689999999999999999988764  456799999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      |||+. +|...+..   ...+|...++..+..|++.|++|||.+   .|+||||||+|+|++..|.+|++|||+|+.+..
T Consensus       157 e~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  157 EYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            99954 88887743   347899999999999999999999999   999999999999999999999999999997766


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC----
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG----  295 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  295 (340)
                      ...  ..+..+.|.+|+|||++.+. ..|+.+.|+||+||++.||+++++.|...+....-    +.+...+....    
T Consensus       230 p~k--~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl----~~If~llGtPte~iw  302 (419)
T KOG0663|consen  230 PLK--PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL----DKIFKLLGTPSEAIW  302 (419)
T ss_pred             Ccc--cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH----HHHHHHhCCCccccC
Confidence            532  34566789999999999986 68899999999999999999999988765532210    11111111100    


Q ss_pred             ----------Cccccc------cchhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 ----------DLELRN------VTEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ----------~~~~~~------~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                ...+..      ...+... .+....+|+..+|..||++|.|++|.|+
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                      000000      0011111 4578899999999999999999999875

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9e-44  Score=318.15  Aligned_cols=245  Identities=24%  Similarity=0.266  Sum_probs=199.3

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-C-CcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-T-GGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~-~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ....|.+.+.||+|+||.||+|... + +..+|+|.+....    ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3345677899999999999999754 3 3589999986432    23356889999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++..
T Consensus       108 lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999999983    345688999999999999999999999   999999999999999999999999999976


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .....     ....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......        .....+..+..
T Consensus       181 ~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~~  245 (340)
T PTZ00426        181 VDTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGII  245 (340)
T ss_pred             cCCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCC
Confidence            53321     234689999999999764  6788999999999999999999999754321        12222222211


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                             ..+...+..+.+++.+||+.||++|+     |++++++
T Consensus       246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                   12223456788999999999999995     8888875

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=295.56  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=205.6

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ...|.+.+.||+|.|+.|+++.. .+|+.+|+|+++...   ..-+++.+|+.+.+.|+||||+++.+.+......|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            34566778999999999999964 489999999986533   34578899999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCcc
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKF  216 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~~  216 (340)
                      |++.|++|..-+..+    ..+++..+..+..||++||.|+|.+   +|+|||+||.|+++.+   ..-+||+|||+|..
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999998777432    5577888899999999999999999   9999999999999954   34589999999987


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .....   ......|||.|+|||++...  +++..+|||+.||+||-|+.|.+||...+...        +.+.+..+..
T Consensus       163 l~~g~---~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~~g~y  229 (355)
T KOG0033|consen  163 VNDGE---AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIKAGAY  229 (355)
T ss_pred             eCCcc---ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHhcccc
Confidence            76322   34567799999999999875  88999999999999999999999998644321        3333333321


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .   -+....+.+++++++|+.+||..||++|.|+.|.|.
T Consensus       230 d---~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 D---YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             C---CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1   112234467789999999999999999999999874

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-43  Score=308.42  Aligned_cols=246  Identities=24%  Similarity=0.325  Sum_probs=195.9

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ||+|+||+||++... +++.+|+|.+......    .+.+..|+++++.++||||+++.+++...+..+++|||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999765 7889999998754322    24567899999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++.........+++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            887754434456789999999999999999999999   999999999999999999999999999875543322  123


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...||+.|+|||.+.+.  .++.++|+||||+++|+|++|+.||..........   . .......       .....+.
T Consensus       156 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~-~~~~~~~-------~~~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---E-LKQRILN-------DSVTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---H-HHHhhcc-------cCCCCcc
Confidence            34689999999999875  67889999999999999999999997544321110   0 1111111       1112233


Q ss_pred             HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                      .++..+.+++.+||+.||++||     |++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            4567899999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-43  Score=317.90  Aligned_cols=262  Identities=18%  Similarity=0.254  Sum_probs=194.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcC-----CeeEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  137 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l  137 (340)
                      |++.+.||+|+||.||+|... +++.||+|++....   .....+.+|+++++.++||||+++++++...     ...|+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            566789999999999999865 78899999986432   2234688999999999999999999987543     34799


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +|||+ +++|.+++.    ....+++..+..++.|+++||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus        82 v~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          82 VFELM-ESDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEecC-CCCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            99999 568888873    345689999999999999999999999   9999999999999999999999999999754


Q ss_pred             CCCCC-ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch-------hHHHHH
Q 044497          218 PKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF-------PSWVYD  289 (340)
Q Consensus       218 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~~~~  289 (340)
                      ..... ........||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+       +.....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221 1112344689999999998653346788999999999999999999999754321100000       000000


Q ss_pred             Hhh---------cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLN---------KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~---------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+.         ..............+..++.+.+++.+||+.||++|||++|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000         00000000000111123567889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-45  Score=320.39  Aligned_cols=237  Identities=27%  Similarity=0.468  Sum_probs=198.3

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCcccc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRH  150 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  150 (340)
                      +=||+|+.|.||+|+++ ++.||||+++.-.      ..+++-|++|+||||+.+.|+|...-.+|||||||..|-|.+.
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            46899999999999987 7899999875433      3588999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccc
Q 044497          151 IFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR  230 (340)
Q Consensus       151 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  230 (340)
                      +    ..+..+....+..+..+||.|+.|||.+   .|||||||.-|||++.+..+||+|||-++.......   .-.+.
T Consensus       203 L----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSFa  272 (904)
T KOG4721|consen  203 L----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSFA  272 (904)
T ss_pred             H----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhhh
Confidence            9    4567788899999999999999999999   999999999999999999999999999886544322   23456


Q ss_pred             cCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHH
Q 044497          231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIA  310 (340)
Q Consensus       231 g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (340)
                      ||..|||||+|...  +.+.|+|||||||+|||||||..||..-+...       .++-.-.+.  ..    ...+..++
T Consensus       273 GTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVGsNs--L~----LpvPstcP  337 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVGSNS--LH----LPVPSTCP  337 (904)
T ss_pred             hhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhe-------eEEeccCCc--cc----ccCcccCc
Confidence            99999999999886  88999999999999999999999987544311       011111111  11    12344567


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          311 RKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       311 ~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .-++-|+++||+..|.+|||+++++.-|+
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            88899999999999999999999998764

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-42  Score=300.18  Aligned_cols=254  Identities=30%  Similarity=0.471  Sum_probs=207.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ...|.+.+.||.|+||.||+|...++..+++|.+..... ....+.+|+.+++.++|||++++++++...+..+++|||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            345778899999999999999988889999999987654 4567899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++...  .+..+++..+..++.|++.|++|||++   +++|+||+|+||++++++.++|+|||.+........
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999998543  245688999999999999999999999   999999999999999999999999999976533221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                        ......++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||......       . .......+....   
T Consensus       160 --~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~~~~~~~~---  224 (261)
T cd05148         160 --LSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-------E-VYDQITAGYRMP---  224 (261)
T ss_pred             --cccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------H-HHHHHHhCCcCC---
Confidence              11233467789999998764  67889999999999999998 88898654321       1 111121211111   


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                         .+...+..+.+++.+||+.||.+|||++++++.|++
T Consensus       225 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 ---CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               112345778999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.1e-43  Score=306.95  Aligned_cols=257  Identities=24%  Similarity=0.414  Sum_probs=202.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ...+.+.+.||.|+||+||++...      ++..+|+|.+..... ..+.+.+|+++++.++|||++++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            345667789999999999999742      345689998865432 2357899999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceE
Q 044497          137 LVYEYMPNGSLDRHIFPKE---------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~k  207 (340)
                      ++|||+++++|.+++....         .....+++..+..++.|++.||+|||++   +++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999998885332         1234589999999999999999999999   999999999999999999999


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  286 (340)
                      |+|||++................++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||.......        
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------  230 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------  230 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence            9999999755433322222233457789999998764  67889999999999999998 888886543211        


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .......+.....      +...+.++.+++.+||+.||.+|||+.++++.|+
T Consensus       231 ~~~~i~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~  277 (288)
T cd05093         231 VIECITQGRVLQR------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ  277 (288)
T ss_pred             HHHHHHcCCcCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            1122222221111      1123467999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.8e-43  Score=300.65  Aligned_cols=254  Identities=28%  Similarity=0.434  Sum_probs=204.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...+.+.+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+.+++.++|+|++++++++. .+..+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4467788999999999999999888889999999887777788999999999999999999999885 456899999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99999988432  234688999999999999999999999   9999999999999999999999999999765433211


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                       ......++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||......       . ....+......     
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~~~~~~~-----  222 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------E-VLEQVERGYRM-----  222 (260)
T ss_pred             -cccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------H-HHHHHHcCCCC-----
Confidence             11222356689999988654  67889999999999999999 88888653321       1 11222222111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       ..+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             1122345789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.4e-43  Score=305.16  Aligned_cols=257  Identities=23%  Similarity=0.367  Sum_probs=203.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      .++.+.+.||+|+||.||+|...      ++..+|+|++......  .+.+.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            45677899999999999999753      2468999999765432  256889999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC
Q 044497          137 LVYEYMPNGSLDRHIFPKE------------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~  204 (340)
                      +++||+++++|.+++....            .....+++..+..++.|++.||+|||++   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence            9999999999998874221            1234588899999999999999999999   999999999999999999


Q ss_pred             ceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccch
Q 044497          205 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYF  283 (340)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~  283 (340)
                      .+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |..||......      
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------  233 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------  233 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence            9999999998765443322222334467899999998754  67889999999999999998 77787643221      


Q ss_pred             hHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       . ..+.........      .+..++..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       234 -~-~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 -D-VIEMIRNRQVLP------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -H-HHHHHHcCCcCC------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             1 222222222111      122455778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-43  Score=328.38  Aligned_cols=253  Identities=23%  Similarity=0.276  Sum_probs=202.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCC-------
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGS-------  133 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------  133 (340)
                      .+|.+.+.||+|+||+||+|... +++.||+|++.....+.   ..+.+|+..+..++|+|++++++.+...+       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            46777899999999999999754 78999999987654332   45778999999999999999988764332       


Q ss_pred             -eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          134 -KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       134 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                       ..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence             36799999999999999865555556799999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      +++...............||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.....       ........ 
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~-  258 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTL-  258 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHh-
Confidence            99765433222222345699999999999774  688899999999999999999999975432       11122222 


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+...      ..+..+++++.+++.+||+.||.+|||+.++++
T Consensus       259 ~~~~~------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        259 AGRYD------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             cCCCC------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            11111      122345678999999999999999999999875

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.8e-43  Score=315.73  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=193.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+++.+.||+|+||.||+|... +++.||+|++......  ...+.+|+++++.++|+||+++++++...+..+++|||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3456789999999999999865 6889999998654332  357889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+..        ...+..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++........
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999986543        235677889999999999999999   999999999999999999999999999976543221


Q ss_pred             ceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          223 FVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                        ......||..|+|||.+...   ....+.++|||||||++|||++|+.||.......    ...... .......   
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~-~~~~~~~---  293 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLMC-AICMSQP---  293 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHH-HHhccCC---
Confidence              12334689999999987432   1234568999999999999999999997433211    111111 1111111   


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         .......+.++.+|+.+||+.||++|||+.|+++
T Consensus       294 ---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        294 ---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1122245678999999999999999999999986

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-43  Score=317.11  Aligned_cols=256  Identities=21%  Similarity=0.212  Sum_probs=193.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ..|.+.+.||+|+||.||+|.+. +++.||+|...     .+.+.+|+++++.++||||+++++++......++++|++ 
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-
Confidence            34677789999999999999765 78899999753     245679999999999999999999999999999999999 


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      .++|..++.    ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++........ 
T Consensus       166 ~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        166 KTDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            568887773    234688999999999999999999999   999999999999999999999999999975332211 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh---HHHHH-----------
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP---SWVYD-----------  289 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~---~~~~~-----------  289 (340)
                      .......||+.|+|||++.+.  .++.++|||||||++|||++|+.|+.............   ..+..           
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            112334699999999999765  67889999999999999999998875433211100000   00000           


Q ss_pred             -----------HhhcCCCcccccc--chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 -----------QLNKGGDLELRNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 -----------~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                 .............  .......+.++.+|+.+||+.||.+|||++|+++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                       0000000000000  0111235678999999999999999999999985

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-45  Score=290.63  Aligned_cols=264  Identities=26%  Similarity=0.339  Sum_probs=208.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCC-----eeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~  136 (340)
                      ..+|++.+.+|+|||+.||+++ ..+++.+|+|++.-.. .+.+...+|++..++++|||+++++++...+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4567888999999999999997 5578899999987554 45578899999999999999999998874433     389


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++++|+..|+|.+.+.....++..+++.+++.++.++++||++||+. .++++||||||.|||+++++.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999999987777778899999999999999999999997 33599999999999999999999999999875


Q ss_pred             CCCCCC-------ceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHH
Q 044497          217 HPKEND-------FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY  288 (340)
Q Consensus       217 ~~~~~~-------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  288 (340)
                      ..-.-.       .........|..|+|||++.-. ....+.++|||||||++|+|+.|..||+..-.......+     
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL-----  253 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL-----  253 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-----
Confidence            422110       1112233578999999998532 236788999999999999999999999754432111110     


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                       ...++.. ...  .  ...++..+.+++++|++.||.+||++.+++..++
T Consensus       254 -Av~n~q~-s~P--~--~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  254 -AVQNAQI-SIP--N--SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             -eeecccc-ccC--C--CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence             0011000 001  1  1126789999999999999999999999998875

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-43  Score=296.90  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=201.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCc-eeeEeeEEEcCC------
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVN-VVQLLGFCSEGS------  133 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------  133 (340)
                      ..+...++||+|+||+||+|... +|+.||+|++..+..   ......+|+.+++.++|+| |+.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34555678999999999999755 788999999976543   4467889999999999999 999999998777      


Q ss_pred             eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      ..++||||+ ..+|..++.........++...+..+..|++.||+|||++   +|+||||||.|+|++++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            899999999 5699998865443324677789999999999999999999   999999999999999999999999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      |+-..-...  ..+...+|..|+|||++.+. ..|+...||||+||++.||+++++-|......+.-    ..+...+..
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql----~~If~~lGt  239 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL----FRIFRLLGT  239 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH----HHHHHHcCC
Confidence            984432221  23455689999999999886 45889999999999999999999888876542110    001111110


Q ss_pred             CC-------------Ccccc------ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          294 GG-------------DLELR------NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       294 ~~-------------~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      ..             .....      ......+..+.+..+++.+||+.+|.+|.|++.+++.
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            00             00000      0011112223588999999999999999999998863

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.8e-43  Score=317.15  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=201.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccC-CCceeeEeeEEEcCCe
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK  134 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  134 (340)
                      ...+.+.+.||+|+||.||+|+..      ++..||+|++......  .+.+.+|+++++.+. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            445667789999999999999753      2346999999754332  357889999999996 9999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCC----------------------------------------------------------
Q 044497          135 RALVYEYMPNGSLDRHIFPKES----------------------------------------------------------  156 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  156 (340)
                      .++||||+++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999888753210                                                          


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC
Q 044497          157 ----------------------------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (340)
Q Consensus       157 ----------------------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~  202 (340)
                                                        ....+++..+..++.|++.||+|||+.   +++|+||||+||++++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                              113478888999999999999999998   9999999999999999


Q ss_pred             CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccccccc
Q 044497          203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKA  281 (340)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~  281 (340)
                      ++.+||+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----  346 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----  346 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchh----
Confidence            999999999999765433222222233467889999998764  67889999999999999997 88888654321    


Q ss_pred             chhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         .........+....      .+..++.++.+++.+||+.+|++|||+.++.+.|+
T Consensus       347 ---~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         347 ---STFYNKIKSGYRMA------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             ---HHHHHHHhcCCCCC------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence               11122222221111      12245678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=300.93  Aligned_cols=253  Identities=28%  Similarity=0.451  Sum_probs=202.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..+.+.+.||+|+||.||+|.+.    +...+|+|.+......  ...+.+|+.+++.++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            34567789999999999999864    2457999998754333  35688999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999998432   24788999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ...........
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------VIKAVEDGYRL  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence            32222222233456789999998764  67889999999999999998 999986543211        12222222111


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       228 ~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~  263 (266)
T cd05033         228 PP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD  263 (266)
T ss_pred             CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11      1234567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-42  Score=298.93  Aligned_cols=247  Identities=23%  Similarity=0.403  Sum_probs=195.3

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      +.||+|+||.||+|... +++.+|+|.+.....  ....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999865 788999998765332  235789999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++..   ....+++..+..++.|+++||+|||++   +++|+||+|+||+++.++.++|+|||++.............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            998842   234688999999999999999999999   99999999999999999999999999987543321111111


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhh
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  306 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (340)
                      ....+..|+|||.+.+.  .++.++|+||||+++|+|++ |..||.......        ...........      ..+
T Consensus       155 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------~~~~~~~~~~~------~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------TREAIEQGVRL------PCP  218 (252)
T ss_pred             CCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCCCC------CCc
Confidence            11234579999998764  67889999999999999998 888886433211        11222221111      112


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       307 ~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            234568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.4e-42  Score=302.43  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=201.0

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      ....+++.+.||+|+||.||+|...      ++..+|+|.+.....  ...++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3456777899999999999998643      346799999865332  23468899999999999999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          135 RALVYEYMPNGSLDRHIFPKESR------GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                      .+++|||+++++|.+++......      ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999988542211      23467888999999999999999998   9999999999999999999999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHH
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  287 (340)
                      +|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......       . .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~-~  230 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------Q-V  230 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-H
Confidence            999998755433322211223357789999998764  67889999999999999999 68887643321       1 1


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ............      +...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       231 ~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         231 LRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111112111111      11234678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8e-43  Score=311.62  Aligned_cols=258  Identities=22%  Similarity=0.313  Sum_probs=198.9

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      +....|++.+.||+|+||.||++.+. ++..+|+|.+......  .+.+.+|+++++.++||||+++++++.+.+..+++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            34456778899999999999999876 6788999988654322  35688999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++.    ....+++..+..++.|++.||+|||+.  .+++|+||||+||++++++.+||+|||++....
T Consensus        82 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          82 MEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999983    234688899999999999999999973  169999999999999999999999999987543


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh--------------
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP--------------  284 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--------------  284 (340)
                      ...    .....|+..|+|||.+.+.  .++.++|+|||||++|+|++|+.||...........+.              
T Consensus       156 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         156 DSM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             hhc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence            221    1234588999999999764  67889999999999999999999987543211000000              


Q ss_pred             ----------------------HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 ----------------------SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                            ................     ....+.++.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP-----SGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCC-----CCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                  0000000000000000     0013467899999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.4e-43  Score=312.27  Aligned_cols=248  Identities=20%  Similarity=0.291  Sum_probs=195.3

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.||+|+++....    ..+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999865 688999999976422    224577899999888 799999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++........  
T Consensus        81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  151 (329)
T cd05588          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--  151 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence            99988873    345789999999999999999999999   999999999999999999999999999874322111  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc-ccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS-KAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      ......||+.|+|||.+.+.  .++.++|+|||||++|+|++|+.||........ ......+..........       
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------  222 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-------  222 (329)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-------
Confidence            12344689999999999775  678899999999999999999999975433221 11112233333322211       


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCC------HHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPS------MTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps------~~evl~  336 (340)
                      ..+..++..+.+++.+||+.||.+|||      ++++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            112234567899999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-42  Score=300.41  Aligned_cols=254  Identities=29%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...|++.++||+|+||.||+|.+.+...+|+|++.......+.+.+|+++++.++||||+++++.+.. ...+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            45678889999999999999988777789999998766667789999999999999999999998754 56899999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...  .+..+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999998432  234578999999999999999999999   9999999999999999999999999999765433221


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                       ......++..|+|||...+.  .++.++|+||||+++|+|+| |..||......        ............     
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~-----  222 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRM-----  222 (262)
T ss_pred             -cccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCCCC-----
Confidence             11223466789999988654  67889999999999999999 78888654321        112222222111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       ......+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence             1123456788999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.7e-44  Score=289.78  Aligned_cols=250  Identities=24%  Similarity=0.306  Sum_probs=204.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-----Ch----HHHHHHHHHhccc-CCCceeeEeeEEEcCCe
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-----SG----EEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  134 (340)
                      .|.-.+.+|.|..++|-++..+ +++.+|+|++.....     +.    +.-..|+.+|+++ .||+|+++.++++....
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            3444578999999999998654 888999999854221     12    3456899999998 69999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .++|+|.|+.|.|.+++    ...-.+++....++..|+.+|+.|||.+   +|+|||+||+|||++++.+++|+|||++
T Consensus        98 ~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             hhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence            99999999999999999    4566789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccc----cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISR----NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      +....+..   ....+|||+|+|||.+.-    ....|+..+|+||+||++|.|+.|.+||.....        ......
T Consensus       171 ~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlMLR~  239 (411)
T KOG0599|consen  171 CQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLMLRM  239 (411)
T ss_pred             eccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHHHH
Confidence            98776654   355679999999999853    234678899999999999999999999864321        111222


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +..|..   ...++-..+++...++|+.+||+.||.+|.|++|+|+
T Consensus       240 ImeGky---qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  240 IMEGKY---QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHhccc---ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            222221   1223445678899999999999999999999999885

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-42  Score=308.46  Aligned_cols=253  Identities=24%  Similarity=0.401  Sum_probs=198.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCc----EEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ...|+..+.||+|+||.||+|.+. ++.    .||+|.++....  ..+++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            445667789999999999999754 333    389999875432  236788999999999999999999999764 578


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            999999999999988432   34578899999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ..............++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        .......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~  228 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGE  228 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhCCC
Confidence            6544332222333356789999998764  77889999999999999998 999986533211        222222222


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....      +..++.++.+++.+||+.+|.+|||+.+++..|.
T Consensus       229 ~~~~------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         229 RLPQ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  266 (316)
T ss_pred             CCCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1111      1123467889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=299.02  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=208.0

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +....+.+.+.||+|+||.||+|..+++..+|+|.+..+....+++.+|+.+++.++|||++++++++......+++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            34456677899999999999999988788999999988777778899999999999999999999999998999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++...  .+..+++..+..++.|++.|++|||++   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999998442  234689999999999999999999999   99999999999999999999999999987654321


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      . ........+..|+|||.+.+.  .++.++|+||+|+++|+|++ |+.||......       . .......+....  
T Consensus       158 ~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~-~~~~~~~~~~~~--  224 (261)
T cd05034         158 Y-TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-------E-VLEQVERGYRMP--  224 (261)
T ss_pred             h-hhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHcCCCCC--
Confidence            1 111222355689999998764  67889999999999999998 99998643321       1 112222211111  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                          .+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus       225 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 ----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                111235678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.8e-43  Score=312.54  Aligned_cols=240  Identities=25%  Similarity=0.358  Sum_probs=193.1

Q ss_pred             hhcCCCCCeEEEEEEE----cCCcEEEEEEccCCC-----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQL----HTGGLIAVKMLANSK-----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.||+|+||.||++..    .+++.+|+|+++...     .....+.+|+.+++.++||||+++++++...+..|++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    357889999987532     2234577899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999883    345678889999999999999999999   99999999999999999999999999987432222


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......       . ....+..+.      
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~-~~~~~~~~~------  216 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------K-TIDKILKGK------  216 (323)
T ss_pred             C--cccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------H-HHHHHHcCC------
Confidence            1  12334689999999999765  6778999999999999999999999754321       1 111121111      


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                       ...+..+++++.+++.+||+.+|++||     ++.++++
T Consensus       217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             112223457889999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=302.23  Aligned_cols=260  Identities=26%  Similarity=0.394  Sum_probs=205.0

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGS  133 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  133 (340)
                      +....+.+.+.||+|+||.||+|...      ++..+|+|.+......  ...+.+|+.++..++|||++++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            34456677889999999999999754      2368999998755432  246889999999999999999999999999


Q ss_pred             eeEEEEEccCCCCcccccccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceE
Q 044497          134 KRALVYEYMPNGSLDRHIFPKES------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~k  207 (340)
                      ..+++|||+++++|.+++.....      ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            99999999999999998854322      123478899999999999999999998   999999999999999999999


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  286 (340)
                      |+|||+++...............++..|+|||.+.+.  .++.++||||||+++||++| |..||.......        
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------  229 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------  229 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHHH--------
Confidence            9999998755433322222333467889999998654  67889999999999999998 888886543221        


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      .......+......      ...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       230 ~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         230 VLKFVIDGGHLDLP------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            12222222222111      1235788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.4e-43  Score=315.25  Aligned_cols=250  Identities=24%  Similarity=0.314  Sum_probs=196.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEE----cCCcEEEEEEccCCC-----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeE
Q 044497           67 NHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLANSK-----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (340)
                      |.+.+.||+|+||.||++..    .+++.+|+|++....     ...+.+..|+.++..+ +||||+++++++...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            45678999999999999975    367899999986532     2235678899999999 5999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++..
T Consensus        82 lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          82 LILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999883    345688999999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ....... ......||+.|+|||.+.+. ..++.++|||||||++|+|+||+.||.........    ..+........ 
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~~-  227 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILKCD-  227 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhcCC-
Confidence            4332221 12234689999999998754 34678999999999999999999999754332211    11222221111 


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                            ...+..++..+.+++.+||+.||++||     +++++++
T Consensus       228 ------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 ------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                  112223567889999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-43  Score=315.07  Aligned_cols=240  Identities=22%  Similarity=0.320  Sum_probs=193.4

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.||+|+||.||++... +++.+|+|++....    .....+..|++++..++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999764 78899999987532    22346778999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      +|.+++.    ....+++..+..++.|++.||+|||+ +   +++||||||+|||+++++.+||+|||++........  
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  151 (325)
T cd05594          81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--  151 (325)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence            9988873    34568999999999999999999997 7   999999999999999999999999999875332221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ........ ..      .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--------~~~~i~~~-~~------~  214 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILME-EI------R  214 (325)
T ss_pred             ccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHHH--------HHHHHhcC-CC------C
Confidence            12334689999999999764  67889999999999999999999996543211        11111111 11      1


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                      .+...++++.+++.+||+.||++|+     ++.++++
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            1223457889999999999999997     8988875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.6e-42  Score=303.11  Aligned_cols=257  Identities=26%  Similarity=0.423  Sum_probs=201.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE-----cCCcEEEEEEccCCCCCh--HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      ..+++.+.||+|+||.||+|..     .++..+++|.+.......  ..+.+|+++++.++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3456778999999999999974     245789999987543322  468899999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC
Q 044497          138 VYEYMPNGSLDRHIFPKES-------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~  204 (340)
                      +|||+++++|.+++.....             ....+++..+..++.|++.||+|||++   +++|+||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999998743211             123578899999999999999999999   999999999999999999


Q ss_pred             ceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccch
Q 044497          205 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYF  283 (340)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~  283 (340)
                      .++|+|||++................++..|+|||.+.+.  .++.++|+||||+++|||++ |..||.....       
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------  232 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------  232 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            9999999999765433322222333456789999998764  67889999999999999998 8888864321       


Q ss_pred             hHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       ....+.........      .+..++..+.+++.+||+.||++||++.++++.|.+
T Consensus       233 -~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 -QEVIEMVRKRQLLP------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             11222222221111      122345788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.4e-43  Score=310.97  Aligned_cols=243  Identities=21%  Similarity=0.308  Sum_probs=191.0

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.+|+|+++....    ..+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46899999999999865 678999999976422    224567888888776 899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|..++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--  151 (329)
T cd05618          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  151 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence            99988873    335689999999999999999999999   999999999999999999999999999875322221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc-ccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS-KAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      ......||..|+|||.+.+.  .++.++|||||||++|+|++|+.||........ ......+.........       .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------~  222 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------I  222 (329)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------C
Confidence            12344689999999999775  678899999999999999999999964332211 1111222223222211       1


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                      ..+...+..+.+++.+||+.||++|||+
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1223345778899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.7e-43  Score=311.48  Aligned_cols=235  Identities=24%  Similarity=0.305  Sum_probs=189.7

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.||+|++....    ...+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999865 68899999987532    2335667888888776 699999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++........  
T Consensus        81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--  151 (320)
T cd05590          81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--  151 (320)
T ss_pred             chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence            99998883    335688999999999999999999999   999999999999999999999999999875322221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ....+.....       .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~-------~  214 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEV-------V  214 (320)
T ss_pred             cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHhcCCC-------C
Confidence            12344689999999999764  67889999999999999999999997543211        1122222111       1


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                      .+...+.++.+++.+||+.||++||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            122345788999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-42  Score=296.38  Aligned_cols=250  Identities=31%  Similarity=0.509  Sum_probs=205.4

Q ss_pred             hhcCCCCCeEEEEEEEcC----CcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLHT----GGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|....    +..+++|.+......  .+.+.+|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998653    789999999875544  47889999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          145 GSLDRHIFPKESR-----GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       145 ~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ++|.+++......     ...+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998544221     46789999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ...........++..|+|||.+...  .++.++||||+|+++|+|++ |..||......        ........+... 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~-  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEYLRKGYRL-  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCC-
Confidence            4432233444578899999998765  67889999999999999999 68998765321        122222222211 


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           ..+...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 122234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-44  Score=284.44  Aligned_cols=244  Identities=23%  Similarity=0.385  Sum_probs=205.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +++.+.||+|-||.||.|+.+ ++-.||+|++.+++.    ...++.+|+++-..|+||||++++++|.+....|+++||
T Consensus        24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy  103 (281)
T KOG0580|consen   24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY  103 (281)
T ss_pred             ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence            357899999999999999754 677899999977543    346889999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      .++|++...+..  .....+++.....+..|++.|+.|+|.+   +++||||||+|+|++..+..|++|||.+...+.+.
T Consensus       104 a~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k  178 (281)
T KOG0580|consen  104 APRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK  178 (281)
T ss_pred             cCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence            999999999843  2456688889999999999999999999   99999999999999999999999999997654222


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                          -.+.+||..|+|||...+.  ..+..+|+|++|++.||++.|.+||......+        ....+...   +   
T Consensus       179 ----R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--------tYkrI~k~---~---  238 (281)
T KOG0580|consen  179 ----RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--------TYKRIRKV---D---  238 (281)
T ss_pred             ----ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhHH--------HHHHHHHc---c---
Confidence                2456799999999999886  78889999999999999999999998655221        22222221   1   


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ..+++.++..+.+++.+|+..+|.+|.+..|+++
T Consensus       239 -~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  239 -LKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence             1233567789999999999999999999999875

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-42  Score=299.46  Aligned_cols=257  Identities=21%  Similarity=0.322  Sum_probs=204.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... +++.+|+|.+.....    ....+.+|+++++.++|||++++++++...+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            3566789999999999999865 788999998764221    22467899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.........+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999988854444455688999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......++..|+|||.+.+.  ..+.++|+||+|+++|+|++|+.||.......     .... ..+......   
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~-~~~~~~~~~---  226 (267)
T cd08228         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FSLC-QKIEQCDYP---  226 (267)
T ss_pred             hH--HHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HHHH-HHHhcCCCC---
Confidence            21  11234588899999998764  67789999999999999999999986433211     1111 122211111   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                        .......+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence              11122456789999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.9e-43  Score=311.16  Aligned_cols=240  Identities=21%  Similarity=0.273  Sum_probs=192.4

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.+|+|++....    ...+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999865 67899999987532    2234567888888766 799999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|...+.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++........  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  151 (321)
T cd05591          81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--  151 (321)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence            99998883    335688999999999999999999999   999999999999999999999999999875332221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ....+.....       .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--------~~~~i~~~~~-------~  214 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--------LFESILHDDV-------L  214 (321)
T ss_pred             cccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC-------C
Confidence            12344689999999998765  67889999999999999999999997544211        1111211111       1


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC-------CHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRP-------SMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rp-------s~~evl~  336 (340)
                      .+...+.++.+++.+||+.||++||       ++.++++
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            1223457889999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.6e-42  Score=297.16  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=203.4

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...+.+.+.||+|++|.||+|....+..+|+|.+..+....+.+.+|+.+++.++|||++++++++.. +..+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            34567778999999999999988777789999988766666788999999999999999999998854 56889999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999988432  234578999999999999999999998   9999999999999999999999999999765432211


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                       ......++..|+|||...+.  .++.++|+||||+++|+|+| |..||.......        ...........     
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~-----  222 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLEQVERGYRM-----  222 (260)
T ss_pred             -ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC-----
Confidence             11223456789999988764  67889999999999999999 888886533211        11222222111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       ..+...+..+.+++.+||+.||.+|||++++++.|+.
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             1122456789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=316.76  Aligned_cols=250  Identities=24%  Similarity=0.280  Sum_probs=200.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++....    .....+.+|++++..++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            3566789999999999999876 78899999987532    233568899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          82 YMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999843    35789999999999999999999998   9999999999999999999999999999765443


Q ss_pred             C---------------------------CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCC
Q 044497          221 N---------------------------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (340)
Q Consensus       221 ~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~  273 (340)
                      .                           .........||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCC
Confidence            2                           00112334589999999999875  778899999999999999999999976


Q ss_pred             CcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 044497          274 HATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLE  336 (340)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~evl~  336 (340)
                      .....       ..................    .+++++.+++.+|++ ||.+||+ ++++++
T Consensus       233 ~~~~~-------~~~~i~~~~~~~~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         233 DTLQE-------TYNKIINWKESLRFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCHHH-------HHHHHhccCCcccCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            54211       111111100111111111    146789999999997 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-42  Score=304.92  Aligned_cols=256  Identities=22%  Similarity=0.337  Sum_probs=191.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc--CCcEEEEEEccCCCC---ChHHHHHHHHHhccc---CCCceeeEeeEEE-----cC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLANSKF---SGEEFINEVSTIGRI---HHVNVVQLLGFCS-----EG  132 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~--~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~  132 (340)
                      +|++.+.||+|+||.||+|...  ++..+|+|.+.....   ....+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            4567789999999999999763  467899999865332   224566777777665   6999999999885     34


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      ...+++|||++ ++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            56899999995 6888887432  234588999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      ++.......   ......||+.|+|||.+.+.  .++.++|||||||++|+|++|++||........-    ..+.+...
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~----~~i~~~~~  226 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL----GKILDVIG  226 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH----HHHHHHhC
Confidence            997554331   12344589999999998764  6788999999999999999999999765432110    00100000


Q ss_pred             cC-------------CCc---cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KG-------------GDL---ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~-------------~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..             ...   .........+..+..+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00             000   000001122345678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.4e-43  Score=310.55  Aligned_cols=243  Identities=26%  Similarity=0.339  Sum_probs=191.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHh---cccCCCceeeEeeEEEcCCeeEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTI---GRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      |++.+.||+|+||.||+|... +++.||+|+++...    ...+.+.+|.+++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            345688999999999999765 78899999997532    2234566666554   566899999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|...+.     ...+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999988772     34689999999999999999999999   99999999999999999999999999987432


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....  ......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ....+.....  
T Consensus       153 ~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~~--  218 (324)
T cd05589         153 GFGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--------VFDSIVNDEV--  218 (324)
T ss_pred             CCCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC--
Confidence            2221  12345689999999999765  67889999999999999999999997543211        1111111111  


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                           ..+..++..+.+++.+||+.||.+||     ++.++++
T Consensus       219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 11223457788999999999999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.7e-42  Score=298.94  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=196.4

Q ss_pred             hhhhhcCCCCCeEEEEEEEcCC-c--EEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEc------CCee
Q 044497           68 HFTHKLGQGGFGSVYKGQLHTG-G--LIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  135 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~~~-~--~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~  135 (340)
                      .+.+.||+|+||.||+|.+..+ .  .+|+|.++.....   .+.+.+|+.+++.++||||+++++++..      ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            3567899999999999986533 2  6899998764322   3567889999999999999999998743      2346


Q ss_pred             EEEEEccCCCCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          136 ALVYEYMPNGSLDRHIFPKE--SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      +++|||+++++|.+++....  .....+++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999998874322  2234589999999999999999999998   999999999999999999999999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhh
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      +................+++.|+|||.+.+.  .++.++||||||+++|+|++ |+.||......        ...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~  228 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYLR  228 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHH
Confidence            9865443321111223456789999998764  67889999999999999999 78888643221        1222333


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      .+.....      +...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       229 ~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         229 QGNRLKQ------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             cCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            3322111      12344678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1e-42  Score=308.76  Aligned_cols=239  Identities=24%  Similarity=0.308  Sum_probs=189.3

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.||+|+++...    ...+....|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999865 67889999987532    2234456676776654 899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--  151 (316)
T cd05592          81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence            99998883    235688999999999999999999999   999999999999999999999999999975432221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ....+....       ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~-------~~  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--------LFDSILNDR-------PH  214 (316)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCC-------CC
Confidence            22344689999999999765  67889999999999999999999997543211        111111111       11


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~-evl  335 (340)
                      .+..++.++.+++.+||+.||++||++. +++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            2223457788999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-42  Score=302.63  Aligned_cols=255  Identities=24%  Similarity=0.439  Sum_probs=202.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      .+.+.+.||+|+||.||+|...      ++..+++|.+...... .+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            4556789999999999999742      3456889988654433 35688999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCce
Q 044497          139 YEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP  206 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~  206 (340)
                      |||+++++|.+++.....            ....+++..+..++.|++.|++|||++   +++||||||+||++++++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            999999999999854321            234588999999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhH
Q 044497          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPS  285 (340)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~  285 (340)
                      +|+|||++................++..|+|||.+.+.  .++.++||||||+++|+|+| |+.||.......       
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------  233 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------  233 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            99999999755443322222334467889999998765  67889999999999999999 999986543211       


Q ss_pred             HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          286 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                       ..+....+.....      +...+..+.+++.+||+.+|++|||++++++.|+
T Consensus       234 -~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         234 -VIECITQGRVLER------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH  280 (291)
T ss_pred             -HHHHHhCCCCCCC------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence             1222222221111      1224567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-42  Score=308.56  Aligned_cols=239  Identities=24%  Similarity=0.318  Sum_probs=190.5

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.||+|+++...    ...+....|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999865 67899999987642    2234566777777764 899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||++........  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05619          81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence            99999883    235688999999999999999999999   999999999999999999999999999874322211  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++||||+||++|+|++|+.||.......        .........       ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~-------~~  214 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--------LFQSIRMDN-------PC  214 (316)
T ss_pred             ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-------CC
Confidence            12344689999999998765  67889999999999999999999997543211        111121111       11


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~-evl  335 (340)
                      .+...+.++.+++.+||+.||++||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            1223456789999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.9e-42  Score=295.76  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=195.4

Q ss_pred             hcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           72 KLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      .||+|+||.||+|.++   ++..+|+|+++.....   .+++.+|+.+++.++||||+++++++.. +..+++|||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            6899999999999643   5788999998754433   3578899999999999999999999864 5678999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||++...........
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999883    234688999999999999999999999   999999999999999999999999999986544432211


Q ss_pred             -eeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          226 -ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       226 -~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                       .....++..|+|||.+...  .++.++|+||||+++|||++ |+.||.......        ..+.+..+.....    
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~~~----  219 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------VTQMIESGERMEC----  219 (257)
T ss_pred             ecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCCCCC----
Confidence             1222345789999988654  67789999999999999998 999987543211        2222333222221    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                        +...+.++.+++.+||+.||++|||+.+|.+.|++
T Consensus       220 --~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 --PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             --CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence              22345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.4e-42  Score=306.57  Aligned_cols=258  Identities=29%  Similarity=0.459  Sum_probs=200.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEc-CC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSE-GS  133 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~  133 (340)
                      ..+|++.+.||.|+||.||+|...      +++.||+|++......  .+.+..|+.++..+ +|+||++++++|.. ..
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            346778899999999999999532      3468999998754332  24677899999999 89999999998754 45


Q ss_pred             eeEEEEEccCCCCcccccccCCCC--------------------------------------------------------
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESR--------------------------------------------------------  157 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------------  157 (340)
                      ..+++|||+++++|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            688999999999999887432210                                                        


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcccc
Q 044497          158 -GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI  236 (340)
Q Consensus       158 -~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~  236 (340)
                       ...+++..+..++.|++.||+|||++   +|+||||||+||++++++.++|+|||++................++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             13688999999999999999999999   99999999999999999999999999998654333222223334677899


Q ss_pred             ccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHH
Q 044497          237 APELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCM  315 (340)
Q Consensus       237 aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  315 (340)
                      |||.+.+.  .++.++|||||||++|+|++ |..||......+       .....+..+.....      +...++++.+
T Consensus       243 aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFCRRLKEGTRMRA------PEYATPEIYS  307 (337)
T ss_pred             CcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------HHHHHHhccCCCCC------CccCCHHHHH
Confidence            99998765  78889999999999999998 999986532211       12222222222111      1234467899


Q ss_pred             HHhhcccCCCCCCCCHHHHHHHhc
Q 044497          316 IGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       316 l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ++.+||+.+|++|||+.|+++.|+
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~  331 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILG  331 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.5e-42  Score=314.04  Aligned_cols=250  Identities=22%  Similarity=0.243  Sum_probs=193.7

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.+.+.||+|+||+||+|... +++.+|+|++.....    ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            456689999999999999765 788999999975432    234678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          83 IPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999999883    334688999999999999999999999   99999999999999999999999999975321100


Q ss_pred             C---------------------------------------------ceeeeccccCccccccccccccccccccccchhh
Q 044497          222 D---------------------------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYG  256 (340)
Q Consensus       222 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  256 (340)
                      .                                             ........||+.|+|||.+.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence            0                                             0001234699999999998764  6788999999


Q ss_pred             HHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhh--cccCCCCCCCCHHHH
Q 044497          257 FGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLW--CIQVKAADRPSMTKV  334 (340)
Q Consensus       257 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~Rps~~ev  334 (340)
                      |||++|||++|+.||.......       ................    ...+++++.+++.+  |+..+|..||++.++
T Consensus       234 lG~il~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~----~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTE-------TQLKVINWENTLHIPP----QVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHH-------HHHHHHccccccCCCC----CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999999997644321       1111111111111111    11245678888888  556677779999999


Q ss_pred             HH
Q 044497          335 LE  336 (340)
Q Consensus       335 l~  336 (340)
                      ++
T Consensus       303 l~  304 (381)
T cd05626         303 KA  304 (381)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-43  Score=304.93  Aligned_cols=250  Identities=27%  Similarity=0.344  Sum_probs=199.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      +|+..+.||+|+||.||++... +++.||+|++......    ...+.+|+.+++.++||||+++++.+...+..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3566789999999999999865 7889999998653322    2456789999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999998877432  234689999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..   .....|+..|+|||.+.+.  .++.++||||+|+++|+|++|+.||.......    ....+...+....     
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~-----  221 (285)
T cd05605         156 ET---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKEDQ-----  221 (285)
T ss_pred             Cc---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhcc-----
Confidence            22   1234589999999999764  67889999999999999999999997543211    0111111111111     


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                        ...+..++..+.+++.+||+.||++||     +++++++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              122234567889999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.6e-42  Score=302.32  Aligned_cols=257  Identities=25%  Similarity=0.428  Sum_probs=202.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCCh--HHHHHHHHHhccc-CCCceeeEeeEEEcCCe
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSG--EEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  134 (340)
                      ...+.+.+.||+|+||.||++...      ....+|+|.+.......  ..+.+|++++..+ +||||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            345566789999999999999754      23579999987643322  4678999999999 89999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC
Q 044497          135 RALVYEYMPNGSLDRHIFPKE------------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~  202 (340)
                      .+++|||+++++|.+++....            .....+++..++.++.|++.||+|||+.   +++|+||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            999999999999999885421            2345688999999999999999999998   9999999999999999


Q ss_pred             CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccccccc
Q 044497          203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKA  281 (340)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~  281 (340)
                      ++.++|+|||+++...............++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......   
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  242 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  242 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence            999999999999865443322222233456789999988664  67889999999999999998 888886433211   


Q ss_pred             chhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           .......+....      .+...+..+.+|+.+||+.||++|||+.++++.|+
T Consensus       243 -----~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         243 -----LFKLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             -----HHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence                 122222222111      11233567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.5e-43  Score=309.34  Aligned_cols=240  Identities=25%  Similarity=0.306  Sum_probs=192.9

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||+||++... +++.+|+|++.+..    ...+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999876 67899999987532    2234567888888877 799999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||++........  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  151 (318)
T cd05570          81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--  151 (318)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence            99998873    334689999999999999999999999   999999999999999999999999999864322211  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......|++.|+|||.+.+.  .++.++|+|||||++|+|++|+.||.......        ....+.....       .
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--------~~~~i~~~~~-------~  214 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--------LFQSILEDEV-------R  214 (318)
T ss_pred             cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCC-------C
Confidence            12334589999999999775  67889999999999999999999997543211        1111211111       1


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~evl~  336 (340)
                      .+...+..+.+++.+||+.||++|||+     .++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            122345788999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=307.86  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=211.7

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccC-CCceeeEeeEEEcCCe
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK  134 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  134 (340)
                      +-....|.+.+.||.|.||.||+|..+ +|+.+|+|++.+...    ..+.+.+|+.+|+++. ||||+.+++.|++.+.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            344556778899999999999999866 699999999976544    3368999999999998 9999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC----CceEEec
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN----FIPKVSD  210 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~----~~~kl~D  210 (340)
                      .++|||++.||.|.+.+...     .+++.....++.|++++++|||+.   |++|||+||+|+|+...    +.+|++|
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence            99999999999999999544     399999999999999999999998   99999999999999543    4799999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      ||++.......   .....+||+.|+|||++...  .++..+||||+|+++|.|++|.+||........        ...
T Consensus       183 FGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------~~~  249 (382)
T KOG0032|consen  183 FGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------FLA  249 (382)
T ss_pred             CCCceEccCCc---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------HHH
Confidence            99999776622   34667899999999999864  888999999999999999999999987664321        112


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +..+.   .....+....++..+.+++..|+..||..|+|+.++|+
T Consensus       250 i~~~~---~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  250 ILRGD---FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHcCC---CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            22221   12223445567889999999999999999999999986

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-42  Score=308.26  Aligned_cols=239  Identities=23%  Similarity=0.294  Sum_probs=190.6

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.||+|+++...    ...+....|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 68899999987532    2334567777777654 899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++........  
T Consensus        81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05620          81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence            99998883    235688999999999999999999999   999999999999999999999999999874322211  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++||||+||++|+|++|+.||.......        ....+....       ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--------~~~~~~~~~-------~~  214 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--------LFESIRVDT-------PH  214 (316)
T ss_pred             ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-------CC
Confidence            22345689999999999875  67889999999999999999999997543211        111121111       11


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~-evl  335 (340)
                      .+..++.++.+++.+||+.||++||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1223457889999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.5e-42  Score=301.26  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=200.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      +++.+.||+|+||.||+|...      ....+++|.+......  .+.+.+|+.+++.++||||+++++.+...+..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            356689999999999999753      2346888888654432  35688999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          139 YEYMPNGSLDRHIFPKE--------------------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      +||+++++|.+++....                    .....+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence            99999999998874321                    1123578999999999999999999998   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATR  277 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~  277 (340)
                      ++++++.++|+|||+++...............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||..... 
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-  235 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-  235 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence            9999999999999999765433322222333456789999988664  67889999999999999998 9989865432 


Q ss_pred             ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                             ..+.+.........      .+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       236 -------~~~~~~~~~~~~~~------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         236 -------ERLFNLLKTGYRME------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE  284 (290)
T ss_pred             -------HHHHHHHhCCCCCC------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence                   12223333222111      11234568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.8e-42  Score=312.14  Aligned_cols=253  Identities=20%  Similarity=0.242  Sum_probs=200.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ...|.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            456677889999999999999865 78899999986532    2234577899999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++.     ...+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         122 MEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999883     23578889999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCceeeeccccCccccccccccccc--cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .... .......||+.|+|||.+.+..  ..++.++|||||||++|||++|+.||......       ............
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~  265 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHKNS  265 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCCCc
Confidence            3221 1123456999999999986531  24778999999999999999999999754421       111122211111


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~evl~  336 (340)
                      .....    ...++.++.+++.+||+.+|++  |||+.++++
T Consensus       266 ~~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 LTFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            11111    1134678899999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=315.49  Aligned_cols=249  Identities=24%  Similarity=0.258  Sum_probs=195.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||+||+|... +++.||+|++....    .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            456789999999999999865 78899999997532    2224577899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.++|+|||++.......
T Consensus        83 ~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          83 LPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999883    234689999999999999999999999   99999999999999999999999999986542211


Q ss_pred             Cce------------------------------------eeeccccCccccccccccccccccccccchhhHHHHHHHHH
Q 044497          222 DFV------------------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  265 (340)
Q Consensus       222 ~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ell  265 (340)
                      ...                                    ......||+.|+|||++.+.  .++.++|||||||++|+|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhh
Confidence            000                                    00123589999999998765  6788999999999999999


Q ss_pred             cCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 044497          266 GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE  336 (340)
Q Consensus       266 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~evl~  336 (340)
                      +|..||.......       .................    ..+++++.+++.+|+. +|.+|++   ++++++
T Consensus       234 ~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDNPQE-------TYRKIINWKETLQFPDE----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCCHHH-------HHHHHHcCCCccCCCCC----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999997544211       11111111111111111    1245678899999996 9999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-43  Score=299.26  Aligned_cols=256  Identities=25%  Similarity=0.309  Sum_probs=194.3

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCC-----eeEEEEEccC
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEYMP  143 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~  143 (340)
                      .+.+|+|+||.||+|... +++.+|||+...+..-.   .+|+++|+.+.|||||++.-+|....     ...+||||++
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP  105 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP  105 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence            478999999999999865 67899999987655322   37999999999999999998874322     3458999995


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-CceEEecccCCccCCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-~~~kl~Dfg~~~~~~~~~~  222 (340)
                      . +|.+.+..-...+..++...+.-+..|+.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+....+..
T Consensus       106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            5 89888854334466788888899999999999999998   99999999999999976 8999999999997766554


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHH----HHHhhcC----
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWV----YDQLNKG----  294 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~----  294 (340)
                      ..   ....|..|+|||++.+. ..|+.+.||||.||++.||+-|++-|...+....-..+...+    .+.+...    
T Consensus       182 ni---SYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  182 NI---SYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             ce---eEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            32   23467899999999886 578999999999999999999999998755422111100000    0011000    


Q ss_pred             ---CCcccccc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 ---GDLELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ---~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ..+.+...   .-.....++++.+|+.++|+.+|.+|.++.|++.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               00001000   1134456789999999999999999999999875

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.1e-43  Score=312.54  Aligned_cols=237  Identities=24%  Similarity=0.323  Sum_probs=191.4

Q ss_pred             hhcCCCCCeEEEEEEE----cCCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           71 HKLGQGGFGSVYKGQL----HTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~----~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      +.||+|+||.||++..    .+++.+|+|++.....   ....+..|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    3678999999875332   23456789999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            999999883    345689999999999999999999999   999999999999999999999999999875433221 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                       ......|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......        ....+....       .
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--------~~~~i~~~~-------~  215 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--------TMTMILKAK-------L  215 (318)
T ss_pred             -ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHHH--------HHHHHHcCC-------C
Confidence             12344689999999998764  66789999999999999999999997543211        111111111       1


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTK  333 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~e  333 (340)
                      ..+..+++.+.+++.+||+.||++|||+.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            122234578899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.9e-42  Score=296.93  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=206.0

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +...++.+.+.||+|+||.||++...++..+++|.+.......+.+.+|+++++.++|+|++++++.+.. ...+++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3456677889999999999999988778889999988766566789999999999999999999999887 778999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999998442  245678889999999999999999998   99999999999999999999999999987554322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .. ......++..|+|||.+...  .++.++|+||||+++|+++| |+.||.......        .......+....  
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~--  223 (260)
T cd05073         157 YT-AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGYRMP--  223 (260)
T ss_pred             cc-cccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCCCC--
Confidence            11 11223456789999998764  67889999999999999999 898987543211        111222221111  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                          .....+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                112345689999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-42  Score=302.91  Aligned_cols=264  Identities=23%  Similarity=0.371  Sum_probs=198.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcC---------------CcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEe
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHT---------------GGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLL  126 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~---------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~  126 (340)
                      ...|.+.+.||+|+||.||+|....               ...+|+|.+......  .+.+.+|+++++.++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3456778899999999999986532               225899998764322  35688999999999999999999


Q ss_pred             eEEEcCCeeEEEEEccCCCCcccccccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          127 GFCSEGSKRALVYEYMPNGSLDRHIFPKES--------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       127 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      +++...+..+++|||+++++|.+++.....        ....+++..++.++.|++.||+|||++   +++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999998843321        112468899999999999999999999   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc--CCCCCCCCcc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMHAT  276 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~~  276 (340)
                      ++++++.+||+|||++................++..|+|||.+.+.  .++.++|+||||+++|+|++  +..||.....
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9999999999999998755433222112223356789999988764  67889999999999999998  5556654332


Q ss_pred             cccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..    ..................   ..+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       239 ~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQ----VIENTGEFFRNQGRQIYL---SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HH----HHHHHHHhhhhccccccC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            11    001111111111000000   111224568999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6e-42  Score=301.31  Aligned_cols=264  Identities=24%  Similarity=0.381  Sum_probs=201.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcC-----------------CcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHT-----------------GGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL  125 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~  125 (340)
                      ..+++.+.||+|+||.||+|....                 +..+|+|.+.....  ..+.+.+|++++..++|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            456778899999999999987542                 24589999876543  23578899999999999999999


Q ss_pred             eeEEEcCCeeEEEEEccCCCCcccccccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKES-------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      ++++...+..+++||++++++|.+++.....       ....+++..++.++.|++.||+|||++   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            9999999999999999999999998854331       123689999999999999999999999   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc--CCCCCCCCcc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMHAT  276 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~~  276 (340)
                      ++++++.++|+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++  +..||.....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999998755433322222334467789999998764  67889999999999999998  5666654321


Q ss_pred             cccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..    .................   ...+...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       240 ~~----~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 QQ----VIENAGHFFRDDGRQIY---LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HH----HHHHHHhcccccccccc---CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            11    01111111111111000   11122345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.8e-42  Score=308.48  Aligned_cols=239  Identities=24%  Similarity=0.286  Sum_probs=190.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCC-CceeeEeeEEEcCCeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      |++.+.||+|+||.||+|... +++.||+|++....    ...+.+..|.+++..++| ++++++++++...+..|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            456789999999999999866 67799999987532    233567789999999866 568889999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.++|+|||++......
T Consensus        82 ~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          82 YVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            999999998883    335688999999999999999999999   9999999999999999999999999998643222


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......||+.|+|||.+.+.  .++.++||||+||++|+|+||+.||.......        ....+....     
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~~~~-----  217 (324)
T cd05587         155 GK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQSIMEHN-----  217 (324)
T ss_pred             CC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCC-----
Confidence            11  12344689999999999875  67889999999999999999999997543211        111111111     


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                        ...+...+.++.+++.+||+.||.+|++.
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 --VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              11122345788999999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-41  Score=294.35  Aligned_cols=256  Identities=24%  Similarity=0.364  Sum_probs=205.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|++.+.||+|++|.||+|... +++.+|+|.++...    ...+.+.+|+++++.++|+|++++++.+...+..+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4567789999999999999876 88999999886422    224678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.........+++..+..++.+++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999998865444456789999999999999999999999   9999999999999999999999999998755433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......     ... ..+....+..... 
T Consensus       160 ~~--~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~~~~~-  228 (267)
T cd08224         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYS-LCKKIEKCDYPPL-  228 (267)
T ss_pred             Cc--ccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHH-HHhhhhcCCCCCC-
Confidence            21  11233578899999998764  6788999999999999999999998643321     111 1111111111111 


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                          .....+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~  263 (267)
T cd08224         229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK  263 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence                11245678999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.7e-42  Score=303.57  Aligned_cols=258  Identities=25%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc--------CCcEEEEEEccCCCC--ChHHHHHHHHHhccc-CCCceeeEeeEEEc
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HHVNVVQLLGFCSE  131 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~  131 (340)
                      ....|.+.+.||+|+||.||++...        +...+|+|.+.....  ....+.+|+++++.+ +|||++++++++..
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            3456788899999999999999642        234699999976432  235688899999999 79999999999999


Q ss_pred             CCeeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCee
Q 044497          132 GSKRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL  199 (340)
Q Consensus       132 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nil  199 (340)
                      .+..+++|||+++++|.+++.....            ....+++..+..++.|++.||+|||+.   +++|+||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence            9999999999999999999854322            123588999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccc
Q 044497          200 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRS  278 (340)
Q Consensus       200 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~  278 (340)
                      ++.++.++|+|||.+................++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||...... 
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-  249 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  249 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence            999999999999998755432221111222345689999998764  67889999999999999998 88887543221 


Q ss_pred             cccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          279 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                             ............      ..+...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       250 -------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~  297 (307)
T cd05098         250 -------ELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             -------HHHHHHHcCCCC------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                   122222222211      112234578899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.9e-42  Score=307.31  Aligned_cols=242  Identities=21%  Similarity=0.294  Sum_probs=191.7

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||+||+|... +++.+|+|++.....    ..+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 678999999976432    224577899998888 699999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|..++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  151 (327)
T cd05617          81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--  151 (327)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence            99988873    335689999999999999999999999   999999999999999999999999999874322211  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......... .............       ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~-------~~  221 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKP-------IR  221 (327)
T ss_pred             ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCC-------CC
Confidence            12345689999999999765  67889999999999999999999997543322111 1122222222211       11


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                      .+...+..+.+++.+||+.||++|+++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            222345678899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.9e-42  Score=297.70  Aligned_cols=245  Identities=26%  Similarity=0.339  Sum_probs=192.4

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ||+|+||.||++... +++.+|+|.+.....    ....+..|+++++.++||||+++++.+......+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999765 689999999865322    223456799999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++........   ..
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~  152 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT  152 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence            8887432  234588899999999999999999999   999999999999999999999999999876543321   23


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...|+..|+|||.+.+.  .++.++||||+||++|+|++|+.||.........   ...........    ...   ...
T Consensus       153 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~----~~~---~~~  220 (277)
T cd05607         153 QRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK---EELKRRTLEDE----VKF---EHQ  220 (277)
T ss_pred             ccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH---HHHHHHhhccc----ccc---ccc
Confidence            34589999999998765  5888999999999999999999998754321110   11111111110    000   011


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      .++.++.+++.+||+.||++||+++|+++.
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            346788999999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.6e-43  Score=311.06  Aligned_cols=251  Identities=22%  Similarity=0.233  Sum_probs=199.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||+||++... +++.+|+|+++....    ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            556789999999999999865 788999999976432    335678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999998432   25689999999999999999999999   99999999999999999999999999998654433


Q ss_pred             CceeeeccccCcccccccccccc----ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          222 DFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      .. ......||+.|+|||.+...    ...++.++|||||||++|+|++|+.||.......       ............
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~~  228 (330)
T cd05601         157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNFQRFL  228 (330)
T ss_pred             ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcCCCcc
Confidence            22 22334689999999998632    1356789999999999999999999997543211       111111111111


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....    ...++.++.+|+.+||+ +|++|||+.++++
T Consensus       229 ~~~~----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFPE----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCC----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1111    11345778999999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-42  Score=301.46  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=196.0

Q ss_pred             hhhhhcCCCCCeEEEEEEE-----cCCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcC--CeeEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALV  138 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  138 (340)
                      .+.+.||+|+||+||++..     .+++.+|+|.+.....  ....+.+|+++++.++|||++++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            5678999999999988642     3577899999876533  346788999999999999999999988653  458899


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++.     ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||++....
T Consensus        87 ~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          87 MEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999883     23589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCcee-eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc-------chhHHHHHH
Q 044497          219 KENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA-------YFPSWVYDQ  290 (340)
Q Consensus       219 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~~~  290 (340)
                      ....... .....++..|+|||.+.+.  .++.++||||||+++|+|+||..|+..........       .......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            4322111 1222356679999998764  67889999999999999999999976543211000       000000111


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......      ...+..++..+.+++.+||+.+|++|||++++++.|+
T Consensus       237 ~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~  279 (283)
T cd05080         237 LERGMR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK  279 (283)
T ss_pred             hhcCCC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            111111      1112234578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.7e-42  Score=309.86  Aligned_cols=253  Identities=21%  Similarity=0.256  Sum_probs=198.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ...|++.+.||+|+||.||++... +++.+|+|++.+..    ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            345677889999999999999876 67899999986422    2234578999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         122 MEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999883     23578899999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeeccccCccccccccccccc--cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .... .......||+.|+|||.+.+..  +.++.++|+||+||++|+|++|+.||......       ............
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~  265 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHKNS  265 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCcc
Confidence            3221 1223456999999999986542  23678999999999999999999999754321       111122211111


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~evl~  336 (340)
                      .....    ...++..+.+++.+||+.+|.+  |+|+.|+++
T Consensus       266 ~~~p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         266 LNFPE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             cCCCC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            11111    1234677889999999855543  889999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.7e-42  Score=298.27  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=202.6

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEcC-----CcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEc-CCe
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLHT-----GGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSE-GSK  134 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~  134 (340)
                      ...++.+.+.||+|+||.||+|....     +..+++|.+......  .+.+.+|+.+++.++|||++++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34566778899999999999998664     678999988754322  3568899999999999999999998765 567


Q ss_pred             eEEEEEccCCCCcccccccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEec
Q 044497          135 RALVYEYMPNGSLDRHIFPKESR----GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~D  210 (340)
                      .+++++|+++++|.+++......    +..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999988543322    25689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHH
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      ||+++...............++..|+|||.+.+.  .++.++||||||+++|++++ |+.||.......        ...
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~  230 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--------MAA  230 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--------HHH
Confidence            9999755333221111223456789999998764  67889999999999999999 999986543211        222


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....+.....      ...++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       231 ~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         231 YLKDGYRLAQ------PINCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             HHHcCCCCCC------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            2222211111      1123567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=294.59  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=198.4

Q ss_pred             hhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCe------
Q 044497           68 HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSK------  134 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------  134 (340)
                      ++.+.||+|+||.||+|...    .+..+|+|.++......   +.+.+|++.++.++|||++++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45688999999999999754    23679999987654332   468899999999999999999998865444      


Q ss_pred             eEEEEEccCCCCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          135 RALVYEYMPNGSLDRHIFPKE--SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      .++++||+++++|..++....  .....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence            789999999999998874432  2234689999999999999999999998   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      +++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||......       . ..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~-~~~~~  228 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------E-IYDYL  228 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHH
Confidence            99865443322222223356789999998654  67889999999999999999 88888643321       1 12222


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..+....      .+...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       229 ~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         229 RHGNRLK------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             HcCCCCC------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            2222111      122345789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-42  Score=309.58  Aligned_cols=236  Identities=26%  Similarity=0.329  Sum_probs=187.3

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHH-HhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||+||+|... +++.||+|++.....    ....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999875 788999999865321    2234455544 56778999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (323)
T cd05575          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--  151 (323)
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence            99998883    345688999999999999999999999   999999999999999999999999999874322221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......       . .........       ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~-~~~~i~~~~-------~~  214 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------E-MYDNILNKP-------LR  214 (323)
T ss_pred             ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHH-------H-HHHHHHcCC-------CC
Confidence            12344689999999998765  6788999999999999999999999754321       1 111111111       11


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMT  332 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~  332 (340)
                      .....+..+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1223457889999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.3e-41  Score=309.28  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=204.4

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccC-CCceeeEeeEEE
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIH-HVNVVQLLGFCS  130 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~  130 (340)
                      .++....+.+.+.||+|+||.||+|.++      .+..||+|+++.....  .+.+.+|++++..+. ||||+++++.+.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4555566677899999999999999854      3457999999765333  246889999999997 999999999999


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCC------------------------------------------------------
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKES------------------------------------------------------  156 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  156 (340)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999988853221                                                      


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 044497          157 ----------------------------------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH  196 (340)
Q Consensus       157 ----------------------------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~  196 (340)
                                                              ....+++..+..++.|++.||+|||+.   +++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                    112467788899999999999999998   9999999999


Q ss_pred             CeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCc
Q 044497          197 NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHA  275 (340)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~  275 (340)
                      |||+++++.++|+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||....
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999999764332221112223467889999998764  67889999999999999998 888886433


Q ss_pred             ccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          276 TRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..       ......+..+....      .+..++.++.+++.+||+.+|.+||+++++++.|+
T Consensus       347 ~~-------~~~~~~~~~~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~  397 (401)
T cd05107         347 MN-------EQFYNAIKRGYRMA------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG  397 (401)
T ss_pred             ch-------HHHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            21       11222222222111      12234578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.2e-42  Score=296.73  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=204.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|++|.||++... +++.+++|.+.....    ..+++.+|+.+++.++|||++++++++...+..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            4567789999999999999854 788999998765322    22578899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.........+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999998854444456789999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ...  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......     .. ...........   
T Consensus       160 ~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~---  226 (267)
T cd08229         160 TTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEQCDYP---  226 (267)
T ss_pred             Ccc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchH-----HH-HhhhhhcCCCC---
Confidence            221  1234588899999998765  67789999999999999999999986433211     01 11111111111   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        .......+..+.+++.+||+.||.+|||+.++++.++
T Consensus       227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~  263 (267)
T cd08229         227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK  263 (267)
T ss_pred             --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence              1112245678999999999999999999998888775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.8e-42  Score=331.46  Aligned_cols=264  Identities=24%  Similarity=0.350  Sum_probs=203.9

Q ss_pred             CCCHHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEc
Q 044497           56 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSE  131 (340)
Q Consensus        56 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~  131 (340)
                      .+...+.....|.+.+.||.|+||+||+|... ++..+|+|.+......   ...+..|+.++..++||||++++++|..
T Consensus         4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266          4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            34444555567788899999999999999865 6778999998754332   3568899999999999999999998844


Q ss_pred             --CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeeecCCCCCCeeEcC---
Q 044497          132 --GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD----VCILHFDIKPHNILLDH---  202 (340)
Q Consensus       132 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~----~~ivH~dik~~Nill~~---  202 (340)
                        ...+|+||||+++++|.+++.........+++..++.|+.||+.||+|||+...    .+|+|+||||+|||++.   
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              456899999999999999885543344679999999999999999999998521    25999999999999964   


Q ss_pred             --------------CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCC
Q 044497          203 --------------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  268 (340)
Q Consensus       203 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~  268 (340)
                                    ...+||+|||++........   .....||+.|+|||++.+....++.++|||||||++|+|+||+
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                          23489999999976533221   2334689999999998765446788999999999999999999


Q ss_pred             CCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          269 RNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       269 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .||......       ..+...+........       ...+.++.+|+..||+.+|.+|||+.|++.
T Consensus       241 ~PF~~~~~~-------~qli~~lk~~p~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        241 TPFHKANNF-------SQLISELKRGPDLPI-------KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCcCCcH-------HHHHHHHhcCCCCCc-------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999643321       112222222221111       123567899999999999999999999984

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.6e-41  Score=339.44  Aligned_cols=261  Identities=23%  Similarity=0.459  Sum_probs=197.9

Q ss_pred             CCHHHHHHHHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           57 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        57 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      ++..++.. .+...+.||+|+||.||+|.. .++..||+|.+......   ..+|++.+++++||||++++++|.+.+..
T Consensus       683 ~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        683 ITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            34444432 234457899999999999986 47889999998654322   23568899999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++||||+++|+|.+++.       .++|..+..++.|+++|++|||..++.+++|||+||+||+++.++..++. |+...
T Consensus       759 ~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             EEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            99999999999999982       37899999999999999999996555699999999999999998888775 55543


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .....      ....+|..|+|||++.+.  .++.++|||||||++|||+||+.||+.....  ......|.........
T Consensus       831 ~~~~~------~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~  900 (968)
T PLN00113        831 LLCTD------TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCH  900 (968)
T ss_pred             ccccC------CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccc
Confidence            22111      122578999999998764  7889999999999999999999998543221  2223344332221111


Q ss_pred             -----CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 -----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 -----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           +...............++.+++.+||+.||++|||++|+++.|+
T Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  949 (968)
T PLN00113        901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE  949 (968)
T ss_pred             hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence                 11111111223345567889999999999999999999999986

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=293.10  Aligned_cols=246  Identities=29%  Similarity=0.468  Sum_probs=195.2

Q ss_pred             hhcCCCCCeEEEEEEEc-C---CcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-T---GGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... .   +..+|+|.+.....  ..+++.+|+.+++.++|||++++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999643 2   26899999986655  3467889999999999999999999876 4568999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+++.........
T Consensus        80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            999999843    33688999999999999999999999   99999999999999999999999999998654433221


Q ss_pred             e-eeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          225 S-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       225 ~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      . .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ....+......     
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~~-----  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------VIAMLESGERL-----  217 (257)
T ss_pred             ccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCcC-----
Confidence            1 1122245689999998764  67889999999999999998 999986543211        12222222111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       ..+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             1122345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-41  Score=291.99  Aligned_cols=251  Identities=28%  Similarity=0.496  Sum_probs=202.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      .+++.+.||.|+||.||++.+..++.+|+|.+.......+.+.+|+++++.++|||++++++++......+++|||++++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            45677899999999999998877889999999877667788999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+......... .
T Consensus        85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~  157 (256)
T cd05112          85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S  157 (256)
T ss_pred             cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence            999988432   24578999999999999999999999   9999999999999999999999999998754332211 1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      .....++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||.......        ..+.+..+.....     
T Consensus       158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-----  222 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--------VVETINAGFRLYK-----  222 (256)
T ss_pred             cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHhCCCCCCC-----
Confidence            1122356789999998764  67789999999999999998 899886533211        1222222211111     


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                       +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             1113467999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7e-42  Score=298.55  Aligned_cols=256  Identities=24%  Similarity=0.415  Sum_probs=199.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      .+.+.++||+|+||.||++...      ++..+++|.+..... ..+.+.+|+++++.++|+||+++++++...+..+++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV   85 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence            3456789999999999999632      355789998765432 235789999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceE
Q 044497          139 YEYMPNGSLDRHIFPKES-----------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~k  207 (340)
                      |||+++++|.+++.....           ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~k  162 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVK  162 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEE
Confidence            999999999998854321           123578999999999999999999999   999999999999999999999


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  286 (340)
                      |+|||++................+++.|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------  232 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------  232 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------
Confidence            9999998754332221112223356789999998765  67889999999999999998 888886433211        


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      .......+....      .+..+++.+.+++.+||+.||.+||++.++++.|+.
T Consensus       233 ~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         233 AIECITQGRELE------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHHcCccCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            111122221111      112345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-41  Score=295.91  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=195.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCc----EEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      .+++.+.||+|+||.||+|.+. ++.    .+++|.+.....  ...++..|+..+..++||||+++++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence            3456689999999999999864 344    477887754322  22467788889999999999999998864 457889


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      +||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||+++...
T Consensus        87 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          87 TQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999843   235689999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ............++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......        ...+.+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEKGERL  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcC
Confidence            33222222334577789999998764  67889999999999999998 99998654321        122223332222


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....      .++.++.+++.+||+.||.+|||+.|+++.|+
T Consensus       231 ~~~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         231 AQPQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFT  266 (279)
T ss_pred             CCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            2111      13356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.4e-42  Score=309.06  Aligned_cols=250  Identities=23%  Similarity=0.251  Sum_probs=191.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |++.+.||+|+||+||+|... +++.+|+|++....    .....+.+|+.++..++||||+++++.+.+....|+||||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~   82 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF   82 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence            456789999999999999765 68899999997532    2234678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          83 LPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999983    345789999999999999999999999   99999999999999999999999999987543211


Q ss_pred             Cc---------------------------------eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCC
Q 044497          222 DF---------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  268 (340)
Q Consensus       222 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~  268 (340)
                      ..                                 .......||+.|+|||.+.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCC
Confidence            00                                 001234699999999999765  6788999999999999999999


Q ss_pred             CCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhccc--CCCCCCCCHHHHHH
Q 044497          269 RNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQ--VKAADRPSMTKVLE  336 (340)
Q Consensus       269 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~~p~~Rps~~evl~  336 (340)
                      .||.......       ..................    .++.++.+++.+|+.  .++..||+++|+++
T Consensus       234 ~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         234 PPFCSETPQE-------TYKKVMNWKETLIFPPEV----PISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCCCCCCHHH-------HHHHHHcCcCcccCCCcC----CCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            9997543211       111111111111111111    134677778877554  23345689999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.7e-42  Score=300.66  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=198.8

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-----------------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-----------------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQL  125 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-----------------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~  125 (340)
                      ..+.+.+.||+|+||.||++...                 ++..+|+|.+......  .+++.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            34667789999999999998532                 2346899998754332  3578899999999999999999


Q ss_pred             eeEEEcCCeeEEEEEccCCCCcccccccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESR-------GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      ++++...+..+++|||+++++|.+++......       ...+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999988543211       23477889999999999999999999   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc--CCCCCCCCcc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMHAT  276 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~~  276 (340)
                      ++++++.++|+|||++................++..|+|||...+.  .++.++|+|||||++|||++  |..||.....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999998755433222111223346789999987654  67889999999999999998  6677754332


Q ss_pred             cccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ...    ................   ...+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       240 ~~~----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 EQV----IENTGEFFRDQGRQVY---LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHH----HHHHHHHHhhcccccc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            111    0101111111100000   01112344788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=312.78  Aligned_cols=249  Identities=24%  Similarity=0.267  Sum_probs=193.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||.||++... +++.||+|++.....    ..+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            456789999999999999765 788999999865322    225678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||+++......
T Consensus        83 ~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          83 LPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999883    345688999999999999999999999   99999999999999999999999999986322110


Q ss_pred             Cc------------e---------------------------------eeeccccCccccccccccccccccccccchhh
Q 044497          222 DF------------V---------------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVYG  256 (340)
Q Consensus       222 ~~------------~---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  256 (340)
                      ..            .                                 ......||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS  233 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEe
Confidence            00            0                                 00123589999999999765  6788999999


Q ss_pred             HHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCC---CCHHH
Q 044497          257 FGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR---PSMTK  333 (340)
Q Consensus       257 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~e  333 (340)
                      |||++|||++|..||.......       .................    ..++.++.+++.+||. +|.+|   +|+.+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~----~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHE-------TYRKIINWRETLYFPDD----IHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHH-------HHHHHHccCCccCCCCC----CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            9999999999999996543211       11111111111111111    1245678999999997 67765   59998


Q ss_pred             HHH
Q 044497          334 VLE  336 (340)
Q Consensus       334 vl~  336 (340)
                      +++
T Consensus       302 ~l~  304 (377)
T cd05629         302 IKS  304 (377)
T ss_pred             Hhc
Confidence            875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-41  Score=298.61  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=203.2

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  132 (340)
                      +....+.+.+.||+|+||.||++...      ++..+|+|.++.....  .+.+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34456677899999999999999642      3457999998764332  35688999999999 799999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      +..+++|||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++++|||
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence            99999999999999999984322  23489999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      ++................++..|+|||.+.+.  .++.++||||+|+++|+|++ |..||.......       ......
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------~~~~~~  257 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------KFYKLI  257 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------HHHHHH
Confidence            99865443322222233467789999998764  67889999999999999998 999986543211       111222


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..+....      .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       258 ~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         258 KEGYRMA------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             HcCCcCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            2221111      11123468999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-42  Score=320.17  Aligned_cols=260  Identities=18%  Similarity=0.234  Sum_probs=190.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcC--------CeeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG--------SKRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~  136 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++....   ....+|+.+++.++||||+++++++...        ..++
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            4667789999999999999864 68899999886543   2345799999999999999999876432        2467


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAK  215 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~  215 (340)
                      +||||++ ++|.+++.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+++
T Consensus       144 lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            8999996 477766644334456789999999999999999999999   999999999999998664 79999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh--------HHH
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP--------SWV  287 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--------~~~  287 (340)
                      .......   .....||+.|+|||++.+. ..++.++|||||||++|||++|.+||........-..+.        ...
T Consensus       220 ~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        220 NLLAGQR---SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             hccCCCC---cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            6543322   1234589999999998653 357889999999999999999999997644321000000        000


Q ss_pred             HHHhhcCCCccccc------cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          288 YDQLNKGGDLELRN------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       288 ~~~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......-.......      ...++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00000000000000      01112234578999999999999999999999874

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-41  Score=297.82  Aligned_cols=258  Identities=24%  Similarity=0.397  Sum_probs=200.0

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      ...+|++.+.||+|+||.||+|..+      .+..+|+|.+......  ...+.+|+.+++.++|||++++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3456778899999999999999643      2447999998754432  2357889999999999999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          135 RALVYEYMPNGSLDRHIFPKES------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                      .+++|||+++|+|.+++.....      ......+..+..++.|++.||+|||++   +++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999854221      123456778899999999999999999   9999999999999999999999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHH
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  287 (340)
                      +|||+++...............++..|+|||.+.+.  .++.++|+|||||++|||++ |..||.......        .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--------~  230 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--------V  230 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------H
Confidence            999998754333221111222356789999998764  67889999999999999998 777876433211        1


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......+.....      +...++.+.+++.+||+.+|++|||+.++++.|+
T Consensus       231 ~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  276 (288)
T cd05061         231 LKFVMDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK  276 (288)
T ss_pred             HHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            122222221111      1123468999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.6e-42  Score=303.94  Aligned_cols=261  Identities=23%  Similarity=0.321  Sum_probs=196.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      +|.+.+.||+|+||.||+|... +++.+|+|.++....  ....+.+|+++++.++||||+++++++...+..+++|||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            4566789999999999999865 678899999875432  2346788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++ +|.+++..   .+..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........
T Consensus        87 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          87 DK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            64 78777632   234578899999999999999999999   999999999999999999999999999875433221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHhhc--
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQLNK--  293 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~--  293 (340)
                        ......+++.|+|||.+.+. ..++.++||||||+++|+|+||+.||...........+.       ...+.....  
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence              12234578899999988653 357889999999999999999999997654321100000       000000000  


Q ss_pred             ----CCCccc--cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 ----GGDLEL--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ----~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          ......  .........++.++.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                000000  0000111235678899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-42  Score=299.90  Aligned_cols=251  Identities=29%  Similarity=0.458  Sum_probs=198.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHH---HHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |++.+.||+|+||+||++... +++.+|+|++.........   ..+|+.++++++||||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999876 5668999999876554433   345999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++.    ....+++..+..++.|+++||++||++   +++|+||||+||++++++.++|+|||.+....... 
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-  152 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-  152 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence            9999999984    456789999999999999999999999   99999999999999999999999999997542211 


Q ss_pred             ceeeeccccCcccccccccc-ccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          223 FVSISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                       .......++..|+|||.+. +  ...+.++|+||+|+++|+|++|..||...........+..........        
T Consensus       153 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------  221 (260)
T PF00069_consen  153 -ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------  221 (260)
T ss_dssp             -SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------
T ss_pred             -ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------
Confidence             2334556899999999987 4  377889999999999999999999998652111111111111000000        


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...........+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000011278999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.4e-42  Score=301.25  Aligned_cols=259  Identities=24%  Similarity=0.414  Sum_probs=203.7

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc--------CCcEEEEEEccCCCC--ChHHHHHHHHHhccc-CCCceeeEeeEEE
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HHVNVVQLLGFCS  130 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  130 (340)
                      +....+.+.+.||+|+||.||+|...        ++..+|+|.+.....  ..+.+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            44566778899999999999999631        234799999875432  235788999999999 8999999999999


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      .....+++|||+++++|.+++.....            ....+++..+..++.|+++||+|||++   +++|+||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999999865322            123578889999999999999999999   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATR  277 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~  277 (340)
                      ++++++.++|+|||.++...............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999999866443332222333466789999998764  67889999999999999998 77777543221


Q ss_pred             ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                              .............      .+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       247 --------~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~  294 (304)
T cd05101         247 --------ELFKLLKEGHRMD------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD  294 (304)
T ss_pred             --------HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence                    1222222222111      11234578999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-41  Score=294.57  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=192.8

Q ss_pred             hhcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCCh--HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.||+|+||.||+|...   ++..+|+|.++......  ..+.+|+.+++.++|||++++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999754   34579999887654332  46888999999999999999999999999999999999999


Q ss_pred             CcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          146 SLDRHIFPKES-RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       146 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      +|.+++..... .....++..+..++.|++.|++|||+.   +++|+||||+||+++.+++++|+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999854322 223566778889999999999999999   99999999999999999999999999987543332222


Q ss_pred             eeeccccCcccccccccccccc-----ccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          225 SISATRGTIGYIAPELISRNFG-----TVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~-----~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ......++..|+|||++.+...     .++.++|+||||+++|||++ |+.||........       ....... ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~-~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-------LTYTVRE-QQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHHhhc-ccCC
Confidence            2223446788999999864311     35779999999999999996 9999965432210       0001111 1111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ... .......+..+.+++.+|+ .+|++|||+++|++.|+
T Consensus       230 ~~~-~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPK-PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCC-CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111 1111123456788999999 68999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.9e-42  Score=308.44  Aligned_cols=239  Identities=26%  Similarity=0.312  Sum_probs=187.8

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHH-HHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEV-STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.+|+|++.....    ....+..|. .+++.++||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46899999999999866 677899999875321    122344444 356778999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|+++||+|||++   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            99999883    335678889999999999999999999   999999999999999999999999999874322221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......       .........        ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~--------~~  214 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKP--------LQ  214 (325)
T ss_pred             CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCC--------cC
Confidence            12344689999999999775  67889999999999999999999997543211       111111111        11


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                      ..+.++..+.+++.+||+.||.+||++.+.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            1224557889999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-41  Score=296.89  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=197.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCc----EEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ...+++.+.||+|+||+||+|.+. ++.    .||+|+++.....  ...+.+|+.++..++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            344566789999999999999754 444    4899998654322  35688999999999999999999998754 578


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            999999999999988432   34689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ..............++..|+|||.+.+.  .++.++||||||+++|||++ |..||.......        ....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~  228 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------IPDLLEKGE  228 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCC
Confidence            6543322222223456789999998764  67889999999999999998 888886433211        122222222


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....      +...+.++.+++.+||+.||++|||+.++++.|+
T Consensus       229 ~~~~------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         229 RLPQ------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS  266 (279)
T ss_pred             cCCC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111      1234567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.3e-42  Score=306.59  Aligned_cols=239  Identities=23%  Similarity=0.284  Sum_probs=190.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      |++.+.||+|+||.||+|... +++.+|+|++.+...    ..+....|..++..+ +|++++++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            456789999999999999866 677999999875422    223466777887777 58999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++......
T Consensus        82 ~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          82 YVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            999999998883    234688999999999999999999999   9999999999999999999999999998743322


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......||+.|+|||.+.+.  .++.++|||||||++|+|+||+.||.......        ....+....     
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------~~~~i~~~~-----  217 (323)
T cd05616         155 GV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHN-----  217 (323)
T ss_pred             CC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-----
Confidence            11  12345689999999999865  67899999999999999999999997543211        111121111     


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                        ...+...+.++.+++.+||+.+|.+|++.
T Consensus       218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              11222356788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=322.55  Aligned_cols=255  Identities=20%  Similarity=0.204  Sum_probs=198.7

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCC-cEEEEEEccC-CCCChHHHHHHHHHhcccC-CCceeeEeeEE-E---c---CC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTG-GLIAVKMLAN-SKFSGEEFINEVSTIGRIH-HVNVVQLLGFC-S---E---GS  133 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~-~~vavK~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~-~---~---~~  133 (340)
                      ..+.++.+.|.+|||+.||+|.+..+ ..+|+|++-. ++...+.+.+|+++|+.|+ |+|||.+++.. .   .   .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34456678999999999999987755 8999999754 4444477899999999996 99999999932 1   1   23


Q ss_pred             eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      .+++.||||++|.|-+++..+..  ..|.+.++++|++|+++|+++||.. +++|||||||-+|||++.+++.||||||.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            46789999999999999966554  3499999999999999999999996 66799999999999999999999999999


Q ss_pred             CccCCCCC-Cce------eeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH
Q 044497          214 AKFHPKEN-DFV------SISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS  285 (340)
Q Consensus       214 ~~~~~~~~-~~~------~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~  285 (340)
                      +.-..... ...      ..-...-|+.|+|||.+.-. ...+++|+|||||||+||-|+....||+......       
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------  265 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------  265 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence            87332221 100      00112368999999987421 1278899999999999999999999998763211       


Q ss_pred             HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          286 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                           +.++.. .    ..-.+.++..+.+||..||++||.+||++-|++..+
T Consensus       266 -----Ilng~Y-~----~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  266 -----ILNGNY-S----FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             -----EEeccc-c----CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence                 111110 0    011136778999999999999999999999999875

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-41  Score=295.05  Aligned_cols=256  Identities=23%  Similarity=0.270  Sum_probs=199.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ...|++.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.++..++|||++++++++...+..+++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            345677899999999999999864 778999999875432 335678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+|++|+||++++++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999999883    234688999999999999999999998   99999999999999999999999999997553222


Q ss_pred             CceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .  ......++..|+|||.+... ...++.++|+||+|+++|+|++|+.||...........        ..... ....
T Consensus       161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--------~~~~~-~~~~  229 (267)
T cd06646         161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------MSKSN-FQPP  229 (267)
T ss_pred             c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--------eecCC-CCCC
Confidence            1  11234578899999987532 23467899999999999999999999864332111000        00000 0000


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                      . .......+..+.+++.+||+.+|++|||++++++.|
T Consensus       230 ~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 K-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             C-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0 001123457899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.9e-41  Score=299.46  Aligned_cols=257  Identities=25%  Similarity=0.432  Sum_probs=200.4

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc--------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  132 (340)
                      ...+.+.+.||+|+||.||++...        ....+|+|.++.....  ...+..|+.+++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            345667899999999999999642        2446999998754332  24678999999999 699999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill  200 (340)
                      +..+++|||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++|+||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            999999999999999999854321            234588999999999999999999998   99999999999999


Q ss_pred             cCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccccc
Q 044497          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSS  279 (340)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~  279 (340)
                      ++++.+||+|||.++...............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......  
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--  243 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--  243 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            99999999999999765432221111222345679999998764  67889999999999999999 88888543321  


Q ss_pred             ccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          280 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            ........+....      .+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       244 ------~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~  291 (314)
T cd05099         244 ------ELFKLLREGHRMD------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD  291 (314)
T ss_pred             ------HHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                  1222222222111      12234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-41  Score=310.77  Aligned_cols=262  Identities=19%  Similarity=0.205  Sum_probs=199.0

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      .+....|.+.+.||+|+||.||+|...   .+..+++|.+...    ....+|+++++.++||||+++++++......++
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            344456788899999999999999643   4568999988653    234689999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +||++. ++|.+++    .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||++...
T Consensus       164 v~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999994 6888877    2346789999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHH---------
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY---------  288 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~---------  288 (340)
                      .............||..|+|||.+.+.  .++.++|||||||++|||++|+.||...........+.....         
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            544332223345699999999999765  678899999999999999999999976543321111100000         


Q ss_pred             ---------HH---hhcCCCccccccc-hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 ---------DQ---LNKGGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ---------~~---~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                               ..   ............. ......+.++.+++.+||..||++|||+.|++.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                     00   0000000000000 001123567889999999999999999999985

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.9e-41  Score=289.73  Aligned_cols=247  Identities=26%  Similarity=0.411  Sum_probs=196.9

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      +.||+|+||.||+|...+++.+|+|.+......  ...+.+|+++++.++|||++++++++...+..+++|||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999998878889999998764332  246889999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeec
Q 044497          149 RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  228 (340)
Q Consensus       149 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  228 (340)
                      +++...   ...+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++......... ....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~  153 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL  153 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence            988432   34578999999999999999999998   9999999999999999999999999998754322111 1112


Q ss_pred             cccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       229 ~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ..++..|+|||.+.+.  .++.++||||||+++|++++ |..||.......        .......+....      .+.
T Consensus       154 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------~~~  217 (250)
T cd05085         154 KQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--------AREQVEKGYRMS------CPQ  217 (250)
T ss_pred             CCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCCCCC------CCC
Confidence            2345679999998764  67889999999999999998 898986543211        112222221111      112


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..+..+.+++.+||+.+|++|||+.++++.|..
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  250 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELAA  250 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence            345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.8e-42  Score=309.62  Aligned_cols=255  Identities=22%  Similarity=0.257  Sum_probs=198.6

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      +....|.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.+++.++||||+++++.+.+.+..+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            34466778899999999999999866 78899999986422    22345778999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+++|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         120 MVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            9999999999999883     23578889999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccCccccccccccccc--cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ...... .......||+.|+|||++.+..  +.++.++|||||||++|+|++|+.||......       ..........
T Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~  263 (371)
T cd05622         192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHK  263 (371)
T ss_pred             cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC
Confidence            543321 1223456999999999987542  23778999999999999999999999754321       1112222111


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~evl~  336 (340)
                      .......    ...++..+.+++.+||+.++.+  |+++.++++
T Consensus       264 ~~~~~~~----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         264 NSLTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             CcccCCC----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            1111111    1235678899999999844433  778988876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=303.12  Aligned_cols=245  Identities=20%  Similarity=0.314  Sum_probs=208.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||+|.|+.|-+|+.- +|..||||++.+...+   ...++.|++.|+.++|||||++|.+.....++|+|.|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            566789999999999999754 8999999999875543   467899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-CCCceEEecccCCccCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      ++|+|.+||.+++   ..+++....+++.||+.|+.|+|+.   .+|||||||+|+.+. .-|.+||.|||++..+....
T Consensus       100 D~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen  100 DGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             CCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999997655   4688999999999999999999998   999999999998775 57899999999998776655


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   ..+.+|+..|-|||++.+. ....+.+|||||||+||.|++|++||......+.-.        .+-+       -
T Consensus       174 k---L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT--------mImD-------C  234 (864)
T KOG4717|consen  174 K---LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT--------MIMD-------C  234 (864)
T ss_pred             h---hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh--------hhhc-------c
Confidence            3   4667899999999999986 234568999999999999999999998765433111        1111       1


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....+...+.++++||..||..||++|.|.+++..
T Consensus       235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            13456788899999999999999999999999864

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.4e-42  Score=312.84  Aligned_cols=249  Identities=23%  Similarity=0.255  Sum_probs=193.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||.||+|... +++.+|+|++....    ...+.+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            566789999999999999865 68899999986532    2335678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||++.......
T Consensus        83 ~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          83 IPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999832    34678899999999999999999999   99999999999999999999999999975221000


Q ss_pred             -----------------------------------------CceeeeccccCccccccccccccccccccccchhhHHHH
Q 044497          222 -----------------------------------------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV  260 (340)
Q Consensus       222 -----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~  260 (340)
                                                               .........||+.|+|||++.+.  .++.++|||||||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvi  233 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccce
Confidence                                                     00001124689999999999775  67889999999999


Q ss_pred             HHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCC---CHHHHHH
Q 044497          261 LLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP---SMTKVLE  336 (340)
Q Consensus       261 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp---s~~evl~  336 (340)
                      +|+|++|+.||.......       ................    ...+++++.+++.+|+ .+|.+|+   |+.++++
T Consensus       234 lyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         234 LYEMLVGQPPFLADTPAE-------TQLKVINWETTLHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eeehhhCCCCCCCCCHHH-------HHHHHhccCccccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999999997654321       1111111111111111    1124567788888876 5999999   8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.7e-41  Score=293.82  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=194.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      +++.+.||+|+||.||+|... +++.+|+|.+..+...  ...+.+|++++.+++|||++++++.+...+..+++|||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            356688999999999999754 7889999998654322  3568899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|..+.        .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......  
T Consensus        83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            99986542        467888999999999999999999   99999999999999999999999999987543322  


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                        .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||............... .............   
T Consensus       150 --~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---  221 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLP---  221 (279)
T ss_pred             --ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccCCCCCC---
Confidence              2334688999999999765  6788999999999999999999998754332211111111 1111111111110   


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ....++++.+++.+||+.+|.+||+++++++
T Consensus       222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              1123467899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.8e-41  Score=289.61  Aligned_cols=245  Identities=25%  Similarity=0.429  Sum_probs=193.7

Q ss_pred             hcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           72 KLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      .||+|+||.||+|.+.   ++..+|+|++......  .+.+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999754   3456999998765332  3568899999999999999999999864 56899999999999


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee-
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-  225 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-  225 (340)
                      |.+++..   ....+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++........... 
T Consensus        81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9998843   235689999999999999999999999   999999999999999999999999999975543322111 


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      .....++..|+|||.+...  .++.++||||||+++|++++ |..||.......        ....+..+....      
T Consensus       155 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~------  218 (257)
T cd05115         155 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------VMSFIEQGKRLD------  218 (257)
T ss_pred             cCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCCC------
Confidence            1122245789999998764  67889999999999999996 999987543211        222223322221      


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .+...+.++.+++.+||+.+|++||++.++.+.|+
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            12234578899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.9e-41  Score=294.01  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=191.7

Q ss_pred             hhcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.||+|+||.||+|...   ....+++|.+......  ...+.+|+..++.++||||+++++.+......+++|||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            36899999999999654   2346888877644322  246789999999999999999999999999999999999999


Q ss_pred             CcccccccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          146 SLDRHIFPKESR-GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       146 ~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      +|.+++...... ....++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999998554322 23456788899999999999999999   99999999999999999999999999987543332222


Q ss_pred             eeeccccCcccccccccccc-----ccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          225 SISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ......++..|+|||++...     ...++.++||||||+++|||++ |..||......       .......... ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~-~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQ-DIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhcc-Ccc
Confidence            22233456789999987531     1256779999999999999999 77787644321       1111112111 111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ... ...+...+..+.+++..|+ .||++|||+++|++.|.
T Consensus       230 ~~~-~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPK-PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC-CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111 1223345577788899998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.1e-42  Score=311.32  Aligned_cols=249  Identities=22%  Similarity=0.242  Sum_probs=192.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.+.+.||+|+||.||+|... +++.+|+|++.....    ..+.+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            456789999999999999765 788999999875432    234678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          83 IPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999998832    34688899999999999999999999   99999999999999999999999999975321100


Q ss_pred             C---------------------------------------------ceeeeccccCccccccccccccccccccccchhh
Q 044497          222 D---------------------------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYG  256 (340)
Q Consensus       222 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  256 (340)
                      .                                             ........||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence            0                                             0001123589999999999765  6788999999


Q ss_pred             HHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCC---HHH
Q 044497          257 FGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTK  333 (340)
Q Consensus       257 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~e  333 (340)
                      |||++|||++|+.||.......       ................    ...+++++.+++.+|+ .+|.+|++   +.+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLE-------TQMKVINWQTSLHIPP----QAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHH-------HHHHHHccCCCcCCCC----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999999997543211       1111111111111111    1234567788888876 59999997   777


Q ss_pred             HHH
Q 044497          334 VLE  336 (340)
Q Consensus       334 vl~  336 (340)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.1e-41  Score=291.45  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=200.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||+|++|.||+|... +++.+++|.+....   ...+.+.+|+++++.++|||++++++++...+..+++|||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            455688999999999999865 68899999986543   23467889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            999999988543  245788999999999999999999998   999999999999999999999999999876544322


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      .  .....+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||......        ........+...     
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~-----  219 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKIIRGVFP-----  219 (256)
T ss_pred             h--hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCC-----
Confidence            1  1234578899999998764  6778999999999999999999998754421        111111111111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ..+..++..+.+++.+||+.+|++||++.++++
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence             122245678999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.9e-41  Score=295.33  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=199.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ..+.+.+.||+|++|.||+|.+.      .+..+++|.+......  ...+..|+.+++.++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            34566789999999999999764      3567999988654332  346889999999999999999999999989999


Q ss_pred             EEEEccCCCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC---ceEEec
Q 044497          137 LVYEYMPNGSLDRHIFPKES---RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSD  210 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~---~~kl~D  210 (340)
                      ++|||+++++|.+++.....   ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++   .+||+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence            99999999999998854321   123589999999999999999999999   999999999999998654   589999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHH
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      ||+++................+..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        ...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--------~~~  232 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--------VME  232 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHH
Confidence            9999865332221111122235689999998764  68899999999999999997 998987543211        112


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .........      .+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       233 ~~~~~~~~~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 FVTGGGRLD------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            222211111      12234578899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-41  Score=311.60  Aligned_cols=257  Identities=19%  Similarity=0.217  Sum_probs=193.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      |.+.+.||+|+||.||+|... +++.||+|...     ...+.+|++++++++|+||+++++++...+..+++||++ .+
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~  244 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RS  244 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CC
Confidence            555678999999999999865 67889999632     234578999999999999999999999999999999999 56


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||+++..........
T Consensus       245 ~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        245 DLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            88887733   234689999999999999999999999   999999999999999999999999999976543322111


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc--ccc---
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL--ELR---  300 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---  300 (340)
                      .....||..|+|||++.+.  .++.++|||||||++|||++|..|+...............+...+......  ...   
T Consensus       319 ~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2234689999999999775  678899999999999999998866543322211111111122222111100  000   


Q ss_pred             --------------------ccc--hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          301 --------------------NVT--EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       301 --------------------~~~--~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                                          ...  ......+.++.+|+.+||+.||.+|||+.|+|+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                000  0001234578899999999999999999999863

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-41  Score=288.84  Aligned_cols=248  Identities=27%  Similarity=0.445  Sum_probs=198.2

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      ++||.|++|.||++...+++.+++|.+......  ...+.+|+++++.++||||+++++++...+..+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999998777899999998765443  357889999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeec
Q 044497          149 RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  228 (340)
Q Consensus       149 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  228 (340)
                      +++...   ...+++..+..++.+++.|++|||++   +++|+||+|+||+++.++.++|+|||.+..............
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            988432   34678899999999999999999999   999999999999999999999999999976543221111112


Q ss_pred             cccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       229 ~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...+..|+|||.+.+.  .++.++|+||||+++|+|+| |..||.......        ...........      ..+.
T Consensus       155 ~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------~~~~~~~~~~~------~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------TRERIESGYRM------PAPQ  218 (251)
T ss_pred             CcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------HHHHHhcCCCC------CCCc
Confidence            2345679999998764  67889999999999999999 788876543211        11112111111      1122


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=291.75  Aligned_cols=249  Identities=29%  Similarity=0.461  Sum_probs=203.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ..+++.+.||.|++|.||+|... ++.+|+|.+.......+++.+|+.+++.++|+|++++++++...+..+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            45567789999999999999875 78999999987665567899999999999999999999999989999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++....  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||.+........  
T Consensus        85 ~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          85 GSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            99999884322  23689999999999999999999999   999999999999999999999999999986533221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                         ....+..|+|||.+...  .++.++|+||||+++|+|++ |..||......        ............      
T Consensus       158 ---~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~------  218 (256)
T cd05039         158 ---SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPHVEKGYRM------  218 (256)
T ss_pred             ---cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCC------
Confidence               22356689999998654  67789999999999999997 99888644321        122222222111      


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..+...++.+.+++.+||+.+|++|||+.++++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            1122345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-41  Score=294.67  Aligned_cols=251  Identities=25%  Similarity=0.434  Sum_probs=197.2

Q ss_pred             hhcCCCCCeEEEEEEEcC-------CcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLHT-------GGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.||+|+||.||+|+..+       +..+++|.+....  .....+.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997542       2579999886543  2346788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-----ceEEecccC
Q 044497          142 MPNGSLDRHIFPKES---RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-----IPKVSDFGL  213 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-----~~kl~Dfg~  213 (340)
                      +++++|.+++.....   ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999854322   234578899999999999999999998   999999999999999877     899999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhh
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      +................++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~  227 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHVT  227 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHHh
Confidence            8755333222112223456789999998764  67889999999999999998 999986443211        111111


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      .+...      ..+...+..+.+++.+||+.+|.+|||++++++.|+.
T Consensus       228 ~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AGGRL------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCCcc------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11111      1223456788999999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-41  Score=297.37  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=200.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ..+++.+.||.|+||.||++...      ++..+|+|.+......  ...+.+|+.+++.++|||++++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            34566789999999999999753      4678999998754322  356889999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          137 LVYEYMPNGSLDRHIFPKE------------------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      ++|||+++++|.+++....                  .....+++..++.++.|++.||+|||++   +++||||+|+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence            9999999999998885321                  1123478889999999999999999999   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATR  277 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~  277 (340)
                      ++++++.++|+|||++.................+..|+|||.+.+.  .++.++|||||||++|+|++ |..||......
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999998754332221112223356679999988764  67889999999999999998 77787543221


Q ss_pred             ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                             . .......+....      .+...+.++.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       240 -------~-~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -------E-VIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -------H-HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                   1 112222222111      112345789999999999999999999999999973

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-41  Score=292.02  Aligned_cols=248  Identities=23%  Similarity=0.311  Sum_probs=200.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      |++.+.||.|+||.||++... +++.+|+|.+....  ...+.+.+|+.+++.++|||++++++.+...+..+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            456789999999999999865 78899999986432  234678899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...  .+..+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++++|||.+........ 
T Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          82 GGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            99999887432  345678999999999999999999999   999999999999999999999999999875543322 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                       ......+++.|+|||.+.+.  .++.++|+||||+++|+|++|..||......       .... ....+...      
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~-~~~~~~~~------  218 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWK-------NLIL-KVCQGSYK------  218 (255)
T ss_pred             -ccccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHH-------HHHH-HHhcCCCC------
Confidence             11234588899999998764  6788999999999999999999999753321       1111 11121111      


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      ..+...+..+.+++.+||+.||.+|||+.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1122345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.7e-41  Score=291.12  Aligned_cols=249  Identities=29%  Similarity=0.423  Sum_probs=197.7

Q ss_pred             hhcCCCCCeEEEEEEEcC--C--cEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLHT--G--GLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~--~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|++|.||+|.+.+  +  ..+|+|.+.....  ..+.+.+|+.++++++|||++++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  2  2689999987655  23678899999999999999999999988 889999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.....  ..+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999854332  5689999999999999999999999   99999999999999999999999999998664432211


Q ss_pred             -eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          225 -SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       225 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                       ......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......       ............     
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-----  220 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-------ILKKIDKEGERL-----  220 (257)
T ss_pred             ecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhcCCcC-----
Confidence             11233467899999998764  67889999999999999999 999986432211       111111111111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       ..+...+..+.+++.+||+.+|++|||+.++++.|..
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence             1112345789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-41  Score=305.32  Aligned_cols=257  Identities=21%  Similarity=0.234  Sum_probs=192.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCC------e
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  134 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~  134 (340)
                      ..|.+.+.||+|+||.||++... ++..+|+|++.....   ....+.+|+.+++.++||||+++++++...+      .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            45677789999999999999765 688999999865322   2356789999999999999999999986443      4


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .|++|||+++ +|.+.+.      ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         101 VYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            7999999954 5655551      3477889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc-----------cch
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK-----------AYF  283 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-----------~~~  283 (340)
                      .......   ......+|..|+|||.+.+.  .++.++|||||||++|+|++|+.||...+....-           ..+
T Consensus       171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         171 RTACTNF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             cccccCc---cCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            7543322   12334589999999999775  6788999999999999999999999755321100           000


Q ss_pred             ----hHHHHHHhhcCCCcc------------ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          284 ----PSWVYDQLNKGGDLE------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       284 ----~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          ...............            ...........++++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                000000000000000            00001111223567899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.2e-41  Score=290.51  Aligned_cols=248  Identities=29%  Similarity=0.459  Sum_probs=198.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEE-EcCCeeEEEEEccC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEYMP  143 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~  143 (340)
                      ..+.+.+.||+|+||.||++... +..+++|...... ..+.+.+|+.+++.++|+|++++++++ ...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            45667789999999999999765 7889999986543 346789999999999999999999975 45567899999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||++.......  
T Consensus        84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          84 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999884322  34588999999999999999999999   99999999999999999999999999987543322  


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                         ....++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+..+...     
T Consensus       157 ---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~-----  218 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKM-----  218 (256)
T ss_pred             ---CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCC-----
Confidence               122345689999998764  67889999999999999997 898886433211        11222222111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       .....+++.+.+++.+||+.+|++|||+.++++.|+.
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence             1122346788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.3e-41  Score=299.96  Aligned_cols=263  Identities=16%  Similarity=0.219  Sum_probs=194.0

Q ss_pred             hhhhcCCC--CCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           69 FTHKLGQG--GFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        69 ~~~~ig~G--~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      +.+.||+|  +|++||++... +++.||+|.+.......   +.+.+|+++++.++||||+++++++...+..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  68899999764 78899999987653322   45778999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++..+.  ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999884332  34588999999999999999999999   999999999999999999999999986543221111


Q ss_pred             c-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc-----chhH------H
Q 044497          223 F-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA-----YFPS------W  286 (340)
Q Consensus       223 ~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-----~~~~------~  286 (340)
                      .     .......++..|+|||.+.+....++.++|||||||++|+|++|+.||..........     ..+.      .
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            0     0012234677899999987643467889999999999999999999997533211000     0000      0


Q ss_pred             HHHHhh-----cCCCc---------------cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 VYDQLN-----KGGDL---------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 ~~~~~~-----~~~~~---------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+...     .+...               ............++.+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000000     00000               000001122345678999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.6e-41  Score=298.59  Aligned_cols=200  Identities=23%  Similarity=0.335  Sum_probs=161.1

Q ss_pred             hhhcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEc--CCeeEEEEEccCC
Q 044497           70 THKLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEYMPN  144 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~  144 (340)
                      .++||+|+||.||+|...   +++.+|+|.+..... ...+.+|+.+++.++||||+++++++..  ....+++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            368999999999999754   567899999876543 3467899999999999999999998854  456889999984 


Q ss_pred             CCcccccccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE----cCCCceEEecccCCc
Q 044497          145 GSLDRHIFPKE-----SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK  215 (340)
Q Consensus       145 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill----~~~~~~kl~Dfg~~~  215 (340)
                      ++|.+++....     .....+++..+..++.|++.||+|||++   +++||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            57777663221     1234589999999999999999999999   99999999999999    456789999999998


Q ss_pred             cCCCCCC-ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCc
Q 044497          216 FHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHA  275 (340)
Q Consensus       216 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~  275 (340)
                      ....... ........+|+.|+|||.+.+. ..++.++||||+||++|+|++|++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            6543321 1122345689999999998763 357889999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.7e-42  Score=309.68  Aligned_cols=259  Identities=22%  Similarity=0.304  Sum_probs=194.3

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCC-----eeEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALV  138 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv  138 (340)
                      .+.+.||+|+||.||++... +++.||+|.+.....   ....+.+|+++++.++||||+++++++...+     ..|++
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            45688999999999999864 789999999865322   2357889999999999999999999998776     78999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      +||+. ++|.+.+.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        83 ~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          83 TELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             eeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            99995 57877772    345689999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch---------hH----
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF---------PS----  285 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~---------~~----  285 (340)
                      .... .......++..|+|||.+.+. ..++.++||||+||++|||++|+.||...........+         ..    
T Consensus       155 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         155 PDES-KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cCcc-ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            3221 112334578899999998764 34678999999999999999999999765432100000         00    


Q ss_pred             --HHHHHhhc-CCCcc-ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 --WVYDQLNK-GGDLE-LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 --~~~~~~~~-~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        .....+.. ..... ...........++++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence              00000000 00000 00000111223578899999999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.2e-41  Score=293.65  Aligned_cols=262  Identities=22%  Similarity=0.347  Sum_probs=199.7

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE-----cCCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcC--Cee
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKR  135 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~  135 (340)
                      .++.+.+.||+|+||.||++..     .++..+|+|.+.....  ..+.+.+|+.+++.++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3456678999999999999973     3577899999875432  235788999999999999999999998765  568


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +++|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999988322   23588999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccc-------cccchhHHH
Q 044497          216 FHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS-------SKAYFPSWV  287 (340)
Q Consensus       216 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-------~~~~~~~~~  287 (340)
                      ......... ......++..|+|||.+.+.  .++.++||||||+++|+|++++.|........       .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            654433221 11234467789999998764  67889999999999999999876643321100       000001111


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ......+....      .+..++..+.+|+.+||+.+|++|||+.++++.|+.
T Consensus       236 ~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         236 VRVLEEGKRLP------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHHHcCccCC------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            12222221111      112346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.5e-42  Score=303.81  Aligned_cols=239  Identities=23%  Similarity=0.292  Sum_probs=190.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      +++.+.||+|+||.||+|... +++.||+|++....    ...+.+..|..++..+. |++++++++++...+..|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            456789999999999999865 78899999987532    22345778888888875 5788889999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||++......
T Consensus        82 y~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          82 YVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999998883    335689999999999999999999999   9999999999999999999999999998753222


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......||+.|+|||.+.+.  .++.++|+||+||++|+|++|+.||.......        ....+....     
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~~~~-----  217 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--------LFQSIMEHN-----  217 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-----
Confidence            21  12334589999999998764  67889999999999999999999997543211        111111111     


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                        ...+...+.++.+++.+||+.+|.+|++.
T Consensus       218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              11222345788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-41  Score=300.84  Aligned_cols=260  Identities=25%  Similarity=0.429  Sum_probs=202.8

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc--------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFC  129 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~  129 (340)
                      ++...++.+.+.||+|+||.||+|...        ++..+|+|.+......  .+++.+|+++++++ +||||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            445567788899999999999999642        1236899988754322  35788999999999 799999999999


Q ss_pred             EcCCeeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 044497          130 SEGSKRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (340)
Q Consensus       130 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~N  197 (340)
                      ...+..++++||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            999999999999999999998854321            223578899999999999999999999   99999999999


Q ss_pred             eeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcc
Q 044497          198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHAT  276 (340)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~  276 (340)
                      |+++.++.++|+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999765443222222223345689999998764  67889999999999999998 8888764332


Q ss_pred             cccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .       . ....+........      +...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       243 ~-------~-~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         243 E-------E-LFKLLKEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             H-------H-HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence            1       1 2222222221111      1233467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-41  Score=294.61  Aligned_cols=256  Identities=25%  Similarity=0.317  Sum_probs=202.0

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ....+++.+.||+|+||+||++... +++.+|+|++.....  ..+.+.+|+++++.++|||++++++.+...+..++||
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            3456778899999999999999865 688999998765432  2467889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      ||+++++|.+++.    ....+++..+..++.+++.||.|||+ .   +++|+||+|+||++++++.++|+|||++....
T Consensus        83 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          83 EFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             ecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999998873    23468999999999999999999996 5   89999999999999999999999999986442


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc----chhHHHHHHhhcC
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA----YFPSWVYDQLNKG  294 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~~  294 (340)
                      ...    .....++..|+|||.+.+.  .++.++|+|||||++|+|++|+.||..........    ....+........
T Consensus       156 ~~~----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd06620         156 NSI----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP  229 (284)
T ss_pred             hhc----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence            221    1234588999999998764  77889999999999999999999998654321111    1112222211111


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                       ...+.     ....+.++.+++.+||+.||.+|||+.|+++.
T Consensus       230 -~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         230 -PPRLP-----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             -CCCCC-----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             11110     11255678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-41  Score=297.88  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=197.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |+..+.||+|+||.||++... +++.+|+|.+......    ...+..|+.+++.++|+|++++++.+...+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            455678999999999999765 7889999998654322    24567899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999887432  234588999999999999999999998   99999999999999999999999999987544332


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   .....|+..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||..........    ......... .     
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~----~~~~~~~~~-~-----  221 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVKEV-Q-----  221 (285)
T ss_pred             c---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH----HHHhhhhhh-h-----
Confidence            2   1234589999999999764  67889999999999999999999997543211100    011111100 0     


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                       ......+++++.+|+.+||+.||.+|||     ++|+++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             1112234577899999999999999999     888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.3e-42  Score=304.58  Aligned_cols=236  Identities=25%  Similarity=0.339  Sum_probs=185.8

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHH-HhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.+|+|++.....    ....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999875 678999999865321    2234455544 67888999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|...+.    ....+++..+..++.|+++||+|||++   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (321)
T cd05603          81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--  151 (321)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence            99988773    345688899999999999999999999   999999999999999999999999999875322211  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||...+..       . ....+....       ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~-~~~~i~~~~-------~~  214 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------Q-MYDNILHKP-------LQ  214 (321)
T ss_pred             ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHH-------H-HHHHHhcCC-------CC
Confidence            12344689999999998764  6788999999999999999999999754321       1 111111111       11


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMT  332 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~  332 (340)
                      .+...+..+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1223346788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.3e-42  Score=306.90  Aligned_cols=237  Identities=25%  Similarity=0.279  Sum_probs=187.2

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHH-HhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... +++.+|+|++....    .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999865 78899999986532    12234555554 46778999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|..++.    ....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++........  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  151 (325)
T cd05604          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--  151 (325)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence            99988873    345789999999999999999999999   999999999999999999999999999874322211  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......       ...........        .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~~~~--------~  214 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILHKPL--------V  214 (325)
T ss_pred             CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHcCCc--------c
Confidence            12344689999999999765  6788999999999999999999999754321       11111111110        1


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTK  333 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~e  333 (340)
                      ..+..+..+.+++.+|++.+|.+||++++
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            11124567889999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.1e-41  Score=291.81  Aligned_cols=254  Identities=28%  Similarity=0.458  Sum_probs=199.7

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCc---EEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGG---LIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~---~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..++..+.||+|+||.||+|... +++   .+++|.+.....  ..+.+..|+++++.++|||++++.+++...+..+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            44566789999999999999864 333   799999876432  235788999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++..   ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++|+|||++....
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999998843   234688999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCceee-eccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          219 KENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       219 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ........ .....+..|+|||.+...  .++.++||||||+++|+|++ |+.||......       . ....+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~-~~~~i~~~~~  228 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------E-VMKAINDGFR  228 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------H-HHHHHhcCCC
Confidence            33221111 112234579999998764  67889999999999999997 99998654321       1 2222222211


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..      .....+..+.+++.+||+.+|++||++.++++.|++
T Consensus       229 ~~------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         229 LP------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             CC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            11      111345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-41  Score=293.15  Aligned_cols=253  Identities=27%  Similarity=0.467  Sum_probs=198.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CC---cEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TG---GLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..+.+.+.||+|+||.||+|... ++   ..||+|.+.....  ...++..|+.+++.++||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34667889999999999999865 23   3699999875422  235789999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999988432   34688999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCceeeecc---ccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          219 KENDFVSISAT---RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       219 ~~~~~~~~~~~---~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ...........   ..+..|+|||.+.+.  .++.++||||||+++|||++ |..||.......        ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------~~~~i~~~  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAIEQD  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcC
Confidence            33221111111   124579999998764  67889999999999999886 999986543211        11111111


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...      ..+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus       228 ~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         228 YRL------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             CcC------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111      111234567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-41  Score=301.45  Aligned_cols=258  Identities=28%  Similarity=0.435  Sum_probs=198.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE------cCCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEc-CC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSE-GS  133 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~  133 (340)
                      ..+|.+.+.||+|+||.||+|.+      .+++.||+|+++.....  ...+.+|+.++..+ +||||+++++++.. ..
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45677889999999999999963      35678999999764332  24678999999999 68999999998754 45


Q ss_pred             eeEEEEEccCCCCcccccccCCC---------------------------------------------------------
Q 044497          134 KRALVYEYMPNGSLDRHIFPKES---------------------------------------------------------  156 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  156 (340)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999988754211                                                         


Q ss_pred             ------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccc
Q 044497          157 ------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR  230 (340)
Q Consensus       157 ------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  230 (340)
                            ....+++..+..++.|+++||+|||++   +++||||||+||++++++.++|+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  012467888899999999999999999   99999999999999999999999999987653332222222234


Q ss_pred             cCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHH
Q 044497          231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI  309 (340)
Q Consensus       231 g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (340)
                      ++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......       .........+......      ...
T Consensus       243 ~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~------~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAP------DYT  307 (343)
T ss_pred             CCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCC------CCC
Confidence            56789999998764  67889999999999999997 88888653321       1112222222221111      123


Q ss_pred             HHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       310 ~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ++++.+++.+||+.+|++|||+.++++.|+
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~  337 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLG  337 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-41  Score=295.99  Aligned_cols=262  Identities=23%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||+|++|.||+|... ++..+|+|.+.....   ..+.+.+|+.+++.++|||++++++++.+++..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            456688999999999999865 788999999865322   2357889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      + ++|.+++.... .+..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          82 S-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             C-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            6 68887774322 235689999999999999999999999   999999999999999999999999999875432221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH-------HHHH------
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS-------WVYD------  289 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-------~~~~------  289 (340)
                        ......+++.|+|||.+.+. ..++.++||||||+++|+|+||+.||..............       ..+.      
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              11233468899999988653 3567899999999999999999999875432110000000       0000      


Q ss_pred             Hhhc-CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .... ...............++.++.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000 0000000000111235678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=289.57  Aligned_cols=249  Identities=25%  Similarity=0.308  Sum_probs=198.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      +...+.||+|++|.||+|... +++.+++|.+......      .+.+.+|+++++.++||||+++++++...+..++++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            456789999999999999764 6889999998654321      246788999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        84 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          84 EYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999999883    234678899999999999999999999   999999999999999999999999999875433


Q ss_pred             CCCcee-eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ...... .....++..|+|||.+.+.  .++.++||||+|+++|+|++|+.||......       ............  
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~--  225 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTN--  225 (263)
T ss_pred             cccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCC--
Confidence            221111 1233477899999999875  5788999999999999999999998653221       111111111111  


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                          ...+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 ----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                12233456788999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.7e-41  Score=288.80  Aligned_cols=240  Identities=23%  Similarity=0.339  Sum_probs=186.4

Q ss_pred             hhcCCCCCeEEEEEEEcC-------------CcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           71 HKLGQGGFGSVYKGQLHT-------------GGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~-------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      +.||+|+||.||+|+..+             ...+++|.+...... ...+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997532             225888987654433 246788999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc-------eEEe
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-------PKVS  209 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~-------~kl~  209 (340)
                      ++|||+++++|..++..   ....+++..+..++.|+++||+|||++   +++||||||+||+++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999888732   234689999999999999999999999   9999999999999986654       8999


Q ss_pred             cccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHH-cCCCCCCCCcccccccchhHHHH
Q 044497          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMHATRSSKAYFPSWVY  288 (340)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~  288 (340)
                      |||++......      ....++..|+|||.+... ..++.++||||||+++|+|+ +|..|+......+        ..
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~  219 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KE  219 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HH
Confidence            99998654322      223477889999988642 36788999999999999998 5777775432211        00


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      . ..... ....      ...+.++.+|+.+||+.||.+||++.++++.|+
T Consensus       220 ~-~~~~~-~~~~------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 R-FYEGQ-CMLV------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             H-HHhcC-ccCC------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1 11110 0000      112357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-41  Score=298.59  Aligned_cols=253  Identities=26%  Similarity=0.442  Sum_probs=195.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCc--EEEEEEccCCCC--ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGG--LIAVKMLANSKF--SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..+.+.+.||+|+||.||+|.+. ++.  .+++|.++....  ....+.+|++++.++ +|||++++++++...+..+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            34567789999999999999865 444  457777654322  235688899999999 899999999999999999999


Q ss_pred             EEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCce
Q 044497          139 YEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP  206 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~  206 (340)
                      |||+++++|.+++.....            ....+++..+..++.|++.|++|||++   +++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999998854321            224688999999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhH
Q 044497          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPS  285 (340)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~  285 (340)
                      +|+|||++.......   ......++..|+|||.+.+.  .++.++||||||+++|+|+| |..||......+       
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------  231 (303)
T cd05088         164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------  231 (303)
T ss_pred             EeCccccCcccchhh---hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH-------
Confidence            999999986322111   11112245679999988664  67889999999999999998 999986433211       


Q ss_pred             HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          286 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                       .......+....      .+...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       232 -~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         232 -LYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             -HHHHHhcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             111121111111      11123567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.7e-41  Score=290.52  Aligned_cols=255  Identities=22%  Similarity=0.335  Sum_probs=189.1

Q ss_pred             hcCCCCCeEEEEEEEcCCc---EEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           72 KLGQGGFGSVYKGQLHTGG---LIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~~~---~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      .||+|+||.||+|...++.   .+++|.+.....  ..+.+.+|+..++.++|||++++++.+......+++|||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            6899999999999754333   456776654332  34678999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceee
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  226 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (340)
                      |.+++..........++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999865433344567788889999999999999998   9999999999999999999999999998643222111112


Q ss_pred             eccccCccccccccccccc-----cccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          227 SATRGTIGYIAPELISRNF-----GTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       227 ~~~~g~~~y~aPE~~~~~~-----~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ....++..|+|||++....     ..++.++||||||+++|||++ |..||.....       ............ ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~~~-~~~~  230 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKDQQ-VKLF  230 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhhcc-cccC
Confidence            3345788999999875321     235678999999999999997 4667654322       111222222211 1111


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      . .......+..+.+++..|| .+|.+|||++++++.|.
T Consensus       231 ~-~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 K-PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             C-CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1 1111224567888999999 67999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.4e-41  Score=290.42  Aligned_cols=252  Identities=22%  Similarity=0.274  Sum_probs=197.8

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ..|.+.+.||+|+||.||+|... +++.+|+|.++.... ....+.+|+.+++.++|||++++++.+...+..+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45677889999999999999765 688999999875433 2356788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++.    ....+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        89 ~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          89 GGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            9999999883    334688999999999999999999999   999999999999999999999999999875433221


Q ss_pred             ceeeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC-cccc
Q 044497          223 FVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD-LELR  300 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  300 (340)
                        ......|+..|+|||.+.. ....++.++|+|||||++|+|++|..||........       .......... ....
T Consensus       162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~  232 (267)
T cd06645         162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMTKSNFQPPKLK  232 (267)
T ss_pred             --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HHhhhccCCCCCccc
Confidence              1233458899999998742 123577899999999999999999999865432110       0010001000 0011


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .    ...++..+.+++.+||+.+|++|||++++++
T Consensus       233 ~----~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 D----KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c----cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            1    1123467889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.7e-41  Score=293.51  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=197.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcC------CeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEG------SKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~l  137 (340)
                      .|++.+.||+|+||.||+|... +++.+|+|.+.........+..|+.++..+ +|||++++++++...      ...++
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            4566788999999999999765 688999999987666667889999999998 799999999998653      45889


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +|||+++++|.+++...  ....+++..+..++.|++.|++|||++   +++|+||+|+||++++++.++|+|||++...
T Consensus        87 v~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          87 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             EEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999988432  235688999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      .....  ......|+..|+|||.+.+.   ...++.++|+|||||++|+|++|+.||.......      .  .......
T Consensus       162 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~--~~~~~~~  231 (272)
T cd06637         162 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------A--LFLIPRN  231 (272)
T ss_pred             ccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------H--HHHHhcC
Confidence            33221  12334588999999998532   1357789999999999999999999986433211      0  0011111


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....     ......+.++.+|+.+||+.+|.+|||+.++++
T Consensus       232 ~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 PAPR-----LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCC-----CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1000     111234567899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4e-41  Score=296.26  Aligned_cols=251  Identities=25%  Similarity=0.433  Sum_probs=194.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCc--EEEEEEccCCCC--ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGG--LIAVKMLANSKF--SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      +.+.+.||+|+||.||+|... ++.  .+++|.++....  ..+.+.+|++++.++ +||||+++++++...+..++++|
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            456789999999999999865 332  478888764322  235688999999999 79999999999999999999999


Q ss_pred             ccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          141 YMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                      |+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence            9999999998854221            123588999999999999999999998   9999999999999999999999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHH
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  287 (340)
                      +|||++......   ........+..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        .
T Consensus       161 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~  227 (297)
T cd05089         161 ADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------L  227 (297)
T ss_pred             CCcCCCccccce---eccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------H
Confidence            999998632211   111112235579999998764  67889999999999999997 999986543211        1


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......+....      .+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       228 ~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         228 YEKLPQGYRME------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS  273 (297)
T ss_pred             HHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11222211111      12234578899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=289.63  Aligned_cols=247  Identities=26%  Similarity=0.450  Sum_probs=192.0

Q ss_pred             hhcCCCCCeEEEEEEEc-CCc--EEEEEEccCCCC--ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGG--LIAVKMLANSKF--SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|... ++.  .+++|.++....  ..+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999875 333  468888875322  335788999999999 899999999999999999999999999


Q ss_pred             CCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          145 GSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       145 ~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      ++|.+++.....            ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++|+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999998854321            123578999999999999999999998   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      ++.......   .......+..|+|||.+...  .++.++|+||||+++|+|++ |..||......       . .....
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~-~~~~~  224 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------E-LYEKL  224 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------H-HHHHH
Confidence            985322111   11112245679999998664  67889999999999999997 99998643321       1 11222


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..+.....      +...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       225 ~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         225 PQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             hCCCCCCC------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            22111111      1224467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.9e-41  Score=294.52  Aligned_cols=247  Identities=25%  Similarity=0.350  Sum_probs=198.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      +|.+.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+.+++.++|||++++++.+......++||||++
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~  100 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence            4556688999999999999864 788999999876443 34678899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++.     ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........ 
T Consensus       101 ~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            999999883     23578899999999999999999999   999999999999999999999999999875433221 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                       ......+++.|+|||.+.+.  ..+.++|||||||++|+|++|+.||.......       ......... ....    
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~~~----  236 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNG-TPEL----  236 (296)
T ss_pred             -ccCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHhcCC-CCCC----
Confidence             11233588899999998764  66789999999999999999999996543211       111111111 1111    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            112345577899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.7e-41  Score=290.77  Aligned_cols=253  Identities=28%  Similarity=0.462  Sum_probs=199.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-C---CcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-T---GGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..+++.+.||+|+||.||+|... +   +..+|+|.++.....  .+.+.+|+.+++.++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45667789999999999999754 2   337999998754332  35788999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999998432   34678999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          219 KENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       219 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ...... ......++..|+|||.+.+.  .++.++|+||||+++|++++ |..||.......        ....+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYR  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCc
Confidence            432211 11112235689999999764  67889999999999999886 999986543221        1112222211


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      .....+..+.+++.+|++.+|.+|||+.++++.|+
T Consensus       228 ~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         228 LP------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             CC------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence            11      11234567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-41  Score=286.27  Aligned_cols=255  Identities=22%  Similarity=0.268  Sum_probs=204.6

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      .+.-...++.+.||+|.-|+||++... ++..+|+|++.+....    ..+...|-++|..++||.++.+++.|+.....
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            333445566789999999999999876 5689999999775433    24677899999999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |++||||+||+|+...+  .+.+..++++.++-++..++.||+|||-.   |||+|||||+|||+.++|++-|+||.++.
T Consensus       153 cl~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EEEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence            99999999999998874  34567899999999999999999999999   99999999999999999999999999874


Q ss_pred             cCCC---------------------------------CCC---------------------ceeeeccccCccccccccc
Q 044497          216 FHPK---------------------------------END---------------------FVSISATRGTIGYIAPELI  241 (340)
Q Consensus       216 ~~~~---------------------------------~~~---------------------~~~~~~~~g~~~y~aPE~~  241 (340)
                      ....                                 ...                     .......+||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            2210                                 000                     0011233599999999999


Q ss_pred             cccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcc
Q 044497          242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCI  321 (340)
Q Consensus       242 ~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  321 (340)
                      .+.  ..+..+|.|+||+++|||+.|.-||......+.       +.+.+..  ...+.+..    ..+..+++||++.|
T Consensus       308 ~G~--GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------l~NIv~~--~l~Fp~~~----~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  308 RGE--GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------LRNIVGQ--PLKFPEEP----EVSSAAKDLIRKLL  372 (459)
T ss_pred             ecC--CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------HHHHhcC--CCcCCCCC----cchhHHHHHHHHHh
Confidence            987  788899999999999999999999987765431       2222222  11222211    56688999999999


Q ss_pred             cCCCCCCCC----HHHHH
Q 044497          322 QVKAADRPS----MTKVL  335 (340)
Q Consensus       322 ~~~p~~Rps----~~evl  335 (340)
                      ..||++|..    +.||-
T Consensus       373 vKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             ccChhhhhccccchHHhh
Confidence            999999987    66664

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=307.84  Aligned_cols=260  Identities=30%  Similarity=0.416  Sum_probs=220.2

Q ss_pred             CHHHHHHHHhhhhhhcCCCCCeEEEEEEEcC-CcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           58 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLHT-GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      .-.|+......+..+||.|.||.||.|.|+. .-.||||.++.+....++|+.|+.+|+.++|||+|+++|+|+.+-..|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            3446666666677899999999999999874 457999999999888999999999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ||.|||..|+|.+|+...  .....+.-.++.++.||..|++||..+   ++|||||..+|+|+.++-.+|++|||++++
T Consensus       340 IiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999543  234567778899999999999999999   999999999999999999999999999998


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      +..+.. .......-+..|.|||.+.-+  .++.|+|||+|||+|||+.| |-.||..-+..        .++..+..+.
T Consensus       415 MtgDTY-TAHAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------qVY~LLEkgy  483 (1157)
T KOG4278|consen  415 MTGDTY-TAHAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYGLLEKGY  483 (1157)
T ss_pred             hcCCce-ecccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------HHHHHHhccc
Confidence            765433 222333457799999998765  78899999999999999998 88888765532        2566666665


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      +.+-.      ..+++.+.+|++.||+.+|.+||++.|+-+.+|
T Consensus       484 RM~~P------eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  484 RMDGP------EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             cccCC------CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            54433      346688999999999999999999999988876

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-41  Score=296.55  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=190.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhccc---CCCceeeEeeEEEc-----CCe
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRI---HHVNVVQLLGFCSE-----GSK  134 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~  134 (340)
                      |.+.+.||+|+||.||+|... +++.+|+|.+.....   ......+|+.+++.+   +||||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            556789999999999999765 788999999875322   223566777777665   79999999998754     345


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .+++||+++ ++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            789999996 5888877432  234589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ........   .....+|..|+|||.+.+.  .++.++||||+||++|+|++|++||........   +.. ........
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~-~~~~~~~~  226 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGK-IFDLIGLP  226 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHH-HHHHhCCC
Confidence            76543221   1234578899999998764  678899999999999999999999865432110   000 00000000


Q ss_pred             -------------CC---ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 -------------GD---LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 -------------~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                   ..   ..........+.++..+.+++.+||+.||++|||+.|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                         00   0000001222345677899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.5e-41  Score=293.28  Aligned_cols=255  Identities=23%  Similarity=0.314  Sum_probs=198.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEE-----cCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv  138 (340)
                      +|++.+.||+|+||.||++... +++.+|+|++.........+.+|+.+++.+ +|||++++++++.     .++..+++
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            4556689999999999999765 678999999876555556788999999999 6999999999873     44568999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++.........+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            999999999988754333456788999999999999999999998   99999999999999999999999999987554


Q ss_pred             CCCCceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          219 KENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ....  ......|+..|+|||.+...   ...++.++||||+||++|+|++|+.|+.......      . .. ......
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~-~~-~~~~~~  245 (286)
T cd06638         176 STRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------A-LF-KIPRNP  245 (286)
T ss_pred             cCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------H-Hh-hccccC
Confidence            3221  12234588999999987532   1356789999999999999999999986543211      0 00 011111


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      .....    .+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         246 PPTLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCccc----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11111    111234678999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.7e-41  Score=289.33  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      .|++.+.||+|++|.||+|... ++..+++|.+..... .+++.+|+++++.++|||++++++.+......++++||+++
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            4567789999999999999876 478999999876543 67899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++..   ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++........  
T Consensus        83 ~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          83 GSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            999998832   245789999999999999999999999   999999999999999999999999999886544321  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++|+.||........       .. .......    ....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~-~~~~~~~----~~~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IF-MIPNKPP----PTLS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hh-hhccCCC----CCCC
Confidence            12234478899999998765  678899999999999999999999875433210       00 0000000    0111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+..++.++.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            23345678999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-40  Score=291.76  Aligned_cols=260  Identities=28%  Similarity=0.433  Sum_probs=196.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-----cCCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEc--CCeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l  137 (340)
                      .+.+.+.||+|+||.||++..     .++..+|+|.+...... .+.+.+|+++++.++|||++++++++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            455678999999999999963     35779999998754432 3578899999999999999999998743  346889


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||++...
T Consensus        85 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          85 VMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999998432   34588999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCceee-eccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc--------cchhHHHH
Q 044497          218 PKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK--------AYFPSWVY  288 (340)
Q Consensus       218 ~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~  288 (340)
                      ......... ....++..|+|||.+.+.  .++.++|+||||+++|||++|..|+.........        ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            443322111 112244569999998764  6788999999999999999987765433211000        00001111


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      +.........      .+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       237 ~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05081         237 ELLKNNGRLP------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE  281 (284)
T ss_pred             HHHhcCCcCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            1122211111      11234568999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-41  Score=303.53  Aligned_cols=257  Identities=20%  Similarity=0.248  Sum_probs=191.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcC------Ce
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  134 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~  134 (340)
                      .+|.+.+.||+|+||.||+|... +++.||+|++.....   ....+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            35666789999999999999764 778999999875432   235677899999999999999999987543      34


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .+++++++ +++|.+++.     ...+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++
T Consensus        95 ~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             EEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence            68999988 788988772     34689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch--------hHH
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF--------PSW  286 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------~~~  286 (340)
                      .......     ....+|..|+|||.+.+. ..++.++|||||||++|+|++|+.||........-..+        ...
T Consensus       166 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         166 RQADDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             eecCCCc-----CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            8654321     334589999999998753 35788999999999999999999999754321100000        000


Q ss_pred             HH--------HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 VY--------DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..        .....-...............++.+.+|+.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00        000000000000000011123456789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-40  Score=287.34  Aligned_cols=240  Identities=24%  Similarity=0.373  Sum_probs=189.7

Q ss_pred             hhcCCCCCeEEEEEEEcCCc-----------EEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           71 HKLGQGGFGSVYKGQLHTGG-----------LIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      +.||+|+||.||+|......           .+++|.+.........+.+|+.+++.++|||++++++++.. ...+++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999876332           57888877655446788999999999999999999999987 7789999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-------ceEEeccc
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-------IPKVSDFG  212 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-------~~kl~Dfg  212 (340)
                      ||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++       .++|+|||
T Consensus        80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999988432   22688999999999999999999998   999999999999999887       79999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      ++......      ....++..|+|||.+.+....++.++|+||||+++|+|++ |..|+.......        .....
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--------~~~~~  219 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------KERFY  219 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--------HHHHH
Confidence            98754431      2234677899999987643467889999999999999999 466665543211        00111


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .........        ....+.+++.+||..+|.+|||+.++++.|+
T Consensus       220 ~~~~~~~~~--------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 QDQHRLPMP--------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hcCCCCCCC--------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111111100        1167889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.1e-41  Score=297.60  Aligned_cols=253  Identities=22%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      |++.+.||+|+||.||++... ++..+|+|.+.....  ...++.+|++++++++||||+++++.+...+..+++|||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            456789999999999999765 677899998865422  22568899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      +++|.+++..    ...+++..+..++.|+++||+|||+ .   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        83 ~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          83 GGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999832    3568899999999999999999997 5   89999999999999999999999999986543221 


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHH----------------
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----------------  286 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~----------------  286 (340)
                         .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||...........+...                
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             ---cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence               1334588999999998764  6788999999999999999999998644321110000000                


Q ss_pred             ------------HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          287 ------------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       287 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                                  ...........     .......+.++.+++.+||+.+|++|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPP-----KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCc-----cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        00000000000     00001245679999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-40  Score=292.08  Aligned_cols=258  Identities=26%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEc--CCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~  141 (340)
                      +...+.||.|++|.||++... +++.+|+|.+.....  ....+.+|+++++.++||||+++++++.+  .+..+++|||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            445678999999999999875 688999999876443  33678999999999999999999998854  3468999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999988754334456788999999999999999999999   99999999999999999999999999987543322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .    ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.........  ..+ ...............
T Consensus       160 ~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~  230 (287)
T cd06621         160 A----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG--PIE-LLSYIVNMPNPELKD  230 (287)
T ss_pred             c----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC--hHH-HHHHHhcCCchhhcc
Confidence            1    223478899999998764  6788999999999999999999999865331100  011 112222211111111


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ........++.+.+++.+||+.+|.+|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11111224578899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=290.40  Aligned_cols=253  Identities=26%  Similarity=0.424  Sum_probs=199.7

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCc----EEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ...+++.+.||+|+||.||+|.+. +++    .+|+|........  ...+.+|+.+++.++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            345667789999999999999754 333    5899988765432  3578899999999999999999999987 7889


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.++.
T Consensus        85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999998432   34589999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ..............++..|+|||.+...  .++.++|+||||+++||+++ |+.||......+        +...+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~  228 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------IPDLLEKGE  228 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhCCC
Confidence            6544332222223346789999988654  67889999999999999998 999986543211        222222222


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....      +...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       229 ~~~~------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         229 RLPQ------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFS  266 (279)
T ss_pred             CCCC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            1111      1123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=311.91  Aligned_cols=308  Identities=25%  Similarity=0.403  Sum_probs=231.0

Q ss_pred             ehhhHHHHHHHHHHHHHHHHH-HHHHhhccchhhhHHHhhhcc-CC---CCCCCC--HHH---HHHHHhhhhhhcCCCCC
Q 044497            9 VDVPIIGRFILAPIVFLVFLI-QRYRKSLKRVDNVEKFLHNQQ-SW---MPKRYS--YPE---IIAVTNHFTHKLGQGGF   78 (340)
Q Consensus         9 i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~--~~~---~~~~~~~~~~~ig~G~~   78 (340)
                      .+++++|+++++.++++.+.. .++|.+..++....++++... ..   .|..+-  ...   +++....-.++||+|+|
T Consensus       630 ~~~~viG~~Ll~~~~~~~~~~~~~~r~q~~~k~~~rr~lq~~~el~eplapS~~~~n~~~lrI~kEtelkk~kvLGsgAf  709 (1177)
T KOG1025|consen  630 TAIAVIGGLLLAFFVFLGFSLYMCRRMQIIIKRTMRRLLQLERELVEPLAPSGFAANLALLRILKETELKKDKVLGSGAF  709 (1177)
T ss_pred             hHHHHHHHHHHHHHHHHHHHHhhhhhHHhHhHHHHHHHHHhcccccCccccccccchhhheeechhhhhhhhceeccccc
Confidence            445566666666555444443 333334444444455544431 11   111111  110   11112223479999999


Q ss_pred             eEEEEEEEc-CCc----EEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCccccc
Q 044497           79 GSVYKGQLH-TGG----LIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI  151 (340)
Q Consensus        79 g~v~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  151 (340)
                      |+||+|.+- .++    +||+|++......  ..++.+|+.+|..+.|||+++++++|.... +.+|++|++.|+|.+++
T Consensus       710 GtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyv  788 (1177)
T KOG1025|consen  710 GTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYV  788 (1177)
T ss_pred             eeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHH
Confidence            999999653 333    7999998764433  578999999999999999999999998765 88999999999999999


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeecccc
Q 044497          152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG  231 (340)
Q Consensus       152 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  231 (340)
                      ..+   +..+..+..+.|..||++|+.|||++   .++||||.++|||+.+-..+|+.|||+++................
T Consensus       789 r~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~  862 (1177)
T KOG1025|consen  789 REH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKV  862 (1177)
T ss_pred             HHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccccccccc
Confidence            653   45788899999999999999999999   999999999999999999999999999998877666555555566


Q ss_pred             CccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHH
Q 044497          232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIA  310 (340)
Q Consensus       232 ~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (340)
                      .+.|+|-|.+...  .++.++|||||||++||++| |..|+......+        +.+.++.+.+      -..++.++
T Consensus       863 pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~geR------LsqPpiCt  926 (1177)
T KOG1025|consen  863 PIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGER------LSQPPICT  926 (1177)
T ss_pred             CcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhcccc------CCCCCCcc
Confidence            7899999999765  88999999999999999999 899988766543        3334444433      23345667


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          311 RKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       311 ~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .++..++.+||..|+..||+++++...+.
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~~fs  955 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAEEFS  955 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence            88999999999999999999999987653

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-41  Score=304.34  Aligned_cols=257  Identities=21%  Similarity=0.219  Sum_probs=192.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcC------Ce
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  134 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~  134 (340)
                      ..|.+.+.||+|+||.||++... +++.+|+|.+......   ...+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            45666789999999999999765 6889999998754322   35678899999999999999999988543      35


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .+++|||+++ ++.+.+.      ..+++..+..++.|+++||+|||++   +++||||||+||++++++.+||+|||++
T Consensus        97 ~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             eEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence            7999999954 6666652      3478889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc--------chhH-
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA--------YFPS-  285 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--------~~~~-  285 (340)
                      +......   ......+|..|+|||.+.+.  .++.++|||||||++|+|++|+.||..........        ..+. 
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         167 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccCCCcc---ccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            7543322   12334689999999999765  67889999999999999999999997543211000        0000 


Q ss_pred             ------HHHHHhhcCCCc---c---------ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 ------WVYDQLNKGGDL---E---------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 ------~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            ............   .         ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                  000000000000   0         00001112223567899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-41  Score=295.81  Aligned_cols=249  Identities=26%  Similarity=0.330  Sum_probs=196.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ++..+.||+|+||+||++... +++.+|+|.+......    ...+.+|+++++.++|+|++++.+.+...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            445578999999999999765 7889999998654322    23577899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999998887432  234689999999999999999999999   99999999999999999999999999987543322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||........    ............      
T Consensus       157 ~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~------  221 (285)
T cd05632         157 S---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETE------  221 (285)
T ss_pred             c---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccc------
Confidence            1   1234589999999999764  678899999999999999999999975432110    011111111111      


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                       .......+..+.+|+.+||+.||++|||     +.+++.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             1122234567889999999999999999     666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=312.49  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=204.7

Q ss_pred             hcCCCCCeEEEEEEEc-CCcEEEEEEccC-CCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCccc
Q 044497           72 KLGQGGFGSVYKGQLH-TGGLIAVKMLAN-SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR  149 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~-~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  149 (340)
                      +||+|.||+||.|++. +...+|||.+.. +....+.+.+|+.+-++++|.|||+.+|.+..++..-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999865 566799998854 33345678999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-CCCceEEecccCCccCCCCCCceee
Q 044497          150 HIFPKESRGQSF--CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSI  226 (340)
Q Consensus       150 ~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (340)
                      ++....   +++  .+.++--+..||++||+|||++   .|||||||-+|+|++ -.|.+||+|||-++....-+.  ..
T Consensus       662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T  733 (1226)
T KOG4279|consen  662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT  733 (1226)
T ss_pred             HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence            995433   445  7889999999999999999999   999999999999996 578999999999987654432  23


Q ss_pred             eccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhh
Q 044497          227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE  306 (340)
Q Consensus       227 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (340)
                      .++.||..|||||++......|+..+|||||||++.||.||++||-.......         ..+.-|..   ....+++
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------AMFkVGmy---KvHP~iP  801 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------AMFKVGMY---KVHPPIP  801 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------hhhhhcce---ecCCCCc
Confidence            56679999999999987767899999999999999999999999976544321         11222211   1124567


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          307 SMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       307 ~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..++.+++.++.+|+.++|.+|||++++|+
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            788999999999999999999999999985

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-41  Score=299.04  Aligned_cols=261  Identities=23%  Similarity=0.336  Sum_probs=196.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|.+.+.||.|+||.||+|... +++.||+|.+.....  ....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            4566789999999999999865 678999999865332  3356788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      + ++|.+++..   ....+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        87 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          87 D-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             c-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            6 588887743   234678999999999999999999999   999999999999999999999999999875433221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHh-hcC
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQL-NKG  294 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~-~~~  294 (340)
                        ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+.       ...+... ...
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             --cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence              11233478899999988653 356789999999999999999999997654321000000       0000000 000


Q ss_pred             C--Cccccc-----cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 G--DLELRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~--~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .  ......     ........++.+.+|+.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0  000000     00111234678899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.6e-41  Score=324.07  Aligned_cols=257  Identities=23%  Similarity=0.306  Sum_probs=196.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|.+. +++.||+|++......    .+++.+|+++++.++|||++++++++.+.+..+++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            3566789999999999999865 6889999998754322    3568899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          141 YMPNGSLDRHIFPKES-------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      |+++++|.+++.....       .....++..+..++.|+++||+|||++   +++||||||+||+++.++.++|+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence            9999999988753211       123456778899999999999999999   999999999999999999999999999


Q ss_pred             CccCCCCCC----------------ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccc
Q 044497          214 AKFHPKEND----------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATR  277 (340)
Q Consensus       214 ~~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~  277 (340)
                      +........                ........||+.|+|||.+.+.  .++.++|||||||++|||+||+.||......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            976521110                0001123589999999998775  6788999999999999999999999753321


Q ss_pred             ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhc
Q 044497          278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLE  339 (340)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~evl~~L~  339 (340)
                      ...      ........  ...    .....+++.+.+++.+||+.||++|| +++++++.|+
T Consensus       238 ki~------~~~~i~~P--~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        238 KIS------YRDVILSP--IEV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             hhh------hhhhccCh--hhc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            100      00000000  000    01123457788999999999999996 5566666553

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=293.23  Aligned_cols=262  Identities=26%  Similarity=0.373  Sum_probs=195.9

Q ss_pred             hhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcc--cCCCceeeEeeEEEcCC----eeEEEEEc
Q 044497           68 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGR--IHHVNVVQLLGFCSEGS----KRALVYEY  141 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~  141 (340)
                      ++.+.||+|+||.||+|.++ ++.||||++...  +.+.+.+|-+++..  ++|+||+++++.-....    .+.+|++|
T Consensus       213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             hhHHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            45679999999999999886 589999998643  34567777777665  58999999999876655    78999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG------CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      .+.|+|.+++     ....++|....+++..++.||+|||+-      .+++|+|||||.+|||+.+|+++.|+|||+|.
T Consensus       290 h~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  290 HPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             ccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            9999999999     456789999999999999999999974      35689999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCcccccccccccccccc----ccccchhhHHHHHHHHHcCCCCCCCCcccccccc---------
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTV----SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY---------  282 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~----~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~---------  282 (340)
                      .+............+||.+|||||++.+.....    -.+.||||+|.++|||++.-.-+......+....         
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            776655444445578999999999997742211    1368999999999999997544322222211111         


Q ss_pred             -hhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          283 -FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       283 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                       +.+..........++.+.+.-... ....-+++.+..||+.||+-|.|+.=+-+.+
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~  500 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM  500 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence             111111222222333333221111 2346789999999999999999987665543

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-40  Score=289.95  Aligned_cols=246  Identities=22%  Similarity=0.339  Sum_probs=198.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..|...+.||+|+||.||+|... ++..+|+|.+.....  ..+.+.+|+++++.++|||++++++++...+..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            44566788999999999999765 678899999875432  235788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.     ...+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999998873     34688999999999999999999998   99999999999999999999999999987554322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.|+.......        ..........     
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~-----  218 (277)
T cd06642         156 I--KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSP-----  218 (277)
T ss_pred             h--hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCC-----
Confidence            1  11233578899999998765  67889999999999999999999986433211        1111111111     


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         219 -PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             1122234577899999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=303.62  Aligned_cols=240  Identities=24%  Similarity=0.321  Sum_probs=186.3

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhccc---CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRI---HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ||+|+||+||+|... +++.||+|++......    ......|..++...   +||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999865 6889999998653221    22345566666555   699999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|+++||+|||++   +++||||||+|||++.++.++|+|||++........  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--  151 (330)
T cd05586          81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--  151 (330)
T ss_pred             ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence            99998883    345689999999999999999999999   999999999999999999999999999875322221  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......||..|+|||.+.+. ..++.++|||||||++|+|++|+.||.......        ....+..+.. .+..   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~-~~~~---  218 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKV-RFPK---  218 (330)
T ss_pred             CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHH--------HHHHHHcCCC-CCCC---
Confidence            12345689999999998653 246789999999999999999999986543211        1122221111 1110   


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCC----CHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRP----SMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rp----s~~evl~  336 (340)
                        ..++.++.+++.+||+.||++||    ++.++++
T Consensus       219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              12456788999999999999998    4666554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.9e-41  Score=303.94  Aligned_cols=257  Identities=21%  Similarity=0.224  Sum_probs=192.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcC------Ce
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  134 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~  134 (340)
                      ..|.+.+.||+|+||.||++... +++.+|+|++....   .....+.+|+.+++.++||||+++++++...      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            45677789999999999999865 68899999987532   2335678999999999999999999987543      35


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .|+||||++ ++|.+.+.      ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++
T Consensus       104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         104 VYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             EEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            799999995 47776662      3477889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc--------chhHH
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA--------YFPSW  286 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--------~~~~~  286 (340)
                      +......   ......+|..|+|||.+.+.  .++.++|||||||++|+|++|+.||...+......        ..+.+
T Consensus       174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         174 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             cccCCCC---cccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            7553322   12334689999999999775  67889999999999999999999997544211000        00000


Q ss_pred             -------HHHHhhcCCCc------------cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 -------VYDQLNKGGDL------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 -------~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                             ......+....            ............+.++.+|+.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   00000000000            000001111123467899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=306.51  Aligned_cols=204  Identities=25%  Similarity=0.342  Sum_probs=176.8

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-C-----CceeeEeeEEEcC
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-H-----VNVVQLLGFCSEG  132 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~  132 (340)
                      .|....+|.+.+.||+|+||.|.+|.+. +++.||||++++...-..+...|+.+|..|+ |     -|+|+++++|...
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            3555557788899999999999999765 7999999999998877788889999999996 4     3899999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC--CCceEEec
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSD  210 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~--~~~~kl~D  210 (340)
                      ++.|+|+|.+ ..+|.+++..+.  ...++...+..++.||+.||.+||+.   +|||+||||+|||+.+  ...+||+|
T Consensus       261 ~HlciVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEe
Confidence            9999999999 779999996554  45589999999999999999999998   9999999999999964  34799999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcc
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT  276 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~  276 (340)
                      ||+++.....-.     ....+..|+|||++.+.  +|+.+.|||||||++.||++|.+.|...+.
T Consensus       335 FGSSc~~~q~vy-----tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  335 FGSSCFESQRVY-----TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             cccccccCCcce-----eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            999986544332     44567799999999996  899999999999999999999887776553

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.5e-41  Score=304.38  Aligned_cols=248  Identities=23%  Similarity=0.261  Sum_probs=192.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +++.+.||+|+||.||++... +++.+|+|++...    ......+..|+.++..++|||++++++.+.+.+..++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            455689999999999999765 7889999998643    22235678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          83 LPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999983    345688999999999999999999999   99999999999999999999999999986442211


Q ss_pred             Cc---------------------------------eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCC
Q 044497          222 DF---------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  268 (340)
Q Consensus       222 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~  268 (340)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence            00                                 001134589999999999775  6788999999999999999999


Q ss_pred             CCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCC---HHHHH
Q 044497          269 RNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVL  335 (340)
Q Consensus       269 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~evl  335 (340)
                      .||.......       .................    ..++.++.+++.+|+ .||.+|++   +.+++
T Consensus       234 ~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  291 (360)
T cd05627         234 PPFCSETPQE-------TYRKVMNWKETLVFPPE----VPISEKAKDLILRFC-TDSENRIGSNGVEEIK  291 (360)
T ss_pred             CCCCCCCHHH-------HHHHHHcCCCceecCCC----CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence            9997544321       11111111111111111    114567888888876 49999985   55554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=288.39  Aligned_cols=246  Identities=24%  Similarity=0.329  Sum_probs=199.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|.+.+.||.|++|.||+|... +++.+|+|.+.....  ....+.+|+.+++.++|+|++++++++.+....++++||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            3566789999999999999865 688999999875432  2356889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++..     ..+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          82 GGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999999832     2789999999999999999999998   999999999999999999999999999976644321


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                        ......++..|+|||.+.+.  .++.++||||||+++|+|+||+.||.......        ............... 
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~-  220 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKNNPPSLEG-  220 (274)
T ss_pred             --ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHHhhhcCCCCCcc-
Confidence              12334578899999999775  58889999999999999999999996543211        111111111111111 


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          ..++..+.+++.+||+.+|++|||++++++
T Consensus       221 ----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 ----NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ----cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                015567899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.8e-40  Score=287.14  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=199.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..|...+.||.|+||.||+|.+. +++.+|+|.+.....  ..+.+.+|+.+++.++|||++++++.+.+.+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34556688999999999999865 688999999875432  235788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.     ..++++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999999883     24578899999999999999999998   99999999999999999999999999997554322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ......++..|+|||.+.+.  ..+.++|+||||+++|+|++|..||.......        .........      
T Consensus       156 ~--~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~------  217 (277)
T cd06640         156 I--KRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIPKNN------  217 (277)
T ss_pred             c--ccccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------HhhhhhcCC------
Confidence            1  11233578899999998764  67889999999999999999999987543221        011111111      


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ........+..+.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            12233456778999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-40  Score=288.39  Aligned_cols=247  Identities=26%  Similarity=0.396  Sum_probs=196.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----------hHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      +.+.+.||+|++|.||+|... +++.+|+|.+......          .+.+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            456789999999999999764 6789999988653322          14578899999999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +++|||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.++
T Consensus        82 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          82 NIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999983    235678899999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCc----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          216 FHPKENDF----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       216 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      ........    .......++..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||.......       ..... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~-  224 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------AIFKI-  224 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-------HHHHH-
Confidence            65432111    111223478899999998764  67789999999999999999999997543211       11111 


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .....      ...+...+..+.+++.+||+.||.+||++.++++
T Consensus       225 ~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GENAS------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hccCC------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            11111      1122345678899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-41  Score=302.06  Aligned_cols=256  Identities=19%  Similarity=0.249  Sum_probs=189.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ...|.+.+.||+|+||.||+|... ++..||+|+....     ....|+.+++.++||||+++++++......++|||++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            345777899999999999999875 5678999975433     2357999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                       .++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||+++.......
T Consensus       140 -~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        140 -SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             -CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence             5688887732   345689999999999999999999999   999999999999999999999999999975332221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch---hHHHHHHhhcCC--Cc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF---PSWVYDQLNKGG--DL  297 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~--~~  297 (340)
                         .....||..|+|||.+.+.  .++.++|||||||++|||+++..|+............   ...+........  ..
T Consensus       213 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        213 ---FLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             ---cccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence               2234589999999999775  6788999999999999999866554322211100000   000111000000  00


Q ss_pred             ccc-----------------------c-cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELR-----------------------N-VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~-----------------------~-~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...                       . ........+.++.+++.+||+.||++|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            000                       0 00001123456778999999999999999999985

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-41  Score=298.73  Aligned_cols=253  Identities=19%  Similarity=0.199  Sum_probs=194.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |++.+.||+|+||.||++... +++.||+|++.+.    ....+.+.+|..++..++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            567789999999999999865 6889999998642    22235578899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.++|+|||++.......
T Consensus        83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          83 YVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             CCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999842   235688999999999999999999999   99999999999999999999999999987544332


Q ss_pred             CceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          222 DFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .. ......||+.|+|||++...   ...++.++||||+||++|+|++|+.||......       ..............
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~  228 (331)
T cd05597         157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHFQ  228 (331)
T ss_pred             Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCccc
Confidence            21 11234589999999998631   235678999999999999999999999754321       11111111111111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCC--CCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKA--ADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p--~~Rps~~evl~  336 (340)
                      ...   ....++..+.+++.+|+..++  ..||++.++++
T Consensus       229 ~~~---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         229 FPP---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             CCC---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            111   111255778889999876533  34789988875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.6e-40  Score=288.04  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=196.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      |++.+.||.|+||.||+|... ++..+++|.+..... ..+.+.+|+++++.++|||++++++.+...+..++++||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566789999999999999876 577889998865432 235688899999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|..++..   ...++++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            999887732   235689999999999999999999999   999999999999999999999999999875433221  


Q ss_pred             eeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          225 SISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      ......++..|+|||.+...   ...++.++|+|||||++|+|++|+.||.......       ...... .......  
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~-~~~~~~~--  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-------VLLKIA-KSEPPTL--  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-------HHHHHh-hcCCCCC--
Confidence            12334588999999997421   1356779999999999999999999986533211       111111 1111111  


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ..+..++.++.+++.+||+.||.+|||+.++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              112234578999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-41  Score=292.84  Aligned_cols=239  Identities=24%  Similarity=0.357  Sum_probs=185.7

Q ss_pred             hcCCCCCeEEEEEEEcC-------------------------CcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeE
Q 044497           72 KLGQGGFGSVYKGQLHT-------------------------GGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQL  125 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~  125 (340)
                      .||+|+||.||+|....                         ...+++|++...... ...+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999996421                         125889988654332 2568889999999999999999


Q ss_pred             eeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-
Q 044497          126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-  204 (340)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-  204 (340)
                      ++++......++||||+++++|..++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999888742   234688999999999999999999999   999999999999997643 


Q ss_pred             ------ceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHH-cCCCCCCCCccc
Q 044497          205 ------IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMHATR  277 (340)
Q Consensus       205 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ell-tg~~p~~~~~~~  277 (340)
                            .++++|||.+......      ....++..|+|||.+.+. ..++.++||||||+++|||+ +|+.||......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence                  3799999987643221      122467889999988653 46788999999999999984 688888654332


Q ss_pred             ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..        ........  ...      ....+.+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 ~~--------~~~~~~~~--~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 EK--------ERFYEKKH--RLP------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH--------HHHHHhcc--CCC------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11        01111110  011      112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4e-40  Score=289.22  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=197.7

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ..|++.+.||.|+||.||+|... ++..+++|.+..... ..+.+.+|+.+++.++|||++++++.+...+..+++|||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45677889999999999999875 578999999865432 2356888999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|..++...   ...+++..+..++.|++.+++|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            999998876322   34688999999999999999999998   999999999999999999999999998864322211


Q ss_pred             ceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          223 FVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                        ......++..|+|||.+.+.   ...++.++|+|||||++|+|++|..||.......        .............
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  235 (292)
T cd06644         166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSEPPTL  235 (292)
T ss_pred             --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--------HHHHHhcCCCccC
Confidence              12234578899999998532   1346778999999999999999999986533211        1111111111111


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          ..+..++.++.+++.+||+.+|++||++.++++
T Consensus       236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                112234567889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-40  Score=289.45  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=198.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcC----CcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      ..++.+.+.||.|+||.||+|...+    ...+++|.......  ..+.+.+|+.+++.++|||++++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4456677899999999999997542    24689998865432  23578899999999999999999999876 45789


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +|||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999998432   34589999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ...... ......++..|+|||.+...  .++.++||||||+++|++++ |..||.......        ....+..+..
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~  226 (270)
T cd05056         158 EDESYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGER  226 (270)
T ss_pred             ccccce-ecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCc
Confidence            443221 11222345689999988764  67889999999999999986 999986544321        1112222222


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      .+..++..+.+++.+|+..+|.+|||+.++++.|+
T Consensus       227 ~~------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         227 LP------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS  263 (270)
T ss_pred             CC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11      12234578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-40  Score=286.77  Aligned_cols=249  Identities=27%  Similarity=0.410  Sum_probs=197.4

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC-------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS-------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      |...+.||.|+||.||+|...+++.+|+|.+......       ...+.+|+++++.++|+|++++++++.+.+..++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            4556789999999999998888899999998654321       145788999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          82 EFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999832    34678999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCC----ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          220 END----FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       220 ~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ...    ........++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......      . ... .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~-~~~-~~~~~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------A-MFY-IGAHR  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH------H-HHH-hhhcc
Confidence            111    1111234588899999998764  67789999999999999999999996533211      0 000 11110


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..    ....+..++.++.+++.+||+.+|.+|||+.++++
T Consensus       225 ~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GL----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CC----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00    01122235578899999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=288.87  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=199.8

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ..|++.+.||.|++|.||++... ++..+|+|.+..... ..+.+..|+++++.++|||++++++.+......+++|||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            35677899999999999999865 688999999865432 2356889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999988432   34689999999999999999999999   999999999999999999999999998865433221


Q ss_pred             ceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          223 FVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                        ......+++.|+|||.+...   ...++.++|+||||+++|+|++|+.||.......        .......+.....
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  228 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSEPPTL  228 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCCCCCc
Confidence              12234588899999987532   1246779999999999999999999987543211        1111111111111


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          ..+..++.++.+++.+||+.+|.+|||+.++++
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         229 ----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                112234567889999999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-40  Score=288.74  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=197.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---C--------hHHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---S--------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      |...+.||.|++|.||+|... +++.+|+|.+.....   .        .+.+.+|+.+++.++|||++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            445678999999999999754 688999998753211   1        1357789999999999999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++
T Consensus        83 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             eEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999998833    25688999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ................++..|+|||.+......++.++|+||||+++|++++|..||......       ..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhccc
Confidence            765432221122334578899999998764334788999999999999999999998643221       1111111111


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .....  .......++..+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPPI--PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCcC--CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11111  11222345678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.3e-41  Score=292.22  Aligned_cols=261  Identities=22%  Similarity=0.291  Sum_probs=198.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|++.+.||+|++|.||+|... +++.+|+|++.....   ..+.+.+|+++++.++|||++++++++......+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            3566788999999999999876 688999999865432   235678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|..+..    ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          82 CDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             cCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99988877662    334689999999999999999999998   99999999999999999999999999998654433


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHH-------HHHhhcC
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWV-------YDQLNKG  294 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~  294 (340)
                      .  ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||......+.........       .+.....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             c--cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            2  11233477899999998653 356789999999999999999999997544321100000000       0000000


Q ss_pred             ------CCcccccc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 ------GDLELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ------~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            ........   .......+..+.+++.+||+.+|++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                  00000000   0112234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-40  Score=289.00  Aligned_cols=261  Identities=26%  Similarity=0.448  Sum_probs=202.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-----CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEc--CCeeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~  136 (340)
                      .+++.+.||+|+||.||++...     ++..+|+|.+......  .+.+.+|+++++.++|||++++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4556789999999999999753     4678999999876654  5689999999999999999999999877  56789


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999998432   23589999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCCcee-eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc-------cchhHHHH
Q 044497          217 HPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK-------AYFPSWVY  288 (340)
Q Consensus       217 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~~~~~  288 (340)
                      ......... .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.|+.........       ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            653332211 1122355679999988764  6788999999999999999999887643321110       00011111


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..+.......      .+..++.++.+++.+||+.+|++|||+.|++++|+.
T Consensus       237 ~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         237 ELLKEGERLP------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHHHcCCcCC------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            2222221111      112344679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-40  Score=295.56  Aligned_cols=260  Identities=19%  Similarity=0.256  Sum_probs=187.3

Q ss_pred             hhcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEE--cCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~  145 (340)
                      .+||+|+||.||+|...   ++..+|+|.+..... ...+.+|+++++.++||||+++++++.  .....+++|||++ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            57999999999999864   456899999876543 346789999999999999999999884  4567889999985 5


Q ss_pred             CcccccccC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE----cCCCceEEecccCCcc
Q 044497          146 SLDRHIFPK-----ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  216 (340)
Q Consensus       146 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill----~~~~~~kl~Dfg~~~~  216 (340)
                      +|.+++...     ......+++..+..++.|++.||+|||+.   +++||||||+||++    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            776665321     11234588999999999999999999999   99999999999999    5667899999999986


Q ss_pred             CCCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc--chhHHHHH----
Q 044497          217 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA--YFPSWVYD----  289 (340)
Q Consensus       217 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--~~~~~~~~----  289 (340)
                      ....... .......+|+.|+|||.+.+. ..++.++|||||||++|||+||++||..........  ........    
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            5433211 122334588999999998653 357889999999999999999999997544321110  00000000    


Q ss_pred             ----------HhhcCC-Cc--------cccccc-------hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 ----------QLNKGG-DL--------ELRNVT-------EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ----------~~~~~~-~~--------~~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                ...... ..        ......       ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                      000000 00        000000       000112356888999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-40  Score=291.43  Aligned_cols=246  Identities=25%  Similarity=0.376  Sum_probs=197.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      |.+.+.||.|++|.||+|.. .+++.+++|.+..... ..+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  100 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence            45667899999999999975 4788999999865433 346788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.     ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus       101 ~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655         101 GSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             CcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            99999883     23588999999999999999999999   999999999999999999999999999875433321  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      ......++..|+|||.+.+.  .++.++|+|||||++|+|++|+.||........       ... .........    .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-------~~~-~~~~~~~~~----~  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYL-IATNGTPEL----Q  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH-HHhcCCccc----C
Confidence            11234588899999998764  678899999999999999999999976443210       111 111111111    1


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+..++..+.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            12234567889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=288.37  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=201.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCC------eeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGS------KRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~~  136 (340)
                      ..|++.+.||+|++|.||+|... +++.+++|++.......+.+.+|+.+++.+ +|+|++++++++....      ..+
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            35667789999999999999875 678999999987766667899999999999 7999999999996544      489


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|||+++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+..
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            99999999999998854433456789999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      ......  ......++..|+|||.+...   ...++.++||||||+++|+|++|+.||.......       .... ...
T Consensus       163 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~-~~~  232 (275)
T cd06608         163 LDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------ALFK-IPR  232 (275)
T ss_pred             cccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------HHHH-hhc
Confidence            443222  12334588899999987532   1346778999999999999999999986432211       1111 111


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......    ......+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 NPPPTL----KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cCCCCC----CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111    112235678999999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-40  Score=292.48  Aligned_cols=248  Identities=24%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ..|.+.+.||+|++|.||++... +++.||+|.+..... ..+.+.+|+.+++.++|||++++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            45666789999999999999864 789999999875443 3356789999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999883     24578899999999999999999999   999999999999999999999999999875433221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                        ......+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||..........       .....+ ...    
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~~~~~~-~~~----  234 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNG-TPE----  234 (297)
T ss_pred             --CcCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------eeccCC-CCC----
Confidence              11234578899999998764  67789999999999999999999996543321100       000000 111    


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...+...+..+.+++.+||+.+|.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1122345567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.8e-40  Score=284.64  Aligned_cols=249  Identities=31%  Similarity=0.517  Sum_probs=198.9

Q ss_pred             hhhhhcCCCCCeEEEEEEEcC-----CcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQLHT-----GGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .+.+.||.|+||.||++....     +..+|+|.+.....  ..+.+..|+..+..++|+|++++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            356789999999999998653     37899999976654  34688999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++....  ...+++..+..++.|++.||++||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999984322  12289999999999999999999999   9999999999999999999999999999766544


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ..... ....++..|+|||.+.+.  .++.++|+||+|+++|+|++ |..||......       . .............
T Consensus       157 ~~~~~-~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~  225 (258)
T smart00219      157 DYYKK-KGGKLPIRWMAPESLKDG--KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-------E-VLEYLKKGYRLPK  225 (258)
T ss_pred             ccccc-ccCCCcccccChHHhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHhcCCCCCC
Confidence            22211 123377899999998553  67889999999999999998 77887653221       1 1122222221111


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                            +...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  122567899999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=302.06  Aligned_cols=254  Identities=24%  Similarity=0.400  Sum_probs=209.2

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc---CCc--EEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH---TGG--LIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      +..+.....+.||.|.||.||+|...   .|.  .||||..+.+..  +.+.|..|..+|+.++||||++++|+|.+ ..
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            33444455688999999999999643   233  589999887443  34789999999999999999999999976 46


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .++|||.++-|.|..++..   +...++..++..++.|+..||+|||+.   ..|||||..+|||+.+...+||+|||++
T Consensus       465 ~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence            8999999999999999954   446788899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhc
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      +.......+.. +...-+..|||||.+.-.  .++..+|||.|||++||+++ |..||..-...+        +.-.+++
T Consensus       539 R~~ed~~yYka-S~~kLPIKWmaPESINfR--rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEn  607 (974)
T KOG4257|consen  539 RYLEDDAYYKA-SRGKLPIKWMAPESINFR--RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIEN  607 (974)
T ss_pred             hhccccchhhc-cccccceeecCccccchh--cccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecC
Confidence            98877665543 355577899999999764  78899999999999999988 889987654432        1112333


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      |.+      ...++.+++.+..|+.+||+.+|.+||++.++...|+
T Consensus       608 GeR------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  608 GER------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             CCC------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            333      3455577889999999999999999999999988875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=304.44  Aligned_cols=250  Identities=24%  Similarity=0.401  Sum_probs=208.7

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc--CCc--EEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH--TGG--LIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~--~~~--~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ....+.+.||+|.||.|++|.|.  .|+  .||||.++.+...  .++|.+|+.+|.+|+|+|++++||+..+ ....||
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            33456689999999999999876  333  6999999876654  4789999999999999999999999987 678899


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      ||.++.|+|.+.+.+  .....|....+..++.||+.|+.||.++   ++||||+..+|+|+.....+||+|||+.+-+.
T Consensus       189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            999999999999955  3456788899999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCceeeec-cccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          219 KENDFVSISA-TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       219 ~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .+.+...+.. ..-...|+|||.++..  .++.++|||+|||++|||+| |..||......        .+.+.+.++. 
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~--kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qIL~~iD~~e-  332 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHR--KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QILKNIDAGE-  332 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccc--cccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HHHHhccccc-
Confidence            7666555433 3467799999999875  88999999999999999999 77888764432        1333333322 


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           ....+..++.++.+++..||..+|++|||+..+.+
T Consensus       333 -----rLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  333 -----RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             -----cCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence                 22344567889999999999999999999999864

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-41  Score=292.92  Aligned_cols=240  Identities=23%  Similarity=0.318  Sum_probs=186.9

Q ss_pred             hhcCCCCCeEEEEEEEc-C-------CcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLH-T-------GGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~-------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.||+|+||.||+|... .       ...+++|.+...... .+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46999999999999754 2       224888887654322 35788999999999999999999999998999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc--------eEEecccC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--------PKVSDFGL  213 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~--------~kl~Dfg~  213 (340)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.        ++++|||.
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999998432   23678999999999999999999999   9999999999999987765        69999998


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCC-CCCCCCcccccccchhHHHHHHhh
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      +......      ....++..|+|||.+.+. ..++.++||||||+++|+|++|. .|+.......        ......
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~  219 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYE  219 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHH
Confidence            8644322      223478899999998753 35678999999999999999995 4544322111        011111


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..  .      ..+...+.++.+++.+||+.+|++|||++++++.|+
T Consensus       220 ~~--~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR--H------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc--c------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11  1      111123367899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.5e-40  Score=284.98  Aligned_cols=247  Identities=28%  Similarity=0.403  Sum_probs=187.7

Q ss_pred             hhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEE-cCCeeEEEEEccC
Q 044497           71 HKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVYEYMP  143 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~  143 (340)
                      +.||+|+||.||+|.+.    ....+|+|.+.....  ..+.+.+|+.+++.++|||++++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999753    235799998854322  2357889999999999999999999775 4556889999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...   .....+..+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999998432   23456778889999999999999998   9999999999999999999999999998754332111


Q ss_pred             --eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcC-CCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          224 --VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       224 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                        .......++..|+|||.+.+.  .++.++||||||+++|||++| .+||......       . .......+..... 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~-~~~~~~~~~~~~~-  223 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------D-ITVYLLQGRRLLQ-  223 (262)
T ss_pred             eecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHhcCCCCCC-
Confidence              111223456789999998764  678899999999999999995 5555432211       1 1112222211111 


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           +...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       224 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~  257 (262)
T cd05058         224 -----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE  257 (262)
T ss_pred             -----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence                 1123467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.7e-40  Score=286.78  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=199.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcC--CcEEEEEEccCCC-----------CChHHHHHHHHHhcc-cCCCceeeEeeEEEcC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHT--GGLIAVKMLANSK-----------FSGEEFINEVSTIGR-IHHVNVVQLLGFCSEG  132 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~  132 (340)
                      |.+.+.||+|+||.||++....  ++.+|+|.+....           ....++..|+.++.. ++|||++++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4567899999999999998764  6789999875321           112346778887764 7999999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Df  211 (340)
                      +..+++|||+++++|.+++.........+++..++.++.|++.+|.|||+ .   +++|+||+|+||++++++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999998875433445678999999999999999999996 5   8999999999999999999999999


Q ss_pred             cCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      |.+.......   ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......       .. ...
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~-~~~  225 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LA-TKI  225 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HH-HHH
Confidence            9997654432   22345588899999999764  67889999999999999999999986443211       11 111


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      .........     ....+..+.+++.+||+.||++|||+.|+.+++++
T Consensus       226 ~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         226 VEAVYEPLP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             hhccCCcCC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            111111111     11345788999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.8e-40  Score=283.73  Aligned_cols=249  Identities=24%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||.|+||.||.+... +++.+++|.+....   ....++.+|+.++++++|+|++++++++.+.+..+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            556789999999999999754 68899999876533   23357889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++....  ...+++..+..++.|++.+++|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999884322  45689999999999999999999998   999999999999999999999999999876544331


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                        ......+++.|+|||.+.+.  .++.++|+||||+++|+|++|..||......       ....... .+...     
T Consensus       157 --~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~~-~~~~~-----  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKIV-QGNYT-----  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHH-cCCCC-----
Confidence              12334588999999998765  5678999999999999999999998653321       1111111 11111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                       ......+.++.+++.+||+.+|.+|||++++++.+
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence             11134457889999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=284.33  Aligned_cols=253  Identities=24%  Similarity=0.286  Sum_probs=200.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+++++.++|||++++++++...+..+++|||++
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            4566789999999999999865 678899999876433 34678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        84 ~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          84 GGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            99999988432   25688999999999999999999999   999999999999999999999999999875543221 


Q ss_pred             eeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                       ......++..|+|||.+.+. ...++.++|+||||+++|+|++|+.||........       ...........   ..
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~~~~~~---~~  225 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISKSNFPP---PK  225 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhccCCC---cc
Confidence             11234578899999998642 12567799999999999999999999875432110       11111110000   00


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .......+.++.+++.+||+.+|.+|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1123345678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-40  Score=288.66  Aligned_cols=246  Identities=26%  Similarity=0.340  Sum_probs=193.3

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      ..||+|+||.||+|... ++..+++|.+..... ..+.+.+|+++++.++|+||+++++++..++..++++||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            57999999999999855 677899998865443 3357889999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCCCCCCcee
Q 044497          149 RHIFPKESRGQSF--CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       149 ~~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +++....   ..+  ++..+..++.|++.||+|||+.   +++|+||||+||+++. ++.++|+|||.+........  .
T Consensus        94 ~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~  165 (268)
T cd06624          94 ALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--C  165 (268)
T ss_pred             HHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--c
Confidence            9884321   234  7788899999999999999998   9999999999999976 67999999999875533221  1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .....++..|+|||.+.+....++.++|+||||+++|+|++|+.||........    .  ........      .....
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~--~~~~~~~~------~~~~~  233 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----A--MFKVGMFK------IHPEI  233 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----h--Hhhhhhhc------cCCCC
Confidence            123347889999999866434577899999999999999999999864332110    0  00000000      01122


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +...+.++.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            3345678999999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.9e-40  Score=283.79  Aligned_cols=247  Identities=25%  Similarity=0.347  Sum_probs=197.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEc-CCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~  141 (340)
                      |++.+.||+|++|.||++... +++.+|+|.+......   .+.+.+|+++++.++|+|++++++.+.. ....+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            567789999999999999865 6788999998654332   3568899999999999999999998764 4468999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++...  ....+++..+..++.+++.|+++||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999999988432  245689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ......+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||......       ..... ...+...    
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~-~~~~~~~----  220 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVYR-IIEGKLP----  220 (257)
T ss_pred             C--ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHH-HHhcCCC----
Confidence            2  12334578899999998764  6778999999999999999999998643321       11111 1111111    


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ..+...++.+.+++.+||+.+|.+|||+.++++
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              122345678999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.4e-40  Score=288.78  Aligned_cols=254  Identities=26%  Similarity=0.329  Sum_probs=198.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcC-----CeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEG-----SKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv  138 (340)
                      .|.+.+.||+|+||.||++... +++.+|+|.+.......+.+.+|+.++..+ +|||++++++++...     +..+++
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            3456689999999999999865 788999999976655567788999999998 899999999998643     358999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++....
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            999999999988754334456789999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCceeeeccccCccccccccccccc---cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .....  .....++..|+|||.+....   ..++.++|+|||||++|+|++|+.||.......       .... .....
T Consensus       180 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-------~~~~-~~~~~  249 (291)
T cd06639         180 STRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-------TLFK-IPRNP  249 (291)
T ss_pred             ccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-------HHHH-HhcCC
Confidence            32211  12335788999999875431   135789999999999999999999987543211       1111 11111


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......    +......+.+++.+||+.+|++|||+.++++
T Consensus       250 ~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         250 PPTLLH----PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCCCc----ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111    1223467899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.2e-40  Score=283.99  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=197.7

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ..+++.+.||+|+||.||++.. +++.+|+|.+.... ..+.+.+|+.+++.++|||++++++++... ..+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            4567788999999999999975 57889999986543 346788999999999999999999998654 47999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++....  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++.......   
T Consensus        83 ~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          83 GNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999985432  34578999999999999999999998   99999999999999999999999999987543221   


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                        .....+..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||.......        .......+.....    
T Consensus       155 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~----  218 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--------VKECVEKGYRMEP----  218 (254)
T ss_pred             --CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhCCCCCCC----
Confidence              122345689999998754  67889999999999999998 898886543211        1222222221111    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                        ...++..+.+++.+||+.+|.+|||++++++.|+.
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              12345778899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-41  Score=294.62  Aligned_cols=251  Identities=21%  Similarity=0.277  Sum_probs=200.2

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---hHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ....|++.++||+||.+.||++...+.+.+|+|.+.....+   .+-+.+|+..|.+++ |.+|+++++|-..++.+|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34556778999999999999999888889999988654443   367899999999994 89999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||- ..+|..++.+..   ...+.-.+..+..||+.|+.+.|++   ||||.||||.|+|+ -.|.+||+|||.|.-..
T Consensus       439 mE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ  510 (677)
T ss_pred             eecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence            9997 669999884432   2233237888999999999999999   99999999999999 45689999999999887


Q ss_pred             CCCCceeeeccccCcccccccccccccc---------ccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFG---------TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~---------~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      ...........+||+.||+||.+.....         ..++++|||||||+||+|+.|+.||.....          .+.
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------~~a  580 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------QIA  580 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------HHH
Confidence            7777666677789999999999854321         367899999999999999999999874322          122


Q ss_pred             HhhcCC----CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNKGG----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+....    ..++....+.     .++.++++.||+.||++|||+.++|+
T Consensus       581 Kl~aI~~P~~~Iefp~~~~~-----~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPEN-----DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHhhcCCCccccccCCCCc-----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            222222    2222222221     22889999999999999999999986

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.5e-40  Score=285.05  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=200.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEE--cCCeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e  140 (340)
                      |++.+.||.|+||.||++... +++.+|+|.+......   .+.+..|+++++.++|||++++++++.  .....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            456688999999999999754 7789999998754433   346788999999999999999999875  3456899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-----~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+++++|.+++.........+++..++.++.|++.||+|||     +.   +++|+||+|+||++++++.++|+|||++.
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence            99999999998655444567899999999999999999999     66   99999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ........  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......       . .......+.
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~~  226 (265)
T cd08217         159 ILGHDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQL-------Q-LASKIKEGK  226 (265)
T ss_pred             cccCCccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------H-HHHHHhcCC
Confidence            66544321  2234588999999998764  5778999999999999999999998764421       1 112222221


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .      ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus       227 ~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         227 F------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             C------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            1      1223345678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=309.44  Aligned_cols=257  Identities=19%  Similarity=0.276  Sum_probs=187.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC------CCceeeEeeEEEcC-CeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH------HVNVVQLLGFCSEG-SKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~-~~~~  136 (340)
                      ..|.+.+.||+|+||+||+|... +++.||||+++...........|+.++..++      |++++++++++... ...+
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            45667789999999999999765 6788999999764444455667777777764      45688999988654 5688


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCC-----------
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNF-----------  204 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~-----------  204 (340)
                      +|||++ +++|.+++.    ....+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++           
T Consensus       209 iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccccccc
Confidence            999988 778888873    23568999999999999999999996 6   999999999999998765           


Q ss_pred             -----ceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc
Q 044497          205 -----IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS  279 (340)
Q Consensus       205 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~  279 (340)
                           .+||+|||.+......     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||........
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             CCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 4999999987643221     2344689999999999875  788899999999999999999999976443210


Q ss_pred             ccc-------hhH-HHH--------HHhhcCCCcccc-cc----------chhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 044497          280 KAY-------FPS-WVY--------DQLNKGGDLELR-NV----------TEIESMIARKLCMIGLWCIQVKAADRPSMT  332 (340)
Q Consensus       280 ~~~-------~~~-~~~--------~~~~~~~~~~~~-~~----------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~  332 (340)
                      ...       ++. |..        ............ ..          ........+.+.+|+.+||+.||++|||++
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            000       000 000        000000000000 00          000111245688999999999999999999


Q ss_pred             HHHH
Q 044497          333 KVLE  336 (340)
Q Consensus       333 evl~  336 (340)
                      |+++
T Consensus       434 e~L~  437 (467)
T PTZ00284        434 QMTT  437 (467)
T ss_pred             HHhc
Confidence            9985

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.5e-41  Score=293.23  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +|++.+.||+|+||.||+|.+. +++.+|+|.+......   .+.+.+|+++++.++|||++++++++...+..++++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            3556789999999999999875 6889999998653322   35688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.++..    ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          82 VDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             CCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99988887652    234589999999999999999999998   99999999999999999999999999987654332


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHhh--
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQLN--  292 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~--  292 (340)
                      .  ......++..|+|||.+.+. ..++.++||||||+++|+|++|++||......+......       ........  
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c--ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            2  12234578899999998653 356788999999999999999999886543211000000       00000000  


Q ss_pred             ---cC-CCcccccc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 ---KG-GDLELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ---~~-~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         .. ........   ....+.++..+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence               00 00000000   0112235678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-40  Score=290.52  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=198.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+++.+.||+|+||.||++... ++..+|+|.+......  .+.+.+|+.++++++||||+++++.+...+..+++|||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            3567789999999999999876 7889999988653222  357889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      ++++|.+++.... ....+++..+..++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999988874321 23478999999999999999999996 5   89999999999999999999999999987543222


Q ss_pred             CceeeeccccCccccccccccccc----cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          222 DFVSISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                          .....++..|+|||.+.+..    ..++.++|+|||||++|+|++|+.||.......    ..... .....+.. 
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~-~~~~~~~~-  227 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQL-SAIVDGDP-  227 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHH-HHHhhcCC-
Confidence                12335788999999885431    135779999999999999999999986432211    00101 11111111 


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           ...+..++.++.+++.+||+.+|.+||++.++++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         228 -----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                 1223346788999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.2e-40  Score=290.54  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=194.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCc----EEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ++..+.||+|+||.||+|.+. ++.    .+|+|.+......  ..++.+|+.+++.++||||+++++++... ..++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~   87 (303)
T cd05110           9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT   87 (303)
T ss_pred             ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence            345678999999999999764 443    5788988754332  24678999999999999999999998754 467899


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||+++....
T Consensus        88 e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          88 QLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             hhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999988432   34678999999999999999999999   999999999999999999999999999986544


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ...........++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        .......+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~  231 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLP  231 (303)
T ss_pred             cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCCCC
Confidence            3322222233456789999998764  67889999999999999997 888886532211        122222222111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .      +...+.++.+++.+||..+|++||+++++++.|+
T Consensus       232 ~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         232 Q------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             C------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1      1123467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.4e-40  Score=284.30  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=195.3

Q ss_pred             hhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCC------e
Q 044497           68 HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  134 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~  134 (340)
                      .+.+.||+|+||.||+|.+.    ++..+|+|++......   .+++.+|+++++.++|||++++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45678999999999999753    4678999998764433   356889999999999999999999885432      2


Q ss_pred             eEEEEEccCCCCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          135 RALVYEYMPNGSLDRHIFPKE--SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      .++++||+++++|.+++....  .....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence            478899999999988764322  1223578899999999999999999998   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      +++...............++..|++||.+...  .++.++||||||+++|+|++ |+.||.......        .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------~~~~~  228 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------IYNYL  228 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------HHHHH
Confidence            99865443322222233456789999998764  67789999999999999999 888876433211        11112


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      .......      .+...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       229 ~~~~~~~------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         229 IKGNRLK------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             HcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1211111      112344689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-40  Score=291.45  Aligned_cols=260  Identities=20%  Similarity=0.263  Sum_probs=194.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||+|++|.||+|... +|+.+|+|.+.....   ....+.+|+.+++.++|||++++++++.+.+..++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            456788999999999999875 788999999865322   2356788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      + ++|.+++..   ....+++..+..++.|+++||+|||++   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          82 D-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             C-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            6 578777632   235689999999999999999999999   999999999999999999999999999875433221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc-ch-------hHHHHHHhhcC
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA-YF-------PSWVYDQLNKG  294 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-~~-------~~~~~~~~~~~  294 (340)
                        ......++..|+|||.+.+. ..++.++||||||+++|+|+||..|+.......... .+       ....+......
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence              11233578899999988653 346789999999999999999998864332211000 00       00000000000


Q ss_pred             CC-c---ccccc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 GD-L---ELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~~-~---~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .. .   .....   .+..+..+.++.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00 0   00000   1112235678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=299.85  Aligned_cols=240  Identities=25%  Similarity=0.363  Sum_probs=199.3

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh----HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +-||.|+||.||.|++. +.+.||||.+..+....    +++..|+..|++++|||++.+.|+|..+...++||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            67999999999999765 78899999997654432    57899999999999999999999999999999999999 66


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +-.|++.-   ...++.+..+..|..+.+.||+|||+.   +.||||||+.|||+++.|.+||+|||.|......+    
T Consensus       111 SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn----  180 (948)
T KOG0577|consen  111 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN----  180 (948)
T ss_pred             cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh----
Confidence            77777733   346788999999999999999999999   99999999999999999999999999998765544    


Q ss_pred             eeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          226 ISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                        .++|||.|||||++.. ..+.|+-++||||||++..||.-.++|+..+..       .+.+++...+.... +     
T Consensus       181 --sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQNesPt-L-----  245 (948)
T KOG0577|consen  181 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPT-L-----  245 (948)
T ss_pred             --cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhcCCCC-C-----
Confidence              4569999999998753 335788899999999999999999999765442       22233333332211 1     


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .....+..+++++..||+.-|.+|||.++++.
T Consensus       246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            12356678999999999999999999999875

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-40  Score=296.26  Aligned_cols=253  Identities=19%  Similarity=0.192  Sum_probs=194.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||.||++..+ +++.+|+|++.+..    .....+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            556789999999999999866 67789999986422    2234578899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999998432   34688999999999999999999999   99999999999999999999999999987543322


Q ss_pred             CceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          222 DFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .. ......||+.|+|||++...   ...++.++|||||||++|||++|+.||......       ..............
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~  228 (332)
T cd05623         157 TV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKERFQ  228 (332)
T ss_pred             cc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCcccc
Confidence            21 12334689999999998631   235788999999999999999999999754321       11111111111111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~evl~  336 (340)
                      ..   .....++.++.+++.+|+..++.+  |++++++++
T Consensus       229 ~p---~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         229 FP---AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             CC---CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            11   111234678889999988654444  688988875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.4e-40  Score=285.00  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=199.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ..+...+.||.|+||.||+|..+      +.+.+++|.+......  .+.+.+|+++++.++|||++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            34455678999999999999854      3457999988664433  367899999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecc
Q 044497          137 LVYEYMPNGSLDRHIFPKESR-----GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Df  211 (340)
                      ++|||+++++|.+++......     ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998543321     12689999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHH
Q 044497          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      |++....... ........++..|+|||.+.+.  ..+.++||||||+++|+|++ |..||.......        ....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--------~~~~  230 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--------VLNR  230 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------HHHH
Confidence            9986443221 1122233467789999988764  56789999999999999999 777875432211        1111


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...+.. ...    .....+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       231 ~~~~~~-~~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAGKL-ELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCCc-CCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111111 111    11134468999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.1e-40  Score=282.99  Aligned_cols=247  Identities=26%  Similarity=0.367  Sum_probs=198.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||+|+||.+|++... +++.+|+|.+.....   ...++.+|+.+++.++|||++++++++...+..++++||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            566789999999999999765 688999999865322   2357889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++...  ....+++..+..++.|++.|++|||++   +++|+||+|+||+++.++.++++|||++........
T Consensus        82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999988432  234578999999999999999999998   999999999999999999999999999975543321


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      .  .....+++.|+|||.+.+.  ..+.++|+||||+++|+|++|+.||.....       ........ .+....    
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~-~~~~~~----  220 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKII-RGSYPP----  220 (256)
T ss_pred             h--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHh-cCCCCC----
Confidence            1  1223478899999998764  677899999999999999999999864322       11222222 221111    


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        .+...+.++.+++.+||+.+|.+||++.++++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              12234578999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-40  Score=290.00  Aligned_cols=257  Identities=23%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||.|++|.||+|.+. +++.+++|++.....   ..+.+.+|+.+++.++|||++++++++......++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            566789999999999999865 788999999876442   2367889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                       +++|.+++...   ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence             99999987432   25689999999999999999999999   999999999999999999999999999886544321


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC--------
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG--------  294 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  294 (340)
                       .......++..|+|||.+.+. ..++.++||||+|+++|+|++|.+||........    ...........        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ----LAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH----HHHHHHHcCCCChHHHhhc
Confidence             112334588899999988653 3567899999999999999999877754332110    00000000000        


Q ss_pred             ------CCccccc-----cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 ------GDLELRN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ------~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            .......     .....+..+..+.+++.+||+.+|.+|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  0000000     01111234578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.4e-40  Score=284.74  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=199.4

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      +++.+.||.|++|.||++... +++.+++|.+.....  ..+++.+|+++++.++||||+++++.+...+..++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            456789999999999999876 688999999876532  33578899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      +++|.+++....   ..+++..+..++.|++.|++|||+ .   +++|+||+|+||++++++.++|+|||.+........
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          83 GGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999884322   678899999999999999999999 8   999999999999999999999999999875432221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                          ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||........  ........ ..........  
T Consensus       157 ----~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~-~~~~~~~~~~--  225 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQY-IVNEPPPRLP--  225 (265)
T ss_pred             ----hcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHH-HhcCCCCCCC--
Confidence                114588899999998775  778899999999999999999999875532111  11111111 1111111111  


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ....+.++.+++.+||..||++|||+.+++.
T Consensus       226 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         226 ---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence               1115678999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-40  Score=291.41  Aligned_cols=261  Identities=23%  Similarity=0.306  Sum_probs=196.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      |++.+.||+|++|.||+|... +++.|++|.+......      ...+..|+++++.++|+|++++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            456678999999999999865 6889999999765432      245678999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+ +++|.+++....   ..+++..+..++.|+++||+|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999 899999884321   3689999999999999999999999   999999999999999999999999999976544


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH-------HHHHHhh
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS-------WVYDQLN  292 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~  292 (340)
                      ...  ......++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||..............       ..+....
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            321  11233467889999988543 3567899999999999999999877764432110000000       0000000


Q ss_pred             ---cCCC---ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          293 ---KGGD---LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       293 ---~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                         ....   .............+..+.+++.+||+.+|++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               0000   00000011223346789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.5e-40  Score=295.32  Aligned_cols=253  Identities=19%  Similarity=0.195  Sum_probs=194.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||.||++... +++.+|+|++....    .....+.+|..++..++|+||+++++++.+.+..|+||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            566789999999999999865 67889999986532    1224578899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999998432   34688999999999999999999999   99999999999999999999999999987654332


Q ss_pred             CceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          222 DFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .. ......||+.|+|||.+.+.   .+.++.++|+||||+++|+|++|+.||......       ..............
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~  228 (331)
T cd05624         157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEERFQ  228 (331)
T ss_pred             ce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCCCccc
Confidence            21 12334699999999998642   125678999999999999999999999754321       11111111111111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~evl~  336 (340)
                      ..   .....++.++.+++.+|+..++++  |++++++++
T Consensus       229 ~p---~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         229 FP---SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             CC---CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            11   111234578899999999866544  467887764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=289.92  Aligned_cols=258  Identities=24%  Similarity=0.351  Sum_probs=192.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|.+.+.||+|++|.||+|... +++.||+|.+.....  ....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL   85 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence            3556789999999999999876 688999999865432  2345778999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      + ++|.+++...   ...+++..+..++.|+++||.|||++   +++|+||+|+||++++++.++|+|||+++.......
T Consensus        86 ~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          86 D-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             C-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            7 4898877432   24678999999999999999999999   999999999999999999999999999875432211


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC--------
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG--------  294 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  294 (340)
                        ......++..|+|||.+.+. ..++.++||||+|+++|+|++|+.||.........   .......+...        
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ---LHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             --cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH---HHHHHHhcCCCChhhhhhh
Confidence              11223467889999988653 35678999999999999999999999654311000   00000000000        


Q ss_pred             ------CC--ccccccchh---hHHHH--HHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 ------GD--LELRNVTEI---ESMIA--RKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ------~~--~~~~~~~~~---~~~~~--~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            ..  .........   .....  .++.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                  00  000000000   01122  67889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-40  Score=285.37  Aligned_cols=246  Identities=28%  Similarity=0.380  Sum_probs=198.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC------ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      |...+.||+|++|.||+|... +++.+++|.+.....      ..+.+.+|+.+++.++|+|++++++++.+....++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            455678999999999999876 788999999865332      2356889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++.    ....+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        82 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          82 ELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999983    234578999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ..   ......++..|+|||.+.... .++.++|+||||+++|+|++|+.||......       ............   
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~---  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKEL---  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccC---
Confidence            32   123445888999999986541 3788999999999999999999998754321       111111110111   


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ...+...++.+.+++.+||+.+|.+|||+.++++
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               1122335678899999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7e-40  Score=288.25  Aligned_cols=243  Identities=25%  Similarity=0.343  Sum_probs=194.5

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ...||.|+||.||++... +++.+|+|.+.... ...+.+.+|+.++..++|||++++++.+..++..++++||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            347999999999999765 78899999986533 2346788999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++.     ...+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++........  ...
T Consensus       106 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         106 TDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             HHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            98772     24578999999999999999999999   999999999999999999999999999875433221  112


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......        ....+........    ....
T Consensus       176 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~----~~~~  241 (297)
T cd06659         176 SLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKL----KNAH  241 (297)
T ss_pred             ceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCc----cccC
Confidence            34588999999998764  67889999999999999999999987543211        1111111111111    1112


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..+.+++.+||+.+|++|||++++++
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            34567889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.2e-40  Score=288.33  Aligned_cols=244  Identities=26%  Similarity=0.349  Sum_probs=194.3

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ...||.|+||.||++... ++..+|+|.+..... ..+.+.+|+..++.++|||++++++.+...+..+++|||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            357999999999999765 688999999865332 235688999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++.     ...+++..+..++.|++.||+|||++   +++||||+|+||++++++.++|+|||++........  ...
T Consensus       107 ~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  176 (292)
T cd06658         107 TDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK  176 (292)
T ss_pred             HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence            98872     23578899999999999999999999   999999999999999999999999999875433221  112


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...++..|+|||.+.+.  .++.++|+||||+++|||++|+.||.......        ...............    ..
T Consensus       177 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~----~~  242 (292)
T cd06658         177 SLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDNLPPRVKD----SH  242 (292)
T ss_pred             eeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCcccc----cc
Confidence            34588899999998764  67789999999999999999999987533211        111111111111111    11


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      ..+..+.+++.+||+.||++|||++++++.
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            345678899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.9e-40  Score=288.10  Aligned_cols=261  Identities=21%  Similarity=0.276  Sum_probs=195.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |+..+.||.|++|.||+|... +++.+|+|.+.....   ..+.+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            445678999999999999865 688999999865432   2257889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      . ++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          82 H-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             c-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            5 6888877432  245689999999999999999999999   999999999999999999999999999875433221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHhhc--
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQLNK--  293 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~--  293 (340)
                        ......++..|+|||.+.+. ..++.++||||||+++|+|+||+.||.............       ...+.....  
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             --ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence              11223467899999988654 345788999999999999999999987543211000000       000000000  


Q ss_pred             -----CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 -----GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 -----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           .............+.++..+.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                 0000000001112234577889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.5e-40  Score=288.10  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=196.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEE------cCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCS------EGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------~~~~~~  136 (340)
                      ..|++.+.||.|+||.||+|... +++.+|+|++........++..|+.++..+ +|||++++++++.      ..+..+
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            34566789999999999999864 678999999876655556788999999998 7999999999984      346789


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|||+++++|.+++....  ...+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            9999999999999884322  34578889999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      ......  ......++..|+|||.+...   ...++.++|+||||+++|+|++|..||........       .. ....
T Consensus       171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-------~~-~~~~  240 (282)
T cd06636         171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------LF-LIPR  240 (282)
T ss_pred             hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-------hh-hHhh
Confidence            432211  12234588899999987531   23567899999999999999999999865432110       00 1111


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....     ......++.++.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 NPPP-----KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCC-----CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            1110     1111235578999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=283.13  Aligned_cols=246  Identities=22%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccC---CCceeeEeeEEEcCCeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      |++.+.||.|+||.||+|.+. +++.+|+|.+....  ...+++.+|+.+++.++   |||++++++++......+++||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            455678999999999999864 78899999986542  23457888999999986   9999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          83 YAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             cCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999873     23688999999999999999999999   9999999999999999999999999998765443


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||.......       .. ............
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~-~~~~~~~~~~~~  223 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AM-MLIPKSKPPRLE  223 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hh-hccccCCCCCCC
Confidence            32  12334588899999988643 356789999999999999999999997543211       11 011111111111


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .     ...+.++.+++.+||+.||++|||+.++++
T Consensus       224 ~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 D-----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             c-----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1     114568899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-39  Score=281.42  Aligned_cols=256  Identities=23%  Similarity=0.313  Sum_probs=201.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      |++.+.||.|++|+||+|... ++..+++|++.....  ..+.+.+|++.++.++|+|++++++.+...+..++++|+++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            566789999999999999854 678999999875433  34678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++..... ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.........
T Consensus        83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            9999999843321 24688999999999999999999999   9999999999999999999999999998765443322


Q ss_pred             e--eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          224 V--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       224 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ......++..|+|||.+... ...+.++|+||||+++|+|++|+.||.......       ........ .......
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~-~~~~~~~  229 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQN-DPPSLET  229 (267)
T ss_pred             cccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcC-CCCCcCC
Confidence            1  11233588899999998654 357789999999999999999999987543321       01111111 1111110


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ......++..+.+++.+||+.||.+|||+.++++
T Consensus       230 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 -GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             -ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             1111245678899999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.7e-39  Score=281.82  Aligned_cols=246  Identities=23%  Similarity=0.338  Sum_probs=198.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..+.+.+.||+|+||.||+|... ++..+|+|.+.....  ..+.+.+|+.++..++|||++++++++...+..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34556788999999999999765 678999999765432  235688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.     ...+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999883     24678999999999999999999998   99999999999999999999999999987554322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ......++..|+|||.+.+.  ..+.++|+||||+++|+|++|..||.......        ..........     
T Consensus       156 ~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~-----  218 (277)
T cd06641         156 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNNP-----  218 (277)
T ss_pred             h--hhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCCC-----
Confidence            1  11234578899999998754  66789999999999999999999986432211        1111111111     


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ......++.++.+++.+||+.+|.+||++.++++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         219 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             -CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             1122345578899999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=284.30  Aligned_cols=261  Identities=23%  Similarity=0.349  Sum_probs=194.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhccc--CCCceeeEeeEEEcC----CeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI--HHVNVVQLLGFCSEG----SKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv~  139 (340)
                      +..+.+.||+|.||.||+|.++ |+.||||++....  .+.+++|.++++.+  +|+||+.+++.-...    ..+++|+
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT  288 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT  288 (513)
T ss_pred             eeEEEEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence            3445688999999999999998 8899999996543  46788999988775  999999999865332    3478999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-----GCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-----~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      +|.+.|||.|++     ....++.+..++++..+|.||++||.     +.++.|.|||||..|||+.+++.+.|+|+|+|
T Consensus       289 dYHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  289 DYHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             ecccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999     34678899999999999999999995     34678999999999999999999999999999


Q ss_pred             ccCCCCCCc--eeeeccccCcccccccccccccc----ccccccchhhHHHHHHHHHcC----------CCCCCCCcccc
Q 044497          215 KFHPKENDF--VSISATRGTIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG----------RRNSNMHATRS  278 (340)
Q Consensus       215 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~----~~~~~~DvwslG~~l~elltg----------~~p~~~~~~~~  278 (340)
                      .......+.  ...+..+||.+|||||++.....    ..-..+||||||.++||+.-.          +.||....+.+
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            877665433  23456679999999999865321    111258999999999999763          35665443322


Q ss_pred             cccchhHHHHHHhhc-CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          279 SKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       279 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                      .  .+.+ ..+.... ..++.++..-. .......+.++++.||..||.-|.|+-.+-+.|
T Consensus       444 P--s~ee-MrkVVCv~~~RP~ipnrW~-s~~~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  444 P--SFEE-MRKVVCVQKLRPNIPNRWK-SDPALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             C--CHHH-HhcceeecccCCCCCcccc-cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence            1  1111 1111111 11222222211 223456788999999999999999988776655

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.2e-39  Score=280.72  Aligned_cols=247  Identities=26%  Similarity=0.322  Sum_probs=192.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC------hHHHHHHHHHhcccCCCceeeEeeEEEc--CCeeEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAL  137 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l  137 (340)
                      |+..+.||+|+||.||+|... ++..+++|.+......      ...+.+|+.+++.++||||+++++++..  ....++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            455689999999999999764 6889999988643221      2457889999999999999999998865  356889


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ++||+++++|.+++.    ....+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++...
T Consensus        84 ~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          84 FMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            999999999999883    234578899999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          218 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       218 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ...... .......++..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||......       ........... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~-  226 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPT-  226 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCC-
Confidence            322111 111233478899999998764  6788999999999999999999998753221       11111111111 


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           ....+...++.+.+++ +||..+|++|||++|+++
T Consensus       227 -----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 -----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                 1223334556778887 688899999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.8e-40  Score=286.46  Aligned_cols=241  Identities=28%  Similarity=0.376  Sum_probs=197.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|++|.||++... +++.+|+|++.....    ..+.+.+|+++++.++||||+++++++...+..+++|||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            566789999999999999865 688999999865332    235688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.    ....+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++...... 
T Consensus        83 ~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          83 VPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            99999999983    335788999999999999999999998   9999999999999999999999999998765443 


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                          .....+++.|+|||.+.+.  ..+.++|+||||+++|+|++|+.||......        ........+.      
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~------  214 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKILEGK------  214 (290)
T ss_pred             ----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCC------
Confidence                1234588999999998764  6778999999999999999999998754421        1111111111      


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                       ...+...+..+.+++.+||+.||.+||     +++++++
T Consensus       215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence             112223357889999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-39  Score=287.82  Aligned_cols=252  Identities=20%  Similarity=0.203  Sum_probs=194.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||.||++... +++.|++|.+.....    ..+.+.+|+++++.++||||+++++.+...+..+++|||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            456689999999999999865 678999999875432    234678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||+++......
T Consensus        83 ~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          83 VEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999832    34688999999999999999999998   99999999999999999999999999886321110


Q ss_pred             C-------------ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHH
Q 044497          222 D-------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY  288 (340)
Q Consensus       222 ~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  288 (340)
                      .             ........++..|+|||.+.+.  .++.++|+||||+++|+|++|..||......       . ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~-~~  225 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------E-LF  225 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HH
Confidence            0             0001123467889999998764  6788999999999999999999998643321       1 11


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .....+......    .....+.++.+++.+||+.+|++||+..++++.|+
T Consensus       226 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         226 GQVISDDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHhcccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            111111111111    11134577899999999999999999655555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.6e-40  Score=283.11  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=198.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCC-------ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKF-------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      |...+.||+|++|.||++.. .+++.+|+|++.....       ..+.+..|+.+++.++|+|++++++++.+.+..+++
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            44567899999999999975 4788999999865332       125688999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCccC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  217 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~  217 (340)
                      |||+++++|.+++.    ...++++..+..++.|++.||+|||++   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        82 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          82 VEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999883    234688999999999999999999999   999999999999998775 5999999998765


Q ss_pred             CCCCCce--eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          218 PKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       218 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .......  ......++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||........    ........... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~-  227 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASAT-  227 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhccC-
Confidence            4332110  11233578899999998764  677899999999999999999999864432111    11111111111 


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           .....+...++++.+++.+||+.+|.+|||+.++++
T Consensus       228 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 -----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                 112333456788999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-39  Score=279.57  Aligned_cols=246  Identities=24%  Similarity=0.361  Sum_probs=197.4

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |++.+.||+|++|.||++... +++.+|+|.+.....   ....+.+|+++++.++|||++++++.+...+..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            456789999999999999764 788999999865432   2357889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-CceEEecccCCccCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-~~~kl~Dfg~~~~~~~~~  221 (340)
                      ++++|.+++...  ....+++..+..++.+++.+++|||++   +++|+||+|+||+++++ +.++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999999998432  244588999999999999999999999   99999999999999855 467999999998654432


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||......       ........ .....   
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~~~~~-~~~~~---  220 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLKIMS-GTFAP---  220 (256)
T ss_pred             c---ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHHHHHh-cCCCC---
Confidence            2   1234578899999998764  6778999999999999999999998654321       11111111 11111   


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         .+...+.++.+++.+||+.+|.+|||+.|+++
T Consensus       221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               11234578899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-40  Score=290.32  Aligned_cols=265  Identities=21%  Similarity=0.283  Sum_probs=195.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc---CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcC--CeeEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH---TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAL  137 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l  137 (340)
                      |.+.+.||+|++|.||+|...   ++..+|+|.+....    ...+.+.+|+.++..++|||++++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            556788999999999999865   47899999987633    2235678899999999999999999999888  88999


Q ss_pred             EEEccCCCCcccccccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC----CCceEEeccc
Q 044497          138 VYEYMPNGSLDRHIFPKESR-GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSDFG  212 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~----~~~~kl~Dfg  212 (340)
                      ||||+++ ++.+.+...... ...+++..+..++.|++.||+|||+.   +++||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999964 676665433222 24789999999999999999999999   9999999999999999    9999999999


Q ss_pred             CCccCCCCCC-ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc-hh----HH
Q 044497          213 LAKFHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-FP----SW  286 (340)
Q Consensus       213 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-~~----~~  286 (340)
                      ++........ ........++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........... ..    ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            9886543322 1122334578899999987653 3567899999999999999999999976544321000 00    00


Q ss_pred             HHHHhh---------------------cCCCccccccc--h-hhH--HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 VYDQLN---------------------KGGDLELRNVT--E-IES--MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 ~~~~~~---------------------~~~~~~~~~~~--~-~~~--~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +...+.                     ...........  . ...  ..+.++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000                     00000000000  0 111  34567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.5e-40  Score=284.35  Aligned_cols=246  Identities=24%  Similarity=0.294  Sum_probs=200.7

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |++.+.||.|+||.||+|... ++..+|+|++....    ...+.+.+|++++++++|||++++++.+...+..++++||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            456789999999999999876 68899999987543    2346789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++..    ..++++..+..++.|+++||.|||++   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        82 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          82 LLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            999999998832    25788999999999999999999999   99999999999999999999999999988654432


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                         ......++..|+|||.+.+.  ..+.++|+||||+++|+|++|..||.......     ..........       .
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-------~  217 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET-------A  217 (258)
T ss_pred             ---cccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc-------c
Confidence               12334588899999998765  57889999999999999999999987654321     1112221111       1


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCH--HHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSM--TKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~--~evl~  336 (340)
                      ....+...+..+.+++.+||+.||.+||++  +|+++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            112233455889999999999999999999  77653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-40  Score=297.75  Aligned_cols=243  Identities=23%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             hhhhcCCCCCeEEEEEEEc-CCcEEEEEEcc-----CCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCe--eEEEEE
Q 044497           69 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLA-----NSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK--RALVYE  140 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e  140 (340)
                      |...||+|+|-+||+|.+. +|-.||--.++     ++....+++..|+.+|+.|+||||+++++++.+..+  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4568999999999999765 66667643332     233334789999999999999999999999977666  678999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~~  219 (340)
                      .+..|+|..|.    .+........+..|++||++||.|||++ +++|+|||||-+|||++. .|.+||+|+|+|.....
T Consensus       124 L~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  124 LFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             cccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999    3445677889999999999999999998 668999999999999975 58999999999987655


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...    ....|||.|||||....   .|+..+||||||++++||+|+..||.....       +..++.....|..+..
T Consensus       199 s~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~s  264 (632)
T KOG0584|consen  199 SHA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPAA  264 (632)
T ss_pred             ccc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHHH
Confidence            443    22469999999999875   788999999999999999999999986554       3335555555544332


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           +...-.++++++|.+||.. .++|||+.|+|+
T Consensus       265 -----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  265 -----LSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                 2222357899999999999 999999999985

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-40  Score=285.80  Aligned_cols=260  Identities=22%  Similarity=0.288  Sum_probs=195.2

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ++.+.||.|++|.||+|... ++..+|+|++.....   ..+.+.+|+++++.++|||++++++++.+.+..+++|||+ 
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-   80 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-   80 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-
Confidence            45678999999999999865 789999999875432   2356889999999999999999999999999999999999 


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++....  ...+++..+..++.|+++||+|||++   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            468988874322  24689999999999999999999998   999999999999999999999999999875432211 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHh-----
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQL-----  291 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~-----  291 (340)
                       ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||.............       ...+...     
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence             11223467899999988653 346789999999999999999999987543211000000       0000000     


Q ss_pred             --hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 --NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 --~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        .................++..+.+++.+||+.+|++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              000000000111122334578899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.7e-39  Score=278.02  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=202.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      +++.+.||+|++|.||+|... +++.+++|++.....  ..+.+.+|+..+..++|+|++++++++...+..+++|||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            456689999999999999876 589999999876543  34678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      +++|.+++..    ...+++..+..++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 ~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          83 GGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999843    3678999999999999999999999 8   999999999999999999999999999886544332


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      .  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......    ..... .........     
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~-~~~~~~~~~-----  221 (264)
T cd06623         156 Q--CNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPS----FFELM-QAICDGPPP-----  221 (264)
T ss_pred             c--ccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccC----HHHHH-HHHhcCCCC-----
Confidence            1  1233578899999998765  67889999999999999999999987654311    11111 111111111     


Q ss_pred             chhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ..+.. ++..+.+++.+||+.+|++|||+.++++
T Consensus       222 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         222 -SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence             11222 5678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.4e-39  Score=277.73  Aligned_cols=252  Identities=27%  Similarity=0.411  Sum_probs=199.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |...+.||+|++|.||+|... +++.+++|.+......   .+.+.+|+++++.++|+||+++++.+...+..++++||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            456689999999999999765 7889999998765543   467899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++.    .+..+++..+..++.+++.|++|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          82 SGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999883    234578899999999999999999999   999999999999999999999999999886544332


Q ss_pred             cee--eeccccCccccccccccccc-cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          223 FVS--ISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       223 ~~~--~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...  .....++..|+|||.+.+.. ...+.++||||||+++|++++|+.||.......      ..... ...+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~~-~~~~~~~~~  227 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMFH-VGAGHKPPI  227 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHHH-HhcCCCCCC
Confidence            111  12345788999999987652 237789999999999999999999996443110      01111 111111111


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..    ....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       228 ~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PD----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             Cc----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11    1123567889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=287.24  Aligned_cols=250  Identities=25%  Similarity=0.285  Sum_probs=198.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |++.+.||+|++|.||+|... ++..+|+|.+......    .+.+.+|++++..++||||+++++.+......+++|||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            456688999999999999866 5889999999765433    25688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +.+++|.+++..  ..+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          83 CPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             cCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999998842  2345789999999999999999999998   99999999999999999999999999986543221


Q ss_pred             Cce---------------------------eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCC
Q 044497          222 DFV---------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMH  274 (340)
Q Consensus       222 ~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~  274 (340)
                      ...                           ......|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            100                           01123578899999998765  6788999999999999999999998754


Q ss_pred             cccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 044497          275 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS----MTKVLE  336 (340)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps----~~evl~  336 (340)
                      ....       .........  .....    ....+..+.+++.+||+.||++|||    ++++++
T Consensus       236 ~~~~-------~~~~~~~~~--~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDE-------TFSNILKKE--VTFPG----SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHH-------HHHHHhcCC--ccCCC----ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            4321       111111111  11111    1115678999999999999999999    877775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.4e-39  Score=277.56  Aligned_cols=241  Identities=24%  Similarity=0.297  Sum_probs=194.4

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ||.|++|.||+|... +++.+++|++.....    ..+.+.+|+.+++.++||||+++++.+.+.+..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999876 588999999875432    235788999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++..    ...+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||++........   ..
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~  150 (262)
T cd05572          81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TW  150 (262)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cc
Confidence            999833    34588999999999999999999998   999999999999999999999999999986644321   12


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||.......     .............      ...+.
T Consensus       151 ~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~------~~~~~  217 (262)
T cd05572         151 TFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIYNDILKGNGK------LEFPN  217 (262)
T ss_pred             cccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HHHHHHHhccCCC------CCCCc
Confidence            23578899999998664  67889999999999999999999997654311     1111111111111      11222


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                      ..+.++.+++.+||+.+|.+|||     ++|+++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            23578999999999999999999     888875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-39  Score=282.68  Aligned_cols=241  Identities=25%  Similarity=0.335  Sum_probs=186.9

Q ss_pred             hcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcc---cCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           72 KLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGR---IHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .||+|+||.||++... +++.+|+|.+......    ...+.+|..+++.   .+|||++.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999865 6889999998654322    1234445443333   479999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++.    ....+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            999998883    335689999999999999999999999   999999999999999999999999999865433221 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                         ....|+..|+|||.+... ..++.++|+||+||++|+|++|..||........     ........       ....
T Consensus       153 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~-------~~~~  216 (279)
T cd05633         153 ---HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL-------TVNV  216 (279)
T ss_pred             ---cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHhh-------cCCc
Confidence               234589999999988642 2577899999999999999999999975433211     11111110       0111


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                      ..+...+.++.+++.+||+.||++||     |++++++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            23334567899999999999999999     5998876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.4e-39  Score=280.71  Aligned_cols=248  Identities=28%  Similarity=0.371  Sum_probs=200.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      |.+.+.||+|++|.||++... +++.+++|++.......+.+.+|++.++.++|+|++++++.+...+..++++||++++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  100 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG  100 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence            455678999999999999876 6889999999766555678899999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........  .
T Consensus       101 ~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  172 (286)
T cd06614         101 SLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--K  172 (286)
T ss_pred             cHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--h
Confidence            9999984322   3789999999999999999999998   999999999999999999999999998865433221  1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......       .... .........    ..
T Consensus       173 ~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~----~~  238 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------ALFL-ITTKGIPPL----KN  238 (286)
T ss_pred             hccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HHhcCCCCC----cc
Confidence            1233477899999998764  67889999999999999999999986433211       0111 111111111    11


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...++..+.+++.+||+.+|.+|||+.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2235578999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.6e-39  Score=283.10  Aligned_cols=246  Identities=26%  Similarity=0.326  Sum_probs=193.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..|...+.||+|+||.||+|... +++.||+|.+......    .+++.+|+++++.++|||++++++++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            34566789999999999999865 6889999998643322    246889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||++ |++.+.+..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9996 577666632   234689999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCCceeeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ..      ...++..|+|||.+.+ ....++.++||||||+++|+|+||+.||.......       ...... ......
T Consensus       168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~~~-~~~~~~  233 (307)
T cd06607         168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIA-QNDSPT  233 (307)
T ss_pred             CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHHHh-cCCCCC
Confidence            22      2347889999998743 12357789999999999999999999986543211       111111 110000


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           ......+..+.+++.+||+.+|++|||+.+++.
T Consensus       234 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         234 -----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             -----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 111235678999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.5e-39  Score=283.34  Aligned_cols=261  Identities=21%  Similarity=0.264  Sum_probs=195.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcC--CeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~  139 (340)
                      .|.+.+.||.|++|.||+|..+ +++.+++|.++.....   ...+.+|+.+++.++|||++++++++...  +..+++|
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4667789999999999999876 6889999998754332   23567899999999999999999998777  8899999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||++ ++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||++.....
T Consensus        86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            9996 5888877432   23689999999999999999999999   999999999999999999999999999886544


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH-------HHHHHhh
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS-------WVYDQLN  292 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~  292 (340)
                      ...  ......++..|+|||.+.+. ...+.++|+||+|+++|+|++|..||...........+..       ..+....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            321  12233478899999998654 2467899999999999999999999875442111000000       0000000


Q ss_pred             c---CC---C--ccccc-cchhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 K---GG---D--LELRN-VTEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~---~~---~--~~~~~-~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .   ..   .  ..... ...++.. .++.+.+++.+||+.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0   00   0  00000 0111111 3677899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.7e-39  Score=283.97  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=198.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+|.+.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            45667789999999999999754 67899999986533 33467889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++.     ...+++..+..++.|++.|++|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999883     23578889999999999999999999   999999999999999999999999998875443322


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                        ......+++.|+|||.+.+.  .++.++|+||||+++|++++|+.||..........       ... ......    
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~~~-~~~~~~----  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIA-TNGTPE----  234 (293)
T ss_pred             --ccccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------ehh-cCCCCC----
Confidence              11234588899999998764  67889999999999999999999997543321100       000 000111    


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .......+..+.+++.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1112234567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.3e-39  Score=283.17  Aligned_cols=262  Identities=23%  Similarity=0.308  Sum_probs=197.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      |.+.+.||.|++|.||+|... ++..+|+|.+.....  ..+.+.+|+++++.++|||++++++++.+.+..+++|||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            456789999999999999875 688999999876432  34577889999999999999999999999999999999997


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      + +|.+++.... ....+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            4 8888774433 234689999999999999999999998   999999999999999999999999999875433211 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHhhcCCC
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQLNKGGD  296 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~  296 (340)
                       ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||.............       ...++.+.....
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             11223468899999988653 356789999999999999999999987554321100000       000000100000


Q ss_pred             --ccc-----cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 --LEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 --~~~-----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ...     .......+..+..+.+++.+|++.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              000     0001222345678999999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-39  Score=280.04  Aligned_cols=247  Identities=23%  Similarity=0.276  Sum_probs=192.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---C---hHHHHHHHHHhcccCCCceeeEeeEEEc--CCeeEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---S---GEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAL  137 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l  137 (340)
                      |.+.+.||+|+||.||+|... ++..||+|.+.....   .   .+.+.+|+.+++.++||||+++++++.+  ....++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            455689999999999999865 688999998754321   1   2467889999999999999999998866  356889


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +|||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          84 FMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            999999999999883    234578888999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          218 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       218 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ...... .......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......       .......... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~-  226 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPT-  226 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHhcCCC-
Confidence            322111 112234588899999998764  67889999999999999999999986432111       1111111111 


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           ....+...+..+.+++.+|+. +|++|||++++++
T Consensus       227 -----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 -----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                 112334556788899999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=292.04  Aligned_cols=262  Identities=21%  Similarity=0.264  Sum_probs=192.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcC-----CeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l  137 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|.+....  .....+.+|+.+++.++|||++++++++...     ...++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            4566789999999999999764 78899999986432  2235678899999999999999999987544     35799


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ++||+. ++|.+.+     ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        86 v~e~~~-~~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          86 VQELME-TDLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             Eehhcc-cCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999995 5777766     234689999999999999999999999   9999999999999999999999999998755


Q ss_pred             CCCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch--------hHHHH
Q 044497          218 PKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF--------PSWVY  288 (340)
Q Consensus       218 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------~~~~~  288 (340)
                      ....... ......++..|+|||.+.+. ..++.++||||+|+++|+|++|+.||...........+        .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            3322211 11234578899999987543 35778999999999999999999999654321100000        00000


Q ss_pred             --------HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          289 --------DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       289 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                              ..................+..+.++.+++.+||+.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    0000000000000011112346789999999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-40  Score=286.72  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=197.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +|++.+.||+|++|.||+|... +++.|++|.++....   ..+.+.+|+++++.++|+|++++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            3567789999999999999876 678999999875332   336789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      ++++.+..+.    .....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9887776554    2234588999999999999999999999   99999999999999999999999999988655443


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc-------hhHHHHHHhhc-
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-------FPSWVYDQLNK-  293 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~-  293 (340)
                      .. ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........       +.......... 
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            21 11234578899999998764 2667899999999999999999999875432110000       00000000000 


Q ss_pred             ----C-CCccccccc----hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 ----G-GDLELRNVT----EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ----~-~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          + .........    ..+..++.++.+++.+||+.+|++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                0 000000000    112223688999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-39  Score=286.58  Aligned_cols=259  Identities=20%  Similarity=0.289  Sum_probs=193.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccC-CCceeeEeeEEEcCCe-----eE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK-----RA  136 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----~~  136 (340)
                      |.+.+.||+|+||.||+|... +++.||+|.+.....   ....+.+|+.+++.++ |||++++++++...+.     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            456688999999999999865 688999999765432   2356888999999995 6999999999877665     89


Q ss_pred             EEEEccCCCCcccccccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCC
Q 044497          137 LVYEYMPNGSLDRHIFPKESR-GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLA  214 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~  214 (340)
                      ++|||+++ +|.+++...... ...+++..+..++.|++.||+|||++   +++||||+|+||+++. ++.++|+|||.+
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence            99999975 788877543322 45689999999999999999999999   9999999999999998 889999999998


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ........  ......+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.........   .. ........
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~-~~~~~~~~  231 (295)
T cd07837         159 RAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL---LH-IFKLLGTP  231 (295)
T ss_pred             eecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH-HHHHhCCC
Confidence            75432211  11222467889999988653 35688999999999999999999998754321100   00 00000000


Q ss_pred             CC---------------c--cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 GD---------------L--ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~~---------------~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..               .  .........+..+..+.+++.+||+.||.+|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00               0  000001111235678999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.7e-39  Score=279.72  Aligned_cols=243  Identities=25%  Similarity=0.346  Sum_probs=194.2

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      .+.||.|++|.||++... +++.+++|.+..... ..+.+.+|+.+++.++|||++++++++...+..++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            468999999999999854 788999998864332 235688999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++..     ..+++..+..++.|++.||+|||++   +++||||+|+||+++.++.++|+|||.+........  ...
T Consensus       104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~  173 (285)
T cd06648         104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK  173 (285)
T ss_pred             HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence            998832     4578899999999999999999999   999999999999999999999999998865433221  112


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......       . ...............    ..
T Consensus       174 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~~----~~  239 (285)
T cd06648         174 SLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------Q-AMKRIRDNLPPKLKN----LH  239 (285)
T ss_pred             cccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------H-HHHHHHhcCCCCCcc----cc
Confidence            34588899999998764  6788999999999999999999998653321       1 111111111111111    11


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..+.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            24568999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.3e-39  Score=284.24  Aligned_cols=258  Identities=22%  Similarity=0.292  Sum_probs=191.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|.+.+.||+|+||.||+|... +++.+|+|.+......  ...+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM   85 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence            3556789999999999999764 6889999998654322  246788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      . +++.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+++.......
T Consensus        86 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          86 H-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             c-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            5 6777666322   24577888999999999999999999   999999999999999999999999999875432221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH-----------Hh
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD-----------QL  291 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~  291 (340)
                        ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........  .+.. .+.           ..
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~  232 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEK-IWTVLGVPTEDTWPGV  232 (291)
T ss_pred             --CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHH-HHHHcCCCChhhhhhh
Confidence              11223468899999998653 2467789999999999999999999975432100  0000 000           00


Q ss_pred             h---cCCCc--cccccchh---h--HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 N---KGGDL--ELRNVTEI---E--SMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 ~---~~~~~--~~~~~~~~---~--~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .   .....  ........   .  ...+..+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0   00000  00000000   0  011467889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-39  Score=282.87  Aligned_cols=257  Identities=21%  Similarity=0.260  Sum_probs=192.4

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccC-CCceeeEeeEEEcC--CeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e  140 (340)
                      |++.+.||+|+||.||+|... ++..+|+|.++.....  .....+|+..+.++. |+|++++++++.+.  +..+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            345678999999999999865 6889999998764322  234567888888885 99999999999887  88999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |++ ++|.+.+..   ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++ +.++|+|||++......
T Consensus        81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 577777733   234689999999999999999999999   9999999999999999 99999999999765433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc--------hhHHHHHHhh
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY--------FPSWVYDQLN  292 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~~  292 (340)
                      ...   ....++..|+|||.+... ..++.++|+||+||++|+|++|..||......+....        ...+ .....
T Consensus       153 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  227 (282)
T cd07831         153 PPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFR  227 (282)
T ss_pred             CCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhc
Confidence            221   223478899999976543 3567899999999999999999999976543210000        0011 01111


Q ss_pred             cCCCccccc-------cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGDLELRN-------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .........       ........+..+.+++.+||+.+|++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000000       01122345789999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-39  Score=282.26  Aligned_cols=243  Identities=27%  Similarity=0.336  Sum_probs=192.0

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ||+|+||+||+|..+ +++.+|+|.+.....    ....+.+|+++++.++|||++++++.+...+..|++|||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999755 688999999865321    234567899999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+........   ..
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~  152 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK  152 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence            99884332  24689999999999999999999999   999999999999999999999999999875543221   22


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...++..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||..........    .......       ......+.
T Consensus       153 ~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-------~~~~~~~~  219 (277)
T cd05577         153 GRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE----ELKRRTL-------EMAVEYPD  219 (277)
T ss_pred             cccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH----HHHhccc-------cccccCCc
Confidence            34578899999998765  57889999999999999999999986544321111    1111100       01112223


Q ss_pred             HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                      ..++.+.+++.+||+.||.+||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            4467899999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.4e-39  Score=279.45  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=192.7

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHH-hcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      +++.+.||+|+||.||++... +++.||+|.++.....  ...+..|+.. ++..+|||++++++++...+..+++|||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            456688999999999999876 6899999998765432  2455566665 56678999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      + ++|.+++.........+++..+..++.|++.||+|||++  .+++||||||+||+++.++.+||+|||++........
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            5 688777754434456789999999999999999999973  2799999999999999999999999999875533211


Q ss_pred             ceeeeccccCccccccccccccc--cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          223 FVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                         .....++..|+|||.+.+..  ..++.++|+||||+++|+|++|+.||......      .......... ......
T Consensus       160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~~~  229 (283)
T cd06617         160 ---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQLKQVVEE-PSPQLP  229 (283)
T ss_pred             ---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------HHHHHHHHhc-CCCCCC
Confidence               12235788999999886421  24678999999999999999999998643221      0111111111 111111


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           ...++.++.+++.+||+.+|.+|||+.++++
T Consensus       230 -----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         230 -----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 1134678999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.1e-39  Score=287.85  Aligned_cols=263  Identities=22%  Similarity=0.284  Sum_probs=195.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC---CCChHHHHHHHHHhccc-CCCceeeEeeEEEcC--CeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEG--SKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~  136 (340)
                      ...|.+.+.||+|+||.||+|.+. +++.+|+|.+...   ......+.+|+.+++.+ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456777899999999999999865 6789999988542   22235677899999999 999999999998643  4689


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||++ ++|.+++..     ..+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999996 588888732     2678889999999999999999999   999999999999999999999999999976


Q ss_pred             CCCCCCc---eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH--------
Q 044497          217 HPKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS--------  285 (340)
Q Consensus       217 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~--------  285 (340)
                      .......   .......++..|+|||.+.+. ...+.++|+||||+++|+|++|+.||..............        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            5433221   122334588899999987653 3567899999999999999999999965443211000000        


Q ss_pred             --------HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 --------WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                              .....+.................++.++.+++.+||+.+|.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                    000000000000001111111225678999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-38  Score=272.75  Aligned_cols=247  Identities=28%  Similarity=0.434  Sum_probs=199.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      |...+.||+|++|.||++... ++..+++|++..... ..+.+.+|++.++.++|||++++++.+......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            345678999999999999876 688999999977554 457889999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++...   ...+++..+..++.|++.|+++||+.   +++|+||+|+||++++++.++|+|||.+........  
T Consensus        82 ~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          82 GSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999988432   25789999999999999999999998   999999999999999999999999999876654331  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                       .....++..|+|||.+.+.  ..+.++|+||||+++|+|++|+.||.......       ...... .........   
T Consensus       154 -~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~-~~~~~~~~~---  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIA-TNGPPGLRN---  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHH-hcCCCCcCc---
Confidence             2334588899999998765  57789999999999999999999987543211       111111 111111111   


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ....+..+.+++.+||+.||++|||+.++++
T Consensus       220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1113577999999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8e-39  Score=275.39  Aligned_cols=249  Identities=28%  Similarity=0.431  Sum_probs=203.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||.|++|.||++... ++..+++|++.....   ..+.+.+|+++++.++|||++++.+.+......++++|++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            455678999999999999865 688999999876543   3457889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++......+..+++..+..++.+++.||++||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            99999998865443457899999999999999999999999   999999999999999999999999999976544431


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                        ......+++.|+|||...+.  ..+.++|+||+|+++|+|++|+.||......       . ............    
T Consensus       159 --~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~----  222 (258)
T cd08215         159 --LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLL-------E-LALKILKGQYPP----  222 (258)
T ss_pred             --eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHH-------H-HHHHHhcCCCCC----
Confidence              22334588899999988765  5778999999999999999999998654321       1 111111111111    


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              12244578899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=282.38  Aligned_cols=256  Identities=23%  Similarity=0.290  Sum_probs=194.9

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcC--CeeEEEEEc
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYEY  141 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~  141 (340)
                      ++.+.||.|++|.||+|... +++.+|+|.+....   .....+.+|+++++.++|||++++++++...  +..++++||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            45678999999999999876 57899999997653   2235688999999999999999999999887  889999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      ++ ++|.+++...   ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        82 ~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          82 MD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            96 4888877332   25789999999999999999999998   99999999999999999999999999998664443


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC-------
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG-------  294 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  294 (340)
                      .. ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||.........    ..+.......       
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~  228 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL----EKIFELCGSPTDENWPG  228 (287)
T ss_pred             cc-cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHHhCCCchhhccc
Confidence            21 12233467889999987653 35678999999999999999999998754421100    0000000000       


Q ss_pred             ---------CCcccccc---chhhHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 ---------GDLELRNV---TEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ---------~~~~~~~~---~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                               ........   ...... .+..+.+++.+||+.+|.+|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                     00000000   011111 2678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=322.31  Aligned_cols=248  Identities=27%  Similarity=0.347  Sum_probs=202.6

Q ss_pred             hhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           70 THKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      ...||.|.||.||.|.. .+|.-.|+|.++-....   ...+.+|..++..++|||+|+.+|+-...+..++.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            45799999999999974 57888999988753332   256889999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc--
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF--  223 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  223 (340)
                      +|.+.+    ..+...++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.|.........  
T Consensus      1320 sLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             cHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            999998    3455567777788999999999999999   9999999999999999999999999999876554311  


Q ss_pred             eeeeccccCccccccccccccc-cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      ...+...||+.|||||++.+.. .....+.||||+||++.||.||++||...+..-.       +.-....+..      
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-------IMy~V~~gh~------ 1459 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-------IMYHVAAGHK------ 1459 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-------HHhHHhccCC------
Confidence            1224557999999999998754 2445689999999999999999999976554210       1112222323      


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      .+++..++.+-++++.+||..||+.|-++.|+++.
T Consensus      1460 Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            34445588999999999999999999999988863

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.2e-38  Score=274.43  Aligned_cols=249  Identities=27%  Similarity=0.360  Sum_probs=201.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcC--CeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e  140 (340)
                      |...+.||+|++|.||+|... +++.+++|++.....   ..+.+.+|+..+++++|||++++++.+...  +..++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            345678999999999999876 788999999876553   346789999999999999999999999888  88999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      ++++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          82 YVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999843    23789999999999999999999998   9999999999999999999999999998866554


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..........++..|+|||.+.+.  ..+.++|+||||+++|+|++|..||......      ...........      
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~------  220 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSG------  220 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccccC------
Confidence            321112334588899999998765  5788999999999999999999998765411      11111111101      


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .....+...+..+.+++.+|++.+|.+||++.++++
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            111223344688999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.2e-40  Score=292.18  Aligned_cols=244  Identities=22%  Similarity=0.322  Sum_probs=205.7

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||+|.|++|.+|+.. ++..||+|++.++..+.   +.+.+|+++|..++|||||+++.+......+|+||||+
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya  137 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence            456689999999999999765 89999999998866554   45789999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      .+|.+.+++..    .+...+.....++.|+.+|++|||++   +|+|||||++|+|++.+.++||+|||++..+.....
T Consensus       138 ~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  138 SGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             cCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccccc
Confidence            99999999943    44556688899999999999999999   999999999999999999999999999988765432


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                         ..+.+|++.|.|||++.+. ...++++|+||+|+++|.|+.|..||+.....+....               .+...
T Consensus       211 ---lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r---------------vl~gk  271 (596)
T KOG0586|consen  211 ---LQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR---------------VLRGK  271 (596)
T ss_pred             ---ccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccch---------------heeee
Confidence               3566799999999999987 3668899999999999999999999987664432211               01111


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..++--++.++.+++.++|-.+|.+|++++++-+
T Consensus       272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            2233335578889999999999999999998754

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-39  Score=305.32  Aligned_cols=266  Identities=16%  Similarity=0.209  Sum_probs=184.1

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc--CCcEEEEE------------------EccCCCCChHHHHHHHHHhcccCCCce
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH--TGGLIAVK------------------MLANSKFSGEEFINEVSTIGRIHHVNV  122 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~e~~~l~~l~h~~i  122 (340)
                      ....|.+.+.||+|+||+||+|..+  ++...+.|                  .+.........+.+|+++++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3456778899999999999998653  22222222                  111122223467899999999999999


Q ss_pred             eeEeeEEEcCCeeEEEEEccCCCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKES-RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                      +++++++...+..|++++++ +++|.+++..... .........+..++.|++.||+|||++   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            99999999999999999998 4577666533221 122334566788999999999999999   999999999999999


Q ss_pred             CCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCC-CCCCcccccc
Q 044497          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMHATRSSK  280 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p-~~~~~~~~~~  280 (340)
                      .++.+||+|||++......... ......||..|+|||++.+.  .++.++|||||||++|||++|..+ +........ 
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~-  377 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG-  377 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH-
Confidence            9999999999999865433221 11234689999999999875  678899999999999999998754 332221110 


Q ss_pred             cchhH-----------------HHHHHhhcCCCcccccc-ch--hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          281 AYFPS-----------------WVYDQLNKGGDLELRNV-TE--IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       281 ~~~~~-----------------~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..                 ...+.+........... ..  .....+.++.+++.+||+.||++|||+.|+++
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00000                 00111110000000000 00  00113456778899999999999999999986

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=277.24  Aligned_cols=247  Identities=26%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.+.++||+|+||.||+|..+ +|..+|+|.+..+ .+.+++..|+.+|.+.+.|++|+++|.+.....+++|||||..|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            456689999999999999654 7899999988654 35578999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      ++.+.+.   .++.++++..+..++.+.+.||+|||..   .-+|||||+.|||++.+|.+||+|||.+-.+...-.  .
T Consensus       114 SiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K  185 (502)
T KOG0574|consen  114 SISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K  185 (502)
T ss_pred             cHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence            9999984   4567899999999999999999999998   889999999999999999999999999865433211  2


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .++..||+.|||||++..-  .|+.++||||||++..||.-|++||..-.+-..-..        +.....+-    ...
T Consensus       186 RNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--------IPT~PPPT----F~K  251 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--------IPTKPPPT----FKK  251 (502)
T ss_pred             hCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeEe--------ccCCCCCC----CCC
Confidence            2455699999999999875  788899999999999999999999975443211000        00000011    123


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ++..+.++.+++++||-.+|++|-|+.++++
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            4556788999999999999999999999886

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=277.97  Aligned_cols=242  Identities=24%  Similarity=0.270  Sum_probs=187.8

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh----HHHHHHHHH-hcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||.|++|.||+|... +++.+|+|.+.......    ..+..|..+ ....+|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999865 68899999987543211    233444444 3455899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......    
T Consensus        82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  150 (260)
T cd05611          82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----  150 (260)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence            99999883    234688999999999999999999998   9999999999999999999999999998754331    


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                        ....++..|+|||.+.+.  .++.++||||||+++|+|++|..||.......        ...........   ....
T Consensus       151 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~---~~~~  215 (260)
T cd05611         151 --KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--------VFDNILSRRIN---WPEE  215 (260)
T ss_pred             --ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcccC---CCCc
Confidence              233478899999998775  47889999999999999999999996543211        11112111110   1111


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                      ....++..+.+++.+||+.+|++|||+.++.+.|
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            2224567899999999999999999876655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.1e-39  Score=277.12  Aligned_cols=247  Identities=28%  Similarity=0.413  Sum_probs=201.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |++.+.||.|++|.||++... +++.+++|.+.....   ....+.+|+++++.++|+||+++++++......+++|||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            456788999999999999755 778999999875432   2346788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence            99999998855444456789999999999999999999999   99999999999999999999999999997654432 


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                         .....++..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||.......        .......+..      
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~------  218 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKY------  218 (256)
T ss_pred             ---cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCC------
Confidence               1234578899999998764  67789999999999999999999987544211        1111111111      


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1122356678999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-39  Score=287.11  Aligned_cols=261  Identities=21%  Similarity=0.295  Sum_probs=193.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcC--CeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~  139 (340)
                      .|++.+.||.|+||.||+|... +++.||+|.+......   ...+.+|+.++++++|+|++++++++...  +..++||
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM   87 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence            4566789999999999999875 6889999998653322   23567899999999999999999998654  5689999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+. ++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+.....
T Consensus        88 e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          88 EYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             ecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9995 5788777432   25689999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH-------HHHHHhh
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS-------WVYDQLN  292 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~  292 (340)
                      ...  ......++..|+|||.+.+. ..++.++||||+|+++|+|++|+.||...........+..       ..+....
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            321  11223357789999998653 3567899999999999999999999975443211000000       0000000


Q ss_pred             cC---CCccc-----cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KG---GDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~---~~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..   .....     ..........++++.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00   00000     0000111124678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-38  Score=284.12  Aligned_cols=261  Identities=20%  Similarity=0.286  Sum_probs=192.3

Q ss_pred             hhcCCC--CCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQG--GFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G--~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ..||+|  +||+||++.+. +++.||+|++.......   +.+.+|+.+++.++||||+++++++..++..++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  89999999865 78999999987654332   5678899999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99999885432  24588999999999999999999998   99999999999999999999999998654322111100


Q ss_pred             -----eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc------hhHH-------
Q 044497          225 -----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY------FPSW-------  286 (340)
Q Consensus       225 -----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~------~~~~-------  286 (340)
                           ......++..|+|||.+.+....++.++|||||||++|+|++|+.||...........      ...+       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                 0111234567999999876544678899999999999999999999975432110000      0000       


Q ss_pred             HHHHh----------------hcCCCcc---ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 VYDQL----------------NKGGDLE---LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 ~~~~~----------------~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      -....                .......   ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00000                0000000   00011223456788999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=268.35  Aligned_cols=245  Identities=21%  Similarity=0.252  Sum_probs=199.3

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEE----cCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCS----EGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~----~~~~~~lv~e~~~~  144 (340)
                      ++||-|-.|+|-.|..+ +++.+|+|++..+.    ...+|+++--.. .|||||.++++|.    ...++.+|||+|+|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG  143 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG  143 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence            78999999999999755 89999999986543    456777765555 5999999999874    34567899999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCccCCCCC
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~~~~~~~  221 (340)
                      |.|.+.+..+.  ...+.+.++..|..||..|+.|||+.   +|.||||||+|+|...   |..+||+|||+|+......
T Consensus       144 GeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~  218 (400)
T KOG0604|consen  144 GELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG  218 (400)
T ss_pred             hHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence            99999995543  46799999999999999999999999   9999999999999964   5678999999998765533


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                         ...+.+.|+.|.|||++...  .++..+|+||+||++|-|++|.+||.......    +..-....+..+..   ..
T Consensus       219 ---~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gqy---~F  286 (400)
T KOG0604|consen  219 ---DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQY---EF  286 (400)
T ss_pred             ---cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccCc---cC
Confidence               34566789999999999876  78899999999999999999999997655432    22333444444332   12


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+-....++..+++++.+|..+|.+|.|+.++.+
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            23445678899999999999999999999999864

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.2e-39  Score=280.32  Aligned_cols=255  Identities=25%  Similarity=0.319  Sum_probs=191.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      +...+.||+|+||.||++... +++.+|+|.+......  ...+.+|+.++.++. ||||+++++++...+..+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            345578999999999999865 6889999998754332  356789999999996 999999999999999999999998


Q ss_pred             CCCCccccccc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          143 PNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       143 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      . +++.++... .......+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.++|+|||++.......
T Consensus        86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            5 455443311 112235789999999999999999999962  289999999999999999999999999987543322


Q ss_pred             CceeeeccccCccccccccccccc-cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .   .....++..|+|||.+.+.. ..++.++||||||+++|+|++|+.||.....      ......... .+......
T Consensus       163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~  232 (288)
T cd06616         163 A---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQLTQVV-KGDPPILS  232 (288)
T ss_pred             c---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHHhhhc-CCCCCcCC
Confidence            1   12234788999999986531 2577899999999999999999999865431      001111111 11111111


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ......++.++.+|+.+||+.+|.+|||+.++++
T Consensus       233 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         233 --NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             --CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              1111235678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.7e-39  Score=288.40  Aligned_cols=263  Identities=18%  Similarity=0.245  Sum_probs=195.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEE----cCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~  136 (340)
                      ..|.+.+.||.|++|.||+|... ++..||+|++....   .....+.+|+.+++.++||||+++++++.    .....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            34566788999999999999765 78899999987542   23356788999999999999999999875    345689


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|||+. ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999995 68888873    345589999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCc--eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc-----------ch
Q 044497          217 HPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA-----------YF  283 (340)
Q Consensus       217 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-----------~~  283 (340)
                      .......  .......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........-.           ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            4332211  111234588899999998653 357889999999999999999999996543211000           00


Q ss_pred             -----hHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          284 -----PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       284 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           ..........................+.++.+++.+||+.+|.+|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 00000000000000000001122335688999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-39  Score=288.36  Aligned_cols=261  Identities=20%  Similarity=0.276  Sum_probs=194.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC---CCChHHHHHHHHHhcccCCCceeeEeeEEEcC-----CeeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  136 (340)
                      +|.+.+.||+|+||+||+|... +++.||+|.+...   ......+.+|+.+++.++|||++++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            4556789999999999999764 7889999998653   22335678899999999999999999988644     3479


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +++||+. ++|.+++.    ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          86 IVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            9999994 68888773    345689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh--------H---
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP--------S---  285 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--------~---  285 (340)
                      ......  ......++..|+|||.+... ..++.++|+||||+++|+|++|+.||...........+.        +   
T Consensus       158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         158 TSEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cCCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            543321  12334578899999987653 247789999999999999999999996543211000000        0   


Q ss_pred             -----HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          286 -----WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       286 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                           .......................++.++.+++.+||+.+|++|||++++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                 0000000000000000011223467889999999999999999999999863

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-38  Score=282.02  Aligned_cols=261  Identities=16%  Similarity=0.180  Sum_probs=191.7

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      .+.+|.|+++.++++.. +++.+|+|++....   ...+.+.+|+++++.++||||+++++++...+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555555555544 68899999987642   233678999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC----
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND----  222 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~----  222 (340)
                      |.+++...  ....+++..+..++.|+++||+|||++   +++|+||||+||+++.++.++++|||.+........    
T Consensus        86 l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99988433  234588999999999999999999999   999999999999999999999999998864432211    


Q ss_pred             -ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc-----chhHHH----HHHhh
Q 044497          223 -FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA-----YFPSWV----YDQLN  292 (340)
Q Consensus       223 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-----~~~~~~----~~~~~  292 (340)
                       ........++..|+|||.+......++.++|+||||+++|+|++|+.||..........     ..+.+.    .....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence             01112334677899999987643457889999999999999999999997543211000     000000    00000


Q ss_pred             cC----------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KG----------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..          ...............+.++.+++.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            00          000001112233456678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=264.01  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=194.7

Q ss_pred             hhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           69 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +...||.|+.|.|++++.. +|...|||.+..+..  +.++++..+.++..-+ .|+||+.+|+|.......+.||.| .
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence            4567999999999999866 688999999976543  3356777888777664 899999999999999999999998 4


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ..+..++.   .-.+++++..+-++...++.||.||.++  .+++|||+||+|||+|+.|++||||||.+-++-...   
T Consensus       175 ~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---  246 (391)
T KOG0983|consen  175 TCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---  246 (391)
T ss_pred             HHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence            34444442   1246799999999999999999999875  489999999999999999999999999987554332   


Q ss_pred             eeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      ..+...|-+.|||||.+... ...|+.++||||||++++||.||+.||.....+-      +.....+++ ..+.+....
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF------e~ltkvln~-ePP~L~~~~  319 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF------EVLTKVLNE-EPPLLPGHM  319 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH------HHHHHHHhc-CCCCCCccc
Confidence            23445688999999998654 4578899999999999999999999998754321      112223332 222222222


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          .+++++++++..||..|+.+||...++++
T Consensus       320 ----gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  320 ----GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ----CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                26789999999999999999999999886

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.1e-39  Score=282.45  Aligned_cols=258  Identities=22%  Similarity=0.311  Sum_probs=192.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|++.+.||.|++|.||+|... +++.+|+|.+.....   ..+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            3556789999999999999865 788999999865432   235688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~~~  220 (340)
                      ++ ++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+|+||+++. ++.+||+|||++......
T Consensus        83 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         83 LD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            95 5787776332  233467888999999999999999999   9999999999999985 567999999999754332


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC------
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG------  294 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  294 (340)
                      ..  ......++..|+|||.+.+. ..++.++||||+|+++|+|+||+.||........   +.. ........      
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~-~~~~~~~~~~~~~~  229 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFK-IFRILGTPNEETWP  229 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-HHHHhCCCChhhcc
Confidence            11  11233468899999988653 3567899999999999999999999975432110   000 00000000      


Q ss_pred             ------------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 ------------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                  ...............+..+.+++.+|++.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                        000000001112234577899999999999999999999985

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=273.82  Aligned_cols=237  Identities=24%  Similarity=0.311  Sum_probs=199.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.|.+.||+|.||+|.+++-+ +++.+|+|++++...-    ...-..|-++|...+||.+..+.-.|+..+.+|+||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            456799999999999999755 8899999999875432    23456788999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      ..||.|.-++    ++...+++...+-+...|+.||.|||++   +||.||+|.+|.++|.+|++||.|||+++.--...
T Consensus       250 anGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  250 ANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             ccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            9999999888    4456788999999999999999999999   99999999999999999999999999998533322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                        ....+.+|||.|+|||++..+  .|+..+|.|.+||++|||++|+.||...+...        +.+.+.       .+
T Consensus       323 --~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------LFeLIl-------~e  383 (516)
T KOG0690|consen  323 --DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------LFELIL-------ME  383 (516)
T ss_pred             --ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH--------HHHHHH-------hh
Confidence              246788999999999999886  88999999999999999999999997655332        111111       11


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCC
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRP  329 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  329 (340)
                      ...++..++++++.|+.-.|..||++|.
T Consensus       384 d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            1235556778999999999999999996

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.1e-39  Score=277.80  Aligned_cols=245  Identities=23%  Similarity=0.312  Sum_probs=193.6

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ||.|+||.||++... +++.+++|.+.....    ..+.+.+|+++++.++|||++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 589999999876543    235788999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC-----
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-----  222 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----  222 (340)
                      .+++..    ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            998832    23689999999999999999999998   999999999999999999999999999875433211     


Q ss_pred             -ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          223 -FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       223 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                       ........++..|+|||...+.  ..+.++|+||||+++|++++|..||.......        .......+.. ....
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~-~~~~  222 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--------IFQNILNGKI-EWPE  222 (265)
T ss_pred             ccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCc-CCCc
Confidence             0112234578899999998765  57789999999999999999999987544211        1111211111 1111


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .    ...+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       223 ~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 D----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             c----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            0    013578899999999999999999955555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=267.56  Aligned_cols=257  Identities=24%  Similarity=0.315  Sum_probs=207.4

Q ss_pred             hhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCCC-hHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           70 THKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFS-GEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      .+.||+|+|+.|-.|. ..++..+|||++.+.... ..+..+|++++.+. .|+||++++++|+++.+.|+|||.|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3689999999999996 568999999999876544 46899999999998 59999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC---ceEEecccCCccCCCCCC-
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKEND-  222 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~---~~kl~Dfg~~~~~~~~~~-  222 (340)
                      |..+|.    +...|++.+..++..+|+.||.|||.+   ||.|||+||+|||-.+..   -+|||||.+..-...... 
T Consensus       163 lLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  163 LLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             HHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            999994    456789999999999999999999999   999999999999986543   479999988753322221 


Q ss_pred             ----ceeeeccccCccccccccc---cccccccccccchhhHHHHHHHHHcCCCCCCCCccc-------ccccchhHHHH
Q 044497          223 ----FVSISATRGTIGYIAPELI---SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATR-------SSKAYFPSWVY  288 (340)
Q Consensus       223 ----~~~~~~~~g~~~y~aPE~~---~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-------~~~~~~~~~~~  288 (340)
                          .....+.+|+..|||||+.   .+....|+.++|.|||||++|-||+|.+||......       +........+.
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                1123455789999999975   344457889999999999999999999999876542       11222344455


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +.+.++..   ..+..-...++.+..+++...+..+|.+|.++.++++
T Consensus       316 esIQEGkY---eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  316 ESIQEGKY---EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHhccCC---cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            55555532   2223456678999999999999999999999998875

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.5e-39  Score=288.15  Aligned_cols=258  Identities=21%  Similarity=0.219  Sum_probs=192.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcC------C
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEG------S  133 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~  133 (340)
                      ...|...+.||+|+||.||+|... +++.+|+|.+.....   ....+.+|+.+++.++|||++++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            345666789999999999999865 788999999865322   235677899999999999999999988543      3


Q ss_pred             eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      ..|+||||+. ++|.+.+.      ..++...+..++.|++.||+|||++   +++||||||+||++++++.++|+|||+
T Consensus        95 ~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             cEEEEEeccC-CCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            5799999995 58877762      1278889999999999999999999   999999999999999999999999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc--------chhH
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA--------YFPS  285 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--------~~~~  285 (340)
                      +........   .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||...+......        ....
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            986543221   2233578899999998775  67889999999999999999999997543211000        0000


Q ss_pred             H-------HHHHhhcCCCcc-------------ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 W-------VYDQLNKGGDLE-------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 ~-------~~~~~~~~~~~~-------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +       ............             ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0       000000000000             00000011234567899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-39  Score=279.45  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=198.2

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .+.+.||.|++|.||+|... +++.+++|.+......   ...+.+|+++++.++|+|++++++++...+..++++||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            45678999999999999865 7889999998764433   4678899999999999999999999999999999999996


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      + +|.+++...   ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        82 ~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          82 T-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             C-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            5 887777432   25789999999999999999999999   999999999999999999999999999876644331 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch--------hHHHHHHhh---
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF--------PSWVYDQLN---  292 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~---  292 (340)
                       ......++..|+|||.+.+. ..++.++|+||||+++|+|+||+.||............        +........   
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             -cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence             11233477889999998653 35788999999999999999999998754431100000        000000000   


Q ss_pred             ----cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 ----KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          .................+.++.+++.+||+.||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                00000011112233456789999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-38  Score=277.75  Aligned_cols=243  Identities=26%  Similarity=0.348  Sum_probs=193.1

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ...||+|+||.||++... +++.+|+|.+..... ....+.+|+.+++.++|+|++++++.+...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            368999999999999764 788999998854332 335688999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++.     ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++........  ...
T Consensus       105 ~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~  174 (292)
T cd06657         105 TDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK  174 (292)
T ss_pred             HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence            98772     23578899999999999999999999   999999999999999999999999998875433221  112


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||.......        ...............    ..
T Consensus       175 ~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~----~~  240 (292)
T cd06657         175 SLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPKLKN----LH  240 (292)
T ss_pred             ccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhhCCcccCC----cc
Confidence            34578899999988654  66789999999999999999999986533211        111111111111111    11


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..+.+++.+||+.+|.+||++.++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            23567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.3e-38  Score=277.99  Aligned_cols=246  Identities=26%  Similarity=0.343  Sum_probs=193.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .+...+.||+|+||.||++... ++..+|+|.+......    ...+.+|+++++.++|||++++++++...+..+++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3455678999999999999865 6889999998654222    2468889999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |++ |+|.+.+..   ...++++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            996 577776632   235688999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CCceeeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          221 NDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                            ....++..|+|||.+.. ..+..+.++||||||+++|+|++|+.||......       .......... ....
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~  244 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE-SPTL  244 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhcc-CCCC
Confidence                  23357889999998743 1235788999999999999999999998653211       1111111111 1111


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                           .....+..+.+++.+||+.+|.+|||+.++++.
T Consensus       245 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         245 -----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             -----CCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence                 112345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.7e-39  Score=283.26  Aligned_cols=261  Identities=19%  Similarity=0.223  Sum_probs=183.6

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEcC----CcEEEEEEccCCCCCh--H----------HHHHHHHHhcccCCCceee
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLANSKFSG--E----------EFINEVSTIGRIHHVNVVQ  124 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~--~----------~~~~e~~~l~~l~h~~iv~  124 (340)
                      ++....|.+.+.||+|+||+||+|...+    +..+|+|+........  +          ....+...+..+.|+|+++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            3444567788999999999999998653    4466777643322211  1          1223344566778999999


Q ss_pred             EeeEEEcCC----eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE
Q 044497          125 LLGFCSEGS----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (340)
Q Consensus       125 ~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill  200 (340)
                      +++.+....    ..+++++++ ..++.+.+.    .....++..+..++.|++.||+|||+.   +++||||||+|||+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehh-ccCHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            998765433    346777776 345555542    223356788999999999999999999   99999999999999


Q ss_pred             cCCCceEEecccCCccCCCCCCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCc
Q 044497          201 DHNFIPKVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHA  275 (340)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~  275 (340)
                      +.++.++|+|||+++........     .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||....
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999765322211     111234699999999998875  67899999999999999999999997653


Q ss_pred             ccccccc-hhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          276 TRSSKAY-FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       276 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....... ........+..+..        .....++.+.+++..|++.+|++||++.++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        238 HNGNLIHAAKCDFIKRLHEGKI--------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             cchHHHHHhHHHHHHHhhhhhh--------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            2211000 00001111111110        01123578999999999999999999999999874

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.4e-39  Score=282.87  Aligned_cols=262  Identities=23%  Similarity=0.273  Sum_probs=195.2

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCC----
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGS----  133 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----  133 (340)
                      .....|.+.+.||+|+||.||+|..+ +++.+|+|.++....   ....+.+|+++++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34456777899999999999999876 688999999865432   2356778999999999999999999987654    


Q ss_pred             ------eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceE
Q 044497          134 ------KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (340)
Q Consensus       134 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~k  207 (340)
                            ..++++||+++ ++.+.+..   ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999965 67666632   234689999999999999999999999   999999999999999999999


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~  287 (340)
                      |+|||++......... ......++..|+|||.+.+. ...+.++|||||||++|+|++|++||.........    ..+
T Consensus       157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~----~~~  230 (302)
T cd07864         157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL----ELI  230 (302)
T ss_pred             eCcccccccccCCccc-ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHH
Confidence            9999999765443321 11223457789999987643 34678999999999999999999999754321100    000


Q ss_pred             HHHhhcCCC---ccc----------------cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          288 YDQLNKGGD---LEL----------------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       288 ~~~~~~~~~---~~~----------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .........   ...                ..........+..+.+++.+||+.+|.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000000   000                0000111124678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-38  Score=274.65  Aligned_cols=247  Identities=26%  Similarity=0.382  Sum_probs=197.4

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||.|+||.||++..+ ++..+|+|.+....   ...+.+.+|+++++.++|+|++++++.+...+..++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            456788999999999999876 67889999986542   23457789999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCccCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~~~~~  221 (340)
                      ++++|.+++...  .+..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++ .++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999988432  234578999999999999999999999   999999999999998875 46999999987654432


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      ..  .....|+..|+|||...+.  .++.++|+||||+++|+|++|..||.....       ........... ..    
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~-~~----  220 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGY-FA----  220 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhccc-CC----
Confidence            21  1234588899999988764  677899999999999999999999864332       12222222111 11    


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ......+.++.+++.+||+.+|++|||+.++++
T Consensus       221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              111234567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-38  Score=276.53  Aligned_cols=241  Identities=25%  Similarity=0.331  Sum_probs=186.9

Q ss_pred             hcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHH---HhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           72 KLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVS---TIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~---~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .||+|+||.||+|... +++.||+|.+......    ...+..|..   .+....|||++++++.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4799999999999764 6889999998654322    122344433   3444579999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++.    ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            999998873    345689999999999999999999998   999999999999999999999999999875433221 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                         ....|+..|+|||.+.+. ..++.++|+||+|+++|+|++|+.||.........     ....... ...      .
T Consensus       153 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~-~~~------~  216 (278)
T cd05606         153 ---HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTL-TMA------V  216 (278)
T ss_pred             ---cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----HHHHHhh-ccC------C
Confidence               234589999999998643 24678999999999999999999999765322110     0111111 111      1


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                      ..+...+.++.+++.+||+.+|.+||     ++.++++
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            12223467899999999999999999     9999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-38  Score=279.82  Aligned_cols=251  Identities=22%  Similarity=0.254  Sum_probs=195.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEE----cCCcEEEEEEccCCC-----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeE
Q 044497           67 NHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLANSK-----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (340)
                      |++.+.||.|+||.||++..    .++..+|+|++....     ...+.+.+|+.++..+ +|+||+++++.+......+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            45678999999999999975    367899999986532     2235678899999999 6999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          82 LILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999998842    34678999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ....... ......++..|+|||.+.+....++.++||||||+++|+|++|..||.......   .............  
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~--  228 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSE--  228 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhccC--
Confidence            5332211 112345788999999987543456789999999999999999999986432211   1111111111111  


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                            ...+..++..+.+++.+||+.+|.+||     ++.++++
T Consensus       229 ------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                  111223457889999999999999997     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.6e-39  Score=282.68  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=190.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCC--------
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  133 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------  133 (340)
                      .|++.+.||.|+||.||+|... +++.+|+|.+......   ...+.+|+++++.++||||+++++++....        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            4667789999999999999865 6889999988643222   235678999999999999999999986554        


Q ss_pred             eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      ..+++|||+. ++|.+.+..   ....+++..+..++.|+++||+|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        93 ~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence            3599999995 578777632   234689999999999999999999999   999999999999999999999999999


Q ss_pred             CccCCCCCCc--eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch-------h
Q 044497          214 AKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF-------P  284 (340)
Q Consensus       214 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~  284 (340)
                      +.........  .......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+       +
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9755432211  111233477889999987653 34678999999999999999999998654421100000       0


Q ss_pred             HHHHHHhh---cCCCcccccc--chhh-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 SWVYDQLN---KGGDLELRNV--TEIE-----SMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 ~~~~~~~~---~~~~~~~~~~--~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ........   ..........  ....     ...+..+.+++.+||+.||.+|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000000   0000000000  0000     012356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8e-39  Score=280.37  Aligned_cols=254  Identities=22%  Similarity=0.273  Sum_probs=197.4

Q ss_pred             hhhhhhcCCCCCeEEEEEEE----cCCcEEEEEEccCCC-----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeE
Q 044497           67 NHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLANSK-----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (340)
                      |.+.+.||+|++|.||++..    .++..+|+|.++...     ...+.+.+|+.++..+ +|||++++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            45668899999999999974    256789999986532     2235678999999999 6999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+++++|.+++..    ...+++..+..++.|++.+|+|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          82 LILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999988832    34688999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ........ .....++..|+|||.+.+.....+.++|+||||+++|+|++|..||........   ... ......... 
T Consensus       155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~-~~~~~~~~~-  228 (288)
T cd05583         155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSE-ISRRILKSK-  228 (288)
T ss_pred             cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHH-HHHHHHccC-
Confidence            54332211 122347889999999876533467899999999999999999999864322111   111 111111111 


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            ...+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus       229 ------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         229 ------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             ------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                  1122234577899999999999999999888877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.3e-38  Score=272.67  Aligned_cols=239  Identities=18%  Similarity=0.247  Sum_probs=185.5

Q ss_pred             hhhhh--cCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           68 HFTHK--LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        68 ~~~~~--ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .+.+.  ||.|+||.||++... ++..+|+|.+........    |+.....+ +|||++++++.+...+..++||||++
T Consensus        17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~   92 (267)
T PHA03390         17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK   92 (267)
T ss_pred             ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence            34455  499999999999865 788899999876443321    22222222 79999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCccCCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~~~~~~  222 (340)
                      +++|.+++..    ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++ .++|+|||++....... 
T Consensus        93 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-  164 (267)
T PHA03390         93 DGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-  164 (267)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence            9999999832    33789999999999999999999999   999999999999999988 99999999987554322 


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                           ...++..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||.......  .....+....     ..    .
T Consensus       165 -----~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-----~~----~  226 (267)
T PHA03390        165 -----CYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ-----QK----K  226 (267)
T ss_pred             -----cCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh-----cc----c
Confidence                 23478899999999764  67889999999999999999999997443321  1111111111     00    1


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~evl~  336 (340)
                      .......++.+.+++.+||+.+|.+||+ ++++++
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1122246688999999999999999996 688874

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1e-38  Score=285.67  Aligned_cols=255  Identities=21%  Similarity=0.294  Sum_probs=192.9

Q ss_pred             hhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---------------HHHHHHHHHhcccCCCceeeEeeEEEcC
Q 044497           69 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---------------EEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~  132 (340)
                      +.+.||.|+||.||+|.+. +++.||+|.+.......               ..+.+|+++++.++|||++++++++...
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            3467999999999999865 78899999986543221               2477899999999999999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      +..+++|||+. ++|.+++.    ....+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence            99999999995 68888873    345688999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCC------------CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc
Q 044497          213 LAKFHPKEN------------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK  280 (340)
Q Consensus       213 ~~~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~  280 (340)
                      .+.......            .........++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||........ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-  242 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-  242 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            987554111            00111223467889999998754 3467899999999999999999999975543210 


Q ss_pred             cchhHHHHHHhhcCCCc-----------------cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          281 AYFPSWVYDQLNKGGDL-----------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ...+..........                 ............+.++.+++.+||+.+|++|||+++++.
T Consensus       243 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             ---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence               01111111100000                 000001111234577899999999999999999999985

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-38  Score=268.88  Aligned_cols=245  Identities=25%  Similarity=0.387  Sum_probs=199.7

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||+|++|.||++... +++.+++|.+.....   ..+.+.+|++++++++|||++++++++.+.+..+++||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            456789999999999999765 678999999977654   3467899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++..    ...+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          82 ENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999998832    35789999999999999999999999   999999999999999999999999999986654332


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      .  .....++..|+|||...+.  ..+.++|+||+|+++|+|++|+.|+......       ......... ..      
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~-~~------  216 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRIVQD-DH------  216 (254)
T ss_pred             c--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhcc-CC------
Confidence            1  2234578899999998765  4778999999999999999999998643311       111111111 11      


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...+...+..+.+++.+||+.+|++|||+.+++.
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1122234578899999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.4e-38  Score=277.69  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=193.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..++...+.||.|++|.||+|... ++..+++|.+.....    ...++.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            344556678999999999999865 678899999864322    224678899999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+. +++.+.+..   ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        94 ~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          94 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            99996 577776632   234588999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCceeeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          219 KENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ..      ....++..|+|||.+.+ .....+.++||||||+++|+|++|..||.......       .... .......
T Consensus       167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~-~~~~~~~  232 (308)
T cd06634         167 PA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQNESP  232 (308)
T ss_pred             Cc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHH-HhhcCCC
Confidence            32      22347889999998753 11356789999999999999999999986432211       1111 1111111


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      .     ......+..+.+++.+||+.+|.+||++.++++.
T Consensus       233 ~-----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         233 A-----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             C-----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            1     1122355778999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=278.81  Aligned_cols=242  Identities=26%  Similarity=0.365  Sum_probs=201.6

Q ss_pred             hhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           69 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .-++||+||||.||-+..+ +|+-+|.|.+.+...    ......+|-.+|..++.+.||.+--.|+..+.+|+|+..|.
T Consensus       189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN  268 (591)
T KOG0986|consen  189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN  268 (591)
T ss_pred             eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence            3478999999999999754 889999998865332    23457899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      ||+|.-+|.+...  ..++++.+.-++.+|+.||++||+.   +||.||+||+|||+|+.|++.|+|+|+|........ 
T Consensus       269 GGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-  342 (591)
T KOG0986|consen  269 GGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-  342 (591)
T ss_pred             CCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc-
Confidence            9999999966553  5799999999999999999999999   999999999999999999999999999997766543 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                        .....||.+|||||++...  .|+.+.|.||+||++|||+.|+.||...........    +...       .+.+..
T Consensus       343 --~~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE----vdrr-------~~~~~~  407 (591)
T KOG0986|consen  343 --IRGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE----VDRR-------TLEDPE  407 (591)
T ss_pred             --cccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH----HHHH-------Hhcchh
Confidence              3445799999999999886  689999999999999999999999975443221111    1111       122334


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                      +++...+++++++....|+.||++|..-
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhccC
Confidence            5667788999999999999999999753

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=277.51  Aligned_cols=260  Identities=23%  Similarity=0.355  Sum_probs=195.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+.+.||.|++|+||+|... +++.+++|.+......  .....+|+..++.++ |||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            346788999999999999876 5788999998654332  234567999999998 999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                       +++|.+++....  +..+++..+..++.|++.+|.|||++   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             889988874322  35789999999999999999999999   999999999999999999999999999975543322


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc---------hhHHHHHH-hh
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY---------FPSWVYDQ-LN  292 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~---------~~~~~~~~-~~  292 (340)
                         .....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........         -..|.... ..
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             ---cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence               1234578899999988653 3578899999999999999999999865543211000         00000000 00


Q ss_pred             cCCCcccc-----ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGDLELR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ........     ......+..+.++.+++.+||+.+|.+|||++|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000     001111122477999999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=269.31  Aligned_cols=248  Identities=23%  Similarity=0.276  Sum_probs=193.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC------CChHHHHHHHHHhcccCCCceeeEeeEEEcC--CeeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK------FSGEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~  136 (340)
                      .|.+.+.||+|++|.||+|... ++..+|+|.+....      .....+.+|+++++.++||||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            3566789999999999999865 68899999875321      1124678899999999999999999998664  4588


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +++||+++++|.+++.    ....+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||+++.
T Consensus        83 ~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          83 IFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            9999999999999883    234578899999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCC-ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          217 HPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       217 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ...... ........++..|+|||.+.+.  ..+.++|+||||+++|+|++|+.||......       ...........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPT  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCC
Confidence            432111 0111234588899999998764  6778999999999999999999998643211       11111111111


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .      ...+...+..+.+++.+||+ +|..|||+.++++
T Consensus       227 ~------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 K------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             C------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1      12334566789999999999 5799999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=289.29  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=199.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccC-CCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLAN-SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      -+++..-||.|+||+||+|..+ ++-..|-|++.. +....+++.-|+++|....||+||++++.|...++++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3566788999999999999866 344556777754 33445789999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      ||.....+..   -+..+.+..+..+++|++.||.|||++   +|+|||||+.|||++-+|.++|+|||.+-......  
T Consensus       113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--  184 (1187)
T KOG0579|consen  113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--  184 (1187)
T ss_pred             CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH--
Confidence            9999887743   357899999999999999999999999   99999999999999999999999999986433221  


Q ss_pred             eeeeccccCccccccccccc---cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          224 VSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..-..+.|||+|||||+..-   ...+|+.++||||||++|.||.-+.+|.....+        +-+.-.+.....+-  
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaKSePPT--  254 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPPT--  254 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhhcCCCc--
Confidence            12345679999999998642   224788999999999999999999999764332        11111111111111  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ...++..+..+.+++.+||..||..||++.++++
T Consensus       255 --LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 --LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence              1233456678999999999999999999999986

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=303.95  Aligned_cols=252  Identities=22%  Similarity=0.229  Sum_probs=204.4

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ...+.+.+.||+|+||.|..++.+ +++.||+|++++.    .....-|.+|-.+|..-+.+-|++++-.|++..++|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            445667899999999999999865 7889999999872    33446788999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      ||||+||+|..++    ++-.++++..+.-++..|+.||.-+|+.   |+|||||||+|||+|.+|++||+|||.+-.+.
T Consensus       154 MdY~pGGDlltLl----Sk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLL----SKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             EecccCchHHHHH----hhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            9999999999998    3334799999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCceeeeccccCccccccccccc---cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          219 KENDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .++. ......+|||.|.+||++..   ..+.|++.+|.||+||++|||+.|.-||...+..       ......++...
T Consensus       227 ~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-------eTY~KIm~hk~  298 (1317)
T KOG0612|consen  227 ADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-------ETYGKIMNHKE  298 (1317)
T ss_pred             CCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-------HHHHHHhchhh
Confidence            5544 44567789999999999853   2357899999999999999999999999754432       22222222222


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCC---HHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVL  335 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~evl  335 (340)
                      ...++.    ...++.++++||.+.+. +|..|..   ++++-
T Consensus       299 ~l~FP~----~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  299 SLSFPD----ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             hcCCCc----ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            222221    12377889999999885 6788877   66653

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.4e-37  Score=273.14  Aligned_cols=242  Identities=26%  Similarity=0.356  Sum_probs=189.9

Q ss_pred             hhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           69 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ..+.||+|+||.||+|... +++.+++|.+......    ...+.+|+++++.++|||++++++++.+.+..+++|||+.
T Consensus        25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  104 (313)
T cd06633          25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL  104 (313)
T ss_pred             cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence            3467999999999999865 6889999998653322    2467889999999999999999999999999999999995


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                       +++.+.+..   ...++++..+..++.|++.|++|||++   +++|+||+|+||++++++.++|+|||++......   
T Consensus       105 -~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633         105 -GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             -CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence             577776632   235688999999999999999999999   9999999999999999999999999998643222   


Q ss_pred             eeeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                         ....++..|+|||.+.. ....++.++||||||+++|+|++|..||.......       ......... ...    
T Consensus       175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~~-~~~----  239 (313)
T cd06633         175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQND-SPT----  239 (313)
T ss_pred             ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcC-CCC----
Confidence               23458889999999853 12357789999999999999999999986543211       111111111 111    


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ......+..+.+++.+||+.+|.+||++.+++.
T Consensus       240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             111223467899999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-38  Score=283.68  Aligned_cols=262  Identities=20%  Similarity=0.253  Sum_probs=190.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcC----------
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEG----------  132 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----------  132 (340)
                      .+|.+.+.||.|+||.||+|... +++.||+|.+..... ..+.+.+|+++++.++|||++++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            35566789999999999999865 688999999865433 346788999999999999999999766443          


Q ss_pred             ----CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-CCCceE
Q 044497          133 ----SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPK  207 (340)
Q Consensus       133 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-~~~~~k  207 (340)
                          ...+++|||++ ++|.+++.     ...+++..+..++.|+++||.|||+.   +++||||||+||+++ +++.++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence                35789999996 58887772     24688999999999999999999999   999999999999997 456789


Q ss_pred             EecccCCccCCCCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc----
Q 044497          208 VSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY----  282 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~----  282 (340)
                      |+|||.+.......... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........    
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999987543321111 11223478899999987542 3577899999999999999999999965432110000    


Q ss_pred             -----------hhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          283 -----------FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       283 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                 +..........................+.++.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                       000000000000000000001112235578899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=272.79  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=191.6

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhccc---CCCceeeEeeEEEcCCe-----e
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRI---HHVNVVQLLGFCSEGSK-----R  135 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----~  135 (340)
                      ++.+.||+|+||.||+|..+ +++.+|+|.+......   ...+.+|+.+++++   +|||++++++++...+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            45678999999999999876 5889999999753322   23566787777665   69999999999987776     9


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +++|||+. ++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+.
T Consensus        82 ~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             EEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence            99999996 57888774322  23589999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc--
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK--  293 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  293 (340)
                      .......   .....++..|+|||.+.+.  .++.++|+||||+++|+|++|.+||........   +.. +......  
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~-~~~~~~~~~  226 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDK-IFDVIGLPS  226 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHH-HHHHcCCCC
Confidence            6543322   1223478899999998765  678899999999999999999999875443210   000 0000000  


Q ss_pred             ------C--------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 ------G--------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ------~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            .        ...............+..+.+++.+||+.||.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                  0        000000011222345678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.7e-38  Score=275.64  Aligned_cols=246  Identities=23%  Similarity=0.294  Sum_probs=198.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      |.+.+.||+|++|.||++... +++.+++|++..+.    ...+.+.+|++++.+++ ||||+++++++...+..+++||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            556788999999999999865 78899999987632    22356789999999998 9999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      ++++++|.+++..    ...+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          83 YAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999832    34789999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCc------------------eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc
Q 044497          221 NDF------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY  282 (340)
Q Consensus       221 ~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~  282 (340)
                      ...                  .......++..|+|||.....  .++.++|+||||++++++++|+.||.......    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----  229 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----  229 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence            211                  112233478899999988764  57889999999999999999999987654211    


Q ss_pred             hhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 044497          283 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSM----TKVLE  336 (340)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~----~evl~  336 (340)
                         .........        ...+...++.+.+++.+||+.+|.+|||+    +++++
T Consensus       230 ---~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 ---TFQKILKLE--------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHHHHHhcC--------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               011111110        11222346788999999999999999999    88764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.4e-38  Score=272.28  Aligned_cols=248  Identities=23%  Similarity=0.340  Sum_probs=193.4

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC------CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS------KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      |.+.+.||+|+||.||++.+. .+..+++|+++..      .....++..|+.+++.++|||++++++++.+....++++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            567789999999999999765 3445666665431      112235678999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++.........+++..+..++.|+++||.|||+.   +++|+||+|+||++++ +.++|+|||.+.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999988855444456789999999999999999999998   9999999999999975 5699999999876543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.....       ..... ....+..   
T Consensus       158 ~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~-~~~~~~~---  222 (260)
T cd08222         158 SCD--LATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVL-RIVEGPT---  222 (260)
T ss_pred             Ccc--cccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHH-HHHcCCC---
Confidence            322  12234578899999988654  667899999999999999999999864321       11111 1111111   


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ...+..++.++.+++.+||+.+|++||++.++++
T Consensus       223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 ---PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               1123355678999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.3e-38  Score=274.72  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=190.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .+.+.+.||+|++|.||+|..+ +++.+|+|.++.....  ...+..|+.++.... ||||+++++++.+....+++|||
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   95 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL   95 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence            3566789999999999999876 4889999998764332  245667777776664 99999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      + ++++.+.+..   ....+++..+..++.|++.|++|||+ .   +++||||+|+||++++++.++|+|||++......
T Consensus        96 ~-~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          96 M-STCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             c-CcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            8 4567666532   13478899999999999999999996 5   8999999999999999999999999998755432


Q ss_pred             CCceeeeccccCccccccccccccc--cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ..   .....++..|+|||.+.+..  +.++.++|+||||+++|+|++|+.||......      ........... ...
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~~  238 (296)
T cd06618         169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEE-PPS  238 (296)
T ss_pred             Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCC-CCC
Confidence            22   12234778999999987542  34778999999999999999999998643211      01111111111 111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...    ...++.++.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         239 LPP----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111    1124567899999999999999999999975

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.4e-38  Score=279.03  Aligned_cols=255  Identities=20%  Similarity=0.256  Sum_probs=191.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEc-CCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  140 (340)
                      .|.+.+.||.|+||.||++... ++..+|+|.+....   ...+.+..|+++++.++|||++++.+++.. ....++++|
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e   90 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE   90 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence            4556789999999999999755 78899999875422   234678899999999999999999998865 567899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+ +++|.+++.     ...+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        91 ~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          91 LL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             hh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            98 668888772     34578888999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch--------hHHHHHHhh
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF--------PSWVYDQLN  292 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~  292 (340)
                      .     ....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||............        .++.. ...
T Consensus       162 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  234 (328)
T cd07856         162 M-----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN-TIC  234 (328)
T ss_pred             c-----CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH-hcc
Confidence            1     233478899999987652 35788999999999999999999999754421100000        00000 000


Q ss_pred             cCCC------cccccc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGD------LELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~------~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....      ......   .+.....+..+.+++.+||+.+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000      000000   0111234578999999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-38  Score=298.18  Aligned_cols=262  Identities=27%  Similarity=0.429  Sum_probs=211.9

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEc----C----CcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeE
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLH----T----GGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGF  128 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~----~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~  128 (340)
                      .|+......+.+.+|+|.||.|++|...    .    ...||||.++.....  .+.+..|+++|+.+ +|+|++.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3455555566779999999999999632    1    347999999875544  46899999999999 69999999999


Q ss_pred             EEcCCeeEEEEEccCCCCcccccccCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 044497          129 CSEGSKRALVYEYMPNGSLDRHIFPKE---SR-------G--QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH  196 (340)
Q Consensus       129 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~-------~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~  196 (340)
                      |...+..++|+||+..|+|.+++..++   .-       .  ..++...++.++.||+.|++||++.   +++|||+.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            999999999999999999999996655   00       1  2388999999999999999999999   9999999999


Q ss_pred             CeeEcCCCceEEecccCCccCCCCCCceee-eccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCC
Q 044497          197 NILLDHNFIPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMH  274 (340)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~  274 (340)
                      |||+..+..+|++|||+++.......+... +...-+..|||||.+...  .++.++||||||++|||++| |..||...
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            999999999999999999966555444321 111145679999999875  88999999999999999999 78888752


Q ss_pred             cccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          275 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..       ...+.+.+..|.+.+.+.      .++.++.++++.||+.+|++||++.++.+.++
T Consensus       526 ~~-------~~~l~~~l~~G~r~~~P~------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  526 PP-------TEELLEFLKEGNRMEQPE------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             Cc-------HHHHHHHHhcCCCCCCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            21       122345666666654443      44578889999999999999999999999875

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-38  Score=281.61  Aligned_cols=261  Identities=20%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcCC-----eeEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRAL  137 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l  137 (340)
                      |.+.+.||.|++|.||+|... +++.+|+|.+....   ...+.+.+|+.+++.++|||++++++++....     ..|+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            566789999999999999865 58899999987643   23467899999999999999999999987765     7899


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +|||++ ++|.+++.    ....+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||.+...
T Consensus        82 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          82 VTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             Eecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            999996 58888873    334789999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH---------H-
Q 044497          218 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS---------W-  286 (340)
Q Consensus       218 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~---------~-  286 (340)
                      ...... .......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||..............         + 
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            443210 112334578899999998764 2678899999999999999999999976543110000000         0 


Q ss_pred             ------HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 ------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            .......................+..+.+++.+||+.+|.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                  00000000000000001122235678999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-38  Score=280.34  Aligned_cols=253  Identities=23%  Similarity=0.313  Sum_probs=187.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcC------CeeE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRA  136 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~  136 (340)
                      |...+.||+|+||.||+|... +++.+|+|.+.....   ....+.+|+.+++.++||||+++++++...      ...+
T Consensus        17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   96 (342)
T cd07879          17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY   96 (342)
T ss_pred             eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence            445578999999999999864 789999999865322   235678999999999999999999998654      3468


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +++||+. .+|.++.      +..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++..
T Consensus        97 lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          97 LVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             EEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            9999985 4666554      24588999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc--------hhHHHH
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY--------FPSWVY  288 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~--------~~~~~~  288 (340)
                      .....     ....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........-..        .+.+ .
T Consensus       167 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~  239 (342)
T cd07879         167 ADAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF-V  239 (342)
T ss_pred             CCCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-H
Confidence            43221     233478889999998653 2567899999999999999999999975432110000        0000 0


Q ss_pred             HHhhcCC------Ccccccc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 DQLNKGG------DLELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ~~~~~~~------~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +......      .......   ....+..+..+.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000000      0000000   1111234567899999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=287.38  Aligned_cols=202  Identities=28%  Similarity=0.453  Sum_probs=173.1

Q ss_pred             hhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCC--CCChHHHHHHHHHhcccCCCceeeEeeEEEcC------CeeEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANS--KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALV  138 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv  138 (340)
                      ...+.||+|+||.||+|+. .+|+.||||.+++.  ....+...+|+++|++++|||||+++++-++.      ....++
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            4457899999999999984 48999999999874  33457889999999999999999999986543      356799


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC--CC--ceEEecccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NF--IPKVSDFGLA  214 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~--~~--~~kl~Dfg~~  214 (340)
                      ||||.+|+|...+...++ ...+++..++.++.++..||.|||++   +|+||||||.||++..  +|  ..||+|||.|
T Consensus        96 mEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999976653 56799999999999999999999999   9999999999999843  23  4699999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccc
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATR  277 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~  277 (340)
                      +..+.+.   ......||..|++||....+ ..++..+|.|||||++|+..||..||......
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9877666   34567799999999999853 47888999999999999999999999765543

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.6e-38  Score=279.13  Aligned_cols=264  Identities=24%  Similarity=0.264  Sum_probs=190.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcC--------
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEG--------  132 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------  132 (340)
                      ..|.+.+.||+|++|.||+|... +++.+|+|.+.....   ....+.+|+++++.++||||+++++++...        
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            34567789999999999999865 688999999864322   224678899999999999999999987443        


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      ...++++||+.+ ++...+..   ....+++..+..++.|+++||+|||++   +++|+||||+||++++++.++|+|||
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence            346899999954 66666532   235689999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCce---------eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch
Q 044497          213 LAKFHPKENDFV---------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF  283 (340)
Q Consensus       213 ~~~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~  283 (340)
                      ++..........         ......+++.|+|||.+.+. ..++.++||||||+++|+|++|++||...........+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            997543322111         11223467889999987653 35778999999999999999999998754432100000


Q ss_pred             h-------HHHHHH---hhcCC--Ccccccc---chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          284 P-------SWVYDQ---LNKGG--DLELRNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       284 ~-------~~~~~~---~~~~~--~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .       ...+..   .....  .......   ........+.+.+++.+||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0       000000   00000  0000000   0111123467889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-37  Score=279.94  Aligned_cols=256  Identities=20%  Similarity=0.270  Sum_probs=191.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCC------ee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~  135 (340)
                      +|.+.+.||+|+||.||++... ++..||+|++......   .+.+.+|+.+++.++||||+++++++....      ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            4556789999999999999754 7889999998653222   246789999999999999999999986543      35


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +++||++ +++|.+++.     ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++.
T Consensus        96 ~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          96 YLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             EEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence            8999998 778988772     34688999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc-------chhHHHH
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA-------YFPSWVY  288 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~  288 (340)
                      ......     ....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||..........       ..+....
T Consensus       167 ~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         167 QTDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             ccccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            553322     233478899999988653 246789999999999999999999997543211000       0000000


Q ss_pred             HHhhcC---------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 DQLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ~~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+...         ...............+..+.+++.+|++.||++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000         000000001122234567899999999999999999999884

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-37  Score=278.30  Aligned_cols=261  Identities=20%  Similarity=0.229  Sum_probs=189.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-C--CcEEEEEEccCCC---CChHHHHHHHHHhccc-CCCceeeEeeEEEc----CCee
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-T--GGLIAVKMLANSK---FSGEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKR  135 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~--~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~  135 (340)
                      |++.+.||+|+||.||++... +  +..+|+|.+....   ...+.+.+|+.+++++ +||||+++++.+..    ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            456789999999999999865 4  6789999986532   2235678899999999 59999999987532    2457


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +++++++. ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||++.
T Consensus        82 ~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          82 YLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            88899884 68888873    345688999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCc--eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc--------chhH
Q 044497          216 FHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA--------YFPS  285 (340)
Q Consensus       216 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--------~~~~  285 (340)
                      ........  .......|+..|+|||.+.+. ..++.++|+||+|+++|+|++|+.||...+....-.        ....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            55432211  112234588999999987653 357789999999999999999999987543211000        0000


Q ss_pred             HHHHH--------hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 WVYDQ--------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .....        ...................+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000        0000000000001111123568999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.5e-38  Score=299.14  Aligned_cols=247  Identities=27%  Similarity=0.371  Sum_probs=184.2

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEc----------------
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSE----------------  131 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------  131 (340)
                      +.||+||||.||+++.+ +|+.||||++....  .....+.+|+..+.+|+|||||+++..+.+                
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            68999999999999987 89999999997653  333578899999999999999998832210                


Q ss_pred             --------------------------------------------------------------------------------
Q 044497          132 --------------------------------------------------------------------------------  131 (340)
Q Consensus       132 --------------------------------------------------------------------------------  131 (340)
                                                                                                      
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                                            


Q ss_pred             ---------------C--------CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 044497          132 ---------------G--------SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI  188 (340)
Q Consensus       132 ---------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i  188 (340)
                                     +        ..+||=||||+..++.+++..+.-..   .....++++.+|++||+|+|++   ||
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~---gi  718 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQ---GI  718 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhC---ce
Confidence                           0        12456677777766666663221110   3577899999999999999999   99


Q ss_pred             eecCCCCCCeeEcCCCceEEecccCCccCC---C-------------CCCceeeeccccCcccccccccccccc-ccccc
Q 044497          189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHP---K-------------ENDFVSISATRGTIGYIAPELISRNFG-TVSCK  251 (340)
Q Consensus       189 vH~dik~~Nill~~~~~~kl~Dfg~~~~~~---~-------------~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~  251 (340)
                      |||||||.|||++++..+||+|||+|....   .             .......+...||.-|.|||++.+... .|+.|
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            999999999999999999999999997611   0             011113355679999999999987632 68999


Q ss_pred             cchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          252 SDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       252 ~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                      +|+||||++++||+.   ||......       ..+...+.++..   +..+.+.....+.-.+++.+|++.||.+||||
T Consensus       799 iDmYSLGIVlFEM~y---PF~TsMER-------a~iL~~LR~g~i---P~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA  865 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLY---PFGTSMER-------ASILTNLRKGSI---PEPADFFDPEHPEEASLIRWLLSHDPSKRPTA  865 (1351)
T ss_pred             hhhHHHHHHHHHHhc---cCCchHHH-------HHHHHhcccCCC---CCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence            999999999999984   45432221       112233333322   22233344445667889999999999999999


Q ss_pred             HHHHH
Q 044497          332 TKVLE  336 (340)
Q Consensus       332 ~evl~  336 (340)
                      .|+|.
T Consensus       866 ~eLL~  870 (1351)
T KOG1035|consen  866 TELLN  870 (1351)
T ss_pred             HHHhh
Confidence            99985

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-38  Score=282.37  Aligned_cols=256  Identities=21%  Similarity=0.273  Sum_probs=192.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCe------e
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------R  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~  135 (340)
                      .|.+.+.||+|++|.||+|... +++.+|+|++.....   ..+.+.+|+.+++.++|||++++++++...+.      .
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            3556789999999999999875 678999999865322   23567789999999999999999988765554      8


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++++||+ +++|.+++.     ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.
T Consensus        96 ~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          96 YLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             EEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence            9999998 679988873     24689999999999999999999998   99999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch-------hHHHH
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF-------PSWVY  288 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~~~  288 (340)
                      .....     .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+       ++...
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            65332     1233578899999988653 25678999999999999999999999754321100000       00000


Q ss_pred             HHhhcCC------Cccccc---cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 DQLNKGG------DLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ~~~~~~~------~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+....      ......   ........+..+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000000      000000   00111224678999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-37  Score=278.35  Aligned_cols=255  Identities=20%  Similarity=0.261  Sum_probs=188.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcC------CeeE
Q 044497           67 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRA  136 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~  136 (340)
                      |.+.+.||+|+||.||+|.. .+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   98 (345)
T cd07877          19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   98 (345)
T ss_pred             eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence            44567899999999999975 4788999999875332   235678899999999999999999988543      3467


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++++++ +++|.+++.     ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++..
T Consensus        99 lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~  169 (345)
T cd07877          99 LVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  169 (345)
T ss_pred             EEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccc
Confidence            888877 789988772     24588999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch-------hHHHHH
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF-------PSWVYD  289 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~~~~  289 (340)
                      .....     ....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+       +.....
T Consensus       170 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         170 TDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccccc-----cccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            43321     234578899999987652 35678999999999999999999998654321100000       000000


Q ss_pred             HhhcC---------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNKG---------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+...         ...............++++.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            00000         000000000001123567899999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=265.94  Aligned_cols=238  Identities=29%  Similarity=0.384  Sum_probs=192.3

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ||.|++|.||++... +++.+++|.+.....    ..+.+..|+.+++.++|||++++++.+...+..+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999865 588999999876443    235788999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      .+++..    ...+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||.+........  ...
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (250)
T cd05123          81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN  151 (250)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence            999832    34688999999999999999999998   999999999999999999999999999876544321  123


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...++..|+|||.+.+.  ..+.++|+||||+++|++++|+.||...+..       . ........ .      ...+.
T Consensus       152 ~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~-~------~~~~~  214 (250)
T cd05123         152 TFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-------E-IYEKILKD-P------LRFPE  214 (250)
T ss_pred             CCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHhcC-C------CCCCC
Confidence            44578899999998765  5678999999999999999999999654321       1 11111111 1      11222


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCH---HHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSM---TKVLE  336 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~---~evl~  336 (340)
                      ..+..+.+++.+||..||++|||+   +++++
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            235788999999999999999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.6e-38  Score=261.20  Aligned_cols=266  Identities=21%  Similarity=0.263  Sum_probs=195.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-c--C--CcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEc-CCeeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-H--T--GGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-~--~--~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~  136 (340)
                      .|+..+.||+|.||.||+|.. +  +  ...+|+|.++.+..   -.....+|+.+++.++|||++.+..++.. ..+.+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            456678999999999999942 2  2  23789999976532   12567899999999999999999999876 77899


Q ss_pred             EEEEccCCCCcccccccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC----CceEEecc
Q 044497          137 LVYEYMPNGSLDRHIFPK-ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN----FIPKVSDF  211 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~----~~~kl~Df  211 (340)
                      +++||.+. +|...|.-+ ......++...+..++.||+.|++|||++   =+.||||||.|||+..+    |.+||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999965 676666433 23345789999999999999999999998   89999999999999876    89999999


Q ss_pred             cCCccCCCCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc--cchhHHH-
Q 044497          212 GLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK--AYFPSWV-  287 (340)
Q Consensus       212 g~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--~~~~~~~-  287 (340)
                      |+++.+...-... .....+.|..|+|||++.+. ..|+...||||.||++.||+|.++.|.........  .+..+-+ 
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999776543322 33445689999999999986 57899999999999999999998877654432111  1111111 


Q ss_pred             --HHHhhcCCCcc--------------------ccccc------hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          288 --YDQLNKGGDLE--------------------LRNVT------EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       288 --~~~~~~~~~~~--------------------~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        .+.+.......                    ..++.      .....-++...+|+.++|..||.+|.|+++.++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence              11111000000                    00000      000112345889999999999999999999876

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=269.17  Aligned_cols=259  Identities=24%  Similarity=0.307  Sum_probs=195.6

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .+.+.||+|++|.||+|... +++.+++|++....   ...+.+..|+.+++.++|+|++++++++.+.+..++++||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            34578999999999999866 58899999987643   233577899999999999999999999999999999999996


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                       ++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        82 -~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          82 -MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             -cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence             58999884321   4689999999999999999999999   999999999999999999999999999876543322 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHhhcC--
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQLNKG--  294 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~--  294 (340)
                       ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........+.       ...+......  
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence             11223457789999998653 367789999999999999999999986644211000000       0000000000  


Q ss_pred             ---CCcc--ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 ---GDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ---~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ....  ........+..+..+.+++.+||+.+|++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence               0000  00001111223678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-38  Score=281.48  Aligned_cols=237  Identities=22%  Similarity=0.304  Sum_probs=192.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|.+...+|.|+|+.|-.+... +++..++|++.+..   .+..+|+.++... +|||++++.+.+.+....|+|||.+.
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            4566678999999999999654 78899999997762   2234666666555 79999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE-cCCCceEEecccCCccCCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill-~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++-+.+.+..     .+.....+..|+.+|+.|+.|||++   |++|||+||+|||+ ++.++++|+|||.++.....  
T Consensus       400 g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  400 GGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             ccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9888877732     2222367778999999999999999   99999999999999 69999999999999866554  


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                         ....+-|..|.|||++...  .+++++|+||||++||+||+|+.||......       ..+...+..+        
T Consensus       470 ---~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~--------  529 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMP--------  529 (612)
T ss_pred             ---hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCC--------
Confidence               2344678899999999865  8999999999999999999999999765543       1122222222        


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       .+...++..+++|+.+||+.||.+||++.++..
T Consensus       530 -~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 -KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             122567889999999999999999999999864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=265.80  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=206.6

Q ss_pred             CCHHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCC--C----ceeeEeeEE
Q 044497           57 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHH--V----NVVQLLGFC  129 (340)
Q Consensus        57 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~~~~~~  129 (340)
                      +...|....+|.+.+.+|+|.||.|..+.++ .+..||+|+++.-..-.+...-|++++.++.+  |    -++++.+||
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            5556777888888999999999999999765 57899999998876666788899999999942  2    388899999


Q ss_pred             EcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-------
Q 044497          130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-------  202 (340)
Q Consensus       130 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-------  202 (340)
                      .-.++.|+|+|.+ |-|+.+++..  +.-.+++...+..++.|++++++|||+.   +++|-||||+|||+.+       
T Consensus       161 dyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence            9999999999999 7799999943  3346789999999999999999999999   9999999999999832       


Q ss_pred             -------------CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCC
Q 044497          203 -------------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  269 (340)
Q Consensus       203 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~  269 (340)
                                   +..++++|||.|..-....     +..+.|..|+|||++.+-  .++.++||||+||+|.|+.||..
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccce
Confidence                         3468999999998655443     344578999999999986  88899999999999999999999


Q ss_pred             CCCCCcccccccc-------hhHHHH------HHhhcCCCcc-------------------ccccchhhHHHHHHHHHHH
Q 044497          270 NSNMHATRSSKAY-------FPSWVY------DQLNKGGDLE-------------------LRNVTEIESMIARKLCMIG  317 (340)
Q Consensus       270 p~~~~~~~~~~~~-------~~~~~~------~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~l~  317 (340)
                      .|...+..+.-..       +|.-..      ..+..+ ..+                   +............++.+|+
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            8887664321110       111100      011111 000                   0000011123346799999


Q ss_pred             hhcccCCCCCCCCHHHHHH
Q 044497          318 LWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       318 ~~cl~~~p~~Rps~~evl~  336 (340)
                      .+||..||.+|+|+.|+++
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999985

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=268.28  Aligned_cols=243  Identities=25%  Similarity=0.279  Sum_probs=197.9

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh----HHHHHHHHHhccc-CCCceeeEeeEEEcCCee
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  135 (340)
                      +....++|...||+|+||+|-+|..+ +.+.+|||+++++..-+    +--..|-++|..- +-|.+++++.+|+..+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            34455688899999999999999755 67789999998864432    2234566666665 578899999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+||||+.||+|.-+++    +-+.+.+..+.-++..|+-||-+||++   ||+.||||.+||+++.+|++||+|||+++
T Consensus       426 yFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence            99999999999998883    445677788889999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ..--.  .....+.+||+.|+|||++.-+  +|+.++|.||+||+||||+.|++||+..+..+.       ... +.+. 
T Consensus       499 Eni~~--~~TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~a-I~eh-  565 (683)
T KOG0696|consen  499 ENIFD--GVTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQA-IMEH-  565 (683)
T ss_pred             ccccC--CcceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHH-HHHc-
Confidence            43222  2245677899999999999765  889999999999999999999999987665331       111 1111 


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  330 (340)
                            ...++..++.++..+....|...|.+|..
T Consensus       566 ------nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  566 ------NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence                  13456677889999999999999999964

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.7e-37  Score=260.20  Aligned_cols=219  Identities=21%  Similarity=0.159  Sum_probs=174.3

Q ss_pred             CCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCcccccccC
Q 044497           76 GGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK  154 (340)
Q Consensus        76 G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  154 (340)
                      |.+|.||++.+. +++.+|+|.+....    ....|...+....|||++++++++...+..+++|||+++++|.+++.. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK-   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence            899999999865 78899999987643    223444555556799999999999999999999999999999998832 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcc
Q 044497          155 ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG  234 (340)
Q Consensus       155 ~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~  234 (340)
                         ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++++|||.+.......     ....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence               34588999999999999999999998   99999999999999999999999999876543321     22345678


Q ss_pred             ccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHH
Q 044497          235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLC  314 (340)
Q Consensus       235 y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  314 (340)
                      |+|||.+.+.  .++.++|+||+|+++|+|++|+.|+.......             .....      ...+..++..+.
T Consensus       148 y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~------~~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTT------LNIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccccc------cCCcccCCHHHH
Confidence            9999998654  67789999999999999999998765322110             00000      012233567889


Q ss_pred             HHHhhcccCCCCCCCCH
Q 044497          315 MIGLWCIQVKAADRPSM  331 (340)
Q Consensus       315 ~l~~~cl~~~p~~Rps~  331 (340)
                      +++.+||+.||++|||+
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            99999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=265.35  Aligned_cols=261  Identities=22%  Similarity=0.331  Sum_probs=201.3

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCCCh--------HHHHHHHHHhcccCCCceeeEeeEEE-
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--------EEFINEVSTIGRIHHVNVVQLLGFCS-  130 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~-  130 (340)
                      -....+|-+...||+|||+.||+|. ....+-||+|+-.......        +...+|..+-+.|.||.||+++++|. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            3445667778899999999999996 4467889999864322221        34678999999999999999999985 


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc---CCCceE
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPK  207 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~---~~~~~k  207 (340)
                      +.+..|-|.|||+|.+|.-++    .....+++.....|+.||+.||.||.+. +++|+|.||||.|||+-   ..|.+|
T Consensus       539 DtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             ccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence            566788999999999999888    3456788999999999999999999986 67899999999999994   457899


Q ss_pred             EecccCCccCCCCCCc-----eeeeccccCccccccccccc--cccccccccchhhHHHHHHHHHcCCCCCCCCcccccc
Q 044497          208 VSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISR--NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK  280 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~--~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~  280 (340)
                      |.|||+++.+......     ...+...||.+|++||++.-  ..+..+.++||||.||++|+.+.|+.||+....... 
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-  692 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-  692 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-
Confidence            9999999987665432     23456679999999998743  245788899999999999999999999986553210 


Q ss_pred             cchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 044497          281 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                        +..  .+-+.......++    ..+..+.++..+|.+||+..-++|....++.
T Consensus       693 --ILq--eNTIlkAtEVqFP----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  693 --ILQ--ENTILKATEVQFP----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             --HHh--hhchhcceeccCC----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence              000  0111111111111    2234567899999999999999998877764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=272.24  Aligned_cols=242  Identities=26%  Similarity=0.357  Sum_probs=199.5

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      +.||+|.||+||-|..+ +|+.||||++.+-+.   ..+++.+|+.+|..++||.||.+.-.|+..++.++|||.+ .|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            78999999999999754 899999999977443   3467899999999999999999999999999999999999 556


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC---CceEEecccCCccCCCCCCc
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~---~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +.+.+...  ..+++++..-.-++.||+.||.|||.+   +|+|+||||+|||+.+.   -.+||||||+|+..+...-.
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            65655443  357788888889999999999999999   99999999999999654   46899999999987765432


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                         ....||+.|+|||+++.+  .|...-|+||.||++|--++|.-||.....          +.+.+.+.   .+.-+.
T Consensus       724 ---rsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----------IndQIQNA---aFMyPp  785 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDED----------INDQIQNA---AFMYPP  785 (888)
T ss_pred             ---hhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccc----------hhHHhhcc---ccccCC
Confidence               345699999999999876  788899999999999999999999875433          22333332   222233


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .-..+++..+.+||...|+..-.+|.|..+.+.
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            445677889999999999999999999887653

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=230.47  Aligned_cols=257  Identities=23%  Similarity=0.280  Sum_probs=196.2

Q ss_pred             hhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           69 FTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      -.++||+|.||+|++|+. ++++.||+|.+..+..   -.....+|+-+++.++|.|||+++++.....++.+|+||| .
T Consensus         6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-d   84 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-D   84 (292)
T ss_pred             HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-h
Confidence            346899999999999974 4788999999876443   3467899999999999999999999999999999999999 5


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      .+|..+..   +.++.+..+....++.|++.||.|+|++   ++.|||+||.|.+++.+|+.|++|||+++-++-.-  .
T Consensus        85 qdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   85 QDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             HHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            58877773   3457788999999999999999999999   99999999999999999999999999998543321  1


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHH-----HHhhcCC---
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVY-----DQLNKGG---  295 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~---  295 (340)
                      ..+....|..|++|.++.+. .-|+.+.|+||-||++.|+.. |++.|+..+..+.-..+ .+..     +.+....   
T Consensus       157 cysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkri-f~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI-FRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH-HHHhCCCccccCCccccCC
Confidence            23445678999999999875 467889999999999999998 55555554432210000 0000     0000000   


Q ss_pred             -------CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 -------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 -------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                             .+....-.++.+.....-++++.+.+.-+|.+|.++++.++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                   00011112344455566788999999999999999998875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.5e-35  Score=285.72  Aligned_cols=143  Identities=26%  Similarity=0.358  Sum_probs=127.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|.+. +++.||+|++......    ...+..|+.++..++||||+++++++...+..|+|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            3566789999999999999876 7889999998754322    2567889999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+.+++|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.++|+|||+++
T Consensus        85 y~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999998832    34578899999999999999999998   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=256.60  Aligned_cols=253  Identities=21%  Similarity=0.267  Sum_probs=204.7

Q ss_pred             hhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEE-EcCCeeEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALV  138 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv  138 (340)
                      +....+-+|.||.||.|.+.      +.+.+.+|.++....  ....+..|.-.+..+.|||+.++.+++ ++...++++
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~  366 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL  366 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence            33467889999999999544      344677888776443  345788999999999999999999987 566778999


Q ss_pred             EEccCCCCcccccccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          139 YEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      +.++.-|+|..++...+    +....+...++..++.|++.|++|||++   +++|.||..+|.++++...+||+|=.++
T Consensus       367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLS  443 (563)
T KOG1024|consen  367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALS  443 (563)
T ss_pred             EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhc
Confidence            99999999999986322    2344577788899999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhc
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      +..-..+..........+..||+||.+...  .++..+|+|||||++|||+| |+.|+..-++.+        ....+.+
T Consensus       444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------m~~ylkd  513 (563)
T KOG1024|consen  444 RDLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------MEHYLKD  513 (563)
T ss_pred             cccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------HHHHHhc
Confidence            865444433333344467899999999876  88999999999999999998 888987666543        5566667


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      |.+...+.      +++.++..++.-||...|++||+++|+..-|.
T Consensus       514 GyRlaQP~------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  514 GYRLAQPF------NCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             cceecCCC------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            66544333      56789999999999999999999999987653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=253.80  Aligned_cols=252  Identities=24%  Similarity=0.300  Sum_probs=192.5

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      ..||.|+||+|++-..+ .|+..|||.+.....  ++.++..|.+...+- +.||||+++|.+..++.+++.||.| ..|
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence            58999999999999755 789999999976544  346788888766554 7899999999999999999999999 556


Q ss_pred             cccccc-cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          147 LDRHIF-PKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       147 L~~~l~-~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      |..+-. -.......+++..+-.|....+.||.||...  ..|+|||+||+|||++..|.+||||||.+-.+...-   .
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---A  223 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---A  223 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---H
Confidence            653321 0122345688999999999999999999864  489999999999999999999999999986443221   1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .+.-.|-..|||||.+......++.++||||||++|||+.||+-|+..++..      .+.+. ....+..+.+.. ..-
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------feql~-~Vv~gdpp~l~~-~~~  295 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------FEQLC-QVVIGDPPILLF-DKE  295 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------HHHHH-HHHcCCCCeecC-ccc
Confidence            2333578899999999876556899999999999999999999999876541      11111 122222222211 112


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....+..+..++.-|+..|...||...++++
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            2346778999999999999999999999875

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=273.90  Aligned_cols=252  Identities=26%  Similarity=0.344  Sum_probs=207.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEE-----cCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv  138 (340)
                      +.+|.+.||.|.+|.||+++. ++++..|+|+...+....+++..|.++++.. +|||++.++|++.     .++.+++|
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            345678999999999999974 4788999999999888889999999999998 6999999999884     35679999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      ||||.+||..|++..-.  +..+.|..+..|+..++.|+.+||.+   .++|||||-.|||++.++.+||+|||.+....
T Consensus       100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            99999999999985443  78899999999999999999999999   99999999999999999999999999987554


Q ss_pred             CCCCceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          219 KENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ....  ...+..||+.|||||++.-.   ...++.++|+||||++..||.-|.+|+.++-+-          ...+.-..
T Consensus       175 sT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----------raLF~IpR  242 (953)
T KOG0587|consen  175 STVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----------RALFLIPR  242 (953)
T ss_pred             cccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----------hhhccCCC
Confidence            3322  33566799999999998532   236778999999999999999999998765431          11222111


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .++..  ...+..-+.++.++|..||..|..+||++.++++
T Consensus       243 NPPPk--Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 NPPPK--LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCcc--ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            11111  1234556789999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=267.93  Aligned_cols=236  Identities=23%  Similarity=0.254  Sum_probs=200.7

Q ss_pred             hhhcCCCCCeEEEEEEEcCCc-EEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           70 THKLGQGGFGSVYKGQLHTGG-LIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~-~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ...||-|+||.|=+...+... .+|+|++++.    ....+.+..|-++|...+.|.||+++..|.+....|+.||-|-|
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG  504 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG  504 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence            457999999999999876433 4899998763    22346788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |.|-..+    ...+.|...+..-++..+++|++|||++   +|+.|||||+|.+++.+|-+||.|||+|+.......  
T Consensus       505 GElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--  575 (732)
T KOG0614|consen  505 GELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--  575 (732)
T ss_pred             chhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc--
Confidence            9999988    4456788889999999999999999999   999999999999999999999999999998776653  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                       ..+++||+.|.|||++...  ..+.++|.||||+++|||++|.+||...++        ...++.+..+.+     ...
T Consensus       576 -TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp--------mktYn~ILkGid-----~i~  639 (732)
T KOG0614|consen  576 -TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP--------MKTYNLILKGID-----KIE  639 (732)
T ss_pred             -eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch--------HHHHHHHHhhhh-----hhh
Confidence             3567899999999999876  778899999999999999999999987664        234444444422     234


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCC
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPS  330 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps  330 (340)
                      ++..+.....+|+++....+|.+|..
T Consensus       640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             cccccchhHHHHHHHHHhcCcHhhhc
Confidence            56677788999999999999999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=247.18  Aligned_cols=245  Identities=20%  Similarity=0.291  Sum_probs=196.2

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEc
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .+.+.||+|+|++|-.+... +.+.+|+|++++.-.    +.+....|-.+..+. +||.+|-++.+|+.+..+++|.||
T Consensus       253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey  332 (593)
T KOG0695|consen  253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY  332 (593)
T ss_pred             eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence            34478999999999999755 788999999986433    334566777777776 799999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      ++||+|.-++    .+...++++...-+...|+.||.|||+.   ||+.||+|.+|+|+|..|++||.|+|+++..-...
T Consensus       333 v~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  333 VNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             ecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            9999998877    3456789999999999999999999999   99999999999999999999999999998654443


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      +  ..++.+||+.|.|||++.+.  .|+.++|.|+|||+++||+.|+.||+.-.....+..-.+++...+.+..      
T Consensus       406 d--~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------  475 (593)
T KOG0695|consen  406 D--TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------  475 (593)
T ss_pred             c--ccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc------
Confidence            3  35678899999999999987  8889999999999999999999999865533322222233333332221      


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPS  330 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  330 (340)
                       ..++...+-.+..+++.-|+.||++|..
T Consensus       476 -iriprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  476 -IRIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence             1122234456667888899999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.7e-34  Score=243.76  Aligned_cols=237  Identities=26%  Similarity=0.367  Sum_probs=190.2

Q ss_pred             CCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCccccccc
Q 044497           77 GFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFP  153 (340)
Q Consensus        77 ~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  153 (340)
                      +||.||+|... +++.+++|++......  .+.+.+|++.++.++|+|++++++++......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 5889999999765443  47899999999999999999999999998999999999999999998843


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCc
Q 044497          154 KESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI  233 (340)
Q Consensus       154 ~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~  233 (340)
                      .    ..+++..+..++.+++.++.+||+.   +++|+||+|+||++++++.++++|||.+.......   ......++.
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence            2    2388999999999999999999999   99999999999999999999999999998665432   123345788


Q ss_pred             cccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHH
Q 044497          234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKL  313 (340)
Q Consensus       234 ~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  313 (340)
                      .|+|||.+.+.  ..+.++|+||||+++|+|++|..||......       ..............    ......++.++
T Consensus       151 ~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~----~~~~~~~~~~~  217 (244)
T smart00220      151 EYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPF----PPPEWKISPEA  217 (244)
T ss_pred             CCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCC----ccccccCCHHH
Confidence            99999998754  6677999999999999999999998653211       11122222211111    00000145688


Q ss_pred             HHHHhhcccCCCCCCCCHHHHHH
Q 044497          314 CMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       314 ~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-34  Score=272.87  Aligned_cols=263  Identities=21%  Similarity=0.226  Sum_probs=164.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-C----CcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeE------EEcCCe
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-T----GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF------CSEGSK  134 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~~~~  134 (340)
                      .|.+.+.||+|+||.||+|.+. +    +..||+|++...... +....+  .+....+.++..+...      ......
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence            4566789999999999999875 4    689999987643321 111111  1122222222222111      245667


Q ss_pred             eEEEEEccCCCCcccccccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          135 RALVYEYMPNGSLDRHIFPKES----------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      .++++||+++++|.+++.....                .........+..++.|++.||+|||++   +|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence            8999999999999988743221                011122345668999999999999999   999999999999


Q ss_pred             eEcC-CCceEEecccCCccCCCCCCceeeeccccCcccccccccccccc--------------------ccccccchhhH
Q 044497          199 LLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG--------------------TVSCKSDVYGF  257 (340)
Q Consensus       199 ll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--------------------~~~~~~Dvwsl  257 (340)
                      |+++ ++.+||+|||++......... ......+++.|+|||.+.....                    .++.++|||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9985 679999999999755433222 1234568899999996533211                    13345699999


Q ss_pred             HHHHHHHHcCCCCCCCCccc------ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          258 GMVLLEMAGGRRNSNMHATR------SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       258 G~~l~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                      ||++|||+++..|++.....      ........|... .......+................+|+.+||+.||++|||+
T Consensus       366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            99999999976554321100      000001111110 00000000000000111112345689999999999999999


Q ss_pred             HHHHH
Q 044497          332 TKVLE  336 (340)
Q Consensus       332 ~evl~  336 (340)
                      +++++
T Consensus       445 ~e~L~  449 (566)
T PLN03225        445 KAALA  449 (566)
T ss_pred             HHHhC
Confidence            99986

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.3e-36  Score=239.78  Aligned_cols=265  Identities=22%  Similarity=0.321  Sum_probs=191.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC---CCChHHHHHHHHHhcccCCCceeeEeeEEEc--------
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVVQLLGFCSE--------  131 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------  131 (340)
                      ..+|.-..+||+|.||.||+|+.+ +++.||+|++--.   ..-.....+|+.+|..++|+|++.++..|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            345555678999999999999754 7788898876432   2223567899999999999999999988732        


Q ss_pred             CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecc
Q 044497          132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (340)
Q Consensus       132 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Df  211 (340)
                      ....|+||++|+. +|.-.+.   .....++..++.++..++..||.|+|..   .|+|||+||.|+|++.++.+||+||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence            2348999999954 7777662   2346788999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCCCCCc--eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc-------
Q 044497          212 GLAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-------  282 (340)
Q Consensus       212 g~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------  282 (340)
                      |+++.+......  ...+....|..|++||.+.+. ..++++.|+|+-||++.||+|+.+.+........-..       
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            999755433222  123445579999999999886 5789999999999999999999877665443210000       


Q ss_pred             hhHHHHHHhhc-----CCCcc-cccc-chhhHH------HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          283 FPSWVYDQLNK-----GGDLE-LRNV-TEIESM------IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       283 ~~~~~~~~~~~-----~~~~~-~~~~-~~~~~~------~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +...+|....+     ....+ +... ...-++      -.++..+|+.+++..||.+|+++.+++.
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            00000000000     00000 0000 000011      1247889999999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-35  Score=260.94  Aligned_cols=204  Identities=25%  Similarity=0.327  Sum_probs=170.4

Q ss_pred             hhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.||-|+||.|+++. ..+...+|+|.+.+...    .....+.|-.+|....++-||+++-.|++.+.+|+||+|++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            679999999999996 44677899999876432    2345788999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc---------
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---------  216 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~---------  216 (340)
                      ++..++.    +-+-|++...+-++..+.+|+++.|..   |+|||||||+|||+|.+|++||.|||++.-         
T Consensus       715 DmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  715 DMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            9999883    445688899999999999999999998   999999999999999999999999999842         


Q ss_pred             CCCCCC-------------------------------ceeeeccccCccccccccccccccccccccchhhHHHHHHHHH
Q 044497          217 HPKEND-------------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  265 (340)
Q Consensus       217 ~~~~~~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ell  265 (340)
                      +..++.                               .......+||+.|+|||++...  .++-.+|.||.||+||||+
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHh
Confidence            111000                               0011233599999999999875  7778899999999999999


Q ss_pred             cCCCCCCCCcccccccch
Q 044497          266 GGRRNSNMHATRSSKAYF  283 (340)
Q Consensus       266 tg~~p~~~~~~~~~~~~~  283 (340)
                      .|+.||-...+.+.+..+
T Consensus       866 ~g~~pf~~~tp~~tq~kv  883 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKV  883 (1034)
T ss_pred             hCCCCccCCCCCcceeee
Confidence            999999887776554443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=225.25  Aligned_cols=202  Identities=27%  Similarity=0.390  Sum_probs=166.9

Q ss_pred             hhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh--HHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           69 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG--EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      -...||+|++|.|-+-++. +|...|+|.+..+-.+.  ++...|+.+..+. ..|.+|.++|........++.||.| .
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~  128 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-D  128 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-h
Confidence            3468999999999887654 78999999997654443  5677888876655 7999999999999999999999999 5


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      .||..+-...-..+..+++..+-+|+..+++||.|||++  ..++|||+||+|||++.+|.+|+||||.+-.+.+.-   
T Consensus       129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---  203 (282)
T KOG0984|consen  129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---  203 (282)
T ss_pred             hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh---
Confidence            688766554456678899999999999999999999997  589999999999999999999999999987654332   


Q ss_pred             eeeccccCccccccccccccc--cccccccchhhHHHHHHHHHcCCCCCCCCcc
Q 044497          225 SISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT  276 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~  276 (340)
                      ..+...|-..|+|||.+....  ..|+.++||||||+++.||.+++.||+.+..
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            112235788999999986532  2688899999999999999999999986553

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.1e-33  Score=257.60  Aligned_cols=260  Identities=19%  Similarity=0.209  Sum_probs=176.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-----------------cCCcEEEEEEccCCCCC-hH--------------HHHHHHHH
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-----------------HTGGLIAVKMLANSKFS-GE--------------EFINEVST  113 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-----------------~~~~~vavK~~~~~~~~-~~--------------~~~~e~~~  113 (340)
                      .+.+.++||+|+||.||+|..                 ..++.||||.+...... .+              ....|+..
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            455678999999999999963                 23467999998653321 12              23346666


Q ss_pred             hcccCCCce-----eeEeeEEEc--------CCeeEEEEEccCCCCcccccccCCC--------------------CCCC
Q 044497          114 IGRIHHVNV-----VQLLGFCSE--------GSKRALVYEYMPNGSLDRHIFPKES--------------------RGQS  160 (340)
Q Consensus       114 l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~  160 (340)
                      +.+++|.++     ++++++|..        ....++||||+++++|.+++.....                    ....
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777766543     667777643        3457999999999999988853211                    1123


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcccccccc
Q 044497          161 FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL  240 (340)
Q Consensus       161 ~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~  240 (340)
                      +++..+..++.|++.+|+|||+.   +++||||||+||+++.++.+||+|||++......... ......+++.|+|||.
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE  381 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence            56778899999999999999998   9999999999999999999999999999754332211 1112235789999998


Q ss_pred             cccccc--------------------ccccccchhhHHHHHHHHHcCCC-CCCCCccccc-----ccchhHHHHHHhhcC
Q 044497          241 ISRNFG--------------------TVSCKSDVYGFGMVLLEMAGGRR-NSNMHATRSS-----KAYFPSWVYDQLNKG  294 (340)
Q Consensus       241 ~~~~~~--------------------~~~~~~DvwslG~~l~elltg~~-p~~~~~~~~~-----~~~~~~~~~~~~~~~  294 (340)
                      +.....                    ....+.|+||+||++|+|++|.. |+........     ......|.  .. ..
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~-~~  458 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MY-KG  458 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hh-cc
Confidence            753210                    11224799999999999999875 5543221110     00011111  11 11


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCC---CCCCCHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKA---ADRPSMTKVLE  336 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~Rps~~evl~  336 (340)
                      ....+    ......+....+|+.+||..+|   .+|+|++|+|+
T Consensus       459 ~~~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QKYDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cCCCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111    1122346788999999999766   68999999985

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=240.16  Aligned_cols=258  Identities=22%  Similarity=0.308  Sum_probs=193.8

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC---CCChHHHHHHHHHhcccCCCceeeEeeEEEcCC-----eeEEEEE
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYE  140 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e  140 (340)
                      .+.||-|+||.||..++. +|+.||+|++.+-   -.+.+.+.+|+++|...+|.|++..++..+..+     ..|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            367999999999999765 8999999998652   334578999999999999999999988765443     3678889


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      .| ..+|+..+    .....++...+.-+++||+.||+|||+.   +|.||||||.|.|+++|..+||||||+++.....
T Consensus       138 Lm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  138 LM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            98 66898888    4456788889999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHH-------------
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWV-------------  287 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~-------------  287 (340)
                      . ...++....|.+|+|||++.+. ..|+...||||.||++.|++..+..|....+.+.-..+.+..             
T Consensus       210 ~-~~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  210 D-RLNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             h-hhhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            2 2344556678999999999886 578889999999999999999887776655432111111100             


Q ss_pred             ---HHHhhcCCCcc-cccc--chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          288 ---YDQLNKGGDLE-LRNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       288 ---~~~~~~~~~~~-~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                         .+.+..+.... +.-.  ...+..-..+...+..+++..||..|.+..+.+..
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence               01111111111 0000  01111233566778889999999999998887653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=243.44  Aligned_cols=144  Identities=24%  Similarity=0.396  Sum_probs=122.6

Q ss_pred             CCCCCCCHHHHHH-HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-----C---Cc
Q 044497           52 WMPKRYSYPEIIA-VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-----H---VN  121 (340)
Q Consensus        52 ~~~~~~~~~~~~~-~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h---~~  121 (340)
                      ...+...+.|... .+|.+.++||.|.|++||+|.+. +.+.||+|+.+..+.-.+....|+++|++++     |   .+
T Consensus        64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            3446666677777 88899999999999999999754 7789999999887776788899999999983     3   46


Q ss_pred             eeeEeeEEE----cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 044497          122 VVQLLGFCS----EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (340)
Q Consensus       122 iv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~N  197 (340)
                      ||++++.|.    .+.+.|||+|++ |.+|..+|.....  ..++...+.+|+.|++.||.|||..+  +|+|-||||+|
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN  218 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN  218 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence            999999984    567899999999 8899999865443  45788899999999999999999875  99999999999


Q ss_pred             eeE
Q 044497          198 ILL  200 (340)
Q Consensus       198 ill  200 (340)
                      ||+
T Consensus       219 vLl  221 (590)
T KOG1290|consen  219 VLL  221 (590)
T ss_pred             eee
Confidence            996

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-34  Score=262.17  Aligned_cols=243  Identities=25%  Similarity=0.286  Sum_probs=184.9

Q ss_pred             hhcCCCCCeE-EEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           71 HKLGQGGFGS-VYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        71 ~~ig~G~~g~-v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      +.+|.|+.|+ ||+|... ++.||||.+-.+-  .+...+|+..|+.- .|||||++++.-++....|+..|.| ..+|.
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~  590 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ  590 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence            6789998875 6899875 7899999885432  24567999999888 6999999999999999999999999 67999


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---C--CceEEecccCCccCCCCCC-
Q 044497          149 RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---N--FIPKVSDFGLAKFHPKEND-  222 (340)
Q Consensus       149 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~--~~~kl~Dfg~~~~~~~~~~-  222 (340)
                      +++...............+.+..|+++||++||+.   +||||||||.|||++.   +  ..++|+|||+++....... 
T Consensus       591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             HHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            99965311111111144577899999999999998   9999999999999975   2  4689999999997765543 


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcC-CCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      ........||.+|+|||.+...  ..+..+||||+||++|+.++| ..||+.....+..          +..+...... 
T Consensus       668 ~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N----------Il~~~~~L~~-  734 (903)
T KOG1027|consen  668 FSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN----------ILTGNYTLVH-  734 (903)
T ss_pred             hhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhhh----------hhcCccceee-
Confidence            2334566799999999999875  445589999999999999996 8999865543211          1111111111 


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ..+....++.+||.+|++++|..||||.+|+.
T Consensus       735 ---L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 ---LEPLPDCEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ---eccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence               11111118899999999999999999999974

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.8e-34  Score=250.96  Aligned_cols=271  Identities=20%  Similarity=0.272  Sum_probs=210.3

Q ss_pred             CCCCHHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC------CCceeeEee
Q 044497           55 KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH------HVNVVQLLG  127 (340)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~  127 (340)
                      .++.+.|+.+.+|.+....|+|-||+|.+|.+. .|..||||++.+.+.-.+.-+.|+++|+.|+      --|+++++.
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            457778999999999999999999999999765 5779999999998887788899999999995      348999999


Q ss_pred             EEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-Cce
Q 044497          128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIP  206 (340)
Q Consensus       128 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-~~~  206 (340)
                      .|...+++|+|||-+ ..+|.+.+..-. ....+....+..++.|+..||..|-..   +++|.||||+|||++++ ..+
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence            999999999999998 668888874432 345677788999999999999999998   99999999999999875 467


Q ss_pred             EEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch---
Q 044497          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF---  283 (340)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~---  283 (340)
                      ||||||.|.....+..    +....+..|.|||++.+-  +|+...|+||.||+||||.||+..|+.......-..+   
T Consensus       577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             eeccCccccccccccc----cHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            9999999986655432    222345579999999996  7888999999999999999999888876654321111   


Q ss_pred             ----hH-------HHHHHhhcCC----------------------C------ccccc---cchhhHHHHHHHHHHHhhcc
Q 044497          284 ----PS-------WVYDQLNKGG----------------------D------LELRN---VTEIESMIARKLCMIGLWCI  321 (340)
Q Consensus       284 ----~~-------~~~~~~~~~~----------------------~------~~~~~---~~~~~~~~~~~l~~l~~~cl  321 (340)
                          +.       +....+...-                      .      ..+..   ...-......++.+|+.+||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence                10       0000000000                      0      00000   11222345678999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 044497          322 QVKAADRPSMTKVLE  336 (340)
Q Consensus       322 ~~~p~~Rps~~evl~  336 (340)
                      ..||++|.|..+.|.
T Consensus       731 ~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  731 ILDPEKRITVNQALK  745 (752)
T ss_pred             ccChhhcCCHHHHhc
Confidence            999999999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.6e-31  Score=221.01  Aligned_cols=211  Identities=35%  Similarity=0.581  Sum_probs=181.7

Q ss_pred             cCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCccc
Q 044497           73 LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR  149 (340)
Q Consensus        73 ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  149 (340)
                      ||+|++|.||++... +++.+++|++......  .+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999876 4889999999876553  5789999999999999999999999999899999999999899999


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCCCCCCceeeec
Q 044497          150 HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISA  228 (340)
Q Consensus       150 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~  228 (340)
                      ++....   ..+++..+..++.+++.++++||+.   +++|+||+|+||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            984321   4688999999999999999999999   9999999999999999 89999999999986544321  1223


Q ss_pred             cccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHH
Q 044497          229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM  308 (340)
Q Consensus       229 ~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (340)
                      ..+...|++||..... ...+.++|+|++|+++++|                                            
T Consensus       153 ~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            3477899999988653 3567789999999999998                                            


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          309 IARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       309 ~~~~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                        ..+.+++.+|++.+|.+||++.++++.+
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              4678899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-33  Score=229.65  Aligned_cols=244  Identities=23%  Similarity=0.278  Sum_probs=186.7

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCC---CCChHHHHHHHHHhcccCCCceeeEeeEEEcC------CeeEEEEE
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALVYE  140 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e  140 (340)
                      +.+|.|.- .|.-+.+. .+++||+|.....   .....+..+|..++..++|+|+++++.+|+-.      ...|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            56888887 66666544 7889999987543   23346788999999999999999999998543      34789999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      +| ..+|.+.+.      ..++-.++..++.|++.|++|||+.   +|+||||||+||++..+..+|+.|||+++.....
T Consensus       102 ~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen  102 LM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             hh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence            99 668888873      3456788999999999999999999   9999999999999999999999999999854332


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHH------------
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY------------  288 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~------------  288 (340)
                         ..++....|..|+|||++.+.  .+.+.+||||+||++.||++|+..|.+.+.      +.+|..            
T Consensus       172 ---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~------idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  172 ---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDH------IDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             ---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchH------HHHHHHHHHHhcCCCHHH
Confidence               244566788999999999886  488899999999999999999988774432      112211            


Q ss_pred             -HHhhc--------C------------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 -DQLNK--------G------------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 -~~~~~--------~------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       +.+..        .            .+.......+.+..-...+++++.+||-.||++|.|++++|+
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence             00000        0            000011111222233457889999999999999999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=7.8e-33  Score=219.70  Aligned_cols=257  Identities=17%  Similarity=0.299  Sum_probs=195.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEcC--CeeEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRALVY  139 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~  139 (340)
                      ...|++.+++|+|.++.|+.|. ..+++++++|++++-.  .+.+.+|+.+|+.+. ||||+++++...+.  ..+.+++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            3457788999999999999996 4578899999997643  467899999999997 99999999998664  4478999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP  218 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~  218 (340)
                      ||+.+.++..+.       ..++...+..++.+++.||.|||+.   ||.|||+||.|+++|. ...++|+|+|+|.+..
T Consensus       115 E~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  115 EYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            999988887665       4577788999999999999999999   9999999999999986 4579999999999877


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc----------hhHH--
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY----------FPSW--  286 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~----------~~~~--  286 (340)
                      .....   +-...+..|--||++..- +.++.+-|+|||||++..|+..+.||........+..          +...  
T Consensus       185 p~~eY---nVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  185 PGKEY---NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCcee---eeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            66543   223456678899998763 5778899999999999999999999976554322110          0000  


Q ss_pred             ---------HHHHhhcCCCcccc--ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 ---------VYDQLNKGGDLELR--NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 ---------~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                               ..+.+.......-.  -.++-....++++.+++.+.|..|-++|+|++|...
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                     00111111110000  001111223588999999999999999999999753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=8e-33  Score=245.39  Aligned_cols=194  Identities=22%  Similarity=0.324  Sum_probs=167.4

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChH---------HHHHHHHHhcccC---CCceeeEeeEEEcCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGE---------EFINEVSTIGRIH---HVNVVQLLGFCSEGS  133 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~---------~~~~e~~~l~~l~---h~~iv~~~~~~~~~~  133 (340)
                      |...+.+|.|+||.|++|.++ +...|++|.+.+.+.-.+         ....|+.+|..++   |+||++++++|++.+
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            444578999999999999876 556799999987654332         2457999999997   999999999999999


Q ss_pred             eeEEEEEcc-CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          134 KRALVYEYM-PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       134 ~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      .+|++||.. ++.+|.+++    .....+++.....|+.|++.|+++||+.   +|+|||||-+|+.++.+|-+||+|||
T Consensus       643 ~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             eeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence            999999986 467899999    4567889999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCC
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~  272 (340)
                      .+.+.....    ....+||..|.|||++.+. ...+..-|||++|++||.++....||.
T Consensus       716 saa~~ksgp----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcCCC----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            998665443    3456799999999999886 345677899999999999999988874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-32  Score=219.16  Aligned_cols=250  Identities=19%  Similarity=0.275  Sum_probs=192.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeE-EEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGF-CSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e~  141 (340)
                      ..|++.+++|+|.||.+-++.++ +++.+++|-+........+|.+|...--.| .|.||+.-++. |+..+.+.+++||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            45778899999999999999876 677899999998888889999999887777 58999988764 6778888899999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc--CCCceEEecccCCccCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~--~~~~~kl~Dfg~~~~~~~  219 (340)
                      ++.|+|.+-+.     ...+.+..-..++.|+++|+.|+|++   ++||||||.+|||+.  +...+||||||..+..+.
T Consensus       104 aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  104 APRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             CccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999988772     34567778889999999999999999   999999999999993  345899999999875433


Q ss_pred             CCCceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          220 ENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .     ......+..|.+||.....   .....+.+|+|+||+++|.++||+.||......+    -+.|.+.....+..
T Consensus       176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d----~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD----KPYWEWEQWLKRKN  246 (378)
T ss_pred             e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC----chHHHHHHHhcccC
Confidence            2     2233456789999976432   1245678999999999999999999998443322    23444444444433


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV  334 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ev  334 (340)
                      ..++..   ....++.+..+.++-|..+|++|=-..++
T Consensus       247 ~~~P~~---F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  247 PALPKK---FNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             ccCchh---hcccCHHHHHHHHHhcCCcccccchhHHH
Confidence            332221   12345678888999999999999444443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=239.20  Aligned_cols=249  Identities=23%  Similarity=0.292  Sum_probs=196.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh-HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      |+...++|+|.||.||++++. +++..|+|+++-..... .-...|+-+++..+||||+.++|.+...++.++.||||.+
T Consensus        17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg   96 (829)
T KOG0576|consen   17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG   96 (829)
T ss_pred             hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence            456689999999999999755 88899999998755433 4566899999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|++.-    .-.+++++.++..+.+...++++|||+.   +=+|||||-.||++++.|.+|++|||.+-.....-  .
T Consensus        97 gslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~  167 (829)
T KOG0576|consen   97 GSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A  167 (829)
T ss_pred             Cccccee----eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh--h
Confidence            9999876    3467899999999999999999999999   98999999999999999999999999875433221  1


Q ss_pred             eeeccccCcccccccccc-ccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC--Cccccc
Q 044497          225 SISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG--DLELRN  301 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~-~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  301 (340)
                      ....+.||++|||||+.. +..+.|...+|+|++|++.-|+--.++|-...-+        .-..-.+....  .+.+.+
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr~l~LmTkS~~qpp~lkD  239 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MRALFLMTKSGFQPPTLKD  239 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------HHHHHHhhccCCCCCcccC
Confidence            224556999999999752 3345788899999999999999888777443221        11111121111  111122


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..    .-++.+.++++.|+-.+|++|||++.+|+
T Consensus       240 k~----kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 KT----KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             Cc----cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11    23467889999999999999999988764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.8e-29  Score=212.54  Aligned_cols=198  Identities=32%  Similarity=0.483  Sum_probs=167.5

Q ss_pred             hhhhhcCCCCCeEEEEEEEcC-CcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           68 HFTHKLGQGGFGSVYKGQLHT-GGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~~-~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      .+.+.||.|++|.||++.... ++.+++|.+.....  ..+.+.+|++.+..++|+|++++++++......++++|++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            456789999999999998764 88999999987554  357888999999999999999999999998999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++....   ..+++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+......... 
T Consensus        82 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       82 GDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            99999884322   1178899999999999999999999   9999999999999999999999999998866544210 


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCC
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~  273 (340)
                      ......++..|++||.+. ....++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            112334778899999984 224667799999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=3.8e-30  Score=221.11  Aligned_cols=258  Identities=21%  Similarity=0.281  Sum_probs=192.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +...++||.|.|++||++.+.    ....||+|.+.... ...++.+|++.|..+ .+.||+++.+++..++...+|+||
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~  116 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY  116 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence            445689999999999999643    46689999987654 346799999999999 589999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~~~  220 (340)
                      ++.....++.       ..++...+..++..+..||+++|.+   ||+||||||+|+|.+. .+.-.|+|||+|......
T Consensus       117 ~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  117 FEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             cCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            9998888887       3456788999999999999999999   9999999999999975 467889999998621000


Q ss_pred             ---------------------------------CCce---------eeeccccCccccccccccccccccccccchhhHH
Q 044497          221 ---------------------------------NDFV---------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFG  258 (340)
Q Consensus       221 ---------------------------------~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG  258 (340)
                                                       ....         ......||++|+|||++.+. +..++++||||.|
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~G  265 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeecc
Confidence                                             0000         01122499999999999875 6778899999999


Q ss_pred             HHHHHHHcCCCCCCCCcccccccc-h-----hHHHH------------H---------HhhcCCCc--------cc--cc
Q 044497          259 MVLLEMAGGRRNSNMHATRSSKAY-F-----PSWVY------------D---------QLNKGGDL--------EL--RN  301 (340)
Q Consensus       259 ~~l~elltg~~p~~~~~~~~~~~~-~-----~~~~~------------~---------~~~~~~~~--------~~--~~  301 (340)
                      ++++.+++++.||.....+..... +     ...+.            +         ........        +.  ..
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            999999999999875543321110 0     00000            0         00000000        00  01


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ........+..+.+|+.+|+..||.+|.|+++.|+
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            11222334568899999999999999999999885

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.9e-28  Score=197.79  Aligned_cols=164  Identities=23%  Similarity=0.221  Sum_probs=122.6

Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|.+++..   .+..+++..+..++.|++.||+|||++   +      ||+||+++.++.+++  ||.+.......   
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            678888832   245699999999999999999999998   5      999999999999999  99987654322   


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                          ..||+.|+|||++.+.  .++.++|||||||++|||+||+.||.......      .............. .....
T Consensus        64 ----~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~-~~~~~  130 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELS------AILEILLNGMPADD-PRDRS  130 (176)
T ss_pred             ----CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHHHHHHhccCC-ccccc
Confidence                2588999999999775  67889999999999999999999986543211      11111111111111 11111


Q ss_pred             hhHHHHH--HHHHHHhhcccCCCCCCCCHHHHHHHh
Q 044497          305 IESMIAR--KLCMIGLWCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       305 ~~~~~~~--~l~~l~~~cl~~~p~~Rps~~evl~~L  338 (340)
                      .....+.  ++.+++.+||+.+|.+|||+.++++.+
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~  166 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHC  166 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHH
Confidence            2223333  699999999999999999999999865

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3.8e-29  Score=246.89  Aligned_cols=196  Identities=18%  Similarity=0.189  Sum_probs=136.3

Q ss_pred             ccCC-CceeeEeeEE-------EcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 044497          116 RIHH-VNVVQLLGFC-------SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC  187 (340)
Q Consensus       116 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~  187 (340)
                      .++| +||.+++++|       ......+.++|++ +++|.+++..   ....+++..+..++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4456 6888888877       2334567788987 6799999842   235689999999999999999999999   9


Q ss_pred             eeecCCCCCCeeEcCCC-------------------ceEEecccCCccCCCCCC--------------ceeeeccccCcc
Q 044497          188 ILHFDIKPHNILLDHNF-------------------IPKVSDFGLAKFHPKEND--------------FVSISATRGTIG  234 (340)
Q Consensus       188 ivH~dik~~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~g~~~  234 (340)
                      |+||||||+|||++..+                   .+|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            99999999999996544                   455556665543211000              000011347889


Q ss_pred             ccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHH
Q 044497          235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLC  314 (340)
Q Consensus       235 y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  314 (340)
                      |+|||++.+.  .++.++|||||||++|||++|.+|+.....         .. ..+......     .. .....+...
T Consensus       181 Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~-~~~~~~~~~-----~~-~~~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR---------TM-SSLRHRVLP-----PQ-ILLNWPKEA  242 (793)
T ss_pred             eEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HH-HHHHHhhcC-----hh-hhhcCHHHH
Confidence            9999998775  678999999999999999998887542211         00 111110000     00 001123456


Q ss_pred             HHHhhcccCCCCCCCCHHHHHH
Q 044497          315 MIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       315 ~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .++.+||+.+|.+|||+.|+++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhh
Confidence            7889999999999999999985

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-26  Score=202.32  Aligned_cols=256  Identities=20%  Similarity=0.237  Sum_probs=189.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCC--cEEEEEEccCCCCC-hHHHHHHHHHhcccCC----CceeeEeeEE-EcCCeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTG--GLIAVKMLANSKFS-GEEFINEVSTIGRIHH----VNVVQLLGFC-SEGSKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~--~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~l  137 (340)
                      +|.+.+.||+|+||.||.+.....  ..+|+|........ ...+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            567789999999999999986643  47888887664322 2377889999988863    6899999988 57778999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-----CceEEeccc
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVSDFG  212 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-----~~~kl~Dfg  212 (340)
                      ||+.+ |.+|.++.....  ...++..+...++.|++.+|+++|+.   |++||||||+|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99998 889999763332  57899999999999999999999999   99999999999999764     468999999


Q ss_pred             CCc--cCCCCCC-----cee-eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh
Q 044497          213 LAK--FHPKEND-----FVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP  284 (340)
Q Consensus       213 ~~~--~~~~~~~-----~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~  284 (340)
                      +++  .......     ... ....+||..|.++..+.+.  ..+++.|+||++.++.+++.|..||...........+.
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            998  3221111     001 2345699999999999886  78889999999999999999999996554332211111


Q ss_pred             HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          285 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .......    ...      .....+..+.++...+-+.+..++|....+...|+
T Consensus       251 ~~~~~~~----~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~  295 (322)
T KOG1164|consen  251 KDPRKLL----TDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLK  295 (322)
T ss_pred             HHhhhhc----ccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence            1110000    000      11112345666666666688999999888877653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=194.99  Aligned_cols=248  Identities=20%  Similarity=0.363  Sum_probs=191.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ..++..+|.....|..|+|+++ |..++.|+++..+.+.   .+|.+|.-.|+...||||+.+++.|....++.++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            3456678999999999999998 4567778887654443   57889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEe--cccCCccCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS--DFGLAKFHPKE  220 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~--Dfg~~~~~~~~  220 (340)
                      +.|+|...+.  +..+...+..+..+++.+++.|++|||+. ++-|.-.-+....+++|++.+++|+  |--++.     
T Consensus       270 p~gslynvlh--e~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-----  341 (448)
T KOG0195|consen  270 PFGSLYNVLH--EQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-----  341 (448)
T ss_pred             cchHHHHHHh--cCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-----
Confidence            9999999884  33445567778899999999999999996 4345556788999999999988775  221111     


Q ss_pred             CCceeeeccccCcccccccccccccccc-ccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                          ........+.|++||.++...... -..+|+|||++++||+.|...||...++-+-.       .....++.    
T Consensus       342 ----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkialegl----  406 (448)
T KOG0195|consen  342 ----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIALEGL----  406 (448)
T ss_pred             ----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhhhccc----
Confidence                112234678999999997652222 24689999999999999999999876653211       11111121    


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        +..+++.++..+.+|+.-|+..||.+||.+..++-+||
T Consensus       407 --rv~ippgis~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  407 --RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             --cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence              13455677889999999999999999999999998886

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.7e-25  Score=198.22  Aligned_cols=164  Identities=21%  Similarity=0.213  Sum_probs=125.9

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc--CCcEEEEEEccCCC----C--ChHHHHHHHHHhcccCCCceee-EeeEEEcC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLANSK----F--SGEEFINEVSTIGRIHHVNVVQ-LLGFCSEG  132 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~vavK~~~~~~----~--~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~  132 (340)
                      .....|.+.+.||+|+||+||+|...  +++.+|+|++....    .  ..+.+.+|+++|+.++|+|+++ +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34455777889999999999999764  56778999865321    1  1356899999999999999985 4432    


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCCeeEcCCCceEEecc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDI-KPHNILLDHNFIPKVSDF  211 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~di-k~~Nill~~~~~~kl~Df  211 (340)
                      +..++||||+++++|....    .. .      ...++.+++++|+|||++   ||+|||| ||+|||++.++.++|+||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~----~~-~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR----PH-G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC----cc-c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            4579999999999996321    10 1      146788999999999999   9999999 999999999999999999


Q ss_pred             cCCccCCCCCCcee------eeccccCccccccccccc
Q 044497          212 GLAKFHPKENDFVS------ISATRGTIGYIAPELISR  243 (340)
Q Consensus       212 g~~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~  243 (340)
                      |+++..........      .....+++.|+|||.+..
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99986655432111      134457888999998854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.8e-26  Score=215.98  Aligned_cols=251  Identities=20%  Similarity=0.247  Sum_probs=189.7

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEcc----CCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLA----NSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~----~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ...+|.|++|.|+.+... ....++.|...    ......   ..+..|+-+-..++|||++..+..+.+.....-.|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            467899999977777533 34444444433    211111   1245666677778999998888877666666666999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      |++ +|...+.    ....+....+..++.|++.|++|+|+.   |+.|||+|++|+++..++.+|++|||.+.......
T Consensus       403 ~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  403 CPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             ccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            999 9998883    234678889999999999999999999   99999999999999999999999999998765554


Q ss_pred             Cc--eeeeccccCcccccccccccccccc-ccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          222 DF--VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       222 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ..  .......|+..|+|||.+.+.  .+ ....||||.|+++..|.+|+.||..........      ...........
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~  546 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNI  546 (601)
T ss_pred             chhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcccccccc
Confidence            43  445667799999999999876  34 346899999999999999999998766543221      11111112223


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+...+...++...+.++.+||+.+|.+|.|++++++
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            33445566778889999999999999999999999986

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2e-24  Score=180.81  Aligned_cols=204  Identities=23%  Similarity=0.308  Sum_probs=170.1

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ....|.+.++||+|+||.++.|+ +-++++||||.-. ......++..|...++.|. .++|.+.+-+.+.+-+-.+|+|
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            34557788999999999999997 4479999999643 3334467889999999984 6899999988888888899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-----CCceEEecccCCc
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAK  215 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-----~~~~kl~Dfg~~~  215 (340)
                      .+ |-||+|+..   -.+..|+..++..++.|++.-++|+|++   .+|.|||||+|+|+..     ...+.++|||+|+
T Consensus       105 LL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  105 LL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            99 889988873   3467899999999999999999999999   9999999999999963     3358999999998


Q ss_pred             cCCCCCCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcc
Q 044497          216 FHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT  276 (340)
Q Consensus       216 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~  276 (340)
                      ......+.     .......||.+||+-..+.+.  ..+.+.|+-|||-++++.|-|..||.....
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            66544332     223445699999999998886  678899999999999999999999986543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=3.4e-23  Score=184.12  Aligned_cols=260  Identities=28%  Similarity=0.378  Sum_probs=194.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCC-ceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHV-NVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.+.+.||.|+||.||++...  ..+++|.+......    ...+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            345678999999999999876  78999998764432    46789999999999988 799999999887778999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCccCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKE  220 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~~~~  220 (340)
                      +.++++.+++...... ..+.......+..|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.+......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999666322111 3688899999999999999999999   999999999999999988 7999999999855443


Q ss_pred             CCce----eeeccccCccccccccccccc-cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          221 NDFV----SISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       221 ~~~~----~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ....    ......|+..|+|||.+.+.. ...+...|+||+|++++++++|..|+........    .......+....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~  231 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA----TSQTLKIILELP  231 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc----HHHHHHHHHhcC
Confidence            3221    235567999999999987631 3677889999999999999999999655443100    011111111111


Q ss_pred             Cc--cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DL--ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..  ...............+.+++..|+..+|..|.+..+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            11  000000000223357888999999999999999887653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-24  Score=173.81  Aligned_cols=211  Identities=23%  Similarity=0.280  Sum_probs=169.7

Q ss_pred             CHHHHH-HHHhhhhhhcCCCCCeEEEEEE-EcCCcEEEEEEccCCCCChHHHHHHHHHhcccCC-CceeeEeeEEEcCCe
Q 044497           58 SYPEII-AVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH-VNVVQLLGFCSEGSK  134 (340)
Q Consensus        58 ~~~~~~-~~~~~~~~~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~  134 (340)
                      +.+++. ...|.+.++||+|+||.+|.|. ...|..||+|+-.+... ..++.-|..+.+.+++ ..|..+..+..+...
T Consensus         7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen    7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            334433 3556778999999999999996 56899999998765443 3567889999999975 678888888888888


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecc
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDF  211 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Df  211 (340)
                      -.+||+.. |.+|+++..-   ....++..+++-.+-|++.-++|+|.+   +.+||||||+|+|..-   ...+.|+||
T Consensus        86 nvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDF  158 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDF  158 (341)
T ss_pred             ceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEec
Confidence            99999999 8899988743   346788999999999999999999999   9999999999999964   346889999


Q ss_pred             cCCccCCCCCCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccc
Q 044497          212 GLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS  278 (340)
Q Consensus       212 g~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~  278 (340)
                      |+++...+....     .......||.+|.+-..+.+.  ..+.+.|+-|+|.++.+..-|..||.......
T Consensus       159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t  228 (341)
T KOG1163|consen  159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT  228 (341)
T ss_pred             cchhhhccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence            999865443321     122344699999998877664  56778999999999999999999998765443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=3.7e-25  Score=209.81  Aligned_cols=249  Identities=21%  Similarity=0.239  Sum_probs=183.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCC--CChHHHHHHHHH--hcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSK--FSGEEFINEVST--IGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .+.+.+.+|++.|=+|.+|+++.|. |+||++.+..  .+-+.+.++++-  ...++|||.+++..+-......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            3456789999999999999988665 9999986533  333444443333  4555899999998887777778888899


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc--CCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPK  219 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~--~~~  219 (340)
                      . .-+|.|.+    +.+.-+...+...|+.|++.||.-+|..   ||+|||||.+|||+++-.-+.|+||..-+.  .+.
T Consensus       103 v-khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 V-KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             H-hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            8 55899888    4444566778889999999999999999   999999999999999999999999987653  222


Q ss_pred             CCCc---eeeeccccCccccccccccccc---------cccccccchhhHHHHHHHHHc-CCCCCCCCcccccc---cch
Q 044497          220 ENDF---VSISATRGTIGYIAPELISRNF---------GTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSK---AYF  283 (340)
Q Consensus       220 ~~~~---~~~~~~~g~~~y~aPE~~~~~~---------~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~---~~~  283 (340)
                      ++..   ....+.+.-.+|+|||.+....         +..+++.||||+||++.||++ |++||...+.....   ...
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            2211   1223344556899999874421         125678999999999999998 68888755432211   111


Q ss_pred             hHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ++...+.                 ..+..+++++..|++.||.+|.|+++.|+.-.|
T Consensus       255 ~e~~Le~-----------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  255 PEQLLEK-----------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHHHHHh-----------------CcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            1211111                 223578999999999999999999999987543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.1e-23  Score=171.92  Aligned_cols=138  Identities=16%  Similarity=0.158  Sum_probs=107.9

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---------------------------HHHHHHHHHhcccCCCce
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---------------------------EEFINEVSTIGRIHHVNV  122 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---------------------------~~~~~e~~~l~~l~h~~i  122 (340)
                      .+.||+|++|.||+|...+|+.||+|+++.+....                           .....|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999988789999999997642210                           122349999999987776


Q ss_pred             eeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeecCCCCCCeeEc
Q 044497          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL-HNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dik~~Nill~  201 (340)
                      .....+..  ...++||||++++++.....    ....++...+..++.|++.+|+++ |+.   +++||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            44333222  22389999998877765431    234688899999999999999999 688   999999999999998


Q ss_pred             CCCceEEecccCCccC
Q 044497          202 HNFIPKVSDFGLAKFH  217 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~  217 (340)
                       ++.++|+|||++...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=5.7e-24  Score=175.61  Aligned_cols=173  Identities=14%  Similarity=0.128  Sum_probs=131.9

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHH----------HHHHHHHhcccCCCceeeEeeEE
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE----------FINEVSTIGRIHHVNVVQLLGFC  129 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~h~~iv~~~~~~  129 (340)
                      .++.+.+|...+.+|.|+||.||++.. +++.+|+|++.......+.          +.+|+..+.++.||+|..+.+++
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            355566777789999999999999766 5778999999754333322          57899999999999999999886


Q ss_pred             EcC--------CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          130 SEG--------SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       130 ~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                      ...        +..+++|||++|.+|.+..        .++.    ....+++.+++.+|+.   |++|||++|+|++++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~  169 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS  169 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence            533        3578999999999998764        1222    2456999999999999   999999999999999


Q ss_pred             CCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHH
Q 044497          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  265 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ell  265 (340)
                      +++ ++++|||...........              ..+....  .++.++|+|+||+++....
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a~--------------d~~vler--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKAK--------------DRIDLER--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhhH--------------HHHHHHh--HhcccccccceeEeehHHH
Confidence            988 999999988644222110              0022222  4457899999999987653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.1e-22  Score=166.78  Aligned_cols=140  Identities=19%  Similarity=0.168  Sum_probs=110.5

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---------------------------hHHHHHHHHHhcccCCCce
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---------------------------GEEFINEVSTIGRIHHVNV  122 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~~i  122 (340)
                      .+.||+|++|.||+|...+|+.||+|++......                           ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999998778999999998764211                           1123578899999999887


Q ss_pred             eeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEc
Q 044497          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~  201 (340)
                      .....+...  ..++||||++++++.....    ....++......++.|++.++.++|+ .   |++||||||+||+++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            544444333  2489999998875543321    12456788899999999999999999 8   999999999999998


Q ss_pred             CCCceEEecccCCccCCC
Q 044497          202 HNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~  219 (340)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             78999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=3.2e-23  Score=176.20  Aligned_cols=232  Identities=20%  Similarity=0.264  Sum_probs=147.6

Q ss_pred             hhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccC----------CCceeeEeeEE----
Q 044497           69 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIH----------HVNVVQLLGFC----  129 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~----------h~~iv~~~~~~----  129 (340)
                      ..+.||.|+++.||.+++. +++.+|+|+.......    .+++.+|.-....+.          |-.++-.++..    
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            3468999999999999876 7899999997543322    245666665554432          21222222222    


Q ss_pred             -----EcC---C-----eeEEEEEccCCCCccccccc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC
Q 044497          130 -----SEG---S-----KRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDI  193 (340)
Q Consensus       130 -----~~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~di  193 (340)
                           ...   +     +.+++|+-+ .++|.+.+..   .......+....+..+..|+++.+++||+.   |++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence                 111   1     235678877 6688766521   121222344556677889999999999999   9999999


Q ss_pred             CCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcccccccccccc------ccccccccchhhHHHHHHHHHcC
Q 044497          194 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGG  267 (340)
Q Consensus       194 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~~DvwslG~~l~elltg  267 (340)
                      +|+|++++.+|.+.|+||+.....+...     .....+..|.|||.....      .-.++.+.|.|+||+++|.|.+|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999999999999998776433211     113456789999976432      12567789999999999999999


Q ss_pred             CCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCC
Q 044497          268 RRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR  328 (340)
Q Consensus       268 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  328 (340)
                      ..||+..........       .+           .... +++..++.|+..+|+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~-------~f-----------~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW-------DF-----------SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG-------GG-----------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc-------cc-----------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999987755432211       00           1122 567889999999999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=9.2e-23  Score=184.08  Aligned_cols=215  Identities=20%  Similarity=0.368  Sum_probs=163.4

Q ss_pred             hcccCCCceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-eecC
Q 044497          114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI-LHFD  192 (340)
Q Consensus       114 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i-vH~d  192 (340)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..   ....+++.....+..+++.||+|||+.   .| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            4678999999999999999999999999999999999944   346788889999999999999999997   44 9999


Q ss_pred             CCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcccccccccccccc-----ccccccchhhHHHHHHHHHcC
Q 044497          193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-----TVSCKSDVYGFGMVLLEMAGG  267 (340)
Q Consensus       193 ik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-----~~~~~~DvwslG~~l~elltg  267 (340)
                      +++.|++++....+||+|||+.................-..-|.|||.+.....     ..+.+.|+||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            999999999999999999999887654222122222234567999999876311     146679999999999999999


Q ss_pred             CCCCCCCcccccccchhHHHHHHhhc-CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          268 RRNSNMHATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       268 ~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      +.||+..........+..    .+.. +.....+...... ...+++..++..||..+|.+||+++++-..++
T Consensus       155 ~~~~~~~~~~~~~~eii~----~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIIL----RVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             cCccccccccCChHHHHH----HHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            999987655443322222    2222 2211111111111 34457889999999999999999999987664

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3e-22  Score=161.93  Aligned_cols=187  Identities=16%  Similarity=0.082  Sum_probs=141.0

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChH-----HHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEccC
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE-----EFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...|++|+||+|+.+.. ++.+++.+.+........     .+.+|+++|++++ |+++++++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45799999999998765 688888888876665333     5789999999995 5889999886    34699999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDI-KPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~di-k~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      |.+|.+...    .       ....++.|++.+|+++|++   |++|||| ||+||+++.++.++|+|||++........
T Consensus        82 G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         82 GAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             CccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            988865431    0       1134778999999999999   9999999 79999999999999999999986554332


Q ss_pred             c----e--e-----eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCc
Q 044497          223 F----V--S-----ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHA  275 (340)
Q Consensus       223 ~----~--~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~  275 (340)
                      .    .  .     ......++.+++|+...-.....-...+.++.|.-+|.++|+..+.....
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            1    0  0     11223677888888643221122246789999999999999998765433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=8.8e-23  Score=184.53  Aligned_cols=230  Identities=24%  Similarity=0.261  Sum_probs=180.9

Q ss_pred             hcCCCCCeEEEEEE----EcCCcEEEEEEccCCCCC---hHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEccC
Q 044497           72 KLGQGGFGSVYKGQ----LHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        72 ~ig~G~~g~v~~~~----~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .+|.|.||.|+++.    ...+..+|+|++++....   ......|..++...+ ||.++++.-.++...+.+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            36899999999874    234667899988652211   124556778888886 9999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +|.|...+    .....+.+.....+...++-+++++|+.   +++|+|+|++||+++.+|++++.|||+++..-.... 
T Consensus        81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99998877    4455677778888899999999999999   999999999999999999999999999985433322 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                           .+||..|||||++.+    ....+|.||||++.+||+||..||..           + +...+..       ...
T Consensus       153 -----~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~-----------~-~~~~Il~-------~~~  204 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG-----------D-TMKRILK-------AEL  204 (612)
T ss_pred             -----cccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch-----------H-HHHHHhh-------hcc
Confidence                 168999999999973    35589999999999999999999875           0 1111111       112


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCH--HHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSM--TKVLEM  337 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~--~evl~~  337 (340)
                      ..+...+..+.+++..++..+|.+|.-.  ..+.+.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~ei  240 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEI  240 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHH
Confidence            3455677889999999999999999755  344443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3.9e-21  Score=185.22  Aligned_cols=200  Identities=23%  Similarity=0.215  Sum_probs=157.5

Q ss_pred             CHHHHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccC---CCceeeEeeEEEcCCe
Q 044497           58 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH---HVNVVQLLGFCSEGSK  134 (340)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~  134 (340)
                      +.-++...++.+.+.||.|+||+||+|...+|+.||+|+-+.....  +|.=..+++.+|+   -+.|..+...+.-.+.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            3345666777888999999999999999888999999998764432  1222233333443   2345555555566777


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-------CCCceE
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-------HNFIPK  207 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-------~~~~~k  207 (340)
                      .++|+||.+.|+|.+++.    ..+.+++.....++.|++..++.||..   +||||||||+|+++.       ++.-++
T Consensus       769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            899999999999999994    456788999999999999999999999   999999999999993       234689


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCC
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  268 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~  268 (340)
                      |+|||.+..+..-.+.......++|-.+--+|...+.  +++.+.|.|.++.+++.||.|+
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHH
Confidence            9999998754333332344566788899999999886  8899999999999999999997

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=2.1e-20  Score=160.41  Aligned_cols=199  Identities=18%  Similarity=0.191  Sum_probs=138.2

Q ss_pred             CCCceeeEeeEEEc---------------------------CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHH
Q 044497          118 HHVNVVQLLGFCSE---------------------------GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA  170 (340)
Q Consensus       118 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~  170 (340)
                      +|||||++.++|.+                           +..+|+||..+ ..+|.+++..     ...+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence            59999999987743                           33478999888 5589888832     345566777899


Q ss_pred             HHHHHHHHHHHcCCCCCeeecCCCCCCeeE--cCCC--ceEEecccCCccCCCCC---Cceee-eccccCcccccccccc
Q 044497          171 LGTARGIEYLHNGCDVCILHFDIKPHNILL--DHNF--IPKVSDFGLAKFHPKEN---DFVSI-SATRGTIGYIAPELIS  242 (340)
Q Consensus       171 ~~i~~~l~~Lh~~~~~~ivH~dik~~Nill--~~~~--~~kl~Dfg~~~~~~~~~---~~~~~-~~~~g~~~y~aPE~~~  242 (340)
                      .|+++|+.|||.+   |+.|||+|.+|||+  ++|+  ..+++|||.+---....   .+... -..-|...-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999998  4444  46789999873211100   01111 1123677899999986


Q ss_pred             cccccc----ccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHh
Q 044497          243 RNFGTV----SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGL  318 (340)
Q Consensus       243 ~~~~~~----~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  318 (340)
                      ...++.    -.++|.|+.|.+.||+++...||.....-.  .....     ..+      ......++.+++.+++++.
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~r~-----Yqe------~qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDTRT-----YQE------SQLPALPSRVPPVARQLVF  491 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--echhh-----hhh------hhCCCCcccCChHHHHHHH
Confidence            543321    238999999999999999999987522110  00000     000      0112344456788999999


Q ss_pred             hcccCCCCCCCCHHHHHHHh
Q 044497          319 WCIQVKAADRPSMTKVLEML  338 (340)
Q Consensus       319 ~cl~~~p~~Rps~~evl~~L  338 (340)
                      ..|+.||++|+|..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999976554443

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=6.1e-20  Score=154.90  Aligned_cols=139  Identities=17%  Similarity=0.135  Sum_probs=108.4

Q ss_pred             hhhhhhcCCCCCeEEEEEE--EcCCcEEEEEEccCCCCC-------------------------hHHHHHHHHHhcccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQ--LHTGGLIAVKMLANSKFS-------------------------GEEFINEVSTIGRIHH  119 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~h  119 (340)
                      +.+.+.||+|++|.||+|.  ..+|+.||+|++......                         ...+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4566899999999999998  458999999998754210                         0125689999999975


Q ss_pred             C--ceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeecCCCCC
Q 044497          120 V--NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC-ILHFDIKPH  196 (340)
Q Consensus       120 ~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dik~~  196 (340)
                      .  .+++++++    ...++||||+++++|.....    ............++.|++.++++||+.   + ++|+||||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            3  34444443    23589999999988876542    123455666789999999999999999   9 999999999


Q ss_pred             CeeEcCCCceEEecccCCccC
Q 044497          197 NILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999988743

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=6.4e-20  Score=151.11  Aligned_cols=133  Identities=17%  Similarity=0.235  Sum_probs=102.3

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCC-CChHHHHHHHHHhccc-----CCCceeeEeeEEEcCC---eeE-EEE
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSK-FSGEEFINEVSTIGRI-----HHVNVVQLLGFCSEGS---KRA-LVY  139 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-lv~  139 (340)
                      .+.||+|+||.||. ...++. .++|++.... ...+.+.+|+.+++.+     .||||++++|++.+..   ..+ +|+
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            35899999999996 323444 4788876542 2346789999999999     5799999999998764   333 789


Q ss_pred             Ec--cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeeecCCCCCCeeEcC----CCceEEeccc
Q 044497          140 EY--MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI-EYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSDFG  212 (340)
Q Consensus       140 e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~~~~~ivH~dik~~Nill~~----~~~~kl~Dfg  212 (340)
                      ||  +++++|.+++..     ..+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    +..++|+||+
T Consensus        85 e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         85 DFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             cCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            99  557999999932     234444  35677888777 999999   9999999999999974    3479999954


Q ss_pred             CC
Q 044497          213 LA  214 (340)
Q Consensus       213 ~~  214 (340)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            43

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.6e-19  Score=148.65  Aligned_cols=133  Identities=22%  Similarity=0.292  Sum_probs=112.0

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.||+|++|.||+|.. .+..+++|+.......         ...+.+|+.++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4789999999999987 5778999986543221         13577899999999999988777777777888999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|++|.+.+...       .. .+..++.+++.+|+++|+.   +++|+|++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999888321       11 7789999999999999999   999999999999999 78899999998874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=5.5e-19  Score=145.89  Aligned_cols=136  Identities=21%  Similarity=0.176  Sum_probs=107.2

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC-----------------------hHHHHHHHHHhcccCCC--c
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS-----------------------GEEFINEVSTIGRIHHV--N  121 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~--~  121 (340)
                      +.+.+.||+|+||.||++...+++.+|+|++..+...                       ......|...+..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            5567899999999999998878999999987543211                       11356788888888776  4


Q ss_pred             eeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       122 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                      ++..++    ....+++|||+++++|......          .....++.+++.++.++|+.   +++|+||+|+||+++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~  159 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD  159 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence            444443    2446899999999998765410          23457889999999999998   999999999999999


Q ss_pred             CCCceEEecccCCccCCC
Q 044497          202 HNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~  219 (340)
                      +++.++|+|||.+.....
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999964433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.2e-18  Score=144.07  Aligned_cols=129  Identities=22%  Similarity=0.324  Sum_probs=104.5

Q ss_pred             hcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           72 KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .||+|++|.||+|.+ ++..+++|........         ..++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999985 4778999986542211         145678999999998887655555555666789999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +|++|.+.+...    ..       .++.+++.+|++||+.   +++|+|++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999877221    10       7899999999999999   999999999999999 88999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.78  E-value=2.3e-19  Score=170.59  Aligned_cols=206  Identities=22%  Similarity=0.241  Sum_probs=139.8

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      +..+.|..|+||.||..+++ +.+.+|+|+-++.-.     .+.  ++....+|.+|                     |+
T Consensus        86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~li-----lRn--ilt~a~npfvv---------------------gD  137 (1205)
T KOG0606|consen   86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-----LRN--ILTFAGNPFVV---------------------GD  137 (1205)
T ss_pred             ceeEeeccCCCCceeeeeccccccchhhcccccchh-----hhc--cccccCCccee---------------------ch
Confidence            34578999999999999766 567888854333221     111  22333344333                     23


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC----
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND----  222 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~----  222 (340)
                      -...+    ...++++...        +.+++|||+-   +|+|||+||+|.+++.-|++|+.|||+++.......    
T Consensus       138 c~tll----k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  138 CATLL----KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             hhhhc----ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence            33333    1223333332        7789999999   999999999999999999999999999864221110    


Q ss_pred             ---------ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          223 ---------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       223 ---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                               .......+||+.|+|||++..+  .|+..+|+|++|+++||.+.|..||....+++.   +...+.+.+..
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpeel---fg~visd~i~w  277 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FGQVISDDIEW  277 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---Hhhhhhhhccc
Confidence                     0112345799999999999875  788899999999999999999999987755331   11111111111


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  330 (340)
                              .+. ..-..+++++++.++|+.+|..|--
T Consensus       278 --------pE~-dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  278 --------PEE-DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             --------ccc-CcCCCHHHHHHHHHHHHhChHhhcc
Confidence                    111 2234578999999999999999953

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.4e-19  Score=160.86  Aligned_cols=175  Identities=21%  Similarity=0.279  Sum_probs=129.3

Q ss_pred             eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      .+|+.|++|...+|.+++..+. .....++.....++.|++.|++|   +   +.+|+|+||.||++..+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            4789999999999999995443 34566788899999999999999   5   899999999999999999999999999


Q ss_pred             CccCCCCC----CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcC-CCCCCCCcccccccchhHHHH
Q 044497          214 AKFHPKEN----DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMHATRSSKAYFPSWVY  288 (340)
Q Consensus       214 ~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~  288 (340)
                      ........    .....+...||..||+||.+.++  .++.++||||||++|+|+++- .-++..           ....
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~er-----------~~t~  469 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFER-----------IATL  469 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHHH-----------HHhh
Confidence            87654443    12234555699999999999986  899999999999999999972 111110           0011


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV  334 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ev  334 (340)
                      ..+.++..++     .+. .--++-..|+.+++++.|.+||++.+.
T Consensus       470 ~d~r~g~ip~-----~~~-~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 TDIRDGIIPP-----EFL-QDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhcCCCCh-----HHh-hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence            2222222110     011 111345679999999999999965543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.4e-18  Score=162.76  Aligned_cols=131  Identities=19%  Similarity=0.282  Sum_probs=107.5

Q ss_pred             hhhhcCCCCCeEEEEEEEcCCcEEEEEE-ccCC-CC-------ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           69 FTHKLGQGGFGSVYKGQLHTGGLIAVKM-LANS-KF-------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~~~~~vavK~-~~~~-~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..+.||+|+||+||++.+.... +++|+ ..+. ..       ..+.+.+|++++..++|++++....++......++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            4578999999999999876443 44443 2221 11       1245789999999999999988888877777889999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ||+++++|.+++.            ....++.+++.+|++||+.   +++|||+||+||++ +++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999998872            3567899999999999999   99999999999999 677999999999974

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=7.8e-18  Score=137.83  Aligned_cols=135  Identities=19%  Similarity=0.191  Sum_probs=97.3

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHH-------------------------HHHHHHHhcccCCCc--e
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE-------------------------FINEVSTIGRIHHVN--V  122 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~-------------------------~~~e~~~l~~l~h~~--i  122 (340)
                      .+.||+|+||+||+|...+++.||+|++.........                         ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998878999999998754322111                         134555555554332  3


Q ss_pred             eeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEc
Q 044497          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~  201 (340)
                      .+.++.    ...+++|||++++++........    ... .....++.+++.++.++|+ .   +++|+||+|+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444433    24689999999855432211100    001 5677899999999999999 7   999999999999999


Q ss_pred             CCCceEEecccCCccC
Q 044497          202 HNFIPKVSDFGLAKFH  217 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~  217 (340)
                       ++.++++|||.+...
T Consensus       150 -~~~~~liDfg~a~~~  164 (187)
T cd05119         150 -DGKVYIIDVPQAVEI  164 (187)
T ss_pred             -CCcEEEEECcccccc
Confidence             889999999999744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=7.5e-17  Score=127.02  Aligned_cols=134  Identities=22%  Similarity=0.222  Sum_probs=113.9

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCC--CceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      .+.||.|.++.||++...+ ..+++|....... ...+..|+..+..++|  .++++++++....+..+++|||++++.+
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            3578999999999998764 7899999876544 5678899999999976  5899999988888889999999988777


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ..+           +......++.+++++++.+|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            543           4456778899999999999986444799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=6.6e-19  Score=166.29  Aligned_cols=255  Identities=23%  Similarity=0.269  Sum_probs=190.8

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc--CCcEEEEEEccCCCCC---hHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLANSKFS---GEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..+.+.+.||+|+|+.|-.....  ....+|+|.+......   ......|..+-..+. |+|++.+++.....+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            34556678999999999888653  3445666666544322   234445777777776 99999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCcc
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKF  216 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~  216 (340)
                      .++..++++.+.+..  ......+....-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus       100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999999888731  11224455566779999999999999 77   999999999999999999 999999999987


Q ss_pred             CCC-CCCceeeecccc-CccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          217 HPK-ENDFVSISATRG-TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       217 ~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ... ...........| ++.|.|||...+. ....+..|+||.|+++..+++|..|+.........  +..|.....   
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~~---  248 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSNKG---  248 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc--ceeeccccc---
Confidence            766 444444455667 9999999998774 35567899999999999999999999877654421  122221110   


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                           .........++....+++.+++..+|..|.+.+++-
T Consensus       249 -----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  249 -----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -----ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence                 000122234456778899999999999999988764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.7e-16  Score=134.24  Aligned_cols=133  Identities=16%  Similarity=0.180  Sum_probs=103.1

Q ss_pred             hhcC-CCCCeEEEEEEEcCCcEEEEEEccCCC--------------CChHHHHHHHHHhcccCCCce--eeEeeEEEcCC
Q 044497           71 HKLG-QGGFGSVYKGQLHTGGLIAVKMLANSK--------------FSGEEFINEVSTIGRIHHVNV--VQLLGFCSEGS  133 (340)
Q Consensus        71 ~~ig-~G~~g~v~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~  133 (340)
                      ..|| .||.|+||.++.. +..+++|.+....              .....+.+|++++..++|+++  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 8999999999875 7789999875311              123467889999999988774  66777643322


Q ss_pred             ----eeEEEEEccCC-CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          134 ----KRALVYEYMPN-GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       134 ----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                          ..++|||++++ .+|.+++..     .+++..    .+.+++.++.+||++   ||+|+||||.|||++.++.++|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence                23599999987 688888732     234443    356899999999999   9999999999999999899999


Q ss_pred             ecccCCcc
Q 044497          209 SDFGLAKF  216 (340)
Q Consensus       209 ~Dfg~~~~  216 (340)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=8.4e-16  Score=129.35  Aligned_cols=204  Identities=23%  Similarity=0.297  Sum_probs=140.1

Q ss_pred             HhcccCCCceeeEeeEEEcCC-----eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 044497          113 TIGRIHHVNVVQLLGFCSEGS-----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC  187 (340)
Q Consensus       113 ~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~  187 (340)
                      -+.++-|.|+++++.++.+..     ...++.|||..|++.+++.........+......+++.||..||.|||+. ++.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            445557999999999986533     46789999999999999977777777888888999999999999999995 788


Q ss_pred             eeecCCCCCCeeEcCCCceEEecccCCccCCCCCC--ceeeeccccCccccccccccccccccccccchhhHHHHHHHHH
Q 044497          188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  265 (340)
Q Consensus       188 ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ell  265 (340)
                      ++|+++..+.|++..++-+|++--.-.........  ........+.++|.+||.-...  +.+..+|||+||+..++|.
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t--n~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT--NTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc--ccccchhhhhhhHHHHHHH
Confidence            99999999999999999988853211111111100  0011233467899999975432  5566899999999999998


Q ss_pred             cCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          266 GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       266 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+..--....   ....    ......+. ...+.         ...-+.++.+|++..|..||+|++++.
T Consensus       277 ilEiq~tnse---S~~~----~ee~ia~~-i~~le---------n~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSE---SKVE----VEENIANV-IIGLE---------NGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCc---ceee----hhhhhhhh-eeecc---------CccccCcCcccccCCCCCCcchhhhhc
Confidence            8763311110   0000    00000000 00000         012245778899999999999998763

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=2e-14  Score=131.99  Aligned_cols=139  Identities=19%  Similarity=0.206  Sum_probs=96.2

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---------------------------H--------------HHHH
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---------------------------E--------------EFIN  109 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---------------------------~--------------~~~~  109 (340)
                      +.||+|++|.||+|+.++|+.||||+..+.....                           .              ++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5699999999999999999999999986532110                           0              1334


Q ss_pred             HHHHhcccC----CCceeeEeeEE-EcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHcC
Q 044497          110 EVSTIGRIH----HVNVVQLLGFC-SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR-GIEYLHNG  183 (340)
Q Consensus       110 e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~-~l~~Lh~~  183 (340)
                      |+..+.+++    |.+-+.+-.++ ...+..++||||++|++|.+......   ...   ....++.+++. .+..+|..
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence            444444442    22222222222 22345789999999999988763211   111   23345666655 46788888


Q ss_pred             CCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       184 ~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                         |++|+|++|.||++++++.++++|||++....
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               99999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=2.4e-14  Score=129.97  Aligned_cols=253  Identities=21%  Similarity=0.192  Sum_probs=183.2

Q ss_pred             HHHHHHHhhhhhhcCC--CCCeEEEEEEE---cCCcEEEEEEccCC---CCChHHHHHHHHHhccc-CCCceeeEeeEEE
Q 044497           60 PEIIAVTNHFTHKLGQ--GGFGSVYKGQL---HTGGLIAVKMLANS---KFSGEEFINEVSTIGRI-HHVNVVQLLGFCS  130 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~--G~~g~v~~~~~---~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~  130 (340)
                      .+..+.+..+.+.+|.  |.+|.+|.+..   .++..+|+|.-+..   ......-.+|+...+.+ .|+|.++.+..+.
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            3556667777889999  99999999964   36778898874321   12223345666666666 4999999888999


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeeecCCCCCCeeEcCC-Cc
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR----GIEYLHNGCDVCILHFDIKPHNILLDHN-FI  205 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~----~l~~Lh~~~~~~ivH~dik~~Nill~~~-~~  205 (340)
                      ..+..++-.|.+ +.+|.++...   ....++...++..+.+...    |+.++|+.   +++|-|+||.||+..++ ..
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence            999999999999 5777777632   2344677788888888888    99999999   99999999999999999 88


Q ss_pred             eEEecccCCccCCCCCCc---eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc
Q 044497          206 PKVSDFGLAKFHPKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY  282 (340)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~  282 (340)
                      ++++|||+........-.   .......+...|++||...+   .++...|++++|.++.+..++..+....-..     
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----  333 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNS-----  333 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCC-----
Confidence            999999999876554421   11223357889999999976   5677899999999999999887554332111     


Q ss_pred             hhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          283 FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        .|  ..+..+.     ...++-...+.++...+.+|++.+|..|++.+.+..
T Consensus       334 --~W--~~~r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 --SW--SQLRQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --Cc--ccccccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              11  1111111     001112223345666889999999999999887653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=1.2e-13  Score=111.03  Aligned_cols=130  Identities=21%  Similarity=0.166  Sum_probs=96.6

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCce-eeEeeEEEcCCeeEEEEEccCCCCccc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNGSLDR  149 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~  149 (340)
                      +.++.|.++.||+++.. ++.+++|+..........+..|+.+++.+.+.++ ++++.+..  ...++||||++|.++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence            46789999999999865 7789999986654333456789999998865444 44554432  34589999999988764


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          150 HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       150 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      .-         .   .....+.+++++|+.||+..  ..+++|+|++|+||+++ ++.++++||+.+..
T Consensus        81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            31         0   11245678999999999972  12369999999999998 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.50  E-value=2.7e-13  Score=124.57  Aligned_cols=166  Identities=17%  Similarity=0.195  Sum_probs=126.5

Q ss_pred             EcCCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHH
Q 044497           86 LHTGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE  164 (340)
Q Consensus        86 ~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  164 (340)
                      ..++.++.|...+.... ..+...+.++.|+.++||||+++++.+......|+|+|.+.  .|..++.       .+...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk-------~l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK-------ELGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH-------HhHHH
Confidence            44678888888876544 23557888999999999999999999999999999999873  4555552       22356


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcccccccccccc
Q 044497          165 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN  244 (340)
Q Consensus       165 ~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  244 (340)
                      .+...+.||+.||.|||+.  .+++|++|..+.|+++..|+.||++|.++........  .......-..|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            7788899999999999854  2899999999999999999999999998864433321  11111223357777766432


Q ss_pred             ccccccccchhhHHHHHHHHHcCC
Q 044497          245 FGTVSCKSDVYGFGMVLLEMAGGR  268 (340)
Q Consensus       245 ~~~~~~~~DvwslG~~l~elltg~  268 (340)
                          ....|.|.||+++++++.|.
T Consensus       181 ----~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 ----EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ----ccchhhhhHHHHHHHHhCcc
Confidence                13569999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=5.6e-14  Score=130.57  Aligned_cols=139  Identities=15%  Similarity=0.171  Sum_probs=89.4

Q ss_pred             hhcCCCCCeEEEEEEEcC-CcEEEEEEccCCCCC---------------------------h--------HH------HH
Q 044497           71 HKLGQGGFGSVYKGQLHT-GGLIAVKMLANSKFS---------------------------G--------EE------FI  108 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~-~~~vavK~~~~~~~~---------------------------~--------~~------~~  108 (340)
                      +.||+|++|.||+|+.++ |+.||||+..+....                           .        +.      +.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999886 999999999754210                           0        11      23


Q ss_pred             HHHHHhcccC----CCceeeEeeEEEc-CCeeEEEEEccCCCCcccccc--cCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 044497          109 NEVSTIGRIH----HVNVVQLLGFCSE-GSKRALVYEYMPNGSLDRHIF--PKESRGQSFCWEKLHEVALGTARGIEYLH  181 (340)
Q Consensus       109 ~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh  181 (340)
                      +|+..+.+++    +.+.+.+-.++.+ .+..++||||++|+.+.+.-.  ........+....+..++.|+.       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence            3333333331    3333333333322 345679999999999976421  1111111233333444444443       


Q ss_pred             cCCCCCeeecCCCCCCeeEcCCC----ceEEecccCCccCCC
Q 044497          182 NGCDVCILHFDIKPHNILLDHNF----IPKVSDFGLAKFHPK  219 (340)
Q Consensus       182 ~~~~~~ivH~dik~~Nill~~~~----~~kl~Dfg~~~~~~~  219 (340)
                      ..   |++|+|++|.||+++.++    .++++|||++...+.
T Consensus       278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            34   999999999999999888    999999999876544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.45  E-value=1.3e-12  Score=105.81  Aligned_cols=136  Identities=12%  Similarity=0.134  Sum_probs=98.4

Q ss_pred             hhcCCCCCeEEEEEEEcC-------CcEEEEEEccCCC----------------------CC-hHH----HHHHHHHhcc
Q 044497           71 HKLGQGGFGSVYKGQLHT-------GGLIAVKMLANSK----------------------FS-GEE----FINEVSTIGR  116 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~-------~~~vavK~~~~~~----------------------~~-~~~----~~~e~~~l~~  116 (340)
                      ..||.|--+.||.|...+       +..+|+|+.+.+.                      .+ ...    ..+|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999997543       4799999974210                      01 112    3489999999


Q ss_pred             cCC--CceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeecCC
Q 044497          117 IHH--VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL-HNGCDVCILHFDI  193 (340)
Q Consensus       117 l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~di  193 (340)
                      +..  -++++++++    ..-++||||+.+..+.....    ....++......+..+++.+|..| |+.   +++|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            853  466677764    45789999996654422111    112344556677889999999999 888   9999999


Q ss_pred             CCCCeeEcCCCceEEecccCCccCC
Q 044497          194 KPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       194 k~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      ++.||+++ ++.++++|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4679999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.38  E-value=1.1e-11  Score=104.21  Aligned_cols=141  Identities=18%  Similarity=0.229  Sum_probs=109.5

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC--ChHHHHHHHHHhcccCC--CceeeEeeEEEcC---CeeEEEEEccC
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHH--VNVVQLLGFCSEG---SKRALVYEYMP  143 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~~  143 (340)
                      +.|+.|..+.+|++...+|+.+++|.......  ....+..|++++..+++  .++.+++.+....   +..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46889999999999877668999999876443  34678899999999965  4467777776553   25689999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC---------------------------------------  184 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---------------------------------------  184 (340)
                      |.++.+.+..     ..++......++.+++++|+.||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888776521     34666777788888888888888521                                       


Q ss_pred             --------------CCCeeecCCCCCCeeEcC--CCceEEecccCCcc
Q 044497          185 --------------DVCILHFDIKPHNILLDH--NFIPKVSDFGLAKF  216 (340)
Q Consensus       185 --------------~~~ivH~dik~~Nill~~--~~~~kl~Dfg~~~~  216 (340)
                                    +..++|+|+.|+||+++.  ++.+.++||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  56789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.9e-11  Score=95.86  Aligned_cols=129  Identities=21%  Similarity=0.239  Sum_probs=96.6

Q ss_pred             hcCCCCCeEEEEEEEcCCcEEEEEEc-cCCCCC--------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           72 KLGQGGFGSVYKGQLHTGGLIAVKML-ANSKFS--------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~~~~vavK~~-~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+++|+-+.++.+.+. |.++++|.= .+.-..        .++..+|+.++..++--.+.-..=+..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999775 445666653 222111        135678999999886555554444556777788999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +|..|.+.+...           ...++..+-.-+.-||..   ||+|+|++++|+.+..+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            998998888322           234666666778889999   999999999999997765 99999999974

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=2.3e-10  Score=102.62  Aligned_cols=216  Identities=19%  Similarity=0.233  Sum_probs=152.5

Q ss_pred             CCeEEEEEEEc-CCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEE----cCCeeEEEEEccCC-CCccc
Q 044497           77 GFGSVYKGQLH-TGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRALVYEYMPN-GSLDR  149 (340)
Q Consensus        77 ~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~~L~~  149 (340)
                      ...+.|++..+ +|..|++|++.-++.. ......=++.++++.|+|+|++.+++.    ....+++|++|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34678999755 8889999999432221 123345577889999999999999885    34558899999985 57766


Q ss_pred             ccccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          150 HIFPKE-----------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       150 ~l~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      +-....           ..+...++..+|.++.|++.||.++|+.   |+..+-+.|++|+++.+..++++..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            543322           1234578899999999999999999999   99999999999999999899998888776544


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .+..                |.+.+     -.+.|.=.||.+++.|.||.......+...      +.-           
T Consensus       445 ~d~~----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~------~s~-----------  486 (655)
T KOG3741|consen  445 EDPT----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQ------SSH-----------  486 (655)
T ss_pred             CCCC----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchH------HHH-----------
Confidence            3320                11211     125799999999999999964321111100      000           


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                         ...+...++.++++++.-....++.+ -++.+++..
T Consensus       487 ---~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  487 ---LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ---HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence               01234456778888888888888776 677777654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.24  E-value=7.1e-11  Score=92.33  Aligned_cols=141  Identities=20%  Similarity=0.246  Sum_probs=101.5

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEc-cCCC--------CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKML-ANSK--------FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~-~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..+.+|+-+.|+++.+. |+...||.- .+.-        .+..+..+|++.+.++.--.|.-..=++.+...-.++|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            46789999999999886 666666653 2211        1235678899999888644444444456666777899999


Q ss_pred             cCC-CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC---ceEEecccCCccC
Q 044497          142 MPN-GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFH  217 (340)
Q Consensus       142 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~---~~kl~Dfg~~~~~  217 (340)
                      +++ .++.+++.....  ...........+.++-+.+.-||..   +++||||..+||++.+++   .+.++|||++...
T Consensus        92 ~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   92 IDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            976 477777754322  2223334467888899999999999   999999999999996654   3589999998743

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.24  E-value=7.8e-10  Score=97.03  Aligned_cols=260  Identities=13%  Similarity=0.112  Sum_probs=157.1

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceee----EeeEE--EcCC-eeEEEEEc
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQ----LLGFC--SEGS-KRALVYEY  141 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~----~~~~~--~~~~-~~~lv~e~  141 (340)
                      +..||+|+-+.+|..-.  -...+-|++.......+.  ..+..|... .||-+-.    .....  -+.. ..-+.|+.
T Consensus        16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CccccCCccceeeecch--hhchhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            46799999999996522  122344666543322211  122222222 3443221    11111  1222 25678888


Q ss_pred             cCCCC-ccccccc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          142 MPNGS-LDRHIFP--KESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       142 ~~~~~-L~~~l~~--~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      +++.. ..++...  ++..-....|..+++.+..++.+.+.||++   |.+-||+.++|+|+++++.+.|.|-..-....
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~  168 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA  168 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeecc
Confidence            76642 2222211  122234578999999999999999999999   99999999999999999999999866554432


Q ss_pred             CCCCceeeeccccCcccccccccc-cc--ccccccccchhhHHHHHHHHHcC-CCCCCCCccccccc-----chhHHHHH
Q 044497          219 KENDFVSISATRGTIGYIAPELIS-RN--FGTVSCKSDVYGFGMVLLEMAGG-RRNSNMHATRSSKA-----YFPSWVYD  289 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~-~~--~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~-----~~~~~~~~  289 (340)
                      ...   ......|...|.+||.-. +.  ...-+...|-|.||+++++++.| +.||..-.......     .+......
T Consensus       169 ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         169 NGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             CCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            222   234556889999999743 11  01345678999999999999987 89987644322111     11111000


Q ss_pred             Hhh-cCCCccccccchhhHHHHHHHHHHHhhcccC--CCCCCCCHHHHHHHhc
Q 044497          290 QLN-KGGDLELRNVTEIESMIARKLCMIGLWCIQV--KAADRPSMTKVLEMLE  339 (340)
Q Consensus       290 ~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~Rps~~evl~~L~  339 (340)
                      ... .+........+--.+.+++++..|..+|+..  ++.-|||++..+..|.
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~  298 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD  298 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence            000 1111111111222345678888999999965  5779999998887663

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=2.3e-12  Score=117.31  Aligned_cols=237  Identities=19%  Similarity=0.206  Sum_probs=164.6

Q ss_pred             hhhcCCCCCeEEEEEEEc--CCcEEEEEEccCCCCCh-HH--HHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           70 THKLGQGGFGSVYKGQLH--TGGLIAVKMLANSKFSG-EE--FINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~--~~~~vavK~~~~~~~~~-~~--~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...||.|.|+.|+....+  ++..+++|...+..... ++  -..|+.+...+ .|.+++.....+......|+=-||++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            467999999999998644  67789999887644332 11  24555555555 58888888777777777889999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-CceEEecccCCccCCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++...+    .....+.+..++++..|++.++.++|+.   .++|+|++|+||++..+ +..+++|||....+.-...
T Consensus       350 ~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  350 GGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             Ccchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc
Confidence            98887665    2234566778889999999999999998   99999999999999876 7889999998864222111


Q ss_pred             ceeeeccccCccccc-cccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          223 FVSISATRGTIGYIA-PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       223 ~~~~~~~~g~~~y~a-PE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                           ...+..++.| +|++... ..+..+.|++|||..+.+..++...-......           ..+..+...    
T Consensus       423 -----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----------~~i~~~~~p----  481 (524)
T KOG0601|consen  423 -----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----------LTIRSGDTP----  481 (524)
T ss_pred             -----cccccccccccchhhccc-cccccccccccccccccccccCcccCcccccc-----------eeeeccccc----
Confidence                 1123334442 5555443 36777999999999999999986432211110           001111111    


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                         .......++..+...+...++..||++.++...
T Consensus       482 ---~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  482 ---NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             ---CCCchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence               111222567778888999999999998887543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.20  E-value=1.3e-10  Score=94.00  Aligned_cols=124  Identities=26%  Similarity=0.267  Sum_probs=80.8

Q ss_pred             EEEEEEEcCCcEEEEEEccCCCCC---------------------------hHHHHHHHHHhcccCCC--ceeeEeeEEE
Q 044497           80 SVYKGQLHTGGLIAVKMLANSKFS---------------------------GEEFINEVSTIGRIHHV--NVVQLLGFCS  130 (340)
Q Consensus        80 ~v~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~--~iv~~~~~~~  130 (340)
                      .||.|...++..+|+|+.+....+                           .....+|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999888999999997431110                           12467899999999754  566776553 


Q ss_pred             cCCeeEEEEEccC--CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeeecCCCCCCeeEcCCCceE
Q 044497          131 EGSKRALVYEYMP--NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY-LHNGCDVCILHFDIKPHNILLDHNFIPK  207 (340)
Q Consensus       131 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~-Lh~~~~~~ivH~dik~~Nill~~~~~~k  207 (340)
                         .-++||||++  |..+..+.. .     .++......++.+++..+.. +|..   |++|||+++.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-V-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-C-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHh-c-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3579999997  544544331 1     11123445677777775555 5788   99999999999999888 999


Q ss_pred             EecccCCccC
Q 044497          208 VSDFGLAKFH  217 (340)
Q Consensus       208 l~Dfg~~~~~  217 (340)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.15  E-value=5e-10  Score=93.24  Aligned_cols=133  Identities=23%  Similarity=0.190  Sum_probs=97.4

Q ss_pred             hhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC-----------------------hHHHHHHHHHhcccCCC--ce
Q 044497           68 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS-----------------------GEEFINEVSTIGRIHHV--NV  122 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~--~i  122 (340)
                      .++.+||-|--|.||.|....|.++|+|.-+....+                       .....+|.++|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            456889999999999999999999999986321111                       12367899999999755  67


Q ss_pred             eeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC
Q 044497          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (340)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~  202 (340)
                      ++.+++    +.-++|||+++|-.|...-.         ..+....++..|++-+...-..   |++|+|+++=||++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            777654    56789999998866654321         1222334444555545444455   9999999999999999


Q ss_pred             CCceEEecccCCcc
Q 044497          203 NFIPKVSDFGLAKF  216 (340)
Q Consensus       203 ~~~~kl~Dfg~~~~  216 (340)
                      +|.++++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999977653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.12  E-value=3e-11  Score=116.17  Aligned_cols=241  Identities=17%  Similarity=0.147  Sum_probs=159.0

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +-+-+|+++.++.+.-. .+...+.|+......    ..+....+-.++-..++|.++...--+......+++++|+.++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            46778888888887533 333334443322111    1122222333333334566665554556677889999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC-----
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE-----  220 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~-----  220 (340)
                      +|...+..    .+..+.+-.......+..++++||+.   .+.|+|++|.|.+...++..++.||+........     
T Consensus       890 ~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  890 DLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             Cchhhhhc----CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            99888733    22344455556677788899999997   7999999999999999999999999843211100     


Q ss_pred             ----------------CC---c-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcc
Q 044497          221 ----------------ND---F-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT  276 (340)
Q Consensus       221 ----------------~~---~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~  276 (340)
                                      ..   .     .......+|+.|.+||...+.  ......|.|+.|++++|.++|.+||.....
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                            00   0     011223589999999999875  666789999999999999999999987654


Q ss_pred             cccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHH
Q 044497          277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT  332 (340)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~  332 (340)
                      ...        ...+.++....    ..-+...+..+++++...+..+|.+|..+.
T Consensus      1041 q~~--------f~ni~~~~~~~----p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQI--------FENILNRDIPW----PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhh--------hhccccCCCCC----CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            331        11122211111    122234557788899999999999998765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=3.4e-09  Score=90.85  Aligned_cols=133  Identities=17%  Similarity=0.072  Sum_probs=95.1

Q ss_pred             CeEEEEEEEcCCcEEEEEEccCCCC------------ChHHHHHHHHHhcccCCC--ceeeEeeEEEc-----CCeeEEE
Q 044497           78 FGSVYKGQLHTGGLIAVKMLANSKF------------SGEEFINEVSTIGRIHHV--NVVQLLGFCSE-----GSKRALV  138 (340)
Q Consensus        78 ~g~v~~~~~~~~~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~-----~~~~~lv  138 (340)
                      ...|.+... +|+.+.+|.......            ....+.+|...+..+...  ..++++++...     ....++|
T Consensus        35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            334666655 477899997643321            112477898888888432  33444555532     2347899


Q ss_pred             EEccCCC-CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-------CCceEEec
Q 044497          139 YEYMPNG-SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-------NFIPKVSD  210 (340)
Q Consensus       139 ~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-------~~~~kl~D  210 (340)
                      +|++++. +|.+++....  ..+.+......++.+++..++-||+.   |++|+|++++|||++.       +..+.++|
T Consensus       114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            9999875 7888873221  23445667778999999999999999   9999999999999975       46789999


Q ss_pred             ccCCcc
Q 044497          211 FGLAKF  216 (340)
Q Consensus       211 fg~~~~  216 (340)
                      |+.+..
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            998863

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=1.9e-10  Score=106.57  Aligned_cols=152  Identities=20%  Similarity=0.271  Sum_probs=103.1

Q ss_pred             HHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceee-------eccccCcccccccccc
Q 044497          170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-------SATRGTIGYIAPELIS  242 (340)
Q Consensus       170 ~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~-------~~~~g~~~y~aPE~~~  242 (340)
                      +.+++.|+.|+|..  .++||++|.|++|.++.++.+||+.|+.+........+...       ........|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34455899999986  58999999999999999999999999998754442221110       0112345799999998


Q ss_pred             ccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcc
Q 044497          243 RNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCI  321 (340)
Q Consensus       243 ~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  321 (340)
                      +.  ..+.++|++|+|+++|.+.. |+.-+........    ........+.+       .......++.++++=+.+++
T Consensus       183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----~~~~~~~~~~~-------~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----YSFSRNLLNAG-------AFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cc--cccccccceeeeeEEEEEecCCcchhhccCCcch----hhhhhcccccc-------cccccccCcHHHHHHHHHHh
Confidence            75  66789999999999999994 5544433222110    00000000000       01222456678888888999


Q ss_pred             cCCCCCCCCHHHHHH
Q 044497          322 QVKAADRPSMTKVLE  336 (340)
Q Consensus       322 ~~~p~~Rps~~evl~  336 (340)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.83  E-value=2.2e-08  Score=92.89  Aligned_cols=141  Identities=17%  Similarity=0.175  Sum_probs=91.0

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---------------------------hH--------------HHHH
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---------------------------GE--------------EFIN  109 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---------------------------~~--------------~~~~  109 (340)
                      +.|+.++-|.||+|++++|+.||||+..++-..                           ..              ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            568999999999999999999999998543211                           00              0233


Q ss_pred             HHHHhccc-----CCCceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 044497          110 EVSTIGRI-----HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC  184 (340)
Q Consensus       110 e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~  184 (340)
                      |...+.++     +.|++.=..=+++-.+...++|||++|..+.+......   ..++...+.....+..--.-+ + . 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~~q~~-~-d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFLRQLL-R-D-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHHHHHH-h-c-
Confidence            44444444     12333222223333456789999999999988742222   233333333333322221111 2 3 


Q ss_pred             CCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       185 ~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                        |++|.|..|.||+++.++.+.+.|||+......
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              899999999999999999999999999875543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=5e-08  Score=80.81  Aligned_cols=108  Identities=21%  Similarity=0.245  Sum_probs=82.6

Q ss_pred             ChHHHHHHHHHhcccC--CCceeeEeeEEEcC----CeeEEEEEccCC-CCcccccccCCCCCCCCCHHHHHHHHHHHHH
Q 044497          103 SGEEFINEVSTIGRIH--HVNVVQLLGFCSEG----SKRALVYEYMPN-GSLDRHIFPKESRGQSFCWEKLHEVALGTAR  175 (340)
Q Consensus       103 ~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~  175 (340)
                      ......+|...+..+.  .-..++.+++....    ...++|+|++++ .+|.+++....    ..+......++.+++.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALAR  129 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHH
Confidence            3456788888888774  33355566665442    245799999987 47888884321    2555677889999999


Q ss_pred             HHHHHHcCCCCCeeecCCCCCCeeEcCCC---ceEEecccCCccC
Q 044497          176 GIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFH  217 (340)
Q Consensus       176 ~l~~Lh~~~~~~ivH~dik~~Nill~~~~---~~kl~Dfg~~~~~  217 (340)
                      .++-||+.   |++|+|+++.|||++.+.   .+.++||+-++..
T Consensus       130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999   999999999999998887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.74  E-value=3.3e-07  Score=74.72  Aligned_cols=136  Identities=18%  Similarity=0.142  Sum_probs=100.0

Q ss_pred             CCCCCeEEEEEEEcCCcEEEEEEccC----C---CCChHHHHHHHHHhcccCC--CceeeEeeEEE-c----CCeeEEEE
Q 044497           74 GQGGFGSVYKGQLHTGGLIAVKMLAN----S---KFSGEEFINEVSTIGRIHH--VNVVQLLGFCS-E----GSKRALVY  139 (340)
Q Consensus        74 g~G~~g~v~~~~~~~~~~vavK~~~~----~---~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~-~----~~~~~lv~  139 (340)
                      |.||.|.|+.-... |..+-+|.-.+    +   ......|.+|...+..+..  -.++++. ++. .    ....++|+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            67899999997765 44788888652    1   2344679999999999853  2345554 332 1    22357899


Q ss_pred             EccCC-CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc--eEEecccCCcc
Q 044497          140 EYMPN-GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLAKF  216 (340)
Q Consensus       140 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~--~kl~Dfg~~~~  216 (340)
                      |-+++ .+|.+++....  -.+.+......+..+++.+++-||+.   |+.|+|+.+.||+++.++.  +.++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97753 58888773321  23456677789999999999999999   9999999999999986666  99999987763

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.74  E-value=1.9e-07  Score=77.20  Aligned_cols=135  Identities=20%  Similarity=0.225  Sum_probs=94.5

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC--------------------h-----HHHHHHHHHhcccC--CCcee
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS--------------------G-----EEFINEVSTIGRIH--HVNVV  123 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~--------------------~-----~~~~~e~~~l~~l~--h~~iv  123 (340)
                      ..|++|--+.||+|...++..+|+|+++.....                    .     ....+|+.-|.++.  +-.++
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            468888899999998888999999998542211                    1     12457888888873  44566


Q ss_pred             eEeeEEEcCCeeEEEEEccCCCCc-ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEc
Q 044497          124 QLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       124 ~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~  201 (340)
                      +.+++..    -.++|||+..... .-.+     ...++.......+..++++.+.-|-. .   ++||+||+.=|||+.
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH  201 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE
Confidence            6665543    3689999854311 1111     12223333566677778888877766 5   999999999999999


Q ss_pred             CCCceEEecccCCccCC
Q 044497          202 HNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~  218 (340)
                       ++.+.++|||-|....
T Consensus       202 -~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 -DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CCeEEEEECccccccC
Confidence             8899999999887544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.74  E-value=3.2e-07  Score=77.00  Aligned_cols=140  Identities=16%  Similarity=0.260  Sum_probs=86.5

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC--ceeeEeeEEEcCCeeEEEEEccCCCC-c
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV--NVVQLLGFCSEGSKRALVYEYMPNGS-L  147 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~-L  147 (340)
                      ..||+|..+.||+.   .+..+++|..... .......+|.++++.+..-  .+.+.+++....+...++||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            47899999999984   2557888887653 3456678999999998643  35677888888888889999998863 2


Q ss_pred             cccccc-------------------CCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHcC-CCCCeeecCCCC
Q 044497          148 DRHIFP-------------------KESRGQSFCWEKLH-EVAL----------GTAR-GIEYLHNG-CDVCILHFDIKP  195 (340)
Q Consensus       148 ~~~l~~-------------------~~~~~~~~~~~~~~-~i~~----------~i~~-~l~~Lh~~-~~~~ivH~dik~  195 (340)
                      ...+..                   +............. .+..          .+.+ ..++|.+. ....++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            111100                   00000000100000 0000          0011 12222211 123578999999


Q ss_pred             CCeeEcCCCceEEecccCCc
Q 044497          196 HNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       196 ~Nill~~~~~~kl~Dfg~~~  215 (340)
                      .|+++++++ +.++||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.63  E-value=5.5e-07  Score=73.71  Aligned_cols=136  Identities=15%  Similarity=0.106  Sum_probs=85.1

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHH----------HHHHHHHhcccCCCce---eeEee--
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE----------FINEVSTIGRIHHVNV---VQLLG--  127 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~h~~i---v~~~~--  127 (340)
                      .+..+...+.+.......|.+-..+ |+.+++|.........++          ..+.+..+..+....+   ..++.  
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            3334444455666666666665554 789999988654332222          2333443444422221   12121  


Q ss_pred             ---EEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC
Q 044497          128 ---FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (340)
Q Consensus       128 ---~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~  204 (340)
                         .+.-.....++|||++|..|.+...        +++    .+...+.+++.-+|+.   |+.|+|..|+|+++++++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc
Confidence               2222344568999999988877541        122    2456677889999999   999999999999998654


Q ss_pred             ceEEecccCCc
Q 044497          205 IPKVSDFGLAK  215 (340)
Q Consensus       205 ~~kl~Dfg~~~  215 (340)
                       ++++||+..+
T Consensus       173 -i~iID~~~k~  182 (229)
T PF06176_consen  173 -IRIIDTQGKR  182 (229)
T ss_pred             -EEEEECcccc
Confidence             8999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.57  E-value=1.1e-06  Score=75.03  Aligned_cols=141  Identities=14%  Similarity=0.128  Sum_probs=86.8

Q ss_pred             hcCCCCC-eEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEccCCCCccc
Q 044497           72 KLGQGGF-GSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPNGSLDR  149 (340)
Q Consensus        72 ~ig~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  149 (340)
                      .|..|.+ +.||+.... +..+++|+.....  ......|+++++.+. +-.+.+++++....+..++|||+++|.++..
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            3455555 789998765 4788999876543  345678999888883 3456677887777677899999999887764


Q ss_pred             cccc-----------------CCCC--CCCCCHH--HHHHH-HH-------------------HHHHHHHHHHcC----C
Q 044497          150 HIFP-----------------KESR--GQSFCWE--KLHEV-AL-------------------GTARGIEYLHNG----C  184 (340)
Q Consensus       150 ~l~~-----------------~~~~--~~~~~~~--~~~~i-~~-------------------~i~~~l~~Lh~~----~  184 (340)
                      ....                 +...  ..++...  ..... ..                   .....+..|-..    .
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            3210                 0000  0011100  00000 00                   011122222111    1


Q ss_pred             CCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       185 ~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +..++|+|+.|.||+++++....|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3469999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=4.7e-07  Score=83.98  Aligned_cols=139  Identities=17%  Similarity=0.187  Sum_probs=89.2

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh----------------------------H----------HHHHHHH
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG----------------------------E----------EFINEVS  112 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~----------------------------~----------~~~~e~~  112 (340)
                      +.||..+.|.|++|+.++|+.||||+-+++-...                            +          +|..|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999975432211                            0          1233333


Q ss_pred             Hhccc----CCCc------eeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 044497          113 TIGRI----HHVN------VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN  182 (340)
Q Consensus       113 ~l~~l----~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  182 (340)
                      -..+.    .|-+      |++++-  .-.....++||||+|..+.+.-.-   ....++...+..-+.+...-+-+.  
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~--  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFK--  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHh--
Confidence            33222    3434      333322  223457899999999888765321   223445554444444433222222  


Q ss_pred             CCCCCeeecCCCCCCeeEcC----CCceEEecccCCccCCC
Q 044497          183 GCDVCILHFDIKPHNILLDH----NFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       183 ~~~~~ivH~dik~~Nill~~----~~~~kl~Dfg~~~~~~~  219 (340)
                         .|.+|+|-.|.||++++    ++.+.+.|||+......
T Consensus       320 ---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 ---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence               28999999999999984    67899999999875443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=1.4e-06  Score=73.51  Aligned_cols=143  Identities=21%  Similarity=0.212  Sum_probs=83.4

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC--ceeeEeeEE---EcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV--NVVQLLGFC---SEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv~e~~~~~  145 (340)
                      +.++.|..+.||+....+ +.+++|..... .....+..|..+++.+...  .+.+++...   ......+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            467889999999998876 69999997665 3446788899998888532  356666644   2334578999999988


Q ss_pred             Cccc----------------ccc---cCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHc--
Q 044497          146 SLDR----------------HIF---PKESRGQSFCWEK---------LHEV------------ALGTAR-GIEYLHN--  182 (340)
Q Consensus       146 ~L~~----------------~l~---~~~~~~~~~~~~~---------~~~i------------~~~i~~-~l~~Lh~--  182 (340)
                      .+..                .+.   .......++....         ....            ...+.. .++.+++  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            7766                010   0000011111100         0000            111222 2333332  


Q ss_pred             --CCCCCeeecCCCCCCeeEc-CCCceEEecccCCc
Q 044497          183 --GCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAK  215 (340)
Q Consensus       183 --~~~~~ivH~dik~~Nill~-~~~~~kl~Dfg~~~  215 (340)
                        ..+..++|+|+.|+||+++ +++.+.++||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              1345799999999999999 56666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.38  E-value=8.7e-06  Score=81.38  Aligned_cols=147  Identities=15%  Similarity=0.273  Sum_probs=92.1

Q ss_pred             hhcCCCCCeEEEEEEEcCC---cEEEEEEccCCC--CChHHHHHHHHHhcccC-CCce--eeEeeEEEcC---CeeEEEE
Q 044497           71 HKLGQGGFGSVYKGQLHTG---GLIAVKMLANSK--FSGEEFINEVSTIGRIH-HVNV--VQLLGFCSEG---SKRALVY  139 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~  139 (340)
                      ++++.|.++.+|+....++   ..+++|+.....  .....+.+|+++++.+. |+++  ++++.+|.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            5788899999999876543   367888765433  23357889999999995 6654  7788888664   4678999


Q ss_pred             EccCCCCccccc-----------------------ccCCCC-------CCC--CCHHHHHHHH---------------HH
Q 044497          140 EYMPNGSLDRHI-----------------------FPKESR-------GQS--FCWEKLHEVA---------------LG  172 (340)
Q Consensus       140 e~~~~~~L~~~l-----------------------~~~~~~-------~~~--~~~~~~~~i~---------------~~  172 (340)
                      ||++|..+.+..                       ......       +.+  .....+..+.               ..
T Consensus       124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~  203 (822)
T PLN02876        124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK  203 (822)
T ss_pred             EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence            999886543210                       000000       001  1111221111               12


Q ss_pred             HHHHHHHHHcCCC--------CCeeecCCCCCCeeEcCC-Cc-eEEecccCCccC
Q 044497          173 TARGIEYLHNGCD--------VCILHFDIKPHNILLDHN-FI-PKVSDFGLAKFH  217 (340)
Q Consensus       173 i~~~l~~Lh~~~~--------~~ivH~dik~~Nill~~~-~~-~kl~Dfg~~~~~  217 (340)
                      +...+++|..+.+        ..++|+|+++.|++++.+ .. .-|.||+++...
T Consensus       204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            3344567744322        359999999999999753 33 578999988653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=4.8e-06  Score=65.37  Aligned_cols=128  Identities=19%  Similarity=0.220  Sum_probs=88.8

Q ss_pred             hhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceee-EeeEEEcCCeeEEEEEccCCCCc
Q 044497           69 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQ-LLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ..+.|++|++|.||+|.+. |..+|+|+-..+. ....+..|+++|..++-.++.+ ++.+-.    -.+.|||..|..|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence            3578999999999999987 5688999765544 4467889999999997665543 444332    2355999988888


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC-CCCeeEcCCCceEEecccCCcc
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIK-PHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik-~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      .+.....       ..+.    ...++++---|...   ||-|+.++ |...++..+..+.|+||..|+.
T Consensus       100 ~~~~~~~-------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG-------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc-------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7765211       2223    33444443445555   99999995 5555555556999999998874

>PRK10593 hypothetical protein; Provisional

Probab=98.32  E-value=1.8e-05  Score=69.43  Aligned_cols=75  Identities=11%  Similarity=0.071  Sum_probs=56.9

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCC---CceeeEeeEEEc---CCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH---VNVVQLLGFCSE---GSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~~~~  144 (340)
                      +.||.|..+.||+....++ .+++|..+. ......+..|.+.++.+..   -.++++++++..   .+..++|||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            5799999999999876545 577777433 2245688999999998843   468888888754   3668999999988


Q ss_pred             CCc
Q 044497          145 GSL  147 (340)
Q Consensus       145 ~~L  147 (340)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.31  E-value=8.3e-06  Score=69.13  Aligned_cols=74  Identities=16%  Similarity=0.210  Sum_probs=47.7

Q ss_pred             hhcCCCCCe-EEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC---ceeeEeeEEEcC---CeeEEEEEccC
Q 044497           71 HKLGQGGFG-SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV---NVVQLLGFCSEG---SKRALVYEYMP  143 (340)
Q Consensus        71 ~~ig~G~~g-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~~~  143 (340)
                      +.|+.|+.. .||+.    +..+++|.... ......+.+|.+++..+...   .+.+.++.....   ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            356767665 58875    34577887554 33456788999999887532   344445444332   23578999999


Q ss_pred             CCCccc
Q 044497          144 NGSLDR  149 (340)
Q Consensus       144 ~~~L~~  149 (340)
                      |.++.+
T Consensus        78 G~~l~~   83 (235)
T cd05155          78 GETATA   83 (235)
T ss_pred             CCCCCc
Confidence            987753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.28  E-value=5e-06  Score=67.54  Aligned_cols=104  Identities=25%  Similarity=0.227  Sum_probs=81.2

Q ss_pred             HHHHHhcccCC-CceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 044497          109 NEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC  187 (340)
Q Consensus       109 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~  187 (340)
                      .|.-+++.+++ +++++++|+|-    ..++.||...+++...-. .-..-...+|..+.+++.++++.+.+|++.....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            57788888865 69999999993    367899997665542100 0011234689999999999999999999865556


Q ss_pred             eeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       188 ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +.-.|++|+|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            889999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.26  E-value=2.7e-07  Score=85.32  Aligned_cols=184  Identities=18%  Similarity=0.174  Sum_probs=130.1

Q ss_pred             hhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCc-eeeEeeEEEcCCeeEEEEEccCCC-C
Q 044497           69 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYMPNG-S  146 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-~  146 (340)
                      +.+-.++|+++++++.+....+....+.+...    ....-++++|.+++||| .+..++-++.+....+.++++..+ +
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            34567889999999886433333335544333    34567899999999999 777777777788888999999765 2


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceee
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  226 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (340)
                      -....   ......+....+..+...-+++++++|+.   .=+|+|    ||+..+ +..+..||+....+.+..   ..
T Consensus       322 ~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~  387 (829)
T KOG0576|consen  322 SALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP  387 (829)
T ss_pred             ccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence            22222   11122344455666777788899999986   457888    777655 688999999887655443   23


Q ss_pred             eccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCC
Q 044497          227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (340)
Q Consensus       227 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~  272 (340)
                      ....+++.++|||+....  .+....|+|++|.-.-++.-|.+|-.
T Consensus       388 ~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence            455699999999988775  77788999999987777777766644

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.25  E-value=2.2e-05  Score=66.47  Aligned_cols=141  Identities=15%  Similarity=0.178  Sum_probs=81.6

Q ss_pred             hhcCCCCCeEEEEEEEcC--CcEEEEEEccCCCCChHHHHHHHHHhcccCCCc-eeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           71 HKLGQGGFGSVYKGQLHT--GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~--~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      +.|..|-...+|+....+  ++.+++|+........-...+|+.++..+...+ .+++++.+.    -.++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            457778888999997664  678999987653222223357888888885333 344444432    2379999998776


Q ss_pred             cccc-----------------ccCCCCC-------CCC-CHHHHHHHHH----------------------HHHHHHHHH
Q 044497          148 DRHI-----------------FPKESRG-------QSF-CWEKLHEVAL----------------------GTARGIEYL  180 (340)
Q Consensus       148 ~~~l-----------------~~~~~~~-------~~~-~~~~~~~i~~----------------------~i~~~l~~L  180 (340)
                      ...-                 .......       ... .+..+..+..                      .+...+..|
T Consensus        80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  159 (235)
T cd05157          80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL  159 (235)
T ss_pred             CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence            3210                 0000000       011 1222212111                      111111222


Q ss_pred             ----HcC-CCCCeeecCCCCCCeeEcC-CCceEEecccCCc
Q 044497          181 ----HNG-CDVCILHFDIKPHNILLDH-NFIPKVSDFGLAK  215 (340)
Q Consensus       181 ----h~~-~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~  215 (340)
                          ... .+..++|+|+.+.||++++ ++.+.++||..|.
T Consensus       160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence                111 2347999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.20  E-value=3.3e-05  Score=63.10  Aligned_cols=126  Identities=17%  Similarity=0.248  Sum_probs=88.2

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCC-----------------CChHHHHHHHHHhcccC------CCceeeEee
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSK-----------------FSGEEFINEVSTIGRIH------HVNVVQLLG  127 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~iv~~~~  127 (340)
                      ..||+|+.=.||.-  ..+....||+.....                 ....+..+|+.....+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            47899999888853  456678889887655                 22355667777666665      789999999


Q ss_pred             EEEcCCeeEEEEEccCC------CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          128 FCSEGSKRALVYEYMPN------GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       128 ~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                      +.++.....+|+|.+.+      .+|.+++     ....++. ...+.+.   +-.+||-+.   +|+.+|++|.||++.
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-----~~~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYL-----KEGGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHH-----HcCCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEE
Confidence            99999999999998642      3455666     1233444 3334443   444566666   899999999999995


Q ss_pred             CC--C--ceEEec
Q 044497          202 HN--F--IPKVSD  210 (340)
Q Consensus       202 ~~--~--~~kl~D  210 (340)
                      ..  +  .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            32  2  467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.10  E-value=6.7e-06  Score=81.26  Aligned_cols=196  Identities=20%  Similarity=0.203  Sum_probs=132.2

Q ss_pred             HHHHHHhcccCCCceeeEeeEEEcCCee----EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 044497          108 INEVSTIGRIHHVNVVQLLGFCSEGSKR----ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG  183 (340)
Q Consensus       108 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~  183 (340)
                      .-|.+.+..+.|+|++.++.|.......    .+..+++...++...+    ......+..+.+.+..+..+|++++|+.
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            4466677778999999999887543322    2345677777777666    3446788899999999999999999997


Q ss_pred             CCCCeeecCCCCC---CeeEcCCCceEEe--cccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHH
Q 044497          184 CDVCILHFDIKPH---NILLDHNFIPKVS--DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG  258 (340)
Q Consensus       184 ~~~~ivH~dik~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG  258 (340)
                         ...|.-+..+   +.-.+..+.+..+  ||+.+........   ......+..+.+||....+....+...|+|.+|
T Consensus       306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             ---ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHH
Confidence               6666555555   4444556666666  8888775544332   112234556788888776645555668999999


Q ss_pred             HHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 044497          259 MVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (340)
Q Consensus       259 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~  337 (340)
                      .....+..|..+-.......          +.+              +........+...+|+..++++|+++.+++..
T Consensus       380 ll~~~~~~~~~i~~~~~~~~----------~~l--------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVPV----------SLL--------------DVLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHHhhhhhcCcccccccchh----------hhh--------------ccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            99999998875533221110          000              00011145667788999999999999998763

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.02  E-value=9.5e-05  Score=64.94  Aligned_cols=143  Identities=17%  Similarity=0.177  Sum_probs=86.2

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC--ceeeEeeE------EEcCCeeEEEEEcc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV--NVVQLLGF------CSEGSKRALVYEYM  142 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~e~~  142 (340)
                      +.+..|....+|+.... ++.+++|+...  .+.+....|+.++..+.+.  .+++++..      ....+..+++++++
T Consensus        20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            46777877899998764 45789998765  3456677888888888432  24444432      23345678999999


Q ss_pred             CCCCcccc----c----------cc--CC--C---CCCCCCHHHHH----------HHHHHHHHHHHHHHc----CCCCC
Q 044497          143 PNGSLDRH----I----------FP--KE--S---RGQSFCWEKLH----------EVALGTARGIEYLHN----GCDVC  187 (340)
Q Consensus       143 ~~~~L~~~----l----------~~--~~--~---~~~~~~~~~~~----------~i~~~i~~~l~~Lh~----~~~~~  187 (340)
                      +|..+...    .          ..  ..  .   ......|....          .....+..++.++.+    ..+.+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            88776420    0          00  00  0   00011111110          011112334444443    22457


Q ss_pred             eeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          188 ILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       188 ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++|+|+.|.|+++++++.+.|+||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            99999999999999987778999998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.97  E-value=8.9e-05  Score=63.69  Aligned_cols=139  Identities=12%  Similarity=0.097  Sum_probs=79.0

Q ss_pred             hcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh-HHHHHHHHHhcccCCCce-eeEeeEEEcCCeeEEEEEccCCCCccc
Q 044497           72 KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNGSLDR  149 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~  149 (340)
                      .+..|-.+.+|+... +++.+++|......... -...+|..+++.+....+ .+++....    -.+||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            355677889998874 46788899865432221 235678888888854322 34444432    368999999877643


Q ss_pred             c-----------------cccCCCCCCCCCHH-HHHHHHHH---------HHHHHHHHHcC-----CCCCeeecCCCCCC
Q 044497          150 H-----------------IFPKESRGQSFCWE-KLHEVALG---------TARGIEYLHNG-----CDVCILHFDIKPHN  197 (340)
Q Consensus       150 ~-----------------l~~~~~~~~~~~~~-~~~~i~~~---------i~~~l~~Lh~~-----~~~~ivH~dik~~N  197 (340)
                      .                 +........+++.. .+..+..+         +...++.+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            2                 00010111122211 11111111         11112222111     12368999999999


Q ss_pred             eeEcCCCceEEecccCCcc
Q 044497          198 ILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~  216 (340)
                      |++++++ +.++||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.92  E-value=0.00013  Score=64.75  Aligned_cols=143  Identities=13%  Similarity=0.180  Sum_probs=79.8

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC--ceeeEee------EEEcCCeeEEEEEcc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV--NVVQLLG------FCSEGSKRALVYEYM  142 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~------~~~~~~~~~lv~e~~  142 (340)
                      +.|+.|....+|+....+| .+++|+..  ....+....|..++..|...  .+.+++.      +....+..+++++|+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            4566777789999876544 78999875  23345555666666666321  1333332      123355678999999


Q ss_pred             CCCCcccc-----------c---ccC-CC------CCCCCCH-HHHHH------------HHHH-HHHHHHHHHc----C
Q 044497          143 PNGSLDRH-----------I---FPK-ES------RGQSFCW-EKLHE------------VALG-TARGIEYLHN----G  183 (340)
Q Consensus       143 ~~~~L~~~-----------l---~~~-~~------~~~~~~~-~~~~~------------i~~~-i~~~l~~Lh~----~  183 (340)
                      +|..+...           +   ... ..      ....+.+ .....            ...+ +...++.+.+    .
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            88754210           0   000 00      0001111 11110            1111 1112233321    1


Q ss_pred             CCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       184 ~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      .+.+++|+|+.|.||+++.+...-++||+.+..
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            355899999999999998766568999998863

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.92  E-value=0.00025  Score=62.71  Aligned_cols=144  Identities=18%  Similarity=0.225  Sum_probs=83.4

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC--ceeeEeeE------EEcCCeeEEEEEcc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV--NVVQLLGF------CSEGSKRALVYEYM  142 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~e~~  142 (340)
                      +.++.|....+|+.... ++.+++|+.... ...+....|.+++..|...  .+++++..      ....+..+++++|+
T Consensus        28 ~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTD-VGRYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             cccCCccccceEEEEeC-CCcEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            45677777899998765 446888887542 2345566777777777422  23444332      12245678999999


Q ss_pred             CCCCcccc--------------cccC-CC---C-CC---CCCHHHHH------------HHHHHHHHHHHHHHc----CC
Q 044497          143 PNGSLDRH--------------IFPK-ES---R-GQ---SFCWEKLH------------EVALGTARGIEYLHN----GC  184 (340)
Q Consensus       143 ~~~~L~~~--------------l~~~-~~---~-~~---~~~~~~~~------------~i~~~i~~~l~~Lh~----~~  184 (340)
                      +|..+...              +... ..   . ..   .-.|....            .....+...++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            88655311              0000 00   0 00   00111100            011123334555532    23


Q ss_pred             CCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       185 ~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +.+++|+|+.+.|+++++++...++||+.+..
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            45899999999999999888778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.82  E-value=0.00029  Score=57.26  Aligned_cols=124  Identities=25%  Similarity=0.390  Sum_probs=85.8

Q ss_pred             HHhhhhhhcCCCCC-eEEEEEEEcCCcEEEEEEccC---C------------C-------CChHHHHHHHHHhcccC---
Q 044497           65 VTNHFTHKLGQGGF-GSVYKGQLHTGGLIAVKMLAN---S------------K-------FSGEEFINEVSTIGRIH---  118 (340)
Q Consensus        65 ~~~~~~~~ig~G~~-g~v~~~~~~~~~~vavK~~~~---~------------~-------~~~~~~~~e~~~l~~l~---  118 (340)
                      ...++.+.||.|.- |.||+++.. |+.+|+|+.+.   .            .       .-.+.|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            55667799999999 999999886 77999999321   0            0       01134778888887774   


Q ss_pred             CCce--eeEeeEEEcC------------------CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 044497          119 HVNV--VQLLGFCSEG------------------SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE  178 (340)
Q Consensus       119 h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~  178 (340)
                      +.++  ++.+||..-.                  ....||.||.+...             .+..    +-+.+|.+-+.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence            4456  8999987211                  11346667664322             1222    23456666688


Q ss_pred             HHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       179 ~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            89998   9999999999986     4588899864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.81  E-value=0.00058  Score=61.93  Aligned_cols=73  Identities=14%  Similarity=0.159  Sum_probs=53.6

Q ss_pred             hhcCCCCCeEEEEEEEcCC-cEEEEEEccC------C--CCChHHHHHHHHHhcccC---CCceeeEeeEEEcCCeeEEE
Q 044497           71 HKLGQGGFGSVYKGQLHTG-GLIAVKMLAN------S--KFSGEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~-~~vavK~~~~------~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv  138 (340)
                      +.||.|....||+....+| +.++||.-..      .  ....++...|.+.|..+.   ..++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999988766 4899998532      1  224467788888888763   2457777766  44567899


Q ss_pred             EEccCCC
Q 044497          139 YEYMPNG  145 (340)
Q Consensus       139 ~e~~~~~  145 (340)
                      ||++++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9998763

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.74  E-value=0.00051  Score=60.50  Aligned_cols=140  Identities=21%  Similarity=0.249  Sum_probs=84.1

Q ss_pred             hcCCCCCeEEEEEEEcC-------CcEEEEEEccCCCCChHHHHHHHHHhcccCCCc-eeeEeeEEEcCCeeEEEEEccC
Q 044497           72 KLGQGGFGSVYKGQLHT-------GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~-------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .+..|-...+|+....+       ++.+++|+............+|.+++..+.... ..++++.+..    .+|+||++
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~   80 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP   80 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence            45567777899987654       578999997665433345678888888885332 3445555532    35899998


Q ss_pred             CCCccccc-----------------ccCCCC--C---CCCC--HHHHHH--------------------------HHHHH
Q 044497          144 NGSLDRHI-----------------FPKESR--G---QSFC--WEKLHE--------------------------VALGT  173 (340)
Q Consensus       144 ~~~L~~~l-----------------~~~~~~--~---~~~~--~~~~~~--------------------------i~~~i  173 (340)
                      |..+....                 ......  .   ...+  +..+..                          ....+
T Consensus        81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (302)
T cd05156          81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE  160 (302)
T ss_pred             CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence            87764311                 000000  0   0111  111111                          11222


Q ss_pred             HHHHHHHHc------CCCCCeeecCCCCCCeeEcCC----CceEEecccCCc
Q 044497          174 ARGIEYLHN------GCDVCILHFDIKPHNILLDHN----FIPKVSDFGLAK  215 (340)
Q Consensus       174 ~~~l~~Lh~------~~~~~ivH~dik~~Nill~~~----~~~kl~Dfg~~~  215 (340)
                      ...+.++..      ..+..++|+|+.+.||+++++    +.+.++||..+.
T Consensus       161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            233344432      235579999999999999875    789999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.67  E-value=7.3e-05  Score=64.56  Aligned_cols=132  Identities=16%  Similarity=0.098  Sum_probs=91.5

Q ss_pred             hhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC-----------------------hHHHHHHHHHhcccCC--Cce
Q 044497           68 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS-----------------------GEEFINEVSTIGRIHH--VNV  122 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h--~~i  122 (340)
                      .+.++||-|--+.+|.+-...|++.++|.-...+.+                       .-...+|...|+.+..  --+
T Consensus        95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            456899999999999999988999999975322111                       0124567777777742  234


Q ss_pred             eeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC
Q 044497          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (340)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~  202 (340)
                      ++.++    .+..++|||++.+-.|.+.-.       .....   .+...++.-+.-|-.+   |+||+|..-=||++++
T Consensus       175 PkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  175 PKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCccc----ccceeeHHHhhcccceeeeee-------cCChH---HHHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence            44443    456789999998877755431       11122   2344444445556666   9999999999999999


Q ss_pred             CCceEEecccCCcc
Q 044497          203 NFIPKVSDFGLAKF  216 (340)
Q Consensus       203 ~~~~kl~Dfg~~~~  216 (340)
                      ++.++++||--+..
T Consensus       238 d~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVS  251 (465)
T ss_pred             CCCEEEeechHhhc
Confidence            99999999976643

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.57  E-value=0.00057  Score=60.18  Aligned_cols=140  Identities=17%  Similarity=0.212  Sum_probs=94.9

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC----------------------Ch-----HHHHHHHHHhcccCCCce
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF----------------------SG-----EEFINEVSTIGRIHHVNV  122 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~----------------------~~-----~~~~~e~~~l~~l~h~~i  122 (340)
                      ...|..|--+.||.++..+|..+|||+++.+-.                      ++     -....|+.-|.+++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            356888999999999988999999999853110                      11     124578888888865443


Q ss_pred             eeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC
Q 044497          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (340)
Q Consensus       123 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~  202 (340)
                      .-.--....  .-.+||+|+......    ...-+...++...+..+-.+++.-+.-|-+.|  ++||.||+-=|+|+. 
T Consensus       229 P~PePIlLk--~hVLVM~FlGrdgw~----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  229 PCPEPILLK--NHVLVMEFLGRDGWA----APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCCceeee--cceEeeeeccCCCCc----CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence            322111111  246899998432221    11123455667778888888888888776643  899999999999994 


Q ss_pred             CCceEEecccCCccCC
Q 044497          203 NFIPKVSDFGLAKFHP  218 (340)
Q Consensus       203 ~~~~kl~Dfg~~~~~~  218 (340)
                      +|.+.++|.+-+....
T Consensus       300 dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             CCEEEEEEccccccCC
Confidence            5689999988776443

>PLN02236 choline kinase

Probab=97.45  E-value=0.0021  Score=57.67  Aligned_cols=142  Identities=18%  Similarity=0.260  Sum_probs=81.7

Q ss_pred             hhcCCCCCeEEEEEEEcC-----CcEEEEEEccCCCCChHHHHHHHHHhcccCCCce-eeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLHT-----GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.+..|-...+|+....+     +..+++|+........-.-..|..+++.+..-++ .++++.+..+    .+.+|+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            345567788999987532     3689999886543221123678888888854333 3455655432    57999987


Q ss_pred             CCcccc-c----------------ccCCCCC--CCCCHHHHHHHHHHH-----------------HHHHHHH----Hc-C
Q 044497          145 GSLDRH-I----------------FPKESRG--QSFCWEKLHEVALGT-----------------ARGIEYL----HN-G  183 (340)
Q Consensus       145 ~~L~~~-l----------------~~~~~~~--~~~~~~~~~~i~~~i-----------------~~~l~~L----h~-~  183 (340)
                      .++... +                .......  ....+.++.++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            776421 0                0000001  112233333332221                 1112222    21 2


Q ss_pred             CCCCeeecCCCCCCeeEcC-CCceEEecccCCcc
Q 044497          184 CDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKF  216 (340)
Q Consensus       184 ~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~  216 (340)
                      .+..++|+|+++.||++++ ++.+.++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2346899999999999976 46899999988864

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.42  E-value=0.003  Score=55.98  Aligned_cols=141  Identities=21%  Similarity=0.317  Sum_probs=85.9

Q ss_pred             hcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCc------eeeEee----EEEcCCeeEEEEEc
Q 044497           72 KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN------VVQLLG----FCSEGSKRALVYEY  141 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~----~~~~~~~~~lv~e~  141 (340)
                      .|.+ .-..+|+....+++. ++|+.... .+..++..|...+..+.-..      +...=|    ....+.+.+-+++|
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            3555 456788888776655 99999888 77888899999998883211      122111    12222367889999


Q ss_pred             cCCCCccc-ccc------------------c----CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHcC--
Q 044497          142 MPNGSLDR-HIF------------------P----KESRGQSFCWEK-------------LHEVALGTARGIEYLHNG--  183 (340)
Q Consensus       142 ~~~~~L~~-~l~------------------~----~~~~~~~~~~~~-------------~~~i~~~i~~~l~~Lh~~--  183 (340)
                      ++|..+.. .-.                  .    +........|..             -.....++...++.+.+.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99888873 110                  0    000011122220             011233344444444432  


Q ss_pred             --CCCC---eeecCCCCCCeeEcCCCc-eEEecccCCc
Q 044497          184 --CDVC---ILHFDIKPHNILLDHNFI-PKVSDFGLAK  215 (340)
Q Consensus       184 --~~~~---ivH~dik~~Nill~~~~~-~kl~Dfg~~~  215 (340)
                        .+..   +||+|+.|.||+++.+.. ..++||+.+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              2334   999999999999998885 8899999875

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.41  E-value=0.0012  Score=57.34  Aligned_cols=72  Identities=17%  Similarity=0.327  Sum_probs=47.3

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhccc---CCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI---HHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.++.|....+|+.+ .+++.+.+|+-..  .....+..|.+-|+.|   ..-.+++++++....+..++++||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            568888889999887 5678999998762  2335678888877777   3456888999888777889999999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.36  E-value=0.0024  Score=55.43  Aligned_cols=69  Identities=12%  Similarity=0.045  Sum_probs=40.3

Q ss_pred             CCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCC--C-ceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           74 GQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH--V-NVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        74 g~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      ++|-...|+.....+|..+++|.-.... ......+|.++++.+..  | -+.+++..  +  .-+++|++++|..+
T Consensus        20 ~~g~~~~v~~i~~~~g~~~VlR~p~~~~-~~~~l~rE~~vL~~L~~~l~vpvP~~~~~--~--~~~~~y~~i~G~p~   91 (276)
T cd05152          20 ESGLDFQVVFAKDTDGVPWVLRIPRRPD-VSERAAAEKRVLALVRKHLPVQVPDWRVH--T--PELIAYPKLPGVPA   91 (276)
T ss_pred             CCcceeEEEEEEcCCCCeEEEEecCCHH-HHHHHHHHHHHHHHHHhcCCCCCCceeee--c--CceEEEeccCCCcc
Confidence            4454556666655568899999875322 23567889999988852  2 11222211  1  22466777766544

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.16  E-value=0.0054  Score=54.25  Aligned_cols=32  Identities=19%  Similarity=0.215  Sum_probs=28.7

Q ss_pred             CCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       185 ~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +.+++|+|+.+.|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999999999999988763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.15  E-value=0.018  Score=51.31  Aligned_cols=71  Identities=15%  Similarity=0.146  Sum_probs=48.2

Q ss_pred             CCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC--ceeeEe---e--EEEcCCeeEEEEEccCCCCc
Q 044497           77 GFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV--NVVQLL---G--FCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        77 ~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~---~--~~~~~~~~~lv~e~~~~~~L  147 (340)
                      .-..||+....+++.+++|+......+..++..|...+..+...  .++...   |  ....++..+.++++++|...
T Consensus        37 ~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         37 YENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             ccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34578988877788999999876666777888888888877321  122211   1  22334567889999987654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.15  E-value=0.0085  Score=52.62  Aligned_cols=138  Identities=20%  Similarity=0.241  Sum_probs=82.9

Q ss_pred             cCCCCCeEEEEEEEcCCcEEEEEEcc--CCCCChHHHHHHHHHhcccCC--CceeeEeeEEEcCC--eeEEEEEccCCCC
Q 044497           73 LGQGGFGSVYKGQLHTGGLIAVKMLA--NSKFSGEEFINEVSTIGRIHH--VNVVQLLGFCSEGS--KRALVYEYMPNGS  146 (340)
Q Consensus        73 ig~G~~g~v~~~~~~~~~~vavK~~~--~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~~~~~~  146 (340)
                      +..|....+|..... ++++++..-.  ..........+|+.+++.+.-  --+...++.|.++.  ..+.||+|++|..
T Consensus        33 ~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~  111 (321)
T COG3173          33 ISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV  111 (321)
T ss_pred             ccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence            334444445554433 7788888221  112223456678888877642  33455667776665  6799999998855


Q ss_pred             cccccccCCCCCCCCCHHHHHHHH-HHHHHHHHHHHc-------------------------------------------
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVA-LGTARGIEYLHN-------------------------------------------  182 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~-~~i~~~l~~Lh~-------------------------------------------  182 (340)
                      +.+......     ..    .+.+ ..++..|+-||+                                           
T Consensus       112 ~~~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         112 VWSALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             ccCcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            443331100     00    1111 234444444442                                           


Q ss_pred             -------CC-----CCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          183 -------GC-----DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       183 -------~~-----~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                             +-     +..++|||+.+.|++++++..+-+.||+++......
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence                   21     235899999999999999888999999999765443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.01  E-value=0.023  Score=50.26  Aligned_cols=30  Identities=33%  Similarity=0.306  Sum_probs=26.1

Q ss_pred             CCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       186 ~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      .+++|+|+.+.|++++. +.+.++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            48999999999999987 5789999997753

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.99  E-value=0.0094  Score=53.19  Aligned_cols=144  Identities=13%  Similarity=0.201  Sum_probs=80.4

Q ss_pred             hhcCCCCCeEEEEEEEcC----CcEEEEEEccCCCCChHHHHHHHHHhcccCCCce-eeEeeEEEcCCeeEEEEEccCCC
Q 044497           71 HKLGQGGFGSVYKGQLHT----GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.|..|-...+|+....+    +..+++|+........-.-.+|..+++.+..-++ +++++++..+    ++.+|+++.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            455557778899886542    2379999886543222223578888888854443 3455555322    588998776


Q ss_pred             Ccccc-------c----------ccCCCC--CCCCCHHHHHHHHHHH-------------------------HHHHHHHH
Q 044497          146 SLDRH-------I----------FPKESR--GQSFCWEKLHEVALGT-------------------------ARGIEYLH  181 (340)
Q Consensus       146 ~L~~~-------l----------~~~~~~--~~~~~~~~~~~i~~~i-------------------------~~~l~~Lh  181 (340)
                      ++...       +          ......  ..+-.+..+..+..++                         +..+..+.
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            66321       0          000000  0111233332222221                         11111121


Q ss_pred             c--CCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCC
Q 044497          182 N--GCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP  218 (340)
Q Consensus       182 ~--~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~  218 (340)
                      +  ..+.-.+|+|+.+.||++++ ++.++++||..|....
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd  215 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY  215 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence            1  11234899999999999974 5789999999886443

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.95  E-value=0.00063  Score=62.37  Aligned_cols=46  Identities=20%  Similarity=0.293  Sum_probs=37.5

Q ss_pred             HHHHHHHHHhcccCCCceeeEeeEEEc-CCeeEEEEEccCCCCccccc
Q 044497          105 EEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEYMPNGSLDRHI  151 (340)
Q Consensus       105 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l  151 (340)
                      .++......++.+.|+|....+++... .....+|+|++ +.||.+.+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~   73 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDIL   73 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHH
Confidence            567788889999999999999888743 44577899999 77998887

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.88  E-value=0.03  Score=50.91  Aligned_cols=71  Identities=15%  Similarity=0.207  Sum_probs=50.3

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccC-----CC---CChHHHHHHHHHhcccC---CCceeeEeeEEEcCCeeEEEE
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLAN-----SK---FSGEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      +.||.|....||+.... ++.++||.-..     ..   .+.++...|.+.|+.+.   ..++++++.++.+  ..+++|
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence            57899999999998764 56799998652     11   13345556677776663   2478888888773  467889


Q ss_pred             EccCC
Q 044497          140 EYMPN  144 (340)
Q Consensus       140 e~~~~  144 (340)
                      |++++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.82  E-value=0.018  Score=51.41  Aligned_cols=71  Identities=18%  Similarity=0.160  Sum_probs=48.1

Q ss_pred             hcCCCCCeEEEEEEEcCC-cEEEEEEccC--------CCCChHHHHHHHHHhcccC--CC-ceeeEeeEEEcCCeeEEEE
Q 044497           72 KLGQGGFGSVYKGQLHTG-GLIAVKMLAN--------SKFSGEEFINEVSTIGRIH--HV-NVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~~-~~vavK~~~~--------~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~  139 (340)
                      -||.|....||++...++ +.++||.-..        -..+.++..-|.+.|+...  -| .+++++.+  +.....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999987644 5899997431        1333466677888887763  24 45555443  555667899


Q ss_pred             EccCC
Q 044497          140 EYMPN  144 (340)
Q Consensus       140 e~~~~  144 (340)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.80  E-value=0.00017  Score=73.71  Aligned_cols=161  Identities=12%  Similarity=0.019  Sum_probs=112.1

Q ss_pred             HHHHHHHhcccCCCceeeEeeEEE--cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 044497          107 FINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC  184 (340)
Q Consensus       107 ~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~  184 (340)
                      ...|..-++...|+++.....-..  .....+..++++.+|.+.+.+.+...+.......-....-.+.+.+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555556667888766544332  234467899999999999998766555555544444444444356666666543


Q ss_pred             C--CCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHH
Q 044497          185 D--VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL  262 (340)
Q Consensus       185 ~--~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~  262 (340)
                      .  .--+|+++|+-|.++..+..++++++|+.+.......  ......+++.|+.|++...-  .++.++|+|..|+.+|
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHH
Confidence            2  2368999999999999999999999999983322221  12334577889999988764  6667799999999999


Q ss_pred             HHHcCCCCC
Q 044497          263 EMAGGRRNS  271 (340)
Q Consensus       263 elltg~~p~  271 (340)
                      +...|..+|
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            998887654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.68  E-value=0.013  Score=48.14  Aligned_cols=116  Identities=17%  Similarity=0.216  Sum_probs=74.2

Q ss_pred             CCCeEEEEEEEcCCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCccccccc
Q 044497           76 GGFGSVYKGQLHTGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFP  153 (340)
Q Consensus        76 G~~g~v~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  153 (340)
                      ++.++.-.++.+- ++..+|++......  ..-+..+..++.+++-  |+++..=  ...++-++.|+|.....      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeecC--CCceeEEEEeeccCccc------
Confidence            4444554444333 35556666554433  4567888999988763  6666622  44456688898843111      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          154 KESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       154 ~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                                 ....++..=+.+|.-.|+. ..+.+|||-.|+||+=|+.|.+||.|-+..
T Consensus       142 -----------~~~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 -----------NFSNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -----------chhHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence                       0111222224567788864 458999999999999999999999997653

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.61  E-value=0.0047  Score=51.31  Aligned_cols=123  Identities=17%  Similarity=0.239  Sum_probs=61.3

Q ss_pred             CcEEEEEEccCCCCChHHHHHHHHHhcccCCCce-eeEeeEEEcCCeeEEEEEccCCCCcccc-ccc-------------
Q 044497           89 GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNGSLDRH-IFP-------------  153 (340)
Q Consensus        89 ~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~-------------  153 (340)
                      ++.|++++........-.-..|..+++.+...++ .++++.+..+    .+.+|+++.+|..- +..             
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4678899887765555566788888888854333 4555554332    56699877665321 100             


Q ss_pred             -----C-CCCCCCCCHHHHHHH----------------------HHHHHHHHHHHH----c-CCCCCeeecCCCCCCeeE
Q 044497          154 -----K-ESRGQSFCWEKLHEV----------------------ALGTARGIEYLH----N-GCDVCILHFDIKPHNILL  200 (340)
Q Consensus       154 -----~-~~~~~~~~~~~~~~i----------------------~~~i~~~l~~Lh----~-~~~~~ivH~dik~~Nill  200 (340)
                           . ......-.+..+..+                      ...+..-+..+.    + ..+..++|+|+.|.||++
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence                 0 000111112222222                      111122222221    1 112368999999999999


Q ss_pred             -cCCCceEEecccCCc
Q 044497          201 -DHNFIPKVSDFGLAK  215 (340)
Q Consensus       201 -~~~~~~kl~Dfg~~~  215 (340)
                       +.++.++++||..|.
T Consensus       158 ~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             TSSSSCEEE--GTT-E
T ss_pred             ccCCCeEEEecHHHHh
Confidence             889999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=96.59  E-value=0.034  Score=57.12  Aligned_cols=144  Identities=15%  Similarity=0.169  Sum_probs=80.1

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccC-------CCceeeEe-e----EEEc-CC--ee
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-------HVNVVQLL-G----FCSE-GS--KR  135 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-------h~~iv~~~-~----~~~~-~~--~~  135 (340)
                      +.|+ |..-.+|+....+++.+++|+.+... .......|...+..|.       -|.+++-. |    .... .+  +.
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            3464 34577898887778899999998653 3344455656665552       23333221 1    1111 11  45


Q ss_pred             EEEEEccCCCCcccccc-----------------------cCCCCCCCCCHH-----------------HHHHHHHHHHH
Q 044497          136 ALVYEYMPNGSLDRHIF-----------------------PKESRGQSFCWE-----------------KLHEVALGTAR  175 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~-----------------------~~~~~~~~~~~~-----------------~~~~i~~~i~~  175 (340)
                      +.+++|.+|..+.+...                       ........+.|.                 ....++.++++
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            67899999877754110                       000000111121                 11222233333


Q ss_pred             HHHH----HHcCCCCCeeecCCCCCCeeEcCCC--ceE-EecccCCcc
Q 044497          176 GIEY----LHNGCDVCILHFDIKPHNILLDHNF--IPK-VSDFGLAKF  216 (340)
Q Consensus       176 ~l~~----Lh~~~~~~ivH~dik~~Nill~~~~--~~k-l~Dfg~~~~  216 (340)
                      ...-    .....+.++||+|+.+.||+++.++  .+. |+|||.+..
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2221    1122355899999999999998775  454 999998864

>PTZ00384 choline kinase; Provisional

Probab=95.88  E-value=0.11  Score=47.27  Aligned_cols=74  Identities=14%  Similarity=0.166  Sum_probs=44.6

Q ss_pred             hhcCCCCCeEEEEEEEcCC--cE-----EEEEEccCCCCChHHHHHHHHHhcccCCCc-eeeEeeEEEcCCeeEEEEEcc
Q 044497           71 HKLGQGGFGSVYKGQLHTG--GL-----IAVKMLANSKFSGEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      +.|..|-...+|++...++  ..     |.++.........-+-..|+++++.+...+ -.++++.+..    .++.||+
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI  131 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV  131 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence            4565688889999975432  22     444443221111112357888999986444 4455666543    5899999


Q ss_pred             CCCCcc
Q 044497          143 PNGSLD  148 (340)
Q Consensus       143 ~~~~L~  148 (340)
                      +|.+|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            987764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.87  E-value=0.094  Score=46.64  Aligned_cols=105  Identities=14%  Similarity=0.108  Sum_probs=70.7

Q ss_pred             cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEec
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~D  210 (340)
                      +....|++|++. |+++...-        .-.+++...++.+-+..++-+..+  ...-|||+.-.||+++ +|++.|+|
T Consensus       297 e~~y~yl~~kdh-gt~is~ik--------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISIIK--------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             CceEEEEEEecC-Cceeeeee--------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEE
Confidence            334566778876 65664322        234678888888888877777664  4679999999999999 99999999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhH
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF  257 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvwsl  257 (340)
                      |-+++.... +...      .....-.|-.+.|.   -+.+-|||-+
T Consensus       365 fklsRl~~~-q~~i------sy~rldhp~lF~G~---dd~QFeIYrl  401 (488)
T COG5072         365 FKLSRLSYS-QGII------SYNRLDHPDLFNGV---DDYQFEIYRL  401 (488)
T ss_pred             eeeeecccC-Ccee------eccccCchhhhcCc---cceeeeHHHH
Confidence            999984322 2211      11233456666653   3556788764

>PTZ00296 choline kinase; Provisional

Probab=95.85  E-value=0.12  Score=47.99  Aligned_cols=74  Identities=14%  Similarity=0.147  Sum_probs=45.4

Q ss_pred             hhcCCCCCeEEEEEEEcC---------CcEEEEEEccCCCCChHHHHHHHHHhcccCCCcee-eEeeEEEcCCeeEEEEE
Q 044497           71 HKLGQGGFGSVYKGQLHT---------GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVV-QLLGFCSEGSKRALVYE  140 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e  140 (340)
                      +.|..|-.-.+|++...+         ++.|.+++.......--.-..|..+++.+...++- ++++.+.    -..+.|
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~e  186 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEE  186 (442)
T ss_pred             EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEE
Confidence            456667777888886542         45799998865433222335677777777543332 3455543    235789


Q ss_pred             ccCCCCcc
Q 044497          141 YMPNGSLD  148 (340)
Q Consensus       141 ~~~~~~L~  148 (340)
                      |++|.+|.
T Consensus       187 fi~g~~l~  194 (442)
T PTZ00296        187 WLYGDPLR  194 (442)
T ss_pred             eeCCccCC
Confidence            99887553

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.75  E-value=0.041  Score=49.85  Aligned_cols=72  Identities=17%  Similarity=0.172  Sum_probs=48.8

Q ss_pred             hhcCCCCCeEEEEEEEcC-CcEEEEEEccC-------CCCChHHHHHHHHHhcccC--CC-ceeeEeeEEEcCCeeEEEE
Q 044497           71 HKLGQGGFGSVYKGQLHT-GGLIAVKMLAN-------SKFSGEEFINEVSTIGRIH--HV-NVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~-~~~vavK~~~~-------~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~  139 (340)
                      +.||.|.-..||++...+ ++.++||.-..       -..+.++..-|.+.|+...  .| ++++++.+  +.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            568999999999998743 56799987431       1334467778888888763  34 45555544  445566788


Q ss_pred             EccCC
Q 044497          140 EYMPN  144 (340)
Q Consensus       140 e~~~~  144 (340)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            88754

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.36  E-value=0.15  Score=43.44  Aligned_cols=78  Identities=19%  Similarity=0.139  Sum_probs=55.3

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc-CCCCccc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM-PNGSLDR  149 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~~L~~  149 (340)
                      ..+..|..+.|+.+...+|++.++|+........++...+ ..|+..+-...|++++.-  ...-.+++|.+ ++.+|.+
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~   84 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS   84 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence            3456789999999998899999999987654333222222 447777777888998764  33567889998 5557765


Q ss_pred             cc
Q 044497          150 HI  151 (340)
Q Consensus       150 ~l  151 (340)
                      ..
T Consensus        85 ~~   86 (253)
T PF04655_consen   85 LP   86 (253)
T ss_pred             cc
Confidence            54

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	340
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-48
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-33
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-26
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-26
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-26
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-25
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-24
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-24
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-24
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-24
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-23
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-23
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-23
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-21
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-21
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-20
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		9e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-04
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-04
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		7e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		8e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		8e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		8e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  192 bits (487), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 116/296 (39%), Positives = 166/296 (56%), Gaps = 15/296 (5%)
Query: 55  KRYSYPEIIAVTNHFTHK--LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE--FINE 110
           KR+S  E+   +++F++K  LG+GGFG VYKG+L  G L+AVK L   +  G E  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA 170
           V  I    H N+++L GFC   ++R LVY YM NGS+   +  +        W K   +A
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           LG+ARG+ YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V   A R
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX-XAVR 204
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-HATRSSKAYFPSWVYD 289
           GTIG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++             WV  
Sbjct: 205 GTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 290 QLNKGG-----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
            L +       D++L+   + E +   +L  + L C Q    +RP M++V+ MLEG
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEV--EQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 115/296 (38%), Positives = 164/296 (55%), Gaps = 15/296 (5%)
Query: 55  KRYSYPEIIAVTNHFTHK--LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE--FINE 110
           KR+S  E+   +++F +K  LG+GGFG VYKG+L  G L+AVK L   +  G E  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA 170
           V  I    H N+++L GFC   ++R LVY YM NGS+   +  +        W K   +A
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           LG+ARG+ YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V   A R
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX-XAVR 196
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-HATRSSKAYFPSWVYD 289
           G IG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++             WV  
Sbjct: 197 GXIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 290 QLNKGG-----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
            L +       D++L+   + E +   +L  + L C Q    +RP M++V+ MLEG
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEV--EQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 148/283 (52%), Gaps = 16/283 (5%)
Query: 65  VTNHFTHK--LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVST-IGRIHHVN 121
            TN+F HK  +G G FG VYKG L  G  +A+K        G E        +    H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +V L+GFC E ++  L+Y+YM NG+L RH++  +    S  WE+  E+ +G ARG+ YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                 I+H D+K  NILLD NF+PK++DFG++K   + +        +GT+GYI PE  
Sbjct: 157 TR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYF 213
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG-----D 296
            +  G ++ KSDVY FG+VL E+    R++ + +          W  +  N G      D
Sbjct: 214 IK--GRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             L +    ES+  RK     + C+ + + DRPSM  VL  LE
Sbjct: 271 PNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 147/283 (51%), Gaps = 16/283 (5%)
Query: 65  VTNHFTHK--LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVST-IGRIHHVN 121
            TN+F HK  +G G FG VYKG L  G  +A+K        G E        +    H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +V L+GFC E ++  L+Y+YM NG+L RH++  +    S  WE+  E+ +G ARG+ YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                 I+H D+K  NILLD NF+PK++DFG++K   +          +GT+GYI PE  
Sbjct: 157 TR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYF 213
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG-----D 296
            +  G ++ KSDVY FG+VL E+    R++ + +          W  +  N G      D
Sbjct: 214 IK--GRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             L +    ES+  RK     + C+ + + DRPSM  VL  LE
Sbjct: 271 PNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 145/296 (48%), Gaps = 21/296 (7%)
Query: 57  YSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE-- 106
           +S+ E+  VTN+F         +K+G+GGFG VYKG ++   +   K+ A    + EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 107 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LDRHIFPKESRGQSFCW 163
             F  E+  + +  H N+V+LLGF S+G    LVY YMPNGS LDR             W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 132
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
               ++A G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 133 HMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           V  S   GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + H         
Sbjct: 190 VMXSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              + D+     D   + + + +S     +  +   C+  K   RP + KV ++L+
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/296 (33%), Positives = 144/296 (48%), Gaps = 21/296 (7%)
Query: 57  YSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE-- 106
           +S+ E+  VTN+F         +K+G+GGFG VYKG ++   +   K+ A    + EE  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 107 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LDRHIFPKESRGQSFCW 163
             F  E+  + +  H N+V+LLGF S+G    LVY YMPNGS LDR             W
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 126
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
               ++A G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 127 HMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           V      GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + H         
Sbjct: 184 VMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 240
Query: 284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              + D+     D   + + + +S     +  +   C+  K   RP + KV ++L+
Sbjct: 241 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/296 (33%), Positives = 144/296 (48%), Gaps = 21/296 (7%)
Query: 57  YSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE-- 106
           +S+ E+  VTN+F         +K+G+GGFG VYKG ++   +   K+ A    + EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 107 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LDRHIFPKESRGQSFCW 163
             F  E+  + +  H N+V+LLGF S+G    LVY YMPNGS LDR             W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 132
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
               ++A G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 133 HMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           V      GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + H         
Sbjct: 190 VMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              + D+     D   + + + +S     +  +   C+  K   RP + KV ++L+
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 99/296 (33%), Positives = 139/296 (46%), Gaps = 21/296 (7%)
Query: 57  YSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE-- 106
           +S+ E+  VTN+F         +K G+GGFG VYKG ++   +   K+ A    + EE  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 107 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCW 163
             F  E+    +  H N+V+LLGF S+G    LVY Y PNGSL DR             W
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDR--LSCLDGTPPLSW 123
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
               ++A G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 124 HXRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           V  S   GT  Y APE +    G ++ KSD+Y FG+VLLE+  G    + H         
Sbjct: 181 VXXSRIVGTTAYXAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 237
Query: 284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              + D+     D   +   + +S        +   C+  K   RP + KV ++L+
Sbjct: 238 KEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 145/273 (53%), Gaps = 22/273 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 18  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F  +KL ++A  TARG++YLH      
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKS--- 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 306
             S +SDVY FG+VL E+  G+   +    R         + + + +G      +++++ 
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------IIEMVGRGSLSP--DLSKVR 239
Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 240 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 144/273 (52%), Gaps = 22/273 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + S   + A+V ++    SL  H+   E++   F  +KL ++A  TARG++YLH      
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 306
             S +SDVY FG+VL E+  G+   +    R         + + + +G      +++++ 
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------IIEMVGRGSLSP--DLSKVR 251
Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 145/273 (53%), Gaps = 22/273 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F  +KL ++A  TARG++YLH      
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 306
             S +SDVY FG+VL E+  G+   +    R         + + + +G      +++++ 
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------IIEMVGRGSLSP--DLSKVR 251
Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 115/201 (57%), Gaps = 10/201 (4%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE---EFINEVSTIGRIHHVNVVQ 124
           +   K+G G FG+V++ + H G  +AVK+L    F  E   EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +G  ++    ++V EY+  GSL R +    +R Q     +L  +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL-SMAYDVAKGMNYLHNR- 156
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  I+H ++K  N+L+D  +  KV DFGL++   K + F+S  +  GT  ++APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 245 FGTVSCKSDVYGFGMVLLEMA 265
               + KSDVY FG++L E+A
Sbjct: 215 --PSNEKSDVYSFGVILWELA 233

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 113/201 (56%), Gaps = 10/201 (4%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE---EFINEVSTIGRIHHVNVVQ 124
           +   K+G G FG+V++ + H G  +AVK+L    F  E   EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +G  ++    ++V EY+  GSL R +    +R Q     +L  +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL-SMAYDVAKGMNYLHNR- 156
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  I+H D+K  N+L+D  +  KV DFGL++   K + F+      GT  ++APE++   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 245 FGTVSCKSDVYGFGMVLLEMA 265
               + KSDVY FG++L E+A
Sbjct: 215 --PSNEKSDVYSFGVILWELA 233

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 122/213 (57%), Gaps = 13/213 (6%)
Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI---NEVSTIG 115
           Y EI A     + ++G G FG+VYKG+ H  G +AVK+L     + E+F    NEV+ + 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 116 RIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
           +  HVN++  +G+ ++ +  A+V ++    SL +H+  +E++ Q F   +L ++A  TA+
Sbjct: 88  KTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQ 143
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G++YLH      I+H D+K +NI L      K+ DFGLA    + +    +    G++ +
Sbjct: 144 GMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 236 IAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGG 267
           +APE+I  ++    S +SDVY +G+VL E+  G
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 138/273 (50%), Gaps = 22/273 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + S   + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 72  Y-STAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 306
             S +SDVY FG+VL E+  G+   +    R    +           G      +++++ 
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---------VGRGYLSPDLSKVR 235
Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 139/273 (50%), Gaps = 22/273 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 306
             S +SDVY FG+VL E+  G+   +    R    +           G      +++++ 
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---------VGRGYLSPDLSKVR 235
Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 16  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
             S +SDVY FG+VL E+  G+
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
             S +SDVY FG+VL E+  G+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
             S +SDVY FG+VL E+  G+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 41  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 151
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
             S +SDVY FG+VL E+  G+
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
             S +SDVY FG+VL E+  G+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG  F  E L  + L    G+ YL    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 179
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 180 SSKSDVWSFGVLMWEV 195

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG  F  E L  + L    G+ YL    + C+
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 127
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 184
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 185 SSKSDVWSFGVLMWEV 200

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG  F  E L  + L    G+ YL    + C+
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 124
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 181
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 182 SSKSDVWSFGVLMWEV 197

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 34  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
             S +SDVY FG+VL E+  G+
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
             S +SDVY FG+VL E+  G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML   A +    + F NEV  + +  HVN++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
             S +SDVY FG+VL E+  G+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S ++FI E   + ++ H  +VQL G 
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG  F  E L  + L    G+ YL    + C+
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 144
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 201
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 202 SSKSDVWSFGVLMWEV 217

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV E+M +G L  ++  +  RG  F  E L  + L    G+ YL    + C+
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 182
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 183 SSKSDVWSFGVLMWEV 198

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 125/270 (46%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      +V EYMP G+L  ++  +E   +      L  +A   +  +EYL        +
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYLEKK---NFI 152
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N  T S
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--TFS 209
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VYD L KG  +E           
Sbjct: 210 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYDLLEKGYRMEQ------PEGC 256
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C +   ADRPS  +  +  E
Sbjct: 257 PPKVYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 125/270 (46%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  F + +  +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-FTAHAGAKFPIKWTAPESLAYN--KFS 188
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +         PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG  F  E L  + L    G+ YL    +  +
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 181
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 182 SSKSDVWSFGVLMWEV 197

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 123/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G FG VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 188
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +         PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 123/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 188
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +         PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMER------PEGC 235
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/219 (35%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLAN--SKFSGEEFINEVSTI 114
           EI A   H    +G G  G V  G+L   G     +A+K L    ++    +F++E S +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  + G    +V EYM NGSLD   F +   GQ F   +L  +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G+ YL    D+  +H D+   N+L+D N + KVSDFGL++    E+D  +   T G   
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAXTTTGGKI 216
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + APE I+  F T S  SDV+ FG+V+ E +A G R
Sbjct: 217 PIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 112/217 (51%), Gaps = 16/217 (7%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLAN--SKFSGEEFINEVSTI 114
           EI A   H    +G G  G V  G+L   G     +A+K L    ++    +F++E S +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  + G    +V EYM NGSLD   F +   GQ F   +L  +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTI 233
            G+ YL    D+  +H D+   N+L+D N + KVSDFGL++    + D   + +  +  I
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            + APE I+  F T S  SDV+ FG+V+ E +A G R
Sbjct: 219 RWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + +I H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 78  -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 131
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 188
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 189 SDVWSFGILLTELTTKGR 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 74  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 127
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 184
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 185 SDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 76  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 129
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 186
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 187 SDVWSFGILLTELTTKGR 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAPAGAKFPIKWTAPESLAYN--KFS 192
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 193 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 239
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 80  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAPAGAKFPIKWTAPESLAYN--KFS 191
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 192 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 238
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVCEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 83  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 137
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 194
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 195 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 241
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 75  -EPIXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 128
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N+  +    +  I + APE  +  +G  + K
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGRFTIK 185
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 186 SDVWSFGILLTELTTKGR 203

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 92  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 146
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 203
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 204 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 250
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 251 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L     S + F+
Sbjct: 5   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 61
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G      KL +
Sbjct: 62  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 118
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N++ +   
Sbjct: 119 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREG 174
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 175 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L     S + F+
Sbjct: 6   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 62
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G      KL +
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 119
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N++ +   
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREG 175
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 176 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 192
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 193 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 239
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 192
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 193 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 239
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D+   NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L +++   A G+ Y+     +  +H 
Sbjct: 82  -EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 192
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 49/285 (17%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQL 125
           +G G FG VYKG L T        +A+K L       +  +F+ E   +G+  H N+++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
            G  S+     ++ EYM NG+LD+  F +E  G+ F   +L  +  G A G++YL N   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLAN--- 165
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS 242
           +  +H D+   NIL++ N + KVSDFGL++    E+D  +   T G    I + APE IS
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 243 -RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSW------VYDQLNKG 294
            R F   +  SDV+ FG+V+ E M  G R              P W      V   +N G
Sbjct: 224 YRKF---TSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAINDG 266
Query: 295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                R  T ++   A    M+  W  Q + A RP    ++ +L+
Sbjct: 267 ----FRLPTPMDCPSAIYQLMMQCW--QQERARRPKFADIVSILD 305

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  G L    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVMEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 334 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 444
Query: 252 SDVYGFGMVLLEMA 265
           SDV+ FG++L E+ 
Sbjct: 445 SDVWSFGILLTELT 458

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L     S + F+
Sbjct: 10  QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 66
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G      KL +
Sbjct: 67  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 123
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N++ +   
Sbjct: 124 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREG 179
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 180 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N+  +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 15/231 (6%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           EI   +     +LG G FG V+ G  +    +AVK L     S + F+ E + +  + H 
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 68
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    +      ++ EYM  GSL    F K   G      KL + +   A G+ Y+
Sbjct: 69  KLVRLYAVVTREEPIYIITEYMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                   +H D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 127 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEA 182
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMHATRSSKAYFP 284
           I  NFG  + KSDV+ FG++L E+         GR N+++    S     P
Sbjct: 183 I--NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMP 231

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L +++   A G+ Y+     +  +H 
Sbjct: 82  -EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPE--AALYGRFTIK 192
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  G L    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 137/292 (46%), Gaps = 40/292 (13%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGE--EFINEVSTI 114
           EI A        +G G FG V  G+L   G     +A+K L       +  +F++E S +
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N++ L G  ++     ++ EYM NGSLD  +   + R   F   +L  +  G  
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIG 141
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 142 SGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 196
Query: 232 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYD 289
            I + APE I+ R F +    SDV+ +G+V+ E M+ G R              P W   
Sbjct: 197 PIRWTAPEAIAYRKFTSA---SDVWSYGIVMWEVMSYGER--------------PYWDMS 239
Query: 290 QLN--KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +  K  +   R    ++  IA    M+  W  Q + +DRP   +++ ML+
Sbjct: 240 NQDVIKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLD 289

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 137/292 (46%), Gaps = 40/292 (13%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGE--EFINEVSTI 114
           EI A        +G G FG V  G+L   G     +A+K L       +  +F++E S +
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N++ L G  ++     ++ EYM NGSLD  +   + R   F   +L  +  G  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIG 120
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 121 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 175
Query: 232 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYD 289
            I + APE I+ R F +    SDV+ +G+V+ E M+ G R              P W   
Sbjct: 176 PIRWTAPEAIAYRKFTSA---SDVWSYGIVMWEVMSYGER--------------PYWDMS 218
Query: 290 QLN--KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +  K  +   R    ++  IA    M+  W  Q + +DRP   +++ ML+
Sbjct: 219 NQDVIKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLD 268

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 122/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 191
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 192 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 238
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 122/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 28/230 (12%)
Query: 53  MPKRYSYP---------EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML-- 97
           MP  Y  P         EI A        +G G FG V  G+L   G     +A+K L  
Sbjct: 1   MPHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKV 60
Query: 98  ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESR 157
             ++    +F+ E S +G+  H N++ L G  ++     +V EYM NGSLD   F K++ 
Sbjct: 61  GYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD--TFLKKND 118
Query: 158 GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 217
           GQ F   +L  +  G + G++YL    D+  +H D+   NIL++ N + KVSDFGL++  
Sbjct: 119 GQ-FTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 174
Query: 218 PKENDFVSISATRG---TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             E+D  +   TRG    I + APE I+  F   +  SDV+ +G+V+ E+
Sbjct: 175 --EDDPEAAYTTRGGKIPIRWTAPEAIA--FRKFTSASDVWSYGIVMWEV 220

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L     S + F+
Sbjct: 1   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 57
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G      KL +
Sbjct: 58  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 114
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 115 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 170
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 171 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 204

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 9/204 (4%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           E+   T     +LG G FG V+ G  +    +AVK L     S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    ++     ++ EYM NGSL    F K   G      KL ++A   A G+ ++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEA 181
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I  N+GT + KSDV+ FG++L E+
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEI 203

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L     S + F+
Sbjct: 2   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 58
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G      KL +
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 115
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 116 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 171
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 172 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 205

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 137/292 (46%), Gaps = 40/292 (13%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGE--EFINEVSTI 114
           EI A        +G G FG V  G+L   G     +A+K L       +  +F++E S +
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N++ L G  ++     ++ EYM NGSLD  +   + R   F   +L  +  G  
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIG 126
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG   
Sbjct: 127 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKI 181
Query: 232 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYD 289
            I + APE I+ R F +    SDV+ +G+V+ E M+ G R              P W   
Sbjct: 182 PIRWTAPEAIAYRKFTSA---SDVWSYGIVMWEVMSYGER--------------PYWDMS 224
Query: 290 QLN--KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +  K  +   R    ++  IA    M+  W  Q + +DRP   +++ ML+
Sbjct: 225 NQDVIKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLD 274

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL    SE
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 252 -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 305
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGL +   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 362
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 363 SDVWSFGILLTELTTKGR 380

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L     S + F+
Sbjct: 9   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 65
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G      KL +
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 122
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 123 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 178
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 179 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H ++   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 397
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 398 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 444
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 445 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 9/204 (4%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           E+   T     +LG G FG V+ G  +    +AVK L     S + F+ E + + ++ H 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    ++     ++ EYM NGSL    F K   G      KL ++A   A G+ ++
Sbjct: 64  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +   +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 121 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEA 176
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I  N+GT + KSDV+ FG++L E+
Sbjct: 177 I--NYGTFTIKSDVWSFGILLTEI 198

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L     S + F+
Sbjct: 8   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 64
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G      KL +
Sbjct: 65  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 121
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 122 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 177
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 178 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 211

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK L     S + F+
Sbjct: 6   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 62
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G      KL +
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 119
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 175
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 176 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 209

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 18/207 (8%)
Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G L   G     +A+K L +  ++    +F++E S +G+  H NV+ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++ +   ++ E+M NGSLD   F +++ GQ F   +L  +  G A G++YL    D+
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG--YIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++F     +D    SA  G I   + APE I  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 212
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+V+ E M+ G R
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGER 239

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSRGSKFPVRWSPPEVLM--YSKF 183
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 184 SSKSDIWAFGVLMWEI 199

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 183
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 184 SSKSDIWAFGVLMWEI 199

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G 
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 125
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 182
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 183 SSKSDIWAFGVLMWEI 198

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           EI   +     +LG G FG V+ G  +    +A+K L     S E F+ E   + ++ H 
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHD 64
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +VQL    SE     +V EYM  GSL    F K+  G++     L ++A   A G+ Y+
Sbjct: 65  KLVQLYAVVSE-EPIYIVTEYMNKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                +  +H D++  NIL+ +  I K++DFGLA+   ++N+  +    +  I + APE 
Sbjct: 122 ER---MNYIHRDLRSANILVGNGLICKIADFGLARLI-EDNEXTARQGAKFPIKWTAPE- 176
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
            +  +G  + KSDV+ FG++L E+    R
Sbjct: 177 -AALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 121
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 178
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 179 SSKSDIWAFGVLMWEI 194

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG C
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q      L  +A   +  +EYL        +
Sbjct: 325 TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 379
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H ++   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 436
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            KSDV+ FG++L E+A        +          S VY+ L K   +E           
Sbjct: 437 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 483
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 484 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 15/231 (6%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           EI   +     KLG G FG V+ G  +    +AVK L     S + F+ E + +  + H 
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 67
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    ++     ++ E+M  GSL    F K   G      KL + +   A G+ Y+
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                   +H D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 126 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEA 181
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMHATRSSKAYFP 284
           I  NFG  + KS+V+ FG++L E+         GR N+++ +  S     P
Sbjct: 182 I--NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMP 230

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G 
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 132
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 189
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 190 SSKSDIWAFGVLMWEI 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           E+   T     +LG G FG V+ G  +    +AVK L     S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    ++     ++ EYM NGSL    F K   G      KL ++A   A G+ ++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEA 181
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I  N+GT + KSDV+ FG++L E+
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEI 203

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           E+   T     +LG G FG V+ G  +    +AVK L     S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    ++     ++ EYM NGSL    F K   G      KL ++A   A G+ ++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +   +H D++  NIL+      K++DFGLA+   ++N+  +    +  I + APE 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEA 181
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I  N+GT + KSDV+ FG++L E+
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEI 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 198
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 199 SSKSDIWAFGVLMWEI 214

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 9/204 (4%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           E+   T     +LG G FG V+ G  +    +AVK L     S + F+ E + + ++ H 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    ++     ++ EYM NGSL    F K   G      KL ++A   A G+ ++
Sbjct: 65  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 121
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +   +H +++  NIL+      K++DFGLA+   ++N++ +    +  I + APE 
Sbjct: 122 E---ERNYIHRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEA 177
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I  N+GT + KSDV+ FG++L E+
Sbjct: 178 I--NYGTFTIKSDVWSFGILLTEI 199

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 138/282 (48%), Gaps = 44/282 (15%)
Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L   G     +A+K L    ++    +F+ E S +G+  H NVV L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  + G    +V E+M NG+LD   F ++  GQ F   +L  +  G A G+ YL    D+
Sbjct: 111 GVVTRGKPVMIVIEFMENGALD--AFLRKHDGQ-FTVIQLVGMLRGIAAGMRYL---ADM 164
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  ++  T G    + + APE I  
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRV--IEDDPEAVYTTTGGKIPVRWTAPEAI-- 220
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
            +   +  SDV+ +G+V+ E M+ G R              P W  D  N+  D+ ++ +
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGER--------------PYW--DMSNQ--DV-IKAI 261
Query: 303 TEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
            E   + A   C  GL      C Q + A+RP   +++ +L+
Sbjct: 262 EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILD 303

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   + +  S+  ++  + +  PE++   +   
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFPVRWSPPEVLM--YSKF 198
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 199 SSKSDIWAFGVLMWEI 214

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G L   G     +A+K L +  ++    +F++E S +G+  H NV+ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++ +   ++ E+M NGSLD   F +++ GQ F   +L  +  G A G++YL    D+
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADM 128
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG--YIAPELISR 243
             +H  +   NIL++ N + KVSDFGL++F     +D    SA  G I   + APE I  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 186
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+V+ E M+ G R
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGER 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 18/207 (8%)
Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V +G+L   G     +A+K L    ++    EF++E S +G+  H N+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +      ++ E+M NG+LD   F + + GQ F   +L  +  G A G+ YL    ++
Sbjct: 82  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 135
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++F  + +   + +++ G    I + APE I+ 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA- 194
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            F   +  SD + +G+V+ E M+ G R
Sbjct: 195 -FRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +LG G FG V  G+      +AVKM+     S +EF  E  T+ ++ H  +V+  G CS+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EY+ NG L  ++    S G+     +L E+      G+ +L +      +H 
Sbjct: 75  EYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D+   N L+D +   KVSDFG+ ++   ++ +VS   T+  + + APE+   ++   S K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF--HYFKYSSK 185
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG+++ E+
Sbjct: 186 SDVWAFGILMWEV 198

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGLA+    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V +G+L   G     +A+K L    ++    EF++E S +G+  H N+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +      ++ E+M NG+LD   F + + GQ F   +L  +  G A G+ YL    ++
Sbjct: 84  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 137
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG--YIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++F     +D    S+  G I   + APE I+ 
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA- 196
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            F   +  SD + +G+V+ E M+ G R
Sbjct: 197 -FRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 114/220 (51%), Gaps = 22/220 (10%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 128
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 129 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 183
Query: 232 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 184 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 220

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 114/220 (51%), Gaps = 22/220 (10%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 145
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 146 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 200
Query: 232 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 201 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 237

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 155
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 210
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 211 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 247

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 112/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL +    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +  P     +     KLG G FG V+    +    +AVK +     S E F+
Sbjct: 2   QKPWEKDAWEIPR---ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL 58
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + +  + H  +V+L    ++     ++ E+M  GSL    F K   G      KL +
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLID 115
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
            +   A G+ ++        +H D++  NIL+  + + K++DFGLA+   ++N++ +   
Sbjct: 116 FSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREG 171
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  NFG+ + KSDV+ FG++L+E+
Sbjct: 172 AKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 205

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           E+   T     +LG G  G V+ G  +    +AVK L     S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    ++     ++ EYM NGSL    F K   G      KL ++A   A G+ ++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +   +H D++  NIL+      K++DFGLA+   ++ +  +    +  I + APE 
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAPEA 181
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I  N+GT + KSDV+ FG++L E+
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEI 203

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI 108
           Q+ W    +   EI   +     KLG G FG V+    +    +AVK +     S E F+
Sbjct: 175 QKPWEKDAW---EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL 231
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E + +  + H  +V+L    ++     ++ E+M  GSL    F K   G      KL +
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLID 288
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
            +   A G+ ++        +H D++  NIL+  + + K++DFGLA+   ++N++ +   
Sbjct: 289 FSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREG 344
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  NFG+ + KSDV+ FG++L+E+
Sbjct: 345 AKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 378

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 47/304 (15%)
Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLAN--SKFSGEEFI 108
           P    YP +      F   +G+G FG V K ++   GL    A+K +    SK    +F 
Sbjct: 4   PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 63
Query: 109 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHIFPKE 155
            E+  + ++ HH N++ LLG C       L  EY P+G+L            D       
Sbjct: 64  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 123
Query: 156 SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           S   +   ++L   A   ARG++YL        +H D+   NIL+  N++ K++DFGL++
Sbjct: 124 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 180
Query: 216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 273
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 181 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 235
Query: 274 HATRSSKAYFPSWVYDQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 236 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 278
Query: 332 TKVL 335
            ++L
Sbjct: 279 AQIL 282

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 22/220 (10%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V E M NGSLD  +   +++   F   +L  +  G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 128
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 129 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 183
Query: 232 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 184 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 220

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 47/304 (15%)
Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLAN--SKFSGEEFI 108
           P    YP +      F   +G+G FG V K ++   GL    A+K +    SK    +F 
Sbjct: 14  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 109 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHIFPKE 155
            E+  + ++ HH N++ LLG C       L  EY P+G+L            D       
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 156 SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           S   +   ++L   A   ARG++YL        +H D+   NIL+  N++ K++DFGL++
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 273
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 191 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245
Query: 274 HATRSSKAYFPSWVYDQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 246 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 288
Query: 332 TKVL 335
            ++L
Sbjct: 289 AQIL 292

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 22/220 (10%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V E M NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+ R F   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGER 249

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 20/219 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTI 114
           E+ A        +G G FG V  G+L         +A+K L    ++    +F+ E S +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           G+  H N+++L G  ++     +V E M NGSLD  +   +++   F   +L  +  G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 157
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G++YL    D+  +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG   
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKI 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            I + +PE I+  +   +  SDV+ +G+VL E M+ G R
Sbjct: 213 PIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +F  +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 134/304 (44%), Gaps = 47/304 (15%)
Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLAN--SKFSGEEFI 108
           P    YP +      F   +G+G FG V K ++   GL    A+K +    SK    +F 
Sbjct: 11  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 70
Query: 109 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHIFPKE 155
            E+  + ++ HH N++ LLG C       L  EY P+G+L            D       
Sbjct: 71  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 130
Query: 156 SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           S   +   ++L   A   ARG++YL        +H ++   NIL+  N++ K++DFGL++
Sbjct: 131 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR 187
Query: 216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 273
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 188 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 242
Query: 274 HATRSSKAYFPSWVYDQLNKGGDLE--LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 243 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 285
Query: 332 TKVL 335
            ++L
Sbjct: 286 AQIL 289

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 134
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 135 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 192 SLTES--KFSVASDVWSFGVVLYEL 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 129
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 130 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 187 SLTES--KFSVASDVWSFGVVLYEL 209

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 135
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 136 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 193 SLTES--KFSVASDVWSFGVVLYEL 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 128
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 129 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 186 SLTES--KFSVASDVWSFGVVLYEL 208

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 136
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 137 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 194 SLTES--KFSVASDVWSFGVVLYEL 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 133
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 148
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 149 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 206 SLTES--KFSVASDVWSFGVVLYEL 228

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   ++  +     KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 161
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 162 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 219 SLTES--KFSVASDVWSFGVVLYEL 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 137
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 138 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 195 SLTES--KFSVASDVWSFGVVLYEL 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 148
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 149 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 206 SLTES--KFSVASDVWSFGVVLYEL 228

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 131
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H ++   NIL+++    K+ DFGL K  P++ ++  +       I + APE
Sbjct: 132 --GTKRYI-HRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 189 SLTES--KFSVASDVWSFGVVLYEL 211

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG-FC 129
             +G+G FG V  G  + G  +AVK + N   + + F+ E S + ++ H N+VQLLG   
Sbjct: 18  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCW-EKLHEVALGTARGIEYLHNGCDVCI 188
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 129
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N+L+  + + KVSDFGL K      D   +      + + APE +       
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALRE--AAF 182
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG++L E+
Sbjct: 183 STKSDVWSFGILLWEI 198

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG-FC 129
             +G+G FG V  G  + G  +AVK + N   + + F+ E S + ++ H N+VQLLG   
Sbjct: 12  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCW-EKLHEVALGTARGIEYLHNGCDVCI 188
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 123
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE-LISRNFGT 247
           +H D+   N+L+  + + KVSDFGL K      D       +  + + APE L  + F T
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFST 178
Query: 248 VSCKSDVYGFGMVLLEM 264
              KSDV+ FG++L E+
Sbjct: 179 ---KSDVWSFGILLWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG-FC 129
             +G+G FG V  G  + G  +AVK + N   + + F+ E S + ++ H N+VQLLG   
Sbjct: 27  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCW-EKLHEVALGTARGIEYLHNGCDVCI 188
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N+L+  + + KVSDFGL K      D       +  + + APE +       
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK--KF 191
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG++L E+
Sbjct: 192 STKSDVWSFGILLWEI 207

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGE--------EFINEVSTIGRIH 118
            +  ++G+GGFG V+KG+L     ++A+K L      GE        EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H N+V+L G      +  +V E++P G L   +     +     W     + L  A GIE
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 179 YLHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           Y+ N  +  I+H D++  NI L   D N     KV+DFGL+     +    S+S   G  
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGNF 190
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            ++APE I     + + K+D Y F M+L  +  G 
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q +TG ++AVK L +S      +F  E+  +  + H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ E++P GSL  ++   + R       KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI---KLLQYTSQICKGMEYL 133
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG-FC 129
             +G+G FG V  G  + G  +AVK + N   + + F+ E S + ++ H N+VQLLG   
Sbjct: 199 QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCW-EKLHEVALGTARGIEYLHNGCDVCI 188
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 310
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE-LISRNFGT 247
           +H D+   N+L+  + + KVSDFGL K      D   +      + + APE L  + F T
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALREKKFST 365
Query: 248 VSCKSDVYGFGMVLLEM 264
              KSDV+ FG++L E+
Sbjct: 366 ---KSDVWSFGILLWEI 379

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGE--------EFINEVSTIGRIH 118
            +  ++G+GGFG V+KG+L     ++A+K L      GE        EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H N+V+L G      +  +V E++P G L   +     +     W     + L  A GIE
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 179 YLHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           Y+ N  +  I+H D++  NI L   D N     KV+DF L+     +    S+S   G  
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGLLGNF 190
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            ++APE I     + + K+D Y F M+L  +  G 
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGE--------EFINEVSTIGRIH 118
            +  ++G+GGFG V+KG+L     ++A+K L      GE        EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H N+V+L G      +  +V E++P G L   +     +     W     + L  A GIE
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 179 YLHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           Y+ N  +  I+H D++  NI L   D N     KV+DFG +     +    S+S   G  
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGLLGNF 190
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            ++APE I     + + K+D Y F M+L  +  G 
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV 120
           EI   +     KLG G FG V+    +    +AVK +     S E F+ E + +  + H 
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 237
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V+L    ++     ++ E+M  GSL    F K   G      KL + +   A G+ ++
Sbjct: 238 KLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 294
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                   +H D++  NIL+  + + K++DFGLA+              +  I + APE 
Sbjct: 295 EQR---NYIHRDLRAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAPEA 340
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I  NFG+ + KSDV+ FG++L+E+
Sbjct: 341 I--NFGSFTIKSDVWSFGILLMEI 362

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 58  SYPEIIAVTNH----FTHKLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSG--EEFINE 110
           + P+   V NH       ++G+G FG V+ G+L     L+AVK    +       +F+ E
Sbjct: 103 AVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQE 162
Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA 170
              + +  H N+V+L+G C++     +V E +  G     +    + G     + L ++ 
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMV 219
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-- 228
              A G+EYL + C  CI H D+   N L+    + K+SDFG+++   +E D V  ++  
Sbjct: 220 GDAAAGMEYLESKC--CI-HRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGG 273
Query: 229 -TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 263
             +  + + APE +  N+G  S +SDV+ FG++L E
Sbjct: 274 LRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 21/214 (9%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
            KLG+G +GSVYK     TG ++A+K +   +   +E I E+S + +    +VV+  G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            + +   +V EY   GS+   I     R ++   +++  +   T +G+EYLH    +  +
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHF---MRKI 147
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELISRNF 245
           H DIK  NILL+     K++DFG+A             A R    GT  ++APE+I +  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVA------GQLTDXMAKRNXVIGTPFWMAPEVI-QEI 200
Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRN-SNMHATRS 278
           G  +C +D++  G+  +EMA G+   +++H  R+
Sbjct: 201 G-YNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSGE-EFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +      +TG L+AVK L +S    + +F  E+  +  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 123 VQLLGFCSEGSKRA---LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+  G  S G  R    LV EY+P+G L   +    +R  +    +L   +    +G+EY
Sbjct: 87  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEY 142
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAP 238
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 143 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E +S N    S +SDV+ FG+VL E+
Sbjct: 200 ESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSGE-EFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +      +TG L+AVK L +S    + +F  E+  +  +H   +
Sbjct: 14  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 123 VQLLGFCSEGSKRA---LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+  G  S G  R    LV EY+P+G L   +    +R  +    +L   +    +G+EY
Sbjct: 74  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEY 129
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAP 238
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 130 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E +S N    S +SDV+ FG+VL E+
Sbjct: 187 ESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 58  SYPEIIAVTNH----FTHKLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSG--EEFINE 110
           + P+   V NH       ++G+G FG V+ G+L     L+AVK    +       +F+ E
Sbjct: 103 AVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQE 162
Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA 170
              + +  H N+V+L+G C++     +V E +  G     +    + G     + L ++ 
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMV 219
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-- 228
              A G+EYL + C  CI H D+   N L+    + K+SDFG+++   +E D V  ++  
Sbjct: 220 GDAAAGMEYLESKC--CI-HRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGG 273
Query: 229 -TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 263
             +  + + APE +  N+G  S +SDV+ FG++L E
Sbjct: 274 LRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSGE-EFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +      +TG L+AVK L +S    + +F  E+  +  +H   +
Sbjct: 15  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 123 VQLLGFCSEGSKRA---LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+  G  S G  R    LV EY+P+G L   +    +R  +    +L   +    +G+EY
Sbjct: 75  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEY 130
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAP 238
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 131 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 187
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E +S N    S +SDV+ FG+VL E+
Sbjct: 188 ESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSGE-EFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +      +TG L+AVK L +S    + +F  E+  +  +H   +
Sbjct: 11  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 123 VQLLGFCSEGSKRA---LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+  G  S G  R    LV EY+P+G L   +    +R  +    +L   +    +G+EY
Sbjct: 71  VKYRGV-SYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEY 126
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAP 238
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D   +    +  I + AP
Sbjct: 127 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAP 183
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E +S N    S +SDV+ FG+VL E+
Sbjct: 184 ESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG-----EEFINEVSTIGRIHHVNVVQLLG 127
           +G GGFG VY+     G  +AVK   +          E    E      + H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
            C +     LV E+   G L+R +      G+    + L   A+  ARG+ YLH+   V 
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 188 ILHFDIKPHNILLDH--------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           I+H D+K  NIL+          N I K++DFGLA    +E    +  +  G   ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPE 184
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +I  +    S  SDV+ +G++L E+  G 
Sbjct: 185 VIRASM--FSKGSDVWSYGVLLWELLTGE 211

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 72  KLGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + HTG  +AVK +   K    E + NEV  +   HH NVV +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  +V E++  G+L   +    +R      E++  V L   R + YLHN     ++
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV--THTRMNE---EQIATVCLSVLRALSYLHNQ---GVI 163
Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 244
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR  
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVISRLP 217
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR----RNSNMHATRSSKAYFPSWVYD 289
           +GT   + D++  G++++EM  G         + A R  +   P  V D
Sbjct: 218 YGT---EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKD 263

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  +C+   H              
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 141 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 198 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  +C+   H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF 70
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 122
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 180 KRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHIFPKESRGQSF--------CWEKLHEVALGTA 174
            LLG C++ G    ++ E+   G+L  ++  K +    +          E L   +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           +G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D+V     R  + 
Sbjct: 155 KGMEFLASRKXI---HRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 WMAPETIFDRVYTI--QSDVWSFGVLLWEI 239

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 69  FTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK++   +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIE 178
           V+  G   EG+ + L  EY   G L   I P     E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV---- 119
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 69  FTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK++   +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIE 178
           V+  G   EG+ + L  EY   G L   I P     E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV---- 118
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------IFPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            + P++        E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------IFPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            + P++        E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------IFPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            + P++        E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 69  FTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK++   +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIE 178
           V+  G   EG+ + L  EY   G L   I P     E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV---- 118
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------IFPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            + P++        E L   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 192 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 249 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 280

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE----------VALG 172
            LLG C++ G    ++ E+   G+L  ++  K +    +  E L++           +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            A+G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D V     R  
Sbjct: 157 VAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 214 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 120
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 178 KRREFHAE-PVDVWSCGIVLTAMLAG 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 27/212 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE----------VALG 172
            LLG C++ G    ++ E+   G+L  ++  +  R +   ++ L++           +  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            A+G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D+V     R  
Sbjct: 153 VAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 210 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 239

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 122
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 180 KRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHI------------FPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  ++             P++        E L   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 157 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 214 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 245

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 122
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 180 KRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 72  KLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEE----FINEVSTIGRIHHVNVVQLL 126
           KLG GG  +VY  +     + +A+K +       EE    F  EV    ++ H N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
               E     LV EY+   +L  +I   ES G     +           GI++ H   D+
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHG-PLSVDTAINFTNQILDGIKHAH---DM 130
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H DIKP NIL+D N   K+ DFG+AK    E      +   GT+ Y +PE  ++   
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTNHVLGTVQYFSPEQ-AKGEA 188
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
           T  C +D+Y  G+VL EM  G 
Sbjct: 189 TDEC-TDIYSIGIVLYEMLVGE 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------IFPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            + P++        E L   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------IFPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            + P++        E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHI-----------FPKESRGQSFCWEKLHEVAL 171
            LLG C++ G    ++ E+   G+L  ++            P++        E L   + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
             A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R 
Sbjct: 156 QVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 213 PLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------IFPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            + P++        E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 70  THKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQLLG 127
           T  LG G FG V+K +    GL +A K++        EE  NE+S + ++ H N++QL  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 128 FCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVAL--GTARGIEYLHNGC 184
                +   LV EY+  G L DR I       +S+   +L  +        GI ++H   
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII------DESYNLTELDTILFMKQICEGIRHMHQ-- 205
Query: 185 DVCILHFDIKPHNILL---DHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPEL 240
            + ILH D+KP NIL    D   I K+ DFGLA ++ P+E     +    GT  ++APE+
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPRE----KLKVNFGTPEFLAPEV 259
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++ +F  VS  +D++  G++   +  G
Sbjct: 260 VNYDF--VSFPTDMWSVGVIAYMLLSG 284

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 16/199 (8%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLANS--KFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+V+KG     G      + +K++ +   + S +   + +  IG + H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           LG C  GS   LV +Y+P GSL  H+  ++ RG +   + L    +  A+G+ YL    +
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E I  +F
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HF 191
Query: 246 GTVSCKSDVYGFGMVLLEM 264
           G  + +SDV+ +G+ + E+
Sbjct: 192 GKYTHQSDVWSYGVTVWEL 210

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 16/199 (8%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLANS--KFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+V+KG     G      + +K++ +   + S +   + +  IG + H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           LG C  GS   LV +Y+P GSL  H+  ++ RG +   + L    +  A+G+ YL    +
Sbjct: 99  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLE---E 151
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E I  +F
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HF 209
Query: 246 GTVSCKSDVYGFGMVLLEM 264
           G  + +SDV+ +G+ + E+
Sbjct: 210 GKYTHQSDVWSYGVTVWEL 228

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 122
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 180 KRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 122
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 180 KRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 206 LESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 122
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 180 KRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 150 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 207 LESLQTQKFTT---KSDVWSFGVLLWEL 231

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 105/214 (49%), Gaps = 28/214 (13%)
Query: 72  KLGQGGFGSVYKGQLHTGG------LIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  + +         L+AVK L +   +  ++F  E   +  + H ++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIF-------------PKESRGQSFCWEKLHEVAL 171
             G C +G    +V+EYM +G L++ +              P++++G+    + LH +A 
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IAS 140
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
             A G+ YL        +H D+   N L+  N + K+ DFG+++     + +     T  
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 232 TIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            I ++ PE ++ R F T   +SDV+ FG++L E+
Sbjct: 198 PIRWMPPESIMYRKFTT---ESDVWSFGVILWEI 228

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 147 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 204 LESLQTQKFTT---KSDVWSFGVLLWEL 228

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE   V + +  +  + ++A
Sbjct: 148 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 205 LESLQTQKFTT---KSDVWSFGVLLWEL 229

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 37/273 (13%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           +G+G FG V K +      +A+K +  S+   + FI E+  + R++H N+V+L G C   
Sbjct: 16  VGRGAFGVVCKAKWRAKD-VAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 133 SKRALVYEYMPNGSL-----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +   LV EY   GSL          P  +   +  W       L  ++G+ YLH+     
Sbjct: 72  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKA 125
Query: 188 ILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           ++H D+KP N+LL     + K+ DFG A      +    ++  +G+  ++APE+   +  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS-- 178
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE-I 305
             S K DV+ +G++L E+   R+  +        A+   W     N      ++N+ + I
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVH--NGTRPPLIKNLPKPI 233
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
           ES++ R        C     + RPSM ++++++
Sbjct: 234 ESLMTR--------CWSKDPSQRPSMEEIVKIM 258

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 98  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 153
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 154 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 211 LESLQTQKFTT---KSDVWSFGVLLWEL 235

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 37/273 (13%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           +G+G FG V K +      +A+K +  S+   + FI E+  + R++H N+V+L G C   
Sbjct: 17  VGRGAFGVVCKAKWRAKD-VAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGACL-- 72
Query: 133 SKRALVYEYMPNGSL-----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +   LV EY   GSL          P  +   +  W       L  ++G+ YLH+     
Sbjct: 73  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKA 126
Query: 188 ILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           ++H D+KP N+LL     + K+ DFG A      +    ++  +G+  ++APE+   +  
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS-- 179
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE-I 305
             S K DV+ +G++L E+   R+  +        A+   W     N      ++N+ + I
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVH--NGTRPPLIKNLPKPI 234
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
           ES++ R        C     + RPSM ++++++
Sbjct: 235 ESLMTR--------CWSKDPSQRPSMEEIVKIM 259

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 206 LESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 152 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 208 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 265 LESLQTQKFTT---KSDVWSFGVLLWEL 289

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +E  G  + +   H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------IFPKESRGQSFCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            + P++        E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 69  FTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK++   +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIE 178
           V+  G   EG+ + L  EY   G L   I P     E   Q F     H++  G      
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV---- 119
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           EL+ R         DV+  G+VL  M  G
Sbjct: 177 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 69  FTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK++   +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIE 178
           V+  G   EG+ + L  EY   G L   I P     E   Q F     H++  G      
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV---- 118
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YLH    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           EL+ R         DV+  G+VL  M  G
Sbjct: 176 ELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 85  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 141 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 196
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 197 ALESLQTQKFTT---KSDVWSFGVLLWEL 222

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 112 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 168 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 223
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 224 ALESLQTQKFTT---KSDVWSFGVLLWEL 249

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 204
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 205 ALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 90  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 146 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 201
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 202 ALESLQTQKFTT---KSDVWSFGVLLWEL 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 204
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 205 ALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 111 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 167 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 222
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 223 ALESLQTQKFTT---KSDVWSFGVLLWEL 248

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 148 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 203
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 204 ALESLQTQKFTT---KSDVWSFGVLLWEL 229

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + + + +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 147 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 202
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 203 ALESLQTQKFTT---KSDVWSFGVLLWEL 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 88  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + ++
Sbjct: 144 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWM 199
Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           A E L ++ F T   KSDV+ FG++L E+
Sbjct: 200 ALESLQTQKFTT---KSDVWSFGVLLWEL 225

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQL 125
               LG+G  G V       T   +AVK++   +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLH 181
            G   EG+ + L  EY   G L   I P     E   Q F     H++  G      YLH
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF----FHQLMAGVV----YLH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R         DV+  G+VL  M  G
Sbjct: 179 KRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 27/207 (13%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIH---HVNV 122
           ++G G +G+VYK +  H+G  +A+K +     +GEE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 123 VQLLGFCSEGS-----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           V+L+  C+        K  LV+E++     D   +  ++       E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTLWYRA 179
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 72  KLGQGGFGSVYKGQLHT------GGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  + H         L+AVK L  +  S  ++F  E   +  + H ++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFC-----------WEKLHEVALGT 173
             G C+EG    +V+EYM +G L+R +       +                +L  VA   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 202 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L  + G  I  AVK L      GE  +F+ E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+    KE D V + +  +  + ++A
Sbjct: 150 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 207 LESLQTQKFTT---KSDVWSFGVLLWEL 231

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     +     +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 209 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 266 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 298

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 72  KLGQGGFGSVYKGQLHT------GGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  + H         L+AVK L  +  S  ++F  E   +  + H ++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFC-----------WEKLHEVALGT 173
             G C+EG    +V+EYM +G L+R +       +                +L  VA   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 139 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 196 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 224

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIH---HVNV 122
           ++G G +G+VYK +  H+G  +A+K +     +GEE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 123 VQLLGFCSEGS-----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           V+L+  C+        K  LV+E++     D   +  ++       E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   +++     T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTLWYRA 179
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 124/273 (45%), Gaps = 38/273 (13%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH----HVNVVQLLG 127
           LG+G F  VY+ + +HTG  +A+KM+          +  V    +IH    H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + +   LV E   NG ++R++   ++R + F   +          G+ YLH+     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSHG--- 132
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRGTIGYIAPELISRNF 245
           ILH D+   N+LL  N   K++DFGLA     P E  +       GT  YI+PE+ +R+ 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEIATRSA 188
Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG--GDLELRNVT 303
             +  +SDV+  G +   +  GR             +    V + LNK    D E+ +  
Sbjct: 189 HGL--ESDVWSLGCMFYTLLIGR-----------PPFDTDTVKNTLNKVVLADYEMPSFL 235
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            IE   A+ L       ++   ADR S++ VL+
Sbjct: 236 SIE---AKDLIH---QLLRRNPADRLSLSSVLD 262

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + +++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINE--VSTIGRIHHVNVVQLL---- 126
           +G+G +G+VYKG L     +AVK+   S  + + FINE  +  +  + H N+ + +    
Sbjct: 21  IGRGRYGAVYKGSLDERP-VAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 127 GFCSEGS-KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC- 184
              ++G  +  LV EY PNGSL +++    S   S C      +A    RG+ YLH    
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC-----RLAHSVTRGLAYLHTELP 132
Query: 185 -----DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-------FHPKENDFVSISATRGT 232
                   I H D+   N+L+ ++    +SDFGL+          P E D  +IS   GT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV-GT 191
Query: 233 IGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEM 264
           I Y+APE++      R+  +   + D+Y  G++  E+
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 150 TYQLARGMEYL--ASQKCI-HRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 207 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 239

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + +   H              
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 149 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 206 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 238

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 155 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 212 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + ++             L   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 152 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 209 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 241

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + +   H              
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 145 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 202 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 234

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + +   H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLAN-SKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           LG+G FG   K     TG ++ +K L    + +   F+ EV  +  + H NV++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
           +  +   + EY+  G+L R I   +S    + W +    A   A G+ YLH+   + I+H
Sbjct: 78  KDKRLNFITEYIKGGTL-RGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKF------HP------KENDFVSISATRGTIGYIAP 238
            D+  HN L+  N    V+DFGLA+        P      K+ D        G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E+I  N  +   K DV+ FG+VL E+  GR N++         Y P  +   LN  G L+
Sbjct: 192 EMI--NGRSYDEKVDVFSFGIVLCEII-GRVNAD-------PDYLPRTMDFGLNVRGFLD 241
Query: 299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                            I + C  +    RPS  K+   LE
Sbjct: 242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIH---HVNV 122
           ++G G +G+VYK +  H+G  +A+K +     +GEE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 123 VQLLGFCSEGS-----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           V+L+  C+        K  LV+E++     D   +  ++       E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +     +     T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV---TLWYRA 179
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + +   H              
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 148 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 205 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 237

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 73  LGQGGFGSVYKGQLH----TGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG+G FGSV +G L     T   +AVK +    +S+   EEF++E + +    H NV++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 126 LGFCSEGS-----KRALVYEYMPNGSLDRHIFPK--ESRGQSFCWEKLHEVALGTARGIE 178
           LG C E S     K  ++  +M  G L  ++     E+  +    + L +  +  A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YL N      LH D+   N +L  +    V+DFGL+K     + +      +  + +IA 
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMA 265
           E ++    T   KSDV+ FG+ + E+A
Sbjct: 219 ESLADRVYT--SKSDVWAFGVTMWEIA 243

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 74  GQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS 133
            +G FG V+K QL     +AVK+         +   EV ++  + H N++Q +G    G+
Sbjct: 33  ARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 134 KRA----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-------N 182
                  L+  +   GSL   +     +     W +L  +A   ARG+ YLH       +
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIG---YIAP 238
           G    I H DIK  N+LL +N    ++DFGLA KF   +    S   T G +G   Y+AP
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK----SAGDTHGQVGTRRYMAP 202
Query: 239 ELI--SRNFGTVS-CKSDVYGFGMVLLEMA 265
           E++  + NF   +  + D+Y  G+VL E+A
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 129
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI--N 187
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 188 YYKFSSKSDVWSFGVLMWE 206

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 72  KLGQGGFGSVYKGQLHT------GGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  + H         L+AVK L  +  S  ++F  E   +  + H ++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFC-----------WEKLHEVALGT 173
             G C+EG    +V+EYM +G L+R +       +                +L  VA   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 225 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 253

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  F +   H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     +     +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIHHVNVVQLL 126
           KLG G + +VYKG   T G+     L   K   EE      I E+S +  + H N+V+L 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVA--LKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 127 GFCSEGSKRALVYEYMPNG---SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
                 +K  LV+E+M N     +D        RG      K  +  L   +G+ + H  
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGLAFCHEN 127
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI- 241
               ILH D+KP N+L++     K+ DFGLA+ F    N F   S+   T+ Y AP+++ 
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPDVLM 181
Query: 242 -SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            SR   T S   D++  G +L EM  G+
Sbjct: 182 GSR---TYSTSIDIWSCGCILAEMITGK 206

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 33/211 (15%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLA--NSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G VY G+ L     IA+K +   +S++S +    E++    + H N+VQ LG  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKL--HEVALG-----TARGIEYLHN 182
           SE     +  E +P GSL   +  K        W  L  +E  +G        G++YLH 
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIGFYTKQILEGLKYLH- 139
Query: 183 GCDVCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIA 237
             D  I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+A
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMA 191
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I +        +D++  G  ++EMA G+
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG------------QSFCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            +   ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     +     +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML +     +  + I+E+  +  I  H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G  + +   H              
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 197 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 254 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 286

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 56  RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--FINEVS 112
           R+   E I     F   LG G F  V   +   T  L+A+K +A     G+E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK-LHEVAL 171
            + +I H N+V L      G    L+ + +  G L   I  K      F  E+    +  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIF 123
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISA 228
                ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S 
Sbjct: 124 QVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLST 177
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
             GT GY+APE++++     S   D +  G++
Sbjct: 178 ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 33/211 (15%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLA--NSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G VY G+ L     IA+K +   +S++S +    E++    + H N+VQ LG  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKL--HEVALG-----TARGIEYLHN 182
           SE     +  E +P GSL   +  K        W  L  +E  +G        G++YLH 
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIGFYTKQILEGLKYLH- 125
Query: 183 GCDVCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIA 237
             D  I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+A
Sbjct: 126 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMA 177
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I +        +D++  G  ++EMA G+
Sbjct: 178 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 37/222 (16%)
Query: 73  LGQGGFGSVYKGQ-LHTGG-----LIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQ 124
           LG+G FG V K    H  G      +AVKML  +    E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG----------------------QSFC 162
           L G CS+     L+ EY   GSL    F +ESR                       ++  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
              L   A   ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 56  RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--FINEVS 112
           R+   E I     F   LG G F  V   +   T  L+A+K +A     G+E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK-LHEVAL 171
            + +I H N+V L      G    L+ + +  G L   I  K      F  E+    +  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIF 123
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISA 228
                ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S 
Sbjct: 124 QVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLST 177
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
             GT GY+APE++++     S   D +  G++
Sbjct: 178 ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 27/204 (13%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLA-NSKFSGEEFIN-----EVSTIGRIHHVNVVQL 125
           LG+G F +VYK +  +T  ++A+K +    +   ++ IN     E+  +  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA--LGTARGIEYLHNG 183
           L      S  +LV+++M     D  +  K++   S      H  A  L T +G+EYLH  
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI- 241
               ILH D+KP+N+LLD N + K++DFGLAK F      +     TR    Y APEL+ 
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR---WYRAPELLF 185
Query: 242 -SRNFGTVSCKSDVYGFGMVLLEM 264
            +R +G      D++  G +L E+
Sbjct: 186 GARMYGV---GVDMWAVGCILAEL 206

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 145
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 203
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 145
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 203
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++  Y   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 56  RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--FINEVS 112
           R+   E I     F   LG G F  V   +   T  L+A+K +A     G+E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK-LHEVAL 171
            + +I H N+V L      G    L+ + +  G L   I  K      F  E+    +  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIF 123
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISA 228
                ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S 
Sbjct: 124 QVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLST 177
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
             GT GY+APE++++     S   D +  G++
Sbjct: 178 ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 125
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 183
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 184 YYKFSSKSDVWSFGVLMWE 202

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLANSKFSGEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G       +AVKML ++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH--EVALGT--- 173
           H N+V LLG C+ G    ++ EY   G L   +  K   G  + +   H  E  L +   
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 174 -------ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
                  A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++  
Sbjct: 169 LHFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 GNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 261

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPAFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+ +VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 56  RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--FINEVS 112
           R+   E I     F   LG G F  V   +   T  L+A+K +A     G+E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK-LHEVAL 171
            + +I H N+V L      G    L+ + +  G L   I  K      F  E+    +  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIF 123
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSISA 228
                ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    +S 
Sbjct: 124 QVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLST 177
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
             GT GY+APE++++     S   D +  G++
Sbjct: 178 ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 135
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 193
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 194 YYKFSSKSDVWSFGVLMWE 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 129
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 187
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 188 YYKFSSKSDVWSFGVLMWE 206

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 123
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 181
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 182 YYKFSSKSDVWSFGVLMWE 200

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 68  HFTHKLGQGGFGSVYKGQLH----TGGLI--AVKMLANSKFSGEE--FINEVSTIGRI-H 118
            F   LG G FG V     +    TG  I  AVKML     S E    ++E+  + ++  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQS------------------ 160
           H N+V LLG C+      L++EY   G L  ++  K  +                     
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 161 -FCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
              +E L   A   A+G+E+L    C    +H D+   N+L+ H  + K+ DFGLA+   
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++++V     R  + ++APE +    G  + KSDV+ +G++L E+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEI 267

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLG-FC 129
           +G G +G VYKG+ + TG L A+K++  +    EE   E++ + +  HH N+    G F 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 130 SEG-----SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +       +  LV E+   GS+   I  K ++G +   E +  +     RG+ +LH   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 150 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 200
Query: 241 ISRNF---GTVSCKSDVYGFGMVLLEMAGGRRN-SNMHATRS 278
           I+ +     T   KSD++  G+  +EMA G     +MH  R+
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 143
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 201
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 202 YYKFSSKSDVWSFGVLMWE 220

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKG--QLHTGGL-IAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G  ++    + +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPK-ESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           G C +     LV E    G L + +  K E    S   E LH+V++G    ++YL    +
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG----MKYLE---E 128
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  N
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 186
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           F   S +SDV+ +G+ + E
Sbjct: 187 FRKFSSRSDVWSYGVTMWE 205

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI---------HHVN 121
           ++G G +G+VYK +  H+G  +A+K +      G      +ST+  +          H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 122 VVQLLGFCSEGS-----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           VV+L+  C+        K  LV+E++     D   +  ++       E + ++     RG
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y 
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYR 186
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE++ ++  T +   D++  G +  EM
Sbjct: 187 APEVLLQS--TYATPVDMWSVGCIFAEM 212

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLANSKFSGEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G       +AVKML ++  + E+   ++E+  +  +  
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK------ESRGQSFCWEKLHEVALG 172
           H N+V LLG C+ G    ++ EY   G L   +  K      +  G+      L   +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++     R  
Sbjct: 161 VAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 218 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 247

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML +     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE------------KLHEV 169
           ++ LLG C++     ++  Y   G+L  ++  +   G  + ++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 73  LGQGGFGSVYKGQ-LHTGG-----LIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQ 124
           LG+G FG V K    H  G      +AVKML  +    E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG----------------------QSFC 162
           L G CS+     L+ EY   GSL    F +ESR                       ++  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
              L   A   ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLANSKFSGEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G       +AVKML ++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK------ESRGQSFCWEKLHEVALG 172
           H N+V LLG C+ G    ++ EY   G L   +  K      +  G+      L   +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++     R  
Sbjct: 169 VAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 255

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFIN-EVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +      G+ F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFIN-EVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +      G+ F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 36  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 89
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 148
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 149 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 203
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 204 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            ++G+G FG V+KG    T  ++A+K+  L  ++   E+   E++ + +     V +  G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 128 FCSEGSKRALVYEYMPNGS-LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
              +GSK  ++ EY+  GS LD        R   F   ++  +     +G++YLH+   +
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHSEKKI 142
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELIS 242
              H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I 
Sbjct: 143 ---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIQ 193
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           ++      K+D++  G+  +E+A G   NS+MH  R
Sbjct: 194 QS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 18  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 71
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 130
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 131 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 185
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 186 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 82
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 142 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 197 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 25  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 78
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 137
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 138 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 192
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 193 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 82
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 142 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 197 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 114/243 (46%), Gaps = 36/243 (14%)
Query: 32  YRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL 91
           Y +S+K+ ++V + L+ +  W        EII        +LG G FG VYK Q     +
Sbjct: 19  YFQSMKQYEHVTRDLNPEDFW--------EIIG-------ELGDGAFGKVYKAQNKETSV 63
Query: 92  IAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR 149
           +A   + ++K     E+++ E+  +    H N+V+LL      +   ++ E+   G++D 
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 150 HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 209
            +   E   +     ++  V   T   + YLH   D  I+H D+K  NIL   +   K++
Sbjct: 124 VMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA 177
Query: 210 DFGLAKFHP----KENDFVSISATRGTIGYIAPELI---SRNFGTVSCKSDVYGFGMVLL 262
           DFG++  +     + + F+      GT  ++APE++   +        K+DV+  G+ L+
Sbjct: 178 DFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 231
Query: 263 EMA 265
           EMA
Sbjct: 232 EMA 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HH 119
           F   LG G FG V +   +          +AVKML  S      E  ++E+  +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R    C +    +          
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 168 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 225 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 263

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK +   TG L A K++   S+   E++I E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
               K  ++ E+ P G++D  I  +  RG      ++  V       + +LH+     I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVD-AIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RII 139
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 242
           H D+K  N+L+      +++DFG++    K   K + F+      GT  ++APE++   +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 193
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
                   K+D++  G+ L+EMA
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMA 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 65  VTNHFT--HKLGQGGFGSVYK------GQLHTGGLIAVKMLANSK--FSGEEFINEVSTI 114
           V +H+    +LG G F  V K      G+ +    I  + L++S+   S EE   EV+ +
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
             I H N++ L       +   L+ E +  G L   +  KES  +    + L ++     
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----L 118
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATR 230
            G+ YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 172
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           GT  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 173 GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 207

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFIN-EVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +      G+ F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK +   TG L A K++   S+   E++I E+  +    H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
               K  ++ E+ P G++D  I  +  RG      ++  V       + +LH+     I+
Sbjct: 78  YHDGKLWIMIEFCPGGAVDA-IMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RII 131
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 242
           H D+K  N+L+      +++DFG++    K   K + F+      GT  ++APE++   +
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 185
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
                   K+D++  G+ L+EMA
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMA 208

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 114/243 (46%), Gaps = 36/243 (14%)
Query: 32  YRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL 91
           Y +S+K+ ++V + L+ +  W        EII        +LG G FG VYK Q     +
Sbjct: 19  YFQSMKQYEHVTRDLNPEDFW--------EIIG-------ELGDGAFGKVYKAQNKETSV 63
Query: 92  IAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR 149
           +A   + ++K     E+++ E+  +    H N+V+LL      +   ++ E+   G++D 
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 150 HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 209
            +   E   +     ++  V   T   + YLH   D  I+H D+K  NIL   +   K++
Sbjct: 124 VMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA 177
Query: 210 DFGLAKFHP----KENDFVSISATRGTIGYIAPELI---SRNFGTVSCKSDVYGFGMVLL 262
           DFG++  +     + + F+      GT  ++APE++   +        K+DV+  G+ L+
Sbjct: 178 DFGVSAKNTRXIQRRDSFI------GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 231
Query: 263 EMA 265
           EMA
Sbjct: 232 EMA 234

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 30  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 83
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 142
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 143 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 197
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 198 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 488
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 546
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 547 YYKFSSKSDVWSFGVLMWE 565

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 131
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 132 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 185
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 186 EIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I +++H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I +++H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 73  LGQGGFGSVYKGQ-LHTGG-----LIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQ 124
           LG+G FG V K    H  G      +AVKML  +    E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG----------------------QSFC 162
           L G CS+     L+ EY   GSL    F +ESR                       ++  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
              L   A   ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEI 245

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 21  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 74
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 133
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 134 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 188
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 189 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIA------VKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      ++       +K  AN     +E + E + + ++ +  +V++
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 487
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 545
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 546 YYKFSSKSDVWSFGVLMWE 564

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 65  VTNHFT--HKLGQGGFGSVYK------GQLHTGGLIAVKMLANSK--FSGEEFINEVSTI 114
           V +H+    +LG G F  V K      G+ +    I  + L++S+   S EE   EV+ +
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
             I H N++ L       +   L+ E +  G L   +  KES  +    + L ++     
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----L 125
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATR 230
            G+ YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    
Sbjct: 126 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 179
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           GT  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 180 GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 45  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 98
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 157
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 158 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 212
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 213 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 114/243 (46%), Gaps = 36/243 (14%)
Query: 32  YRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL 91
           Y +S+K+ ++V + L+ +  W        EII        +LG G FG VYK Q     +
Sbjct: 19  YFQSMKQYEHVTRDLNPEDFW--------EIIG-------ELGDGAFGKVYKAQNKETSV 63
Query: 92  IAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR 149
           +A   + ++K     E+++ E+  +    H N+V+LL      +   ++ E+   G++D 
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 150 HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 209
            +   E   +     ++  V   T   + YLH   D  I+H D+K  NIL   +   K++
Sbjct: 124 VMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA 177
Query: 210 DFGLA----KFHPKENDFVSISATRGTIGYIAPELI---SRNFGTVSCKSDVYGFGMVLL 262
           DFG++    +   + + F+      GT  ++APE++   +        K+DV+  G+ L+
Sbjct: 178 DFGVSAKNTRXIQRRDXFI------GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 231
Query: 263 EMA 265
           EMA
Sbjct: 232 EMA 234

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 104
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 164 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 219 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 104
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 164 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 218
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 219 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 24/214 (11%)
Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG VYKG   HT  ++A+K+  L  ++   E+   E++ + +     + +  G 
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
             + +K  ++ EY+  GS    + P     +++    L E+     +G++YLH+   +  
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGPLE-ETYIATILREIL----KGLDYLHSERKI-- 138
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELISRN 244
            H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I ++
Sbjct: 139 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEVIKQS 191
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
                 K+D++  G+  +E+A G   NS++H  R
Sbjct: 192 --AYDFKADIWSLGITAIELAKGEPPNSDLHPMR 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 22  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 75
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 134
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 135 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 189
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 190 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 71  HKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG----- 231
           + YL+       +H D+   N ++ H+F  K+ DFG+ +      D       R      
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIXETDXXRKGGKGL 193
Query: 232 -TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
             + ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 194 LPVRWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HH 119
           F   LG G FG V +   +          +AVKML  S      E  ++E+  +  + +H
Sbjct: 45  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R    C +    +          
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 163 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 220 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 258

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 68  HFTHKLGQGGFGSVYKGQ------LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHH 119
            +   +G+G FG V++ +           ++AVKML     +    +F  E + +    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFP------------KESRGQS---- 160
            N+V+LLG C+ G    L++EYM  G L+   R + P              +R  S    
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 161 --FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
              C E+L  +A   A G+ YL    +   +H D+   N L+  N + K++DFGL++   
Sbjct: 170 PLSCAEQLC-IARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + + +       I ++ PE I  N  T   +SDV+ +G+VL E+
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNRYTT--ESDVWAYGVVLWEI 269

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 71  HKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG----- 231
           + YL+       +H D+   N ++ H+F  K+ DFG+ +      D       R      
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIXETDXXRKGGKGL 190
Query: 232 -TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
             + ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 191 LPVRWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 223

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLANSKFSGEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G       +AVKML ++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H N+V LLG C+ G    ++ EY   G L   +  K    ++   +    +A  TA   +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET---DPAFAIANSTASTRD 165
Query: 179 YLHNGCDVC----------ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
            LH    V            +H D+   N+LL +  + K+ DFGLA+    +++++    
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 71  HKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG----- 231
           + YL+       +H D+   N ++ H+F  K+ DFG+ +      D       R      
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIXETDXXRKGGKGL 193
Query: 232 -TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
             + ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 194 LPVRWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 131
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 132 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 185
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 186 EIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HH 119
           F   LG G FG V +   +          +AVKML  S      E  ++E+  +  + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R    C +    +          
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 145 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 202 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 240

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HH 119
           F   LG G FG V +   +          +AVKML  S      E  ++E+  +  + +H
Sbjct: 43  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R    C +    +          
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 161 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 218 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 256

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF--SGEEFINEVSTIGRI-HH 119
           F   LG G FG V +   +          +AVKML  S      E  ++E+  +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R    C +    +          
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 168 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 225 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 53  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 106
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 165
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 166 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 220
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 221 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 74  GQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS 133
            +G FG V+K QL     +AVK+         +   E+ +   + H N++Q +     GS
Sbjct: 24  ARGRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 134 ----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC-- 187
               +  L+  +   GSL  ++     +G    W +L  VA   +RG+ YLH     C  
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 188 ------ILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIG---YIA 237
                 I H D K  N+LL  +    ++DFGLA +F P +        T G +G   Y+A
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGK----PPGDTHGQVGTRRYMA 193
Query: 238 PELI--SRNFGTVS-CKSDVYGFGMVLLEM 264
           PE++  + NF   +  + D+Y  G+VL E+
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 71  HKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMA 265
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 96  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 149
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 208
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 209 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 263
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 264 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLA--NSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L    S  + +E ++E   +  +    V +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + LV + MP G L  H+  +E+RG+    + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHV--RENRGR-LGSQDLLNWCMQIAKGMSYLE---D 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           V ++H D+   N+L+      K++DFGLA+    +         +  I ++A E I R  
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 246 GTVSCKSDVYGFGMVLLEM 264
            T   +SDV+ +G+ + E+
Sbjct: 198 FT--HQSDVWSYGVTVWEL 214

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 242 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 281
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 282 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLAN---SKFSGEEFINEVSTIGRIHHVNVVQL 125
           F  KLG G FG V+  +  + GL  V    N   S+   E+   E+  +  + H N++++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
                +     +V E    G L   I   ++RG++     + E+       + Y H+   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-- 143
Query: 186 VCILHFDIKPHNILLD----HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
             ++H D+KP NIL      H+ I K+ DFGLA+    ++D  S +A  GT  Y+APE+ 
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELF--KSDEHSTNAA-GTALYMAPEVF 198
Query: 242 SRNFGTVSCKSDVYGFGMVL 261
            R+   V+ K D++  G+V+
Sbjct: 199 KRD---VTFKCDIWSAGVVM 215

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 115/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L       +E  F+ E   I + +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 71  HKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMA 265
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 199 APE--SLKDGVFTTSSDMWSFGVVLWEIT 225

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 222 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 261
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 262 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRI 117
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L + +F   E    +  + ++
Sbjct: 55  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 108
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHIFPKESRGQSFCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 167
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 168 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 222
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 223 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 17/219 (7%)
Query: 69  FTHKLGQGGFGSVYKGQ-LHTGGLIAVK-MLANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           F  KLG+GGF  V   + LH G   A+K +L + +   EE   E       +H N+++L+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 127 GFC--SEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
            +C    G+K    L+  +   G+L   I   + +G     +++  + LG  RG+E +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFG---LAKFHPKEN----DFVSISATRGTIGY 235
                  H D+KP NILL     P + D G    A  H + +         +A R TI Y
Sbjct: 153 KG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 236 IAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 273
            APEL S ++   +  ++DV+  G VL  M  G    +M
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 130/301 (43%), Gaps = 72/301 (23%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           +G GGFG V+K +    G   V  +   K++ E+   EV  + ++ HVN+V   G C +G
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYV--IRRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDG 76
Query: 133 SKRALVYEYMPNGSLDR----HIFPKESRGQS------------FC-------W------ 163
                 ++Y P  S D        P+ S+  S            FC       W      
Sbjct: 77  ------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 164 EKLHEV-AL----GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           EKL +V AL       +G++Y+H+     ++H D+KP NI L      K+ DFGL     
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSKK---LIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK 187
Query: 219 KENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATR 277
            +      + ++GT+ Y++PE I S+++G    + D+Y  G++L E+        +H   
Sbjct: 188 NDG---KRTRSKGTLRYMSPEQISSQDYGK---EVDLYALGLILAEL--------LHVCD 233
Query: 278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
           +  A+  S  +  L  G          I  +  +K   +    +  K  DRP+ +++L  
Sbjct: 234 T--AFETSKFFTDLRDGI---------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 282
Query: 338 L 338
           L
Sbjct: 283 L 283

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 232 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 271
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 272 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 215 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 254
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 215 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 254
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 207 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 246
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 247 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 65  VTNHFT--HKLGQGGFGSVYK------GQLHTGGLIAVKMLANSK--FSGEEFINEVSTI 114
           V +H+    +LG G F  V K      G+ +    I  + L +S+   S EE   EV+ +
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
             I H N++ L       +   L+ E +  G L   +  KES  +    + L ++     
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----L 139
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATR 230
            G+ YLH+     I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    
Sbjct: 140 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 193
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           GT  ++APE++  N+  +  ++D++  G++   +  G
Sbjct: 194 GTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSG 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 196
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 197 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLANSKFSGEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G       +AVKML ++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESR-----------GQSFCWEKLH 167
           H N+V LLG C+ G    ++ EY   G L  +   ++SR             +     L 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
             +   A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++   
Sbjct: 168 HFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 225 NARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 196
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 197 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +      D       R    
Sbjct: 134 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIXETDXXRKGGK 184
Query: 232 ---TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
               + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 185 GLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 219

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   +      E +  + C E L          +E+LH+   
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ--------ALEFLHSNQ- 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 191
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 192 AYGP---KVDIWSLGIMAIEMIEGE 213

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 71  HKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG----- 231
           + YL+       +H D+   N ++ H+F  K+ DFG+ +      D    +  R      
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETAYYRKGGKGL 193
Query: 232 -TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
             + ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 194 LPVRWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 51  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 171 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 225
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 226 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 256

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P  +           K+ ++A   A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 139 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 193
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 194 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 20  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 140 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 194
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 195 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 190
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 191 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   +      E +  + C E L        + +E+LH+   
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 138 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK 192
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 193 AYGP---KVDIWSLGIMAIEMIEGE 214

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 197
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 198 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 73  LGQGGFGSVY----KGQLHTGGLIAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQL 125
           LGQG FG V+      +  +G L A+K+L  +     + +    E   +  ++H  VV+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 126 -LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              F +EG K  L+ +++  G L    F + S+   F  E +       A G+++LH+  
Sbjct: 96  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLDHLHS-- 148
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 240
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 149 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC------GTVEYMAPEV 201
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++R   + S   D + +G+++ EM  G
Sbjct: 202 VNRQGHSHSA--DWWSYGVLMFEMLTG 226

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 115/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   +   +         + ++ P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 233 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 272
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 273 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 115/286 (40%), Gaps = 42/286 (14%)
Query: 73  LGQGGFGSVYKGQLH------TGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   +   +         + ++ P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 256 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 295
Query: 299 LRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           L  VT    M   K C      I   C Q +  DRP+   +LE +E
Sbjct: 296 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 203
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 204 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P  +           K+ ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 203
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 204 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--- 231
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +      D       R    
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIXETDXXRKGGK 193
Query: 232 ---TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
               + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 194 GLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   +      E +  + C E L        + +E+LH+   
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SEMVGTPYWMAPEVVTRK 191
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 192 AYGP---KVDIWSLGIMAIEMIEGE 213

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 29/232 (12%)
Query: 55  KRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSG---E 105
           K+    EI      F  +LG+  FG VYKG L           +A+K L + K  G   E
Sbjct: 16  KQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLRE 74
Query: 106 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK----------E 155
           EF +E     R+ H NVV LLG  ++    ++++ Y  +G L   +  +          +
Sbjct: 75  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 134
Query: 156 SRGQSFCWEK---LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
            R      E    +H VA   A G+EYL +     ++H D+   N+L+      K+SD G
Sbjct: 135 DRTVKSALEPPDFVHLVA-QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLG 190
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           L +     + +  +  +   I ++APE I   +G  S  SD++ +G+VL E+
Sbjct: 191 LFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 240

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   +      E +  + C E L        + +E+LH+   
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK 191
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 192 AYGP---KVDIWSLGIMAIEMIEGE 213

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 72  KLGQGGFGSVYKGQLHT------GGLIAVKMLAN-SKFSGEEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  + +         L+AVK L + S  + ++F  E   +  + H ++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIF-------------PKESRGQSFCWEKLHEVAL 171
             G C EG    +V+EYM +G L++ +              P     QS   + LH +A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS---QMLH-IAQ 135
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
             A G+ YL        +H D+   N L+  N + K+ DFG+++     + +     T  
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 192
Query: 232 TIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            I ++ PE ++ R F T   +SDV+  G+VL E+
Sbjct: 193 PIRWMPPESIMYRKFTT---ESDVWSLGVVLWEI 223

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSG---EEFINEV 111
           EI      F  +LG+  FG VYKG L           +A+K L + K  G   EEF +E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEA 63
Query: 112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK----------ESRGQSF 161
               R+ H NVV LLG  ++    ++++ Y  +G L   +  +          + R    
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 162 CWEK---LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
             E    +H VA   A G+EYL +     ++H D+   N+L+      K+SD GL +   
Sbjct: 124 ALEPPDFVHLVA-QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + +  +  +   I ++APE I   +G  S  SD++ +G+VL E+
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 128/283 (45%), Gaps = 49/283 (17%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG----- 127
           +G GGFG V+K +    G   V  +   K++ E+   EV  + ++ HVN+V   G     
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYV--IKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 128 -----FCSEGSKRA------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
                  S+ S R+      +  E+   G+L++ I  ++ RG+        E+     +G
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKG 134
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           ++Y+H+     +++ D+KP NI L      K+ DFGL      +ND     + +GT+ Y+
Sbjct: 135 VDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRXRS-KGTLRYM 188
Query: 237 APELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG 295
           +PE I S+++G    + D+Y  G++L E+        +H   +  A+  S  +  L  G 
Sbjct: 189 SPEQISSQDYGK---EVDLYALGLILAEL--------LHVCDT--AFETSKFFTDLRDGI 235
Query: 296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                    I  +  +K   +    +  K  DRP+ +++L  L
Sbjct: 236 ---------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKG--QLHTGGL-IAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G  ++    + +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPK-ESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           G C +     LV E    G L + +  K E    S   E LH+V++G    ++YL    +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG----MKYLE---E 454
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H ++   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  N
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 512
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           F   S +SDV+ +G+ + E
Sbjct: 513 FRKFSSRSDVWSYGVTMWE 531

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+             K+ ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N  +  +F  K+ DFG+ +    E D+      +G   
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 190
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 191 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQL--HTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG VY+G    H G  I V +    K     + E+F++E   +  + H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G   E     ++ E  P G L  ++   E    S     L   +L   + + YL +   +
Sbjct: 76  GIIEE-EPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 128
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 185
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ F + + E+
Sbjct: 186 RFTTASDVWMFAVCMWEI 203

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + + G L+AVK +   K    E + NEV  +    H NVV++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 130 SEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  + C   L  +++  A+G+         
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 137
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 138 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 189
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 190 RLPYGP---EVDIWSLGIMVIEMVDG 212

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 72  KLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L     S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L G       + +V E  P GSL   +  ++ +G  F    L   A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPE-LI 241
                +H D+   N+LL    + K+ DFGL +  P+ +D +V     +    + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 242 SRNFGTVSCKSDVYGFGMVLLEM 264
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G +G VYK +   G ++A+K +   A  +      I E+S +  +HH N+V L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV+E+M      + +  +   G      K++   L   RG+ + H      
Sbjct: 87  VIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQL--LRGVAHCHQHR--- 139
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELI--SR 243
           ILH D+KP N+L++ +   K++DFGLA+    P      S +    T+ Y AP+++  S+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVVTLWYRAPDVLMGSK 195
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
            + T     D++  G +  EM  G+
Sbjct: 196 KYST---SVDIWSIGCIFAEMITGK 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQLLGF 128
           KLG+G + +VYKG+   T  L+A+K +      G     I EVS +  + H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV+EY+ +  L +++   +  G       +        RG+ Y H      +
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQK---V 121
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRNFG 246
           LH D+KP N+L++     K++DFGLA+   K     +      T+ Y  P+++  S ++ 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
           T   + D++G G +  EMA GR
Sbjct: 180 T---QIDMWGVGCIFYEMATGR 198

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + + G L+AVK +   K    E + NEV  +    H NVV++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 130 SEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  + C   L  +++  A+G+         
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 146
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 147 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 198
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 199 RLPYGP---EVDIWSLGIMVIEMVDG 221

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQL--HTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG VY+G    H G  I V +    K     + E+F++E   +  + H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G   E     ++ E  P G L  ++   E    S     L   +L   + + YL +   +
Sbjct: 92  GIIEE-EPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 144
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 201
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ F + + E+
Sbjct: 202 RFTTASDVWMFAVCMWEI 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 72  KLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L     S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L G       + +V E  P GSL   +  ++ +G  F    L   A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-LI 241
                +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 242 SRNFGTVSCKSDVYGFGMVLLEM 264
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 71  HKLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEE----FINEVSTIGRIHHVNV 122
            KLG G FG V +G+          +AVK L     S  E    FI EV+ +  + H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           ++L G       + +V E  P GSL   +  ++ +G  F    L   A+  A G+ YL +
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLES 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D +V     +    + APE L
Sbjct: 134 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 191 KTRTF---SHASDTWMFGVTLWEM 211

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV 122
           IA T      +G+G FG V++G+   G  +AVK+ ++ +        E+     + H N+
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 123 VQLLGFCSEGSKRA-------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
              LGF +  +K         LV +Y  +GSL    F   +R  +   E + ++AL TA 
Sbjct: 60  ---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTAS 111
Query: 176 GIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+   
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 231 --GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
             GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 212

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQL 125
           LGQG FG V+  +  +G     L A+K+L  +     + +    E   +  ++H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 126 -LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              F +EG K  L+ +++  G L    F + S+   F  E +       A  +++LH+  
Sbjct: 92  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 240
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 197
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++R   T S  +D + FG+++ EM  G
Sbjct: 198 VNRRGHTQS--ADWWSFGVLMFEMLTG 222

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 32/209 (15%)
Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQL 125
           LGQG FG V+  +  +G     L A+K+L  +     + +    E   +  ++H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 126 -LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              F +EG K  L+ +++  G L    F + S+   F  E +       A  +++LH+  
Sbjct: 92  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR------GTIGYIAP 238
            + I++ D+KP NILLD     K++DFGL+K         SI   +      GT+ Y+AP
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESIDHEKKAYSFCGTVEYMAP 195
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E+++R   T S  +D + FG+++ EM  G
Sbjct: 196 EVVNRRGHTQS--ADWWSFGVLMFEMLTG 222

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 72  KLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L     S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L G       + +V E  P GSL   +  ++ +G  F    L   A+  A G+ YL + 
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 130
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPE-LI 241
                +H D+   N+LL    + K+ DFGL +  P+ +D +V     +    + APE L 
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 242 SRNFGTVSCKSDVYGFGMVLLEM 264
           +R F   S  SD + FG+ L EM
Sbjct: 188 TRTF---SHASDTWMFGVTLWEM 207

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 71  HKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YL+       +H ++   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMA 265
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 73  LGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQL 125
           LGQG FG V+  +  +G     L A+K+L  +     + +    E   +  ++H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 126 -LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              F +EG K  L+ +++  G L    F + S+   F  E +       A  +++LH+  
Sbjct: 93  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 240
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 146 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 198
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++R   T S  +D + FG+++ EM  G
Sbjct: 199 VNRRGHTQS--ADWWSFGVLMFEMLTG 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 71  HKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YL+       +H ++   N ++ H+F  K+ DFG+ +   + + +         + ++
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMA 265
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 201 APE--SLKDGVFTTSSDMWSFGVVLWEIT 227

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV 122
           IA T      +G+G FG V++G+   G  +AVK+ ++ +        E+     + H N+
Sbjct: 2   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 60
Query: 123 VQLLGFCSEGSKRA-------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
              LGF +  +K         LV +Y  +GSL    F   +R  +   E + ++AL TA 
Sbjct: 61  ---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTAS 112
Query: 176 GIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+   
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 172
Query: 231 --GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
             GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 173 RVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV 122
           IA T      +G+G FG V++G+   G  +AVK+ ++ +        E+     + H N+
Sbjct: 27  IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 85
Query: 123 VQLLGFCSEGSKRA-------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
              LGF +  +K         LV +Y  +GSL    F   +R  +   E + ++AL TA 
Sbjct: 86  ---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTAS 137
Query: 176 GIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+   
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 197
Query: 231 --GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
             GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 198 RVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 238

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + + G L+AVK +   K    E + NEV  +    H NVV++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 130 SEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  + C   L  +++  A+G+         
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 148
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 149 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 200
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 201 RLPYGP---EVDIWSLGIMVIEMVDG 223

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV 122
           IA T      +G+G FG V++G+   G  +AVK+ ++ +        E+     + H N+
Sbjct: 7   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 65
Query: 123 VQLLGFCSEGSKRA-------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
              LGF +  +K         LV +Y  +GSL    F   +R  +   E + ++AL TA 
Sbjct: 66  ---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTAS 117
Query: 176 GIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+   
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 231 --GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
             GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 178 RVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 218

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQL--HTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG VY+G    H G  I V +    K     + E+F++E   +  + H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G   E     ++ E  P G L  ++   E    S     L   +L   + + YL +   +
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 189
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ F + + E+
Sbjct: 190 RFTTASDVWMFAVCMWEI 207

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV 122
           IA T      +G+G FG V++G+   G  +AVK+ ++ +        E+     + H N+
Sbjct: 40  IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 98
Query: 123 VQLLGFCSEGSKRA-------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
              LGF +  +K         LV +Y  +GSL    F   +R  +   E + ++AL TA 
Sbjct: 99  ---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTAS 150
Query: 176 GIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+   
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 231 --GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
             GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 251

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 72  KLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L     S  E    FI EV+ +  + H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L G       + +V E  P GSL   +  ++ +G  F    L   A+  A G+ YL + 
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLESK 134
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPE-LI 241
                +H D+   N+LL    + K+ DFGL +  P+ +D +V     +    + APE L 
Sbjct: 135 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 242 SRNFGTVSCKSDVYGFGMVLLEM 264
           +R F   S  SD + FG+ L EM
Sbjct: 192 TRTF---SHASDTWMFGVTLWEM 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV 122
           IA T      +G+G FG V++G+   G  +AVK+ ++ +        E+     + H N+
Sbjct: 4   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 62
Query: 123 VQLLGFCSEGSKRA-------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
              LGF +  +K         LV +Y  +GSL    F   +R  +   E + ++AL TA 
Sbjct: 63  ---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLALSTAS 114
Query: 176 GIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+   
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 174
Query: 231 --GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
             GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 175 RVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 215

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G +G VYK +   G ++A+K +   A  +      I E+S +  +HH N+V L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV+E+M      + +  +   G      K++   L   RG+ + H      
Sbjct: 87  VIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQL--LRGVAHCHQHR--- 139
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELI--SR 243
           ILH D+KP N+L++ +   K++DFGLA+    P      S +    T+ Y AP+++  S+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVVTLWYRAPDVLMGSK 195
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
            + T     D++  G +  EM  G+
Sbjct: 196 KYST---SVDIWSIGCIFAEMITGK 217

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 33/271 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLANS--KFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L  +    +  EF++E   +  + H ++V+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + LV + MP+G L  ++   K++ G       L    +  A+G+ YL    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 157
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 215
Query: 245 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT 303
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 267
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
            I+      + M+ + C  + A  RP   ++
Sbjct: 268 TID------VYMVMVKCWMIDADSRPKFKEL 292

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 71  HKLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEE----FINEVSTIGRIHHVNV 122
            KLG G FG V +G+          +AVK L     S  E    FI EV+ +  + H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           ++L G       + +V E  P GSL   +  ++ +G  F    L   A+  A G+ YL +
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLES 139
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 197 KTRTF---SHASDTWMFGVTLWEM 217

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + + G L+AVK +   K    E + NEV  +    H NVV++    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 130 SEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  + C   L  +++  A+G+         
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 141
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 142 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 193
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 194 RLPYGP---EVDIWSLGIMVIEMVDG 216

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 72  KLGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + H+G  +AVKM+   K    E + NEV  +    H NVV++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  ++ E++  G+L   +   + R      E++  V     + + YLH      ++
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV--SQVR---LNEEQIATVCEAVLQALAYLHAQG---VI 163
Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR+ 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV------GTPYWMAPEVISRSL 217
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
              + + D++  G++++EM  G
Sbjct: 218 --YATEVDIWSLGIMVIEMVDG 237

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +  K SR   F  ++        A  + Y H+     
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSR---FDEQRTATYITELANALSYCHSKR--- 132
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL  N   K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 187
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
              K D++  G++  E   G
Sbjct: 188 -DEKVDLWSLGVLCYEFLVG 206

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 71  HKLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFSGEE----FINEVSTIGRIHHVNV 122
            KLG G FG V +G+          +AVK L     S  E    FI EV+ +  + H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           ++L G       + +V E  P GSL   +  ++ +G  F    L   A+  A G+ YL +
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGYLES 139
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D +V     +    + APE L
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 197 KTRTF---SHASDTWMFGVTLWEM 217

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 126/271 (46%), Gaps = 33/271 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLANS--KFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L  +    +  EF++E   +  + H ++V+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + LV + MP+G L  ++   K++ G       L    +  A+G+ YL    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 134
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 192
Query: 245 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT 303
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 244
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
            I+      + M+ + C  + A  RP   ++
Sbjct: 245 TID------VYMVMVKCWMIDADSRPKFKEL 269

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V K Q    GLI  + L + +       + I E+  +   +   +V   G 
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  KE++      E L +V++   RG+ YL       I
Sbjct: 83  FYSDGEISICMEHMDGGSLDQVL--KEAK--RIPEEILGKVSIAVLRGLAYLREKHQ--I 136
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y+APE   R  G
Sbjct: 137 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMAPE---RLQG 187
Query: 247 T-VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD 289
           T  S +SD++  G+ L+E+A GR        +  +A F   V D
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVD 231

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 70  THKLGQGGFGSVYKGQLHTG-GLIAVKMLANSKFSG--------------EEFINEVSTI 114
             KLG G +G V   +   G    A+K++  S+F                EE  NE+S +
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
             + H N+++L     +     LV E+   G L   I  +    +      + ++     
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI----L 156
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRG 231
            GI YLH      I+H DIKP NILL++       K+ DFGL+ F  K+     +    G
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLG 210
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           T  YIAPE++ + +     K DV+  G+++
Sbjct: 211 TAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 73  LGQGGFGSVY-----KGQLHTGGLIAVKML----ANSKFSGEEFINEVSTIGRIHHVNVV 123
           LG+G FG V           TG ++AVK L         SG  +  E+  +  ++H +++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG--WKQEIDILRTLYHEHII 79
Query: 124 QLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +  G C +  +++L  V EY+P GSL R   P+ S G +    +L   A     G+ YLH
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSL-RDYLPRHSIGLA----QLLLFAQQICEGMAYLH 134
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL 240
           +      +H ++   N+LLD++ + K+ DFGLAK  P+ +++  +       + + APE 
Sbjct: 135 SQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATR 277
           +          SDV+ FG+ L E+     +S    T+
Sbjct: 192 LKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTK 226

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 37/274 (13%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 134
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 303 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+  MI RK       C  + A  RP   +++
Sbjct: 244 CTIDVYMIMRK-------CWMIDADSRPKFRELI 270

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   +      E +  + C E L        + +E+LH+   
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSN-- 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H +IK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 192
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 193 AYGP---KVDIWSLGIMAIEMIEGE 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANS---KFSGEEFIN-EVSTIGRIHHVNVVQLLG 127
           LG G FG V+     H G   A+K+L      +    E  N E   +  + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  +  ++ +Y+  G L    F    + Q F        A      +EYLH+     
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I++ D+KP NILLD N   K++DFG AK+ P     +      GT  YIAPE++S     
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYN 181
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
            S   D + FG+++ EM  G
Sbjct: 182 KSI--DWWSFGILIYEMLAG 199

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLANSKFSGEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G       +AVKML ++  + E+   ++E+  +  +  
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL--------------------DRHIFPKESRG 158
           H N+V LLG C+ G    ++ EY   G L                    D     KE  G
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED-G 152
Query: 159 QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           +      L   +   A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+   
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +++++     R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 253

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 37/274 (13%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 145 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 205 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 253
Query: 303 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+  MI RK       C  + A  RP   +++
Sbjct: 254 CTIDVYMIMRK-------CWMIDADSRPKFRELI 280

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANS-KFSGEEF---INEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + +    ++A+K ++ S K S E++   I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G         LV EY    + D      E   +     ++  V  G  +G+ YLH+    
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDE 188
Query: 246 GTVSCKSDVYGFGMVLLEMA 265
           G    K DV+  G+  +E+A
Sbjct: 189 GQYDGKVDVWSLGITCIELA 208

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANS-KFSGEEF---INEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + +    ++A+K ++ S K S E++   I EV  + ++ H N +Q  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G         LV EY    + D      E   +     ++  V  G  +G+ YLH+    
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 174
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 175 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDE 227
Query: 246 GTVSCKSDVYGFGMVLLEMA 265
           G    K DV+  G+  +E+A
Sbjct: 228 GQYDGKVDVWSLGITCIELA 247

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +  K SR   F  ++        A  + Y H+     
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSR---FDEQRTATYITELANALSYCHSKR--- 132
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL  N   K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEGRMH- 187
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
              K D++  G++  E   G
Sbjct: 188 -DEKVDLWSLGVLCYEFLVG 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH- 183
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 184 -DEKVDLWSLGVLCYEFLVGK 203

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 150
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +A  GT  Y++PEL++     
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK--- 207
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 208 SACKSSDLWALGCIIYQLVAG 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 105 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL---DRHIFPKESRGQSF 161
           ++F NE+  I  I +   +   G  +   +  ++YEYM N S+   D + F  +     F
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 162 CWEKLHEVALGTA-RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
              ++ +  + +      Y+HN  ++C  H D+KP NIL+D N   K+SDFG +++   +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
                I  +RGT  ++ PE  S        K D++  G+ L  M
Sbjct: 206 ----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---K 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMH- 183
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 184 -DEKVDLWSLGVLCYEFLVGK 203

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +      + ++      G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHT 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+   TG  +AVK+L   K    + +     E+  +    H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             S  S   +V EY+  G L  +I  K  R       +L +  L    G++Y H      
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILS---GVDYCHRHM--- 136
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSC--GSPNYAAPEVISGRL-Y 192
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
              + D++  G++L  +  G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 37/274 (13%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 137
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 198 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 246
Query: 303 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+  MI RK       C  + A  RP   +++
Sbjct: 247 CTIDVYMIMRK-------CWMIDADSRPKFRELI 273

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 128
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 189 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 237
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 238 CTID------VYMIMVKCWMIDADSRPKFRELI 264

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 135
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 196 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 244
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 245 CTID------VYMIMVKCWMIDADSRPKFRELI 271

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 47/283 (16%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM-----LANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           K+G+G F  VY+   L  G  +A+K      L ++K +  + I E+  + +++H NV++ 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKY 97
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHI--FPKESR--GQSFCWEKLHEVALGTARGIEYLH 181
                E ++  +V E    G L R I  F K+ R   +   W+    V L +A  +E++H
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF--VQLCSA--LEHMH 153
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I
Sbjct: 154 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERI 208
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA-------GGRRNSNMHATRSSKAYFPSWVYDQLNKG 294
             N    + KSD++  G +L EMA       G + N      +  +  +P    D  ++ 
Sbjct: 209 HEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE- 265
Query: 295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
              ELR +  +              CI      RP +T V ++
Sbjct: 266 ---ELRQLVNM--------------CINPDPEKRPDVTYVYDV 291

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 135
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 196 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 244
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 245 CTID------VYMIMVKCWMIDADSRPKFRELI 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 137
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 198 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 246
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 247 CTID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 134
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 134
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 136
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 246 CTID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMHD 187
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 188 E--KVDLWSLGVLCYEFLVGK 206

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 138
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 199 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 247
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 248 CTID------VYMIMVKCWMIDADSRPKFRELI 274

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +      + ++      G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHT 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +      + ++      G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHT 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + + G L+AVK +   K    E + NEV  +    H NVV++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 130 SEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  + C   L  +++  A+G+         
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 191
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 192 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 243
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 244 RLPYGP---EVDIWSLGIMVIEMVDG 266

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +      + ++      G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHT 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 73  LGQGGFGSVY-----KGQLHTGGLIAVKML----ANSKFSGEEFINEVSTIGRIHHVNVV 123
           LG+G FG V           TG ++AVK L         SG  +  E+  +  ++H +++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG--WKQEIDILRTLYHEHII 79
Query: 124 QLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +  G C +  +++L  V EY+P GSL R   P+ S G +    +L   A     G+ YLH
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSL-RDYLPRHSIGLA----QLLLFAQQICEGMAYLH 134
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL 240
                  +H ++   N+LLD++ + K+ DFGLAK  P+ +++  +       + + APE 
Sbjct: 135 AQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           +          SDV+ FG+ L E+
Sbjct: 192 LKEY--KFYYASDVWSFGVTLYEL 213

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 134
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 149
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++     
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK--- 206
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 207 SACKSSDLWALGCIIYQLVAG 227

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 140
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 141 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 201 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 249
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 250 CTID------VYMIMVKCWMIDADSRPKFRELI 276

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 202 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 250
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 251 CTID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 137
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 198 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 246
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 247 CTID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 137
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 198 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 246
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 247 CTID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 159
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 160 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 220 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 268
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 269 CTID------VYMIMVKCWMIDADSRPKFRELI 295

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLHTGG-LIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    + + G L+AVK +   K    E + NEV  +    H NVV++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 130 SEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  + C   L  +++  A+G+         
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 268
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 269 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 320
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 321 RLPYGP---EVDIWSLGIMVIEMVDG 343

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 136
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 246 CTID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSK-------FSGEEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +      + ++      G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHT 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 73  LGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVV 123
           LG+G FG V           TG ++AVK L      G +    +  E+  +  ++H ++V
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREIEILRTLYHEHIV 73
Query: 124 QLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +  G C +  +++  LV EY+P GSL R   P+   G +    +L   A     G+ YLH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSL-RDYLPRHCVGLA----QLLLFAQQICEGMAYLH 128
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL 240
                  +H  +   N+LLD++ + K+ DFGLAK  P+ +++  +       + + APE 
Sbjct: 129 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 241 ISRNFGTVSCK----SDVYGFGMVLLEM 264
           +        CK    SDV+ FG+ L E+
Sbjct: 186 LK------ECKFYYASDVWSFGVTLYEL 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR----TTLSGTLDYLPPEMIEGRMH- 184
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 185 -DEKVDLWSLGVLCYEFLVGK 204

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 73  LGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVV 123
           LG+G FG V           TG ++AVK L      G +    +  E+  +  ++H ++V
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREIEILRTLYHEHIV 74
Query: 124 QLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +  G C +  +++  LV EY+P GSL R   P+   G +    +L   A     G+ YLH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSL-RDYLPRHCVGLA----QLLLFAQQICEGMAYLH 129
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL 240
                  +H  +   N+LLD++ + K+ DFGLAK  P+ +++  +       + + APE 
Sbjct: 130 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 241 ISRNFGTVSCK----SDVYGFGMVLLEM 264
           +        CK    SDV+ FG+ L E+
Sbjct: 187 LK------ECKFYYASDVWSFGVTLYEL 208

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 154
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 245
           ++H DIKP N+LL      K++DFG +   P  + +D        GT+ Y+ PE+I    
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEMIEGRM 208
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                K D++  G++  E   G+
Sbjct: 209 HDE--KVDLWSLGVLCYEFLVGK 229

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 100 TFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++    +
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK--S 210
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
            S  SD++  G ++ ++  G
Sbjct: 211 ASKSSDLWALGCIIYQLVAG 230

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 245
           ++H DIKP N+LL      K++DFG +   P  + +D        GT+ Y+ PE+I    
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEMIEGRM 185
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                K D++  G++  E   G+
Sbjct: 186 H--DEKVDLWSLGVLCYEFLVGK 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 77
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I     +  SF               +EYLH      
Sbjct: 78  TFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 187
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 188 SACKSSDLWALGCIIYQLVAG 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L ++I    S  ++       E+       +EYLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 152
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++ 
Sbjct: 153 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 210 K---SACKSSDLWALGCIIYQLVAG 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I     +  SF               +EYLH      
Sbjct: 77  TFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGKG--- 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 186
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 187 SACKSSDLWALGCIIYQLVAG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 74
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++ C  + +   + +A  +EYLH      
Sbjct: 75  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-C-TRFYTAEIVSA--LEYLHGKG--- 127
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 184
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 185 SACKSSDLWALGCIIYQLVAG 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 75  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 127
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 182
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 183 -DEKVDLWSLGVLCYEFLVGK 202

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQL 125
           LG+G FG V           TG ++AVK L           +  E+  +  ++H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 126 LGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            G C +    +L  V EY+P GSL R   P+ S G +    +L   A     G+ YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL-RDYLPRHSIGLA----QLLLFAQQICEGMAYLHAQ 153
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELIS 242
                +H D+   N+LLD++ + K+ DFGLAK  P+ ++   +       + + APE + 
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
                    SDV+ FG+ L E+
Sbjct: 211 EY--KFYYASDVWSFGVTLYEL 230

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 186
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 187 -DEKVDLWSLGVLCYEFLVGK 206

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A G+ YL    
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAEGMNYLE--- 131
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 132 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 192 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 240
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 241 CTID------VYMIMVKCWMIDADSRPKFRELI 267

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++ C  + +   + +A  +EYLH      
Sbjct: 76  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-C-TRFYTAEIVSA--LEYLHGKG--- 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 185
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 186 SACKSSDLWALGCIIYQLVAG 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 245
           ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I    
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRM 182
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                K D++  G++  E   G+
Sbjct: 183 HDE--KVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 245
           ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I    
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRM 183
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                K D++  G++  E   G+
Sbjct: 184 HDE--KVDLWSLGVLCYEFLVGK 204

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 149
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 206
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 207 SACKSSDLWALGCIIYQLVAG 227

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 245
           ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I    
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRM 182
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                K D++  G++  E   G+
Sbjct: 183 HDE--KVDLWSLGVLCYEFLVGK 203

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 81
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 82  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 134
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 191
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 192 SACKSSDLWALGCIIYQLVAG 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 187
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 188 E--KVDLWSLGVLCYEFLVGK 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSG-------EEFINEVSTIGRIHHVNV 122
            +LG G F  V K +  + GL  A K +   +          EE   EVS + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +      + ++      G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYLHT 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                I HFD+KP NI+L    IP    K+ DFGLA  H  E D V      GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAP 187
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 188 EIV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNF 245
           ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I    
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRM 187
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                K D++  G++  E   G+
Sbjct: 188 HDE--KVDLWSLGVLCYEFLVGK 208

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 209
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 210 SACKSSDLWALGCIIYQLVAG 230

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 189
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 132
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 187
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 188 -DEKVDLWSLGVLCYEFLVGK 207

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 150
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 207
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 208 SACKSSDLWALGCIIYQLVAG 228

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+   TG  +AVK+L   K    + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             S  +   +V EY+  G L  +I  K  R +     +L +  L     ++Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILS---AVDYCHRHM--- 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC--GSPNYAAPEVISGRL-Y 187
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
              + D++  G++L  +  G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 150
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 207
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 208 SACKSSDLWALGCIIYQLVAG 228

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPPEMIEGRMH- 183
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 184 -DEKVDLWSLGVLCYEFLVGK 203

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 184
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 93  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 145
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 201
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 202 E--KVDLWSLGVLCYEFLVGK 220

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 209
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 210 SACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L ++I    S  ++       E+       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 209
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 210 SACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGS-VYKGQLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F + V   +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 150
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 207
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 208 SACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K      Y  NG L ++I    S  ++       E+       +EYLH      
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGKG--- 153
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++     
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK--- 210
Query: 248 VSCK-SDVYGFGMVLLEMAGG 267
            +CK SD++  G ++ ++  G
Sbjct: 211 SACKSSDLWALGCIIYQLVAG 231

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEGRMHD 185
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 186 E--KVDLWSLGVLCYEFLVGK 204

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V
Sbjct: 39  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 98
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L ++I    S  ++       E+       +EYLH  
Sbjct: 99  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 154
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 155 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 212 K---SACKSSDLWALGCIIYQLVAG 233

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH- 186
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 187 -DEKVDLWSLGVLCYEFLVGK 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V
Sbjct: 41  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 100
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L ++I    S  ++       E+       +EYLH  
Sbjct: 101 KLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 156
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 157 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 214 K---SACKSSDLWALGCIIYQLVAG 235

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPEMIEGRMHD 184
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 185 E--KVDLWSLGVLCYEFLVGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 73  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 180
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 181 -DEKVDLWSLGVLCYEFLVGK 200

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G     ++ +  +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 189
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMHD 186
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 187 E--KVDLWSLGVLCYEFLVGK 205

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQL 125
           LG+G FG V   +      +TG  +AVK L          +   E+  +  ++H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 126 LGFCSE--GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            G C+E  G+   L+ E++P+GSL  ++ PK     +   ++  + A+   +G++YL + 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINL--KQQLKYAVQICKGMDYLGSR 133
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
             V   H D+   N+L++     K+ DFGL K    + +  ++   R + + + APE + 
Sbjct: 134 QYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
           ++   ++  SDV+ FG+ L E+
Sbjct: 191 QSKFYIA--SDVWSFGVTLHEL 210

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G     ++ +  +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEGRMH- 188
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 189 -DEKVDLWSLGVLCYEFLVGK 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 154
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I      
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 210
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 211 E--KVDLWSLGVLCYEFLVGK 229

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I      
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH- 183
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 184 -DEKVDLWSLGVLCYEFLVGK 203

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 31/201 (15%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI--NEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG V++      G + V    N+ +  +++   NE+S + ++HH  ++ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC----- 184
            +  +  L+ E++  G L   I  ++ +             +  A  I Y+   C     
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYK-------------MSEAEVINYMRQACEGLKH 164
Query: 185 --DVCILHFDIKPHNILLDHNFIP--KVSDFGLA-KFHPKENDFVSISATRGTIGYIAPE 239
             +  I+H DIKP NI+ +       K+ DFGLA K +P E     +  T  T  + APE
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPE 220
Query: 240 LISRNFGTVSCKSDVYGFGMV 260
           ++ R    V   +D++  G++
Sbjct: 221 IVDRE--PVGFYTDMWAIGVL 239

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K L   +     GE   +NE   + +++   VV L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQS-FCWEKLHEVALGTARGIEYLHNGCDV 186
                    LV   M  G L  HI+     GQ+ F   +    A     G+E LH     
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIY---HMGQAGFPEARAVFYAAEICCGLEDLHRER-- 306
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+APE++     
Sbjct: 307 -IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERY 362
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
           T S   D +  G +L EM  G+
Sbjct: 363 TFS--PDWWALGCLLYEMIAGQ 382

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 138
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 199 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 247
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 248 CTID------VYMIMVKCWMIDADSRPKFRELI 274

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           L  G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 202 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 250
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 251 CTID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQL 125
           LG+G FG V   +      +TG  +AVK L          +   E+  +  ++H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 126 LGFCSE--GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            G C+E  G+   L+ E++P+GSL  ++ PK     +   ++  + A+   +G++YL + 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINL--KQQLKYAVQICKGMDYLGSR 145
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
             V   H D+   N+L++     K+ DFGL K    + +  ++   R + + + APE + 
Sbjct: 146 QYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
           ++   ++  SDV+ FG+ L E+
Sbjct: 203 QSKFYIA--SDVWSFGVTLHEL 222

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           L  G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 134
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 136
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 303 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+  MI RK       C  + A  RP   +++
Sbjct: 246 CTIDVYMIMRK-------CWMIDADSRPKFRELI 272

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K L   +     GE   +NE   + +++   VV L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQS-FCWEKLHEVALGTARGIEYLHNGCDV 186
                    LV   M  G L  HI+     GQ+ F   +    A     G+E LH     
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIY---HMGQAGFPEARAVFYAAEICCGLEDLHRER-- 306
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+APE++     
Sbjct: 307 -IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERY 362
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
           T S   D +  G +L EM  G+
Sbjct: 363 TFS--PDWWALGCLLYEMIAGQ 382

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 136
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 303 TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+  MI RK       C  + A  RP   +++
Sbjct: 246 CTIDVYMIMRK-------CWMIDADSRPKFRELI 272

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+   TG  +AVK+L   K    + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             S  +   +V EY+  G L  +I  K  R +     +L +  L     ++Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILS---AVDYCHRHM--- 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSC--GSPNYAAPEVISGRL-Y 187
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
              + D++  G++L  +  G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 50  QSWMPKRYSYPEIIAVTNHFT-------HKLGQGGFGSVYKGQLHTGGLI-AVKMLANSK 101
           Q  M      P+I+  T HFT         LG+G FG+VY  +      I A+K+L  S+
Sbjct: 3   QKVMENSSGTPDIL--TRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ 60
Query: 102 FSGE----EFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESR 157
              E    +   E+     +HH N+++L  +  +  +  L+ EY P G L + +     +
Sbjct: 61  IEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QK 116
Query: 158 GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 217
             +F  ++   +    A  + Y H      ++H DIKP N+LL      K++DFG +   
Sbjct: 117 SCTFDEQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHA 173
Query: 218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           P     +      GT+ Y+ PE+I         K D++  G++  E+  G
Sbjct: 174 PS----LRRKTMCGTLDYLPPEMIEGRMHNE--KVDLWCIGVLCYELLVG 217

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVK-MLANSKFSGEEFINEVSTIGRI-HHV 120
           IA TN     +G G FG V++ +L     +A+K +L + +F   E       I RI  H 
Sbjct: 40  IAYTN--CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL-----QIMRIVKHP 92
Query: 121 NVVQLLGF-CSEGSKRA-----LVYEYMPNG--SLDRHIFPKESRGQSFCWEKLHEVALG 172
           NVV L  F  S G K+      LV EY+P       RH + K  +       KL+   L 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQL- 150
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRG 231
             R + Y+H+   + I H DIKP N+LLD  + + K+ DFG AK        VS   +R 
Sbjct: 151 -LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR- 205
Query: 232 TIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
              Y APELI   FG  +  +  D++  G V+ E+  G+
Sbjct: 206 --YYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           L  G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 202 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 250
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 251 CTID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 69  FTHKLGQGGFGSVY-KGQLHTGGLIAVKMLANS-KFSGEEFINEVSTIGRIHHVNVVQLL 126
           F   LG G F  V+   Q  TG L A+K +  S  F      NE++ + +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCD 185
                 +   LV + +  G L   I     RG  +  +    V       ++YLH NG  
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRIL---ERG-VYTEKDASLVIQQVLSAVKYLHENG-- 126
Query: 186 VCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KP N+L    + N    ++DFGL+K   ++N  +S +   GT GY+APE+++
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC--GTPGYVAPEVLA 180
Query: 243 RNFGTVSCKSDVYGFGMV 260
           +     S   D +  G++
Sbjct: 181 QK--PYSKAVDCWSIGVI 196

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G V+K +   TG ++A+K    S+      +  + E+  + ++ H N+V LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRG------QSFCWEKLHEVALGTARGIEYLH 181
                 +  LV+EY  +  L  H   +  RG      +S  W+ L  V         + H
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFC------HKH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           N    CI H D+KP NIL+  + + K+ DFG A+     +D+        T  Y +PEL+
Sbjct: 122 N----CI-HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--ATRWYRSPELL 174
Query: 242 --SRNFGTVSCKSDVYGFGMVLLEMAGG 267
                +G      DV+  G V  E+  G
Sbjct: 175 VGDTQYGP---PVDVWAIGCVFAELLSG 199

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 136
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 197 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 245
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 246 CTID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 37/274 (13%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 142 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY--FP-SWVYDQLNKGGDLELRN 301
             T   +SDV+ +G+ + E+           T  SK Y   P S +   L KG  L    
Sbjct: 202 IYT--HQSDVWSYGVTVWEL----------MTFGSKPYDGIPASEISSILEKGERLPQPP 249
Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
           +  I+      + MI + C  + A  RP   +++
Sbjct: 250 ICTID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQ 124
           H   K+G+G +G VYK Q + G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L        +  LV+E++ +  L + +   E   +S   +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELI- 241
           D  +LH D+KP N+L++     K++DFGLA+    P       I     T+ Y AP+++ 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLM 173
Query: 242 -SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            S+ + T     D++  G +  EM  G
Sbjct: 174 GSKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG---LIAVKML----ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G    I V ++    A S  + +E ++E   +  + + +V +L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 168
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 169 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 228
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 229 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 277
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 278 CTID------VYMIMVKCWMIDADSRPKFRELI 304

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 20/200 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQ 124
            F   LG G F  V   +   TG L AVK +      G+E    NE++ + +I H N+V 
Sbjct: 25  EFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVA 84
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA-RGIEYLHNG 183
           L       +   LV + +  G L   I  K      F  EK     +      + YLH  
Sbjct: 85  LEDIYESPNHLYLVMQLVSGGELFDRIVEK-----GFYTEKDASTLIRQVLDAVYYLHR- 138
Query: 184 CDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
             + I+H D+KP N+L    D      +SDFGL+K   K  D +S +   GT GY+APE+
Sbjct: 139 --MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK-GDVMSTAC--GTPGYVAPEV 193
Query: 241 ISRNFGTVSCKSDVYGFGMV 260
           +++     S   D +  G++
Sbjct: 194 LAQK--PYSKAVDCWSIGVI 211

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+L       E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L ++I    S  ++       E+       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
                S  SD++  G ++ ++  G
Sbjct: 209 KSAXKS--SDLWALGCIIYQLVAG 230

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + L+ + MP G L  ++   K++ G  +    L    +  A+G+ YL    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLE--- 134
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D  ++H D+   N+L+      K++DFG AK    E         +  I ++A E I   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
             T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    +
Sbjct: 195 IYT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPI 243
Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
             I+      + MI + C  + A  RP   +++
Sbjct: 244 CTID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQ 124
           H   K+G+G +G VYK Q + G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L        +  LV+E++ +  L + +   E   +S   +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 241
           D  +LH D+KP N+L++     K++DFGLA+ F      +        T+ Y AP+++  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV---TLWYRAPDVLMG 174
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           S+ + T     D++  G +  EM  G
Sbjct: 175 SKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQ 124
           H   K+G+G +G VYK Q + G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L        +  LV+E++ +  L + +   E   +S   +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 241
           D  +LH D+KP N+L++     K++DFGLA+ F      +        T+ Y AP+++  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV---TLWYRAPDVLMG 174
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           S+ + T     D++  G +  EM  G
Sbjct: 175 SKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   +  +  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K+++FG +   P        +   GT+ Y+ PE+I      
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMH- 186
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 187 -DEKVDLWSLGVLCYEFLVGK 206

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 65  VTNHFTHKLGQGGFGSVYKG----QLHTGGLIAVKMLA--NSKFSGEEFINEVSTIGRIH 118
           V  H    +G+G FG VY G    Q       A+K L+        E F+ E   +  ++
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 119 HVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           H NV+ L+G     EG    L+  YM +G L + I    S  ++   + L    L  ARG
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARG 136
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA---TRGTI 233
           +EYL    +   +H D+   N +LD +F  KV+DFGLA+    + ++ S+      R  +
Sbjct: 137 MEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR-DILDREYYSVQQHRHARLPV 192
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            + A E L +  F T   KSDV+ FG++L E+
Sbjct: 193 KWTALESLQTYRFTT---KSDVWSFGVLLWEL 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 114/296 (38%), Gaps = 86/296 (29%)
Query: 46  LHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG------QLHTGGLIAVKMLAN 99
           L  Q   +P   S  E           LG+G FG V +       +  T   +AVKML  
Sbjct: 8   LDEQCERLPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKE 67
Query: 100 SKFSGE--EFINEVSTIGRI-HHVNVVQLLG--------------FCSEG-------SKR 135
              + E    + E+  +  I HH+NVV LLG              +C  G       SKR
Sbjct: 68  GATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKR 127
Query: 136 ALVYEYMPNGSLDRHIFPKESR------------------GQSFC--------------- 162
            L   +  N     H+ PK+ +                   +SF                
Sbjct: 128 DL---FFLNKDAALHMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEE 184
Query: 163 -------------WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 209
                         E L   +   ARG+E+L +    CI H D+   NILL  N + K+ 
Sbjct: 185 EEDSDGFYKEPITMEDLISYSFQVARGMEFLSSR--KCI-HRDLAARNILLSENNVVKIC 241
Query: 210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           DFGLA+   K  D+V    TR  + ++APE I   F  + S KSDV+ +G++L E+
Sbjct: 242 DFGLARDIYKNPDYVRKGDTRLPLKWMAPESI---FDKIYSTKSDVWSYGVLLWEI 294

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K      GL+  + L + +       + I E+  +   +   +V   G 
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       I
Sbjct: 76  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 129
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE--NDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++     E  N+FV      GT  Y++PE   R  G
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV------GTRSYMSPE---RLQG 180
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V K +   TG ++A+K    S   K   +  + E+  + ++ H N+V LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 129 CSEGSKRALVYEYMPNGSLDR-HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           C +  +  LV+E++ +  LD   +FP         ++ + +       GI + H+     
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRNF 245
           I+H DIKP NIL+  + + K+ DFG A+      +         T  Y APEL+     +
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAPELLVGDVKY 202
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      DV+  G ++ EM  G 
Sbjct: 203 GKA---VDVWAIGCLVTEMFMGE 222

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 55  KRYSYPEIIAVTNHFTHKLGQGGFGSV-----YKGQLHTGGLIAVKMLANSKFSGEEFIN 109
           KR+  P II  T      LG+G FG V     YK Q         + L            
Sbjct: 5   KRHIGPYIIRET------LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58
Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK----ESRGQSFCWEK 165
           E+S +  + H ++++L    +  +   +V EY   G L  +I  K    E  G+ F  + 
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           +          IEY H      I+H D+KP N+LLD N   K++DFGL+      N F+ 
Sbjct: 118 IC--------AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLK 165
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            S   G+  Y APE+I+        + DV+  G+VL  M  GR
Sbjct: 166 TSC--GSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K+++FG +   P        +   GT+ Y+ PE+I      
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHD 186
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 187 E--KVDLWSLGVLCYEFLVGK 205

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 18/222 (8%)
Query: 67  NHFT--HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFIN---EVSTIGRIHH 119
           +HF     +G+G FG V   Q + T  + A+K +   K     E  N   E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
             +V L     +     +V + +  G L  H+     +   F  E +          ++Y
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDY 130
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           L N     I+H D+KP NILLD +    ++DF +A   P+E     I+   GT  Y+APE
Sbjct: 131 LQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPE 184
Query: 240 LISRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK 280
           + S   G   S   D +  G+   E+  GRR  ++ ++ SSK
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     +G G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EYMP G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     +G G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EYMP G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE I      
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEXIEGRXHD 189
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K D++  G++  E   G+
Sbjct: 190 E--KVDLWSLGVLCYEFLVGK 208

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 31/249 (12%)
Query: 28  LIQRYRKSLKRVDNVEKFLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-Q 85
           L+ R   SL R     K   N+ +W +PK Y  P         TH +G G +GSV     
Sbjct: 14  LVPRGSMSLIRKKGFYKQDVNKTAWELPKTYVSP---------TH-VGSGAYGSVCSAID 63
Query: 86  LHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY- 141
             +G  +A+K L+    S+   +    E+  +  + H NV+ LL   +  S     Y++ 
Sbjct: 64  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123
Query: 142 --MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL 199
             MP    D     ++  G  F  EK+  +     +G++Y+H+     ++H D+KP N+ 
Sbjct: 124 LVMPFMQTDL----QKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLA 176
Query: 200 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 259
           ++ +   K+ DFGLA+    E     ++    T  Y APE+I  ++   +   D++  G 
Sbjct: 177 VNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGC 230
Query: 260 VLLEMAGGR 268
           ++ EM  G+
Sbjct: 231 IMAEMLTGK 239

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K      GL+  + L + +       + I E+  +   +   +V   G 
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       I
Sbjct: 92  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 145
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 146 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 196
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 72  KLGQGGFGSVYKGQ-LHTGG-LIAVKMLANSKFSGEE-----FINEVSTIGRIH---HVN 121
           ++G+G +G V+K + L  GG  +A+K +     +GEE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 122 VVQLLGFCS-----EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           VV+L   C+       +K  LV+E++     D   +  +        E + ++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 72  KLGQGGFGSVYKGQ-LHTGG-LIAVKMLANSKFSGEE-----FINEVSTIGRIH---HVN 121
           ++G+G +G V+K + L  GG  +A+K +     +GEE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 122 VVQLLGFCS-----EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           VV+L   C+       +K  LV+E++     D   +  +        E + ++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 116/248 (46%), Gaps = 32/248 (12%)
Query: 72  KLGQGGFGSVYKGQLH--TGGLIAVKMLANSKFSGEE--FINEVSTIGRIHHVN-VVQLL 126
           ++G+G +GSV K  +H  +G ++AVK + ++    E+   + ++  + R      +VQ  
Sbjct: 29  EIGRGAYGSVNK-MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 127 GFCSEGSKRALVYEYMPNGSLDR-HIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           G         +  E M + S D+ + +           E L ++ L T + + +L    +
Sbjct: 88  GALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--N 144
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SR 243
           + I+H DIKP NILLD +   K+ DFG++    +  D ++ +   G   Y+APE I  S 
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW--VYDQLN---KGGDLE 298
           +      +SDV+  G+ L E+A GR              +P W  V+DQL    KG   +
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFP------------YPKWNSVFDQLTQVVKGDPPQ 249
Query: 299 LRNVTEIE 306
           L N  E E
Sbjct: 250 LSNSEERE 257

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K      GL+  + L + +       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 21/241 (8%)
Query: 34  KSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIA 93
           K L+ ++  E+     ++++ ++    E+         +LG G  G V+K      GL+ 
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 94  VKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRH 150
            + L + +       + I E+  +   +   +V   G      + ++  E+M  GSLD+ 
Sbjct: 62  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ- 120
Query: 151 IFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 210
           +  K  R      + L +V++   +G+ YL       I+H D+KP NIL++     K+ D
Sbjct: 121 VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCD 175
Query: 211 FGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMAGG 267
           FG++        N FV      GT  Y++PE   R  GT  S +SD++  G+ L+EMA G
Sbjct: 176 FGVSGQLIDSMANSFV------GTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 268 R 268
           R
Sbjct: 227 R 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 71  HKLGQGGFG-SVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLL 126
            K+G+G FG ++       G    +K +  S+ S    EE   EV+ +  + H N+VQ  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
               E     +V +Y   G L + I     +G  F  +++ +  +     ++++H   D 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DR 144
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-ATRGTIGYIAPELISRNF 245
            ILH DIK  NI L  +   ++ DFG+A+     N  V ++ A  GT  Y++PE+     
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENK- 200
Query: 246 GTVSCKSDVYGFGMVLLEM 264
              + KSD++  G VL E+
Sbjct: 201 -PYNNKSDIWALGCVLYEL 218

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V++G  H G  +AVK+ ++    S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRDEQSWFRETEIYNTV----LLRHDNI---LGF 67
Query: 129 CSE-------GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +         ++  L+  Y  +GSL   +     + Q+        +A+  A G+ +LH
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFL-----QRQTLEPHLALRLAVSAACGLAHLH 122
Query: 182 -----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 234
                      I H D K  N+L+  N    ++D GLA  H + +D++ I  +   GT  
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182
Query: 235 YIAPELISRNFGTVSCKS----DVYGFGMVLLEMA 265
           Y+APE++     T   +S    D++ FG+VL E+A
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K      GL+  + L + +       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K      GL+  + L + +       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K      GL+  + L + +       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 72  KLGQGGFGSVYKGQ-LHTGG-LIAVKMLANSKFSGEE-----FINEVSTIGRIH---HVN 121
           ++G+G +G V+K + L  GG  +A+K +     +GEE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 122 VVQLLGFCS-----EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           VV+L   C+       +K  LV+E++     D   +  +        E + ++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K      GL+  + L + +       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 72  KLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +    T GL  A K++   K S  +F     E     ++ H N+V+L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKE---SRGQSFCWEKLHEVALGTARGIEYLH-NG 183
              E S   LV++ +  G L   I  +E       S C +++ E        I Y H NG
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSNG 125
Query: 184 CDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE+
Sbjct: 126 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 178
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
           + ++    S   D++  G++L  +  G              Y P W  DQ
Sbjct: 179 LKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQ 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           GLAK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG- 127
           +LG G  G V+K      GL+  + L + +       + I E+  +   +   +V   G 
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F S+G + ++  E+M  GSLD+ +  K  R      + L +V++   +G+ YL       
Sbjct: 135 FYSDG-EISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-- 187
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 245
           I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQ 238
Query: 246 GT-VSCKSDVYGFGMVLLEMAGGR 268
           GT  S +SD++  G+ L+EMA GR
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 30/218 (13%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG    T  ++A+K+  L  ++   E+   E++ + +     V +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  +   E L        +G++YLH+  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 124
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 125 KI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 175
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           I ++      K+D++  G+  +E+A G   +S +H  +
Sbjct: 176 IKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMK 211

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 71  HKLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 +K  LV+E++   S+D   F   S         +        +G+ + H+    
Sbjct: 71  DVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 125
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRN 244
            +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++   
Sbjct: 126 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LG 179
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               S   D++  G +  EM   R
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 30/218 (13%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG    T  ++A+K+  L  ++   E+   E++ + +     V +  G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  +   E L        +G++YLH+  
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 145 KI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 195
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           I ++      K+D++  G+  +E+A G   +S +H  +
Sbjct: 196 IKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMK 231

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 72  KLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +    T GL  A K++   K S  +F     E     ++ H N+V+L  
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKE---SRGQSFCWEKLHEVALGTARGIEYLH-NG 183
              E S   LV++ +  G L   I  +E       S C +++ E        I Y H NG
Sbjct: 72  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSNG 124
Query: 184 CDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE+
Sbjct: 125 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 177
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
           + ++    S   D++  G++L  +  G              Y P W  DQ
Sbjct: 178 LKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQ 211

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 71  HKLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 +K  LV+E++   S+D   F   S         +        +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 126
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRN 244
            +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++   
Sbjct: 127 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LG 180
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               S   D++  G +  EM   R
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 73  LGQGGFGSVYKGQLHTGG------LIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V      T G      +I  K+LA S   G     E+S +  + H ++++L 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 70
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +V EY  N   D +I  ++   +        ++       +EY H     
Sbjct: 71  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK-- 123
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS    
Sbjct: 124 -IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC--GSPNYAAPEVISGKL- 178
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
               + DV+  G++L  M   R
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRR 200

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 30/218 (13%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG    T  ++A+K+  L  ++   E+   E++ + +     V +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  +   E L        +G++YLH+  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 124
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 125 KI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEV 175
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           I ++      K+D++  G+  +E+A G   +S +H  +
Sbjct: 176 IKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMK 211

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 71  HKLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 +K  LV+E++   S+D   F   S         +        +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 124
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRN 244
            +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++   
Sbjct: 125 -VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LG 178
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               S   D++  G +  EM   R
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 24/236 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVN 121
            F   LG+G FG V   ++  TG L AVK+L       ++ +    T  RI     +H  
Sbjct: 26  EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           + QL        +   V E++  G L  HI     + + F   +    A      + +LH
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLH 141
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
              D  I++ D+K  N+LLDH    K++DFG+ K      + V+ +   GT  YIAPE++
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL 196
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG-------RRNSNMHATRSSKAYFPSWVYDQ 290
                  +   D +  G++L EM  G         +    A  + +  +P+W+++ 
Sbjct: 197 QEMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 18/237 (7%)
Query: 35  SLKRVDNVEKFLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG----QLHTG 89
           S+   D+  + +  + ++ MP    Y EI          +G+G FG V++G      +  
Sbjct: 360 SVSETDDYAEIIDEEDTYTMPSTRDY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418
Query: 90  GLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL 147
             +A+K   N  S    E+F+ E  T+ +  H ++V+L+G  +E     ++ E    G L
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGEL 477
Query: 148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK 207
              +   + R  S     L   A   +  + YL +      +H DI   N+L+  N   K
Sbjct: 478 RSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 531
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + DFGL+++  +++ +   S  +  I ++APE I  NF   +  SDV+ FG+ + E+
Sbjct: 532 LGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEI 585

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 71  HKLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 +K  LV+E++   S+D   F   S         +        +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 126
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRN 244
            +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++   
Sbjct: 127 -VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LG 180
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               S   D++  G +  EM   R
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 30/218 (13%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG    T  ++A+K+  L  ++   E+   E++ + +     V +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFP---KESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  +   E L        +G++YLH+  
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 139
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 140 KI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEV 190
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           I ++      K+D++  G+  +E+A G   +S +H  +
Sbjct: 191 IKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMK 226

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 73  LGQGGFGSVYKGQLHTGG------LIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V      T G      +I  K+LA S   G     E+S +  + H ++++L 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 80
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +V EY  N   D +I  ++   +        ++       +EY H     
Sbjct: 81  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK-- 133
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+LLD +   K++DFGL+      N F+  S   G+  Y APE+IS    
Sbjct: 134 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSC--GSPNYAAPEVISGKL- 188
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
               + DV+  G++L  M   R
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRR 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 73  LGQGGFGSVYKGQLHTGG------LIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V      T G      +I  K+LA S   G     E+S +  + H ++++L 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 79
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +V EY  N   D +I  ++   +        ++       +EY H     
Sbjct: 80  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK-- 132
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+LLD +   K++DFGL+      N F+  S   G+  Y APE+IS    
Sbjct: 133 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSC--GSPNYAAPEVISGKL- 187
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
               + DV+  G++L  M   R
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRR 209

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 72  KLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +    T GL  A K++   K S  +F     E     ++ H N+V+L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKE---SRGQSFCWEKLHEVALGTARGIEYLH-NG 183
              E S   LV++ +  G L   I  +E       S C +++ E        I Y H NG
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSNG 125
Query: 184 CDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE+
Sbjct: 126 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 178
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
           + ++    S   D++  G++L  +  G              Y P W  DQ
Sbjct: 179 LKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQ 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 73  LGQGGFGSVYKGQLHTGG------LIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V      T G      +I  K+LA S   G     E+S +  + H ++++L 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 74
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +V EY  N   D +I  ++   +        ++       +EY H     
Sbjct: 75  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK-- 127
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS    
Sbjct: 128 -IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC--GSPNYAAPEVISGKL- 182
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
               + DV+  G++L  M   R
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRR 204

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 41/231 (17%)
Query: 71  HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQLL 126
            +LG+G F  V +    T GL  A K++   K S  +F     E     ++ H N+V+L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKE---SRGQSFCWEKLHEVALGTARGIEYLH-N 182
               E S   LV++ +  G L   I  +E       S C +++ E        I Y H N
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSN 147
Query: 183 GCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           G    I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE
Sbjct: 148 G----IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPE 200
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
           ++ ++    S   D++  G++L  +  G              Y P W  DQ
Sbjct: 201 VLKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQ 235

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 72  KLGQGGFGSVY--KGQLHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVVQL 125
           KLG G +G V   K +L TG   A+K++  S  +        ++EV+ + ++ H N+++L
Sbjct: 28  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
             F  +     LV E    G L   I  ++   +      + +V  GT     YLH    
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT----YLHKHN- 141
Query: 186 VCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KP N+LL+    + + K+ DFGL+           +    GT  YIAPE++ 
Sbjct: 142 --IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGTAYYIAPEVLR 196
Query: 243 RNFGTVSCKSDVYGFGMVL 261
           + +     K DV+  G++L
Sbjct: 197 KKYDE---KCDVWSCGVIL 212

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 72  KLGQGGFGSVY--KGQLHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVVQL 125
           KLG G +G V   K +L TG   A+K++  S  +        ++EV+ + ++ H N+++L
Sbjct: 11  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
             F  +     LV E    G L   I  ++   +      + +V  GT     YLH    
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT----YLHKHN- 124
Query: 186 VCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KP N+LL+    + + K+ DFGL+           +    GT  YIAPE++ 
Sbjct: 125 --IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGTAYYIAPEVLR 179
Query: 243 RNFGTVSCKSDVYGFGMVL 261
           + +     K DV+  G++L
Sbjct: 180 KKYDE---KCDVWSCGVIL 195

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 33/230 (14%)
Query: 48  NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGE 105
           N+ +W +PK Y  P         TH +G G +GSV       +G  +A+K L+   F  E
Sbjct: 16  NKTAWELPKTYVSP---------TH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSE 64
Query: 106 EFIN----EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY---MPNGSLDRHIFPKESRG 158
            F      E+  +  + H NV+ LL   +  S     Y++   MP    D     ++  G
Sbjct: 65  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL----QKIMG 120
Query: 159 QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
             F  EK+  +     +G++Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+   
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            E     ++    T  Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 178 AE-----MTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 128
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 129 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 184
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 185 RFTSASDVWMFGVCMWEI 202

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSGE----EFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  S+   E    +   E+     + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 128 FCSEGSKRALVYEYMPNGSL----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +  +  +  L+ E+ P G L     +H    E R  +F  E         A  + Y H  
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH-- 131
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            +  ++H DIKP N+L+ +    K++DFG +   P     +      GT+ Y+ PE+I  
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 186
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
              T   K D++  G++  E   G
Sbjct: 187 K--THDEKVDLWCAGVLCYEFLVG 208

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           +LG+G +G V K + + +G ++AVK +    NS+      ++   ++  +     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    +  E M + SLD+       +GQ+   + L ++A+   + +E+LH+   + 
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 174
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+L++     K+ DFG++ +     D V+ +   G   Y+APE I+     
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 248 --VSCKSDVYGFGMVLLEMA 265
              S KSD++  G+ ++E+A
Sbjct: 232 KGYSVKSDIWSLGITMIELA 251

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 133
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 134 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 189
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 190 RFTSASDVWMFGVCMWEI 207

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 11/178 (6%)
Query: 97  LANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LD--RHIFP 153
           L   + S +E + E+  + + HH N+V          +  LV + +  GS LD  +HI  
Sbjct: 45  LEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVA 104
Query: 154 K-ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
           K E +        +  +      G+EYLH    +   H D+K  NILL  +   +++DFG
Sbjct: 105 KGEHKSGVLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFG 161
Query: 213 LAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++ F     D       +   GT  ++APE++ +  G    K+D++ FG+  +E+A G
Sbjct: 162 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 136
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 192
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 193 RFTSASDVWMFGVCMWEI 210

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 159
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 160 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 215
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 216 RFTSASDVWMFGVCMWEI 233

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 73  LGQGGFGSVYKGQLHTGGLI-AVKMLANSKFSGE----EFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      I A+K+L  S+   E    +   E+     + H N++++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 128 FCSEGSKRALVYEYMPNGSL----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           +  +  +  L+ E+ P G L     +H    E R  +F  E         A  + Y H  
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH-- 132
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            +  ++H DIKP N+L+ +    K++DFG +   P     +      GT+ Y+ PE+I  
Sbjct: 133 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 187
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
              T   K D++  G++  E   G
Sbjct: 188 K--THDEKVDLWCAGVLCYEFLVG 209

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     +G G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G+GGFG VY   +  TG + A+K L   +   ++        G    +N   +L   S 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 248
Query: 132 GS---------------KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           G                K + + + M  G L  H+    S+   F    +   A     G
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 304
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 357
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS 278
           APE++ +     S  +D +  G +L ++  G      H T+ 
Sbjct: 358 APEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G+GGFG VY   +  TG + A+K L   +   ++        G    +N   +L   S 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 248
Query: 132 GS---------------KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           G                K + + + M  G L  H+    S+   F    +   A     G
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 304
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 357
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS 278
           APE++ +     S  +D +  G +L ++  G      H T+ 
Sbjct: 358 APEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           GLAK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 134
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 135 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 190
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 191 RFTSASDVWMFGVCMWEI 208

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G+GGFG VY   +  TG + A+K L   +   ++        G    +N   +L   S 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 247
Query: 132 GS---------------KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           G                K + + + M  G L  H+    S+   F    +   A     G
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 303
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 304 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 356
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS 278
           APE++ +     S  +D +  G +L ++  G      H T+ 
Sbjct: 357 APEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD 397

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 11/178 (6%)
Query: 97  LANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LD--RHIFP 153
           L   + S +E + E+  + + HH N+V          +  LV + +  GS LD  +HI  
Sbjct: 50  LEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVA 109
Query: 154 K-ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
           K E +        +  +      G+EYLH    +   H D+K  NILL  +   +++DFG
Sbjct: 110 KGEHKSGVLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFG 166
Query: 213 LAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++ F     D       +   GT  ++APE++ +  G    K+D++ FG+  +E+A G
Sbjct: 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 223

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G+GGFG VY   +  TG + A+K L   +   ++        G    +N   +L   S 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 248
Query: 132 GS---------------KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           G                K + + + M  G L  H+    S+   F    +   A     G
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 304
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 357
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS 278
           APE++ +     S  +D +  G +L ++  G      H T+ 
Sbjct: 358 APEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK   K   +       GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAK-RVKGRTWTLC----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     H     +A+K +  S F  + +    + E+  + R  H NV+ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKI--SPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +  A+   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+L++     K+ DFGLA+    E+D    ++    T  Y APE++  + G
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 225 YTKS-IDIWSVGCILAEMLSNR 245

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           +LG+G +G V K + + +G ++AVK +    NS+      ++   ++  +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    +  E M + SLD+       +GQ+   + L ++A+   + +E+LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+L++     K+ DFG++ +     D V+     G   Y+APE I+     
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 248 --VSCKSDVYGFGMVLLEMA 265
              S KSD++  G+ ++E+A
Sbjct: 188 KGYSVKSDIWSLGITMIELA 207

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLGF 128
           LG+G FG V K +   T    AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
             + S   +V E    G L   I  +    + F       +      GI Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 189 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           +H D+KP NILL   + +   K+ DFGL+    +      +    GT  YIAPE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR--- 196
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 24/235 (10%)
Query: 42  VEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVKML 97
           V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K+L
Sbjct: 1   VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 60
Query: 98  ANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFP 153
              K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+  
Sbjct: 61  DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-- 118
Query: 154 KESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 213
              R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DFG 
Sbjct: 119 --RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF 173
Query: 214 AKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           AK   K   +       GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 174 AK-RVKGRTWTLC----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLGF 128
           LG+G FG V K +   T    AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
             + S   +V E    G L    F +  + + F       +      GI Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 189 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           +H D+KP NILL   + +   K+ DFGL+    +      +    GT  YIAPE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR--- 196
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TIGYIAPELISRN 244
             +H DI   N+L+  N   K+ DFGL+++     D     A++G   I ++APE I  N
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESI--N 185
Query: 245 FGTVSCKSDVYGFGMVLLEM 264
           F   +  SDV+ FG+ + E+
Sbjct: 186 FRRFTSASDVWMFGVCMWEI 205

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 35/293 (11%)
Query: 53  MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAV-KMLANSKFSGEE---FI 108
           MP R    E++       + +G G +G   K +  + G I V K L     +  E    +
Sbjct: 1   MPSRAEDYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV 53
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKL 166
           +EV+ +  + H N+V+      + +   L  V EY   G L   I       Q    E +
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 167 HEVALGTARGIEYLHNGCD--VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
             V       ++  H   D    +LH D+KP N+ LD     K+ DFGLA+    + DF 
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA 173
Query: 225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP 284
                 GT  Y++PE ++R   + + KSD++  G +L E+                A  P
Sbjct: 174 KEFV--GTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELC---------------ALMP 214
Query: 285 SWV-YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            +  + Q    G +       I    + +L  I    + +K   RPS+ ++LE
Sbjct: 215 PFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLGF 128
           LG+G FG V K +   T    AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
             + S   +V E    G L    F +  + + F       +      GI Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 189 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           +H D+KP NILL   + +   K+ DFGL+    +      +    GT  YIAPE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR--- 196
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 73  LGQGGFGSVY--KGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK+++      K   E  + EV  + ++ H N+++L 
Sbjct: 34  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   I  +    + F       +      GI Y+H     
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 147 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 200
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT   K DV+  G++L  +  G
Sbjct: 201 ---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 61  EIIAVTNHFT--HKLGQGGFGSVYKGQL--HTGGLI--AVKMLANSKFSG---EEFINEV 111
           +++     FT    LG+G FGSV + QL    G  +  AVKML     +    EEF+ E 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 112 STIGRIHHVNVVQLLGFCSEGSKRA------LVYEYMPNGSLDRHIFPKESR-GQS---F 161
           + +    H +V +L+G       +       ++  +M +G L  H F   SR G++    
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL--HAFLLASRIGENPFNL 134
Query: 162 CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 221
             + L    +  A G+EYL +      +H D+   N +L  +    V+DFGL++     +
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +    A++  + ++A E ++ N  TV   SDV+ FG+ + E+
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTV--HSDVWAFGVTMWEI 232

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 73  LGQGGFGSVY--KGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK+++      K   E  + EV  + ++ H N+++L 
Sbjct: 40  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   I  +    + F       +      GI Y+H     
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNK-- 152
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 153 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 206
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT   K DV+  G++L  +  G
Sbjct: 207 H---GTYDEKCDVWSTGVILYILLSG 229

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 63  IAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV 122
           IA       ++G+G +G V+ G+   G  +AVK+   ++ +      E+     + H N+
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENI 93
Query: 123 VQLLGFCSEGS----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           +  +    +G+    +  L+ +Y  NGSL  ++     +  +   + + ++A  +  G+ 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 179 YLHNGC-----DVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATR-G 231
           +LH           I H D+K  NIL+  N    ++D GLA KF    N+      TR G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 232 TIGYIAPEL----ISRNFGTVSCKSDVYGFGMVLLEMA 265
           T  Y+ PE+    ++RN       +D+Y FG++L E+A
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 124/284 (43%), Gaps = 43/284 (15%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLGFC 129
           +G+G FG VY G+ H  G +A++++   + + ++   F  EV    +  H NVV  +G C
Sbjct: 41  IGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE--KLHEVALGTARGIEYLHNGCDVC 187
                 A++       +L   +     R      +  K  ++A    +G+ YLH      
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVV-----RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--- 150
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP-----KENDFVSISATRGTIGYIAPELIS 242
           ILH D+K  N+  D+  +  ++DFGL          +  D + I    G + ++APE+I 
Sbjct: 151 ILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQ--NGWLCHLAPEIIR 207
Query: 243 R-------NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG 295
           +       +    S  SDV+  G +  E+     ++     ++  A    W   Q+  G 
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYEL-----HAREWPFKTQPAEAIIW---QMGTGM 259
Query: 296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              L  +      + +++  I L+C   +  +RP+ TK+++MLE
Sbjct: 260 KPNLSQIG-----MGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVK--MLANSKFSGEEFINEVSTIGRIHHVNVVQLL-GF 128
           LG+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+    +
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 129 CSEGSKRAL------VYEYMPNGSLDRHIFPK--------ESRGQSFCWEKLHEVALGTA 174
             + +   L      VY Y+      +             E R +S C   LH + L  A
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC---LH-IFLQIA 128
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-------- 226
             +E+LH+     ++H D+KP NI    + + KV DFGL     ++ +  ++        
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 227 --SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             +   GT  Y++PE I  N  + S K D++  G++L E+
Sbjct: 186 RHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI- 117
           P++      +   LG+G FG V    +  TG   A+K+L       ++ +    T  R+ 
Sbjct: 5   PKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 118 ---HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
               H  +  L        +   V EY   G L  H+    SR + F  E+         
Sbjct: 65  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIV 120
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
             +EYLH+     +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  
Sbjct: 121 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPE 175
Query: 235 YIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 268
           Y+APE++  N +G      D +G G+V+ EM  GR
Sbjct: 176 YLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 35/293 (11%)
Query: 53  MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAV-KMLANSKFSGEE---FI 108
           MP R    E++       + +G G +G   K +  + G I V K L     +  E    +
Sbjct: 1   MPSRAEDYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV 53
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKL 166
           +EV+ +  + H N+V+      + +   L  V EY   G L   I       Q    E +
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 167 HEVALGTARGIEYLHNGCD--VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
             V       ++  H   D    +LH D+KP N+ LD     K+ DFGLA+    +  F 
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP 284
              A  GT  Y++PE ++R   + + KSD++  G +L E+                A  P
Sbjct: 174 --KAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELC---------------ALMP 214
Query: 285 SWV-YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            +  + Q    G +       I    + +L  I    + +K   RPS+ ++LE
Sbjct: 215 PFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 73  LGQGGFGSVYKGQLH--TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           +G G + SV K  +H  T    AVK++  SK    E I  +   G+  H N++ L     
Sbjct: 30  IGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYD 86
Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
           +G    +V E M  G L   I     R + F   +   V     + +EYLH      ++H
Sbjct: 87  DGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQG---VVH 139
Query: 191 FDIKPHNIL-LDHNFIP---KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            D+KP NIL +D +  P   ++ DFG AK    EN  +       T  ++APE++ R   
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLERQGY 197
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             +C  D++  G++L  M  G
Sbjct: 198 DAAC--DIWSLGVLLYTMLTG 216

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 39/246 (15%)
Query: 63  IAVTNHFTHK-LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI--- 117
           + + +   HK LG+G FG V+  +   T    A+K L       ++ +       R+   
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 118 --HHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
              H  +  +  FC+  +K  L  V EY+  G L  HI         F   +    A   
Sbjct: 74  AWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEI 127
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISAT 229
             G+++LH+     I++ D+K  NILLD +   K++DFG+ K +     K N F      
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC----- 179
Query: 230 RGTIGYIAPELISRNFGTVSCKS-DVYGFGMVLLEMA-------GGRRNSNMHATRSSKA 281
            GT  YIAPE++    G     S D + FG++L EM        G       H+ R    
Sbjct: 180 -GTPDYIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235
Query: 282 YFPSWV 287
           ++P W+
Sbjct: 236 FYPRWL 241

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 105/246 (42%), Gaps = 39/246 (15%)
Query: 63  IAVTNHFTHK-LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI--- 117
           + + +   HK LG+G FG V+  +   T    A+K L       ++ +       R+   
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 118 --HHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
              H  +  +  FC+  +K  L  V EY+  G L  HI         F   +    A   
Sbjct: 75  AWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEI 128
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISAT 229
             G+++LH+     I++ D+K  NILLD +   K++DFG+ K +     K N+F      
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC----- 180
Query: 230 RGTIGYIAPELISRNFGTVSCKS-DVYGFGMVLLEMA-------GGRRNSNMHATRSSKA 281
            GT  YIAPE++    G     S D + FG++L EM        G       H+ R    
Sbjct: 181 -GTPDYIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 236
Query: 282 YFPSWV 287
           ++P W+
Sbjct: 237 FYPRWL 242

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  E+           +EYLH+     
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 187 RA---VDWWGLGVVMYEMMCGR 205

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 35  SLKRVDNVEKFLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG----QLHTG 89
           S+   D+  + +  + ++ MP    Y EI          +G+G FG V++G      +  
Sbjct: 360 SVSETDDYAEIIDEEDTYTMPSTRDY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418
Query: 90  GLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL 147
             +A+K   N  S    E+F+ E  T+ +  H ++V+L+G  +E     ++ E    G L
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGEL 477
Query: 148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK 207
              +   + R  S     L   A   +  + YL +      +H DI   N+L+      K
Sbjct: 478 RSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVK 531
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + DFGL+++  +++ +   S  +  I ++APE I  NF   +  SDV+ FG+ + E+
Sbjct: 532 LGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEI 585

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 73  LGQGGFGSVY--KGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK+++      K   E  + EV  + ++ H N+++L 
Sbjct: 57  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   I  +    + F       +      GI Y+H     
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNK-- 169
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 170 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 223
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT   K DV+  G++L  +  G
Sbjct: 224 ---HGTYDEKCDVWSTGVILYILLSG 246

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 24/236 (10%)
Query: 41  NVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVKM 96
           +V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K+
Sbjct: 7   DVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI 66
Query: 97  LANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF 152
           L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+ 
Sbjct: 67  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL- 125
Query: 153 PKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
               R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 126 ---RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 180 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   + +L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   + +L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 73  LGQGGFGSVY--KGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK+++      K   E  + EV  + ++ H N+++L 
Sbjct: 58  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   I  +    + F       +      GI Y+H     
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNK-- 170
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 171 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 224
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT   K DV+  G++L  +  G
Sbjct: 225 ---HGTYDEKCDVWSTGVILYILLSG 247

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGXKY 180
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRR 201

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 180
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 181
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 117/293 (39%), Gaps = 35/293 (11%)
Query: 53  MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAV-KMLANSKFSGEE---FI 108
           MP R    E++       + +G G +G   K +  + G I V K L     +  E    +
Sbjct: 1   MPSRAEDYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV 53
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKL 166
           +EV+ +  + H N+V+      + +   L  V EY   G L   I       Q    E +
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 167 HEVALGTARGIEYLHNGCD--VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
             V       ++  H   D    +LH D+KP N+ LD     K+ DFGLA+    +  F 
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP 284
                 GT  Y++PE ++R   + + KSD++  G +L E+                A  P
Sbjct: 174 KTFV--GTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELC---------------ALMP 214
Query: 285 SWV-YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            +  + Q    G +       I    + +L  I    + +K   RPS+ ++LE
Sbjct: 215 PFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 73  LGQGGFGSVYK------GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQL 125
           LG+G F    K       Q     +I+ +M AN++        E++ +     H N+V+L
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-------KEITALKLCEGHPNIVKL 71
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
                +     LV E +  G L    F +  + + F   +   +       + ++H   D
Sbjct: 72  HEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMH---D 124
Query: 186 VCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
           V ++H D+KP N+L    + N   K+ DFG A+  P +N    +     T+ Y APEL++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLN 182
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +N    SC  D++  G++L  M  G+
Sbjct: 183 QNGYDESC--DLWSLGVILYTMLSGQ 206

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 24/236 (10%)
Query: 41  NVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVKM 96
           +V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K+
Sbjct: 7   DVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI 66
Query: 97  LANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF 152
           L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+ 
Sbjct: 67  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL- 125
Query: 153 PKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
               R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 126 ---RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 180 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 227

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 93
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 153
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 207 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 255

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 180
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKF------SGEEFINEVSTIGRIHHVNVVQL 125
           +G+G F  V +     TG   AVK++  +KF      S E+   E S    + H ++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           L   S      +V+E+M    L   I  +   G  +               + Y H   D
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 186 VCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KP N+LL    N  P K+ DFG+A     E+  V+     GT  ++APE++ 
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 206
Query: 243 RN-FGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G      DV+G G++L  +  G
Sbjct: 207 REPYGK---PVDVWGCGVILFILLSG 229

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 179
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 77  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGXKY 187
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRR 208

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   + +L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 44/237 (18%)
Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
               +LG GGFG V +     TG  +A+K      S  + E +  E+  + +++H NVV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 125 LLGFCSEGSKRA------LVYEYMPNGSLDRHIFPKESRGQSFCWEK---LHEVALGTAR 175
                    K A      L  EY   G L +++    ++ ++ C  K   +  +    + 
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISS 132
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE---NDFVSISAT 229
            + YLH      I+H D+KP NI+L       I K+ D G AK   +     +FV     
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----- 184
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW 286
            GT+ Y+APEL+ +   TV+   D + FG +  E   G R            + P+W
Sbjct: 185 -GTLQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFR-----------PFLPNW 227

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 44/237 (18%)
Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQ 124
               +LG GGFG V +     TG  +A+K      S  + E +  E+  + +++H NVV 
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 125 LLGFCSEGSKRA------LVYEYMPNGSLDRHIFPKESRGQSFCWEK---LHEVALGTAR 175
                    K A      L  EY   G L +++    ++ ++ C  K   +  +    + 
Sbjct: 78  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISS 133
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE---NDFVSISAT 229
            + YLH      I+H D+KP NI+L       I K+ D G AK   +     +FV     
Sbjct: 134 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----- 185
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW 286
            GT+ Y+APEL+ +   TV+   D + FG +  E   G R            + P+W
Sbjct: 186 -GTLQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFR-----------PFLPNW 228

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 179
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 101/243 (41%), Gaps = 38/243 (15%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV----------- 120
           LGQG FG V K +        A+K + +++      ++EV  +  ++H            
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 121 --NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
             N V+ +    + S   +  EY  NG+L   I  +    Q   + +L    L     + 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL---EALS 130
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------- 230
           Y+H+     I+H D+KP NI +D +   K+ DFGLAK   +  D + + +          
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 231 ----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMHATRSSKA 281
               GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +   RS   
Sbjct: 188 TSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246
Query: 282 YFP 284
            FP
Sbjct: 247 EFP 249

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 180
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 181
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 177
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  ++           ++YLH+  +V 
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 270
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 271 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 328 RA---VDWWGLGVVMYEMMCGR 346

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 77  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 187
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRR 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 74  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 127
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 184
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRR 205

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  ++           ++YLH+  +V 
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 273
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 274 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 330
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 331 RA---VDWWGLGVVMYEMMCGR 349

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 178
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKG----QLHTGGLIAVKMLAN--SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G      +    +A+K   N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  S     L   A   +  + YL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+      K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 179
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 71  HKLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 +K  LV+E++     D   F   S         +        +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 123
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRN 244
            +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++   
Sbjct: 124 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LG 177
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               S   D++  G +  EM   R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 177
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE      ++   +V+L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 178
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 73  LGQGGFGSVY--KGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK+++      K   E  + EV  + ++ H N+ +L 
Sbjct: 34  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   I  +    + F       +      GI Y H     
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYXHKNK-- 146
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLA---KFHPKENDFVSISATRGTIGYIAP 238
            I+H D+KP N+LL     D N   ++ DFGL+   +   K  D +      GT  YIAP
Sbjct: 147 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKKXKDKI------GTAYYIAP 197
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++    GT   K DV+  G++L  +  G
Sbjct: 198 EVL---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQDLKD---FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 178
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 178
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 181
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 180
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAV-KMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+ K+  +++  G     I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 180
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAV-KMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+ K+  +++  G     I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGCKY 179
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF 152
           AVK++  SK    E I  +   G+  H N++ L     +G    LV E M  G L   I 
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 153 PKESRGQSFCWEKLHEVALGT-ARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---K 207
                 Q F  E+     L T  + +EYLH+     ++H D+KP NIL +D +  P   +
Sbjct: 114 -----RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           + DFG AK    EN  +       T  ++APE++ R      C  D++  G++L  M  G
Sbjct: 166 ICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGC--DIWSLGILLYTMLAG 221

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 179
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 74  GQGGFGSVYKGQLHTGGL-IAVK-MLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF--- 128
           GQG FG+V  G+  + G+ +A+K ++ + +F   E +  +  +  +HH N+VQL  +   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 129 CSEGSKRAL----VYEYMPN-------GSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
             E  +R +    V EY+P+           R + P     + F ++ +        R I
Sbjct: 91  LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI--------RSI 142
Query: 178 EYLH-NGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLA-KFHPKENDFVSISATRGTIG 234
             LH    +VC  H DIKPHN+L++  +   K+ DFG A K  P E +   I +      
Sbjct: 143 GCLHLPSVNVC--HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY---- 196
Query: 235 YIAPELISRNFGT--VSCKSDVYGFGMVLLEMAGG 267
           Y APELI   FG    +   D++  G +  EM  G
Sbjct: 197 YRAPELI---FGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 180
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 179
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 181
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 74  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 127
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 182
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 60  PEIIAVTNHFTHKLGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI- 117
           P +      +   LG+G FG V    +  TG   A+K+L       ++ +    T  R+ 
Sbjct: 5   PRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 118 ---HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
               H  +  L        +   V EY   G L  H+    SR + F  ++         
Sbjct: 65  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIV 120
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
             ++YLH+  +V  ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  
Sbjct: 121 SALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPE 176
Query: 235 YIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 268
           Y+APE++  N +G      D +G G+V+ EM  GR
Sbjct: 177 YLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 208

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 21/193 (10%)
Query: 64  AVTNHF---THKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF--SGEEFINEVSTIGRI 117
           + +NH    +  LGQG   +V++G+   TG L A+K+  N  F    +  + E   + ++
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 118 HHVNVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
           +H N+V+L     E + R   L+ E+ P GSL   +  + S        +   V      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL-YTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 176 GIEYL-HNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           G+ +L  NG    I+H +IKP NI+     D   + K++DFG A+    +  FVS+    
Sbjct: 124 GMNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 231 GTIGYIAPELISR 243
           GT  Y+ P++  R
Sbjct: 177 GTEEYLHPDMYER 189

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 179
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 180
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 72  KLGQGGFGSVY---KGQLHTGGLIAV-KMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           KLG G +G V        H    I + +  + S  S  + + EV+ +  + H N+++L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA-----RGIEYLHN 182
           F  +     LV E    G L   I  +          K +EV           G+ YLH 
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHK 154
Query: 183 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
                I+H D+KP N+LL   + + + K+ DFGL+     +     +    GT  YIAPE
Sbjct: 155 HN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE 208
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++ + +     K DV+  G++L  +  G
Sbjct: 209 VLRKKYDE---KCDVWSIGVILFILLAG 233

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q+  TG L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G +  HI+  +     F   +          G+E+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAPEL 240
           I++ D+KP N+LLD +   ++SD GLA         V + A +       GT G++APEL
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +       S   D +  G+ L EM   R
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF 152
           AVK++  SK    E I  +   G+  H N++ L     +G    LV E M  G L   I 
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 153 PKESRGQSFCWEKLHEVALGT-ARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---K 207
                 Q F  E+     L T  + +EYLH+     ++H D+KP NIL +D +  P   +
Sbjct: 114 -----RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           + DFG AK    EN  +       T  ++APE++ R      C  D++  G++L  M  G
Sbjct: 166 ICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGC--DIWSLGILLYTMLAG 221

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q+  TG L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G +  HI+  +     F   +          G+E+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAPEL 240
           I++ D+KP N+LLD +   ++SD GLA         V + A +       GT G++APEL
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +       S   D +  G+ L EM   R
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q+  TG L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G +  HI+  +     F   +          G+E+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAPEL 240
           I++ D+KP N+LLD +   ++SD GLA         V + A +       GT G++APEL
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +       S   D +  G+ L EM   R
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  ++           ++YLH+  +V 
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 132 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 189 RA---VDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSV-YKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L       ++ +    T  R+     H  +  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR + F  ++           ++YLH+  +V 
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 131 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYLAPEVLEDNDYG 187
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 188 RA---VDWWGLGVVMYEMMCGR 206

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S         +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEHVDQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL-LGC 181
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
              S   D++  G +  EM   R
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q+  TG L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G +  HI+  +     F   +          G+E+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAPEL 240
           I++ D+KP N+LLD +   ++SD GLA         V + A +       GT G++APEL
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +       S   D +  G+ L EM   R
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V     + TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVK-MLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFC 129
           L +GGF  VY+ Q + +G   A+K +L+N +      I EV  + ++  H N+VQ     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 130 SEGSKRA-------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           S G + +       L+   +  G L   +   ESRG   C + + ++   T R ++++H 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC-DTVLKIFYQTCRAVQHMHR 154
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLA---------KFHPKENDFVSISATRGTI 233
                I+H D+K  N+LL +    K+ DFG A          +  +    V    TR T 
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 234 G-YIAPELIS--RNFGTVSCKSDVYGFGMVL 261
             Y  PE+I    NF  +  K D++  G +L
Sbjct: 214 PMYRTPEIIDLYSNF-PIGEKQDIWALGCIL 243

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVK--MLANSKFSGEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +   TG  +A+K  ++ N K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 125 LLGFCSEGSK-----RALVY------EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
           L+  C   +      +A +Y      E+   G L   +         F   ++  V    
Sbjct: 82  LIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQML 134
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-G 231
             G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  
Sbjct: 135 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 232 TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           T+ Y  PEL+   R++G      D++G G ++ EM
Sbjct: 192 TLWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 30/237 (12%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-------HV 120
           H   K+G G FGSV+K      G I     +    +G   ++E + +  ++       H 
Sbjct: 10  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHS 67
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           +VV+     +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+
Sbjct: 68  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDF------VSIS 227
           H+   + ++H DIKP NI +    IP  +       D+   K   K  D        S  
Sbjct: 128 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 184
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG----RRNSNMHATRSSK 280
              G   ++A E++  N+ T   K+D++   + ++  AG     R     H  R  +
Sbjct: 185 VEEGDSRFLANEVLQENY-THLPKADIFALALTVVXAAGAEPLPRNGDQWHEIRQGR 240

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVK--MLANSKFSGEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +   TG  +A+K  ++ N K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 125 LLGFCSEGSKRA--------LVYEYMPN--GSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           L+  C   +           LV+++  +    L  ++  K      F   ++  V     
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 136 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVK--MLANSKFSGEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +   TG  +A+K  ++ N K   E F    + E+  +  + H NVV 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 80
Query: 125 LLGFCSEGSKRA--------LVYEYMPN--GSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           L+  C   +           LV+++  +    L  ++  K      F   ++  V     
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 134
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 222

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        ++     GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLA-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS------GEEFIN-- 109
           YP+ +      +  LG G  G V    +  T   +A+K+++  KF+       +  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   +   +   ++ C    ++
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 123 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           ++    GT  Y+APE L+S      +   D +  G++L     G    + H T+ S    
Sbjct: 175 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---- 227
Query: 284 PSWVYDQLNKG 294
              + DQ+  G
Sbjct: 228 ---LKDQITSG 235

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS------GEEFIN-- 109
           YP+ +      +  LG G  G V    +  T   +A+K+++  KF+       +  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   +   +   ++ C    ++
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 123 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           ++    GT  Y+APE L+S      +   D +  G++L     G    + H T+ S    
Sbjct: 175 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---- 227
Query: 284 PSWVYDQLNKG 294
              + DQ+  G
Sbjct: 228 ---LKDQITSG 235

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 73  LGQGGFGSVYKGQ----LHTGGLIAVKMLA------NSKFSGEEFINEVSTIGRIHHVNV 122
           LG+GG+G V++ +     +TG + A+K+L       N+K +      E + +  + H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           V L+     G K  L+ EY+  G L    F +  R   F  +         +  + +LH 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I++ D+KP NI+L+H    K++DFGL K     +D        GTI Y+APE++ 
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R+    +   D +  G ++ +M  G
Sbjct: 195 RSGHNRAV--DWWSLGALMYDMLTG 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK++  ++ +    ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANS---KFSGEEFINEVSTIGRIH-HVNVV 123
              KLG+G +G V+K     TG ++AVK + ++       +    E+  +  +  H N+V
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 124 QLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE--VALGTARGIEY 179
            LL      + R   LV++YM     D H   + +       E +H+  V     + I+Y
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM---ETDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKY 124
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           LH+G    +LH D+KP NILL+     KV+DFGL++
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVK--MLANSKFSGEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +   TG  +A+K  ++ N K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 125 LLGFCSEGSKRA--------LVYEYMPN--GSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           L+  C   +           LV+++  +    L  ++  K      F   ++  V     
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 136 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 42/217 (19%)
Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G+V+K +   T  ++A+K +    + +      + E+  +  + H N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 127 GFCSEGSKRALVYEYMP----------NGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
                  K  LV+E+            NG LD  I       +SF ++ L        +G
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV------KSFLFQLL--------KG 113
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIG 234
           + + H+     +LH D+KP N+L++ N   K++DFGLA+    P        SA   T+ 
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR----CYSAEVVTLW 166
Query: 235 YIAPELISRNFGT--VSCKSDVYGFGMVLLEMAGGRR 269
           Y  P+++   FG    S   D++  G +  E+A   R
Sbjct: 167 YRPPDVL---FGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS------GEEFIN-- 109
           YP+ +      +  LG G  G V    +  T   +A+K+++  KF+       +  +N  
Sbjct: 3   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 62
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   +   +   ++ C    ++
Sbjct: 63  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 121
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 122 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 173
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           ++    GT  Y+APE L+S      +   D +  G++L     G    + H T+ S    
Sbjct: 174 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---- 226
Query: 284 PSWVYDQLNKG 294
              + DQ+  G
Sbjct: 227 ---LKDQITSG 234

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 38/243 (15%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV----------- 120
           LGQG FG V K +        A+K + +++      ++EV  +  ++H            
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 121 --NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
             N V+ +    + S   +  EY  N +L   I  +    Q   + +L    L     + 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---EALS 130
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------SI 226
           Y+H+     I+H D+KP NI +D +   K+ DFGLAK   +  D +            ++
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMHATRSSKA 281
           ++  GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +   RS   
Sbjct: 188 TSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246
Query: 282 YFP 284
            FP
Sbjct: 247 EFP 249

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 69  FTHKLGQGGFGSVYKG---------QLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH 118
           F   LGQG F  ++KG         QLH T  L+ V   A+  +S E F    S + ++ 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS-ESFFEAASMMSKLS 70
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H ++V   G C  G +  LV E++  GSLD ++  K     +  W+   EVA   A  + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKL--EVAKQLAAAMH 127
Query: 179 YLHNGCDVCILHFDIKPHNILL---------DHNFIPKVSDFGLA-KFHPKENDFVSISA 228
           +L       ++H ++   NILL         +  FI K+SD G++    PK+        
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLPKD-------I 176
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            +  I ++ PE I  N   ++  +D + FG  L E+  G
Sbjct: 177 LQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS------GEEFIN-- 109
           YP+ +      +  LG G  G V    +  T   +A+K+++  KF+       +  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   +   +   ++ C    ++
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 123 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           ++    GT  Y+APE L+S      +   D +  G++L     G    + H T+ S    
Sbjct: 175 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---- 227
Query: 284 PSWVYDQLNKG 294
              + DQ+  G
Sbjct: 228 ---LKDQITSG 235

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 73  LGQGGFGSVY---KGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGR--IHHVNVVQLL 126
           LG G +G V+   K   H TG L A+K+L  +    +    E +   R  + H+     L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 127 -----GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
                 F +E +K  L+ +Y+  G L  H+  +E   +      + E+ L     +E+LH
Sbjct: 122 VTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA----LEHLH 176
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYI 236
               + I++ DIK  NILLD N    ++DFGL+K      +FV+    R     GTI Y+
Sbjct: 177 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVADETERAYDFCGTIEYM 227
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA 281
           AP+++           D +  G+++ E+  G     +   ++S+A
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 73  LGQGGFGSVYKGQ----LHTGGLIAVKMLA------NSKFSGEEFINEVSTIGRIHHVNV 122
           LG+GG+G V++ +     +TG + A+K+L       N+K +      E + +  + H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           V L+     G K  L+ EY+  G L    F +  R   F  +         +  + +LH 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I++ D+KP NI+L+H    K++DFGL K     +D        GTI Y+APE++ 
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R+    +   D +  G ++ +M  G
Sbjct: 195 RSGHNRAV--DWWSLGALMYDMLTG 217

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 101/264 (38%), Gaps = 77/264 (29%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGS---------------- 146
            LLG              FC  G       SKR     Y   G+                
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 154
Query: 147 --------------------------LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
                                     ++    P++        E L   +   A+G+E+L
Sbjct: 155 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 214
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                 CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE 
Sbjct: 215 --ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 271
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I     T+  +SDV+ FG++L E+
Sbjct: 272 IFDRVYTI--QSDVWSFGVLLWEI 293

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 102/264 (38%), Gaps = 77/264 (29%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGS---------------L 147
            LLG              FC  G       SKR     Y   G+               L
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 148 DRHI---------------------------FPKESRGQSFCWEKLHEVALGTARGIEYL 180
            R +                            P++        E L   +   A+G+E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                 CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE 
Sbjct: 210 --ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I     T+  +SDV+ FG++L E+
Sbjct: 267 IFDRVYTI--QSDVWSFGVLLWEI 288

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS------GEEFIN-- 109
           YP+ +      +  LG G  G V    +  T   +A+K+++  KF+       +  +N  
Sbjct: 10  YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 69
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   +   +   ++ C    ++
Sbjct: 70  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 128
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 129 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 180
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           ++    GT  Y+APE L+S      +   D +  G++L     G    + H T+ S    
Sbjct: 181 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---- 233
Query: 284 PSWVYDQLNKG 294
              + DQ+  G
Sbjct: 234 ---LKDQITSG 241

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK               GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRT-----WXLXGTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 101/264 (38%), Gaps = 77/264 (29%)
Query: 73  LGQGGFGSVYKG------QLHTGGLIAVKMLANSKFSGEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML       E    ++E+  +  I HH+NVV
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGS---------------- 146
            LLG              FC  G       SKR     Y   G+                
Sbjct: 88  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 147
Query: 147 --------------------------LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
                                     ++    P++        E L   +   A+G+E+L
Sbjct: 148 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 207
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                 CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE 
Sbjct: 208 --ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 264
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I     T+  +SDV+ FG++L E+
Sbjct: 265 IFDRVYTI--QSDVWSFGVLLWEI 286

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 37/205 (18%)
Query: 55  KRYSYPEIIA-----VTNHFT--HKLGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEE 106
           K+Y YP+ +      V +H+    +LG G FG V++  +  TG   A K +     S +E
Sbjct: 35  KQY-YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 93
Query: 107 FI-NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK 165
            +  E+ T+  + H  +V L     + ++  ++YE+M  G L   +  + ++        
Sbjct: 94  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-------- 145
Query: 166 LHEVALGTARGIEYLHNGCD-VC------ILHFDIKPHNILL--DHNFIPKVSDFGL-AK 215
                +     +EY+   C  +C       +H D+KP NI+     +   K+ DFGL A 
Sbjct: 146 -----MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 200
Query: 216 FHPKENDFVSISATRGTIGYIAPEL 240
             PK+    S+  T GT  + APE+
Sbjct: 201 LDPKQ----SVKVTTGTAEFAAPEV 221

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 69  FTHKLGQGGFGSVYKG---------QLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH 118
           F   LGQG F  ++KG         QLH T  L+ V   A+  +S E F    S + ++ 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS-ESFFEAASMMSKLS 70
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H ++V   G C  G +  LV E++  GSLD ++  K     +  W+   EVA   A  + 
Sbjct: 71  HKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKL--EVAKQLAWAMH 127
Query: 179 YLHNGCDVCILHFDIKPHNILL---------DHNFIPKVSDFGLA-KFHPKENDFVSISA 228
           +L       ++H ++   NILL         +  FI K+SD G++    PK+        
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLPKD-------I 176
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            +  I ++ PE I  N   ++  +D + FG  L E+  G
Sbjct: 177 LQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 39/206 (18%)
Query: 55  KRYSYPEIIA-----VTNHFT--HKLGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEE 106
           K+Y YP+ +      V +H+    +LG G FG V++  +  TG   A K +     S +E
Sbjct: 141 KQY-YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 107 FI-NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK 165
            +  E+ T+  + H  +V L     + ++  ++YE+M  G L   +  + ++        
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-------- 251
Query: 166 LHEVALGTARGIEYLHNGCD-VC------ILHFDIKPHNILLD---HNFIPKVSDFGL-A 214
                +     +EY+   C  +C       +H D+KP NI+      N + K+ DFGL A
Sbjct: 252 -----MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTA 305
Query: 215 KFHPKENDFVSISATRGTIGYIAPEL 240
              PK+    S+  T GT  + APE+
Sbjct: 306 HLDPKQ----SVKVTTGTAEFAAPEV 327

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 73  LGQGGFGSVYKGQLH--TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           +G G + SV K  +H  T    AVK++  SK    E I  +   G+  H N++ L     
Sbjct: 30  IGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYD 86
Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
           +G    +V E    G L   I     R + F   +   V     + +EYLH      ++H
Sbjct: 87  DGKYVYVVTELXKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQG---VVH 139
Query: 191 FDIKPHNIL-LDHNFIP---KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            D+KP NIL +D +  P   ++ DFG AK    EN  +       T  ++APE++ R   
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY--TANFVAPEVLERQGY 197
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             +C  D++  G++L     G
Sbjct: 198 DAAC--DIWSLGVLLYTXLTG 216

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 30/237 (12%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-------HV 120
           H   K+G G FGSV+K      G I     +    +G   ++E + +  ++       H 
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHS 69
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           +VV+     +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDF------VSIS 227
           H+   + ++H DIKP NI +    IP  +       D+   K   K  D        S  
Sbjct: 130 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 186
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG----RRNSNMHATRSSK 280
              G   ++A E++  N+  +  K+D++   + ++  AG     R     H  R  +
Sbjct: 187 VEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR 242

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 73
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 133
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 30/237 (12%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-------HV 120
           H   K+G G FGSV+K      G I     +    +G   ++E + +  ++       H 
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHS 69
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           +VV+     +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDF------VSIS 227
           H+   + ++H DIKP NI +    IP  +       D+   K   K  D        S  
Sbjct: 130 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 186
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG----RRNSNMHATRSSK 280
              G   ++A E++  N+  +  K+D++   + ++  AG     R     H  R  +
Sbjct: 187 VEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR 242

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V++G    G  +AVK+ ++    S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENI---LGF 67
Query: 129 CSE-------GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +         ++  L+  Y   GSL  ++        S        + L  A G+ +LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-----RIVLSIASGLAHLH 122
Query: 182 -----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 234
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 235 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 265
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 183 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V++G    G  +AVK+ ++    S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----LRHENI---LGF 67
Query: 129 CSE-------GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +         ++  L+  Y   GSL  ++        S        + L  A G+ +LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-----RIVLSIASGLAHLH 122
Query: 182 -----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 234
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 235 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 265
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 183 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK++  ++ +    ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 30/237 (12%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-------HV 120
           H   K+G G FGSV+K      G I     +    +G   ++E + +  ++       H 
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHS 71
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           +VV+     +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDF------VSIS 227
           H+   + ++H DIKP NI +    IP  +       D+   K   K  D        S  
Sbjct: 132 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG----RRNSNMHATRSSK 280
              G   ++A E++  N+  +  K+D++   + ++  AG     R     H  R  +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR 244

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK++  ++ +    ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 93
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 153
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK         +     GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 207 GFAKRVKG-----ATWTLCGTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 255

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--FINEVSTIGR-IHHVNVVQLLG 127
           +LG+G +G V K + + +G + AVK +  +  S E+   + ++    R +     V   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 128 -FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
               EG     +   + + SLD+       +GQ+   + L ++A+   + +E+LH+   +
Sbjct: 101 ALFREGD--VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--L 156
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            ++H D+KP N+L++     K  DFG++ +     D V+     G   Y APE I+    
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISGYL---VDDVAKDIDAGCKPYXAPERINPELN 213
Query: 247 T--VSCKSDVYGFGMVLLEMA 265
               S KSD++  G+  +E+A
Sbjct: 214 QKGYSVKSDIWSLGITXIELA 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 8   ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 67
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 68  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 127
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 128 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 180
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 181 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V++G    G  +AVK+ ++    S F   E  N V     + H N+   LGF
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENI---LGF 96
Query: 129 CSE-------GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            +         ++  L+  Y   GSL  ++        S        + L  A G+ +LH
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-----RIVLSIASGLAHLH 151
Query: 182 -----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 234
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 235 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 265
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 212 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NIL+      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNR 225

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 36/210 (17%)
Query: 105 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDR--HIFPKESRGQS 160
           E+   E++ + ++ H NVV+L+    + ++  L  V+E +  G +     + P       
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 161 FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
           F ++ L        +GIEYLH      I+H DIKP N+L+  +   K++DFG++      
Sbjct: 141 FYFQDL-------IKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS------ 184
Query: 221 NDF----VSISATRGTIGYIAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR------R 269
           N+F      +S T GT  ++APE +S      S K+ DV+  G+ L     G+      R
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 270 NSNMHATRSSKAY-FPSWVYDQLNKGGDLE 298
              +H+   S+A  FP    DQ +   DL+
Sbjct: 245 IMCLHSKIKSQALEFP----DQPDIAEDLK 270

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 24/236 (10%)
Query: 41  NVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVKM 96
           +V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K+
Sbjct: 1   SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 60
Query: 97  LANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF 152
           L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+ 
Sbjct: 61  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL- 119
Query: 153 PKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
               R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 120 ---RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFG 173
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 174 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS------GEEFIN-- 109
           YP+ +      +  LG G  G V    +  T   +A+++++  KF+       +  +N  
Sbjct: 143 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 202
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   +   +   ++ C    ++
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 262 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 313
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           ++    GT  Y+APE L+S      +   D +  G++L     G    + H T+ S    
Sbjct: 314 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---- 366
Query: 284 PSWVYDQLNKG 294
              + DQ+  G
Sbjct: 367 ---LKDQITSG 374

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 59  YPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFS------GEEFIN-- 109
           YP+ +      +  LG G  G V    +  T   +A+++++  KF+       +  +N  
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   +   +   ++ C    ++
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 248 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
           ++    GT  Y+APE L+S      +   D +  G++L     G    + H T+ S    
Sbjct: 300 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---- 352
Query: 284 PSWVYDQLNKG 294
              + DQ+  G
Sbjct: 353 ---LKDQITSG 360

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNR 225

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 93
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 153
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 207 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 255

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKF------SGEEFINEVSTIGRIHHVNVVQL 125
           +G+G F  V +     TG   AVK++  +KF      S E+   E S    + H ++V+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           L   S      +V+E+M    L   I  +   G  +               + Y H   D
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 186 VCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KPH +LL    N  P K+  FG+A     E+  V+     GT  ++APE++ 
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 206
Query: 243 RN-FGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G      DV+G G++L  +  G
Sbjct: 207 REPYGK---PVDVWGCGVILFILLSG 229

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK++  ++    S ++   EV  +  ++H N+V+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIV----SAVQYCHQKF---I 127
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 128 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 182 YD--GPEVDVWSLGVILYTLVSG 202

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNR 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +A+K++  ++    S ++   EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   L+ EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR---I 135
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL   + 
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 190 YD--GPEVDVWSLGVILYTLVSG 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK++  ++ +    ++   EV     ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTK-SIDIWSVGCILAEMLSNR 225

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 194 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 232

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKF------SGEEFINEVSTIGRIHHVNVVQL 125
           +G+G F  V +     TG   AVK++  +KF      S E+   E S    + H ++V+L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           L   S      +V+E+M    L   I  +   G  +               + Y H   D
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 150
Query: 186 VCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KPH +LL    N  P K+  FG+A     E+  V+     GT  ++APE++ 
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 208
Query: 243 RN-FGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G      DV+G G++L  +  G
Sbjct: 209 REPYGK---PVDVWGCGVILFILLSG 231

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG------EEFINEVSTIGRIHHV 120
           H    +GQG +G V    +  T  + A+K++  +K         E    EV  + ++HH 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL-DR-HIFPKESRGQSF----------CWEKLHE 168
           N+ +L     +     LV E    G L D+ ++F  +S G+            C E   E
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 169 VALGTARG------------------------IEYLHNGCDVCILHFDIKPHNILLDHN- 203
              G+  G                        + YLHN     I H DIKP N L   N 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNK 205
Query: 204 -FIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
            F  K+ DFGL+K   K N  ++  ++   GT  ++APE+++    +   K D +  G++
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 261 L 261
           L
Sbjct: 266 L 266

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AV+++  ++ +    ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +    F  K ++F       G+  Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC------GSPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 42/213 (19%)
Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNVVQ 124
           KLG+G +G VYK     T   +A+K +   +   EE       I EVS +  + H N+++
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY-LHNG 183
           L        +  L++EY  N  L +++            +K  +V++   +   Y L NG
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYM------------DKNPDVSMRVIKSFLYQLING 144
Query: 184 CDVC----ILHFDIKPHNILL---DHNFIP--KVSDFGLAK-FHPKENDFVSISATRGTI 233
            + C     LH D+KP N+LL   D +  P  K+ DFGLA+ F      F   +    T+
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF---THEIITL 201
Query: 234 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
            Y  PE++  SR++ T     D++    +  EM
Sbjct: 202 WYRPPEILLGSRHYST---SVDIWSIACIWAEM 231

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 207 YTK-SIDIWSVGCILAEMLSNR 227

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AV+++  ++ +    ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE +IS+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIIISKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 213 YTK-SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTK-SIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNR 229

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ +MA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYQMAAG 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 225 YTK-SIDIWSVGCILAEMLSNR 245

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 203 YTK-SIDIWSVGCILAEMLSNR 223

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK++  ++    S ++   EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKY---I 135
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFS------NEFTVGNKLDTFCGSPPYAAPELFQGKK 189
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 190 YD--GPEVDVWSLGVILYTLVSG 210

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPE-IMLN 192
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 210 YTK-SIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 150
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 211 YTK-SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 141
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 202 YTK-SIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 128 FCSEGSKRALVYEYMPNGSLDRHI----FPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
                  RA   E M +  L  H+      K  + Q    + +        RG++Y+H+ 
Sbjct: 109 II-----RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELIS 242
               +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++ 
Sbjct: 164 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR 268
            + G      D++  G +L EM   R
Sbjct: 221 NSKGYTK-SIDIWSVGCILAEMLSNR 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 203 YTK-SIDIWSVGCILAEMLSNR 223

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 5/91 (5%)
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  +
Sbjct: 210 AKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++APE I     T+  +SDV+ FG++L E+
Sbjct: 267 KWMAPETIFDRVYTI--QSDVWSFGVLLWEI 295

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 31/247 (12%)
Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL--HTGGLI 92
           +L++  N++ FL N+   + K+    ++ A        +G+G FG V   QL  H     
Sbjct: 46  ALRKNKNIDNFL-NRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEV---QLVRHKASQK 101
Query: 93  AVKMLANSKF------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS 146
              M   SKF          F  E   +   +   VVQL     +     +V EYMP G 
Sbjct: 102 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGD 161
Query: 147 L----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH 202
           L      +  P++       W K +   +  A  ++ +H+   + ++H D+KP N+LLD 
Sbjct: 162 LVNLMSNYDVPEK-------WAKFYTAEVVLA--LDAIHS---MGLIHRDVKPDNMLLDK 209
Query: 203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMV 260
           +   K++DFG       E   V      GT  YI+PE++    G      + D +  G+ 
Sbjct: 210 HGHLKLADFGTC-MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 268
Query: 261 LLEMAGG 267
           L EM  G
Sbjct: 269 LFEMLVG 275

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 192
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 100 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 155
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 156 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 206
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKCQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGXVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA-NSKFSGEEFINEVSTIGRIH-HVNVVQLLGFC 129
           LG+G +  V     L  G   AVK++   +  S      EV T+ +   + N+++L+ F 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            + ++  LV+E +  GS+  HI     + + F   +   V    A  +++LH      I 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI----QKQKHFNEREASRVVRDVAAALDFLHTK---GIA 133
Query: 190 HFDIKPHNILLD--HNFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI 241
           H D+KP NIL +      P K+ DF L       N    I+        G+  Y+APE++
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 242 -----SRNFGTVSCKSDVYGFGMVLLEMAGG 267
                   F    C  D++  G+VL  M  G
Sbjct: 194 EVFTDQATFYDKRC--DLWSLGVVLYIMLSG 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +A+K++  ++    S ++   EV  +  ++H N+V+L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   L+ EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR---I 132
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 187 YD--GPEVDVWSLGVILYTLVSG 207

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 101 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 157 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 207
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 42/217 (19%)
Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G+V+K +   T  ++A+K +    + +      + E+  +  + H N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 127 GFCSEGSKRALVYEYMP----------NGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
                  K  LV+E+            NG LD  I       +SF ++ L        +G
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV------KSFLFQLL--------KG 113
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIG 234
           + + H+     +LH D+KP N+L++ N   K+++FGLA+    P        SA   T+ 
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR----CYSAEVVTLW 166
Query: 235 YIAPELISRNFGT--VSCKSDVYGFGMVLLEMAGGRR 269
           Y  P+++   FG    S   D++  G +  E+A   R
Sbjct: 167 YRPPDVL---FGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    +     T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    +     T  Y APE++  + G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 210 YTK-SIDIWSVGCILAEMLSNR 230

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 216
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 109 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 165 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 215
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 192
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 87  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 143 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 193
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 87  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 143 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 193
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 89  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 145 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 195
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 203
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 101 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 157 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 207
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 198
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 208
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 88  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 143
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 144 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 194
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 198
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 208
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 208
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+AP +I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPAIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 198
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 113 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 169 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 219
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/202 (22%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A++ +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMXGXVATR---WYRAPEIM-LN 216
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 198
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 109 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 165 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 215
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 216
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 60  PEIIAVTNHFT---HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIG 115
           P+  AVT+ +      LG G  G V +     TG   A+K+L +S  + +E  +     G
Sbjct: 2   PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG 61
Query: 116 RIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
             H V ++ +      G KR L  + E M  G L   I  +E   Q+F   +  E+    
Sbjct: 62  GPHIVCILDVYENMHHG-KRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDI 118
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              I++LH+     I H D+KP N+L    + + + K++DFG A    KE    ++    
Sbjct: 119 GTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPC 171
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
            T  Y+APE++       SC  D++  G+++
Sbjct: 172 YTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 200

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLI-AVKMLANS----KFSGEEFINEVSTIGR-IHHVN 121
           HF   +G+G FG V   +     +  AVK+L       K   +  ++E + + + + H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +V L        K   V +Y+  G L  H+     R + F   +    A   A  + YLH
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLH 156
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +   + I++ D+KP NILLD      ++DFGL K + + N   + S   GT  Y+APE++
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVL 211
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            +         D +  G VL EM  G
Sbjct: 212 HKQ--PYDRTVDWWCLGAVLYEMLYG 235

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV     + +G  IAVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +  +      E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 119 FTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 174
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 175 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 225
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 226 WMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 60  PEIIAVTNHFT---HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIG 115
           P+  AVT+ +      LG G  G V +     TG   A+K+L +S  + +E  +     G
Sbjct: 21  PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG 80
Query: 116 RIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
             H V ++ +      G KR L  + E M  G L   I  +E   Q+F   +  E+    
Sbjct: 81  GPHIVCILDVYENMHHG-KRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDI 137
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              I++LH+     I H D+KP N+L    + + + K++DFG A    KE    ++    
Sbjct: 138 GTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPC 190
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
            T  Y+APE++       SC  D++  G+++
Sbjct: 191 YTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 219

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE++  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIM-LN 203
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE I  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE-IMLN 203
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE++  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIM-LN 203
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 113 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE++  N
Sbjct: 169 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMXGYVATR---WYRAPEIM-LN 219
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ D+GLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDYGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFTH--KLGQGGFGSV-YKGQLHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V       +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT   +APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGL +    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDSELKILDFGLCRH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCW----EKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +      C     + +  +     RG++Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 192
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 69  FTHKLGQGGFG--SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           F   +G G FG   + + +L T  L+AVK +       E    E+     + H N+V+  
Sbjct: 24  FVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 +  A++ EY   G L   I         F  ++          G+ Y H+   +
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGVSYCHS---M 135
Query: 187 CILHFDIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELI 241
            I H D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE++
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVL 189
Query: 242 SRN--FGTVSCKSDVYGFGMVLLEMAGG 267
            R    G +   +DV+  G+ L  M  G
Sbjct: 190 LRQEYDGKI---ADVWSCGVTLYVMLVG 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +  ++ TG   A K++   K S    ++   E      + H N+V+L  
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ---SFCWEKLHEVALGTARGIEYLH-NG 183
             SE     LV++ +  G L   I  +E   +   S C +++ E        + + H NG
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------SVNHCHLNG 123
Query: 184 CDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H D+KP N+LL         K++DFGLA     + D  +     GT GY++PE+
Sbjct: 124 ----IVHRDLKPENLLLASKSKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEV 177
Query: 241 ISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
           + ++ +G      D++  G++L  +  G              Y P W  DQ
Sbjct: 178 LRKDPYGK---PVDMWACGVILYILLVG--------------YPPFWDEDQ 211

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +  ++ TG   A K++   K S    ++   E      + H N+V+L  
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ---SFCWEKLHEVALGTARGIEYLH-NG 183
             SE     LV++ +  G L   I  +E   +   S C +++ E        + + H NG
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------SVNHCHLNG 123
Query: 184 CDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H D+KP N+LL         K++DFGLA     + D  +     GT GY++PE+
Sbjct: 124 ----IVHRDLKPENLLLASKSKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEV 177
Query: 241 ISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
           + ++ +G      D++  G++L  +  G              Y P W  DQ
Sbjct: 178 LRKDPYGK---PVDMWACGVILYILLVG--------------YPPFWDEDQ 211

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGR 116
           E+ AV       +G G +G+V       TG  +A+K L     S+   +    E+  +  
Sbjct: 22  EVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH 80
Query: 117 IHHVNVVQLLGF------CSEGSKRALVYEYMPN--GSLDRHIFPKESRGQSFCWEKLHE 168
           + H NV+ LL          + +   LV  +M    G L +H    E R Q   ++ L  
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML-- 138
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
                 +G+ Y+H      I+H D+KP N+ ++ +   K+ DFGLA+    +++      
Sbjct: 139 ------KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMXGXVV 187
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           TR    Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 188 TR---WYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 22/243 (9%)
Query: 31  RYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTG 89
           R R+   + ++ E  L  ++   P  Y Y E +    H   +LG+G FG V++ +   TG
Sbjct: 42  RSREPSPKTEDNEGVLLTEK-LKPVDYEYREEVHWATHQL-RLGRGSFGEVHRMEDKQTG 99
Query: 90  GLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR 149
              AVK +    F  EE +        +    +V L G   EG    +  E +  GSL +
Sbjct: 100 FQCAVKKVRLEVFRAEELM----ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 155
Query: 150 HIFPKESRGQSFCWEKLHEVALGTA-RGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PK 207
            +     + Q    E      LG A  G+EYLH+     ILH D+K  N+LL  +     
Sbjct: 156 LV-----KEQGCLPEDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAA 207
Query: 208 VSDFGLAK-FHPK--ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + DFG A    P     D ++     GT  ++APE++     +   K DV+    ++L M
Sbjct: 208 LCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHM 265
Query: 265 AGG 267
             G
Sbjct: 266 LNG 268

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 77  GFGSVYKGQLH--TGGLIAVKML--ANSKFSGEEFINEVSTIGRIH---------HVNVV 123
           G  SV +  +H  TG   AVK++     + S E+ + EV    R           H +++
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ-LEEVREATRRETHILRQVAGHPHII 163
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            L+      S   LV++ M  G L  ++  K +  +    ++   +       + +LH  
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE----KETRSIMRSLLEAVSFLHAN 219
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELIS 242
               I+H D+KP NILLD N   ++SDFG +    P E     +    GT GY+APE++ 
Sbjct: 220 N---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEILK 272
Query: 243 RNFGTVSC----KSDVYGFGMVLLEMAGG 267
            +          + D++  G++L  +  G
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               +   D++  G ++ E+  GR
Sbjct: 197 AMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 73  LGQGGFGSV---YKGQLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G +GSV   Y  +L     +AVK L+    S         E+  +  + H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
              +  +      E     +L         + Q+   E +  +     RG++Y+H+    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY-DQLNK 293
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 240

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 38/243 (15%)
Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LGQG FG V K +        A+K + +++      ++EV  +  ++H  VV+      E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 132 G----------SKRALVY---EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
                       K++ ++   EY  N +L   I  +    Q   + +L    L     + 
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---EALS 130
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------- 230
           Y+H+     I+H ++KP NI +D +   K+ DFGLAK   +  D + + +          
Sbjct: 131 YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 231 ----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMHATRSSKA 281
               GT  Y+A E++    G  + K D Y  G++  E       G  R + +   RS   
Sbjct: 188 TSAIGTAXYVATEVLD-GTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRSVSI 246
Query: 282 YFP 284
            FP
Sbjct: 247 EFP 249

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 72  KLGQGGFGSVYKGQLH-TGGLIAVKMLANS--KFSGEEFINEVSTIGRIHHVN-VVQLLG 127
           ++G G  G V+K +   TG +IAVK +  S  K   +  + ++  + + H    +VQ  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK-LHEVALGTARGIEYLHNGCDV 186
                +   +  E M  G+    +   + R Q    E+ L ++ +   + + YL     V
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+KP NILLD     K+ DFG++    +  D  +   + G   Y+APE I     
Sbjct: 147 --IHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 247 T---VSCKSDVYGFGMVLLEMAGGR 268
           T      ++DV+  G+ L+E+A G+
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  +    H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 207 YTK-SIDIWSVGCILAEMLSNR 227

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 104/247 (42%), Gaps = 31/247 (12%)
Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL----HTGG 90
           +L++  N++ FL   +  + K      + A        +G+G FG V   QL     T  
Sbjct: 45  ALRKNKNIDNFLSRYKDTINKIRDL-RMKAEDYEVVKVIGRGAFGEV---QLVRHKSTRK 100
Query: 91  LIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS 146
           + A+K+L+      +     F  E   +   +   VVQL     +     +V EYMP G 
Sbjct: 101 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 160
Query: 147 L----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH 202
           L      +  P++       W + +   +  A  ++ +H+   +  +H D+KP N+LLD 
Sbjct: 161 LVNLMSNYDVPEK-------WARFYTAEVVLA--LDAIHS---MGFIHRDVKPDNMLLDK 208
Query: 203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMV 260
           +   K++DFG      KE   V      GT  YI+PE++    G      + D +  G+ 
Sbjct: 209 SGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 261 LLEMAGG 267
           L EM  G
Sbjct: 268 LYEMLVG 274

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 73  LGQGGFGSV---YKGQLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G +GSV   Y  +L     +AVK L+    S         E+  +  + H NV+ LL
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
              +  +      E     +L         + Q+   E +  +     RG++Y+H+    
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 143
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 144 -IIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 196
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY-DQLNK 293
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 197 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 232

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 104/247 (42%), Gaps = 31/247 (12%)
Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL----HTGG 90
           +L++  N++ FL   +  + K      + A        +G+G FG V   QL     T  
Sbjct: 40  ALRKNKNIDNFLSRYKDTINKIRDL-RMKAEDYEVVKVIGRGAFGEV---QLVRHKSTRK 95
Query: 91  LIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS 146
           + A+K+L+      +     F  E   +   +   VVQL     +     +V EYMP G 
Sbjct: 96  VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155
Query: 147 L----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH 202
           L      +  P++       W + +   +  A  ++ +H+   +  +H D+KP N+LLD 
Sbjct: 156 LVNLMSNYDVPEK-------WARFYTAEVVLA--LDAIHS---MGFIHRDVKPDNMLLDK 203
Query: 203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMV 260
           +   K++DFG      KE   V      GT  YI+PE++    G      + D +  G+ 
Sbjct: 204 SGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 261 LLEMAGG 267
           L EM  G
Sbjct: 263 LYEMLVG 269

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V +  +L TG   A K++   K S    ++   E      + H N+V+L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQ---SFCWEKLHEVALGTARGIEYLHNGCD 185
            SE     LV++ +  G L   I  +E   +   S C +++ E  L       + H    
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQ--- 121
Query: 186 VCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
           + ++H D+KP N+LL         K++DFGLA     + D  +     GT GY++PE++ 
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAI--EVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 243 RN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
           +  +G      D++  G++L  +  G              Y P W  DQ
Sbjct: 180 KEAYGK---PVDIWACGVILYILLVG--------------YPPFWDEDQ 211

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V     +   + +A+K +  S F  + +    + E+  +    H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q    + +        RG++Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 207 YTK-SIDIWSVGCILAEMLSNR 227

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 104/247 (42%), Gaps = 31/247 (12%)
Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQL----HTGG 90
           +L++  N++ FL   +  + K      + A        +G+G FG V   QL     T  
Sbjct: 45  ALRKNKNIDNFLSRYKDTINKIRDL-RMKAEDYEVVKVIGRGAFGEV---QLVRHKSTRK 100
Query: 91  LIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS 146
           + A+K+L+      +     F  E   +   +   VVQL     +     +V EYMP G 
Sbjct: 101 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 160
Query: 147 L----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH 202
           L      +  P++       W + +   +  A  ++ +H+   +  +H D+KP N+LLD 
Sbjct: 161 LVNLMSNYDVPEK-------WARFYTAEVVLA--LDAIHS---MGFIHRDVKPDNMLLDK 208
Query: 203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMV 260
           +   K++DFG      KE   V      GT  YI+PE++    G      + D +  G+ 
Sbjct: 209 SGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 261 LLEMAGG 267
           L EM  G
Sbjct: 268 LYEMLVG 274

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/268 (22%), Positives = 111/268 (41%), Gaps = 31/268 (11%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R ++    +       T +G++YLHN     
Sbjct: 94  FFEDDDFVYVVLEICRRRSL----LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--- 146
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +    
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCKK--G 202
Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 307
            S + D++  G +L  +  G+        + +        Y ++ K      R++  + S
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIKKNEYSVPRHINPVAS 254
Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            + R++       +      RPS+ ++L
Sbjct: 255 ALIRRM-------LHADPTLRPSVAELL 275

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 73  LGQGGFGSV---YKGQLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +G G +GSV   Y  +L     +AVK L+    S         E+  +  + H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
              +  +      E     +L         + Q+   E +  +     RG++Y+H+    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY-DQLNK 293
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 31/268 (11%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E        R +     R ++    +       T +G++YLHN     
Sbjct: 110 FFEDDDFVYVVLEI----CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--- 162
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKTLCGTPNYIAPEVLCKKGH- 219
Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 307
            S + D++  G +L  +  G+        + +        Y ++ K      R++  + S
Sbjct: 220 -SFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIKKNEYSVPRHINPVAS 270
Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            + R++       +      RPS+ ++L
Sbjct: 271 ALIRRM-------LHADPTLRPSVAELL 291

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 77  GFGSVYKGQLH--TGGLIAVKML---ANSKFSGEEF-------INEVSTIGRIH-HVNVV 123
           G  SV +  +H  T    AVK++       FS EE        + EV  + ++  H N++
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           QL       +   LV++ M  G L  ++  K +  +    ++  ++       I  LH  
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE----KETRKIMRALLEVICALHK- 142
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI- 241
             + I+H D+KP NILLD +   K++DFG + +  P E     + +  GT  Y+APE+I 
Sbjct: 143 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LRSVCGTPSYLAPEIIE 196
Query: 242 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 267
              + N      + D++  G+++  +  G
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 31/268 (11%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E        R +     R ++    +       T +G++YLHN     
Sbjct: 110 FFEDDDFVYVVLEI----CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--- 162
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKXLCGTPNYIAPEVLCKKGH- 219
Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 307
            S + D++  G +L  +  G+        + +        Y ++ K      R++  + S
Sbjct: 220 -SFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIKKNEYSVPRHINPVAS 270
Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            + R++       +      RPS+ ++L
Sbjct: 271 ALIRRM-------LHADPTLRPSVAELL 291

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DF LA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFYLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 16/174 (9%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHI 151
           A+KML +   +  E           H V +V +      G K  L V E +  G L   I
Sbjct: 61  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 120
Query: 152 FPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK 207
              + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      N I K
Sbjct: 121 ---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 174
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           ++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 175 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 223

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN----- 121
           +F   LG+G FG V   +   T  L AVK+L       ++ +       R+  +      
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV--ALGTARGIEY 179
           + QL        +   V EY+  G L  HI       Q   +++ H V  A   A G+ +
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIA 237
           L +     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  YIA
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENIWDGVTTKXFCGTPDYIA 189
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I+  +       D + FG++L EM  G+
Sbjct: 190 PEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 77  GFGSVYKGQLH--TGGLIAVKML---ANSKFSGEEF-------INEVSTIGRIH-HVNVV 123
           G  SV +  +H  T    AVK++       FS EE        + EV  + ++  H N++
Sbjct: 15  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 74
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           QL       +   LV++ M  G L  ++  K +  +    ++  ++       I  LH  
Sbjct: 75  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE----KETRKIMRALLEVICALHK- 129
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI- 241
             + I+H D+KP NILLD +   K++DFG + +  P E     +    GT  Y+APE+I 
Sbjct: 130 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIE 183
Query: 242 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 267
              + N      + D++  G+++  +  G
Sbjct: 184 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 16/179 (8%)
Query: 88  TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGS 146
           T    A+KML +   +  E           H V +V +      G K  L V E +  G 
Sbjct: 47  TQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 106
Query: 147 LDRHIFPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--- 202
           L   I   + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      
Sbjct: 107 LFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRP 160
Query: 203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           N I K++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 161 NAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 214

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 16/174 (9%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHI 151
           A+KML +   +  E           H V +V +      G K  L V E +  G L   I
Sbjct: 53  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 112
Query: 152 FPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK 207
              + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      N I K
Sbjct: 113 ---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 166
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           ++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 167 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 215

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 118 HHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHIFPKESRG-QSFCWEKLHEVALGTAR 175
           H V +V +      G K  L V E +  G L   I   + RG Q+F   +  E+      
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGE 172
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            I+YLH+   + I H D+KP N+L      N I K++DFG AK     N   S++    T
Sbjct: 173 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVL 261
             Y+APE++       SC  D++  G+++
Sbjct: 227 PYYVAPEVLGPEKYDKSC--DMWSLGVIM 253

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 16/174 (9%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHI 151
           A+KML +   +  E           H V +V +      G K  L V E +  G L   I
Sbjct: 47  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 152 FPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK 207
              + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      N I K
Sbjct: 107 ---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 160
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           ++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 161 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 209

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 16/179 (8%)
Query: 88  TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGS 146
           T    A+KML +   +  E           H V +V +      G K  L V E +  G 
Sbjct: 46  TQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 105
Query: 147 LDRHIFPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--- 202
           L   I   + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      
Sbjct: 106 LFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRP 159
Query: 203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           N I K++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 160 NAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 213

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 16/174 (9%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHI 151
           A+KML +   +  E           H V +V +      G K  L V E +  G L   I
Sbjct: 47  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 152 FPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK 207
              + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      N I K
Sbjct: 107 ---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 160
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           ++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 161 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 209

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 118 HHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHIFPKESRG-QSFCWEKLHEVALGTAR 175
           H V +V +      G K  L V E +  G L   I   + RG Q+F   +  E+      
Sbjct: 122 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGE 178
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            I+YLH+   + I H D+KP N+L      N I K++DFG AK     N   S++    T
Sbjct: 179 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 232
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVL 261
             Y+APE++       SC  D++  G+++
Sbjct: 233 PYYVAPEVLGPEKYDKSC--DMWSLGVIM 259

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 16/174 (9%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHI 151
           A+KML +   +  E           H V +V +      G K  L V E +  G L   I
Sbjct: 45  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 152 FPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK 207
              + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      N I K
Sbjct: 105 ---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 158
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           ++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 159 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 207

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 31/268 (11%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E        R +     R ++    +       T +G++YLHN     
Sbjct: 110 FFEDDDFVYVVLEI----CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--- 162
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCKKGH- 219
Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 307
            S + D++  G +L  +  G+        + +        Y ++ K      R++  + S
Sbjct: 220 -SFEVDIWSLGCILYTLLVGKPPFETSCLKET--------YIRIKKNEYSVPRHINPVAS 270
Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            + R++       +      RPS+ ++L
Sbjct: 271 ALIRRM-------LHADPTLRPSVAELL 291

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 16/174 (9%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHI 151
           A+KML +   +  E           H V +V +      G K  L V E +  G L   I
Sbjct: 46  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 105
Query: 152 FPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK 207
              + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      N I K
Sbjct: 106 ---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 159
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           ++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 160 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 208

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDAGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 77  GFGSVYKGQLH--TGGLIAVKML---ANSKFSGEEF-------INEVSTIGRIH-HVNVV 123
           G  SV +  +H  T    AVK++       FS EE        + EV  + ++  H N++
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
           QL       +   LV++ M  G L  ++  K +  +    ++  ++       I  LH  
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE----KETRKIMRALLEVICALHK- 142
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI- 241
             + I+H D+KP NILLD +   K++DFG + +  P E     +    GT  Y+APE+I 
Sbjct: 143 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIE 196
Query: 242 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 267
              + N      + D++  G+++  +  G
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 68  HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFIN----EVSTIGRIHHVNV 122
           +F   LG+G FG V       T  L A+K+L       ++ +     E   +  +     
Sbjct: 22  NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 123 VQLLGFCSEGSKRA-LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +  L  C +   R   V EY+  G L  HI     +   F   +    A   + G+ +LH
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                 I++ D+K  N++LD     K++DFG+ K H    D V+     GT  YIAPE+I
Sbjct: 138 KRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH--MMDGVTTREFCGTPDYIAPEII 192
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +  +       D + +G++L EM  G+
Sbjct: 193 A--YQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE----FINEVSTIGRI-HHVNVVQLL 126
           +LG G +G V+K +    G +     + S F G +     + EV +  ++  H   V+L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSF----CWEKLHEVALGTARGIEYLHN 182
               EG    L  E +   SL +H    E+ G S      W  L +  L  A    +LH+
Sbjct: 124 QAWEEGGILYLQTE-LCGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALA----HLHS 175
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                ++H D+KP NI L      K+ DFGL     +     +     G   Y+APEL+ 
Sbjct: 176 ---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
            ++GT    +DV+  G+ +LE+A
Sbjct: 230 GSYGTA---ADVFSLGLTILEVA 249

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 16/174 (9%)
Query: 93  AVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHI 151
           A+KML +   +  E           H V +V +      G K  L V E +  G L   I
Sbjct: 45  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 152 FPKESRG-QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK 207
              + RG Q+F   +  E+       I+YLH+   + I H D+KP N+L      N I K
Sbjct: 105 ---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 158
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           ++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++
Sbjct: 159 LTDFGFAKETTSHN---SLTEPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 207

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 72  KLGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
           +LG+G    VY+  Q  T    A+K+L  +    +    E+  + R+ H N+++L     
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDVCIL 189
             ++ +LV E +  G L   I  K    +    + + ++       + YLH NG    I+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYLHENG----IV 170
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           H D+KP N+L      +   K++DFGL+K    +   V +    GT GY APE++
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEIL 222

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L  T  + A+K++     + +E I+ V T   +     +H  +V L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R +    E     +   +  + YLH   + 
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 125
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 183
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 184 G---FSVDWWALGVLMFEMMAGR 203

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDRGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+  FGLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILGFGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L  T  + A+K++     + +E I+ V T   +     +H  +V L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R +    E     +   +  + YLH   + 
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 140
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 198
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 199 G---FSVDWWALGVLMFEMMAGR 218

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L  T  + A+K++     + +E I+ V T   +     +H  +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R +    E     +   +  + YLH   + 
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 129
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 187
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 188 G---FSVDWWALGVLMFEMMAGR 207

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 12/163 (7%)
Query: 109 NEVSTIGRIHHVNVVQLLG--FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKL 166
            E+  + R+ H NV+QL+   +  E  K  +V EY   G  +      E R   F   + 
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQA 111
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVS 225
           H        G+EYLH+     I+H DIKP N+LL      K+S  G+A+  HP   D  +
Sbjct: 112 HGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DT 167
Query: 226 ISATRGTIGYIAPELISRNFGTVSC-KSDVYGFGMVLLEMAGG 267
              ++G+  +  PE I+    T S  K D++  G+ L  +  G
Sbjct: 168 CRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 40/230 (17%)
Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +  ++  G   A K++   K S    ++   E      + H N+V+L  
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ---SFCWEKLHEVALGTARGIEYLHNGC 184
             SE     L+++ +  G L   I  +E   +   S C +++ E  L       + H   
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQ-- 139
Query: 185 DVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            + ++H D+KP N+LL         K++DFGLA     E +  +     GT GY++PE++
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVL 196
Query: 242 SRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
            ++ +G      D++  G++L  +  G              Y P W  DQ
Sbjct: 197 RKDPYGK---PVDLWACGVILYILLVG--------------YPPFWDEDQ 229

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN----- 121
           +F   LG+G FG V   +   T  L AVK+L       ++ +       R+  +      
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV--ALGTARGIEY 179
           + QL        +   V EY+  G L  HI       Q   +++ H V  A   A G+ +
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIA 237
           L +     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  YIA
Sbjct: 458 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENIWDGVTTKXFCGTPDYIA 510
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I+  +       D + FG++L EM  G+
Sbjct: 511 PEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKE----SRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q    + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE++  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDGGLARH--TDDEMTGYVATR---WYRAPEIM-LN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 105/247 (42%), Gaps = 42/247 (17%)
Query: 59  YPEIIAVTNHFT------HKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSG---EEFI 108
           Y + +A    FT       +LG+G F  V +    T     A K++   K S    ++  
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
            E      + H N+V+L    SE     LV++ +  G L   I  +E   ++     +H+
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQ 138
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLA-KFHPKENDFV 224
           +       + ++H      I+H D+KP N+LL         K++DFGLA +   ++  + 
Sbjct: 139 I----LESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 225 SISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF 283
             +   GT GY++PE++ ++ +G      D++  G++L  +  G              Y 
Sbjct: 192 GFA---GTPGYLSPEVLRKDPYGK---PVDIWACGVILYILLVG--------------YP 231
Query: 284 PSWVYDQ 290
           P W  DQ
Sbjct: 232 PFWDEDQ 238

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 41/209 (19%)
Query: 73  LGQGGFGS-VYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCS 130
           LG G  G+ VY+G       +AVK +    FS  +   EV  +     H NV++   FC+
Sbjct: 32  LGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFAD--REVQLLRESDEHPNVIRY--FCT 86
Query: 131 EGSKRALVYEYMP----NGSLDRHIFPKESRGQSFCWEKLHEVAL--GTARGIEYLHNGC 184
           E  ++   ++Y+       +L  ++  K+     F    L  + L   T  G+ +LH+  
Sbjct: 87  EKDRQ---FQYIAIELCAATLQEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 185 DVCILHFDIKPHNILLD----HNFIPK-VSDFGLA-KFHPKENDFVSISATRGTIGYIAP 238
            + I+H D+KPHNIL+     H  I   +SDFGL  K     + F   S   GT G+IAP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 239 ELISRNFGTVSCKS------DVYGFGMVL 261
           E++S +     CK       D++  G V 
Sbjct: 196 EMLSED-----CKENPTYTVDIFSAGCVF 219

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 36/232 (15%)
Query: 53  MPKRYSYPEIIAVTNHFTHK--LGQGGFGSVYKG-QLHTGGLIAVKMLA--NSKFSGEEF 107
           MPKR  Y     +++ F  K  LG+G +G V       TG ++A+K +   +        
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 108 INEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEYMPNGSLDRHIFPKESRGQSFCW 163
           + E+  +    H N++ +       S        + + +    L R I       Q    
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSD 111
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------- 216
           + +      T R ++ LH      ++H D+KP N+L++ N   KV DFGLA+        
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 217 --HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              P  +++  V   ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 169 NSEPTGQQSGMVEFVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 22/243 (9%)
Query: 31  RYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTG 89
           R R+   + ++ E  L  ++   P  Y Y E +    H   +LG+G FG V++ +   TG
Sbjct: 61  RSREPSPKTEDNEGVLLTEK-LKPVDYEYREEVHWATHQL-RLGRGSFGEVHRMEDKQTG 118
Query: 90  GLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR 149
              AVK +    F  EE +        +    +V L G   EG    +  E +  GSL +
Sbjct: 119 FQCAVKKVRLEVFRAEELM----ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 174
Query: 150 HIFPKESRGQSFCWEKLHEVALGTA-RGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PK 207
            +     + Q    E      LG A  G+EYLH+     ILH D+K  N+LL  +     
Sbjct: 175 LV-----KEQGCLPEDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAA 226
Query: 208 VSDFGLAK-FHPK--ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + DFG A    P       ++     GT  ++APE++     +   K DV+    ++L M
Sbjct: 227 LCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHM 284
Query: 265 AGG 267
             G
Sbjct: 285 LNG 287

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +       +  L+AVK +   +   E    E+     + H N+V+       
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +      F  ++          G+ Y H    VC  H 
Sbjct: 86  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVC--HR 138
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVLLKKEY 192
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 193 DGKV---ADVWSCGVTLYVMLVG 212

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L  T  + A++++     + +E I+ V T   +     +H  +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R +    E     +   +  + YLH   + 
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 172
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDY 230
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 231 G---FSVDWWALGVLMFEMMAGR 250

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 68/148 (45%), Gaps = 16/148 (10%)
Query: 118 HHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHIFPKESRG-QSFCWEKLHEVALGTAR 175
           H V +V +      G K  L V E +  G L   I   + RG Q+F   +  E+      
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRI---QDRGDQAFTEREASEIXKSIGE 172
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            I+YLH+   + I H D+KP N+L      N I K++DFG AK     N   S++    T
Sbjct: 173 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMV 260
             Y+APE++       SC  D +  G++
Sbjct: 227 PYYVAPEVLGPEKYDKSC--DXWSLGVI 252

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 34/207 (16%)
Query: 70  THKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           + +LG+G F  V +     TG   A K L   +  G++   E+     +H + V++L   
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEI-----LHEIAVLELAKS 87
Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQ--SFCWEKLHEVALGTA---------RGI 177
           C        VYE   N S    I    + G+  S C  +L E+               G+
Sbjct: 88  CPRVINLHEVYE---NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTI 233
            YLH      I+H D+KP NILL  +  P    K+ DFG+++   K      +    GT 
Sbjct: 145 YYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSR---KIGHACELREIMGTP 197
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMV 260
            Y+APE++  N+  ++  +D++  G++
Sbjct: 198 EYLAPEIL--NYDPITTATDMWNIGII 222

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +       +  L+AVK +   +   E    E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +      F  ++          G+ Y H    VC  H 
Sbjct: 87  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVC--HR 139
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K+  FG +K    H +  D V      GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV------GTPAYIAPEVLLKKEY 193
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVV---QL 125
           +G G +G V   +   TG  +A+K + N+     + +  + E+  +    H N++    +
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           L       +   VY  +     D H     S  Q    E +        RG++Y+H+   
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ- 178
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELIS 242
             ++H D+KP N+L++ N   K+ DFG+A+     P E+ +  ++    T  Y APEL+ 
Sbjct: 179 --VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-MTEYVATRWYRAPELML 235
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR 269
            +    +   D++  G +  EM   R+
Sbjct: 236 -SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 36/232 (15%)
Query: 53  MPKRYSYPEIIAVTNHFTHK--LGQGGFGSVYKG-QLHTGGLIAVKMLA--NSKFSGEEF 107
           MPKR  Y     +++ F  K  LG+G +G V       TG ++A+K +   +        
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 108 INEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEYMPNGSLDRHIFPKESRGQSFCW 163
           + E+  +    H N++ +       S        + + +    L R I       Q    
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSD 111
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------- 216
           + +      T R ++ LH      ++H D+KP N+L++ N   KV DFGLA+        
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 217 --HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              P  +++      ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 169 NSEPTGQQSGMTEXVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 103/258 (39%), Gaps = 50/258 (19%)
Query: 51  SWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHT--GGLIAVKMLANSKFSGEEFI 108
            W+ +RY   EI++        LG+G FG V +   H   G  +A+K++ N +   E   
Sbjct: 29  DWLQERY---EIVST-------LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAAR 78
Query: 109 NEVSTIGRIHHVN------VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFC 162
            E++ + +I+  +       VQ+  +        + +E +   + D   F K++    + 
Sbjct: 79  LEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFD---FLKDNNYLPYP 135
Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL-------LDHNFIPK-------- 207
             ++  +A    + +++LH   D  + H D+KP NIL       L +N   K        
Sbjct: 136 IHQVRHMAFQLCQAVKFLH---DNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKS 192
Query: 208 ----VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 263
               V DFG A F     D    S    T  Y APE+I     +  C  DV+  G ++ E
Sbjct: 193 TAVRVVDFGSATF-----DHEHHSTIVSTRHYRAPEVILELGWSQPC--DVWSIGCIIFE 245
Query: 264 MAGGRRNSNMHATRSSKA 281
              G      H  R   A
Sbjct: 246 YYVGFTLFQTHDNREHLA 263

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 54  PKRYSYPEIIAVTNHFTHK------LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE 106
           PK      + A    ++ K      LG G FG V+          + VK +   K   + 
Sbjct: 7   PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 107 FIN---------EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-----LDRHIF 152
           +I          E++ + R+ H N++++L          LV E   +G      +DRH  
Sbjct: 67  WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR 126
Query: 153 PKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
             E    S+ + +L      +A G   L +     I+H DIK  NI++  +F  K+ DFG
Sbjct: 127 LDEPLA-SYIFRQLV-----SAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELISRN 244
            A +  +   F +     GTI Y APE++  N
Sbjct: 176 SAAYLERGKLFYTFC---GTIEYCAPEVLMGN 204

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +       +  L+AVK +   +        E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +      F  ++          G+ Y H    VC  H 
Sbjct: 87  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVC--HR 139
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVLLKKEY 193
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 36/232 (15%)
Query: 53  MPKRYSYPEIIAVTNHFTHK--LGQGGFGSVYKG-QLHTGGLIAVKMLA--NSKFSGEEF 107
           MPKR  Y     +++ F  K  LG+G +G V       TG ++A+K +   +        
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 108 INEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEYMPNGSLDRHIFPKESRGQSFCW 163
           + E+  +    H N++ +       S        + + +    L R I       Q    
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSD 111
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------- 216
           + +      T R ++ LH      ++H D+KP N+L++ N   KV DFGLA+        
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 217 --HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              P  +++      ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 169 NSEPTGQQSGMTEYVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVV---QL 125
           +G G +G V   +   TG  +A+K + N+     + +  + E+  +    H N++    +
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           L       +   VY  +     D H     S  Q    E +        RG++Y+H+   
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ- 179
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELIS 242
             ++H D+KP N+L++ N   K+ DFG+A+     P E+ +  ++    T  Y APEL+ 
Sbjct: 180 --VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-MTEYVATRWYRAPELM- 235
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR 269
            +    +   D++  G +  EM   R+
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +          L+AVK +   +   E    E+     + H N+V+       
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +      F  ++          G+ Y H    + + H 
Sbjct: 87  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYAHA---MQVAHR 139
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K++DFG +K    H +    V      GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV------GTPAYIAPEVLLKKEY 193
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 29/210 (13%)
Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQ 124
           F  ++G+G F +VYKG    T   +A   L + K +  E   F  E   +  + H N+V+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 125 LLGFCSEGSKR----ALVYEYMPNGSLDRHI----FPKESRGQSFCWEKLHEVALGTARG 176
                    K      LV E   +G+L  ++      K    +S+C + L        +G
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL--------KG 141
Query: 177 IEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           +++LH      I+H D+K  NI +       K+ D GLA    K   F    A  GT  +
Sbjct: 142 LQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFA--KAVIGTPEF 196
Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            APE     +       DVY FG   LE A
Sbjct: 197 XAPEXYEEKYDE---SVDVYAFGXCXLEXA 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL      +++  +      L ++ LG     +YLH      
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR--- 135
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGH- 192
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 193 -SFEVDVWSIGCIMYTLLVGK 212

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 44/232 (18%)
Query: 72  KLGQGGFGSVYK------GQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG+G F  V +      GQ +   +I  K L  S    ++   E      + H N+V+L
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRL 75
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ---SFCWEKLHEVALGTARGIEYLHN 182
               SE     L+++ +  G L   I  +E   +   S C +++ E  L       + H 
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQ 128
Query: 183 GCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
              + ++H ++KP N+LL         K++DFGLA     E +  +     GT GY++PE
Sbjct: 129 ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPE 183
Query: 240 LISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
           ++ ++ +G      D++  G++L  +  G              Y P W  DQ
Sbjct: 184 VLRKDPYGK---PVDLWACGVILYILLVG--------------YPPFWDEDQ 218

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 40/234 (17%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGG--LIAVKMLANSKFSGEEFINEVSTIGRIH 118
           ++++        LG+G FG V +   H  G   +AVK++ N     E   +E+  +  ++
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 119 HVN------VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALG 172
             +       VQ+L +        +V+E +   + D   F KE+    F  + + ++A  
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQ 126
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVS--------------DFGL 213
             + + +LH+     + H D+KP NIL   +     + PK+               DFG 
Sbjct: 127 ICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           A +  + +     S    T  Y APE+I     +  C  DV+  G +L+E   G
Sbjct: 184 ATYDDEHH-----STLVSTRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLG 230

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL      +++  +      L ++ LG     +YLH      
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR--- 137
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKKGH- 194
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 195 -SFEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL      +++  +      L ++ LG     +YLH      
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR--- 137
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKKGH- 194
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 195 -SFEVDVWSIGCIMYTLLVGK 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL      +++  +      L ++ LG     +YLH      
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR--- 141
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKKGH- 198
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 199 -SFEVDVWSIGCIMYTLLVGK 218

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL      +++  +      L ++ LG     +YLH      
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR--- 159
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGH- 216
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 217 -SFEVDVWSIGCIMYTLLVGK 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLHTGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL      +++  +      L ++ LG     +YLH      
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC----QYLHRNR--- 161
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGH- 218
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 219 -SFEVDVWSIGCIMYTLLVGK 238

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 63/142 (44%), Gaps = 18/142 (12%)
Query: 137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH 196
           LV+E M  GS+  HI  +    + F   +   V    A  +++LHN     I H D+KP 
Sbjct: 88  LVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPE 140
Query: 197 NILLDH--NFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI---SRNF 245
           NIL +H     P K+ DFGL        D   IS        G+  Y+APE++   S   
Sbjct: 141 NILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                + D++  G++L  +  G
Sbjct: 201 SIYDKRCDLWSLGVILYILLSG 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 56/120 (46%), Gaps = 19/120 (15%)
Query: 155 ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
           E R    C   LH + +  A  +E+LH+     ++H D+KP NI    + + KV DFGL 
Sbjct: 159 EDREHGVC---LH-IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 211
Query: 215 KFHPKEND----------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
               ++ +          + +     GT  Y++PE I  N    S K D++  G++L E+
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFEL 269

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 113/283 (39%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 122
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 176 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 217
Query: 294 GGDLELRN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 218 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 252

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 113/283 (39%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 154
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 249
Query: 294 GGDLELRN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 284

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 110/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 154
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 249
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  R     E     +      WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSXECQHLIR------WCLALRPSDRPTFEEI 284

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 113/283 (39%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 154
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 249
Query: 294 GGDLELRN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 284

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +       +  L+AVK +   +   E    E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +      F  ++          G+ Y H    VC  H 
Sbjct: 87  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVC--HR 139
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K+  FG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK------STVGTPAYIAPEVLLKKEY 193
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 113/283 (39%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 155
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 250
Query: 294 GGDLELRN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 285

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 114/283 (40%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 155
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IP-FEHDEEII 250
Query: 294 GGDLELRN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  R    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 110/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 155
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 250
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  R     E     +      WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSXECQHLIR------WCLALRPSDRPTFEEI 285

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 110/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 155
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 250
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  R     E     +      WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSXECQHLIR------WCLALRPSDRPTFEEI 285

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 57/280 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 123 VQLLGFCSEGSKRALVYEYM-PNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGI 177
           ++LL +        L+ E M P   L   I  +    E   +SF W+ L          +
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLE--------AV 127
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYI 236
            + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y 
Sbjct: 128 RHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VYS 180
Query: 237 APELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG 294
            PE I   R  G  +    V+  G++L +M  G                     D   + 
Sbjct: 181 PPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFEH 216
Query: 295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
            +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 217 DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 23/221 (10%)
Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVS 112
           P  Y Y E +    H   +LG+G FG V++     TG   AVK +    F  EE +    
Sbjct: 62  PVDYEYREEVHWMTH-QPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV---- 116
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA-L 171
               +    +V L G   EG    +  E +  GSL + I       Q  C  +   +  L
Sbjct: 117 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYL 170
Query: 172 GTA-RGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLA-KFHPK--ENDFVSI 226
           G A  G+EYLH      ILH D+K  N+LL  +     + DFG A    P       ++ 
Sbjct: 171 GQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 227
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT  ++APE++         K D++    ++L M  G
Sbjct: 228 DYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNG 266

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLA---NSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           H +G G +G V +        ++A+K +          +  + E++ + R++H +VV++L
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 127 GFC--SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVAL--GTARGIEYLHN 182
                 +  K   +Y  +     D   F K  R   +  E LH   L      G++Y+H+
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSD---FKKLFRTPVYLTE-LHIKTLLYNLLVGVKYVHS 174
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-------------FHPKEND--FVSIS 227
                ILH D+KP N L++ +   KV DFGLA+               P+E+D   V+  
Sbjct: 175 AG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 228 ATRG----------TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMH 274
            T+           T  Y APELI    N+       DV+  G +  E+    + N   H
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEA---IDVWSIGCIFAELLNMIKENVAYH 288
Query: 275 ATR 277
           A R
Sbjct: 289 ADR 291

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH-VNVVQLLGFC 129
           KLG+G +  V++   +     + VK+L   K    +   E+  +  +    N++ L    
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVK--KNKIKREIKILENLRGGPNIITLADIV 101
Query: 130 SEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
            +   R  ALV+E++ N          +   Q+     +        + ++Y H+   + 
Sbjct: 102 KDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALDYCHS---MG 151
Query: 188 ILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   PEL+  ++ 
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLV-DYQ 207
Query: 247 TVSCKSDVYGFGMVLLEM 264
                 D++  G +L  M
Sbjct: 208 MYDYSLDMWSLGCMLASM 225

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 96/234 (41%), Gaps = 40/234 (17%)
Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQLHTGG--LIAVKMLANSKFSGEEFINEVSTIGRIH 118
           ++++        LG+G FG V +   H  G   +AVK++ N     E   +E+  +  ++
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 119 HVN------VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALG 172
             +       VQ+L +        +V+E +   + D   F KE+    F  + + ++A  
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQ 126
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVS--------------DFGL 213
             + + +LH+     + H D+KP NIL   +     + PK+               DFG 
Sbjct: 127 ICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           A +  + +     S       Y APE+I     +  C  DV+  G +L+E   G
Sbjct: 184 ATYDDEHH-----STLVXXRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLG 230

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+KP NIL+  +    + DFG+A     E     +  T GT+ Y APE  S +  T  
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYXAPERFSESHATY- 214
Query: 250 CKSDVYGFGMVLLEMAGG 267
            ++D+Y    VL E   G
Sbjct: 215 -RADIYALTCVLYECLTG 231

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 122
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                     D   +
Sbjct: 176 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFE 211
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 212 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 17/137 (12%)
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI---SRNF 245
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-----------FPSWVYDQLNKG 294
           G    + D +  G+ + EM  G   +  +A    + Y           FPS V D   + 
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 313
Query: 295 GDLELRNVTEIESMIAR 311
            DL  R +   E  + +
Sbjct: 314 KDLIQRLICSRERRLGQ 330

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 17/137 (12%)
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI---SRNF 245
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-----------FPSWVYDQLNKG 294
           G    + D +  G+ + EM  G   +  +A    + Y           FPS V D   + 
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 329
Query: 295 GDLELRNVTEIESMIAR 311
            DL  R +   E  + +
Sbjct: 330 KDLIQRLICSRERRLGQ 346

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFP------KESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 127
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                     D   +
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFE 216
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 217 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 23/221 (10%)
Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVS 112
           P  Y Y E +    H   ++G+G FG V++     TG   AVK +    F  EE +    
Sbjct: 64  PVDYEYREEVHWMTH-QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV---- 118
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA-L 171
               +    +V L G   EG    +  E +  GSL + I       Q  C  +   +  L
Sbjct: 119 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYL 172
Query: 172 GTA-RGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLA-KFHPK--ENDFVSI 226
           G A  G+EYLH      ILH D+K  N+LL  +     + DFG A    P       ++ 
Sbjct: 173 GQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 229
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT  ++APE++         K D++    ++L M  G
Sbjct: 230 DYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNG 268

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 126
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 127 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 179
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                     D   +
Sbjct: 180 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFE 215
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 216 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFP------KESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 127
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                     D   +
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFE 216
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 217 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFP------KESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 125
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 126 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 178
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                     D   +
Sbjct: 179 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFE 214
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 215 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 23/221 (10%)
Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYK-GQLHTGGLIAVKMLANSKFSGEEFINEVS 112
           P  Y Y E +    H   ++G+G FG V++     TG   AVK +    F  EE +    
Sbjct: 48  PVDYEYREEVHWMTH-QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV---- 102
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA-L 171
               +    +V L G   EG    +  E +  GSL + I       Q  C  +   +  L
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYL 156
Query: 172 GTA-RGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLA-KFHPK--ENDFVSI 226
           G A  G+EYLH      ILH D+K  N+LL  +     + DFG A    P       ++ 
Sbjct: 157 GQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT  ++APE++         K D++    ++L M  G
Sbjct: 214 DYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNG 252

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 111/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 154
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 250
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+     + R       WC+ ++ +DRP+  ++
Sbjct: 251 GQVFFRQRVSSECQHLIR-------WCLALRPSDRPTFEEI 284

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 108/281 (38%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFP------KESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 122
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN---XGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                     D   +
Sbjct: 176 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFE 211
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 212 HDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 169
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 170 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 222
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 223 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 265
Query: 294 GGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 266 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 299

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 62/142 (43%), Gaps = 18/142 (12%)
Query: 137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH 196
           LV+E M  GS+  HI  +    + F   +   V    A  +++LHN     I H D+KP 
Sbjct: 88  LVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPE 140
Query: 197 NILLDH--NFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI---SRNF 245
           NIL +H     P K+ DF L        D   IS        G+  Y+APE++   S   
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                + D++  G++L  +  G
Sbjct: 201 SIYDKRCDLWSLGVILYILLSG 222

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 113/300 (37%), Gaps = 60/300 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANS------------KFSGEEFINEVSTIGRIHHV 120
           +  G +G+V  G    G  +A+K + N+             F  +  + E+  +   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 121 NVVQLLGFCSEGSKRA-----LVYEYMPNGSL----DRHIFPKESRGQSFCWEKLHEVAL 171
           N++ L        + A     LV E M         D+ I       Q F +  L     
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL----- 144
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
               G+  LH   +  ++H D+ P NILL  N    + DF LA+    + +       R 
Sbjct: 145 ---LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR- 197
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQ 290
              Y APEL+ + F   +   D++  G V+ EM             + KA F  S  Y+Q
Sbjct: 198 --WYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMF------------NRKALFRGSTFYNQ 242
Query: 291 LNK----GGDLELRNVTEIESMIARKLCMIGL-------WCIQVKAADRPSMTKVLEMLE 339
           LNK     G  ++ +V    S  AR      L       W   V  AD  ++  + +MLE
Sbjct: 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 113/300 (37%), Gaps = 60/300 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGLIAVKMLANS------------KFSGEEFINEVSTIGRIHHV 120
           +  G +G+V  G    G  +A+K + N+             F  +  + E+  +   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 121 NVVQLLGFCSEGSKRA-----LVYEYMPNGSL----DRHIFPKESRGQSFCWEKLHEVAL 171
           N++ L        + A     LV E M         D+ I       Q F +  L     
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL----- 144
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
               G+  LH   +  ++H D+ P NILL  N    + DF LA+    + +       R 
Sbjct: 145 ---LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR- 197
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQ 290
              Y APEL+ + F   +   D++  G V+ EM             + KA F  S  Y+Q
Sbjct: 198 --WYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMF------------NRKALFRGSTFYNQ 242
Query: 291 LNK----GGDLELRNVTEIESMIARKLCMIGL-------WCIQVKAADRPSMTKVLEMLE 339
           LNK     G  ++ +V    S  AR      L       W   V  AD  ++  + +MLE
Sbjct: 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLE--------A 127
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                     D   +
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFE 216
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 217 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 111/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 169
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 170 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 222
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 223 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 265
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+     + R       WC+ ++ +DRP+  ++
Sbjct: 266 GQVFFRQRVSSECQHLIR-------WCLALRPSDRPTFEEI 299

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 174
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 175 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 227
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 228 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 270
Query: 294 GGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 271 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 304

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 149
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 150 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 202
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 203 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 245
Query: 294 GGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 246 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 279

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 141
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 142 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 194
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 195 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 237
Query: 294 GGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 238 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 271

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 141
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 142 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 194
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                     D   +
Sbjct: 195 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCG---------------------DIPFE 230
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             +  +R        ++ +   +  WC+ ++ +DRP+  ++
Sbjct: 231 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 111/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 143 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 195
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 196 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 238
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+     + R       WC+ ++ +DRP+  ++
Sbjct: 239 GQVFFRQRVSSECQHLIR-------WCLALRPSDRPTFEEI 272

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFP------KESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 143 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 195
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 196 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 238
Query: 294 GGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 239 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 111/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIF------PKESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 161
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 162 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 214
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 215 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 257
Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+     + R       WC+ ++ +DRP+  ++
Sbjct: 258 GQVFFRQRVSSECQHLIR-------WCLALRPSDRPTFEEI 291

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 59/283 (20%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFIN-------EVSTIGRI----HHV 120
           LG+GGFG+V+ G   T  L +A+K++  ++  G   ++       EV+ + ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 121 NVVQLLGFCSEGSKRALVYEY-MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            V++LL +        LV E  +P   L  +I  K   G+        +V       I++
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV----VAAIQH 154
Query: 180 LHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKE--NDFVSISATRGTIGYI 236
            H+     ++H DIK  NIL+D      K+ DFG       E   DF       GT  Y 
Sbjct: 155 CHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF------DGTRVYS 205
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGG----RRNSNMHATRSSKAYFPSWVYDQLN 292
            PE ISR+    +  + V+  G++L +M  G     R+  +     ++ +FP        
Sbjct: 206 PPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQEI---LEAELHFP-------- 253
Query: 293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
                         + ++   C +   C+  K + RPS+ ++L
Sbjct: 254 --------------AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLHTGGL-IAVKMLANSKFS-------GEEFINEVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +   + S       G     EV  + ++      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFP------KESRGQSFCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +SF W+ L          
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 143 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 195
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 196 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 238
Query: 294 GGDLELRNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     + V+ E + +I         WC+ ++  DRP+  ++
Sbjct: 239 GQVFFRQRVSXECQHLIR--------WCLALRPXDRPTFEEI 272

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 20/150 (13%)
Query: 68  HFTHKLGQGGFGSVY-KGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN----- 121
           H   KLG G F +V+    +     +A+K++ +++   E  ++E+  +  + + +     
Sbjct: 24  HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 83
Query: 122 ---VVQLLGFCS----EGSKRALVYEYMPNGSLDRHIFPKESRGQSF-CWEKLHEVALGT 173
              VVQLL         G+   +V+E + +  L + I     +G    C +K+ +  L  
Sbjct: 84  REMVVQLLDDFKISGVNGTHICMVFEVLGHHLL-KWIIKSNYQGLPLPCVKKIIQQVL-- 140
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHN 203
            +G++YLH  C   I+H DIKP NILL  N
Sbjct: 141 -QGLDYLHTKCR--IIHTDIKPENILLSVN 167

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 20/150 (13%)
Query: 68  HFTHKLGQGGFGSVY-KGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN----- 121
           H   KLG G F +V+    +     +A+K++ +++   E  ++E+  +  + + +     
Sbjct: 40  HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 122 ---VVQLLGFCS----EGSKRALVYEYMPNGSLDRHIFPKESRGQSF-CWEKLHEVALGT 173
              VVQLL         G+   +V+E + +  L + I     +G    C +K+ +  L  
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLL-KWIIKSNYQGLPLPCVKKIIQQVL-- 156
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHN 203
            +G++YLH  C   I+H DIKP NILL  N
Sbjct: 157 -QGLDYLHTKCR--IIHTDIKPENILLSVN 183

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 245
           +H DIKP NIL+D N   +++DFG +     E+  V  S   GT  YI+PE++       
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G    + D +  G+ + EM  G 
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGE 278

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 73  LGQGGFGSVYKG-QLHTGGLIAVK-MLANSKFSGEEFINEVSTIGRIHHVNVVQL----- 125
           LG GG G V+          +A+K ++     S +  + E+  I R+ H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 126 ---------LGFCSEGSKRALVYEYMPN---GSLDRHIFPKESRGQSFCWEKLHEVALGT 173
                    +G  +E +   +V EYM       L++     E   + F ++ L       
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-LEEHARLFMYQLL------- 130
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAK-FHPKENDFVSISATRG 231
            RG++Y+H+     +LH D+KP N+ ++  + + K+ DFGLA+   P  +    +S    
Sbjct: 131 -RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 232 TIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           T  Y +P  L+S N  T +   D++  G +  EM  G+
Sbjct: 187 TKWYRSPRLLLSPNNYTKAI--DMWAAGCIFAEMLTGK 222

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N         K+ R Q+     +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF------KQLR-QTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 72  KLGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI--HHVNVVQ 124
           ++G GG   V+     K Q++    + ++   N     + + NE++ + ++  H   +++
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIR 92
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L  +         +Y  M  G++D + + K+ +     WE+           +E +H   
Sbjct: 93  LYDY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIH 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--- 241
              I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I   
Sbjct: 145 QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 242 --SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
             SR  G     +S KSDV+  G +L  M  G+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N    + ++      Q+     +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF-KQLY------QTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+L+DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 19/149 (12%)
Query: 120 VNVVQLLGFCSEGSKR--ALVYEYMPNGSLDR-HIFPKESRGQSFCWEKLHEVALGTARG 176
            N+++L+    +   +  ALV+EY+ N    + +    +   + + +E L        + 
Sbjct: 93  TNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELL--------KA 144
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           ++Y H+     I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G 
Sbjct: 145 LDYCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKG- 200
Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             PEL+  ++       D++  G +L  M
Sbjct: 201 --PELLV-DYQMYDYSLDMWSLGCMLASM 226

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 72  KLGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI--HHVNVVQ 124
           ++G GG   V+     K Q++    + ++   N     + + NE++ + ++  H   +++
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIR 92
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L  +         +Y  M  G++D + + K+ +     WE+           +E +H   
Sbjct: 93  LYDY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIH 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--- 241
              I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I   
Sbjct: 145 QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDM 203
Query: 242 --SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
             SR  G     +S KSDV+  G +L  M  G+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 72  KLGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI--HHVNVVQ 124
           ++G GG   V+     K Q++    + ++   N     + + NE++ + ++  H   +++
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIR 76
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L  +         +Y  M  G++D + + K+ +     WE+           +E +H   
Sbjct: 77  LYDY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIH 128
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--- 241
              I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I   
Sbjct: 129 QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 187
Query: 242 --SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
             SR  G     +S KSDV+  G +L  M  G+
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 72  KLGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI--HHVNVVQ 124
           ++G GG   V+     K Q++    + ++   N     + + NE++ + ++  H   +++
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIR 72
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L  +         +Y  M  G++D + + K+ +     WE+           +E +H   
Sbjct: 73  LYDY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIH 124
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--- 241
              I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I   
Sbjct: 125 QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 183
Query: 242 --SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
             SR  G     +S KSDV+  G +L  M  G+
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 66/126 (52%), Gaps = 20/126 (15%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPK--ESRGQSFCWEKLHEVALGTARG 176
           N+V+LL    +   +  +L++EY+ N    + ++P   +   + + +E L        + 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELL--------KA 138
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           ++Y H+     I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G 
Sbjct: 139 LDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 194
Query: 236 IAPELI 241
             PEL+
Sbjct: 195 --PELL 198

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 19/149 (12%)
Query: 120 VNVVQLLGFCSEGSKR--ALVYEYMPNGSLDR-HIFPKESRGQSFCWEKLHEVALGTARG 176
            N+++L+    +   +  ALV+EY+ N    + +    +   + + +E L        + 
Sbjct: 98  TNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELL--------KA 149
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           ++Y H+     I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G 
Sbjct: 150 LDYCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKG- 205
Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             PEL+  ++       D++  G +L  M
Sbjct: 206 --PELLV-DYQMYDYSLDMWSLGCMLASM 231

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 72  KLGQGGFGSVY-----KGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI--HHVNVVQ 124
           ++G GG   V+     K Q++    + ++   N     + + NE++ + ++  H   +++
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL--DSYRNEIAYLNKLQQHSDKIIR 73
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L  +         +Y  M  G++D + + K+ +     WE+           +E +H   
Sbjct: 74  LYDY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIH 125
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--- 241
              I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I   
Sbjct: 126 QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 242 --SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
             SR  G     +S KSDV+  G +L  M  G+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 66/126 (52%), Gaps = 20/126 (15%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPK--ESRGQSFCWEKLHEVALGTARG 176
           N+V+LL    +   +  +L++EY+ N    + ++P   +   + + +E L        + 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELL--------KA 138
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           ++Y H+     I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G 
Sbjct: 139 LDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 194
Query: 236 IAPELI 241
             PEL+
Sbjct: 195 --PELL 198

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 66/126 (52%), Gaps = 20/126 (15%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPK--ESRGQSFCWEKLHEVALGTARG 176
           N+V+LL    +   +  +L++EY+ N    + ++P   +   + + +E L        + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELL--------KA 137
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           ++Y H+     I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G 
Sbjct: 138 LDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 236 IAPELI 241
             PEL+
Sbjct: 194 --PELL 197

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 66/126 (52%), Gaps = 20/126 (15%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPK--ESRGQSFCWEKLHEVALGTARG 176
           N+V+LL    +   +  +L++EY+ N    + ++P   +   + + +E L        + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELL--------KA 137
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           ++Y H+     I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G 
Sbjct: 138 LDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 236 IAPELI 241
             PEL+
Sbjct: 194 --PELL 197

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 66/126 (52%), Gaps = 20/126 (15%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPK--ESRGQSFCWEKLHEVALGTARG 176
           N+V+LL    +   +  +L++EY+ N    + ++P   +   + + +E L        + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELL--------KA 137
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           ++Y H+     I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G 
Sbjct: 138 LDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 236 IAPELI 241
             PEL+
Sbjct: 194 --PELL 197

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 66/126 (52%), Gaps = 20/126 (15%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHIFPK--ESRGQSFCWEKLHEVALGTARG 176
           N+V+LL    +   +  +L++EY+ N    + ++P   +   + + +E L        + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELL--------KA 137
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           ++Y H+     I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G 
Sbjct: 138 LDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 236 IAPELI 241
             PEL+
Sbjct: 194 --PELL 197
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	340
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-115
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-100
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-100
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-71
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-49
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-48
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  336 bits (864), Expect = e-115
 Identities = 113/302 (37%), Positives = 160/302 (52%), Gaps = 25/302 (8%)

Query: 54  PKRYSYPEIIAVTNHF--THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE--EFIN 109
            KR+S  E+   +++F   + LG+GGFG VYKG+L  G L+AVK L   +  G   +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV 169
           EV  I    H N+++L GFC   ++R LVY YM NGS+   +  +        W K   +
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           ALG+ARG+ YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V+   T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---T 193

Query: 230 R--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-HATRSSKAYFPSW 286
              GTIG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++             W
Sbjct: 194 AVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 287 VYDQLNKGGDLEL--------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
           V   L +     L            E+E +I      + L C Q    +RP M++V+ ML
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ-----VALLCTQSSPMERPKMSEVVRML 306

Query: 339 EG 340
           EG
Sbjct: 307 EG 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  297 bits (763), Expect = e-100
 Identities = 96/309 (31%), Positives = 146/309 (47%), Gaps = 39/309 (12%)

Query: 54  PKRYSYPEIIAVTNHF--------THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG- 104
              +S+ E+  VTN+F         +K+G+GGFG VYKG ++    +AVK LA       
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITT 70

Query: 105 ----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQS 160
               ++F  E+  + +  H N+V+LLGF S+G    LVY YMPNGSL   +   +     
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PP 129

Query: 161 FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
             W    ++A G A GI +LH       +H DIK  NILLD  F  K+SDFGLA+   K 
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 221 ND-FVSISATR--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATR 277
               ++   +R  GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + H   
Sbjct: 187 AQTVMT---SRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEH--- 237

Query: 278 SSKAYFPSWVYDQLNKGGDLE------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
                      +  ++   +E      + +           +  +   C+  K   RP +
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNKRPDI 294

Query: 332 TKVLEMLEG 340
            KV ++L+ 
Sbjct: 295 KKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  297 bits (764), Expect = e-100
 Identities = 106/297 (35%), Positives = 150/297 (50%), Gaps = 22/297 (7%)

Query: 55  KRYSYPEIIAVTNHF--THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE-EFINEV 111
            R    ++   TN+F     +G G FG VYKG L  G  +A+K        G  EF  E+
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVAL 171
            T+    H ++V L+GFC E ++  L+Y+YM NG+L RH++  +    S  WE+  E+ +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATR 230
           G ARG+ YLH      I+H D+K  NILLD NF+PK++DFG++K   + +   +S   T 
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS---TV 200

Query: 231 --GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY 288
             GT+GYI PE   +   T   KSDVY FG+VL E+   R        R        W  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAV 257

Query: 289 DQLNKGG-----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           +  N G      D  L +    ES+  RK     + C+ + + DRPSM  VL  LE 
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  224 bits (572), Expect = 2e-71
 Identities = 70/308 (22%), Positives = 113/308 (36%), Gaps = 34/308 (11%)

Query: 58  SYPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIG 115
               +   +          +G FG V+K QL     +AVK+         +   EV ++ 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 116 RIHHVNVVQLLGFCSEGSKRA----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVAL 171
            + H N++Q +G    G+       L+  +   GSL   +     +     W +L  +A 
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAE 128

Query: 172 GTARGIEYLH-------NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
             ARG+ YLH       +G    I H DIK  N+LL +N    ++DFGLA          
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 225 SISATRGTIGYIAPELISRNFGT---VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA 281
                 GT  Y+APE++            + D+Y  G+VL E+A     ++         
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV-DEYML 247

Query: 282 YFPSWVYDQ----------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
            F   +             ++K     LR+  +  + +   LC     C    A  R S 
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM-AMLCETIEECWDHDAEARLSA 306

Query: 332 TKVLEMLE 339
             V E + 
Sbjct: 307 GCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  208 bits (531), Expect = 1e-65
 Identities = 78/278 (28%), Positives = 139/278 (50%), Gaps = 29/278 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQ 124
           +   K+G G FG+V++ + H G  +AVK+L    F      EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +G  ++    ++V EY+  GSL R +    +R +     +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHN-R 156

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  I+H ++K  N+L+D  +  KV DFGL++   K + F+S  +  GT  ++APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT 303
               + KSDVY FG++L E+A  ++   N++  +         V     K   LE+    
Sbjct: 215 --PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKCKRLEIPRNL 264

Query: 304 --EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             ++ ++I          C   +   RPS   ++++L 
Sbjct: 265 NPQVAAIIEG--------CWTNEPWKRPSFATIMDLLR 294

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  193 bits (493), Expect = 1e-59
 Identities = 70/321 (21%), Positives = 123/321 (38%), Gaps = 49/321 (15%)

Query: 58  SYPEIIAVTNHFT--HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINE--VST 113
           +  E     ++      +G+G +G+VYKG L     +AVK+   S  + + FINE  +  
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFINEKNIYR 60

Query: 114 IGRIHHVNVVQLLGFCSEGSKRA-----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE 168
           +  + H N+ + +      +        LV EY PNGSL +++        +  W     
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCR 115

Query: 169 VALGTARGIEYLHN------GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----P 218
           +A    RG+ YLH            I H D+   N+L+ ++    +SDFGL+        
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 219 KENDFVSISATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMAGGRRNS 271
                   +A    GTI Y+APE++      R+  +   + D+Y  G++  E+    R +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF--MRCT 233

Query: 272 NMHATRSSKAY---FPSWVYDQ----------LNKGGDLELRNVTEIESMIARKLCMIGL 318
           ++    S   Y   F + V +             +    +     +  S+  R L     
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 319 WCIQVKAADRPSMTKVLEMLE 339
            C    A  R +     E + 
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (483), Expect = 1e-58
 Identities = 81/275 (29%), Positives = 145/275 (52%), Gaps = 26/275 (9%)

Query: 71  HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGE---EFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+ H  G +AVKML  +  + +    F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
           + +   + A+V ++    SL  H+    +    F  +KL ++A  TARG++YLH      
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHA---KS 140

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 247 TVSCKSDVYGFGMVLLEMAGGRR-NSNMHATRSSKAYFPSWVYDQLNKGGDLELR-NVTE 304
             S +SDVY FG+VL E+  G+   SN++            + + + +G    L  ++++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIEMVGRGS---LSPDLSK 249

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           + S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  187 bits (478), Expect = 6e-58
 Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 42/288 (14%)

Query: 69  FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--------EEFINEVSTIGRIHH 119
           +  ++G+GGFG V+KG+ +    ++A+K L      G        +EF  EV  +  ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            N+V+L G         +V E++P G L   +     +     W     + L  A GIEY
Sbjct: 83  PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 180 LHNGCDVCILHFDIKPHNILLD-----HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           + N  +  I+H D++  NI L           KV+DFGL++         S+S   G   
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQ 191

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATRSSKAYFPSWVYDQLNK 293
           ++APE I     + + K+D Y F M+L  +  G          +        ++     +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------IKFINMIREE 245

Query: 294 GGDLELRNVT--EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           G    +       + ++I          C       RP  + +++ L 
Sbjct: 246 GLRPTIPEDCPPRLRNVIEL--------CWSGDPKKRPHFSYIVKELS 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  185 bits (472), Expect = 9e-57
 Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 31/276 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G FG V K +      +A+K + +     + FI E+  + R++H N+V+L G
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER-KAFIVELRQLSRVNHPNIVKLYG 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
            C       LV EY   GSL   +   E     +         L  ++G+ YLH+     
Sbjct: 69  ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 188 ILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           ++H D+KP N+LL     + K+ DFG A           ++  +G+  ++APE+   +  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS-- 178

Query: 247 TVSCKSDVYGFGMVLLEMAGGRR-NSNMHATRSSKAYFPSWVYDQLNKGGDLEL-RNV-T 303
             S K DV+ +G++L E+   R+    +             +   ++ G    L +N+  
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGP-------AFRIMWAVHNGTRPPLIKNLPK 231

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            IES++ R        C     + RPSM ++++++ 
Sbjct: 232 PIESLMTR--------CWSKDPSQRPSMEEIVKIMT 259

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  184 bits (468), Expect = 2e-56
 Identities = 71/288 (24%), Positives = 112/288 (38%), Gaps = 44/288 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG-----EEFINEVSTIGRIHHVNV 122
                +G GGFG VY+     G  +AVK   +          E    E      + H N+
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           + L G C +     LV E+   G L+R +      G+    + L   A+  ARG+ YLH+
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 183 GCDVCILHFDIKPHNILLD--------HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
              V I+H D+K  NIL+          N I K++DFGLA+   +     +  +  G   
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYA 179

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATRSSKAYFPSWVYDQLNK 293
           ++APE+I  +    S  SDV+ +G++L E+  G      +              Y     
Sbjct: 180 WMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------VAYGVAMN 229

Query: 294 GGDLELRNVT--EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              L + +        ++          C       RPS T +L+ L 
Sbjct: 230 KLALPIPSTCPEPFAKLMED--------CWNPDPHSRPSFTNILDQLT 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  184 bits (470), Expect = 2e-56
 Identities = 61/286 (21%), Positives = 111/286 (38%), Gaps = 37/286 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQ 124
                +G+G FG VY G+ H  G +A++++   + +    + F  EV    +  H NVV 
Sbjct: 36  EIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +G C      A++       +L   +             K  ++A    +G+ YLH   
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHA-- 148

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELI 241
              ILH D+K  N+  D+  +  ++DFGL               +    G + ++APE+I
Sbjct: 149 -KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 242 SRNFGTVSC-------KSDVYGFGMVLLEMAGGRR-NSNMHATRSSKAYFPSWVYDQLNK 293
            +               SDV+  G +  E+                       +  Q+  
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---------AEAIIWQMGT 257

Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           G    L      +  + +++  I L+C   +  +RP+ TK+++MLE
Sbjct: 258 GMKPNL-----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  180 bits (459), Expect = 3e-55
 Identities = 56/279 (20%), Positives = 105/279 (37%), Gaps = 32/279 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQ 124
           +F  KL +   G ++KG+   G  I VK+L    +S     +F  E   +    H NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 125 LLGFCSE--GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           +LG C         L+  +MP GSL   +   E         +  + AL  ARG+ +LH 
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI- 241
             +  I    +   ++++D +   ++S   +                     ++APE + 
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQ 181

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATRSSKAYFPSWVYDQLNKGGDLELR 300
            +   T    +D++ F ++L E+       +++                   +G    LR
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEG----LR 229

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               I   I+  +  +   C+    A RP    ++ +LE
Sbjct: 230 --PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  174 bits (442), Expect = 7e-52
 Identities = 62/305 (20%), Positives = 118/305 (38%), Gaps = 34/305 (11%)

Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH 119
              IA       ++G+G +G V+ G+   G  +AVK+   ++ +      E+     + H
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRH 90

Query: 120 VNVVQLLGFCSEGSKR----ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
            N++  +    +G+       L+ +Y  NGSL  ++     +  +   + + ++A  +  
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVS 145

Query: 176 GIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT- 229
           G+ +LH           I H D+K  NIL+  N    ++D GLA     + + V I    
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 230 -RGTIGYIAPELISRNFGTVSC----KSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP 284
             GT  Y+ PE++  +           +D+Y FG++L E+A  RR  +       +  + 
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEEYQLPYH 263

Query: 285 SWVYDQ----------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             V               K       N    +    R++  +   C     A R +  +V
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDE-CLRQMGKLMTECWAHNPASRLTALRV 322

Query: 335 LEMLE 339
            + L 
Sbjct: 323 KKTLA 327

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  169 bits (431), Expect = 1e-50
 Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 34/286 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLAN-SKFSGEEFINEVSTIGRIHHVNVVQL 125
                LG+G FG   K     TG ++ +K L    + +   F+ EV  +  + H NV++ 
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G   +  +   + EY+  G+L   I   +S    + W +    A   A G+ YLH    
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLH---S 126

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF------------HPKENDFVSISATRGTI 233
           + I+H D+  HN L+  N    V+DFGLA+               K+ D        G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
            ++APE+I  N  +   K DV+ FG+VL E+ G                 P ++   ++ 
Sbjct: 187 YWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLPRTMDF 232

Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           G ++                  I + C  +    RPS  K+   LE
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  166 bits (422), Expect = 2e-49
 Identities = 58/297 (19%), Positives = 108/297 (36%), Gaps = 34/297 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G +G V++G    G  +AVK+ ++          E+     + H N++  + 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 128 FCSEGSKRA----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-- 181
                   +    L+  Y   GSL  ++     +  +        + L  A G+ +LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 182 ---NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT--RGTIGYI 236
                    I H D+K  NIL+  N    ++D GLA  H +  + + +      GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 237 APELI----SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ-- 290
           APE++      +      + D++ FG+VL E+A  RR  +       K  F   V +   
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 291 --------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                           + N    +      L  +   C     + R +  ++ + L 
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDP-TLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  165 bits (419), Expect = 2e-48
 Identities = 68/305 (22%), Positives = 122/305 (40%), Gaps = 34/305 (11%)

Query: 60  PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH 119
              IA T      +G+G FG V++G+   G  +AVK+ ++ +        E+     + H
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRH 95

Query: 120 VNVVQLLGFCSEGSKRA----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
            N++  +   ++ +       LV +Y  +GSL  ++        +   E + ++AL TA 
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTAS 150

Query: 176 GIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT- 229
           G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+   
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 230 -RGTIGYIAPELISRNFGTVSC----KSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP 284
             GT  Y+APE++  +          ++D+Y  G+V  E+A  RR S        +  + 
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHEDYQLPYY 268

Query: 285 SWVYDQ----------LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             V               +     + N  +    + R +  I   C     A R +  ++
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGAARLTALRI 327

Query: 335 LEMLE 339
            + L 
Sbjct: 328 KKTLS 332

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  149 bits (378), Expect = 3e-41
 Identities = 77/279 (27%), Positives = 123/279 (44%), Gaps = 36/279 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
             HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
            C+      ++ E+M  G+L    + +E   Q      L  +A   +  +EYL       
Sbjct: 284 VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H ++   N L+  N + KV+DFGL++     + + + +  +  I + APE +   +  
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL--AYNK 395

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKGGDLEL-R 300
            S KSDV+ FG++L E+A             +    P        VY+ L K   +E   
Sbjct: 396 FSIKSDVWAFGVLLWEIA-------------TYGMSPYPGIDLSQVYELLEKDYRMERPE 442

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              E       K+  +   C Q   +DRPS  ++ +  E
Sbjct: 443 GCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFE 474

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  141 bits (359), Expect = 3e-40
 Identities = 82/280 (29%), Positives = 125/280 (44%), Gaps = 36/280 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL-IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
              HKLG G +G VY+G      L +AVK L       EEF+ E + +  I H N+VQLL
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNGC 184
           G C+      ++ E+M  G+L    + +E   Q      L  +A   +  +EYL   N  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I H D+   N L+  N + KV+DFGL++     + + + +  +  I + APE +   
Sbjct: 132 --FI-HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL--A 185

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----VYDQLNKGGDLEL- 299
           +   S KSDV+ FG++L E+          AT     Y P      VY+ L K   +E  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEI----------ATYGMSPY-PGIDLSQVYELLEKDYRMERP 234

Query: 300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               E       K+  +   C Q   +DRPS  ++ +  E
Sbjct: 235 EGCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  147 bits (372), Expect = 3e-40
 Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 36/278 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
              KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
            SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE     +G  
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA--LYGRF 441

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKGGDLEL-RN 301
           + KSDV+ FG++L E+              +K   P        V DQ+ +G  +     
Sbjct: 442 TIKSDVWSFGILLTELT-------------TKGRVPYPGMVNREVLDQVERGYRMPCPPE 488

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             E        L  +   C + +  +RP+   +   LE
Sbjct: 489 CPE-------SLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  145 bits (367), Expect = 5e-40
 Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 36/278 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
              KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
            SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE     +G  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA--LYGRF 358

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKGGDLEL-RN 301
           + KSDV+ FG++L E+              +K   P        V DQ+ +G  +     
Sbjct: 359 TIKSDVWSFGILLTELT-------------TKGRVPYPGMVNREVLDQVERGYRMPCPPE 405

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             E        L  +   C + +  +RP+   +   LE
Sbjct: 406 CPE-------SLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  140 bits (356), Expect = 7e-40
 Identities = 77/279 (27%), Positives = 126/279 (45%), Gaps = 36/279 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
               +LG G FG V+ G  +    +AVK L     S + F+ E + + ++ H  +V+L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNGCD 185
             ++     ++ EYM NGSL    F K   G      KL ++A   A G+ ++   N   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+
Sbjct: 130 -YI-HRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI--NY 184

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----VYDQLNKGGDLEL-R 300
           GT + KSDV+ FG++L E+           T     Y P      V   L +G  +    
Sbjct: 185 GTFTIKSDVWSFGILLTEI----------VTHGRIPY-PGMTNPEVIQNLERGYRMVRPD 233

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           N  E       +L  +   C + +  DRP+   +  +LE
Sbjct: 234 NCPE-------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (366), Expect = 8e-40
 Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 28/274 (10%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
              KLG G FG V+    +    +AVK +     S E F+ E + +  + H  +V+L   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
            ++     ++ E+M  GSL    F K   G      KL + +   A G+ ++        
Sbjct: 252 VTK-EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ 
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI--NFGSF 362

Query: 249 SCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL-RNVTEI 305
           + KSDV+ FG++L+E+   G      M             V   L +G  +    N  E 
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERGYRMPRPENCPE- 412

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 +L  I + C + +  +RP+   +  +L+
Sbjct: 413 ------ELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  140 bits (355), Expect = 8e-40
 Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 46/284 (16%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
               +LG G FG V  G+      +AVKM+     S +EF  E  T+ ++ H  +V+  G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL-HNGCDV 186
            CS+     +V EY+ NG L  ++    S G+     +L E+      G+ +L  +    
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   N L+D +   KVSDFG+ ++   ++ +VS   T+  + + APE+   ++ 
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF--HYF 180

Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKGGDLEL- 299
             S KSDV+ FG+++ E+              S    P        V  ++++G  L   
Sbjct: 181 KYSSKSDVWAFGILMWEVF-------------SLGKMPYDLYTNSEVVLKVSQGHRLYRP 227

Query: 300 ----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 + +I  M           C       RP+  ++L  +E
Sbjct: 228 HLASDTIYQI--M---------YSCWHELPEKRPTFQQLLSSIE 260

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  142 bits (360), Expect = 1e-39
 Identities = 63/282 (22%), Positives = 113/282 (40%), Gaps = 38/282 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL-IAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQ 124
               ++G+G FG V+ G+L      +AVK            +F+ E   + +  H N+V+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           L+G C++     +V E +  G     +    + G     + L ++    A G+EYL    
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE--- 230

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
             C +H D+   N L+    + K+SDFG+++         S    +  + + APE +  N
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL--N 288

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKGGDLE 298
           +G  S +SDV+ FG++L E               S    P          + + KGG L 
Sbjct: 289 YGRYSSESDVWSFGILLWETF-------------SLGASPYPNLSNQQTREFVEKGGRLP 335

Query: 299 L-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 +        +  +   C   +   RPS + + + L+
Sbjct: 336 CPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (354), Expect = 5e-39
 Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 33/280 (11%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGL-----IAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
               LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           V +LLG C   S   L+ + MP G L  ++  +E +      + L    +  A+G+ YL 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYLE 134

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
              D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
                  + +SDV+ +G+ + E+   G +    + A+          +   L KG  L  
Sbjct: 192 --LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ 240

Query: 300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +  I+      + MI   C  + A  RP   +++    
Sbjct: 241 PPICTID------VYMIMRKCWMIDADSRPKFRELIIEFS 274

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (348), Expect = 7e-39
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 46/284 (16%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNGCD 185
            C E +   LV E+M +G L    + +  RG  F  E L  + L    G+ YL       
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSD--YLRTQRGL-FAAETLLGMCLDVCEGMAYLEEAC--- 124

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+   +F
Sbjct: 125 -VI-HRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVF--SF 179

Query: 246 GTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSW----VYDQLNKGGDLELR 300
              S KSDV+ FG+++ E  + G+              + +     V + ++ G  L   
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIP------------YENRSNSEVVEDISTGFRLY-- 225

Query: 301 NVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
                      +L       I   C + +  DRP+ +++L  L 
Sbjct: 226 ---------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (346), Expect = 2e-38
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 48/285 (16%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNGCD 185
            C++     ++ EYM NG L    + +E R + F  ++L E+       +EYL       
Sbjct: 87  VCTKQRPIFIITEYMANGCLLN--YLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ--- 140

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             + H D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +
Sbjct: 141 -FL-HRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL--MY 195

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKGGDLEL 299
              S KSD++ FG+++ E+              S    P          + + +G  L  
Sbjct: 196 SKFSSKSDIWAFGVLMWEIY-------------SLGKMPYERFTNSETAEHIAQGLRLY- 241

Query: 300 RNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
                        L       I   C   KA +RP+   +L  + 
Sbjct: 242 ----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (341), Expect = 2e-37
 Identities = 59/291 (20%), Positives = 113/291 (38%), Gaps = 35/291 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHV 120
                LG+G FG V   +    G      +AVK L   +      +   E+  +  ++H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 121 NVVQLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           N+V+  G C+E       L+ E++P+GSL  ++            ++  + A+   +G++
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMD 140

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 235
           YL        +H D+   N+L++     K+ DFGL K    + ++   +        + +
Sbjct: 141 YLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDRDSPVFW 195

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMHATRSSKAYFPSW------VY 288
            APE +          SDV+ FG+ L E +     +S+  A                 + 
Sbjct: 196 YAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253

Query: 289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           + L +G  L        E      +  +   C + + ++R S   ++E  E
Sbjct: 254 NTLKEGKRLPCPPNCPDE------VYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (342), Expect = 2e-37
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 39/284 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL-----IAVKML--ANSKFSGEEFINEVSTIGRIHHV 120
                LG G FG+V+KG     G      + +K++   + + S +   + +  IG + H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           ++V+LLG C   S   LV +Y+P GSL  H+  ++ RG     + L    +  A+G+ YL
Sbjct: 76  HIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGA-LGPQLLLNWGVQIAKGMYYL 131

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +  ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E 
Sbjct: 132 E---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----VYDQLNKGGD 296
           I  +FG  + +SDV+ +G+ + E+           T  ++ Y        V D L KG  
Sbjct: 189 I--HFGKYTHQSDVWSYGVTVWEL----------MTFGAEPY-AGLRLAEVPDLLEKGER 235

Query: 297 LEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           L   +  T         + M+ + C  +    RP+  ++     
Sbjct: 236 LAQPQICTI-------DVYMVMVKCWMIDENIRPTFKELANEFT 272

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (342), Expect = 2e-37
 Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 33/280 (11%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
               LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           V +LLG C   S   L+ + MP G L  ++  +E +      + L    +  A+G+ YL 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYLE 134

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
              D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
                  + +SDV+ +G+ + E+   G +    + A+          +   L KG  L  
Sbjct: 192 --LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ 240

Query: 300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +  I+      + MI + C  + A  RP   +++    
Sbjct: 241 PPICTID------VYMIMVKCWMIDADSRPKFRELIIEFS 274

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (333), Expect = 2e-36
 Identities = 77/289 (26%), Positives = 117/289 (40%), Gaps = 46/289 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 122 VVQLLGFCSEGSKRAL-VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+ LLG C       L V  YM +G L   I    +   +   + L    L  A+G++YL
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 181 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 235
                    + H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + +
Sbjct: 145 ASKK----FV-HRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKW 198

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----VYDQL 291
           +A E  S      + KSDV+ FG++L E+           TR +  Y P      +   L
Sbjct: 199 MALE--SLQTQKFTTKSDVWSFGVLLWEL----------MTRGAPPY-PDVNTFDITVYL 245

Query: 292 NKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            +G  L       +        L  + L C   KA  RPS ++++  + 
Sbjct: 246 LQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 287

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  132 bits (333), Expect = 3e-36
 Identities = 71/289 (24%), Positives = 115/289 (39%), Gaps = 46/289 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
           H    +G+G FG VY G+           A+K L         E F+ E   +  ++H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 122 VVQLLGFCSEGSKRAL-VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+ L+G           +  YM +G L + I    S  ++   + L    L  ARG+EYL
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 181 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 235
                    + H D+   N +LD +F  KV+DFGLA+    + ++ S+   R     + +
Sbjct: 141 AEQK----FV-HRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHRHARLPVKW 194

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----VYDQL 291
            A E  S      + KSDV+ FG++L E+           TR +  Y        +   L
Sbjct: 195 TALE--SLQTYRFTTKSDVWSFGVLLWEL----------LTRGAPPY-RHIDPFDLTHFL 241

Query: 292 NKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            +G  L       +        L  +   C +   A RP+   ++  +E
Sbjct: 242 AQGRRLPQPEYCPD-------SLYQVMQQCWEADPAVRPTFRVLVGEVE 283

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  131 bits (331), Expect = 4e-36
 Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 45/295 (15%)

Query: 69  FTHKLGQGGFGSVYKGQLH-----TGGLIAVKML-ANSKFSGEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV   +       TG ++AVK L  +++    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   +   +     KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 237
                   +H D+   NIL+++    K+ DFGL K  P++ +F            I + A
Sbjct: 131 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--FKVKEPGESPIFWYA 185

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSW------VYD 289
           PE +       S  SDV+ FG+VL E+     +  S                     + +
Sbjct: 186 PESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 290 QLNKGGDLELRNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
            L   G L                C     MI   C       RPS   +   ++
Sbjct: 244 LLKNNGRLP-----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  131 bits (331), Expect = 6e-36
 Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 43/293 (14%)

Query: 69  FTHKLGQGGFGSVYKGQLH-----TGGLIAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
               LG+G FG V           TG ++AVK L           +  E+  +  ++H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 122 VVQLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
           +++  G C +    +  LV EY+P GSL  ++        S    +L   A     G+ Y
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAY 149

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VSISATRGTIGYIAP 238
           LH       +H D+   N+LLD++ + K+ DFGLAK  P+ +++          + + AP
Sbjct: 150 LH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMHATRSSKAYFPSW------VYDQL 291
           E +          SDV+ FG+ L E+      + +                    + + L
Sbjct: 207 ECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 292 NKGGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            +G  L         V  +  M   K C    W  + +A+ RP+   ++ +L+
Sbjct: 265 ERGERLPRPDKCPAEVYHL--M---KNC----W--ETEASFRPTFENLIPILK 306

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  132 bits (333), Expect = 1e-35
 Identities = 76/289 (26%), Positives = 117/289 (40%), Gaps = 46/289 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 122 VVQLLGFCSEG-SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+ LLG C        +V  YM +G L   I    +   +   + L    L  A+G+++L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 208

Query: 181 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 235
                    + H D+   N +LD  F  KV+DFGLA+    + +F S+    G    + +
Sbjct: 209 ASKK----FV-HRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKW 262

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----VYDQL 291
           +A E  S      + KSDV+ FG++L E+           TR +  Y P      +   L
Sbjct: 263 MALE--SLQTQKFTTKSDVWSFGVLLWEL----------MTRGAPPY-PDVNTFDITVYL 309

Query: 292 NKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            +G  L       +        L  + L C   KA  RPS ++++  + 
Sbjct: 310 LQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 351

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  130 bits (330), Expect = 2e-35
 Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 47/288 (16%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
               +G G FG VYKG L T        +A+K L    ++    +F+ E   +G+  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +++L G  S+     ++ EYM NG+LD+  F +E  G+ F   +L  +  G A G++YL 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLA 164

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAP 238
              ++  +H D+   NIL++ N + KVSDFGL++    E+D  +   T G    I + AP
Sbjct: 165 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAP 219

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLN 292
           E I  ++   +  SDV+ FG+V+ E+              +    P W      V   +N
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEVM-------------TYGERPYWELSNHEVMKAIN 264

Query: 293 KGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            G  L    +           +  + + C Q + A RP    ++ +L+
Sbjct: 265 DGFRLPTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSILD 305

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  129 bits (326), Expect = 2e-35
 Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 47/286 (16%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNV 122
               +G+G FG V++G   +       +A+K      S    E+F+ E  T+ +  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL-- 180
           V+L+G  +E +   ++ E    G L    F +  +        L   A   +  + YL  
Sbjct: 79  VKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKYS-LDLASLILYAYQLSTALAYLES 134

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                  + H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE 
Sbjct: 135 KR----FV-HRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPES 188

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKG 294
           I  NF   +  SDV+ FG+ + E+                   P        V  ++  G
Sbjct: 189 I--NFRRFTSASDVWMFGVCMWEIL-------------MHGVKPFQGVKNNDVIGRIENG 233

Query: 295 GDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             L +  N           L  +   C     + RP  T++   L 
Sbjct: 234 ERLPMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLS 272

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (327), Expect = 2e-35
 Identities = 70/284 (24%), Positives = 107/284 (37%), Gaps = 53/284 (18%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLG 127
           ++G+G F +VYKG    T   +A   L + K +  E   F  E   +  + H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 128 FCSEGSKRA----LVYEYMPNGSL----DRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
                 K      LV E M +G+L     R    K    +S+C + L         G+++
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK--------GLQF 144

Query: 180 LHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           LH      I+H D+K  NI +       K+ D GLA             A  GT  ++AP
Sbjct: 145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 199

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMHA--TRSSKAYFPSWVYDQLN 292
           E+    +       DVY FGM +LEMA          N      R +    P       +
Sbjct: 200 EMYEEKYDE---SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----ASFD 252

Query: 293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           K    E++ + E               CI+    +R S+  +L 
Sbjct: 253 KVAIPEVKEIIE--------------GCIRQNKDERYSIKDLLN 282

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  131 bits (331), Expect = 2e-35
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 54/291 (18%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNV 122
               +G G FG V  G+L         +A+K L    ++    +F+ E S +G+  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           ++L G  ++     +V EYM NGSLD   F ++   Q F   +L  +  G A G++YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIASGMKYLS- 164

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPE 239
             D+  +H D+   NIL++ N + KVSDFGL +    + +      TRG    I + +PE
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA--YTTRGGKIPIRWTSPE 220

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNK 293
            I   +   +  SDV+ +G+VL E+              S    P W      V   +++
Sbjct: 221 AI--AYRKFTSASDVWSYGIVLWEVM-------------SYGERPYWEMSNQDVIKAVDE 265

Query: 294 GGDLELRNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
           G  L                C   L+     C Q    +RP   +++ +L+
Sbjct: 266 GYRLP-----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  128 bits (325), Expect = 3e-35
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 42/280 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G FG V  G    G  +AVK +  +  + + F+ E S + ++ H N+VQLLG
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 128 FCSEGSKRA-LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNGC 184
              E      +V EYM  GSL    + +         + L + +L     +EYL  +N  
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 137

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              + H D+   N+L+  + + KVSDFGL K         +    +  + + APE +   
Sbjct: 138 --FV-HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL--R 187

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----VYDQLNKGGDLEL- 299
               S KSDV+ FG++L E+           +     Y P      V  ++ KG  ++  
Sbjct: 188 EKKFSTKSDVWSFGILLWEI----------YSFGRVPY-PRIPLKDVVPRVEKGYKMDAP 236

Query: 300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                        +  +   C  + AA RPS  ++ E LE
Sbjct: 237 DGCPP-------AVYEVMKNCWHLDAAMRPSFLQLREQLE 269

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  130 bits (328), Expect = 3e-35
 Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 40/292 (13%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGG-----LIAVKML-ANSKFSGEEFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +    G     L+AVK L  +      +F  E+  +  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G      +++  LV EY+P+G L    F +  R +     +L   +    +G+EYL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRAR-LDASRLLLYSSQICKGMEYL 143

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPE 239
                   +H D+   NIL++     K++DFGLAK  P + D +V     +  I + APE
Sbjct: 144 G---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
            +  +    S +SDV+ FG+VL E+           T   K+  PS  + ++        
Sbjct: 201 SL--SDNIFSRQSDVWSFGVVLYEL----------FTYCDKSCSPSAEFLRMMGCERDVP 248

Query: 300 RNVTEIESMIAR-------KLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
              + +  ++           C      +   C      DRPS + +   L+
Sbjct: 249 AL-SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  129 bits (327), Expect = 3e-35
 Identities = 81/323 (25%), Positives = 139/323 (43%), Gaps = 52/323 (16%)

Query: 42  VEKFLHNQQSWM-PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKML 97
           ++K  H+      P    YP +      F   +G+G FG V K ++   GL    A+K +
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 98  ---ANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------ 147
              A+      +F  E+  + ++ HH N++ LLG C       L  EY P+G+L      
Sbjct: 61  KEYASKD-DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119

Query: 148 ------DRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNIL 199
                 D       S   +   ++L   A   ARG++YL         I H D+   NIL
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ----FI-HRDLAARNIL 174

Query: 200 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 259
           +  N++ K++DFGL++    +  +V  +  R  + ++A E  S N+   +  SDV+ +G+
Sbjct: 175 VGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGV 229

Query: 260 VLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL-RNVTEIESMIARKLCMI 316
           +L E+   GG     M             +Y++L +G  LE   N  +       ++  +
Sbjct: 230 LLWEIVSLGGTPYCGMTCAE---------LYEKLPQGYRLEKPLNCDD-------EVYDL 273

Query: 317 GLWCIQVKAADRPSMTKVLEMLE 339
              C + K  +RPS  ++L  L 
Sbjct: 274 MRQCWREKPYERPSFAQILVSLN 296

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (326), Expect = 5e-35
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 45/295 (15%)

Query: 69  FTHKLGQGGFGSVYKGQLH-----TGGLIAVKML-ANSKFSGEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV   +       TG ++AVK L  +++    +F  E+  +  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   +   +     KL +      +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 161

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 237
                   +H D+   NIL+++    K+ DFGL K  P++ ++            I + A
Sbjct: 162 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFWYA 216

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSW------VYD 289
           PE +       S  SDV+ FG+VL E+     +  S                     + +
Sbjct: 217 PESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 290 QLNKGGDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            L   G L         +  I         M   W        RPS   +   ++
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMI---------MTECW--NNNVNQRPSFRDLALRVD 318

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  129 bits (326), Expect = 5e-35
 Identities = 78/301 (25%), Positives = 119/301 (39%), Gaps = 62/301 (20%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML--ANSKFSGEEFINEVSTIGRIHH 119
                LG G FG VY+GQ+           +AVK L    S+    +F+ E   I + +H
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARG 176
            N+V+ +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 177 IEYL--HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATR- 230
            +YL  ++     I H DI   N LL       + K+ DFG+A+      D    S  R 
Sbjct: 153 CQYLEENH----FI-HRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRK 201

Query: 231 GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS 285
           G    +      PE  +   G  + K+D + FG++L E+              S  Y P 
Sbjct: 202 GGCAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEIF-------------SLGYMPY 246

Query: 286 W------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                  V + +  GG ++  +N           +  I   C Q +  DRP+   +LE +
Sbjct: 247 PSKSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERI 299

Query: 339 E 339
           E
Sbjct: 300 E 300

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  131 bits (331), Expect = 6e-35
 Identities = 66/278 (23%), Positives = 110/278 (39%), Gaps = 38/278 (13%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCS 130
            LG G  G++    +     +AVK +    FS  +   EV  +     H NV++      
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYFCTEK 88

Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDVCIL 189
           +   + +  E     +L  ++   E +  +    +   +   T  G+ +LH       I+
Sbjct: 89  DRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN----IV 140

Query: 190 HFDIKPHNILL-----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISR 243
           H D+KPHNIL+            +SDFGL K      + F   S   GT G+IAPE++S 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 244 NFGT-VSCKSDVYGFGMVLLEM-AGGRRNSNMH---ATRSSKAYFPSWVYDQLNKGGDLE 298
           +     +   D++  G V   + + G      H    +   +A         L     L+
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQANI-------LLGACSLD 248

Query: 299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
             +  + E +IAR+L  I    I +    RPS   VL+
Sbjct: 249 CLHPEKHEDVIAREL--I-EKMIAMDPQKRPSAKHVLK 283

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  128 bits (325), Expect = 7e-35
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 50/290 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
           H    +G G  G V  G+L   G     +A+K L    ++    +F++E S +G+  H N
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +++L G  + G    +V EYM NGSLD   F +   GQ F   +L  +  G   G+ YL 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQ-FTIMQLVGMLRGVGAGMRYLS 168

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAP 238
              D+  +H D+   N+L+D N + KVSDFGL++    + D      T G    I + AP
Sbjct: 169 ---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA--YTTTGGKIPIRWTAP 223

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW----VYDQLNKG 294
           E I   F T S  SDV+ FG+V+ E+               + Y  +     V   + +G
Sbjct: 224 EAI--AFRTFSSASDVWSFGVVMWEV----------LAYGERPY-WNMTNRDVISSVEEG 270

Query: 295 GDLEL-----RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             L         + ++  M         L C     A RP  ++++ +L+
Sbjct: 271 YRLPAPMGCPHALHQL--M---------LDCWHKDRAQRPRFSQIVSVLD 309

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  127 bits (322), Expect = 7e-35
 Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 46/283 (16%)

Query: 72  KLGQGGFGSVYKGQLHTGG---LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G          +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G C       LV E    G L + +     + +      + E+    + G++YL    + 
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---EEK 129

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPELISR 243
             +H D+   N+LL +    K+SDFGL+K    ++ +   +A       + + APE I  
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPECI-- 185

Query: 244 NFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN 301
           NF   S +SDV+ +G+ + E    G +    M             V   + +G  +E   
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKRME--- 233

Query: 302 VTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
                       C   L+     C   K  DRP    V + + 
Sbjct: 234 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (321), Expect = 9e-35
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 49/284 (17%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF-- 128
            +G GGFG V+K +    G    +K +   K++ E+   EV  + ++ HVN+V   G   
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 129 -----------CSEGSKRALVY---EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTA 174
                       S  SK   ++   E+   G+L++ I  ++ RG+        E+     
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQIT 132

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           +G++Y+H      +++ D+KP NI L      K+ DFGL      +        ++GT+ 
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR---SKGTLR 186

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG 294
           Y++PE IS        + D+Y  G++L E+                A+  S  +  L  G
Sbjct: 187 YMSPEQISSQ--DYGKEVDLYALGLILAEL----------LHVCDTAFETSKFFTDLRDG 234

Query: 295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                     I  +  +K   +    +  K  DRP+ +++L  L
Sbjct: 235 ---------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (321), Expect = 1e-34
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 27/209 (12%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVK--MLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G VY G  L     IA+K     +S+   +    E++    + H N+VQ LG  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-YSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 130 SEGSKRALVYEYMPNGSLD---RHIF----PKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           SE     +  E +P GSL    R  +      E     +  + L         G++YLH 
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE--------GLKYLH- 139

Query: 183 GCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL 240
             D  I+H DIK  N+L++ ++ + K+SDFG +K   +       + T  GT+ Y+APE+
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEI 194

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           I +        +D++  G  ++EMA G+ 
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (328), Expect = 2e-34
 Identities = 70/275 (25%), Positives = 114/275 (41%), Gaps = 34/275 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
               +G+G FG V  G    G  +AVK + N   + + F+ E S + ++ H N+VQLLG 
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 129 CSEGSKRA-LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             E      +V EYM  GSL    + +         + L + +L     +EYL       
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNN 309

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H D+   N+L+  + + KVSDFGL K         +    +  + + APE +      
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL--REKK 362

Query: 248 VSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL-RNVTE 304
            S KSDV+ FG++L E+   G      +             V  ++ KG  ++       
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYKMDAPDGCPP 413

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                   +  +   C  + AA RP+  ++ E LE
Sbjct: 414 -------AVYDVMKNCWHLDAATRPTFLQLREQLE 441

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  128 bits (324), Expect = 2e-34
 Identities = 77/299 (25%), Positives = 119/299 (39%), Gaps = 58/299 (19%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML--ANSKFSGEEFINEVSTIGRIHH 119
                LG G FG VY+GQ+           +AVK L    S+    +F+ E   I + +H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARG 176
            N+V+ +G   +   R ++ E M  G L    R   P+ S+  S     L  VA   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 177 IEYL--HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATR- 230
            +YL  ++     I H DI   N LL       + K+ DFG+A+      D       R 
Sbjct: 194 CQYLEENH----FI-HRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRK 242

Query: 231 GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS 285
           G    +      PE  +   G  + K+D + FG++L E+           +     Y PS
Sbjct: 243 GGCAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEI----------FSLGYMPY-PS 289

Query: 286 W----VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                V + +  GG ++  +N           +  I   C Q +  DRP+   +LE +E
Sbjct: 290 KSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERIE 341

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  125 bits (317), Expect = 3e-34
 Identities = 71/287 (24%), Positives = 115/287 (40%), Gaps = 47/287 (16%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL----IAVKML--ANSKFSGEEFINEVSTIGRIHHVN 121
                LG+G FG VY+G           +AVK      +  + E+F++E   +  + H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL- 180
           +V+L+G   E     ++ E  P G L  ++   E    S     L   +L   + + YL 
Sbjct: 75  IVKLIGIIEEEPTW-IIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 181 -HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
             N    C+ H DI   NIL+      K+ DFGL+++  ++ D+   S TR  I +++PE
Sbjct: 131 SIN----CV-HRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPE 184

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNK 293
            I  NF   +  SDV+ F + + E+              S    P +      V   L K
Sbjct: 185 SI--NFRRFTTASDVWMFAVCMWEIL-------------SFGKQPFFWLENKDVIGVLEK 229

Query: 294 GGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           G  L                L  +   C     +DRP  T+++  L 
Sbjct: 230 GDRLPKPDLCPP-------VLYTLMTRCWDYDPSDRPRFTELVCSLS 269

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  125 bits (317), Expect = 4e-34
 Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 52/286 (18%)

Query: 72  KLGQGGFGSVYKGQLHTGGL---IAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG      +   +AVK+L   AN     +E + E + + ++ +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNG 183
           +G C       LV E    G L++++     + +    + + E+    + G++YL   N 
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 137

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPEL 240
               + H D+   N+LL      K+SDFGL+K    + ++    A       + + APE 
Sbjct: 138 ---FV-HRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPEC 191

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           I  N+   S KSDV+ FG+++ E    G +    M  +          V   L KG  + 
Sbjct: 192 I--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------VTAMLEKGERMG 240

Query: 299 LRNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
                          C   ++     C      +RP    V   L 
Sbjct: 241 -----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  126 bits (319), Expect = 4e-34
 Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 47/294 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG----LIAVKML---ANSKFSGEEFINEVSTIGRIHHV 120
                LG+G FGSV + QL         +AVKML     +    EEF+ E + +    H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 121 NVVQLLGFCSEGSKRA------LVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVAL 171
           +V +L+G       +       ++  +M +G L          E+   +   + L    +
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN-PFNLPLQTLVRFMV 144

Query: 172 GTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
             A G+EYL   N     I H D+   N +L  +    V+DFGL++     + +    A+
Sbjct: 145 DIACGMEYLSSRN----FI-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF---PSW 286
           +  + ++A E  S      +  SDV+ FG+ + E+           TR    Y     + 
Sbjct: 200 KLPVKWLALE--SLADNLYTVHSDVWAFGVTMWEI----------MTRGQTPYAGIENAE 247

Query: 287 VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +Y+ L  G  L+      E       ++  +   C       RPS T +   LE
Sbjct: 248 IYNYLIGGNRLKQPPECME-------EVYDLMYQCWSADPKQRPSFTCLRMELE 294

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  126 bits (318), Expect = 6e-34
 Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 29/218 (13%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
            ++G+G FG V++ +   TG   AVK +    F  EE    +     +    +V L G  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAV 119

Query: 130 SEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            EG    +  E +  GSL + I      P E R   +  + L         G+EYLH   
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLGQALE--------GLEYLH--- 167

Query: 185 DVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISAT---RGTIGYIAPEL 240
              ILH D+K  N+LL  +     + DFG A     +    S+       GT  ++APE+
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
           +         K D++    ++L M  G    +      
Sbjct: 228 VMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (316), Expect = 1e-33
 Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 48/294 (16%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLANSKFS---GEEFINEVSTIGRIHHV 120
                LG+G FGSV +G L         +AVK +     S    EEF++E + +    H 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 121 NVVQLLGFCSEGSKRA-----LVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALG 172
           NV++LLG C E S +      ++  +M  G L     +    E+  +    + L +  + 
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL-ETGPKHIPLQTLLKFMVD 155

Query: 173 TARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
            A G+EYL   N     + H D+   N +L  +    V+DFGL+K     + +      +
Sbjct: 156 IALGMEYLSNRN----FL-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW---- 286
             + +IA E  S      + KSDV+ FG+ + E+          ATR    Y P      
Sbjct: 211 MPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEI----------ATRGMTPY-PGVQNHE 257

Query: 287 VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +YD L  G  L+   +  +       +L  I   C +    DRP+ + +   LE
Sbjct: 258 MYDYLLHGHRLKQPEDCLD-------ELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (314), Expect = 1e-33
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 22/208 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLANSKFSG----EEFINEVSTIGRIHH 119
               KLG G FG V +G+          +AVK L     S     ++FI EV+ +  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            N+++L G         +V E  P GSL   +  ++ +G  F    L   A+  A G+ Y
Sbjct: 81  RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGY 136

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L        +H D+   N+LL    + K+ DFGL +  P+ +D               + 
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWC 191

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE +     T S  SD + FG+ L EM
Sbjct: 192 APESL--KTRTFSHASDTWMFGVTLWEM 217

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (314), Expect = 1e-33
 Identities = 65/301 (21%), Positives = 105/301 (34%), Gaps = 66/301 (21%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
            LGQG FG V K +        A+K + +++      ++EV  +  ++H  VV+      
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 131 EGSKRA-------------LVYEYMPNGSLDRHIFPKESRGQSF----CWEKLHEVALGT 173
           E                  +  EY  NG+L   I    S   +      W    ++    
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEA- 128

Query: 174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-- 230
              + Y+H  G    I+H D+KP NI +D +   K+ DFGLAK   +  D + + +    
Sbjct: 129 ---LSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 231 ----------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT---- 276
                     GT  Y+A E++    G  + K D+Y  G++  EM                
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240

Query: 277 -RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            RS    FP    D                +  + +K+       I      RP    +L
Sbjct: 241 LRSVSIEFPPDFDDN---------------KMKVEKKII---RLLIDHDPNKRPGARTLL 282

Query: 336 E 336
            
Sbjct: 283 N 283

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  124 bits (314), Expect = 2e-33
 Identities = 74/299 (24%), Positives = 119/299 (39%), Gaps = 58/299 (19%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML--ANSKFSGEEFINEVSTIGRIHH 119
             + +LGQG FG VY+G             +A+K +  A S     EF+NE S +   + 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD------RHIFPKESRGQSFCWEKLHEVALGT 173
            +VV+LLG  S+G    ++ E M  G L       R               K+ ++A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 174 ARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR- 230
           A G+ YL  +      + H D+   N ++  +F  K+ DFG+ +      D       R 
Sbjct: 148 ADGMAYLNANK----FV-HRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRK 196

Query: 231 GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS 285
           G  G +     +PE  S   G  +  SDV+ FG+VL E+          AT + + Y   
Sbjct: 197 GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI----------ATLAEQPY-QG 243

Query: 286 W----VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                V   + +GG L+   N  +        L  +   C Q     RPS  +++  ++
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIK 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (315), Expect = 3e-33
 Identities = 60/273 (21%), Positives = 109/273 (39%), Gaps = 33/273 (12%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLG 127
           K+G+G FG     +    G    +K +  S+ S +E      EV+ +  + H N+VQ   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
              E     +V +Y   G L + I     +G  F  +++ +  +     ++++H   D  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ILH DIK  NI L  +   ++ DFG+A+      +        GT  Y++PE+       
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENK--P 201

Query: 248 VSCKSDVYGFGMVLLEMAGGRR---NSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE 304
            + KSD++  G VL E+   +      +M             +  ++  G      +   
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----------LVLKIISG------SFPP 244

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
           +    +  L  +     +    DRPS+  +LE 
Sbjct: 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  124 bits (313), Expect = 3e-33
 Identities = 76/341 (22%), Positives = 127/341 (37%), Gaps = 69/341 (20%)

Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSY---PEIIAVTNHFTHKLGQGGFGSVYKGQLHTGG- 90
           SL   +     L       P+ +S      I         +LG+G FG V+  + H    
Sbjct: 8   SLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLP 67

Query: 91  -----LIAVKML-ANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN 144
                L+AVK L   S+ + ++F  E   +  + H ++V+  G C+EG    +V+EYM +
Sbjct: 68  EQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRH 127

Query: 145 GSL-----------DRHIFPKESRGQSFCWEKLHEVALGTARGIEYL--HNGCDVCILHF 191
           G L                 ++         +L  VA   A G+ YL   +     + H 
Sbjct: 128 GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH----FV-HR 182

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYI-----APELISRNF 245
           D+   N L+    + K+ DFG+++      D  S    R G    +      PE I   +
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSR------DIYSTDYYRVGGRTMLPIRWMPPESI--LY 234

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKGGDLEL 299
              + +SDV+ FG+VL E+              +    P +        D + +G +LE 
Sbjct: 235 RKFTTESDVWSFGVVLWEIF-------------TYGKQPWYQLSNTEAIDCITQGRELER 281

Query: 300 -RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            R           ++  I   C Q +   R S+  V   L+
Sbjct: 282 PRACPP-------EVYAIMRGCWQREPQQRHSIKDVHARLQ 315

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (322), Expect = 7e-33
 Identities = 63/286 (22%), Positives = 112/286 (39%), Gaps = 47/286 (16%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGG----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNV 122
               +G+G FG V++G   +       +A+K      S    E+F+ E  T+ +  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL-- 180
           V+L+G  +E +   ++ E    G L   +   + R  S     L   A   +  + YL  
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLES 509

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                  + H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE 
Sbjct: 510 KR----FV-HRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPES 563

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW------VYDQLNKG 294
           I  NF   +  SDV+ FG+ + E+                   P        V  ++  G
Sbjct: 564 I--NFRRFTSASDVWMFGVCMWEIL-------------MHGVKPFQGVKNNDVIGRIENG 608

Query: 295 GDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             L +  N           L  +   C     + RP  T++   L 
Sbjct: 609 ERLPMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLS 647

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (307), Expect = 1e-32
 Identities = 63/306 (20%), Positives = 119/306 (38%), Gaps = 67/306 (21%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML-ANSKFSGEEFINEVSTIGRIHHV 120
               +LG+G FG V+  + +         L+AVK L   +  + ++F  E   +  + H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHIFPKESRGQSFCWEKLHE 168
           ++V+  G C +G    +V+EYM +G L                             ++  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 169 VALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
           +A   A G+ YL   +     + H D+   N L+  N + K+ DFG+++      D  S 
Sbjct: 138 IASQIASGMVYLASQH----FV-HRDLATRNCLVGANLLVKIGDFGMSR------DVYST 186

Query: 227 SATR-GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK 280
              R G    +      PE I   +   + +SDV+ FG++L E+              + 
Sbjct: 187 DYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIF-------------TY 231

Query: 281 AYFPSW------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK 333
              P +      V + + +G  LE  R   +       ++  + L C Q +   R ++ +
Sbjct: 232 GKQPWFQLSNTEVIECITQGRVLERPRVCPK-------EVYDVMLGCWQREPQQRLNIKE 284

Query: 334 VLEMLE 339
           + ++L 
Sbjct: 285 IYKILH 290

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (318), Expect = 2e-32
 Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 42/281 (14%)

Query: 72  KLGQGGFGSVYKGQLHTGG---LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G          +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G C       LV E    G L +  F    R +      + E+    + G++YL    + 
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHK--FLVGKREE-IPVSNVAELLHQVSMGMKYL---EEK 455

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPELISRNF 245
             +H ++   N+LL +    K+SDFGL+K    ++  + + SA +  + + APE I  NF
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 513

Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT 303
              S +SDV+ +G+ + E    G +    M             V   + +G  +E     
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKRME----- 559

Query: 304 EIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
                     C   L+     C   K  DRP    V + + 
Sbjct: 560 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  121 bits (306), Expect = 2e-32
 Identities = 64/301 (21%), Positives = 108/301 (35%), Gaps = 56/301 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML--ANSKFSGEEFINEVSTIGRIHH 119
            F  +LG+  FG VYKG L           +A+K L         EEF +E     R+ H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD------------RHIFPKESRGQSFCWEKLH 167
            NVV LLG  ++    ++++ Y  +G L                    +   +       
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 168 EVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
            +    A G+EYL  H+     + H D+   N+L+      K+SD GL +     + +  
Sbjct: 132 HLVAQIAAGMEYLSSHH----VV-HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS 285
           +  +   I ++APE I   +G  S  SD++ +G+VL E+              S    P 
Sbjct: 187 LGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVF-------------SYGLQPY 231

Query: 286 W------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                  V + +     L    +           +  + + C     + RP    +   L
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCPDDCPA-------WVYALMIECWNEFPSRRPRFKDIHSRL 284

Query: 339 E 339
            
Sbjct: 285 R 285

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (307), Expect = 2e-32
 Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 47/291 (16%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVK-MLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           KLG+GGF  V   + LH G   A+K +L + +   EE   E       +H N+++L+ +C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 130 SEGSKRA----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
                      L+  +   G+L   I   + +G     +++  + LG  RG+E +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-------ISATRGTIGYIAP 238
               H D+KP NILL     P + D G         +           +A R TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 239 ELIS-RNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMHATR---SSKAYFPSW-VY 288
           EL S ++   +  ++DV+  G VL  M  G            +      ++   P    +
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272

Query: 289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                     L  +  + SM            + V    RP +  +L  LE
Sbjct: 273 SS-------ALWQL--LNSM------------MTVDPHQRPHIPLLLSQLE 302

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  120 bits (304), Expect = 4e-32
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 51/286 (17%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVK--MLANSKFSGE--EFINEVSTIGRIHHVNVVQL 125
            K+G+G F  VY+   L  G  +A+K   + +   +    + I E+  + +++H NV++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSF----CWEKLHEVALGTARGIEYLH 181
                E ++  +V E    G L R I   + + +       W+   ++       +E++H
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA----LEHMH 153

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                 ++H DIKP N+ +    + K+ D GL +F   +          GT  Y++PE I
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERI 208

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR-----NSNMHA-----TRSSKAYFPSWVYDQL 291
             N    + KSD++  G +L EMA  +        N+++      +      PS  Y + 
Sbjct: 209 HEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE- 265

Query: 292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
                 ELR +                 CI      RP +T V ++
Sbjct: 266 ------ELRQLVN--------------MCINPDPEKRPDVTYVYDV 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  120 bits (303), Expect = 5e-32
 Identities = 53/295 (17%), Positives = 103/295 (34%), Gaps = 57/295 (19%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
            LG+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 129 CSEG---------SKRALVY---EYMPNGSLDRHIFPKESRGQSF-----CWEKLHEVAL 171
             E          S +  +Y   +     +L   +               C     ++A 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIFLQIAE 129

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR- 230
                +E+LH      ++H D+KP NI    + + KV DFGL     ++ +  ++     
Sbjct: 130 A----VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 231 ---------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA 281
                    GT  Y++PE I  N  + S K D++  G++L E+                 
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLYPFSTQMERVR----- 235

Query: 282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                    +      +   +   +      +       +     +RP    ++E
Sbjct: 236 -----TLTDVRNL---KFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINIIE 279

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (299), Expect = 1e-31
 Identities = 61/277 (22%), Positives = 108/277 (38%), Gaps = 32/277 (11%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLG 127
            +G G +G   K +    G ++  K L     +  E    ++EV+ +  + H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH--NG 183
              + +   L  V EY   G L   I       Q    E +  V       ++  H  + 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               +LH D+KP N+ LD     K+ DFGLA+    +  F       GT  Y++PE ++R
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNR 190

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRR---NSNMHATRSSKAYFPSWVYDQLNKGGDLELR 300
              + + KSD++  G +L E+          +              +  ++ +G      
Sbjct: 191 M--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----------LAGKIREG------ 231

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
               I    + +L  I    + +K   RPS+ ++LE 
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  118 bits (299), Expect = 2e-31
 Identities = 61/297 (20%), Positives = 104/297 (35%), Gaps = 61/297 (20%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL--------IAVKMLANSKFSG-EEFINEVSTIGRIH 118
            F   LGQG F  ++KG     G         + +K+L  +  +  E F    S + ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           H ++V   G C  G +  LV E++  GSLD ++   +            EVA   A  + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMH 127

Query: 179 YL--HNGCDVCILHFDIKPHNILLD--------HNFIPKVSDFGLAKFHPKENDFVSISA 228
           +L  +      I H ++   NILL         +    K+SD G++         +    
Sbjct: 128 FLEENT----LI-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------TVLPKDI 176

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW-- 286
            +  I ++ PE I  N   ++  +D + FG  L E+              S    P    
Sbjct: 177 LQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEIC-------------SGGDKPLSAL 222

Query: 287 ----VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                         L      E+ ++I          C+  +   RPS   ++  L 
Sbjct: 223 DSQRKLQFYEDRHQLPAPKAAELANLI--------NNCMDYEPDHRPSFRAIIRDLN 271

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  118 bits (299), Expect = 4e-31
 Identities = 65/299 (21%), Positives = 115/299 (38%), Gaps = 52/299 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML---ANSKFSGEEFINEVSTIGRI- 117
            F   LG G FG V +      G       +AVKML   A++    E  ++E+  +  + 
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSHLG 107

Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSL----------DRHIFPKESRGQSFCWEKLH 167
            H N+V LLG C+ G    ++ EY   G L                      +     L 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 168 EVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
             +   A+G+ +L   N    CI H D+   N+LL +  + K+ DFGLA+    +++++ 
Sbjct: 168 HFSSQVAQGMAFLASKN----CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY--F 283
               R  + ++APE  S      + +SDV+ +G++L E+           +     Y   
Sbjct: 223 KGNARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEI----------FSLGLNPYPGI 270

Query: 284 PSW--VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 Y  +  G  +       +        +  I   C  ++   RP+  ++   L+
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQ 322

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  117 bits (296), Expect = 7e-31
 Identities = 60/280 (21%), Positives = 100/280 (35%), Gaps = 52/280 (18%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE---FINEVSTIGRI-HHVNVVQLL 126
           +LG G +G V+K +    G L AVK   +     ++    + EV +  ++  H   V+L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
               EG    L  E     SL +H    E+ G S    ++      T   + +LH     
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELISR 243
            ++H D+KP NI L      K+ DFGL                    G   Y+APEL+  
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE------GDPRYMAPELLQG 230

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMHATRSSKAY--FPSWVYDQLNKGGDL 297
           ++G     +DV+  G+ +LE+A               R       F + +          
Sbjct: 231 SYG---TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL---------- 277

Query: 298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
                    S   R + +     ++     R +   +L +
Sbjct: 278 ---------SSELRSVLV---MMLEPDPKLRATAEALLAL 305

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (293), Expect = 1e-30
 Identities = 59/293 (20%), Positives = 107/293 (36%), Gaps = 59/293 (20%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVK----MLANSKFSGEEFINEVSTIGRI-HHVNVVQL 125
           K+G G FGSV+K      G + A+K     LA S    +  + EV     +  H +VV+ 
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAVLGQHSHVVRY 76

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
               +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+H    
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133

Query: 186 VCILHFDIKPHNILLDHN-------------------FIPKVSDFGLAKFHPKENDFVSI 226
           + ++H DIKP NI +                       + K+ D G              
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191

Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHATRSSKAYF 283
               G   ++A E++  N+     K+D++   + ++  AG     RN +           
Sbjct: 192 ----GDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ---------- 236

Query: 284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
               + ++ +G       +  I  +++++   +    I      RPS   +++
Sbjct: 237 ----WHEIRQG------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (292), Expect = 3e-30
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 34/222 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQ 124
             +  LGQG   +V++G+   TG L A+K+  N  F       + E   + +++H N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 125 LLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE-VALGTAR----GI 177
           L     E + R   L+ E+ P GSL   +    +         L E   L   R    G+
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPESEFLIVLRDVVGGM 125

Query: 178 EYLH-NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            +L  NG    I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT
Sbjct: 126 NHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGT 178

Query: 233 IGYIAPELISRNFGTV------SCKSDVYGFGMVLLEMAGGR 268
             Y+ P++  R               D++  G+     A G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  116 bits (292), Expect = 7e-30
 Identities = 68/302 (22%), Positives = 122/302 (40%), Gaps = 55/302 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLH--------TGGLIAVKML---ANSKFSGEEFINEVSTIGR 116
                LG+G FG V   +              +AVKML   A  K    + ++E+  +  
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKM 142

Query: 117 I-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHIFPKESRGQSFCW 163
           I  H N++ LLG C++     ++ EY   G+L            +          +   +
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 164 EKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 221
           + L       ARG+EYL        CI H D+   N+L+  N + K++DFGLA+     +
Sbjct: 203 KDLVSCTYQLARGMEYLASQK----CI-HRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA 281
            +   +  R  + ++APE  +      + +SDV+ FG+++ E+           T     
Sbjct: 258 YYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEI----------FTLGGSP 305

Query: 282 YF---PSWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
           Y       ++  L +G  ++   N T        +L M+   C     + RP+  +++E 
Sbjct: 306 YPGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVED 358

Query: 338 LE 339
           L+
Sbjct: 359 LD 360

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  115 bits (289), Expect = 1e-29
 Identities = 68/302 (22%), Positives = 122/302 (40%), Gaps = 55/302 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLH--------TGGLIAVKML---ANSKFSGEEFINEVSTIGR 116
                LG+G FG V   +              +AVKML   A  K    + ++E+  +  
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKM 96

Query: 117 I-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHIFPKESRGQSFCW 163
           I  H N++ LLG C++     ++ EY   G+L            +          +   +
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156

Query: 164 EKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 221
           + L       ARG+EYL        CI H D+   N+L+  N + K++DFGLA+     +
Sbjct: 157 KDLVSCTYQLARGMEYLASQK----CI-HRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA 281
            +   +  R  + ++APE  +      + +SDV+ FG+++ E+           T     
Sbjct: 212 YYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEI----------FTLGGSP 259

Query: 282 YF---PSWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
           Y       ++  L +G  ++   N T        +L M+   C     + RP+  +++E 
Sbjct: 260 YPGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVED 312

Query: 338 LE 339
           L+
Sbjct: 313 LD 314

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  115 bits (289), Expect = 1e-29
 Identities = 66/310 (21%), Positives = 115/310 (37%), Gaps = 66/310 (21%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML---ANSKFSGEEFINEVSTIGRIH 118
            +   +G+G FG V++ +           ++AVKML   A++     +F  E + +    
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFD 108

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL--------------------DRHIFPKESRG 158
           + N+V+LLG C+ G    L++EYM  G L                               
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 159 QSFCWEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
                 +   +A   A G+ YL         + H D+   N L+  N + K++DFGL++ 
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERK----FV-HRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT 276
               + + +       I ++ PE  S  +   + +SDV+ +G+VL E+            
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIF----------- 270

Query: 277 RSSKAYFPSW------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRP 329
             S    P +      V   +  G  L    N          +L  +   C     ADRP
Sbjct: 271 --SYGLQPYYGMAHEEVIYYVRDGNILACPENCPL-------ELYNLMRLCWSKLPADRP 321

Query: 330 SMTKVLEMLE 339
           S   +  +L+
Sbjct: 322 SFCSIHRILQ 331

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  115 bits (289), Expect = 1e-29
 Identities = 73/304 (24%), Positives = 123/304 (40%), Gaps = 53/304 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML---ANSKFSGEEFINEVSTIGRI- 117
            F   LG G FG V     +          +AVKML   A+S    E  ++E+  + ++ 
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLG 106

Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSL-------------------DRHIFPKESRG 158
            H N+V LLG C+      L++EY   G L                   ++    +E   
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 159 QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
               +E L   A   A+G+E+L      C+ H D+   N+L+ H  + K+ DFGLA+   
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKS--CV-HRDLAARNVLVTHGKVVKICDFGLARDIM 223

Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHAT 276
            ++++V     R  + ++APE  S   G  + KSDV+ +G++L E+   G      +   
Sbjct: 224 SDSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281

Query: 277 RSSKAYFPSWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            +         Y  +  G  ++     TE       ++ +I   C    +  RPS   + 
Sbjct: 282 AN--------FYKLIQNGFKMDQPFYATE-------EIYIIMQSCWAFDSRKRPSFPNLT 326

Query: 336 EMLE 339
             L 
Sbjct: 327 SFLG 330

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  114 bits (288), Expect = 1e-29
 Identities = 57/302 (18%), Positives = 110/302 (36%), Gaps = 56/302 (18%)

Query: 61  EIIAVTN---HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE---FINEVSTI 114
           E I+V         ++G GG   V++       + A+K +   +   +    + NE++ +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 115 GRI--HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALG 172
            ++  H   +++L  +        +V E   N  L+  +  K+S            +   
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEA 120

Query: 173 TARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
               +  +H +G    I+H D+KP N L+    + K+ DFG+A     +   V   +  G
Sbjct: 121 ----VHTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 232 TIGYIAPELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR--------RNSNMH 274
           T+ Y+ PE I     +         +S KSDV+  G +L  M  G+        + S +H
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231

Query: 275 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           A                            +I     + +      C++     R S+ ++
Sbjct: 232 AIIDPNHEIEFP-----------------DIPEKDLQDVLK---CCLKRDPKQRISIPEL 271

Query: 335 LE 336
           L 
Sbjct: 272 LA 273

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  114 bits (287), Expect = 2e-29
 Identities = 74/303 (24%), Positives = 122/303 (40%), Gaps = 56/303 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLI--------AVKML---ANSKFSGEEFINEVSTIGR 116
            F   LG G FG V +   +  GLI        AVKML   A+     E  ++E+  +  
Sbjct: 26  SFGKTLGAGAFGKVVEATAY--GLIKSDAAMTVAVKMLKPSAHLT-EREALMSELKVLSY 82

Query: 117 I-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL--------------DRHIFPKESRGQSF 161
           + +H+N+V LLG C+ G    ++ EY   G L                     E    + 
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 162 CWEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
             E L   +   A+G+ +L   N    CI H D+   NILL H  I K+ DFGLA+    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN----CI-HRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMHATR 277
           ++++V     R  + ++APE  S      + +SDV+ +G+ L E+   G      M    
Sbjct: 198 DSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 278 SSKAYFPSWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                     Y  + +G  +    +          ++  I   C       RP+  ++++
Sbjct: 256 K--------FYKMIKEGFRMLSPEHAPA-------EMYDIMKTCWDADPLKRPTFKQIVQ 300

Query: 337 MLE 339
           ++E
Sbjct: 301 LIE 303

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  115 bits (290), Expect = 2e-29
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 34/222 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQ 124
             +  LGQG   +V++G+   TG L A+K+  N  F       + E   + +++H N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 125 LLGFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE-VALGTAR----GI 177
           L     E + R   L+ E+ P GSL   +    +         L E   L   R    G+
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPESEFLIVLRDVVGGM 125

Query: 178 EYLH-NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            +L  NG    I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT
Sbjct: 126 NHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GT 178

Query: 233 IGYIAPELISRNFGTV------SCKSDVYGFGMVLLEMAGGR 268
             Y+ P++  R               D++  G+     A G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  113 bits (284), Expect = 4e-29
 Identities = 68/308 (22%), Positives = 124/308 (40%), Gaps = 62/308 (20%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGG------LIAVKML---ANSKFSGEEFINEVSTIGRIH 118
                LG+G FG V K              +AVKML   A+      + ++E + + +++
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLSEFNVLKQVN 84

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL--------------------DRHIFPKESRG 158
           H +V++L G CS+     L+ EY   GSL                               
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144

Query: 159 QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           ++     L   A   ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   
Sbjct: 145 RALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201

Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS 278
           +E+ +V  S  R  + ++A E  S      + +SDV+ FG++L E+              
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIV------------- 246

Query: 279 SKAYFPSW------VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
           +    P        +++ L  G  +E   N +E       ++  + L C + +   RP  
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSE-------EMYRLMLQCWKQEPDKRPVF 299

Query: 332 TKVLEMLE 339
             + + LE
Sbjct: 300 ADISKDLE 307

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  112 bits (283), Expect = 5e-29
 Identities = 49/246 (19%), Positives = 97/246 (39%), Gaps = 33/246 (13%)

Query: 46  LHNQQSW-----MPKRYSYPEIIAVTN---HFTHKLGQGGFGSVYKGQLHTGGLIAVKML 97
           +H+         +     Y + ++V         ++G GG   V++       + A+K +
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60

Query: 98  ANSKFSGEE---FINEVSTIGRI--HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF 152
              +   +    + NE++ + ++  H   +++L  +        +V E   N  L+  + 
Sbjct: 61  NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK 119

Query: 153 PKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
            K+S            +       +  +H +G    I+H D+KP N L+    + K+ DF
Sbjct: 120 KKKSIDPWERKSYWKNML----EAVHTIHQHG----IVHSDLKPANFLIVDGML-KLIDF 170

Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLL 262
           G+A     +   V   +  GT+ Y+ PE I     +         +S KSDV+  G +L 
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230

Query: 263 EMAGGR 268
            M  G+
Sbjct: 231 YMTYGK 236

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  112 bits (283), Expect = 5e-29
 Identities = 72/301 (23%), Positives = 124/301 (41%), Gaps = 53/301 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSGEE---FINEVSTIGRI- 117
                LG+G FG V +          T   +AVKML     +  E    ++E+  +  I 
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIG 88

Query: 118 HHVNVVQLLGFCS-EGSKRALVYEYMPNGSL------------DRHIFPKESRGQSFCWE 164
           HH+NVV LLG C+  G    ++ E+   G+L               + P++        E
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 165 KLHEVALGTARGIEYL-HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
            L   +   A+G+E+L    C    +H D+   NILL    + K+ DFGLA+   K+ D+
Sbjct: 149 HLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204

Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY- 282
           V     R  + ++APE  +      + +SDV+ FG++L E+           +  +  Y 
Sbjct: 205 VRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEI----------FSLGASPYP 252

Query: 283 -FPSW--VYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                     +L +G  +      T        ++    L C   + + RP+ ++++E L
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 305

Query: 339 E 339
            
Sbjct: 306 G 306

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  114 bits (286), Expect = 6e-29
 Identities = 69/305 (22%), Positives = 125/305 (40%), Gaps = 61/305 (20%)

Query: 68  HFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKFSGEE---FINEVSTIGR 116
                LG+G FG V   +              +AVKML  S  + ++    I+E+  +  
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKM 130

Query: 117 I-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHIFPKESRGQSFCW 163
           I  H N++ LLG C++     ++ EY   G+L            +    P  +  +    
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 164 EKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 221
           + L   A   ARG+EYL        CI H D+   N+L+  + + K++DFGLA+     +
Sbjct: 191 KDLVSCAYQVARGMEYLASKK----CI-HRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA 281
            +   +  R  + ++APE  +      + +SDV+ FG++L E+              +  
Sbjct: 246 YYKKTTNGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIF-------------TLG 290

Query: 282 YFP------SWVYDQLNKGGDLEL-RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             P        ++  L +G  ++   N T        +L M+   C     + RP+  ++
Sbjct: 291 GSPYPGVPVEELFKLLKEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQL 343

Query: 335 LEMLE 339
           +E L+
Sbjct: 344 VEDLD 348

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (283), Expect = 9e-29
 Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 29/219 (13%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFI------------------NEVST 113
            L QG F  +   +       A+K    S    +                     NE+  
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI----FPKESRGQSFCWEKLHEV 169
           I  I +   +   G  +   +  ++YEYM N S+ +         ++       + +  +
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
                    Y+HN  ++C  H D+KP NIL+D N   K+SDFG +++   +     I  +
Sbjct: 157 IKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGS 210

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           RGT  ++ PE  S        K D++  G+ L  M    
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (280), Expect = 1e-28
 Identities = 63/221 (28%), Positives = 92/221 (41%), Gaps = 29/221 (13%)

Query: 56  RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-----FIN 109
           RY   +I+        KLG GG  +VY  +       +A+K +       +E     F  
Sbjct: 12  RY---KIVD-------KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFER 60

Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEV 169
           EV    ++ H N+V ++    E     LV EY+   +L  +I   ES G     +     
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGP-LSVDTAINF 116

Query: 170 ALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
                 GI++ H       I+H DIKP NIL+D N   K+ DFG+AK    E      + 
Sbjct: 117 TNQILDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNH 171

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
             GT+ Y +PE            +D+Y  G+VL EM  G  
Sbjct: 172 VLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEP 210

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  112 bits (281), Expect = 3e-28
 Identities = 42/221 (19%), Positives = 86/221 (38%), Gaps = 35/221 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHH--VNV 122
               ++G GG   V++       + A+K +   +   +    + NE++ + ++      +
Sbjct: 59  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT-----ARGI 177
           ++L  +        +V E   N  L+  +   + +        +      +        +
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKK------SIDPWERKSYWKNMLEAV 168

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
             +H +G    I+H D+KP N L+    + K+ DFG+A     +   V   +  G + Y+
Sbjct: 169 HTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 237 APELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 268
            PE I     +         +S KSDV+  G +L  M  G+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (274), Expect = 5e-28
 Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 45/239 (18%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQL 125
             LG+G FG+VY  +   +  ++A+K+L  ++        +   EV     + H N+++L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARGIEYL 180
            G+  + ++  L+ EY P G++ R +     F  E R  ++    + E+A      + Y 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATY----ITELANA----LSYC 125

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGY 235
           H       ++H DIKP N+LL      K++DFG +   P        S+ R    GT+ Y
Sbjct: 126 HSKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAP--------SSRRTDLCGTLDY 173

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHAT----RSSKAYFPSWV 287
           + PE+I         K D++  G++  E   G+     +    T       +  FP +V
Sbjct: 174 LPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  110 bits (276), Expect = 6e-28
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVK-MLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V   +  H+G  +AVK M    +   E   NEV  +    H NVV++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 130 SEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  ++ E++  G+L      +   E +  + C   L        + + YLH     
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL--------QALAYLHAQG-- 161

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
            ++H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+IS
Sbjct: 162 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVIS 214

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
           R+    + + D++  G++++EM  G     +    +
Sbjct: 215 RS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 248

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 2e-27
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 29/217 (13%)

Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVK-MLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ M    +   E  INE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 129 CSEGSKRALVYEYMPNGSLD---RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL          E +  + C E L        + +E+LH+   
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 136

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELI 241
             ++H DIK  NILL  +   K++DFG    +     K +  V      GT  ++APE++
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEVV 188

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
           +R       K D++  G++ +EM  G     N +  R
Sbjct: 189 TRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  111 bits (279), Expect = 3e-27
 Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 44/215 (20%)

Query: 72  KLGQGGFGSVYKG---QLHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIHHVNVV 123
            +  GG G +Y      ++ G  + +K L     SG+       + E   +  + H ++V
Sbjct: 87  CIAHGGLGWIYLALDRNVN-GRPVVLKGL---VHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 124 QLLGFCSEGSKRA-----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
           Q+  F     +       +V EY+   SL      K S+GQ     +     L     + 
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYLLEILPALS 196

Query: 179 YLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIG 234
           YLH  G    +++ D+KP NI+L    + K+ D G             I++     GT G
Sbjct: 197 YLHSIG----LVYNDLKPENIMLTEEQL-KLIDLGAVS---------RINSFGYLYGTPG 242

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           + APE++       +  +D+Y  G  L  +     
Sbjct: 243 FQAPEIVR---TGPTVATDIYTVGRTLAALTLDLP 274

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (270), Expect = 3e-27
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 32/221 (14%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLA-NSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK +   TG L A K++   S+   E++I E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHE-----VALGTARGIEYLHNGC 184
               K  ++ E+ P G++D  +   +          L E     V       + +LH+  
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              I+H D+K  N+L+      +++DFG      K   K + F+      GT  ++APE+
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEV 188

Query: 241 ISRNFGTVS---CKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
           +       +    K+D++  G+ L+EMA     +  ++  R
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  108 bits (271), Expect = 4e-27
 Identities = 64/285 (22%), Positives = 108/285 (37%), Gaps = 63/285 (22%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEY 179
           F  +     +V E     SL       + R        L E     AR        G +Y
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRK------ALTE---PEARYYLRQIVLGCQY 156

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 238
           LH      ++H D+K  N+ L+ +   K+ DFGLA     + +         GT  YIAP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAP 210

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHAT----RSSKAYFPSWVYDQL 291
           E++S+     S + DV+  G ++  +  G+     S +  T    + ++   P  +    
Sbjct: 211 EVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI---- 264

Query: 292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                          + +A  L  I    +Q     RP++ ++L 
Sbjct: 265 ---------------NPVAASL--IQ-KMLQTDPTARPTINELLN 291

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  110 bits (275), Expect = 8e-27
 Identities = 64/254 (25%), Positives = 93/254 (36%), Gaps = 46/254 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQ 124
               +LG GGFG V +     TG  +A+K           E +  E+  + +++H NVV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 125 LLGFCSEGSKRA------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--- 175
                    K A      L  EY   G L +++   E+         L E      R   
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC------GLKEG---PIRTLL 127

Query: 176 -----GIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSIS 227
                 + YLH   +  I+H D+KP NI+L       I K+ D G AK   +        
Sbjct: 128 SDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184

Query: 228 ATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMHATRSS 279
              GT+ Y+APEL+  + +       D + FG +  E   G R           H     
Sbjct: 185 ---GTLQYLAPELLEQKKYT---VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 280 KAYFPSWVYDQLNK 293
           K+     VYD L  
Sbjct: 239 KSNEHIVVYDDLTG 252

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (266), Expect = 1e-26
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 31/225 (13%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
            +G G    V           +A+K   L   + S +E + E+  + + HH N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALG-----TARGIEYLH-N 182
                +  LV + +  GS+   I              L E  +         G+EYLH N
Sbjct: 82  FVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---------HPKENDFVSISATRGTI 233
           G     +H D+K  NILL  +   +++DFG++ F         +     FV      GT 
Sbjct: 141 G----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV------GTP 190

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
            ++APE++ +  G    K+D++ FG+  +E+A G          +
Sbjct: 191 CWMAPEVMEQVRG-YDFKADIWSFGITAIELATGAAPYHKYPPMK 234

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  106 bits (267), Expect = 1e-26
 Identities = 68/293 (23%), Positives = 112/293 (38%), Gaps = 46/293 (15%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVK-MLANSKFSGEEFINEVSTIGRI-HHVNVVQLLG 127
             L +GGF  VY+ Q + +G   A+K +L+N +      I EV  + ++  H N+VQ   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 128 FCSEGSKRA-------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
             S G + +       L+   +  G L   +   ESRG   C   L  +   T R ++++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK-IFYQTCRAVQHM 152

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---------HPKENDFVSISATR- 230
           H      I+H D+K  N+LL +    K+ DFG A             +    V    TR 
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 231 GTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR---RNSNMHATRSSKAYFPSW 286
            T  Y  PE+I       +  K D++  G +L  +   +    +       + K   P  
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPH 271

Query: 287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                           T   S+I           +QV   +R S+ +V+  L+
Sbjct: 272 ------------DTQYTVFHSLIR--------AMLQVNPEERLSIAEVVHQLQ 304

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  105 bits (265), Expect = 1e-26
 Identities = 64/285 (22%), Positives = 107/285 (37%), Gaps = 63/285 (22%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEY 179
           F  +     +V E     SL       + R        L E     AR        G +Y
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH---KRRK------ALTE---PEARYYLRQIVLGCQY 130

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 238
           LH      ++H D+K  N+ L+ +   K+ DFGLA     + +         GT  YIAP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAP 184

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHAT----RSSKAYFPSWVYDQL 291
           E++S+     S + DV+  G ++  +  G+     S +  T    + ++   P  +    
Sbjct: 185 EVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI---- 238

Query: 292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                          S+I + L        Q     RP++ ++L 
Sbjct: 239 ----------NPVAASLIQKML--------QTDPTARPTINELLN 265

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (268), Expect = 1e-26
 Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 27/192 (14%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI------NEVSTIGRIHHVN 121
               +G+G F  V +     TG   AVK++  +KF+    +       E S    + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTAR----G 176
           +V+LL   S      +V+E+M    L    I  +   G  +  E    VA    R     
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYS-EA---VASHYMRQILEA 142

Query: 177 IEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
           + Y H N     I+H D+KPH +LL   +++   K+  FG+A    +           GT
Sbjct: 143 LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV--GT 196

Query: 233 IGYIAPELISRN 244
             ++APE++ R 
Sbjct: 197 PHFMAPEVVKRE 208

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (266), Expect = 3e-26
 Identities = 44/257 (17%), Positives = 91/257 (35%), Gaps = 46/257 (17%)

Query: 47  HNQQSWMPKRYSYPEIIAVTNHFT--HKLGQG--GFGSVYKGQ-LHTGGLIAVKMLANSK 101
           H +  +     S+         +     +G+G     +V   +   TG  + V+ +    
Sbjct: 8   HMENLYFQGMSSFL---PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64

Query: 102 FSGEEF---INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG 158
            S E       E+      +H N+V         ++  +V  +M  GS  + +       
Sbjct: 65  CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLI------ 117

Query: 159 QSFCWEKLHE-----VALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
            +   + ++E     +  G  + ++Y+H  G     +H  +K  +IL+  +    +S   
Sbjct: 118 CTHFMDGMNELAIAYILQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSGLR 173

Query: 213 LA-----------KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
                          H      V        + +++PE++ +N      KSD+Y  G+  
Sbjct: 174 SNLSMISHGQRQRVVHDFPKYSV------KVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227

Query: 262 LEMAGGRR-NSNMHATR 277
            E+A G     +M AT+
Sbjct: 228 CELANGHVPFKDMPATQ 244

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  105 bits (263), Expect = 4e-26
 Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 39/229 (17%)

Query: 56  RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-----FIN 109
           RY   E+          LG GG   V+  + L     +AVK+L  +  + +      F  
Sbjct: 13  RY---ELGE-------ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRR 61

Query: 110 EVSTIGRIHHVNVVQLL--GFCSEGSKRALVY---EYMPNGSLDRHIFPKESRGQSFCWE 164
           E      ++H  +V +   G  +E     L Y   EY+   +L   +            +
Sbjct: 62  EAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 116

Query: 165 KLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
           +  EV     + + + H NG    I+H D+KP NI++      KV DFG+A+     +  
Sbjct: 117 RAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSG 170

Query: 224 VSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
            S++ T    GT  Y++PE       +V  +SDVY  G VL E+  G  
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEP 217

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  104 bits (261), Expect = 4e-26
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 19/223 (8%)

Query: 47  HNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG- 104
           H+  S   +   +   I     F  KLG G FG V+   +  +G    +K +   +    
Sbjct: 4   HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63

Query: 105 -EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFC 162
            E+   E+  +  + H N++++     +     +V E    G L +R I   ++RG++  
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER-IVSAQARGKALS 122

Query: 163 WEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHP 218
              + E+       + Y H       ++H D+KP NIL      +   K+ DFGLA+   
Sbjct: 123 EGYVAELMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178

Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
            +    + +   GT  Y+APE+  R+      K D++  G+V+
Sbjct: 179 SDEHSTNAA---GTALYMAPEVFKRDVTF---KCDIWSAGVVM 215

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  103 bits (258), Expect = 1e-25
 Identities = 61/233 (26%), Positives = 108/233 (46%), Gaps = 34/233 (14%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G F  VY+ + +HTG  +A+KM+           +   NEV    ++ H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPK-----ESRGQSFCWEKLHEVALGTARGIEYLHN 182
           +  + +   LV E   NG ++R++  +     E+  + F    +H++      G+ YLH+
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF----MHQII----TGMLYLHS 130

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELI 241
                ILH D+   N+LL  N   K++DFGLA      ++      T  GT  YI+PE+ 
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPEIA 184

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHAT----RSSKAYFPSWV 287
           +R+      +SDV+  G +   +  GR       +  T      +    PS++
Sbjct: 185 TRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL 235

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  103 bits (259), Expect = 1e-25
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 30/218 (13%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG    T  ++A+K+  L  ++   E+   E++ + +     V +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPK---ESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  +   E L        +G++YLH+  
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 139

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
               +H DIK  N+LL  +   K++DFG    L     K N FV      GT  ++APE+
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 190

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
           I +       K+D++  G+  +E+A G   +S +H  +
Sbjct: 191 IKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMK 226

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  104 bits (261), Expect = 1e-25
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 71  HKLGQGGFGSVYKGQL-HTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            +LG G  G V+K     +G ++A K+  L        + I E+  +   +   +V   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 128 -FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            F S+G + ++  E+M  GSLD+ +     +      + L +V++   +G+ YL      
Sbjct: 99  AFYSDG-EISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KH 151

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRN 244
            I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +   
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT 205

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               S +SD++  G+ L+EMA GR
Sbjct: 206 --HYSVQSDIWSMGLSLVEMAVGR 227

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  102 bits (257), Expect = 1e-25
 Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 43/236 (18%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +      ++A+K+L  S+        +   E+     + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 128 FCSEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           +  +  +  L+ E+ P G L + +     F  E R  +F  E         A  + Y H 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFMEE--------LADALHYCHE 132

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAP 238
                ++H DIKP N+L+ +    K++DFG +   P        S  R    GT+ Y+ P
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--------SLRRRTMCGTLDYLPP 181

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHAT----RSSKAYFPSWV 287
           E+I     T   K D++  G++  E   G     + +   T     +    FP ++
Sbjct: 182 EMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  105 bits (264), Expect = 1e-25
 Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 25/204 (12%)

Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNV 122
                LG+G FG V       TG   AVK+++  +   +      + EV  + ++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           ++L  F  +     LV E    G L D  I    SR   F       +      GI Y+H
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRK-RFSEVDAARIIRQVLSGITYMH 143

Query: 182 -NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            N     I+H D+KP N+LL     +   ++ DFGL+                GT  YIA
Sbjct: 144 KNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIA 196

Query: 238 PELISRNFGTVSCKSDVYGFGMVL 261
           PE++   +     K DV+  G++L
Sbjct: 197 PEVLHGTYDE---KCDVWSTGVIL 217

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  105 bits (264), Expect = 2e-25
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 24/203 (11%)

Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVV 123
               KLG G +G V       T    A+K++  +  S       + EV+ +  + H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH- 181
           +L  F  +     LV E    G L D  I     R   F       +      G+ YLH 
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEII----HRM-KFNEVDAAVIIKQVLSGVTYLHK 154

Query: 182 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           +     I+H D+KP N+LL   + + + K+ DFGL+     +          GT  YIAP
Sbjct: 155 HN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAP 207

Query: 239 ELISRNFGTVSCKSDVYGFGMVL 261
           E++ + +     K DV+  G++L
Sbjct: 208 EVLRKKYDE---KCDVWSIGVIL 227

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (258), Expect = 2e-25
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
            KLG+G +GSVYK     TG ++A+K +       +E I E+S + +    +VV+  G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            + +   +V EY   GS+   I     R ++   +++  +   T +G+EYLH       +
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFMR---KI 147

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           H DIK  NILL+     K++DFG    L     K N  +      GT  ++APE+I    
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQE-- 199

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
              +C +D++  G+  +EMA G+   +++H  R
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (263), Expect = 2e-25
 Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 24/224 (10%)

Query: 47  HNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGE 105
           H+  S   +   +    A   +    LG+G FG V K     T    AVK++  +    +
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63

Query: 106 E---FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSF 161
           +    + EV  + ++ H N+++L     + S   +V E    G L D  I     R   F
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRK-RF 118

Query: 162 CWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFH 217
                  +      GI Y+H +     I+H D+KP NILL   + +   K+ DFGL+   
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
            +           GT  YIAPE++   +     K DV+  G++L
Sbjct: 175 QQNTKMKDRI---GTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  102 bits (256), Expect = 4e-25
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 27/223 (12%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLG- 127
             +G G +G VYKG+ + TG L A+K++  +    EE   E++ + +  HH N+    G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 128 -----FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
                      +  LV E+   GS+   I  K ++G +   E +  +     RG+ +LH 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQ 147

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAP 238
                ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++AP
Sbjct: 148 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAP 198

Query: 239 ELISRNFGTVS---CKSDVYGFGMVLLEMAGGR-RNSNMHATR 277
           E+I+ +    +    KSD++  G+  +EMA G     +MH  R
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (256), Expect = 4e-25
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEFINEVSTIGR-IHHVNVVQLLG 127
           ++G+G +GSV K     +G ++AVK       +   ++ + ++  + R      +VQ  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 128 FCSEGSKRALVYEYMPNGSLDRHI-FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
                    +  E M + S D+   +           E L ++ L T + + +L    ++
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NL 145

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG---YIAPELI-- 241
            I+H DIKP NILLD +   K+ DFG++         V   A     G   Y+APE I  
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISG------QLVDSIAKTRDAGCRPYMAPERIDP 199

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           S +      +SDV+  G+ L E+A GR
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (256), Expect = 4e-25
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 28/218 (12%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKML----ANSKFSGEEFINEVSTIGRIHHVNVVQL 125
            ++G G FG+VY  + +    ++A+K +      S    ++ I EV  + ++ H N +Q 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 126 LGFCSEGSKRALVYEYMPNGSLD----RHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
            G         LV EY    + D         +E    +     L        +G+ YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL--------QGLAYLH 171

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVI 222

Query: 242 SRNF-GTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATR 277
                G    K DV+  G+  +E+A  +    NM+A  
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  103 bits (257), Expect = 5e-25
 Identities = 41/218 (18%), Positives = 72/218 (33%), Gaps = 28/218 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQ------LHTGGLIAVKMLANSKFSGEEF---INEVSTIGRIH 118
           +  H LG+G F  VY+                +K+      +  EF      +  +    
Sbjct: 68  YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ--KPANPWEFYIGTQLMERLKPSM 125

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI-FPKESRGQSFCWEKLHEVALGTARGI 177
               ++        +   LV E    G+L   I   K +  +      +   A+     I
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIP-----------KVSDFGLAKFHPKENDFVSI 226
           E +H   D  I+H DIKP N +L + F+             + D G +            
Sbjct: 186 EQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +A   T G+   E++S      + + D +G    +  M
Sbjct: 243 TAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (253), Expect = 6e-25
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEFINEVSTIGR-IHHVNVVQLLG 127
           +LG+G +G V K + + +G ++AVK      +    +  + ++    R +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                    +  E M + SLD+       +GQ+   + L ++A+   + +E+LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFG--------LAKFHPKENDFVSISATRGTIGYIAPE 239
           ++H D+KP N+L++     K+ DFG        +AK     +         G   Y+APE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-----DIDA------GCKPYMAPE 179

Query: 240 LI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            I    N    S KSD++  G+ ++E+A  R
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  103 bits (258), Expect = 6e-25
 Identities = 48/231 (20%), Positives = 86/231 (37%), Gaps = 30/231 (12%)

Query: 58  SYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI 117
           ++ + +         LG G  G+V       G  +AVK +       +  + E+  +   
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTES 65

Query: 118 -HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA---LGT 173
             H NV++     +      +  E   N +L   +  K    ++   +K +         
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDH-------------NFIPKVSDFGLAK-FHPK 219
           A G+ +LH    + I+H D+KP NIL+               N    +SDFGL K     
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 220 ENDFVSISATR-GTIGYIAPELISRNFGTV-----SCKSDVYGFGMVLLEM 264
           ++ F +      GT G+ APEL+  +         +   D++  G V   +
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (254), Expect = 6e-25
 Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 19/205 (9%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIHHVNVVQL 125
            +G+GG G VY+ +      ++A+K++ +   S +         E  T GR+   +VV +
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGC 184
             F     +  +    +    L   +     R       +   +       ++  H  G 
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAAG- 154

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
                H D+KP NIL+  +    + DFG+A     +     +  T GT+ Y+APE  S  
Sbjct: 155 ---ATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSE- 209

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRR 269
               + ++D+Y    VL E   G  
Sbjct: 210 -SHATYRADIYALTCVLYECLTGSP 233

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  100 bits (251), Expect = 1e-24
 Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 32/230 (13%)

Query: 46  LHNQQSWMPKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKF 102
           +H+       R +          +     LG+G FG V K     T    AVK++  +  
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 103 SGEE---FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKES-- 156
             ++    + EV  + ++ H N+++L     + S   +V E    G L D  I  ++   
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE-IIKRKRFS 119

Query: 157 -RGQSFCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDF 211
               +   +++          I Y+H +     I+H D+KP NILL   + +   K+ DF
Sbjct: 120 EHDAARIIKQVFSG-------ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDF 168

Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           GL+    +           GT  YIAPE++   +     K DV+  G++L
Sbjct: 169 GLSTCFQQNTKMKDRI---GTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  101 bits (253), Expect = 2e-24
 Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 29/196 (14%)

Query: 70  THKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQLLG 127
           T  LG G FG V+K  +  TG  +A K++        EE  NE+S + ++ H N++QL  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTAR----GIEYLH- 181
                +   LV EY+  G L DR I        +   E      +   +    GI ++H 
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII----DESYNLT-EL---DTILFMKQICEGIRHMHQ 205

Query: 182 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                 ILH D+KP NIL    D   I K+ DFGLA+ +             GT  ++AP
Sbjct: 206 MY----ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF---GTPEFLAP 257

Query: 239 ELISRNFGTVSCKSDV 254
           E+++ +F  VS  +D+
Sbjct: 258 EVVNYDF--VSFPTDM 271

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 99.2 bits (248), Expect = 3e-24
 Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 21/183 (11%)

Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLL 126
            +LG+G F  V +     TG   A K++   K S  +      E     ++ H N+V+L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 127 GFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGC 184
               E S   LV++ +  G L +  I  +E     +               I Y H NG 
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFED-IVARE----FYSEADASHCIQQILESIAYCHSNG- 125

Query: 185 DVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
              I+H ++KP N+LL         K++DFGLA        +   +   GT GY++PE++
Sbjct: 126 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVL 179

Query: 242 SRN 244
            ++
Sbjct: 180 KKD 182

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (253), Expect = 5e-24
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 35/214 (16%)

Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG--------------EEFINEVS 112
               KLG G +G V    + +     A+K++  S+F                EE  NE+S
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVAL 171
            +  + H N+++L     +     LV E+   G L ++ I    +R + F       +  
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHK-FDECDAANIMK 153

Query: 172 GTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSIS 227
               GI YLH +     I+H DIKP NILL   +     K+ DFGL+ F  K+       
Sbjct: 154 QILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209

Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
              GT  YIAPE++ + +     K DV+  G+++
Sbjct: 210 ---GTAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (251), Expect = 6e-24
 Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 31/211 (14%)

Query: 72  KLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFIN-EVSTIGRIHHVNVVQLLG-F 128
            +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++ H N+V+L   F
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 129 CSEGSKRA-----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT---ARGIEYL 180
            S G K+      LV +Y+P  ++ R         Q+     +  V L      R + Y+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTL---PVIYVKLYMYQLFRSLAYI 172

Query: 181 HNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R    Y APE
Sbjct: 173 HS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPE 226

Query: 240 LISRNFGTV--SCKSDVYGFGMVLLEMAGGR 268
           LI   FG    +   DV+  G VL E+  G+
Sbjct: 227 LI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 38/202 (18%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  +  TG   A K +   +          EE   EVS + ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEV-ALGTAR----GI 177
            L       +   L+ E +  G L D  +  KES         L E  A    +    G+
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDF-LAQKES---------LSEEEATSFIKQILDGV 128

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGT 232
            YLH       I HFD+KP NI+L    IP    K+ DFGLA       +F +I    GT
Sbjct: 129 NYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GT 181

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             ++APE+++     +  ++D+
Sbjct: 182 PEFVAPEIVNYEP--LGLEADM 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 99.3 bits (248), Expect = 8e-24
 Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 21/182 (11%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +     TG   A K++   K S  +      E     ++ H N+V+L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCD 185
              E S   LV++ +  G L +  I  +E     +               I Y H NG  
Sbjct: 96  SIQEESFHYLVFDLVTGGELFED-IVARE----FYSEADASHCIQQILESIAYCHSNG-- 148

Query: 186 VCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H ++KP N+LL         K++DFGLA        +   +   GT GY++PE++ 
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLK 203

Query: 243 RN 244
           ++
Sbjct: 204 KD 205

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 99.7 bits (249), Expect = 8e-24
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFIN-EVSTIGRIHHVNVVQLLG-FC 129
            +G G FG V++ +L     +A+K +   K     F N E+  +  + H NVV L   F 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 130 SEGSKRA-----LVYEYMPNGSLDRHI--FPKESRG------QSFCWEKLHEVALGTARG 176
           S G K+      LV EY+P  ++ R    + K  +       + + ++ L        R 
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL--------RS 153

Query: 177 IEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + Y+H+   + I H DIKP N+LLD  + + K+ DFG AK        VS   +R    Y
Sbjct: 154 LAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR---YY 207

Query: 236 IAPELISRNFGTV--SCKSDVYGFGMVLLEMAGGR 268
            APELI   FG    +   D++  G V+ E+  G+
Sbjct: 208 RAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 57/202 (28%), Positives = 85/202 (42%), Gaps = 38/202 (18%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  +  TG   A K +   +          EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEV-ALGTAR----GI 177
            L       +   L+ E +  G L D  +  KES         L E  A    +    G+
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDF-LAQKES---------LSEEEATSFIKQILDGV 128

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGT 232
            YLH       I HFD+KP NI+L    IP    K+ DFGLA    ++          GT
Sbjct: 129 NYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIF--GT 181

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             ++APE+++     +  ++D+
Sbjct: 182 PEFVAPEIVNYEP--LGLEADM 201

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 97.7 bits (244), Expect = 1e-23
 Identities = 42/201 (20%), Positives = 76/201 (37%), Gaps = 22/201 (10%)

Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE-FINEVSTIGRIHHVNVVQL 125
              + +G+G +G V    Q  T    A K +        + F  E+  +  + H N+++L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 126 LGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NG 183
                + +   LV E    G L +R +  K      F       +       + Y H   
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFER-VVHKR----VFRESDAARIMKDVLSAVAYCHKLN 126

Query: 184 CDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               + H D+KP N L      +   K+ DFGLA          +     GT  Y++P++
Sbjct: 127 ----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQV 179

Query: 241 ISRNFGTVSCKSDVYGFGMVL 261
           +   +G    + D +  G+++
Sbjct: 180 LEGLYGP---ECDEWSAGVMM 197

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 39/202 (19%), Positives = 77/202 (38%), Gaps = 30/202 (14%)

Query: 65  VTNHFT--HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN 121
           +   +     LG+G FG V++  +  +      K +            E+S +    H N
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTAR----G 176
           ++ L        +  +++E++    + +R      +       E+     +         
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERIN----TSAFELN-ER---EIVSYVHQVCEA 114

Query: 177 IEYLH-NGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGT 232
           +++LH +     I HFDI+P NI+      + I K+ +FG A+   K  D   +      
Sbjct: 115 LQFLHSHN----IGHFDIRPENIIYQTRRSSTI-KIIEFGQARQL-KPGDNFRLLF--TA 166

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             Y APE+   +   VS  +D+
Sbjct: 167 PEYYAPEVHQHDV--VSTATDM 186

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 99.0 bits (246), Expect = 1e-23
 Identities = 22/229 (9%), Positives = 50/229 (21%), Gaps = 41/229 (17%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLG 127
           L  G    V+    +      A+K+      +     E          R+   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 128 FCSEGSKRA--------------------------LVYEYMP--NGSLDRHIFPKESRGQ 159
                                              L+          L   +        
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 160 SFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
                 LH +     R    L       ++H    P N+ +  +    + D         
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                   A+   + Y   E ++ +  T +   + +  G+ +  +    
Sbjct: 247 -----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 97.2 bits (243), Expect = 2e-23
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 40/211 (18%)

Query: 65  VTNHFT--HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG-------EEFINEVSTI 114
           V +H+    +LG G F  V K  Q  TG   A K +   + S        EE   EV+ +
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEV-ALG 172
             I H N++ L       +   L+ E +  G L D  +  KES         L E  A  
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDF-LAEKES---------LTEDEATQ 112

Query: 173 TAR----GIEYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDF 223
             +    G+ YLH       I HFD+KP NI+L    +P    K+ DFG+A      N+F
Sbjct: 113 FLKQILDGVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDV 254
            +I    GT  ++APE+++     +  ++D+
Sbjct: 169 KNIF---GTPEFVAPEIVNYEP--LGLEADM 194

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 98.4 bits (245), Expect = 2e-23
 Identities = 51/242 (21%), Positives = 87/242 (35%), Gaps = 52/242 (21%)

Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG------EEFINEVSTIGRIHHV 120
           H    +GQG +G V    +  T  + A+K++  +K         E    EV  + ++HH 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR----- 175
           N+ +L     +     LV E    G L   +          C   + +  +         
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 176 -------------------------------GIEYLH-NGCDVCILHFDIKPHNILL--D 201
                                           + YLH  G    I H DIKP N L   +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTN 204

Query: 202 HNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 259
            +F  K+ DFGL+K        ++  ++   GT  ++APE+++    +   K D +  G+
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264

Query: 260 VL 261
           +L
Sbjct: 265 LL 266

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 96.5 bits (241), Expect = 2e-23
 Identities = 67/235 (28%), Positives = 95/235 (40%), Gaps = 35/235 (14%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEYLH 181
            EG+ + L  EY   G L   I P            + E     A+        G+ YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI---------GMPE---PDAQRFFHQLMAGVVYLH 122

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMHATR---SSKAYFPSWVY 288
            R     +   DV+  G+VL  M  G       + +          K Y   W  
Sbjct: 180 KRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 47/202 (23%), Positives = 85/202 (42%), Gaps = 29/202 (14%)

Query: 65  VTNHFT--HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHV 120
           V +++    +LG G FG V++  +  TG +   K +            NE+S + ++HH 
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTAR---- 175
            ++ L     +  +  L+ E++  G L DR      +       E      +   R    
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMS-EA---EVINYMRQACE 160

Query: 176 GIEYLH-NGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGT 232
           G++++H +     I+H DIKP NI+ +       K+ DFGLA     +      +    T
Sbjct: 161 GLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---AT 213

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             + APE++ R    V   +D+
Sbjct: 214 AEFAAPEIVDREP--VGFYTDM 233

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 46/238 (19%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEF----INEVSTIGRIHHVNVVQ 124
            LG+G F +VYK +  +T  ++A+K   L +   + +      + E+  +  + H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 125 LLGFCSEGSKRALVYEYMPN---GSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYL 180
           LL      S  +LV+++M       +  +      S  +++    L        +G+EYL
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL--------QGLEYL 128

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 239
           H      ILH D+KP+N+LLD N + K++DFGLAK F      +     TR    Y APE
Sbjct: 129 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR---WYRAPE 182

Query: 240 LI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQLNK 293
           L+  +R +G  V    D++  G +L E+                 + P     DQL +
Sbjct: 183 LLFGARMYGVGV----DMWAVGCILAELLLR------------VPFLPGDSDLDQLTR 224

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 98.4 bits (245), Expect = 7e-23
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 33/204 (16%)

Query: 65  VTNHFT--HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHV 120
           V +H+    +LG G FG V++  +  TG   A K +     S +E +  E+ T+  + H 
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEV-ALGTAR--- 175
            +V L     + ++  ++YE+M  G L ++ +  +          K+ E  A+   R   
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEK-VADEH--------NKMSEDEAVEYMRQVC 265

Query: 176 -GIEYLH-NGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATR 230
            G+ ++H N      +H D+KP NI+      N + K+ DFGL          V ++   
Sbjct: 266 KGLCHMHENN----YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHL-DPKQSVKVTT-- 317

Query: 231 GTIGYIAPELISRNFGTVSCKSDV 254
           GT  + APE+       V   +D+
Sbjct: 318 GTAEFAAPEVA--EGKPVGYYTDM 339

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 95.9 bits (239), Expect = 7e-23
 Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 24/208 (11%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML----ANSKFSGEEFINEVSTIGR-IHHVNVVQL 125
           ++G G  G V+K +   TG +IAVK +       +   +  + ++  + +      +VQ 
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN--KRILMDLDVVLKSHDCPYIVQC 89

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
            G     +   +  E M   +       K+          L ++ +   + + YL     
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKL----KKRMQGPIPERILGKMTVAIVKALYYLKE--K 143

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELISR 243
             ++H D+KP NILLD     K+ DFG++            +  R  G   Y+APE I  
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISG-----RLVDDKAKDRSAGCAAYMAPERIDP 198

Query: 244 NF---GTVSCKSDVYGFGMVLLEMAGGR 268
                     ++DV+  G+ L+E+A G+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQ 226

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 95.7 bits (239), Expect = 8e-23
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 20/183 (10%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI-NEVSTIGRIHHVNVVQLL 126
           F   LG G F  V+   Q  TG L A+K +  S    +  + NE++ + +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 127 GFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGC 184
                 +   LV + +  G L DR I  +      +  +    V       ++YLH NG 
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDR-ILERG----VYTEKDASLVIQQVLSAVKYLHENG- 126

Query: 185 DVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
              I+H D+KP N+L    + N    ++DFGL+K   +     +     GT GY+APE++
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTAC---GTPGYVAPEVL 179

Query: 242 SRN 244
           ++ 
Sbjct: 180 AQK 182

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 67/235 (28%), Positives = 95/235 (40%), Gaps = 35/235 (14%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEYLH 181
            EG+ + L  EY   G L   I   E          + E     A+        G+ YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI---EPDI------GMPE---PDAQRFFHQLMAGVVYLH 122

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMHATR---SSKAYFPSWVY 288
            R     +   DV+  G+VL  M  G       + +          K Y   W  
Sbjct: 180 KRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 20/185 (10%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQ 124
              +LG+G F  V +  ++  G   A  ++   K S    ++   E      + H N+V+
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 125 LLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-N 182
           L    SE     L+++ +  G L +  I  +E     +               + + H  
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFED-IVARE----YYSEADASHCIQQILEAVLHCHQM 129

Query: 183 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           G    ++H ++KP N+LL         K++DFGLA     E       A  GT GY++PE
Sbjct: 130 G----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPE 183

Query: 240 LISRN 244
           ++ ++
Sbjct: 184 VLRKD 188

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 94.9 bits (237), Expect = 2e-22
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 45/236 (19%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF-SGEEFIN--EVSTIGRIHHVNVVQLLG 127
           K+G+G +G V+K +   TG ++A+K    S+     + I   E+  + ++ H N+V LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 128 FCSEGSKRALVYEYMPN---GSLDRH-IFPKESRGQSFCWEKLHEVALGTARGIEYLH-N 182
                 +  LV+EY  +     LDR+     E   +S  W+ L        + + + H +
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL--------QAVNFCHKH 121

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI 241
                 +H D+KP NIL+  + + K+ DFG A+      + +    ATR    Y +PEL+
Sbjct: 122 N----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR---WYRSPELL 174

Query: 242 --SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQLNK 293
                +G  V    DV+  G V  E+  G               +P     DQL  
Sbjct: 175 VGDTQYGPPV----DVWAIGCVFAELLSGV------------PLWPGKSDVDQLYL 214

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 38/202 (18%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  +  TG   A K +   +          E+   EVS +  I H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEV-ALGTAR----GI 177
            L       +   L+ E +  G L D  +  KES         L E  A    +    G+
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDF-LAEKES---------LTEEEATEFLKQILNGV 127

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGT 232
            YLH       I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT
Sbjct: 128 YYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             ++APE+++     +  ++D+
Sbjct: 181 PEFVAPEIVNYEP--LGLEADM 200

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 22/184 (11%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGR-IHHVNVVQLL 126
               +G G +    +     T    AVK++  SK    E   E+  + R   H N++ L 
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82

Query: 127 GFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGC 184
               +G    +V E M  G L D+ I  +    + F   +   V     + +EYLH  G 
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDK-ILRQ----KFFSEREASAVLFTITKTVEYLHAQG- 136

Query: 185 DVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H D+KP NIL      +    ++ DFG AK    EN  +       T  ++APE+
Sbjct: 137 ---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEV 191

Query: 241 ISRN 244
           + R 
Sbjct: 192 LERQ 195

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 53/242 (21%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN-----EVSTIGRIHHVNVVQL 125
           KLG G + +VYKG    TG  +A+K +   K   EE        E+S +  + H N+V+L
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 126 LGFCSEGSKRALVYEYMPN---GSLDRHIFPKESRG------QSFCWEKLHEVALGTARG 176
                  +K  LV+E+M N     +D        RG      + F W+ L        +G
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL--------QG 120

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGY 235
           + + H      ILH D+KP N+L++     K+ DFGLA+ F    N F S   T     Y
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL---WY 174

Query: 236 IAPELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQL 291
            AP+++  SR + T +    D++  G +L EM  G            K  FP +   +QL
Sbjct: 175 RAPDVLMGSRTYSTSI----DIWSCGCILAEMITG------------KPLFPGTNDEEQL 218

Query: 292 NK 293
             
Sbjct: 219 KL 220

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.9 bits (239), Expect = 3e-22
 Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 32/194 (16%)

Query: 68  HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE---------FINEVSTIGRI 117
             +  LG G  G V    +  T   +A+++++  KF+               E+  + ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DR---HIFPKESRGQSFCWEKLHEVALGT 173
           +H  ++++  F  +     +V E M  G L D+   +   KE+  + + ++ L       
Sbjct: 198 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL------ 250

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              ++YLH   +  I+H D+KP N+LL   + + + K++DFG +K    E   +      
Sbjct: 251 --AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-- 302

Query: 231 GTIGYIAPELISRN 244
           GT  Y+APE++   
Sbjct: 303 GTPTYLAPEVLVSV 316

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.9 bits (234), Expect = 4e-22
 Identities = 52/183 (28%), Positives = 74/183 (40%), Gaps = 20/183 (10%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE-FINEVSTIGRI-HHVNVVQLLGFC 129
           LG+G    V     L T    AVK++             EV  + +   H NV++L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDVCI 188
            E  +  LV+E M  GS+  HI     R   F   +   V    A  +++LH  G    I
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHI---HKRR-HFNELEASVVVQDVASALDFLHNKG----I 132

Query: 189 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPEL 240
            H D+KP NIL    +     K+ DF L        D   IS        G+  Y+APE+
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192

Query: 241 ISR 243
           +  
Sbjct: 193 VEA 195

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.5 bits (233), Expect = 5e-22
 Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 30/212 (14%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN-----EVSTIGRIHHVNVVQLL 126
           LG+G +G V +     T    AVK+L   K             E+  + R+ H NV+QL+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 127 GFCSEGSKRA--LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------G 176
                  K+   +V EY   G  +  +             +        A         G
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK------RFPV---CQAHGYFCQLIDG 121

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +EYLH+     I+H DIKP N+LL      K+S  G+A+         +   ++G+  + 
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            PE+ +        K D++  G+ L  +  G 
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 93.1 bits (232), Expect = 8e-22
 Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 32/198 (16%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRI-HHVNVVQLL 126
           +LG+G F  V +     TG   A K L   +       E ++E++ +        V+ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 127 GFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEV-ALGTAR----GIEYL 180
                 S+  L+ EY   G +      P+ +       E + E   +   +    G+ YL
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSL-CLPELA-------EMVSENDVIRLIKQILEGVYYL 147

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIP---KVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           H N     I+H D+KP NILL   +     K+ DFG+++        +      GT  Y+
Sbjct: 148 HQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIM--GTPEYL 200

Query: 237 APELISRNFGTVSCKSDV 254
           APE+++ +   ++  +D+
Sbjct: 201 APEILNYDP--ITTATDM 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 92.6 bits (231), Expect = 8e-22
 Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 46/236 (19%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNVVQL 125
           K+G+G +G VYK Q + G   A+K +   +   E+       I E+S +  + H N+V+L
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 126 LGFCSEGSKRALVYEYMPN---GSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLH 181
                   +  LV+E++       LD      +    +SF  + L         GI Y H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL--------NGIAYCH 117

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 240
              D  +LH D+KP N+L++     K++DFGLA+ F      +     T     Y AP++
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL---WYRAPDV 171

Query: 241 I--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQLNK 293
           +  S+ + T     D++  G +  EM  G               FP     DQL +
Sbjct: 172 LMGSKKYST---TIDIWSVGCIFAEMVNGT------------PLFPGVSEADQLMR 212

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 93.9 bits (233), Expect = 9e-22
 Identities = 42/308 (13%), Positives = 88/308 (28%), Gaps = 73/308 (23%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRI---------- 117
           LGQ    +  +     TG    V +   ++      I     EV  +  +          
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 118 ---------------HHVNVVQLLGFCSEGSKRALVYEYM----PNGSLDRHIFPKESRG 158
                              ++++     +    +  + Y        +    +    S  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 159 QSFCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 217
           +S       ++ L   R +  LH  G    ++H  ++P +I+LD      ++ F      
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 218 PKENDFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 268
            ++   V    +  + G+  PEL +R             ++   D +  G+V+  +    
Sbjct: 255 -RDGARVV---SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA- 309

Query: 269 RNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR 328
                          P    D    G +   R+   I     R L       ++    DR
Sbjct: 310 -------------DLP-ITKDAALGGSEWIFRSCKNI-PQPVRALLE---GFLRYPKEDR 351

Query: 329 PSMTKVLE 336
               + +E
Sbjct: 352 LLPLQAME 359

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 91.9 bits (229), Expect = 1e-21
 Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 26/188 (13%)

Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG----------EEFINEVSTIGRI-H 118
             LG+G    V +     T    AVK++  +              E  + EV  + ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           H N++QL       +   LV++ M  G L D  +  K     +   ++  ++       I
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEK----VTLSEKETRKIMRALLEVI 137

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
             LH       I+H D+KP NILLD +   K++DFG +           +    GT  Y+
Sbjct: 138 CALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYL 190

Query: 237 APELISRN 244
           APE+I  +
Sbjct: 191 APEIIECS 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.4 bits (228), Expect = 2e-21
 Identities = 54/237 (22%), Positives = 102/237 (43%), Gaps = 46/237 (19%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNVVQ 124
           K+G+G +G+V+K +   T  ++A+K +   +   ++       + E+  +  + H N+V+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIVR 65

Query: 125 LLGFCSEGSKRALVYEYMPN---GSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYL 180
           L        K  LV+E+         D           +SF ++ L        +G+ + 
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL--------KGLGFC 117

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 239
           H      +LH D+KP N+L++ N   K+++FGLA+ F      + +   T     Y  P+
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL---WYRPPD 171

Query: 240 LISRNFGTV--SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQLNK 293
           ++   FG    S   D++  G +  E+A              +  FP + V DQL +
Sbjct: 172 VL---FGAKLYSTSIDMWSAGCIFAELANAG-----------RPLFPGNDVDDQLKR 214

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 91.6 bits (228), Expect = 2e-21
 Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 59/236 (25%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN---------------------- 109
           +G+G +G V      +     A+K+L+  K   +                          
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 110 -----EVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFC 162
                E++ + ++ H NVV+L+    + ++  L  V+E +  G +        +      
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132

Query: 163 WEKLHEVALGTAR--------GIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 213
              L E     AR        GIEYLH       I+H DIKP N+L+  +   K++DFG+
Sbjct: 133 --PLSED---QARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGR 268
           +      +  +S +   GT  ++APE +S      S    DV+  G+ L     G+
Sbjct: 184 SNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 46/236 (19%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE-----FINEVSTIGRIHHVNVVQL 125
           KLG+G + +VYKG    T  L+A+K +   +   EE      I EVS +  + H N+V L
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65

Query: 126 LGFCSEGSKRALVYEYMPN---GSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLH 181
                      LV+EY+       LD           + F ++ L        RG+ Y H
Sbjct: 66  HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL--------RGLAYCH 117

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 240
                 +LH D+KP N+L++     K++DFGLA+        + +   T     Y  P++
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL---WYRPPDI 171

Query: 241 I--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQLNK 293
           +  S ++ T   + D++G G +  EMA GR              FP S V +QL+ 
Sbjct: 172 LLGSTDYST---QIDMWGVGCIFYEMATGR------------PLFPGSTVEEQLHF 212

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 46/236 (19%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNVVQL 125
           K+G+G +G VYK +   G ++A+K +   +   E+       I E+S +  +HH N+V L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84

Query: 126 LGFCSEGSKRALVYEYMPN---GSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLH 181
           +          LV+E+M       LD +    ++S+ + + ++ L        RG+ + H
Sbjct: 85  IDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL--------RGVAHCH 136

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 240
                 ILH D+KP N+L++ +   K++DFGLA+ F      +     T     Y AP++
Sbjct: 137 ---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL---WYRAPDV 190

Query: 241 I--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQLNK 293
           +  S+ + T     D++  G +  EM  G            K  FP     DQL K
Sbjct: 191 LMGSKKYST---SVDIWSIGCIFAEMITG------------KPLFPGVTDDDQLPK 231

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 37/232 (15%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF-SGEEFIN--EVSTIGRIHHVNVVQLLG 127
            +G+G +G V K +   TG ++A+K    S      + I   E+  + ++ H N+V LL 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDV 186
            C +  +  LV+E++ + ++   +   E       ++ + +       GI + H +    
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI--SR 243
            I+H DIKP NIL+  + + K+ DFG A+        +    ATR    Y APEL+    
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR---WYRAPELLVGDV 200

Query: 244 NFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQLNK 293
            +G  V    DV+  G ++ EM  G               FP     DQL  
Sbjct: 201 KYGKAV----DVWAIGCLVTEMFMGE------------PLFPGDSDIDQLYH 236

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 70  THKLGQGGFGSVYKGQL-HTGGLIAVK-MLANSKFSGEEFINEVSTIGRIHHVNVVQLL- 126
               GQG FG+V  G+   TG  +A+K ++ + +F   E +  +  +  +HH N+VQL  
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQS 86

Query: 127 GFCSEGSKR------ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT---ARGI 177
            F + G +        +V EY+P+ +L R       R  +        + +      R I
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP---PPILIKVFLFQLIRSI 142

Query: 178 EYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
             LH    V + H DIKPHN+L++  +   K+ DFG AK        V+   +R    Y 
Sbjct: 143 GCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR---YYR 198

Query: 237 APELISRNFGTV--SCKSDVYGFGMVLLEMAGGR 268
           APELI   FG    +   D++  G +  EM  G 
Sbjct: 199 APELI---FGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 91.2 bits (227), Expect = 3e-21
 Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 42/207 (20%)

Query: 58  SYPEIIAVTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEE---------F 107
            YP+ +      +  LG G  G V    +  T   +A+K+++  KF+             
Sbjct: 3   VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV 62

Query: 108 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKL 166
             E+  + +++H  ++++  F  +     +V E M  G L D+ +             +L
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNK------RL 111

Query: 167 HEVALGTAR--------GIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAK 215
            E      +         ++YLH   +  I+H D+KP N+LL   + + + K++DFG +K
Sbjct: 112 KEAT---CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165

Query: 216 FHPKENDFVSISATRGTIGYIAPELIS 242
               E   +      GT  Y+APE++ 
Sbjct: 166 IL-GETSLMRTLC--GTPTYLAPEVLV 189

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 46/187 (24%), Positives = 72/187 (38%), Gaps = 29/187 (15%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN---------EVSTIGRIHHVNV 122
           LG G FG V+          + VK +   K   + +I          E++ + R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 123 VQLLGFCSEGSKRALVYEYMPNGS-----LDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           +++L          LV E   +G      +DRH    E        +            +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ--------LVSAV 143

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            YL       I+H DIK  NI++  +F  K+ DFG A +  +           GTI Y A
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC--GTIEYCA 197

Query: 238 PELISRN 244
           PE++  N
Sbjct: 198 PEVLMGN 204

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 90.8 bits (226), Expect = 6e-21
 Identities = 61/245 (24%), Positives = 98/245 (40%), Gaps = 59/245 (24%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF------INEVSTIGRIHHVNVVQ 124
           KLG+G +G VYK     T   +A+K +   +   EE       I EVS +  + H N+++
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97

Query: 125 LLGFCSEGSKRALVYEYMPN---GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           L        +  L++EY  N     +D++        +SF ++ +         G+ + H
Sbjct: 98  LKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI--------NGVNFCH 149

Query: 182 NGCDVCILHFDIKPHNILLDHNFIP-----KVSDFGLAK-FHPKENDF----VSISATRG 231
                  LH D+KP N+LL  +        K+ DFGLA+ F      F    +       
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII------- 199

Query: 232 TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVY 288
           T+ Y  PE++  SR++ T     D++    +  EM                  FP     
Sbjct: 200 TLWYRPPEILLGSRHYST---SVDIWSIACIWAEMLMK------------TPLFPGDSEI 244

Query: 289 DQLNK 293
           DQL K
Sbjct: 245 DQLFK 249

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 90.8 bits (226), Expect = 6e-21
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 22/181 (12%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFC 129
            LG+G F    K     +    AVK+++    +  +   E++ +     H N+V+L    
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKES---RGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
            +     LV E +  G L   I  K+       S+   KL          + ++H   DV
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA-------VSHMH---DV 125

Query: 187 CILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            ++H D+KP N+L    + N   K+ DFG A+  P +N  +       T+ Y APEL+++
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYAAPELLNQ 183

Query: 244 N 244
           N
Sbjct: 184 N 184

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 92.0 bits (228), Expect = 6e-21
 Identities = 25/233 (10%), Positives = 62/233 (26%), Gaps = 41/233 (17%)

Query: 73  LGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFI----NEVSTIGRI---------- 117
           LGQ    +  +     TG    V +   ++      I     EV  +  +          
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 118 ---------------HHVNVVQLLGFCSEGSKRALV----YEYMPNGSLDRHIFPKESRG 158
                              ++++     +    +             +    +    S  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 159 QSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           +S       ++ L   R +  LH      ++H  ++P +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-RD 261

Query: 219 KENDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGR 268
             +    I          A  ++     +   ++   D +  G+ +  +    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 25/187 (13%)

Query: 71  HKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSG---------EEFINEVSTIGRIH-H 119
             +G+G    V +     TG   AVK++  +             E    E   + ++  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
            +++ L+      S   LV++ M  G L D        +  +   ++   +       + 
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKV-ALSEKETRSIMRSLLEAVS 214

Query: 179 YLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           +LH N     I+H D+KP NILLD N   ++SDFG +           +    GT GY+A
Sbjct: 215 FLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYLA 267

Query: 238 PELISRN 244
           PE++  +
Sbjct: 268 PEILKCS 274

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 24/207 (11%)

Query: 73  LGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q+  TG L A K L      K  G +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 128 FCSE-GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK----LHEVALGTARGIEYLHN 182
           +  E  +   LV   M  G +  HI+  +     F   +      ++  G    +E+LH 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQ 307

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELI 241
                I++ D+KP N+LLD +   ++SD GLA                 GT G++APEL+
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELL 361

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                  S   D +  G+ L EM   R
Sbjct: 362 LGEEYDFSV--DYFALGVTLYEMIAAR 386

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 49/182 (26%), Positives = 73/182 (40%), Gaps = 29/182 (15%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG     +   T  L+AVK +       E    E+     + H N+V+       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEYLHNG 183
            +  A++ EY   G L   I    + G      +  E     AR        G+ Y H+ 
Sbjct: 88  PTHLAIIMEYASGGELYERI---CNAG------RFSE---DEARFFFQQLLSGVSYCHS- 134

Query: 184 CDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
             + I H D+K  N LLD +  P  K+ DFG +K     +     +   GT  YIAPE++
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV--GTPAYIAPEVL 189

Query: 242 SR 243
            R
Sbjct: 190 LR 191

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 50/319 (15%), Positives = 101/319 (31%), Gaps = 45/319 (14%)

Query: 36  LKRVDNVEKFLHNQQSW----MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGL 91
           +KR+    + L  ++         +  +P I+   N +     +     + +  L     
Sbjct: 36  IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDEST 95

Query: 92  IAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
                   S    +    ++  +      N V  L   S      +  +     +L   +
Sbjct: 96  DWPLS---SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152

Query: 152 ---FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV 208
                 E R    C     ++A      +E+LH      ++H D+KP NI    + + KV
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEA----VEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 205

Query: 209 SDFGLAKFHPKENDFVSISATR----------GTIGYIAPELISRNFGTVSCKSDVYGFG 258
            DFGL     ++ +  ++              GT  Y++PE I  N    S K D++  G
Sbjct: 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVDIFSLG 263

Query: 259 MVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGL 318
           ++L E+                      +   +             + +    +  M+  
Sbjct: 264 LILFELLYSFSTQMERVR----------IITDVRNL------KFPLLFTQKYPQEHMMVQ 307

Query: 319 WCIQVKAADRPSMTKVLEM 337
             +     +RP  T ++E 
Sbjct: 308 DMLSPSPTERPEATDIIEN 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 3/96 (3%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
             +G+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+   
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCW 163
              E        E       D       S       
Sbjct: 72  AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDA 107

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 25/184 (13%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
              +LG+G    VY+  Q  T    A+K+L  +    +    E+  + R+ H N+++L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHIFPKES---RGQSFCWEKLHEVALGTARGIEYLH-N 182
                ++ +LV E +  G L DR I  K     R  +   +++ E        + YLH N
Sbjct: 116 IFETPTEISLVLELVTGGELFDR-IVEKGYYSERDAADAVKQILEA-------VAYLHEN 167

Query: 183 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           G    I+H D+KP N+L      +   K++DFGL+K    +    ++    GT GY APE
Sbjct: 168 G----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAPE 220

Query: 240 LISR 243
           ++  
Sbjct: 221 ILRG 224

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 40/220 (18%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--F----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +   TG  +A+K +       E+  F    + E+  +  + H NVV 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVVN 80

Query: 125 LLGFCSEGSKRA--------LVYEYMPN---GSLDRHIFP-KESRGQSFCWEKLHEVALG 172
           L+  C   +           LV+++  +   G L   +     S  +      L      
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL------ 134

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG- 231
              G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+      +      T   
Sbjct: 135 --NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189

Query: 232 -TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            T+ Y  PEL+   R++G      D++G G ++ EM    
Sbjct: 190 VTLWYRPPELLLGERDYGP---PIDLWGAGCIMAEMWTRS 226

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 89.6 bits (222), Expect = 8e-20
 Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 41/263 (15%)

Query: 28  LIQRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFT------HK-LGQGGFGS 80
           L Q Y + + +    + F    +S    R+   + + +  H T      H+ +G+GGFG 
Sbjct: 145 LFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGE 204

Query: 81  VYKGQL-HTGGLIAVKMLANS---KFSGEEF-INE---VSTIGRIHHVNVVQLLGFCSEG 132
           VY  +   TG + A+K L         GE   +NE   +S +       +V +       
Sbjct: 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264

Query: 133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK----LHEVALGTARGIEYLHNGCDVCI 188
            K + + + M  G L  H+    S+   F          E+ L    G+E++HN     +
Sbjct: 265 DKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIIL----GLEHMHN---RFV 313

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE--NDFVSISATRGTIGYIAPELISRNFG 246
           ++ D+KP NILLD +   ++SD GLA    K+  +  V      GT GY+APE++ +   
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGVA 367

Query: 247 -TVSCKSDVYGFGMVLLEMAGGR 268
              S   D +  G +L ++  G 
Sbjct: 368 YDSSA--DWFSLGCMLFKLLRGH 388

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 87.3 bits (217), Expect = 9e-20
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 31/232 (13%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANS---KFSGEEFIN-EVSTIGRIHHVNVVQLLG 127
           LG+G F +V   +   T    A+K+L      K +   ++  E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK----LHEVALGTARGIEYLH-N 182
              +  K      Y  NG L ++I     +  SF          E+       +EYLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA----LEYLHGK 149

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
           G    I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHAT----RSSKAYFPSWV 287
                 S  SD++  G ++ ++  G    R  N +         +  FP   
Sbjct: 206 EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 255

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 87.4 bits (217), Expect = 9e-20
 Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 31/208 (14%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN---EVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +A+K++  ++ +         EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEYL 180
                   L+ EY   G +  ++    + G      ++ E     AR         ++Y 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL---VAHG------RMKE---KEARSKFRQIVSAVQYC 130

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H      I+H D+K  N+LLD +   K++DFG +         +      G   Y APEL
Sbjct: 131 HQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC--GAPPYAAPEL 184

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                     + DV+  G++L  +  G 
Sbjct: 185 FQGK-KYDGPEVDVWSLGVILYTLVSGS 211

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 81/295 (27%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGR-----------IHHV 120
           LG+GGFG+V+ G  L     +A+K++  ++  G   +++  T                H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 121 NVVQLLGFCSEGSKRALVYEY-MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR---- 175
            V++LL +        LV E  +P   L  +I     +G       L E   G +R    
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKG------PLGE---GPSRCFFG 146

Query: 176 ----GIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKEN--DFVSIS 227
                I++ H      ++H DIK  NIL+D       K+ DFG       E   DF    
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA-KLIDFGSGALLHDEPYTDFD--- 199

Query: 228 ATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS 285
              GT  Y  PE ISR+         + V+  G++L +M  G                P 
Sbjct: 200 ---GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCG--------------DIP- 238

Query: 286 WVYDQLNK--GGDLELRNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
             +++  +    +L        +  ++I          C+  K + RPS+ ++L 
Sbjct: 239 --FERDQEILEAELHFPAHVSPDCCALIR--------RCLAPKPSSRPSLEEILL 283

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 58/279 (20%), Positives = 102/279 (36%), Gaps = 59/279 (21%)

Query: 45  FLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ---LHTGGLIAVKMLANSK 101
           F     S   +     E          K+G+G +G VYK +          A+K     +
Sbjct: 7   FKVKLSSERERVEDLFEYEG------CKVGRGTYGHVYKAKRKDGKDDKDYALK-----Q 55

Query: 102 FSGEEF----INEVSTIGRIHHVNVVQLLGFCSEGSKRA--LVYEYMPN---GSLDRHIF 152
             G         E++ +  + H NV+ L       + R   L+++Y  +     +  H  
Sbjct: 56  IEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA 115

Query: 153 PKESRG---------QSFCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILL-- 200
            K ++          +S  ++ L         GI YLH N     +LH D+KP NIL+  
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQIL--------DGIHYLHANW----VLHRDLKPANILVMG 163

Query: 201 --DHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI--SRNFGT-VSCKSDV 254
                   K++D G A  F+        +     T  Y APEL+  +R++   +    D+
Sbjct: 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DI 219

Query: 255 YGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
           +  G +  E+         H  +        + +DQL++
Sbjct: 220 WAIGCIFAELLTSE--PIFHCRQEDIKTSNPYHHDQLDR 256

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)

Query: 67  NHFT-HK-LGQGGFGSVYKGQL-HTGGLIAVKMLANSKF----SGEEFINEVSTIGRIHH 119
           +HF   + +G+G FG V   Q   T  + A+K +   K            E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 120 VNVVQLLG-FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK----LHEVALGTA 174
             +V L   F  E     +V + +  G L  H+     +   F  E     + E+ +   
Sbjct: 75  PFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMA-- 127

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
             ++YL        I+H D+KP NILLD +    ++DF +A   P+E    +++   GT 
Sbjct: 128 --LDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTK 178

Query: 234 GYIAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGRR 269
            Y+APE+ S   G     + D +  G+   E+  GRR
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 32/209 (15%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN----EVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+   TG  +AVK+L   K    + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEY 179
             S  +   +V EY+  G L  +I             ++ E+    AR         ++Y
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHG---------RVEEM---EARRLFQQILSAVDY 126

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
            H      ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE
Sbjct: 127 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC--GSPNYAAPE 180

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +IS        + D++  G++L  +  G 
Sbjct: 181 VISGR-LYAGPEVDIWSCGVILYALLCGT 208

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 84.7 bits (210), Expect = 7e-19
 Identities = 59/220 (26%), Positives = 83/220 (37%), Gaps = 48/220 (21%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN-------EVSTIGRIHHV--NV 122
           LG GGFGSVY G  +     +A+K +   + S    +        EV  + ++      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 123 VQLLGFCSEGSKRALVYEY-MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR------ 175
           ++LL +        L+ E   P   L   I     RG       L E     AR      
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERG------ALQE---ELARSFFWQV 158

Query: 176 --GIEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKE--NDFVSISATR 230
              + + HN     +LH DIK  NIL+D N    K+ DFG           DF       
Sbjct: 159 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------ 209

Query: 231 GTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGR 268
           GT  Y  PE I  +   G     + V+  G++L +M  G 
Sbjct: 210 GTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 47/184 (25%), Positives = 75/184 (40%), Gaps = 28/184 (15%)

Query: 72  KLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFC 129
            LG G  G V +     TG   A+K+L +S  + +E    V    +     ++V +L   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCILDVY 91

Query: 130 SEGSKRA----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT---ARGIEYLHN 182
                      ++ E M  G L   I   + RG     E+  E A         I++LH 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRI---QERGDQAFTER--EAAEIMRDIGTAIQFLH- 145

Query: 183 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
                I H D+KP N+L    + + + K++DFG AK    +N   +      T  Y+APE
Sbjct: 146 --SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTPC---YTPYYVAPE 199

Query: 240 LISR 243
           ++  
Sbjct: 200 VLGP 203

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 31/184 (16%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN----EVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+   TG  +AVK+L   K    + +     E+  +    H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEY 179
             S  S   +V EY+  G L  +I             +L E     +R        G++Y
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNG---------RLDEK---ESRRLFQQILSGVDY 131

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
            H      ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE
Sbjct: 132 CHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC--GSPNYAAPE 185

Query: 240 LISR 243
           +IS 
Sbjct: 186 VISG 189

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 48/188 (25%), Positives = 72/188 (38%), Gaps = 29/188 (15%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLL 126
            +  LG G  G V +     T    A+KML +      +   EV    R     ++V+++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 121

Query: 127 GFCSEGSKRA----LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT---ARGIEY 179
                         +V E +  G L   I   + RG     E+  E +         I+Y
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTER--EASEIMKSIGEAIQY 176

Query: 180 LH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           LH       I H D+KP N+L      N I K++DFG AK     N   +      T  Y
Sbjct: 177 LHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPYY 229

Query: 236 IAPELISR 243
           +APE++  
Sbjct: 230 VAPEVLGP 237

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 82.6 bits (205), Expect = 3e-18
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 38/218 (17%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKM--LANSKFSGEEF----INEVSTIGRIH---HVN 121
           ++G G +G+VYK +  H+G  +A+K   + N    G       + EV+ + R+    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 122 VVQLLGFCSEGSKRA-----LVYEYMPN---GSLDRHIFPKESRGQ--SFCWEKLHEVAL 171
           VV+L+  C+           LV+E++       LD+   P            + L     
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL----- 130

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
              RG+++LH     CI+H D+KP NIL+      K++DFGLA+ +  +     +  T  
Sbjct: 131 ---RGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL- 183

Query: 232 TIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR 268
              Y APE++      T +   D++  G +  EM   +
Sbjct: 184 --WYRAPEVL---LQSTYATPVDMWSVGCIFAEMFRRK 216

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 69/209 (33%), Positives = 95/209 (45%), Gaps = 31/209 (14%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANS---KFSGEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K L      K  GE   +NE   + +++   VV L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 128 FCSEGSKRALVYEYMPNGSLDRHI-------FPKESRGQSFCWEKLHEVALGTARGIEYL 180
                    LV   M  G L  HI       FP E+R   +      E+  G    +E L
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYA----AEICCG----LEDL 302

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPE 239
           H      I++ D+KP NILLD +   ++SD GLA  H  E   +     R GT+GY+APE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIK---GRVGTVGYMAPE 355

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           ++     T S   D +  G +L EM  G+
Sbjct: 356 VVKNERYTFSP--DWWALGCLLYEMIAGQ 382

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 54/261 (20%), Positives = 101/261 (38%), Gaps = 73/261 (27%)

Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN-EV 111
            K+YS  + +          G G FG V +   + +G   A+K +         + N E+
Sbjct: 6   SKKYSLGKTL----------GTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNREL 51

Query: 112 STIGRIHHVNVVQLL-GFCSEGSKRA---------------------------------- 136
             +  + HVN+++L+  F + G +                                    
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 137 ---LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT---ARGIEYLHNGCDVCILH 190
              ++ EY+P+ +L + +      G+S        +++      R + ++H+   + I H
Sbjct: 112 YLNVIMEYVPD-TLHKVLKSFIRSGRSI--PMNL-ISIYIYQLFRAVGFIHS---LGICH 164

Query: 191 FDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV- 248
            DIKP N+L++  +   K+ DFG AK        V+   +R    Y APEL+    G   
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR---FYRAPELM---LGATE 218

Query: 249 -SCKSDVYGFGMVLLEMAGGR 268
            +   D++  G V  E+  G+
Sbjct: 219 YTPSIDLWSIGCVFGELILGK 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 48/258 (18%)

Query: 35  SLKRVDNVEKFLH----NQQSWMPKRYSYP--EIIAVTNHFTHKLGQGGFGSVYKGQL-H 87
            L+R  N+ ++L             R      EI+ V       +G+G FG V   +L +
Sbjct: 45  PLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKV-------IGRGAFGEVAVVKLKN 97

Query: 88  TGGLIAVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY 141
              + A+K+L  +K+          F  E   +       +  L     + +   LV +Y
Sbjct: 98  ADKVFAMKIL--NKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155

Query: 142 MPNGSLDRHI------FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP 195
              G L   +       P E   + +    L E+ +     I+ +H    +  +H DIKP
Sbjct: 156 YVGGDLLTLLSKFEDRLP-EEMARFY----LAEMVIA----IDSVHQ---LHYVHRDIKP 203

Query: 196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-----TVSC 250
            NIL+D N   +++DFG      ++    S  A  GT  YI+PE++    G        C
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPEC 262

Query: 251 KSDVYGFGMVLLEMAGGR 268
             D +  G+ + EM  G 
Sbjct: 263 --DWWSLGVCMYEMLYGE 278

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 41/232 (17%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLG-F 128
           KLG+G +  V++   +     + VK+L       ++   E+  +  +    N++ L    
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKKKIKREIKILENLRGGPNIITLADIV 100

Query: 129 CSEGSKR-ALVYEYMPNGSLDRHIFP-KESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
               S+  ALV+E++ N    +      +   + + +E L        + ++Y H+    
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL--------KALDYCHSMG-- 150

Query: 187 CILHFDIKPHNILLDH-NFIPKVSDFGLAKF-HPKE--NDFVSISATRGTIGYIAPELIS 242
            I+H D+KPHN+++DH +   ++ D+GLA+F HP +  N  V   A+R    +  PEL+ 
Sbjct: 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASR---YFKGPELLV 203

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-SWVYDQLNK 293
            ++       D++  G +L  M   +             +F     YDQL +
Sbjct: 204 -DYQMYDYSLDMWSLGCMLASMIFRKE-----------PFFHGHDNYDQLVR 243

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 67/255 (26%), Positives = 106/255 (41%), Gaps = 45/255 (17%)

Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSYP------EIIAVTNHFTHKLGQGGFGSVYKGQL-H 87
           +L++  N++ FL   +  + K           E++ V       +G+G FG V   +   
Sbjct: 40  ALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKV-------IGRGAFGEVQLVRHKS 92

Query: 88  TGGLIAVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY 141
           T  + A+K+L  SKF          F  E   +   +   VVQL     +     +V EY
Sbjct: 93  TRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150

Query: 142 MPNGSL----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN 197
           MP G L      +  P E   + +      EV L     ++ +H+   +  +H D+KP N
Sbjct: 151 MPGGDLVNLMSNYDVP-EKWARFY----TAEVVLA----LDAIHS---MGFIHRDVKPDN 198

Query: 198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG----TVSCKSD 253
           +LLD +   K++DFG      KE      +A  GT  YI+PE++    G       C  D
Sbjct: 199 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC--D 255

Query: 254 VYGFGMVLLEMAGGR 268
            +  G+ L EM  G 
Sbjct: 256 WWSVGVFLYEMLVGD 270

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFIN----EVSTIGRIHHVNVVQLLG 127
           LG+G FG V       T   +A+K ++       +       E+S +  + H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR--------GIEY 179
             +  +   +V EY   G L  +I  K+         ++ E      R         IEY
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKK---------RMTED---EGRRFFQQIICAIEY 123

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
            H      I+H D+KP N+LLD N   K++DFGL+     + +F+  S   G+  Y APE
Sbjct: 124 CHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTSC--GSPNYAAPE 177

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +I+        + DV+  G+VL  M  GR
Sbjct: 178 VINGK-LYAGPEVDVWSCGIVLYVMLVGR 205

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 42/219 (19%)

Query: 72  KLGQGGFGSVYKGQ--LHTGGLIAVKMLANSKFSGEE------FINEVST---IGRIHHV 120
           ++G+G +G V+K +   + G  +A+K +   +    E       I EV+    +    H 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHP 74

Query: 121 NVVQLL-----GFCSEGSKRALVYEYMPN---GSLDRH--IFPKESRGQSFCWEKLHEVA 170
           NVV+L            +K  LV+E++       LD+           +   ++ L    
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL---- 130

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
               RG+++LH      ++H D+KP NIL+  +   K++DFGLA+ +  +    S+  T 
Sbjct: 131 ----RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183

Query: 231 GTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR 268
               Y APE++      + +   D++  G +  EM   +
Sbjct: 184 ---WYRAPEVL---LQSSYATPVDLWSVGCIFAEMFRRK 216

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 58/260 (22%), Positives = 98/260 (37%), Gaps = 50/260 (19%)

Query: 35  SLKRVDNVEKFLHNQQSWMPKRYSYP------EIIAVTNHFTHKLGQGGFGSVYKGQL-H 87
            L +   V  FL   +  + +           EI+ V       +G+G F  V   ++  
Sbjct: 32  ELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKV-------IGRGAFSEVAVVKMKQ 84

Query: 88  TGGLIAVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL--VY 139
           TG + A+K++  +K+          F  E   +       + QL    +   +  L  V 
Sbjct: 85  TGQVYAMKIM--NKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVM 140

Query: 140 EYMPNGSLDRHI------FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDI 193
           EY   G L   +       P     + +    L E+ +     I+ +H    +  +H DI
Sbjct: 141 EYYVGGDLLTLLSKFGERIP-AEMARFY----LAEIVMA----IDSVHR---LGYVHRDI 188

Query: 194 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS- 252
           KP NILLD     +++DFG       +    S+ A  GT  Y++PE++    G     S 
Sbjct: 189 KPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSY 247

Query: 253 ----DVYGFGMVLLEMAGGR 268
               D +  G+   EM  G+
Sbjct: 248 GPECDWWALGVFAYEMFYGQ 267

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 23/208 (11%), Positives = 51/208 (24%), Gaps = 55/208 (26%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML----ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
             G       ++         +A+  +           +E ++    + RI    V ++L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 127 GFCSEGSKRALVYEYMPNGSL----DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH- 181
                 +   +V E++  GSL    D    P  +                 A   +  H 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAI----------RAMQSLAAAADAAHR 147

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            G    +      P  + +  +    ++                          +     
Sbjct: 148 AG----VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD--- 178

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
                  + + D+ G G  L  +   R 
Sbjct: 179 ------ANPQDDIRGIGASLYALLVNRW 200

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 59/246 (23%)

Query: 73  LGQGGFGSVY----KGQLHTGGLIAVKMLANSKFSGEEFI---NEVSTIG------RIHH 119
           LGQG FG V+            L A+K+L   K      +   + V T         ++H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVL--KK----ATLKVRDRVRTKMERDILVEVNH 85

Query: 120 VNVVQLLGFCS--EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK----LHEVALGT 173
             +V+L    +     K  L+ +++  G L   +    S+   F  E     L E+AL  
Sbjct: 86  PFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALA- 138

Query: 174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR- 230
              +++LH  G    I++ D+KP NILLD    I K++DFGL+K                
Sbjct: 139 ---LDHLHSLG----IIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKK-----AYS 185

Query: 231 --GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMHATRSSKA 281
             GT+ Y+APE+++R   T S   D + FG+++ EM  G        R   M     +K 
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243

Query: 282 YFPSWV 287
             P ++
Sbjct: 244 GMPQFL 249

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 27/215 (12%)

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           S+ S  +   E      ++    P++        E L   +   A+G+E+L      CI 
Sbjct: 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI- 215

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE I     T+ 
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI- 274

Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY----FPSWVYDQLNKGGDLEL-RNVTE 304
            +SDV+ FG++L E+           +  +  Y           +L +G  +      T 
Sbjct: 275 -QSDVWSFGVLLWEI----------FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 323

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                  ++    L C   + + RP+ ++++E L 
Sbjct: 324 -------EMYQTMLDCWHGEPSQRPTFSELVEHLG 351

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 21/158 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSGE--EFINEVSTIGRI-H 118
                LG+G FG V +          T   +AVKML       E    ++E+  +  I H
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 119 HVNVVQLLGFCSEGSKRALV-YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGI 177
           H+NVV LLG C++     +V  E+   G+L            ++   K +E      +G 
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-----------STYLRSKRNEFVPYKTKGA 133

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
            +      V  +  D+K     +  +     S F   K
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 34/243 (13%)

Query: 40  DNVEKFLHNQQSWMPKRYSYPEIIAVT-NHFTHK--LGQGGFGSVYKGQL-HTGGLIAVK 95
           ++V++FL   +    K++  P       + F     LG G FG V   +   +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 152 -----FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP 206
                F  E   + F      ++ L      EYLH    + +++ D+KP N+L+D     
Sbjct: 133 RRIGRFS-EPHAR-FY---AAQIVLT----FEYLH---SLDLIYRDLKPENLLIDQQGYI 180

Query: 207 KVSDFGLAKFHP-KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           +V+DFG AK    +           GT   +APE+I       +   D +  G+++ EMA
Sbjct: 181 QVTDFGFAKRVKGRTWTLC------GTPEALAPEIILSKGYNKAV--DWWALGVLIYEMA 232

Query: 266 GGR 268
            G 
Sbjct: 233 AGY 235

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 45/216 (20%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---NEV-STIG------RIHHVN 121
           LG+G FG V   +   TG   A+K+L   K    E I   +EV  T+          H  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKIL--KK----EVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 122 VVQLLGFCS--EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH----EVALGTAR 175
           +  L    S     +   V EY   G L  H+    SR + F  ++      E+      
Sbjct: 210 LTAL--KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSA--- 260

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GT 232
            ++YLH+  +  +++ D+K  N++LD +   K++DFGL K   K+         +   GT
Sbjct: 261 -LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-----TMKTFCGT 312

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             Y+APE++  N    +   D +G G+V+ EM  GR
Sbjct: 313 PEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGR 346

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.2 bits (178), Expect = 1e-14
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 47/215 (21%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---------NEVSTIGRIHHVNV 122
           LG G FG V+  +  H G   A+K+L   K   E  +         +E   +  + H  +
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVL--KK---EIVVRLKQVEHTNDERLMLSIVTHPFI 68

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTARGI 177
           +++ G   +  +  ++ +Y+  G L   +     FP     + +      EV L     +
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-NPVAKFYA----AEVCLA----L 119

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTI 233
           EYLH+  D  I++ D+KP NILLD N  I K++DFG AK      D      T    GT 
Sbjct: 120 EYLHS-KD--IIYRDLKPENILLDKNGHI-KITDFGFAK---YVPD-----VTYTLCGTP 167

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            YIAPE++S      S   D + FG+++ EM  G 
Sbjct: 168 DYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAGY 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.8 bits (177), Expect = 2e-14
 Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 55/245 (22%)

Query: 73  LGQGGFGSVY----KGQLHTGGLIAVKMLANSKFSGEEFINEV-STIG------RIHHVN 121
           LG+GG+G V+        +TG + A+K+L   K        +   T         + H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 122 VVQLLGFCS--EGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTA 174
           +V L    +   G K  L+ EY+  G L   +     F  E     +    L E+++   
Sbjct: 83  IVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFY----LAEISMA-- 133

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR-- 230
             + +LH  G    I++ D+KP NI+L+H   + K++DFGL K    +        T   
Sbjct: 134 --LGHLHQKG----IIYRDLKPENIMLNHQGHV-KLTDFGLCKESIHDGT-----VTHTF 181

Query: 231 -GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMHATRSSKAY 282
            GTI Y+APE++ R+    +   D +  G ++ +M  G        R   +      K  
Sbjct: 182 CGTIEYMAPEILMRSGHNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239

Query: 283 FPSWV 287
            P ++
Sbjct: 240 LPPYL 244

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 51/219 (23%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---NEV-STIG--RI-----HHV 120
           LG+G FG V+  +   T    A+K L   K    + +   ++V  T+   R+      H 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKAL--KK----DVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 121 NVVQLLG-FCSEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTA 174
            +  +   F ++      V EY+  G L  HI     F   SR   +      E+ LG  
Sbjct: 79  FLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCHKFD-LSRATFYA----AEIILG-- 130

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR-- 230
             +++LH  G    I++ D+K  NILLD +  I K++DFG+ K +   +       T   
Sbjct: 131 --LQFLHSKG----IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAK-----TNTF 178

Query: 231 -GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            GT  YIAPE++       S   D + FG++L EM  G+
Sbjct: 179 CGTPDYIAPEILLGQKYNHSV--DWWSFGVLLYEMLIGQ 215

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 50/218 (22%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---NEV-STIG------RIHHVN 121
           LG+G FG V   +   TG   A+K+L   K    E I   +EV  T+          H  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL--RK----EVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 122 VVQLLGFCS--EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLH----EVALGTAR 175
           +  L    +     +   V EY   G L  H+    SR + F  E+      E+      
Sbjct: 67  LTAL--KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSA--- 117

Query: 176 GIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR--- 230
            +EYLH       +++ DIK  N++LD +  I K++DFGL K    +         +   
Sbjct: 118 -LEYLHSRD----VVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGA-----TMKTFC 166

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           GT  Y+APE++  N    +   D +G G+V+ EM  GR
Sbjct: 167 GTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGR 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 60/246 (24%), Positives = 90/246 (36%), Gaps = 60/246 (24%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---NEV-STIG-------RIHHV 120
           +G+G FG V   +        AVK+L   K    + I    E    +         + H 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVL--QK----KAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 121 NVVQLLGFCS--EGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGT 173
            +V L    S     K   V +Y+  G L  H+     F  E R + +      E+A   
Sbjct: 100 FLVGL--HFSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRARFYA----AEIASA- 151

Query: 174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR- 230
              + YLH       I++ D+KP NILLD    I  ++DFGL K + + N       T  
Sbjct: 152 ---LGYLHSLN----IVYRDLKPENILLDSQGHI-VLTDFGLCKENIEHNST-----TST 198

Query: 231 --GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMHATRSSKA 281
             GT  Y+APE++ +     +   D +  G VL EM  G                 +   
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 256

Query: 282 YFPSWV 287
                +
Sbjct: 257 QLKPNI 262

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.8 bits (174), Expect = 7e-14
 Identities = 54/253 (21%), Positives = 85/253 (33%), Gaps = 67/253 (26%)

Query: 48  NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEE 106
             +   M   Y               +  G +G+V  G    G  +A+K + N+   G  
Sbjct: 14  IAELHAMQSPY----------TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63

Query: 107 ---FIN---------EVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEYM------- 142
                +         E+  +   HH N++ L        + A     LV E M       
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123

Query: 143 ---PNGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 198
                  +  +HI       Q F +  L         G+  LH      ++H D+ P NI
Sbjct: 124 IHDQRIVISPQHI-------QYFMYHIL--------LGLHVLHEAG---VVHRDLHPGNI 165

Query: 199 LLDHNFIPKVSDFGLAKFHPKEN---DFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 255
           LL  N    + DF LA+    +     +V     R    Y APEL+   F   +   D++
Sbjct: 166 LLADNNDITICDFNLAREDTADANKTHYV---THR---WYRAPELVM-QFKGFTKLVDMW 218

Query: 256 GFGMVLLEMAGGR 268
             G V+ EM   +
Sbjct: 219 SAGCVMAEMFNRK 231

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 44/229 (19%)

Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF----I 108
           PK Y  P  +          G G +GSV       +G  +A+K L+   F  E F     
Sbjct: 23  PKTYVSPTHV----------GSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAY 71

Query: 109 NEVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEYMPNGSLDRHI--FPKESRGQS 160
            E+  +  + H NV+ LL  F    S R      LV  +M    L + +     E + Q 
Sbjct: 72  RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY 130

Query: 161 FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPK 219
             ++ L        +G++Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    +
Sbjct: 131 LVYQML--------KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
              +V    TR    Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 180 MTGYV---VTR---WYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 63/244 (25%), Positives = 101/244 (41%), Gaps = 56/244 (22%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---NEV-STIG--RI-----HHV 120
           LG+G FG V   +   T  L AVK+L   K    + +   ++V  T+   R+        
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL--KK----DVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 121 NVVQLLGFCSEGSKRA-LVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTA 174
            + QL   C +   R   V EY+  G L  HI     F  E     +      E+A+G  
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHAVFYA----AEIAIG-- 454

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR--- 230
             + +L       I++ D+K  N++LD    I K++DFG+ K +  +        T+   
Sbjct: 455 --LFFLQ---SKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGV-----TTKTFC 503

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMHATRSSKAYF 283
           GT  YIAPE+I+      S   D + FG++L EM  G+        +    +       +
Sbjct: 504 GTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 561

Query: 284 PSWV 287
           P  +
Sbjct: 562 PKSM 565

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 49/218 (22%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---NEV-STIG--RI-----HHV 120
           LG+G FG V   ++  TG L AVK+L   K    + I   ++V  T+   RI     +H 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVL--KK----DVILQDDDVECTMTEKRILSLARNHP 84

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTAR 175
            + QL        +   V E++  G L  HI     F  E+R + +      E+      
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EARARFYA----AEIISA--- 136

Query: 176 GIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR--- 230
            + +LH  G    I++ D+K  N+LLDH     K++DFG+ K             T    
Sbjct: 137 -LMFLHDKG----IIYRDLKLDNVLLDHEGHC-KLADFGMCKEGICNGVT-----TATFC 185

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           GT  YIAPE++       +   D +  G++L EM  G 
Sbjct: 186 GTPDYIAPEILQEMLYGPAV--DWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 53/220 (24%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFI---NEV-STIG--RI-----HHV 120
           LG+G FG V   +   T  L AVK+L   K    + +   ++V  T+   R+        
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKIL--KK----DVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 121 NVVQLLGFCS--EGSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGT 173
            + QL          +   V EY+  G L  HI     F  E     +      E+A+G 
Sbjct: 82  FLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHAVFY----AAEIAIG- 133

Query: 174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR- 230
              + +L   G    I++ D+K  N++LD    I K++DFG+ K +  +        T+ 
Sbjct: 134 ---LFFLQSKG----IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGV-----TTKT 180

Query: 231 --GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             GT  YIAPE+I+      S   D + FG++L EM  G+
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQ 218

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 54/263 (20%), Positives = 97/263 (36%), Gaps = 48/263 (18%)

Query: 30  QRYRKSLKRVDNVEKFLHNQQSWMPKRYSYP---EIIAVTNHFT--HKLGQGGFGSVYKG 84
           Q + K +      + +  ++     + YS         V   +     +G G  G V   
Sbjct: 22  QGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAA 81

Query: 85  Q-LHTGGLIAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG-FCSEGSKRA-- 136
                   +A+K L+   F  +        E+  +  ++H N++ LL  F  + +     
Sbjct: 82  YDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140

Query: 137 ---LVYEYMPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
              LV E M     +     +      R     ++ L         GI++LH+     I+
Sbjct: 141 DVYLVMELMDA---NLCQVIQMELDHERMSYLLYQML--------CGIKHLHSAG---II 186

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN---DFVSISATRGTIGYIAPELI-SRNF 245
           H D+KP NI++  +   K+ DFGLA+          +V    TR    Y APE+I    +
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTR---YYRAPEVILGMGY 240

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                  D++  G ++ EM   +
Sbjct: 241 KE---NVDIWSVGCIMGEMVRHK 260

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 51/219 (23%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRI-----------HHV 120
           +G+G +  V   +L  T  + A+K++   K    E +N+   I  +           +H 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVV--KK----ELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 121 NVVQLLGFCSE-GSKRALVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTA 174
            +V L   C +  S+   V EY+  G L  H+      P E   + +      E++L   
Sbjct: 71  FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYS----AEISLA-- 122

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR-- 230
             + YLH  G    I++ D+K  N+LLD    I K++D+G+ K   +  D      T   
Sbjct: 123 --LNYLHERG----IIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDT-----TSTF 170

Query: 231 -GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            GT  YIAPE++       S   D +  G+++ EM  GR
Sbjct: 171 CGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 207

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 58/246 (23%), Positives = 95/246 (38%), Gaps = 48/246 (19%)

Query: 65  VTNHFTH--KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF----INEVSTIGRI 117
           V   + +   +G G  G V           +A+K L+   F  +        E+  +  +
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 81

Query: 118 HHVNVVQLLG-FCSEGSKRA-----LVYEYMPNGSLDRHIFPK--ESRGQSFCWEKLHEV 169
           +H N++ LL  F  + S        +V E M   +L + I  +    R     ++ L   
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQML--- 137

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
                 GI++LH+     I+H D+KP NI++  +   K+ DFGLA+             T
Sbjct: 138 -----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 189

Query: 230 RGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY 288
           R    Y APE+I    +       D++  G ++ EM  G               FP   +
Sbjct: 190 R---YYRAPEVILGMGYKE---NVDIWSVGCIMGEMIKG------------GVLFPGTDH 231

Query: 289 -DQLNK 293
            DQ NK
Sbjct: 232 IDQWNK 237

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 51/219 (23%)

Query: 73  LGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRI-----------HHV 120
           +G+G +  V   +L  T  + A++++   K    E +N+   I  +           +H 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVV--KK----ELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 121 NVVQLLGFCSEGSKRA-LVYEYMPNGSLDRHI-----FPKESRGQSFCWEKLHEVALGTA 174
            +V L   C +   R   V EY+  G L  H+      P E   + +      E++L   
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYS----AEISLA-- 165

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR-- 230
             + YLH  G    I++ D+K  N+LLD    I K++D+G+ K   +  D      T   
Sbjct: 166 --LNYLHERG----IIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGD-----TTSTF 213

Query: 231 -GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            GT  YIAPE++       S   D +  G+++ EM  GR
Sbjct: 214 CGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 250

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 37/221 (16%)

Query: 65  VTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF----INEVSTIGRI 117
           V   +     +G G +G+V       TG  +A+K L    F  E F      E+  +  +
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHM 81

Query: 118 HHVNVVQLLG-FCSEGSKRA-----LVYEYMPNGSLDRHIFPK---ESRGQSFCWEKLHE 168
            H NV+ LL  F  + +        LV  +M    L + +  +   E R Q   ++ L  
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQML-- 138

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSIS 227
                 +G+ Y+H      I+H D+KP N+ ++ +   K+ DFGLA+    +   +V   
Sbjct: 139 ------KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV--- 186

Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            TR    Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 187 VTR---WYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 43/253 (16%)

Query: 30  QRYRKSLKRVDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHT 88
             +  S +R     + L+     +P+RY               +G G +GSV       T
Sbjct: 4   HHHHHSQERPTFYRQELNKTIWEVPERY----------QNLSPVGSGAYGSVCAAFDTKT 53

Query: 89  GGLIAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LV 138
           G  +AVK L+   F           E+  +  + H NV+ LL  F    S        LV
Sbjct: 54  GLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112

Query: 139 YEYMPNGSLDRHIFPK---ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP 195
              M    L+  +  +   +   Q   ++ L        RG++Y+H+     I+H D+KP
Sbjct: 113 THLMGA-DLNNIVKCQKLTDDHVQFLIYQIL--------RGLKYIHSAD---IIHRDLKP 160

Query: 196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 255
            N+ ++ +   K+ DFGLA+     ++     ATR    Y APE++  N+   +   D++
Sbjct: 161 SNLAVNEDCELKILDFGLAR--HTADEMTGYVATR---WYRAPEIML-NWMHYNQTVDIW 214

Query: 256 GFGMVLLEMAGGR 268
             G ++ E+  GR
Sbjct: 215 SVGCIMAELLTGR 227

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 42/218 (19%)

Query: 73  LGQGGFGSVY----KGQLHTGGLIAVKMLANSKFSGEEFINEV-STIG--RI-----HHV 120
           LG G +G V+         TG L A+K+L   K +  +       T    ++        
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 121 NVVQLLGFCS--EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEK----LHEVALGTA 174
            +V L    +    +K  L+ +Y+  G L  H+    S+ + F   +    + E+ L   
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLA-- 171

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--- 230
             +E+LH  G    I++ DIK  NILLD N    ++DFGL+    KE             
Sbjct: 172 --LEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLS----KEFVADETERAYDFC 221

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           GTI Y+AP+++           D +  G+++ E+  G 
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 49/229 (21%)

Query: 65  VTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF----INEVSTIGRI 117
           V   +T    +G+G +G V           +A+K ++   F  + +    + E+  + R 
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRF 82

Query: 118 HHVNVVQLLGFCSEGSKRA-----LVYEYMP--------NGSL-DRHIFPKESRGQSFCW 163
            H N++ +       +        +V + M            L + HI         F +
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLY 135

Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
           + L        RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    ++D 
Sbjct: 136 QIL--------RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

Query: 224 VSIS----ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                   ATR    Y APE++  N    +   D++  G +L EM   R
Sbjct: 185 TGFLTEYVATR---WYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 41/163 (25%), Positives = 61/163 (37%), Gaps = 32/163 (19%)

Query: 69  FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLL 126
            +  LG G  G V +     T    A+KML +      +   EV    R     ++V+++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 77

Query: 127 GFCSEGSKRA----LVYEYMPNGSL-DRHIFPKESRGQSFCWEK-----LHEVALGTARG 176
                         +V E +  G L  R       RG     E+     +  +       
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIG----EA 129

Query: 177 IEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAK 215
           I+YLH       I H D+KP N+L      N I K++DFG AK
Sbjct: 130 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 44/205 (21%), Positives = 75/205 (36%), Gaps = 50/205 (24%)

Query: 31  RYRKSLKRVDNVEKFLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHT 88
           + RK                 W +P RY             H +G G +G V +      
Sbjct: 28  QQRKQHHSSKPTASMPRPHSDWQIPDRY----------EIRHLIGTGSYGHVCEAYDKLE 77

Query: 89  GGLIAVKMLANSKFSGEEF----INEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVY 139
             ++A+K +    F         + E++ + R++H +VV++L               +V 
Sbjct: 78  KRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 140 EYMP---------NGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           E               L + HI       ++  +  L         G++Y+H+     IL
Sbjct: 137 EIADSDFKKLFRTPVYLTELHI-------KTLLYNLL--------VGVKYVHSAG---IL 178

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLA 214
           H D+KP N L++ +   KV DFGLA
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLA 203

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 45/220 (20%), Positives = 95/220 (43%), Gaps = 36/220 (16%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV---------- 120
           KLG G F +V+  + +     +A+K++   K   E   +E+  + R++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 121 -NVVQLLG-FCSEGSKRA---LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTAR 175
            ++++LL  F  +G       +V+E +     +     K+   +      + +++     
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL---GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDH------NFIPKVSDFGLAKFHPKENDFVSISAT 229
           G++Y+H  C   I+H DIKP N+L++           K++D G A +   +  + +   T
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQT 198

Query: 230 RGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGR 268
           R    Y +PE++    G    C +D++    ++ E+  G 
Sbjct: 199 R---EYRSPEVL---LGAPWGCGADIWSTACLIFELITGD 232

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.6 bits (153), Expect = 3e-11
 Identities = 58/245 (23%), Positives = 96/245 (39%), Gaps = 54/245 (22%)

Query: 53  MPKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEF-- 107
           MPKR  Y     +++ F     LG+G +G V       TG ++A+K +    F    F  
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFAL 54

Query: 108 --INEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEYMP--------NGSL-DRHI 151
             + E+  +    H N++ +       S        ++ E M            L D HI
Sbjct: 55  RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI 114

Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                  Q F ++ L        R ++ LH      ++H D+KP N+L++ N   KV DF
Sbjct: 115 -------QYFIYQTL--------RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDF 156

Query: 212 GLAKFHPKENDFVSISATRGTI--GYI------APELISRNFGTVSCKSDVYGFGMVLLE 263
           GLA+   +     S    + +    ++      APE++       S   DV+  G +L E
Sbjct: 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAE 215

Query: 264 MAGGR 268
           +   R
Sbjct: 216 LFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 50/255 (19%), Positives = 94/255 (36%), Gaps = 69/255 (27%)

Query: 48  NQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGE 105
           N   + +  RY   + +          G GG G V+          +A+K +     +  
Sbjct: 3   NIHGFDLGSRYMDLKPL----------GCGGNGLVFSAVDNDCDKRVAIKKIV---LTDP 49

Query: 106 EF----INEVSTIGRIHHVNVVQLLGFCSEGSKRA--------------LVYEYMP---- 143
           +     + E+  I R+ H N+V++         +               +V EYM     
Sbjct: 50  QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA 109

Query: 144 ----NGSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 198
                G L + H        + F ++ L        RG++Y+H+     +LH D+KP N+
Sbjct: 110 NVLEQGPLLEEHA-------RLFMYQLL--------RGLKYIHSAN---VLHRDLKPANL 151

Query: 199 LLD-HNFIPKVSDFGLAKFHPKENDFVSIS----ATRGTIGYIAPELISRNFGTVSCKSD 253
            ++  + + K+ DFGLA+                 T+    Y +P L+  +    +   D
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK---WYRSPRLLL-SPNNYTKAID 207

Query: 254 VYGFGMVLLEMAGGR 268
           ++  G +  EM  G+
Sbjct: 208 MWAAGCIFAEMLTGK 222

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 52/232 (22%)

Query: 56  RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTI 114
           RY   E++ V       +G+G FG V K         +A+KM+ N K    +   E+  +
Sbjct: 98  RY---EVLKV-------IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRIL 147

Query: 115 GRIHHV------NVVQLLGF-------CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSF 161
             +         NV+ +L         C       + +E +   S++ +   K+++ Q F
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHIC-------MTFELL---SMNLYELIKKNKFQGF 197

Query: 162 CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPK 219
               + + A    + ++ LH      I+H D+KP NILL        KV DFG + +   
Sbjct: 198 SLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--- 251

Query: 220 ENDFVS--ISATRGTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 268
           E+  V   I  +R    Y APE+I    G       D++  G +L E+  G 
Sbjct: 252 EHQRVYTYIQ-SR---FYRAPEVI---LGARYGMPIDMWSLGCILAELLTGY 296

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 52/281 (18%), Positives = 95/281 (33%), Gaps = 72/281 (25%)

Query: 45  FLHNQQSW-MPKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF 102
           +    ++  +P  Y             H +G+G +G VY     +T   +A+K +    F
Sbjct: 15  YFQGIKNVHVPDNY----------IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-F 63

Query: 103 SGEEF----INEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEYMP---------N 144
                    + E++ + R+    +++L                +V E             
Sbjct: 64  EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP 123

Query: 145 GSL-DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN 203
             L + HI       ++  +  L         G  ++H      I+H D+KP N LL+ +
Sbjct: 124 IFLTEEHI-------KTILYNLL--------LGENFIHESG---IIHRDLKPANCLLNQD 165

Query: 204 FIPKVSDFGLAKFHPKENDFVSISATRGTIG--------------------YIAPELISR 243
              KV DFGLA+    E D   ++                           Y APELI  
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL- 224

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP 284
                +   D++  G +  E+    + S+++   +    FP
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQ-SHINDPTNRFPLFP 264

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 22/169 (13%)

Query: 58  SYPEIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGGLIAVKML-ANSKFSGEEFINEVST 113
           S   ++ V  +F    K+G G FG +  G+ L+T   +A+K+    S+            
Sbjct: 1   SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYK 59

Query: 114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG-SLDRHIFPKESRGQSFCWEKLHEVALG 172
                   + Q+  F   G   A+V E +  G SL+  +F  +   ++F  + +  +A+ 
Sbjct: 60  Q-LGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLE-DLF--DLCDRTFSLKTVLMIAIQ 113

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILL------DHNFIPKVSDFGLAK 215
               +EY+H+     +++ D+KP N L+          I  + DF LAK
Sbjct: 114 LISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 46/228 (20%), Positives = 84/228 (36%), Gaps = 42/228 (18%)

Query: 61  EIIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-- 117
           E           +G+G FG V K         +A+K++ N K    +   EV  +  +  
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109

Query: 118 ------HHVNVVQLLGF-------CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWE 164
                 +++  V L          C       LV+E +   S + +   + +  +     
Sbjct: 110 HDTEMKYYI--VHLKRHFMFRNHLC-------LVFEML---SYNLYDLLRNTNFRGVSLN 157

Query: 165 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKEND 222
              + A      + +L    ++ I+H D+KP NILL +      K+ DFG +        
Sbjct: 158 LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQ 213

Query: 223 FV-SISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGR 268
            +     +R    Y +PE++    G       D++  G +L+EM  G 
Sbjct: 214 RIYQYIQSR---FYRSPEVL---LGMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 50/263 (19%), Positives = 94/263 (35%), Gaps = 78/263 (29%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN-------- 121
            KLG G F +V+    +     +A+K++ +++   E  ++E+  +  + + +        
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 122 VVQLLG-FCSEGSK---RALVYEYMPNG-SLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
           VVQLL  F   G       +V+E +  G  L +  +  +S  Q      + ++     +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL--GHHLLK--WIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 177 IEYLHNGCDVCILHFDIKPHNILL------------------------------------ 200
           ++YLH  C +   H DIKP NILL                                    
Sbjct: 159 LDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 201 -------------DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
                              K++D G A     ++    I     T  Y + E++    G+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTEDIQ----TRQYRSLEVL---IGS 268

Query: 248 -VSCKSDVYGFGMVLLEMAGGRR 269
             +  +D++    +  E+A G  
Sbjct: 269 GYNTPADIWSTACMAFELATGDY 291

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 57/248 (22%), Positives = 93/248 (37%), Gaps = 70/248 (28%)

Query: 65  VTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI---- 117
           V   +    KLG+G +G V+K     TG ++AVK + ++      F N      R     
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQ-RTFREI 59

Query: 118 -------HHVNVVQLLG-FCSEGSKRA-LVYEYMP--------NGSL-DRHIFPKESRGQ 159
                   H N+V LL    ++  +   LV++YM            L   H        Q
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK-------Q 112

Query: 160 SFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
              ++ +        + I+YLH+G    +LH D+KP NILL+     KV+DFGL++    
Sbjct: 113 YVVYQLI--------KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 220 ENDFVSISATRGTIG-------------------YIAPELISRNFGTVSCKSDVYGFGMV 260
                +                            Y APE++       +   D++  G +
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCI 220

Query: 261 LLEMAGGR 268
           L E+  G+
Sbjct: 221 LGEILCGK 228

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 37/192 (19%), Positives = 75/192 (39%), Gaps = 37/192 (19%)

Query: 53  MPKRYSYPEIIA--VTNHFT--HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF------ 102
           + ++++  EII       +     +GQGGFG +Y   +++   +        K       
Sbjct: 19  LAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG 78

Query: 103 ------------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK----RALVYEYMPNG- 145
                       +  E I +     ++ ++ V +  G           R ++ +    G 
Sbjct: 79  PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GS 136

Query: 146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI 205
            L   I+  E+  + F  + + +++L     +EY+H       +H DIK  N+LL++   
Sbjct: 137 DLQ-KIY--EANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNP 190

Query: 206 PKV--SDFGLAK 215
            +V   D+GLA 
Sbjct: 191 DQVYLVDYGLAY 202

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 33/160 (20%), Positives = 61/160 (38%), Gaps = 17/160 (10%)

Query: 65  VTNHF--THKLGQGGFGSVYKGQ-LHTGGLIAVKM-LANSKFSGEEFINEVSTIGRIHHV 120
           V  H+    ++G+G FG +++G  L     +A+K     S             +      
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCT 66

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +  +  F  EG    LV + +   SL+  +   +  G+ F  + +   A      ++ +
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLL--DLCGRKFSVKTVAMAAKQMLARVQSI 122

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPK-----VSDFGLAK 215
           H      +++ DIKP N L+            V DFG+ K
Sbjct: 123 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.5 bits (130), Expect = 2e-08
 Identities = 45/310 (14%), Positives = 82/310 (26%), Gaps = 90/310 (29%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLA---------NSKFSGEEFINEV---------ST 113
           K+G+G FG V++        +A+K++A         + + + EE + E+         S 
Sbjct: 27  KIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 114 IGRIHHVNVVQLLGF--CSEGSKRALVYEY---------------------------MPN 144
                    + L             L+  +                              
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF 204
           G +D      +    +     LH++    A     L         H D+   N+LL    
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR------FEHRDLHWGNVLLKKTS 199

Query: 205 IPKVSDFGLAK--------FHPKENDFVSISATRGTIGYIA-----PELISRNFGTVSCK 251
           + K+      K              D+      R  I          +L +   G    +
Sbjct: 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT---GDGDYQ 256

Query: 252 SDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS----WVY---DQLNKGGDLELRNVTE 304
            D+Y             R            Y P     W++   D++ K    + +  T 
Sbjct: 257 FDIY-------------RLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303

Query: 305 IESMIARKLC 314
               I RK+ 
Sbjct: 304 AMKQIKRKIQ 313

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 26/168 (15%), Positives = 54/168 (32%), Gaps = 31/168 (18%)

Query: 72  KLGQGGFGSVYKGQLHTGGLI---------AVKM-LANSKFSGE----------EFINEV 111
              +   G +Y+    +             ++K+   + +   E            +N+ 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 112 STIGRIHHVNVVQLLGF-CSEGSKRALVYEYMPNG-SLDRHIFPKESRGQSFCWEKLHEV 169
             +     + +   +GF   +   R LV   +  G SL        S         + +V
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQ-SAL-DVSPKHVLSERSVLQV 164

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV--SDFGLAK 215
           A      +E+LH       +H ++   NI +D     +V  + +G A 
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 20/164 (12%)

Query: 61  EIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGGLIAVKM-LANSKFSGEEFINEVSTIGR 116
           E+  V N +    K+G G FG +Y G  +  G  +A+K+    +K        E      
Sbjct: 4   ELR-VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKM 60

Query: 117 IHH-VNVVQLLGFCSEGSKRALVYEYMPNG-SLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           +   V +  +    +EG    +V E +  G SL+  +F      + F  + +  +A    
Sbjct: 61  MQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLE-DLF--NFCSRKFSLKTVLLLADQMI 115

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAK 215
             IEY+H+      +H D+KP N L+       +  + DFGLAK
Sbjct: 116 SRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 22/165 (13%)

Query: 61  EIIAVTNHF--THKLGQGGFGSVYKGQ-LHTGGLIAVKM-LANSKFSGEEFINEVSTIGR 116
           E   V N F    K+G G FG +Y G  + T   +A+K+    +K     +  E      
Sbjct: 2   EPR-VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRI 58

Query: 117 IH-HVNVVQLLGFCSEGSKRALVYEYMPNG-SLDRHIFPKESRGQSFCWEKLHEVALGTA 174
           +     +  +  F  EG    LV + +  G SL+  +F      +    + +  +A    
Sbjct: 59  LQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLE-DLF--NFCSRKLSLKTVLMLADQMI 113

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK 215
             +E++H+      LH DIKP N L+      N +  + DFGLAK
Sbjct: 114 NRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAK 154

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 2e-07
 Identities = 33/269 (12%), Positives = 67/269 (24%), Gaps = 92/269 (34%)

Query: 27  FLIQRYRKSLKRVDNV------EKFLHNQQ------------SWMPKRYSYPEIIAVTNH 68
              + Y   L  + NV        F  + +                   ++  +   +  
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297

Query: 69  FTHKLGQGGFGSVYKG-------QLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN 121
            T    +                ++ T     + ++       E   + ++T     HVN
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII------AESIRDGLATWDNWKHVN 351

Query: 122 VVQL-------LGFCSEGSKRALVYEYMPNGSLDRHIFPKESR--GQSFC--W------- 163
             +L       L        R + ++ +        +FP  +          W       
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKM-FDRLS-------VFPPSAHIPTILLSLIWFDVIKSD 403

Query: 164 -----EKLHEVAL---GTARGIEYLHNGCDVCILHFDIKP--------HNILLDHNFIPK 207
                 KLH+ +L           + +      ++ ++K         H  ++DH  IPK
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKVKLENEYALHRSIVDHYNIPK 457

Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYI 236
             D       P   D            Y 
Sbjct: 458 TFDSD--DLIPPYLD-----------QYF 473

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 34/167 (20%), Positives = 66/167 (39%), Gaps = 32/167 (19%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLAN-----------SKF----SGEEFINEVSTIG 115
           K+G GGFG +Y     +     A  ++              KF    + ++ I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 116 RIHHVNVVQLLGF----CSEGSKRALVYEYMPNG-SLDRHIFPKESRGQSFCWEKLHEVA 170
           ++ ++ +    G         S R +V E +  G  L   I   ++   +F    + ++ 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-KIS-GQNG--TFKKSTVLQLG 157

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV--SDFGLAK 215
           +     +EY+H       +H DIK  N+LL +    +V  +D+GL+ 
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 56/237 (23%), Positives = 88/237 (37%), Gaps = 64/237 (27%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-----HHVNVVQL 125
           K+G G FG V   Q +      AVK++ N K        E   + +I     ++ N+V+ 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 126 LGF-------CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE 178
            G        C       L++E +       +     +    F  E +    +   + + 
Sbjct: 102 HGKFMYYDHMC-------LIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-------------------------KVSDFGL 213
           YL     + + H D+KP NILLD  +                           K+ DFG 
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 214 AKFHPKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGG 267
           A F   ++D+    I+ TR    Y APE+I           SD++ FG VL E+  G
Sbjct: 209 ATF---KSDYHGSIIN-TR---QYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTG 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 60/233 (25%)

Query: 72  KLGQGGFGSVYKGQLH--TGGLIAVKMLANSKFSGEEFINEVSTIGRIHH------VNVV 123
            LG+G FG V +   H      +A+K++ N     E    E++ + +I           V
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85

Query: 124 QLLGF-------CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARG 176
            +  +       C       + +E +     +   F KE+  Q +    +  +A      
Sbjct: 86  LMSDWFNFHGHMC-------IAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-------------------KVSDFGLAKFH 217
           + +LH   +  + H D+KP NIL  ++                      +V+DFG A F 
Sbjct: 136 LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 191

Query: 218 PKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGG 267
             +++  +  ++ TR    Y  PE+I        +   DV+  G +L E   G
Sbjct: 192 --DHEHHTTIVA-TR---HYRPPEVI---LELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 40.7 bits (96), Expect = 4e-04
 Identities = 56/236 (23%), Positives = 90/236 (38%), Gaps = 66/236 (27%)

Query: 72  KLGQGGFGSVYKGQLH--TGGLIAVKML-ANSKFSGE--------EFINEVSTIGRIHHV 120
            LG+G FG V +   H   G  +AVK++    ++           E +N           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR-- 78

Query: 121 NVVQLLGF-------CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT 173
             VQ+L +       C       +V+E +    L  + F KE+    F  + + ++A   
Sbjct: 79  -CVQMLEWFEHHGHIC-------IVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP-------------------KVSDFGLA 214
            + + +LH      + H D+KP NIL   +                      KV DFG A
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 215 KFHPKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGG 267
            +   +++  S  +S TR    Y APE+I        S   DV+  G +L+E   G
Sbjct: 185 TY---DDEHHSTLVS-TR---HYRAPEVI---LALGWSQPCDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	340
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.3
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.16
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.57
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.33
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.3
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.2
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.94
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.86
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.86
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.82
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.81
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.78
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.68
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.67
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.59
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.5
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.43
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.09
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.81
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.23
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	92.82
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	91.78
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	91.59
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.79
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.47
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.54

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.6e-61  Score=420.52  Aligned_cols=263  Identities=24%  Similarity=0.361  Sum_probs=215.8

Q ss_pred             CHHHHHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEE
Q 044497           58 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFC  129 (340)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~  129 (340)
                      ...|+...+.+|.++||+|+||+||+|.+.      +++.||||+++....  ..++|.+|+.++++++|||||+++|+|
T Consensus        19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            334455566778899999999999999863      467899999975432  347899999999999999999999999


Q ss_pred             EcCCeeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 044497          130 SEGSKRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (340)
Q Consensus       130 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~N  197 (340)
                      .+.+..++|||||++|+|.+++.....            ....+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~N  175 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN  175 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccc
Confidence            999999999999999999999854321            134689999999999999999999999   99999999999


Q ss_pred             eeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcc
Q 044497          198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHAT  276 (340)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~  276 (340)
                      ||+++++.+||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~  253 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  253 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred             eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999865443333333455799999999999875  78999999999999999999 8999976543


Q ss_pred             cccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .        .+...+..+.....      +..++.++.+|+.+||+.||++|||++||++.|+
T Consensus       254 ~--------~~~~~i~~~~~~~~------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~  302 (308)
T 4gt4_A          254 Q--------DVVEMIRNRQVLPC------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR  302 (308)
T ss_dssp             H--------HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H--------HHHHHHHcCCCCCC------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2        13333444433222      2345678999999999999999999999999987

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-59  Score=408.74  Aligned_cols=256  Identities=28%  Similarity=0.502  Sum_probs=201.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+.+.++||+|+||+||+|+++  ..||||+++....+.   +.|.+|++++++++|||||++++++.+ +.+++|||||
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            4456789999999999999865  469999997654443   568999999999999999999999865 5689999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.......
T Consensus       114 ~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          114 EGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             SSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999998432   35699999999999999999999999   999999999999999999999999999987655443


Q ss_pred             ceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          223 FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      ........||+.|+|||++.+. .+.++.++|||||||++|||+||+.||......       ..+......+....  .
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~~~p--~  258 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGYASP--D  258 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTCCCC--C
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCC--C
Confidence            3344556799999999999653 236889999999999999999999999754321       11222233322111  1


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....+..+++++.+|+.+||+.||++|||+.|+++.|+
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            12233356678999999999999999999999998875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-60  Score=414.34  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=208.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      .+.+.+.||+|+||+||+|.+.      ++..||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV   93 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   93 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            4556789999999999999763      467899999976432 236799999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEe
Q 044497          139 YEYMPNGSLDRHIFPKE---------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~  209 (340)
                      ||||++|+|.+++....         .....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+
T Consensus        94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence            99999999999996432         2345799999999999999999999999   99999999999999999999999


Q ss_pred             cccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHH
Q 044497          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVY  288 (340)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  288 (340)
                      |||+|+...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||......        .+.
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--------~~~  240 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EVI  240 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence            99999865444333333344689999999999875  78999999999999999999 89999765432        133


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..+..+.....      +..+++++.+|+.+||+.||++|||++|+++.|+
T Consensus       241 ~~i~~~~~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          241 ECITQGRVLQR------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             HHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCCCCC------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            33344433222      2245678999999999999999999999999886

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.9e-59  Score=414.05  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=202.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      +.+.+.||+|+||+||+|+++      ++..||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..++||
T Consensus        43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~  122 (329)
T 4aoj_A           43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF  122 (329)
T ss_dssp             EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            445688999999999999864      477899999976432 2367999999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          140 EYMPNGSLDRHIFPKES-----------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                      |||++|+|.+++.....           ...++++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||
T Consensus       123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki  199 (329)
T 4aoj_A          123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKI  199 (329)
T ss_dssp             ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEE
T ss_pred             EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEE
Confidence            99999999999865432           235699999999999999999999999   9999999999999999999999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHH
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  287 (340)
                      +|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||......        .+
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--------~~  269 (329)
T 4aoj_A          200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--------EA  269 (329)
T ss_dssp             CCCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--------HH
T ss_pred             cccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence            999999866554433333456799999999999875  78999999999999999999 89999764432        12


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...+..+.....      +..+++++.+|+.+||+.||++|||++||++.|+
T Consensus       270 ~~~i~~g~~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~  315 (329)
T 4aoj_A          270 IDCITQGRELER------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ  315 (329)
T ss_dssp             HHHHHHTCCCCC------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred             HHHHHcCCCCCC------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            333334433222      2245678999999999999999999999999886

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-59  Score=406.74  Aligned_cols=246  Identities=23%  Similarity=0.299  Sum_probs=208.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|++.+.||+|+||+||+|... +++.||+|++.+.    ....+.+.+|+++|+.++|||||++++++.+.+..|+|||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4778899999999999999865 7899999999752    3445789999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |++||+|.+++.    ..+.+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus       113 y~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          113 YAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             cCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999993    345799999999999999999999999   9999999999999999999999999999877554


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .........+||+.|+|||++.+.  .++.++||||+||++|+|+||+.||...+..       . +...+..+. .   
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~-~~~~i~~~~-~---  251 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------L-IFAKIIKLE-Y---  251 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTC-C---
T ss_pred             CCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHcCC-C---
Confidence            443344567899999999999875  7889999999999999999999999754321       1 222222221 1   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                         .++..+++++.+|+.+||+.||++|||++|++
T Consensus       252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               12224567899999999999999999999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-58  Score=407.78  Aligned_cols=246  Identities=26%  Similarity=0.324  Sum_probs=205.7

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      |++.++||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+++|+.++|||||++++++.+.+.+|+|||||++
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            556688999999999999876 78999999996533 3446788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.......  
T Consensus       156 g~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          156 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence            99999883     24689999999999999999999999   999999999999999999999999999987654332  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+.........    
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~~~~~~----  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPRLK----  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSSCCCCS----
T ss_pred             cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCCCCCC----
Confidence            23456799999999999875  78999999999999999999999997543211        22222222222222    


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....+++++.+|+.+||+.||++|||++|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12345678999999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.5e-59  Score=411.43  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=200.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +|.+.+.||+|+||+||+|... +|+.||+|++.......   +.+.+|+++|+.++|||||++++++.+.+.+|+||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            4677889999999999999865 78999999997655443   5688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      |+||+|.+++...  .+..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+......
T Consensus       105 ~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          105 CEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999998532  245678999999999999999999999   99999999999999999999999999998654321


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  .....+||+.|+|||++.+.  .++.++|||||||++|||+||+.||......       ..... +..+....   
T Consensus       180 ~--~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~-i~~~~~~~---  244 (350)
T 4b9d_A          180 E--LARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMK-------NLVLK-IISGSFPP---  244 (350)
T ss_dssp             H--HHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHH-HHHTCCCC---
T ss_pred             c--cccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHH-HHcCCCCC---
Confidence            1  12345699999999999875  7889999999999999999999999764321       11222 22222211   


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         .+..+++++.+|+.+||+.||++|||++|+++
T Consensus       245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               12245678999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.4e-58  Score=395.58  Aligned_cols=243  Identities=26%  Similarity=0.381  Sum_probs=198.7

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEc----CCeeEEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVY  139 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~  139 (340)
                      .+.+.||+|+||+||+|.+. ++..||+|++.......   +.+.+|+++++.++|||||+++++|.+    .+.+|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999875 78899999997654433   568999999999999999999999864    35589999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeeEcC-CCceEEecccCCcc
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDH-NFIPKVSDFGLAKF  216 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dik~~Nill~~-~~~~kl~Dfg~~~~  216 (340)
                      |||++|+|.+++.    ....+++..+..++.|++.||+|||++   +  |+||||||+|||+++ ++.+||+|||+|+.
T Consensus       109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            9999999999993    346789999999999999999999998   7  999999999999974 78999999999986


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .....    .....||+.|+|||++.+   .++.++|||||||++|||+||+.||......       ..+...+..+..
T Consensus       182 ~~~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~~~  247 (290)
T 3fpq_A          182 KRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK  247 (290)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred             CCCCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcCCC
Confidence            43322    245579999999999864   5789999999999999999999999653321       112233333222


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +     ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       248 ~-----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 P-----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             C-----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C-----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1     1222334568999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-57  Score=401.38  Aligned_cols=248  Identities=22%  Similarity=0.234  Sum_probs=201.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      +.+.++||+|+||+||+|.+. +|+.||||+++.....    .+|+.+++.++|||||++++++.+.+.+|+|||||+||
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            445678999999999999875 7899999999765433    47999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCccCCCCCCc-
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDF-  223 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~-  223 (340)
                      +|.+++.    ..+.+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+|+........ 
T Consensus       136 ~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          136 SLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             BHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999993    345799999999999999999999999   999999999999999887 6999999999876543221 


Q ss_pred             --eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          224 --VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       224 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                        ......+||+.|+|||++.+.  .++.++|||||||++|||+||+.||........       ....... ...    
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~-~~~----  274 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------CLKIASE-PPP----  274 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-------HHHHHHS-CCG----
T ss_pred             ceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHHcC-CCC----
Confidence              122345799999999999875  788999999999999999999999976543221       1111111 110    


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....++.+++++.+++.+||+.||++|||+.|+++.|.
T Consensus       275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            11233456788999999999999999999999988763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.5e-58  Score=391.91  Aligned_cols=244  Identities=22%  Similarity=0.358  Sum_probs=191.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|++.+.||+|+||+||+|... +++.||+|++.+...    ..+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            5778899999999999999865 789999999975432    23578999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+ +|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        94 y~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           94 YA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             CC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             CC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            99 689999884    345799999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .   ......||+.|+|||++.+. ..++.++||||+||++|+|+||+.||......       . ....+.++..    
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------~-~~~~i~~~~~----  229 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------V-LFKNISNGVY----  229 (275)
T ss_dssp             ------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTCC----
T ss_pred             C---ccCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHcCCC----
Confidence            2   23456799999999999875 23467999999999999999999999754321       1 2222222221    


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus       230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               122235678999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-57  Score=408.32  Aligned_cols=246  Identities=26%  Similarity=0.333  Sum_probs=205.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      |++.+.||+|+||+||+|... +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||||+|
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            556688999999999999876 78999999997543 3446789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.......  
T Consensus       233 G~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          233 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            99999883     24689999999999999999999999   999999999999999999999999999986654332  


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+..........   
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~~~~~~~---  369 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPRLKN---  369 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCCSC---
T ss_pred             cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCCCCCcc---
Confidence            23456799999999999875  78999999999999999999999997543211        222222222222221   


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ...+++++.+|+.+||+.||++|||+.|+++
T Consensus       370 -~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1234678999999999999999999999975

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.6e-57  Score=394.19  Aligned_cols=266  Identities=23%  Similarity=0.283  Sum_probs=199.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCC----eeEEEEEcc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEYM  142 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~  142 (340)
                      +.+.+.||+|+||+||+|++ +|+.||||++............|+..+..++|||||++++++.+.+    .+++|||||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~   83 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence            45678999999999999987 4889999999765433233445666677889999999999997653    579999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG-----CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ++|+|.+++.     ..+++++.+.+++.|++.||+|||++     .+++|+||||||+|||+++++++||+|||+++..
T Consensus        84 ~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           84 EHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             TTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999993     34689999999999999999999975     2458999999999999999999999999999866


Q ss_pred             CCCCCce--eeeccccCccccccccccccc----cccccccchhhHHHHHHHHHcCCCCCCCCccccc--------ccch
Q 044497          218 PKENDFV--SISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS--------KAYF  283 (340)
Q Consensus       218 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~--------~~~~  283 (340)
                      .......  ......||+.|+|||++.+..    ..++.++|||||||++|||+||.+|+........        ....
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5443321  123456999999999987531    2467899999999999999999888764432211        1111


Q ss_pred             hHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .............+.+... ......+..+.+|+.+||+.||++|||+.|+++.|+
T Consensus       239 ~~~~~~~~~~~~rp~~p~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  293 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCCcc-ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            1222222222222222221 122345678899999999999999999999999886

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.1e-57  Score=402.25  Aligned_cols=261  Identities=26%  Similarity=0.413  Sum_probs=213.9

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEcC------CcEEEEEEccCCCCC--hHHHHHHHHHhcccCC-CceeeEeeEEEc
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLHT------GGLIAVKMLANSKFS--GEEFINEVSTIGRIHH-VNVVQLLGFCSE  131 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h-~~iv~~~~~~~~  131 (340)
                      |+....+.+.+.||+|+||+||+|.+..      ++.||||.+......  .+.+.+|+++|.+++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            3445667778999999999999997542      357999999765433  3568999999999965 999999999965


Q ss_pred             -CCeeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          132 -GSKRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       132 -~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                       .+.+++|||||++|+|.+++.....            ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence             4678999999999999999864322            234589999999999999999999999   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATR  277 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~  277 (340)
                      |+++++.+||+|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||......
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999977665555455566799999999999875  78999999999999999998 89999764432


Q ss_pred             ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                             ..+...+..+......      ..+++++.+++.+||+.||++|||+.|+++.|+
T Consensus       295 -------~~~~~~i~~g~~~~~p------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~  343 (353)
T 4ase_A          295 -------EEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  343 (353)
T ss_dssp             -------HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHHHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence                   2233444444443332      234578999999999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-57  Score=394.53  Aligned_cols=245  Identities=22%  Similarity=0.297  Sum_probs=195.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      .|++.+.||+|+||+||+|+..    +++.||+|++++...   ....+.+|+++++.++|||||++++++.+.+.+|+|
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4778899999999999999752    567899999975332   224678999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      ||||+||+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+...
T Consensus       105 mEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          105 LDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             ECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999993    345799999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....  ......||+.|+|||++.+.  .++.++||||+||++|||+||+.||...+..       . ....+..+..  
T Consensus       178 ~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------~-~~~~i~~~~~--  243 (304)
T 3ubd_A          178 DHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-------E-TMTMILKAKL--  243 (304)
T ss_dssp             ---C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHCCC--
T ss_pred             CCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHH-------H-HHHHHHcCCC--
Confidence            3322  23456799999999999875  7889999999999999999999999754322       1 1222222211  


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~evl~  336 (340)
                           ..+..+++++.+|+.+||+.||++|||+     +|+++
T Consensus       244 -----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 -----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                 1223456789999999999999999985     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-54  Score=378.83  Aligned_cols=249  Identities=20%  Similarity=0.277  Sum_probs=187.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCC---------
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGS---------  133 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------  133 (340)
                      .|++.+.||+|+||+||+|... +++.||+|+++.....  .+.+.+|+++|+.++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            3667789999999999999875 7899999998754332  357889999999999999999999986544         


Q ss_pred             ---eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEec
Q 044497          134 ---KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       134 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~D  210 (340)
                         ..|+|||||++|+|.+++..... ....++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence               36899999999999999854322 23456777899999999999999999   999999999999999999999999


Q ss_pred             ccCCccCCCCCCc----------eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc
Q 044497          211 FGLAKFHPKENDF----------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK  280 (340)
Q Consensus       211 fg~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~  280 (340)
                      ||+|+........          ......+||+.|+|||++.+.  .++.++|||||||++|||++   ||.....    
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~----  232 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME----  232 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence            9999866543221          112345699999999999875  78899999999999999996   6643211    


Q ss_pred             cchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          281 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ... ..........      .......++.+.+|+.+||+.||++|||+.|+++
T Consensus       233 --~~~-~~~~~~~~~~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 --RVR-TLTDVRNLKF------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --HHH-HHHHHHTTCC------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHH-HHHHHhcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              001 1111111111      1233445567889999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-53  Score=381.98  Aligned_cols=258  Identities=19%  Similarity=0.239  Sum_probs=199.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEc------CCee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~  135 (340)
                      .|++.+.||+|+||+||+|.+. +|+.||||+++......   +.+.+|+++|+.++|||||++++++..      .+..
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            4677789999999999999875 79999999997654433   467899999999999999999998753      3678


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+|||||+ |+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus       135 ~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence            99999995 68999883    346799999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCC--ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh--
Q 044497          216 FHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL--  291 (340)
Q Consensus       216 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  291 (340)
                      .......  .......+||+.|+|||++.+. ..++.++||||+||++|||++|++||...+....    ...+....  
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~----l~~I~~~~g~  281 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ----LQLIMMVLGT  281 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH----HHHHHHHHCC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH----HHHHHHhcCC
Confidence            6543221  1223456799999999998764 3568899999999999999999999976543210    00010000  


Q ss_pred             ------------------hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 ------------------NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 ------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                        ...............+..++++.+|+.+||+.||++|||++|+++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                              000000000001122234678999999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-51  Score=368.49  Aligned_cols=259  Identities=19%  Similarity=0.245  Sum_probs=195.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|++.+.||+|+||+||+|+.+    +++.||+|++.... ...++.+|+++|+.+ +||||+++++++.+.+..|+|||
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            4677899999999999999753    46789999986643 456788999999998 69999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-CceEEecccCCccCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPK  219 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-~~~kl~Dfg~~~~~~~  219 (340)
                      |+++|+|.+++       ..+++..+..++.|++.||+|||++   ||+||||||+|||++.+ +.+||+|||+|+....
T Consensus       101 ~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          101 YLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             CCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             CCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            99999999988       3588999999999999999999999   99999999999999876 7999999999975433


Q ss_pred             CCC--------------------------ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCC
Q 044497          220 END--------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (340)
Q Consensus       220 ~~~--------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~  273 (340)
                      ...                          .......+||+.|+|||++.+. ..++.++||||+||++|||+||+.||..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            211                          0112345699999999998764 3578899999999999999999999965


Q ss_pred             Ccccccccc-hh------------------------------HHHHHHhhcCCC--cccc-------ccchhhHHHHHHH
Q 044497          274 HATRSSKAY-FP------------------------------SWVYDQLNKGGD--LELR-------NVTEIESMIARKL  313 (340)
Q Consensus       274 ~~~~~~~~~-~~------------------------------~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~l  313 (340)
                      ......... +.                              ....+.......  +...       ........+++++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            432110000 00                              000000000000  0000       0001112345788


Q ss_pred             HHHHhhcccCCCCCCCCHHHHHH
Q 044497          314 CMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       314 ~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+|+.+||+.||++|||++|+++
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHCcCChhHCcCHHHHhc
Confidence            99999999999999999999985

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.6e-51  Score=387.11  Aligned_cols=249  Identities=20%  Similarity=0.288  Sum_probs=206.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|.+.+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|+++|+.++||||+++++++.+.+.+|+|||||+
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~  237 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  237 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            5677899999999999999875 789999999876443 34578899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC--CceEEecccCCccCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN--FIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~--~~~kl~Dfg~~~~~~~~~  221 (340)
                      ||+|.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++......
T Consensus       238 gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          238 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999998842   345799999999999999999999999   99999999999999854  899999999998765543


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   ....+||+.|+|||++.+.  .++.++||||+||++|+|++|+.||.......        ....+.....   ..
T Consensus       312 ~---~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--------~~~~i~~~~~---~~  375 (573)
T 3uto_A          312 S---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDW---NM  375 (573)
T ss_dssp             E---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHTTCC---CC
T ss_pred             c---eeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHhCCC---CC
Confidence            2   3455799999999999876  78899999999999999999999997544321        1122222111   11


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .......+++++.+|+.+||+.||.+|||+.|+++
T Consensus       376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12223345678999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.7e-51  Score=384.91  Aligned_cols=245  Identities=24%  Similarity=0.319  Sum_probs=197.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHH---HHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFIN---EVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      |++.+.||+|+||+||+|... +|+.||+|++.+.    ........+   ++.+++.++|||||+++++|.+.+.+|+|
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            556689999999999999876 7899999999653    222333344   46677788999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||++||+|.+++.    ..+.+++..+..++.||+.||+|||++   +|+||||||+|||++.+|++||+|||+|+...
T Consensus       271 mEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          271 LDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             ECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999994    345799999999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ...    ....+||+.|+|||++.+. ..++.++|+|||||++|||++|+.||........    .. +........   
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~----~~-i~~~i~~~~---  410 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HE-IDRMTLTMA---  410 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----HH-HHHHHHHCC---
T ss_pred             CCC----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HH-HHHhhcCCC---
Confidence            433    2456799999999999642 3678899999999999999999999975443221    11 111111111   


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVL  335 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl  335 (340)
                          ..++..+++++.+|+.+||+.||++|++     ++|++
T Consensus       411 ----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          411 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence                1122345688999999999999999998     56665

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-48  Score=347.12  Aligned_cols=267  Identities=36%  Similarity=0.625  Sum_probs=217.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      |.+.+.||+|+||.||+|.+++++.||+|++...... .+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus        41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (321)
T 2qkw_B           41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG  120 (321)
T ss_dssp             CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred             cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence            4556889999999999999888999999998765433 467899999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCcee
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +|.+++.........+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...........
T Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  197 (321)
T 2qkw_B          121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL  197 (321)
T ss_dssp             BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred             cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999966554455799999999999999999999999   999999999999999999999999999986543332222


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc---ccc
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL---RNV  302 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  302 (340)
                      .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......... ....|.......+.....   ...
T Consensus       198 ~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             BCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-CHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             ccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-HHHHHhhhccccccHHHhcChhhc
Confidence            2344589999999998764  6788999999999999999999999865544322 222332222222211111   111


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .......+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            2345677889999999999999999999999999886

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.7e-49  Score=350.58  Aligned_cols=283  Identities=38%  Similarity=0.645  Sum_probs=226.0

Q ss_pred             CCCCHHHHHHHHhh--hhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEE
Q 044497           55 KRYSYPEIIAVTNH--FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCS  130 (340)
Q Consensus        55 ~~~~~~~~~~~~~~--~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~  130 (340)
                      ..++..++...+.+  +.+.||+|+||.||+|...+++.||+|++.....  ....+.+|+++++.++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            46777777765544  4589999999999999887899999999976433  2247899999999999999999999999


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEec
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~D  210 (340)
                      ..+..++||||+++++|.+++.........+++..+..++.|++.||+|||++...+++||||||+||+++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            99999999999999999999977665666799999999999999999999997667899999999999999999999999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccc-cccchhHHHHH
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS-SKAYFPSWVYD  289 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~  289 (340)
                      ||++......... ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||....... .......|...
T Consensus       178 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          178 FGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             CccccccCccccc-ccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999866543322 23445599999999999765  67889999999999999999999996433211 12223333333


Q ss_pred             HhhcCCCccc---cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          290 QLNKGGDLEL---RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       290 ~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ..........   ..........+..+.+++.+||+.||.+|||++|+++.|++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            2222211111   11123456677899999999999999999999999999974

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-48  Score=346.57  Aligned_cols=268  Identities=25%  Similarity=0.329  Sum_probs=207.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCC----eeEEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYE  140 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e  140 (340)
                      ..|.+.+.||+|+||+||+|... ++.||+|++............|+.+++.++||||+++++++....    ..++|||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            34567789999999999999876 789999999766555556777999999999999999999997744    3699999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC-------DVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-------~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      |+++|+|.+++..     ..+++..+..++.|++.||+|||+..       ..+++||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          103 FHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            9999999999832     45899999999999999999999751       23899999999999999999999999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccc---cccccccchhhHHHHHHHHHcCCCCCCCCccccccc---------
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA---------  281 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~---------  281 (340)
                      ++...............||+.|+|||.+.+..   ..++.++|||||||++|+|+||+.||..........         
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            97655444333334456999999999987521   256678999999999999999999997654322111         


Q ss_pred             chhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....+............... .......+..+.+|+.+||+.||++|||+.|+++.|+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  314 (322)
T 3soc_A          258 SLEDMQEVVVHKKKRPVLRD-YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT  314 (322)
T ss_dssp             CHHHHHHHHTTSCCCCCCCG-GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             chhhhhhhhhcccCCCCccc-cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11111111112222221111 1122245677999999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-47  Score=346.76  Aligned_cols=256  Identities=24%  Similarity=0.424  Sum_probs=207.7

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc--------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  133 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  133 (340)
                      ..|.+.+.||+|+||.||+|.+.        ++..||+|+++.....  .+.+.+|+.+++.+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            45566789999999999999752        3457999999765432  25689999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          134 KRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                      ..|+||||+++|+|.+++.....            ....+++..+..++.|++.||+|||++   +++||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence            99999999999999999865432            124588999999999999999999999   999999999999999


Q ss_pred             CCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccc
Q 044497          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSK  280 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~  280 (340)
                      .++.+||+|||+++...............+|+.|+|||++.+.  .++.++|||||||++|||++ |+.||.......  
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--  313 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  313 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            9999999999999866544332233344578899999999775  68889999999999999999 999987644321  


Q ss_pred             cchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          281 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            ....+..+.....      +..++.++.+++.+||+.||.+|||+.|+++.|+
T Consensus       314 ------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~  360 (370)
T 2psq_A          314 ------LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  360 (370)
T ss_dssp             ------HHHHHHTTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                  2222333322221      2234578999999999999999999999999886

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-48  Score=345.72  Aligned_cols=245  Identities=19%  Similarity=0.333  Sum_probs=202.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.+.||+|+||.||+|.+ .+++.||+|++.......   +.+.+|+++++.++||||+++++++...+..++||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            356678999999999999987 488999999997654443   4678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        96 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           96 ASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999843    35689999999999999999999999   99999999999999999999999999997654433


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   .....||+.|+|||.+.+. ...+.++||||+||++|+|++|+.||......       . .......+..     
T Consensus       169 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~-~~~~i~~~~~-----  231 (328)
T 3fe3_A          169 K---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------E-LRERVLRGKY-----  231 (328)
T ss_dssp             G---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHCCC-----
T ss_pred             c---cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCCC-----
Confidence            2   3455699999999999875 23357899999999999999999999764421       1 2222222211     


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ..+...++++.+|+.+||+.||.+|||++|+++
T Consensus       232 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 --RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              111234578899999999999999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.4e-48  Score=337.42  Aligned_cols=247  Identities=25%  Similarity=0.350  Sum_probs=203.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  100 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence            4566789999999999999864 78899999986543 345678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++..     ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........ 
T Consensus       101 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A          101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             TCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            9999999832     3588999999999999999999999   999999999999999999999999999876544332 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                       ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       ......... .....   
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~~~~~-~~~~~---  237 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNG-TPELQ---  237 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHHC-SCCCS---
T ss_pred             -ccCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC-CCCCC---
Confidence             22345699999999999875  77889999999999999999999997543211       111111111 11111   


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       .+..++..+.+++.+||+.||++|||++|+++
T Consensus       238 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             12235578899999999999999999999975

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.4e-47  Score=336.03  Aligned_cols=275  Identities=35%  Similarity=0.572  Sum_probs=220.1

Q ss_pred             CCCCCHHHHHHHHhhhh--------hhcCCCCCeEEEEEEEcCCcEEEEEEccCCC-----CChHHHHHHHHHhcccCCC
Q 044497           54 PKRYSYPEIIAVTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLANSK-----FSGEEFINEVSTIGRIHHV  120 (340)
Q Consensus        54 ~~~~~~~~~~~~~~~~~--------~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~  120 (340)
                      .+.++..++...+.+|.        +.||+|+||.||+|.. +++.+|+|++....     ...+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            36789999999998876        4599999999999986 58899999986532     1236788999999999999


Q ss_pred             ceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE
Q 044497          121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (340)
Q Consensus       121 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill  200 (340)
                      ||+++++++.+.+..+++|||+++++|.+++.... ....+++..+..++.|++.||+|||++   +++||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            99999999999999999999999999999885432 245689999999999999999999999   99999999999999


Q ss_pred             cCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc
Q 044497          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK  280 (340)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~  280 (340)
                      +.++.+||+|||++................||+.|+|||.+.+   .++.++||||||+++|+|++|..||.........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence            9999999999999986655443333344568999999998865   5678999999999999999999999865543221


Q ss_pred             cchhHHHHHHhhcCCCcc---ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          281 AYFPSWVYDQLNKGGDLE---LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         ..+............   .......+...+..+.+++.+||+.||.+|||++++++.|+
T Consensus       244 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~  302 (307)
T 2nru_A          244 ---LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ  302 (307)
T ss_dssp             ---THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ---HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence               111111111110000   00112234566788999999999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-48  Score=342.55  Aligned_cols=249  Identities=17%  Similarity=0.218  Sum_probs=206.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      .|.+.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g   85 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence            4567789999999999999876 688999999986655556788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC--CCceEEecccCCccCCCCCC
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~--~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.  ++.+||+|||++........
T Consensus        86 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            999999832   234689999999999999999999999   9999999999999987  78999999999987654432


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                         .....||+.|+|||++.+.  .++.++||||||+++|+|++|..||......       ............    ..
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~----~~  223 (321)
T 1tki_A          160 ---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYT----FD  223 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCC----CC
T ss_pred             ---cccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHcCCCC----CC
Confidence               2345689999999999775  6788999999999999999999999754321       112222221111    11


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......++.++.+++.+||+.||.+|||+.|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1222345678999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-47  Score=331.91  Aligned_cols=253  Identities=26%  Similarity=0.442  Sum_probs=211.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...|.+.+.||+|+||.||+|..+++..||+|++.......+++.+|+++++.++||||+++++++.+.+..++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            34567788999999999999998888899999999887788899999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++..   .+..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++........ 
T Consensus        87 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  159 (268)
T 3sxs_A           87 NGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-  159 (268)
T ss_dssp             TCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred             CCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence            9999999843   234689999999999999999999999   999999999999999999999999999986654432 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        .......+......  
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--  227 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVSQGHRLYRP--  227 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCCCC--
T ss_pred             hcccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChHH--------HHHHHHcCCCCCCC--
Confidence            222344567889999999765  67889999999999999999 999987544321        11222222211111  


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                          ...++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (268)
T 3sxs_A          228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE  260 (268)
T ss_dssp             ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred             ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                123467899999999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-47  Score=344.62  Aligned_cols=248  Identities=22%  Similarity=0.286  Sum_probs=204.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-------ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   92 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL   92 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence            4667789999999999999876 788999999876432       24678999999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC----ceEEecccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDFGL  213 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~----~~kl~Dfg~  213 (340)
                      ||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++++++    .+||+|||+
T Consensus        93 v~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           93 ILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999983    345789999999999999999999999   999999999999998776    799999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      +........   .....||+.|+|||++.+.  .++.++||||||+++|+|++|..||.......        ....+..
T Consensus       166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--------~~~~i~~  232 (361)
T 2yab_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANITA  232 (361)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHT
T ss_pred             ceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh
Confidence            986654332   2345699999999999765  67889999999999999999999997543211        1122222


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +..   .........++..+.+|+.+||+.||.+|||+.|+++
T Consensus       233 ~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          233 VSY---DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TCC---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCC---CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111   1112233345678999999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.8e-48  Score=332.89  Aligned_cols=252  Identities=28%  Similarity=0.503  Sum_probs=209.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ..|.+.+.||+|+||.||+|.+.+++.||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   89 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence            34667789999999999999988888999999998887888999999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........ .
T Consensus        90 ~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           90 GCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             CBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            999999843   235689999999999999999999999   999999999999999999999999999986543221 1


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      ......+|+.|+|||.+.+.  .++.++||||+|+++|+|++ |+.||.......        .......+.....    
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~----  228 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYK----  228 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCC----
T ss_pred             cccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhcCccCCC----
Confidence            12334467889999999765  67889999999999999999 999987543321        2222222221111    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        +...+..+.+++.+||+.||.+|||++++++.|+
T Consensus       229 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  262 (269)
T 4hcu_A          229 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  262 (269)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence              1123567899999999999999999999999886

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.4e-47  Score=335.38  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=209.9

Q ss_pred             CCCCCHHHHHHHHhh------------hhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCC
Q 044497           54 PKRYSYPEIIAVTNH------------FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHH  119 (340)
Q Consensus        54 ~~~~~~~~~~~~~~~------------~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h  119 (340)
                      +..++..++..++..            ..+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|+.+++.++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            356788888776643            3468999999999999876 789999999876443 34678999999999999


Q ss_pred             CceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCee
Q 044497          120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL  199 (340)
Q Consensus       120 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nil  199 (340)
                      |||+++++++...+..++||||+++++|.+++.     ...+++..+..++.|++.||+|||+.   +++||||||+||+
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            999999999999999999999999999999883     34689999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc
Q 044497          200 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS  279 (340)
Q Consensus       200 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~  279 (340)
                      ++.++.+||+|||++........  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||....... 
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-  248 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-  248 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred             ECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            99999999999999976544322  12345699999999999764  67889999999999999999999997543211 


Q ss_pred             ccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          280 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                             ....+..........    ....++.+.+++.+||+.||++|||+.|+++
T Consensus       249 -------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          249 -------AMKRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             -------HHHHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------HHHHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   122222222221111    1234567899999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=338.48  Aligned_cols=254  Identities=27%  Similarity=0.400  Sum_probs=204.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|.+.+.||+|+||+||+|.+. +++.+|+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   90 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK   90 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence            4566789999999999999875 68899999885532 234678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.........
T Consensus        91 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           91 GGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            99999998432   45689999999999999999999999   9999999999999999999999999999865443221


Q ss_pred             e------------eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          224 V------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       224 ~------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      .            ......||+.|+|||.+.+.  .++.++||||||+++|+|++|..|+.............  .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--~~~~~  240 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--VRGFL  240 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--HHHHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--hhccc
Confidence            1            01144699999999999875  77889999999999999999999987654432221110  11111


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..          ..+..+++.+.+++.+||+.||++|||+.++++.|+
T Consensus       241 ~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          241 DR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             HH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11          011233467889999999999999999999999886

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.8e-47  Score=337.14  Aligned_cols=254  Identities=29%  Similarity=0.469  Sum_probs=197.9

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...|.+.+.||+|+||+||+|.. +++.||+|++.......   +.+.+|++++++++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            34566778999999999999987 48899999997765443   468899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |+++++|.+++.... ....+++..+..++.|++.||+|||++   +  ++||||||+||+++.++.+||+|||+++...
T Consensus       115 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          115 YLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             CCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             cCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            999999999984322 122489999999999999999999998   8  9999999999999999999999999997543


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       ............ 
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~~~-  258 (309)
T 3p86_A          191 STFL--SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-------VVAAVGFKCKRL-  258 (309)
T ss_dssp             -------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-------HHHHHHHSCCCC-
T ss_pred             cccc--ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcCCCC-
Confidence            3221  22345699999999999875  67889999999999999999999997544321       111111111111 


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           ..+..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       259 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          259 -----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                 122234578999999999999999999999999886

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=337.81  Aligned_cols=250  Identities=24%  Similarity=0.284  Sum_probs=205.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-------ChHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      ...|.+.+.||+|+||.||+|... +++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456778899999999999999876 688999999865332       356789999999999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC----ceEEecc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDF  211 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~----~~kl~Df  211 (340)
                      ++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999983    345789999999999999999999999   999999999999998877    8999999


Q ss_pred             cCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      |++........   .....||+.|+|||++.+.  .++.++||||||+++|+|++|..||.......        .....
T Consensus       163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~~  229 (326)
T 2y0a_A          163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANV  229 (326)
T ss_dssp             TTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHH
T ss_pred             CCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHH
Confidence            99986644332   2345699999999999764  67889999999999999999999997543211        11111


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....   ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          230 SAVN---YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHTC---CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhcC---CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111   01111223345678999999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=337.43  Aligned_cols=255  Identities=30%  Similarity=0.470  Sum_probs=204.4

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ...+|.+.+.||+|+||.||+|.+.    .+..||+|++......  .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            3455667789999999999999874    3446999999764332  357899999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+++++|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       127 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999843   235689999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          217 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       217 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ....... .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        .......+
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~  270 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--------VISSVEEG  270 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcC
Confidence            6543322 222334467889999999765  78889999999999999999 999996544321        22222222


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....      .+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       271 ~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~  309 (325)
T 3kul_A          271 YRLP------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD  309 (325)
T ss_dssp             CCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            2221      11234578999999999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.7e-47  Score=339.38  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=202.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|++.+.||+|+||+||+|... +++.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            4567789999999999999876 7899999999753    3345678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           86 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             CCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999883    345689999999999999999999999   9999999999999999999999999999854332


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......||+.|+|||++.+.  .++.++|+||||+++|||++|+.||......       . ....+.... .   
T Consensus       159 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~-~~~~i~~~~-~---  222 (337)
T 1o6l_A          159 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------R-LFELILMEE-I---  222 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHCC-C---
T ss_pred             CC--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHH-------H-HHHHHHcCC-C---
Confidence            22  23455699999999999775  6789999999999999999999999754321       1 112221111 1   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                         .++..+++++.+++.+||+.||++||     +++|+++
T Consensus       223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence               11223467899999999999999999     8998875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.9e-48  Score=348.64  Aligned_cols=254  Identities=24%  Similarity=0.418  Sum_probs=205.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...+.+.+.||+|+||.||+|.+. +++.||+|+++.....  .+.+.+|+++++.++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            345667789999999999999886 7889999998754322  2467899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++..   .+..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999999843   234689999999999999999999999   9999999999999999999999999999754332


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ..........++..|+|||.+.+.  .++.++||||||+++|||+| |..||......        ........+.....
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~  336 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVEKGGRLPC  336 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHHTTCCCCC
T ss_pred             ceeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC
Confidence            211111122357789999999764  78889999999999999998 99998765432        12233333322222


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            +..++..+.+++.+||+.||++|||++++++.|+
T Consensus       337 ------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          337 ------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence                  1234568899999999999999999999999886

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.1e-47  Score=334.51  Aligned_cols=255  Identities=25%  Similarity=0.323  Sum_probs=201.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .+|.+.+.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            45677899999999999999865 7889999998654332    256889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++.    ...++++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           91 EYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             ECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999983    335689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      .... ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       .......... .  
T Consensus       164 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~-~--  230 (294)
T 4eqm_A          164 TSLT-QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDSV-P--  230 (294)
T ss_dssp             ------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHHHHSSCC-C--
T ss_pred             cccc-ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhhccC-C--
Confidence            3221 22344689999999999875  67889999999999999999999997644211       1111221111 0  


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhc
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLE  339 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~evl~~L~  339 (340)
                      .........++..+.+++.+||+.||.+|| +++++.+.|+
T Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            111122234567899999999999999998 8999988875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-47  Score=334.86  Aligned_cols=261  Identities=20%  Similarity=0.292  Sum_probs=200.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcc--cCCCceeeEeeEEEc----CCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGR--IHHVNVVQLLGFCSE----GSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~~lv  138 (340)
                      ..|.+.+.||+|+||+||+|.. +++.||+|++....  ...+..|.+++..  ++||||+++++++..    ....++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            4566779999999999999987 58899999986543  3455666666666  799999999998643    3558999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeecCCCCCCeeEcCCCceEEec
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH--------NGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dik~~Nill~~~~~~kl~D  210 (340)
                      |||+++|+|.+++.     ...+++..+..++.|++.||+|||        +.   +++||||||+|||++.++.+||+|
T Consensus        85 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           85 THYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             ECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred             hhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence            99999999999992     346899999999999999999999        77   999999999999999999999999


Q ss_pred             ccCCccCCCCCCcee--eeccccCcccccccccccccc----ccccccchhhHHHHHHHHHcC----------CCCCCCC
Q 044497          211 FGLAKFHPKENDFVS--ISATRGTIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG----------RRNSNMH  274 (340)
Q Consensus       211 fg~~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~----~~~~~~DvwslG~~l~elltg----------~~p~~~~  274 (340)
                      ||++...........  .....||+.|+|||.+.+...    .++.++||||||+++|||+||          +.||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            999976544333211  233469999999999876422    355789999999999999999          7777554


Q ss_pred             cccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          275 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......  ... .......................+..+.+++.+||+.||++|||+.++++.|+
T Consensus       237 ~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          237 VPNDPS--FED-MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             SCSSCC--HHH-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcc--hhh-hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            332211  111 12222111111111222334457789999999999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.3e-47  Score=335.67  Aligned_cols=251  Identities=26%  Similarity=0.307  Sum_probs=201.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   87 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence            4567789999999999999876 788999999865432  2356889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           88 SGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             TTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999983    345689999999999999999999999   999999999999999999999999999976543333


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      ........||+.|+|||++.+. ...+.++||||||+++|+|++|+.||........  .    ...........     
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~----~~~~~~~~~~~-----  228 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTYL-----  228 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--H----HHHHHTTCTTS-----
T ss_pred             ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHHhcccccC-----
Confidence            2233455799999999999764 2347789999999999999999999976543211  0    11111111110     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       .....++..+.+|+.+||+.||.+|||+.|+++
T Consensus       229 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             111234577889999999999999999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.7e-47  Score=332.81  Aligned_cols=258  Identities=22%  Similarity=0.291  Sum_probs=200.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..|.+.+.||+|+||+||+|.+.+++.||+|++......   .+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            346677899999999999999888999999999754333   25788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++ +|.+.+..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          101 MEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            974 77777743   235689999999999999999999999   99999999999999999999999999998654332


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc----
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL----  297 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  297 (340)
                      .  ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.........    ..+..........    
T Consensus       174 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          174 R--SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL----PKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH----HHHHHHHCCCCTTTSGG
T ss_pred             c--cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHHHCCCChHHhhh
Confidence            2  22344689999999998753 36788999999999999999999999765543211    1111111110000    


Q ss_pred             ---------------cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ---------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ---------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                     .........+.+++++.+|+.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                           000001122234578899999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.4e-47  Score=341.22  Aligned_cols=255  Identities=22%  Similarity=0.303  Sum_probs=206.5

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC------CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS------KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      ....|.+.+.||+|+||+||+|... +++.||+|++...      ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3557888899999999999999875 7899999998532      22457899999999999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc---eEEeccc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFG  212 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~---~kl~Dfg  212 (340)
                      ++||||+++++|.+.+......+..+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999888755444455689999999999999999999999   9999999999999986654   9999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      ++........  ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        . ....+.
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~-~~~~i~  245 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE--------R-LFEGII  245 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------H-HHHHHH
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------H-HHHHHH
Confidence            9986654332  12345699999999999775  678899999999999999999999975321        1 111121


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+..   .........++.++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 KGKY---KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HTCC---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCC---CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111   0111122245678999999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.5e-47  Score=330.46  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=208.5

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +....|.+.+.||+|+||.||+|.+.++..||+|++.......+++.+|+++++.++||||+++++++.+.+..++||||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            34456677899999999999999998888999999998877888999999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            9999999998432   35689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      . .......+|+.|+|||.+.+.  .++.++||||||+++|+|+| |+.||.......        ....+..+......
T Consensus       175 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  243 (283)
T 3gen_A          175 Y-TSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRP  243 (283)
T ss_dssp             H-HSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCCCC
T ss_pred             c-ccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChhH--------HHHHHhcccCCCCC
Confidence            1 112233467889999999865  67889999999999999998 999987644321        22222222221111


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            ...++.+.+++.+||+.||.+|||++++++.|+
T Consensus       244 ------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          244 ------HLASEKVYTIMYSCWHEKADERPTFKILLSNIL  276 (283)
T ss_dssp             ------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence                  123467899999999999999999999999885

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=348.33  Aligned_cols=251  Identities=20%  Similarity=0.270  Sum_probs=203.4

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ...|.+.+.||+|+||.||+|... +++.+|+|++......   .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            456778899999999999999865 7889999999765533   256889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc---CCCceEEecccCCcc
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKF  216 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~---~~~~~kl~Dfg~~~~  216 (340)
                      ||+++|+|.+.+.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++   .++.+||+|||++..
T Consensus        90 E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999884    345689999999999999999999999   999999999999998   467899999999976


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ......  ......||+.|+|||++.+.  .++.++||||+||++|+|++|..||.......        ....+..+..
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~  230 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQHR--------LYQQIKAGAY  230 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCC
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhCCC
Confidence            654332  22345699999999999775  68889999999999999999999997543211        2222222211


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...   ......+++++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 DFP---SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCC---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC---ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            110   1111234578999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.2e-47  Score=333.28  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=208.9

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE------cCCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      ...|.+.+.||+|+||.||+|..      .++..||+|++......  .+.+.+|+++++.++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            34566778999999999999975      24578999999764332  25688999999999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 044497          136 ALVYEYMPNGSLDRHIFPKES--------------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  195 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~  195 (340)
                      ++||||+++++|.+++.....                    ....+++..+..++.|++.||+|||++   +++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999865432                    123488999999999999999999999   999999999


Q ss_pred             CCeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCC
Q 044497          196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMH  274 (340)
Q Consensus       196 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~  274 (340)
                      +||++++++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||...
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999876554443333445578899999999764  67889999999999999999 99998765


Q ss_pred             cccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          275 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....        .......+....      .+..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       257 ~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~  307 (314)
T 2ivs_A          257 PPER--------LFNLLKTGHRME------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE  307 (314)
T ss_dssp             CGGG--------HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHH--------HHHHhhcCCcCC------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            4321        222233322211      11234578999999999999999999999999886

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-47  Score=354.85  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=210.6

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ++....+.+.+.||+|+||.||+|.++++..||+|+++......+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3445566778999999999999999988889999999887777889999999999999999999999986 567899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       263 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          263 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             CCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             ecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999998432  223678899999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      .. .......+|..|+|||.+...  .++.++||||||+++|||+| |+.||.......        +...+..+.....
T Consensus       338 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~  406 (454)
T 1qcf_A          338 EY-TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGYRMPR  406 (454)
T ss_dssp             HH-HTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHHTCCCCC
T ss_pred             ce-eccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC
Confidence            11 111233467889999999764  68889999999999999999 999997543221        2222333322211


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                            +..++.++.+++.+||+.||++|||++++++.|+.
T Consensus       407 ------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~  441 (454)
T 1qcf_A          407 ------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  441 (454)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                  12345789999999999999999999999999873

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=341.90  Aligned_cols=260  Identities=25%  Similarity=0.412  Sum_probs=211.5

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc--------CCcEEEEEEccCCCCCh--HHHHHHHHHhccc-CCCceeeEeeEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKFSG--EEFINEVSTIGRI-HHVNVVQLLGFC  129 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~  129 (340)
                      ++...++.+.+.||+|+||.||+|...        .+..||+|++.......  +.+.+|+++++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            444567778899999999999999753        23579999997654332  5688999999999 999999999999


Q ss_pred             EcCCeeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 044497          130 SEGSKRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (340)
Q Consensus       130 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~N  197 (340)
                      ...+..++||||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999999865432            124689999999999999999999999   99999999999


Q ss_pred             eeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcc
Q 044497          198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHAT  276 (340)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~  276 (340)
                      ||++.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.....
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999876554433333445678899999999775  78889999999999999999 9999875432


Q ss_pred             cccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .        .....+..+......      ..++.++.+++.+||+.||++|||++|+++.|+
T Consensus       300 ~--------~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  348 (382)
T 3tt0_A          300 E--------ELFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  348 (382)
T ss_dssp             H--------HHHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H--------HHHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1        122333333222221      234578999999999999999999999999886

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.9e-47  Score=339.63  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=205.6

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      .....|.+.+.||+|+||.||+|... +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34567888899999999999999875 78899999997655443   467899999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC---CceEEecccCC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLA  214 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~---~~~kl~Dfg~~  214 (340)
                      ||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||+++.+   +.+||+|||++
T Consensus       106 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          106 VFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            999999999999883    345689999999999999999999999   99999999999999765   45999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ........   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......        .....+..+
T Consensus       179 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~  245 (362)
T 2bdw_A          179 IEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAG  245 (362)
T ss_dssp             BCCTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT
T ss_pred             eEecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC
Confidence            86654332   2345699999999999765  6788999999999999999999999754321        122222222


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....   .......+++++.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          246 AYDY---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCCC---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCC---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111   11112234678999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=331.60  Aligned_cols=264  Identities=19%  Similarity=0.289  Sum_probs=208.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCC--eeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e  140 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++....  ...+.+.+|+++++.++||||+++++++...+  ..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            4567789999999999999876 68899999987533  34577889999999999999999999997655  7899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE----cCCCceEEecccCCcc
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  216 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill----~~~~~~kl~Dfg~~~~  216 (340)
                      |+++++|.+++.... ....+++..+..++.|++.||+|||++   +++||||||+||++    +.++.+||+|||++..
T Consensus        90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             CCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             CCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            999999999985432 233489999999999999999999999   99999999999999    7788899999999987


Q ss_pred             CCCCCCceeeeccccCcccccccccccc------ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      ......   .....||+.|+|||.+...      ...++.++|||||||++|+|++|+.||..........   ......
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~  239 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYKI  239 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH---HHHHHH
T ss_pred             cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH---HHHHHH
Confidence            655432   2344699999999998631      2467889999999999999999999997544322211   112222


Q ss_pred             hhcCCC-----------------ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          291 LNKGGD-----------------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       291 ~~~~~~-----------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......                 .............+..+.+++.+||+.||++|||++|+++...
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            211110                 0111223455678889999999999999999999999998653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9e-47  Score=342.05  Aligned_cols=249  Identities=20%  Similarity=0.292  Sum_probs=199.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..|.+.+.||+|+||+||+|... +++.||+|++++....    .+.+..|..++.++ +||||+++++++.+.+..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            34667789999999999999876 6789999999764322    24578899999887 899999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       132 ~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999884    335689999999999999999999999   99999999999999999999999999998533


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc-cchhHHHHHHhhcCCCc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK-AYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  297 (340)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......... ..........+..... 
T Consensus       205 ~~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-  279 (396)
T 4dc2_A          205 RPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-  279 (396)
T ss_dssp             CTTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred             cCCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence            2222  23456799999999999875  7889999999999999999999999754322211 1111222222222211 


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                            ..+..++.++.+|+.+||+.||++||++
T Consensus       280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 ------RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                  1222356789999999999999999996

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1e-46  Score=352.67  Aligned_cols=258  Identities=29%  Similarity=0.446  Sum_probs=214.2

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ++....+.+.+.||+|+||.||+|.+. ++..||+|+++.+....+.+.+|+.+++.++||||+++++++......++||
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            444556777899999999999999877 4789999999887777889999999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            999999999998543  235689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .. ........++..|+|||.+.+.  .++.++||||||+++|||+| |..||.......        +...+..+....
T Consensus       371 ~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~  439 (495)
T 1opk_A          371 DT-YTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRME  439 (495)
T ss_dssp             CC-EECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCC
T ss_pred             Cc-eeecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence            32 1222334467899999999764  78889999999999999999 999987654322        222333322221


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                            .+..++..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus       440 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~  475 (495)
T 1opk_A          440 ------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  475 (495)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence                  122345788999999999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-47  Score=343.53  Aligned_cols=260  Identities=27%  Similarity=0.418  Sum_probs=207.9

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCCh--HHHHHHHHHhccc-CCCceeeEeeEEEcC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSG--EEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  132 (340)
                      +....|.+.+.||+|+||.||+|.+.      +++.||+|++.......  +.+.+|++++..+ +||||+++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            34456677899999999999999742      45789999997654322  4689999999999 799999999998775


Q ss_pred             Ce-eEEEEEccCCCCcccccccCCCC------------------------------------------------------
Q 044497          133 SK-RALVYEYMPNGSLDRHIFPKESR------------------------------------------------------  157 (340)
Q Consensus       133 ~~-~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------  157 (340)
                      +. .++||||+++|+|.+++......                                                      
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            54 89999999999999998654321                                                      


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeecc
Q 044497          158 --------GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT  229 (340)
Q Consensus       158 --------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  229 (340)
                              ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...............
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                    12289999999999999999999999   9999999999999999999999999999876555444444556


Q ss_pred             ccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHH
Q 044497          230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM  308 (340)
Q Consensus       230 ~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (340)
                      .+|+.|+|||.+.+.  .++.++||||||+++|+|+| |+.||.......       ........+......      ..
T Consensus       256 ~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~------~~  320 (359)
T 3vhe_A          256 RLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMRAP------DY  320 (359)
T ss_dssp             EECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHHHHTCCCCCC------TT
T ss_pred             CCCceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------HHHHHHHcCCCCCCC------CC
Confidence            689999999999764  77889999999999999998 999997544321       122233332222221      22


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          309 IARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       309 ~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .++++.+++.+||+.||.+|||+.|+++.|+
T Consensus       321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            4567899999999999999999999999886

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.5e-46  Score=324.82  Aligned_cols=253  Identities=27%  Similarity=0.441  Sum_probs=203.0

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh--------HHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG--------EEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      ...|.+.+.||+|+||+||+|.+. +++.||+|++.......        +.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            345677899999999999999875 78899999986543221        57889999999999999999999997654 


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeeEcCCCc-----eE
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFI-----PK  207 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dik~~Nill~~~~~-----~k  207 (340)
                       ++||||+++++|.+++..   ....+++..+..++.|++.||+|||++   +  ++||||||+||+++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence             799999999999888743   345789999999999999999999998   8  999999999999988776     99


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~  287 (340)
                      |+|||++.....     ......||+.|+|||.+......++.++||||||+++|+|++|+.||.......     ....
T Consensus       170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~  239 (287)
T 4f0f_A          170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFI  239 (287)
T ss_dssp             ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHH
T ss_pred             eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHH
Confidence            999999974433     224456999999999985544567889999999999999999999997544322     1111


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ...........      .+..+++.+.+++.+||+.||.+|||++++++.|+.
T Consensus       240 ~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          240 NMIREEGLRPT------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHHSCCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHhccCCCCC------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            11112221111      222345789999999999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.5e-46  Score=324.86  Aligned_cols=248  Identities=22%  Similarity=0.303  Sum_probs=195.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---------------------------ChHHHHHHHHHhccc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---------------------------SGEEFINEVSTIGRI  117 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~e~~~l~~l  117 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.....                           ..+.+.+|+++++.+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            4567789999999999999865 688999999865431                           124688999999999


Q ss_pred             CCCceeeEeeEEEc--CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 044497          118 HHVNVVQLLGFCSE--GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  195 (340)
Q Consensus       118 ~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~  195 (340)
                      +||||+++++++.+  .+..++||||+++++|.+++     ....+++..+..++.|++.||+|||++   +++||||||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  165 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP  165 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence            99999999999986  56799999999999998865     235789999999999999999999999   999999999


Q ss_pred             CCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcccccccccccccc-ccccccchhhHHHHHHHHHcCCCCCCCC
Q 044497          196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNMH  274 (340)
Q Consensus       196 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~  274 (340)
                      +||+++.++.+||+|||++........  ......||+.|+|||.+.+... ..+.++||||||+++|+|++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999986554332  2244569999999999876422 2467899999999999999999999754


Q ss_pred             cccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          275 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...       . ....+..... ....    ...++.++.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~-------~-~~~~~~~~~~-~~~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RIM-------C-LHSKIKSQAL-EFPD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SHH-------H-HHHHHHHCCC-CCCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cHH-------H-HHHHHhcccC-CCCC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321       1 1122222111 1111    1124567899999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.1e-47  Score=337.89  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=200.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|.. .+++.||+|++...    ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            456778999999999999986 47889999998642    2234678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+ +|+|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++......
T Consensus        90 ~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           90 YA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             CC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            99 7889888843    35689999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..   .....||+.|+|||.+.+. ...+.++||||||+++|+|++|+.||...........        ...+      
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------i~~~------  223 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--------VNSC------  223 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC--------CCSS------
T ss_pred             cc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH--------HHcC------
Confidence            32   2345699999999999765 2336799999999999999999999976443221111        0000      


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ....+...++.+.+|+.+||+.||.+|||++|+++
T Consensus       224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             01122234578899999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=341.22  Aligned_cols=248  Identities=23%  Similarity=0.286  Sum_probs=198.6

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~  136 (340)
                      .-..|++.+.||+|+||+||+|... +++.||+|++.+.    ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3345677899999999999999876 6889999999753    23446688999999988 7999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       101 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999983    345689999999999999999999999   999999999999999999999999999985


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ......  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+.....
T Consensus       174 ~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~  241 (353)
T 3txo_A          174 GICNGV--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEV  241 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC
T ss_pred             cccCCc--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            433221  23455699999999999875  67889999999999999999999997654321        1222222211


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCH------HHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSM------TKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~evl~  336 (340)
                             .++...+.++.+++.+||+.||.+||++      +++++
T Consensus       242 -------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 -------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   1122345788999999999999999998      66653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=343.09  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=205.4

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGS  133 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  133 (340)
                      +....+.+.+.||+|+||.||+|.+.      ++..||+|++......  ...+.+|+.+++.++||||+++++++....
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34456677899999999999999843      4668999999754332  246889999999999999999999999999


Q ss_pred             eeEEEEEccCCCCcccccccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC---ceE
Q 044497          134 KRALVYEYMPNGSLDRHIFPKE---SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPK  207 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~---~~k  207 (340)
                      ..++||||+++|+|.+++....   .....+++..++.++.|++.||+|||++   +|+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999986433   2234689999999999999999999999   999999999999998554   599


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  286 (340)
                      |+|||+++...............+|+.|+|||.+.+.  .++.++|||||||++|||++ |..||......        .
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~  294 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------E  294 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------H
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------H
Confidence            9999999743222211122344578999999999765  78889999999999999998 99998764422        1


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .......+......      ..++..+.+|+.+||+.||.+|||+.++++.|+
T Consensus       295 ~~~~i~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          295 VLEFVTSGGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            22333333222211      234467899999999999999999999999885

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=340.54  Aligned_cols=250  Identities=23%  Similarity=0.336  Sum_probs=203.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            44667899999999999999866 6889999998643    334567889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        95 e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999983    345789999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ...   .....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||........     ...........   
T Consensus       168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~---  236 (384)
T 4fr4_A          168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIVHTFETTV---  236 (384)
T ss_dssp             TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHHHHHHHCC---
T ss_pred             CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhhcc---
Confidence            332   3455699999999998653 13578899999999999999999999975543321     11112222111   


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~evl~  336 (340)
                          ...+..++..+.+|+.+||+.||.+||+ ++++++
T Consensus       237 ----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 ----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                1122234578999999999999999998 676653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.7e-47  Score=335.05  Aligned_cols=249  Identities=21%  Similarity=0.317  Sum_probs=182.5

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      +.||+|+||.||+|... +++.||+|++...  ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            68999999999999876 7889999998653  3467789999999997 999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC---ceEEecccCCccCCCCCCcee
Q 044497          149 RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       149 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      +++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++   .+||+|||++........  .
T Consensus        95 ~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~  165 (325)
T 3kn6_A           95 ERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P  165 (325)
T ss_dssp             HHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence            9984    345789999999999999999999999   999999999999997665   899999999986544322  2


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.............. ....+..+.   .......
T Consensus       166 ~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~---~~~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGD---FSFEGEA  239 (325)
T ss_dssp             ------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTC---CCCCSHH
T ss_pred             ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCC---CCCCccc
Confidence            2345689999999999775  678899999999999999999999986554322222122 222222221   1112233


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...+++++.+|+.+||+.||.+|||++|+++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            3456788999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-47  Score=337.29  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=205.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ..|.+.+.||+|+||.||+|...      +++.||+|++......  .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            45566789999999999999874      3478999999765432  356889999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 044497          137 LVYEYMPNGSLDRHIFPKESR--------------------GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH  196 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~  196 (340)
                      +||||+++++|.+++......                    ...+++..++.++.|+++||+|||++   +++||||||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~  203 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR  203 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcc
Confidence            999999999999998653211                    25789999999999999999999999   9999999999


Q ss_pred             CeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCc
Q 044497          197 NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHA  275 (340)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~  275 (340)
                      ||+++.++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|+| |..||....
T Consensus       204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            999999999999999999755433222223345588999999998765  67889999999999999999 999987543


Q ss_pred             ccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          276 TRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..        .....+..+.....      +..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       282 ~~--------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~  331 (343)
T 1luf_A          282 HE--------EVIYYVRDGNILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  331 (343)
T ss_dssp             HH--------HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hH--------HHHHHHhCCCcCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence            21        12222223222111      2234578999999999999999999999999886

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.7e-47  Score=350.69  Aligned_cols=256  Identities=29%  Similarity=0.433  Sum_probs=205.8

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +....+.+.+.||+|+||.||+|.++++..||+|+++......+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            3445567778999999999999999888889999998877777899999999999999999999999976 678999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++...  .+..+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++......
T Consensus       260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999999432  234588999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      . .......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .+...+..+..... 
T Consensus       335 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~-  402 (452)
T 1fmk_A          335 Y-TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMPC-  402 (452)
T ss_dssp             ---------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCC-
T ss_pred             e-ecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC-
Confidence            1 112334477899999998764  78889999999999999999 99998754322        12233333322221 


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                           +..++..+.+++.+||+.||++|||++++++.|+.
T Consensus       403 -----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~  437 (452)
T 1fmk_A          403 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  437 (452)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                 22345788999999999999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.8e-47  Score=329.26  Aligned_cols=257  Identities=22%  Similarity=0.278  Sum_probs=197.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|.+.+.||+|+||+||+|...+++.+|+|++.....   ..+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            3567789999999999999988899999999865432   2367889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++ +|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........
T Consensus        83 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           83 DQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             SE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             CC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            65 88888743   235689999999999999999999999   999999999999999999999999999975533221


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc-----
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL-----  297 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  297 (340)
                        ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||........    ..............     
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ----LMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTG
T ss_pred             --ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHHCCCChhhchhh
Confidence              12334589999999998653 3578899999999999999999999976442210    00011111000000     


Q ss_pred             --------c-----ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 --------E-----LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 --------~-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                              .     ..........++.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    0     00001112235678899999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-46  Score=337.02  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=194.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .+|.+.+.||+|+||+||++... +++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            35677899999999999999876 78899999998777667889999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc--eEEecccCCccCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLAKFHPKEN  221 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~--~kl~Dfg~~~~~~~~~  221 (340)
                      +++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.  +||+|||+++......
T Consensus       100 ~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A          100 GGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             SCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            999999883    335689999999999999999999999   9999999999999987765  9999999987432222


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                         ......||+.|+|||++.+. ...+.++|||||||++|+|++|+.||........   ..............  ...
T Consensus       173 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~--~~~  243 (361)
T 3uc3_A          173 ---QPKSTVGTPAYIAPEVLLRQ-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVKYS--IPD  243 (361)
T ss_dssp             -----------CTTSCHHHHHCS-SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTCCC--CCT
T ss_pred             ---CCCCCcCCCCcCChhhhcCC-CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCCCC--CCC
Confidence               12344699999999998764 2234458999999999999999999976543221   11112222211111  111


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          ...+++++.+|+.+||+.||++|||+.|+++
T Consensus       244 ----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          244 ----DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ----cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                1123478899999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.8e-47  Score=329.43  Aligned_cols=257  Identities=30%  Similarity=0.442  Sum_probs=213.0

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ++....|.+.+.||+|+||.||+|.+. ++..||+|++..+....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            344556777899999999999999876 5788999999887767788999999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999998542  235689999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ... .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ............
T Consensus       164 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~  232 (288)
T 3kfa_A          164 DTY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRME  232 (288)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCC
T ss_pred             Ccc-ccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhccCCCC
Confidence            432 223344578899999999765  67889999999999999999 999987654322        222222222111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            .+..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       233 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          233 ------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence                  11234578999999999999999999999999885

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=330.56  Aligned_cols=242  Identities=25%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.+.    ....+.+.+|..+++.++||||+++++++.+.+..++|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            4567789999999999999876 7889999998753    2345678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        87 ~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           87 YIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999984    345689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                           .....||+.|+|||++.+.  .++.++|+|||||++|+|++|+.||......       ...........     
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~-----  220 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAEL-----  220 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCCC-----
T ss_pred             -----cccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC-----
Confidence                 2345699999999999775  6788999999999999999999999754321       11222222211     


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                         ..+...+.++.+++.+||+.||++||     +++++++
T Consensus       221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               11223457899999999999999999     8888874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-46  Score=333.61  Aligned_cols=260  Identities=25%  Similarity=0.415  Sum_probs=207.7

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEE------cCCcEEEEEEccCCC--CChHHHHHHHHHhccc-CCCceeeEeeEEEcC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSK--FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  132 (340)
                      +....|.+.+.||+|+||.||+|..      .++..||+|++....  ...+.+.+|+.++..+ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3345667789999999999999985      245589999997543  2346789999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESR-------------------GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDI  193 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~di  193 (340)
                      +..++||||+++++|.+++......                   ...+++..+..++.|++.||+|||++   +++||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            9999999999999999998654321                   13479999999999999999999999   9999999


Q ss_pred             CCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCC
Q 044497          194 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSN  272 (340)
Q Consensus       194 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~  272 (340)
                      ||+||+++.++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|+| |..||.
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            999999999999999999999866544443334455678899999998764  67889999999999999998 999997


Q ss_pred             CCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          273 MHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......       ........+.....      +...+.++.+++.+||+.||.+|||+.++++.|+
T Consensus       277 ~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          277 GIPVDA-------NFYKLIQNGFKMDQ------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             TCCCSH-------HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCcHH-------HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            654321       12223333222211      1223578999999999999999999999999885

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.7e-47  Score=338.18  Aligned_cols=245  Identities=22%  Similarity=0.294  Sum_probs=201.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++++.    ....+.+..|..++..+ +||||+++++++.+.+..|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            45667789999999999999876 6889999999753    33456788899999877 899999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999984    235689999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....  ......||+.|+|||++.+.  .++.++|+|||||++|||++|+.||.......        ....+.....  
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~--  235 (345)
T 1xjd_A          170 LGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNP--  235 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC--
T ss_pred             cCCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCCC--
Confidence            3221  23455799999999999875  67889999999999999999999997543211        1222222211  


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-evl  335 (340)
                           ..+..++.++.+++.+||+.||++||++. +++
T Consensus       236 -----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 -----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                 11223457899999999999999999997 654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.4e-46  Score=343.96  Aligned_cols=246  Identities=29%  Similarity=0.465  Sum_probs=202.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCC-eeEEEEEccCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVYEYMPN  144 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~  144 (340)
                      .+.+.+.||+|+||.||+|.+. ++.||+|+++... ..+.+.+|+.+++.++||||+++++++.... ..++||||+++
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             HeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            4556689999999999999876 7799999998754 5578999999999999999999999987655 78999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++......   
T Consensus       272 g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          272 GSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             CBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence            99999995432  23478999999999999999999999   99999999999999999999999999998543321   


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                        ....++..|+|||.+.+.  .++.++||||||+++|||+| |+.||.......        +...+..+.....    
T Consensus       344 --~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~----  407 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDA----  407 (450)
T ss_dssp             -----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTTCCCCC----
T ss_pred             --cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC----
Confidence              223578899999999765  78889999999999999998 999997654322        2223333322222    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        +..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       408 --p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          408 --PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE  441 (450)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence              2234578999999999999999999999999886

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-46  Score=324.03  Aligned_cols=252  Identities=28%  Similarity=0.493  Sum_probs=208.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ..|.+.+.||+|+||.||+|...+++.||+|++.......+.+.+|+++++.++||||+++++++.+.+..+++|||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH   87 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence            34567789999999999999988888999999998877778999999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++........ .
T Consensus        88 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  160 (267)
T 3t9t_A           88 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  160 (267)
T ss_dssp             CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence            9999998432   35689999999999999999999999   999999999999999999999999999986543211 1


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+..+.....    
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~----  226 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRLYK----  226 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCC----
T ss_pred             ccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHHH--------HHHHHhcCCcCCC----
Confidence            11233477889999999764  67889999999999999999 899987543211        2222222221111    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        +...+..+.+++.+||+.||.+|||++++++.|+
T Consensus       227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (267)
T 3t9t_A          227 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  260 (267)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence              1123567899999999999999999999999886

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.1e-46  Score=332.99  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=198.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCc----EEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ...|.+.+.||+|+||+||+|.+. +++    +||+|.+....  ...+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            345667789999999999999864 444    36888876432  34478999999999999999999999998765 78


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +++|++++|+|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            899999999999998432   35689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ..............+|+.|+|||.+.+.  .++.++||||||+++|+|+| |+.||.......        ....+..+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~  236 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGE  236 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTC
T ss_pred             ccCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------HHHHHHcCC
Confidence            6554433333445578899999999875  78889999999999999999 999997654322        222233322


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....      +...+.++.+++.+||+.||.+|||+.++++.|+
T Consensus       237 ~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~  274 (327)
T 3poz_A          237 RLPQ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CCCC------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             CCCC------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            2211      1223467899999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.3e-46  Score=330.30  Aligned_cols=261  Identities=23%  Similarity=0.331  Sum_probs=189.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            34667789999999999999865 68899999987543  2346788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          142 MPNGSLDRHIFPKE--SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       142 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ++ ++|.+++....  .....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            97 68988875322  2234689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC---
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD---  296 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  296 (340)
                      ...  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||........    ...+.+.......   
T Consensus       161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          161 PVN--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ----LKLIFDIMGTPNESLW  233 (317)
T ss_dssp             CCC--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCTTTC
T ss_pred             Ccc--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCChhHh
Confidence            322  12344689999999998753 3578899999999999999999999976543211    0111111100000   


Q ss_pred             ----------cccc--cc--------chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 ----------LELR--NV--------TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ----------~~~~--~~--------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                ....  ..        .......+.++.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                      0000  00        0011124568999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.7e-47  Score=331.00  Aligned_cols=262  Identities=27%  Similarity=0.415  Sum_probs=200.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE-----cCCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEc--CCee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKR  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~  135 (340)
                      ...|++.+.||+|+||+||+|..     .+++.||+|++...... .+.+.+|+++++.++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            45567789999999999999974     26789999998764322 3578899999999999999999999854  3558


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            9999999999999998433   34589999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccc--------cccchhHH
Q 044497          216 FHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS--------SKAYFPSW  286 (340)
Q Consensus       216 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~--------~~~~~~~~  286 (340)
                      ........ .......++..|+|||.+.+.  .++.++||||||+++|+|+||..|+.......        ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            66543322 122334477789999999875  67889999999999999999999986543210        00001111


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ............      .+..++.++.+++.+||+.||++|||++|+++.|+
T Consensus       241 ~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~  287 (295)
T 3ugc_A          241 LIELLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD  287 (295)
T ss_dssp             HHHHHHTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhccCcCC------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            222222222211      12234578999999999999999999999999886

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-46  Score=339.26  Aligned_cols=255  Identities=28%  Similarity=0.454  Sum_probs=193.8

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ....+.+.+.||+|+||.||+|...    ++..||+|+++....  ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3445667789999999999999764    567899999976432  2357899999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999843   235689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          217 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       217 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ....... .......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        .......+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------~~~~i~~~  266 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDEG  266 (373)
T ss_dssp             -----------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------HHHHHHTT
T ss_pred             cccCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcC
Confidence            5443221 111223357789999999765  67889999999999999998 999997543211        22222222


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .....      +..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       267 ~~~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~  305 (373)
T 2qol_A          267 YRLPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD  305 (373)
T ss_dssp             EECCC------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCC------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence            11111      1234577899999999999999999999999885

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-46  Score=332.13  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=189.7

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcC-Cc---EEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCee-
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHT-GG---LIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~---~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-  135 (340)
                      ...|.+.+.||+|+||.||+|.+.. ++   .||+|++.....   ..+.+.+|+.+++.++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4467778999999999999998653 32   799999976432   236789999999999999999999999877665 


Q ss_pred             -----EEEEEccCCCCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          136 -----ALVYEYMPNGSLDRHIFPKE--SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       136 -----~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                           +++|||+++++|.+++....  .....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999885432  2233689999999999999999999999   9999999999999999999999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHH
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  287 (340)
                      +|||++................+++.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        .
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~  248 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------I  248 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------H
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHH--------H
Confidence            999999866544333333344578899999999775  67889999999999999999 899987654322        1


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......+.....      +..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       249 ~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          249 YNYLIGGNRLKQ------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             HHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhcCCCCCC------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            222222221111      1234568899999999999999999999999886

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-46  Score=324.05  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=200.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...|.+.+.||+|+||.||+|... ++..+|+|++....  ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            357788899999999999999875 68899999987643  345789999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE---cCCCceEEecccCCccC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill---~~~~~~kl~Dfg~~~~~  217 (340)
                      |+++++|.+++......+..+++..+..++.|++.||+|||++   +++||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999998865444457799999999999999999999999   99999999999999   45678999999999765


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      .....   .....||+.|+|||.+.+   .++.++||||||+++|+|++|+.||.......        ...........
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~  243 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--------VQQKATYKEPN  243 (285)
T ss_dssp             ------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCC
T ss_pred             CCccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--------HHhhhccCCcc
Confidence            44322   234468999999999864   56789999999999999999999997544221        11111111111


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .....    ...++++.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YAVEC----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccc----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000    113467889999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.7e-46  Score=328.58  Aligned_cols=250  Identities=23%  Similarity=0.283  Sum_probs=205.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-------ChHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      ...|.+.+.||+|+||.||+|... +++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456788899999999999999876 688999999865332       346799999999999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC----ceEEecc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDF  211 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~----~~kl~Df  211 (340)
                      ++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999984    345689999999999999999999999   999999999999999887    7999999


Q ss_pred             cCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      |++........   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       . ....+
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~~i  230 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLANI  230 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHH
T ss_pred             ccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHH
Confidence            99986654332   2344589999999998764  6788999999999999999999999754321       1 11112


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .....   ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          231 TSVSY---DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HTTCC---CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Hhccc---ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111   1112223345678999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.3e-46  Score=328.26  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=209.6

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE------cCCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcCCe
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  134 (340)
                      ...|.+.+.||+|+||.||+|.+      .+++.||+|++......  .+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45667789999999999999975      25678999999765432  36788999999999 99999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE
Q 044497          135 RALVYEYMPNGSLDRHIFPKES--------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill  200 (340)
                      .++||||+++++|.+++.....              ....+++..+..++.|++.||+|||++   +++||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            9999999999999999865432              123589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccccc
Q 044497          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSS  279 (340)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~  279 (340)
                      +.++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|+| |+.||....... 
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-  255 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-  255 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence            99999999999999877655544334445678899999998765  77889999999999999999 999987544321 


Q ss_pred             ccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          280 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            ..............      +...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus       256 ------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  303 (313)
T 1t46_A          256 ------KFYKMIKEGFRMLS------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (313)
T ss_dssp             ------HHHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------HHHHHhccCCCCCC------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence                  12222222221111      1234578899999999999999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.6e-46  Score=330.15  Aligned_cols=250  Identities=20%  Similarity=0.299  Sum_probs=196.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCC--------
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  133 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------  133 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            45677789999999999999876 889999999875432  3467899999999999999999999985543        


Q ss_pred             -------------------------------------------------eeEEEEEccCCCCcccccccCCCCCCCCCHH
Q 044497          134 -------------------------------------------------KRALVYEYMPNGSLDRHIFPKESRGQSFCWE  164 (340)
Q Consensus       134 -------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  164 (340)
                                                                       ..+++|||+++++|.+++..... ....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence                                                             37999999999999999865432 3445777


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc----------eeeeccccCcc
Q 044497          165 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF----------VSISATRGTIG  234 (340)
Q Consensus       165 ~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g~~~  234 (340)
                      .++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            8999999999999999999   9999999999999999999999999999866544221          11233469999


Q ss_pred             ccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHH
Q 044497          235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLC  314 (340)
Q Consensus       235 y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  314 (340)
                      |+|||.+.+.  .++.++||||||+++|+|++|..|+...          ..........      .........++++.
T Consensus       242 y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~~~------~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVRNL------KFPLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHHTT------CCCHHHHHHCHHHH
T ss_pred             ccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhhcc------CCCcccccCChhHH
Confidence            9999999875  6788999999999999999987653211          0111111111      11223345567789


Q ss_pred             HHHhhcccCCCCCCCCHHHHHH
Q 044497          315 MIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       315 ~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +++.+||+.||++|||++|+++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            9999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.8e-46  Score=325.00  Aligned_cols=258  Identities=19%  Similarity=0.272  Sum_probs=198.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++......   .+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            3567789999999999999876 6889999999754433   26788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++ ++.+.+..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           83 CDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             CCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            965 55555532   245789999999999999999999999   99999999999999999999999999998654332


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc----
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL----  297 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  297 (340)
                      .  ......||+.|+|||.+.+. ..++.++||||||+++|+|++|..|+........   ....+..........    
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~---~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          156 R--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTCTT
T ss_pred             c--cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhhhh
Confidence            2  22345689999999998764 3478899999999999999999888643322110   001111111000000    


Q ss_pred             --------------cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 --------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 --------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                    ............+..+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                          000011222345678899999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-46  Score=332.86  Aligned_cols=248  Identities=21%  Similarity=0.296  Sum_probs=198.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.+....    .+.+.+|..++..+ +||||+++++++.+.+..|+||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            4567789999999999999876 6889999999765432    24578899999887 8999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        90 e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           90 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             CCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999884    235689999999999999999999999   999999999999999999999999999985433


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc-cchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK-AYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  298 (340)
                      ...  ......||+.|+|||++.+.  .++.++|+|||||++|||++|+.||......... ..........+.....  
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--  236 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--  236 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred             CCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence            222  23455799999999999875  6788999999999999999999999753322111 0111222222222211  


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                           ..+..++.++.+++.+||+.||++||++
T Consensus       237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 -----RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 1122345789999999999999999996

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6e-46  Score=321.31  Aligned_cols=247  Identities=29%  Similarity=0.438  Sum_probs=192.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC-----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF-----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|.+. ++.+|+|++.....     ..+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            4566789999999999999875 88999999875432     23678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC---eeecCCCCCCeeEcC--------CCceEEe
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC---ILHFDIKPHNILLDH--------NFIPKVS  209 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~---ivH~dik~~Nill~~--------~~~~kl~  209 (340)
                      |+++++|.+++.     ...+++..+..++.|++.||+|||++   +   ++||||||+||+++.        ++.+||+
T Consensus        87 ~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           87 FARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             CCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             cCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999882     35789999999999999999999998   7   999999999999986        7789999


Q ss_pred             cccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH
Q 044497          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      |||++........    ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       ....
T Consensus       159 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~  225 (271)
T 3dtc_A          159 DFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYG  225 (271)
T ss_dssp             CCCC-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-------HHHH
T ss_pred             cCCcccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHh
Confidence            9999976543322    234589999999999765  67889999999999999999999997543211       1111


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      .........      .+..++..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus       226 ~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          226 VAMNKLALP------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHTSCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hhcCCCCCC------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            111111111      122345789999999999999999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.8e-46  Score=330.00  Aligned_cols=259  Identities=24%  Similarity=0.414  Sum_probs=208.3

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc--------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEE
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCS  130 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~  130 (340)
                      +....|.+.+.||+|+||.||+|.+.        ++..||+|++......  .+.+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            33456777899999999999999863        4668999999765432  25688999999999 8999999999999


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKESR------------GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      ..+..++||||+++++|.+++......            ...+++..+..++.|++.||+|||++   +++||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence            999999999999999999998654321            23488999999999999999999999   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATR  277 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~  277 (340)
                      +++.++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||......
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            9999999999999999876554433333445578899999998764  67889999999999999999 99998754321


Q ss_pred             ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                              .....+..+.....      +..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       267 --------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  314 (334)
T 2pvf_A          267 --------ELFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  314 (334)
T ss_dssp             --------HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --------HHHHHHhcCCCCCC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                    12222222222111      1234578899999999999999999999999886

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4e-46  Score=337.62  Aligned_cols=250  Identities=20%  Similarity=0.294  Sum_probs=202.8

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ..|.+.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            35677899999999999999876 788999999875432 2357889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC--CCceEEecccCCccCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~--~~~~kl~Dfg~~~~~~~~  220 (340)
                      ++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+|||++.  ++.+||+|||++......
T Consensus       131 ~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          131 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999998842   234689999999999999999999999   9999999999999974  577999999999876544


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..   .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......       ..............  
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~~--  270 (387)
T 1kob_A          205 EI---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDWEFD--  270 (387)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCCCCC--
T ss_pred             cc---eeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCC--
Confidence            32   2334699999999999775  6788999999999999999999999754321       11111111111111  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ......++.++.+++.+||+.||++|||+.|+++
T Consensus       271 --~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          271 --EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence              1112234678999999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=335.72  Aligned_cols=249  Identities=20%  Similarity=0.279  Sum_probs=188.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            34667789999999999999876 67899999997653 34678899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCccCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~~~~~~  220 (340)
                      +++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.   ++.+||+|||++......
T Consensus       132 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          132 GGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             SCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999883    345689999999999999999999999   9999999999999975   889999999999865433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .   ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......       ......+.......  
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~~~--  270 (349)
T 2w4o_A          205 V---LMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEYYF--  270 (349)
T ss_dssp             -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCCCC--
T ss_pred             c---ccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCCcc--
Confidence            2   12345689999999999875  6788999999999999999999999654322       11122222221111  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ........+.++.+|+.+||+.||++|||+.|+++
T Consensus       271 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 -ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             11122345578999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.7e-46  Score=322.42  Aligned_cols=252  Identities=27%  Similarity=0.445  Sum_probs=206.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      .+|.+.+.||+|+||.||+|...++..||+|++.......+.+.+|+++++.++||||+++++++.. +..+++|||+++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   91 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence            4667789999999999999998888899999998877778899999999999999999999999864 568999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      ++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++........ .
T Consensus        92 ~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            9999998321  123689999999999999999999999   999999999999999999999999999986654321 1


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+..+.....    
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~----  231 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------VIQNLERGYRMVR----  231 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCC----
T ss_pred             cccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--------HHHHHhcccCCCC----
Confidence            22334467899999999764  67889999999999999999 899987543211        2222222221111    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        +..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       232 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --cccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence              1234578999999999999999999999999886

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-46  Score=329.18  Aligned_cols=266  Identities=30%  Similarity=0.506  Sum_probs=196.5

Q ss_pred             CCCHHHHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcC
Q 044497           56 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (340)
Q Consensus        56 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~  132 (340)
                      .....|+....|.+.+.||+|+||+||+|...  ..+|+|+++......   +.+.+|+.+++.++||||+++++++ ..
T Consensus        15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             ---CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CCCCCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            33444566667788899999999999999764  469999997655443   5688999999999999999999965 45


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      ...++||||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             CccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence            668999999999999998843   345689999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      ++................||+.|+|||.+... ...++.++||||||+++|+|++|+.||......       .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~  238 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMV  238 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHH
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHh
Confidence            99765443333333445699999999998622 236778999999999999999999999754332       1122222


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..+....  ........+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       239 ~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  284 (289)
T 3og7_A          239 GRGSLSP--DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE  284 (289)
T ss_dssp             HHTSCCC--CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccccCc--chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            2221111  111122345578999999999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.9e-46  Score=338.45  Aligned_cols=266  Identities=16%  Similarity=0.170  Sum_probs=201.7

Q ss_pred             HhhhhhhcCCC--CCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           66 TNHFTHKLGQG--GFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G--~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .|++.+.||+|  +||+||+|... +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            56778999999  99999999876 78999999997654443   46778999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+.....
T Consensus       106 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          106 SFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             ECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            9999999999985432  35689999999999999999999999   999999999999999999999999998864322


Q ss_pred             CCCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc-
Q 044497          220 ENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK-  293 (340)
Q Consensus       220 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  293 (340)
                      ....     .......||+.|+|||++.+....++.++|||||||++|+|++|+.||...................... 
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            1110     1112346899999999998743478889999999999999999999997644322100000000000000 


Q ss_pred             -------------------CC-----------CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 -------------------GG-----------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 -------------------~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                         +.           .............+++.+.+|+.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                               00           00000001233445678999999999999999999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-46  Score=334.02  Aligned_cols=242  Identities=24%  Similarity=0.286  Sum_probs=201.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            4667789999999999999876 7889999998653    2345678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus       122 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          122 YVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             CCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999843    34689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......       . ....+..+. ..  
T Consensus       195 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~-~~~~i~~~~-~~--  256 (350)
T 1rdq_E          195 T-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------Q-IYEKIVSGK-VR--  256 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHCC-CC--
T ss_pred             c-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------H-HHHHHHcCC-CC--
Confidence            2     344699999999999875  6788999999999999999999999754321       1 222222221 11  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                          .+..++.++.+++.+||+.||++||+     ++++++
T Consensus       257 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                12234578999999999999999998     888764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-46  Score=333.42  Aligned_cols=256  Identities=16%  Similarity=0.198  Sum_probs=202.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|.+.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.+++.+ +||||+++++++...+..++||||+ 
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            456778999999999999986 4788999999865432 35688999999999 9999999999999999999999999 


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc-----eEEecccCCccCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-----PKVSDFGLAKFHP  218 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~-----~kl~Dfg~~~~~~  218 (340)
                      +++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.     +||+|||++....
T Consensus        88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           88 GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999998432   45799999999999999999999999   9999999999999998887     9999999998654


Q ss_pred             CCCCce-----eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          219 KENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       219 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      ......     ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||...........+..........
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            332211     12345699999999999875  67889999999999999999999998754332111111110000000


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                             .........+ ++.+++.+||+.||.+||++.++++.|+
T Consensus       240 -------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          240 -------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             -------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             -------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence                   0001111133 8999999999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.6e-46  Score=332.97  Aligned_cols=251  Identities=23%  Similarity=0.308  Sum_probs=200.7

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEc
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ...|.+.+.||+|+||.||+|... +++.||+|++......   ..+|++++.++ +||||+++++++.+.+..|+||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            456777899999999999999876 7889999999765433   35788888888 799999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC----CceEEecccCCccC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN----FIPKVSDFGLAKFH  217 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~----~~~kl~Dfg~~~~~  217 (340)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++.++    +.+||+|||++...
T Consensus        98 ~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           98 MKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999884    345689999999999999999999999   99999999999998543    35999999999865


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      .....  ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||.......     ...+...+..+...
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSGKFS  241 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHCCCC
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccCCcc
Confidence            44332  22345689999999999765  67889999999999999999999997543221     12222333332211


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .   .......++.++.+|+.+||+.||++|||+.++++
T Consensus       242 ~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 L---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             C---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             c---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1   11122345678999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.6e-46  Score=327.77  Aligned_cols=269  Identities=21%  Similarity=0.346  Sum_probs=208.2

Q ss_pred             CCHHHHHHHHhhhhhhcCCCCCeEEEEEEE-----cCCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEE
Q 044497           57 YSYPEIIAVTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFC  129 (340)
Q Consensus        57 ~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~  129 (340)
                      .....+....|.+.+.||+|+||.||+|.+     .+++.||+|++....  ...+.+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC   92 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            333444455577789999999999999983     368899999987543  3347889999999999999999999999


Q ss_pred             EcC--CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceE
Q 044497          130 SEG--SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (340)
Q Consensus       130 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~k  207 (340)
                      ...  +..++||||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.++
T Consensus        93 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A           93 TEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             EC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             ecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEE
Confidence            776  668999999999999999843   235689999999999999999999999   999999999999999999999


Q ss_pred             EecccCCccCCCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccc-------cc
Q 044497          208 VSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATR-------SS  279 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-------~~  279 (340)
                      |+|||++......... .......+|..|+|||.+.+.  .++.++||||||+++|+|++|..|+......       ..
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  244 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH  244 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcc
Confidence            9999999876554432 222345588889999999775  6788999999999999999999886433210       00


Q ss_pred             ccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          280 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..............+....      .+..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          245 GQMTVTRLVNTLKEGKRLP------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             GGGHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCHHHHHHHHhccCCCC------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            0011111222222222211      12234578999999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.3e-46  Score=326.01  Aligned_cols=258  Identities=17%  Similarity=0.247  Sum_probs=205.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.++..+ +|+|++++++++......++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            3466778999999999999986 478899999986543 335688999999999 7999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc-----eEEecccCCccC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-----PKVSDFGLAKFH  217 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~-----~kl~Dfg~~~~~  217 (340)
                       +++|.+++...   +..+++..+..++.|++.||+|||++   +++||||||+||+++.++.     +||+|||++...
T Consensus        89 -~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           89 -GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence             99999998432   34689999999999999999999999   9999999999999987766     999999999865


Q ss_pred             CCCCCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          218 PKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       218 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      ......     .......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||...........+.. +.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~  238 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQ  238 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHH
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH-HHhhcc
Confidence            443221     112345699999999998775  678899999999999999999999987543321111111 111000


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      ........+++++.+++.+||+.||++|||++++++.|+
T Consensus       239 ~~------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          239 ST------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             HS------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             Cc------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            00      011122245678999999999999999999999999885

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.7e-46  Score=331.17  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=198.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcE----EEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGL----IAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      .|.+.+.||+|+||+||+|.+. +++.    +|+|.+....  .....+.+|+.+++.++||||+++++++.+ +..++|
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v   92 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLV   92 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEE
Confidence            4566789999999999999865 4443    7888775432  223567889999999999999999999864 568899


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999998432   35688899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ............+|..|+|||.+.+.  .++.++||||||+++|+|+| |+.||.......        ....+..+...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~  236 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEKGERL  236 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHTTCBC
T ss_pred             cccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCCCC
Confidence            55443333455688899999999765  68889999999999999999 999997654322        22222222222


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...      ..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus       237 ~~~------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~  272 (325)
T 3kex_A          237 AQP------QICTIDVYMVMVKCWMIDENIRPTFKELANEFT  272 (325)
T ss_dssp             CCC------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred             CCC------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111      123457888999999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-45  Score=330.67  Aligned_cols=259  Identities=22%  Similarity=0.256  Sum_probs=201.0

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC------CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS------KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ..+|.+.+.||+|+||.||+|... ++..+|+|++...      ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            456778899999999999999875 7889999998643      233467899999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCC------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 044497          137 LVYEYMPNGSLDRHIFPKES------------------------------------RGQSFCWEKLHEVALGTARGIEYL  180 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~------------------------------------~~~~~~~~~~~~i~~~i~~~l~~L  180 (340)
                      +||||+++++|.+++.....                                    ....+++..+..++.|++.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999988842100                                    122346778889999999999999


Q ss_pred             HcCCCCCeeecCCCCCCeeEcCCC--ceEEecccCCccCCCCC--CceeeeccccCccccccccccccccccccccchhh
Q 044497          181 HNGCDVCILHFDIKPHNILLDHNF--IPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYG  256 (340)
Q Consensus       181 h~~~~~~ivH~dik~~Nill~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Dvws  256 (340)
                      |++   +++||||||+||+++.++  .+||+|||++.......  .........||+.|+|||.+.+....++.++||||
T Consensus       185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999   999999999999998776  89999999997543221  11123455699999999999764457888999999


Q ss_pred             HHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          257 FGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       257 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ||+++|+|++|+.||......       ..............    ......+++.+.+++.+||+.||.+|||+.++++
T Consensus       262 lG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFE----NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTT----SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccC----CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999754432       11222222221111    1112234578999999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-45  Score=339.67  Aligned_cols=245  Identities=23%  Similarity=0.356  Sum_probs=203.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... +|+.||+|++...    ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4567789999999999999876 7899999998653    2234678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        97 ~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           97 YVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             CCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999983    345789999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..   .....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||......       . ....+..+...   
T Consensus       170 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~-~~~~i~~~~~~---  234 (476)
T 2y94_A          170 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------T-LFKKICDGIFY---  234 (476)
T ss_dssp             CC---BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------H-HHHHHHTTCCC---
T ss_pred             cc---ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------H-HHHHHhcCCcC---
Confidence            32   2345699999999999874 23467999999999999999999999754321       1 12222222111   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          .+..+++++.+|+.+||+.||.+|||++|+++
T Consensus       235 ----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          235 ----TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                11224567899999999999999999999985

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-46  Score=333.42  Aligned_cols=246  Identities=24%  Similarity=0.273  Sum_probs=200.8

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..|++.+.||+|+||+||+|... +++.||+|++.+.    ....+.+..|..++..+ +||||+++++++.+.+..|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            34667789999999999999876 5788999998753    33456788999999988 899999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       100 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999984    235689999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....  ......||+.|+|||++.+.  .++.++|+|||||++|||++|+.||......       . ....+.....  
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~-~~~~i~~~~~--  238 (353)
T 2i0e_A          173 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------E-LFQSIMEHNV--  238 (353)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHCCC--
T ss_pred             cCCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHH-------H-HHHHHHhCCC--
Confidence            2221  23455799999999999765  6789999999999999999999999754321       1 1222222111  


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                           .++..++.++.+|+.+||+.||.+||+     ++++++
T Consensus       239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 112235678999999999999999995     466653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.6e-45  Score=316.20  Aligned_cols=248  Identities=21%  Similarity=0.327  Sum_probs=201.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcC--CeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|.+. ++.+|+|++.......   +.+.+|+.+++.++||||+++++++.+.  +..+++||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            4567789999999999999986 8899999998765443   4688999999999999999999999877  77899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |+++++|.+++...  ....+++..+..++.|++.||+|||++   +  ++||||||+||+++.++.++++|||++....
T Consensus        90 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           90 WMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             CCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999532  233689999999999999999999998   8  9999999999999999999999998876432


Q ss_pred             CCCCceeeeccccCccccccccccccc-cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      .       ....+|+.|+|||.+.+.. ..++.++||||||+++|+|++|+.||......       .............
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~  230 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGLRP  230 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCCCC
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCCCC
Confidence            2       2235899999999987641 22344799999999999999999999754322       1122222222222


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      +..++..+.+++.+||+.||++|||++++++.|+
T Consensus       231 ~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~  266 (271)
T 3kmu_A          231 TI------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE  266 (271)
T ss_dssp             CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11      2234578999999999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.3e-46  Score=334.86  Aligned_cols=245  Identities=27%  Similarity=0.318  Sum_probs=195.1

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      .+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            357999999999999865 788999999976542 346789999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE--cCCCceEEecccCCccCCCCCCcee
Q 044497          148 DRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHPKENDFVS  225 (340)
Q Consensus       148 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (340)
                      .+++..   ....+++..+..++.|++.||+|||+.   +++||||||+|||+  +.++.+||+|||++........   
T Consensus       174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            988843   234689999999999999999999999   99999999999999  5678999999999986654332   


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......       ..............    ...
T Consensus       245 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~~~----~~~  311 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRWDLE----DEE  311 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCCSC----SGG
T ss_pred             cccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCCCC----hhh
Confidence            2334699999999998764  6788999999999999999999999754421       11222222211111    112


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...+++++.+|+.+||+.||.+|||+.|+++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2245678999999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.1e-46  Score=339.42  Aligned_cols=251  Identities=22%  Similarity=0.262  Sum_probs=201.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++.+.    ....+.+.+|+.++..++||||+++++++.+.+..|+|||
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4556789999999999999876 6889999998652    2233568899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus       150 ~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          150 YMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             CCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            999999999883     23589999999999999999999999   9999999999999999999999999999865543


Q ss_pred             CCceeeeccccCccccccccccccc--cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .. .......||+.|+|||++.+..  +.++.++|||||||++|||++|+.||.......       .............
T Consensus       222 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~  293 (410)
T 3v8s_A          222 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHKNSLT  293 (410)
T ss_dssp             SE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTHHHHCC
T ss_pred             Cc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-------HHHHHHhcccccc
Confidence            32 2234567999999999997642  127889999999999999999999997544321       1111111110011


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~evl~  336 (340)
                      ...    ...++.++.+|+.+||+.+|++  ||+++|+++
T Consensus       294 ~p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          294 FPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CCT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             CCC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            111    1124578999999999999988  999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-45  Score=326.90  Aligned_cols=272  Identities=21%  Similarity=0.305  Sum_probs=201.5

Q ss_pred             CCCHHHHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhccc--CCCceeeEeeEEEcC-
Q 044497           56 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI--HHVNVVQLLGFCSEG-  132 (340)
Q Consensus        56 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~-  132 (340)
                      ...........|.+.+.||+|+||.||+|... ++.||+|++....  ......|.+++...  +||||+++++++... 
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            34445566678888999999999999999876 8899999986543  34455566665554  899999999999877 


Q ss_pred             ---CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeecCCCCCCeeEcCCC
Q 044497          133 ---SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC-----DVCILHFDIKPHNILLDHNF  204 (340)
Q Consensus       133 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dik~~Nill~~~~  204 (340)
                         ...++||||+++++|.+++.     ...+++..+..++.|++.||+|||++.     ..+++||||||+||+++.++
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence               78999999999999999983     236899999999999999999999751     33899999999999999999


Q ss_pred             ceEEecccCCccCCCCCCce--eeeccccCcccccccccccccccc----ccccchhhHHHHHHHHHcC----------C
Q 044497          205 IPKVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFGTV----SCKSDVYGFGMVLLEMAGG----------R  268 (340)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~----~~~~DvwslG~~l~elltg----------~  268 (340)
                      .+||+|||++..........  ......||+.|+|||.+.+.....    +.++|||||||++|||+||          +
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            99999999997654433221  122446999999999987642111    1248999999999999999          5


Q ss_pred             CCCCCCcccccccchhHHHHHHhhc-CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          269 RNSNMHATRSSKAYFPSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       269 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .||........  .... ....... ....... .......++.++.+++.+||+.||++|||+.++++.|+
T Consensus       260 ~p~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          260 LPYHDLVPSDP--SYED-MREIVCIKKLRPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             CTTTTTSCSSC--CHHH-HHHHHTTSCCCCCCC-GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ccHhhhcCCCC--chhh-hHHHHhhhccCcccc-ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence            55544332211  1111 1121111 1111111 11223367788999999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=329.17  Aligned_cols=250  Identities=24%  Similarity=0.288  Sum_probs=198.4

Q ss_pred             CHHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhccc-CCCceeeEeeEEEcC
Q 044497           58 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (340)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  132 (340)
                      ...++....|.+.+.||+|+||+||+|.+. +++.||+|++.......   .....|+..+..+ +||||+++++++.+.
T Consensus        50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            344566778888899999999999999876 78999999987654433   2345555555555 899999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      +..++||||+ +++|.+++...   +..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             CEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence            9999999999 77998887432   35699999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      ++........   .....||+.|+|||++.+   .++.++||||||+++|||++|..|+.....           ...+.
T Consensus       203 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~  265 (311)
T 3p1a_A          203 LLVELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLR  265 (311)
T ss_dssp             TCEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHT
T ss_pred             eeeecccCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHh
Confidence            9876544322   234458999999999875   578899999999999999999776543211           11122


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+..     .......++.++.+++.+||+.||++|||++|+++
T Consensus       266 ~~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          266 QGYL-----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TTCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCC-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            1111     12233445688999999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=330.85  Aligned_cols=241  Identities=21%  Similarity=0.261  Sum_probs=198.9

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---------ChHHHHHHHHHhcccCCCceeeEeeEEEcCC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGS  133 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  133 (340)
                      ...|.+.+.||+|+||.||+|... +++.||+|++.....         ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            345677789999999999999865 788999999976542         2235778999999999999999999999999


Q ss_pred             eeEEEEEccCCC-CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          134 KRALVYEYMPNG-SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       134 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      ..++||||+.+| +|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999998766 9998883    345689999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      ++........   .....||+.|+|||.+.+. ...+.++||||||+++|+|++|+.||........             
T Consensus       176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------  238 (335)
T 3dls_A          176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------  238 (335)
T ss_dssp             TCEECCTTCC---BCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------
T ss_pred             cceECCCCCc---eeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------
Confidence            9987654432   2334589999999998764 2337789999999999999999999965322110             


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...        ..+..++.++.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          239 AAI--------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             TCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcc--------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000        001123567899999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.7e-45  Score=315.48  Aligned_cols=252  Identities=25%  Similarity=0.313  Sum_probs=203.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            45677899999999999999876 788999999865432  236789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.    ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+.......
T Consensus        87 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999983    345689999999999999999999999   99999999999999999999999999997654332


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .........||+.|+|||.+.+. ...+.++||||||+++|+|++|+.||........  ..     ........ ..  
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~-----~~~~~~~~-~~--  228 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY-----SDWKEKKT-YL--  228 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HH-----HHHHTTCT-TS--
T ss_pred             chhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HH-----HHhhhccc-cc--
Confidence            22223445689999999998764 2346789999999999999999999976543211  11     11111111 00  


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        .....++..+.+++.+||+.||.+|||++|+++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              111234578899999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=328.81  Aligned_cols=250  Identities=20%  Similarity=0.301  Sum_probs=193.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccCC--CceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||++...+++.||+|++.......   +.+.+|+.++..++|  |||+++++++...+..++|||
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e   89 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME   89 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence            456778999999999999998889999999997655443   568899999999976  999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      + .+++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++ ++.+||+|||++......
T Consensus        90 ~-~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           90 C-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             C-CSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             C-CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            5 5889999984    345789999999999999999999999   999999999999997 578999999999876544


Q ss_pred             CCceeeeccccCcccccccccccc---------ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          221 NDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      ..........||+.|+|||++.+.         ...++.++|||||||++|+|++|+.||......      ........
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~  234 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  234 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHH
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HHHHHHHh
Confidence            433233455699999999998641         136788999999999999999999999643221      11112222


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .........      ...+.++.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          235 DPNHEIEFP------DIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CTTSCCCCC------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCcccCCc------ccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            211111111      122357889999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.1e-46  Score=328.81  Aligned_cols=258  Identities=27%  Similarity=0.420  Sum_probs=207.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE------cCCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcCC-
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEGS-  133 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-  133 (340)
                      ...|.+.+.||+|+||.||+|.+      .+++.||+|++......  .+.+.+|+.++..+ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            45667789999999999999974      25678999999765432  24688999999999 7999999999987654 


Q ss_pred             eeEEEEEccCCCCcccccccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESR------------GQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                      ..+++|||+++++|.+++......            ...+++..+..++.|++.||+|||++   +++||||||+||+++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~  182 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  182 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence            489999999999999998654321            22388999999999999999999999   999999999999999


Q ss_pred             CCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccc
Q 044497          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSK  280 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~  280 (340)
                      .++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|+| |..||......   
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---  257 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---  257 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchh---
Confidence            9999999999999876555444444555688999999999765  67889999999999999998 99998754422   


Q ss_pred             cchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          281 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                          .........+......      ...++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       258 ----~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          258 ----EEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  306 (316)
T ss_dssp             ----HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----HHHHHHhccCccCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                1122223332222211      123567899999999999999999999999886

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-45  Score=321.02  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=192.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      ...|.+.+.||+|+||.||+|...    .+..+|+|++......  .+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            446677899999999999999864    2456999998764332  356889999999999999999999985 467899


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999998432   34689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ...... ......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ....+..+..
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~~  235 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGER  235 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             Cccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCCC
Confidence            443221 12333467899999999764  67889999999999999997 999987644321        1122222222


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      .+..+++.+.+++.+||+.||++|||+.++++.|+
T Consensus       236 ~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          236 LP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  272 (281)
T ss_dssp             CC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11      12234578899999999999999999999999886

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6e-46  Score=330.00  Aligned_cols=246  Identities=23%  Similarity=0.311  Sum_probs=192.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE----cCCcEEEEEEccCCC-----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLANSK-----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      ..|.+.+.||+|+||.||+|..    .+++.+|+|+++...     .....+.+|+.+++.++||||+++++++...+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            4567789999999999999986    478899999997643     2234678899999999999999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        97 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           97 YLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999883    235688999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .......  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       ...........
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~~  238 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTIDKILKCKL  238 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCC
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCC
Confidence            5433221  22345699999999999765  6788999999999999999999999754321       11112221111


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                              ..+..++.++.+++.+||+.||++||     ++.|+++
T Consensus       239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                    11223457899999999999999999     7778765

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.9e-45  Score=319.19  Aligned_cols=249  Identities=18%  Similarity=0.214  Sum_probs=203.6

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC-CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS-KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ...|.+.+.||+|+||.||+|... ++..+|+|++... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            456777899999999999999876 5778999998764 34557899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE---cCCCceEEecccCCccCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill---~~~~~~kl~Dfg~~~~~~  218 (340)
                      +++++|.+++..    ...+++..+..++.|++.||+|||++   +++|+||||+||++   +.++.++|+|||++....
T Consensus        88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999988843    35689999999999999999999999   99999999999999   788999999999998655


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....   .....||+.|+|||.+.+   .++.++||||||+++|+|++|+.||.......        .......+... 
T Consensus       161 ~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~-  225 (277)
T 3f3z_A          161 PGKM---MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--------VMLKIREGTFT-  225 (277)
T ss_dssp             TTSC---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCC-
T ss_pred             Cccc---hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCC-
Confidence            4332   234569999999999865   47889999999999999999999997644211        11222222111 


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ........+++.+.+++.+||+.||.+|||+.++++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 --FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              111111234678999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-45  Score=338.98  Aligned_cols=262  Identities=19%  Similarity=0.267  Sum_probs=193.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcC-----CeeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  136 (340)
                      .|.+.+.||+|+||.||+|.+. +++.||+|++......   .+.+.+|+.+++.++||||+++++++...     +..|
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            5667789999999999999875 6789999999764333   35788999999999999999999999765     5789


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+. ++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            9999985 69999883    345689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCCc--------------------eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcc
Q 044497          217 HPKENDF--------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT  276 (340)
Q Consensus       217 ~~~~~~~--------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~  276 (340)
                      .......                    .......||+.|+|||++... ..++.++||||+||++|||++|..||.....
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccccccc
Confidence            5443211                    123456799999999987543 3688899999999999999986655543211


Q ss_pred             cc-----cccch----------------hH---HHH--------------------HHhhcCCCccccccchhhHHHHHH
Q 044497          277 RS-----SKAYF----------------PS---WVY--------------------DQLNKGGDLELRNVTEIESMIARK  312 (340)
Q Consensus       277 ~~-----~~~~~----------------~~---~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~  312 (340)
                      ..     ....+                ..   .+.                    ..+...............+.++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence            10     00000                00   000                    000000000000111112335688


Q ss_pred             HHHHHhhcccCCCCCCCCHHHHHH
Q 044497          313 LCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       313 l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +.+|+.+||+.||++|||++|+++
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhc
Confidence            999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-45  Score=332.76  Aligned_cols=250  Identities=20%  Similarity=0.294  Sum_probs=194.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccC--CCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|...+++.||+|++.......   +.+.+|+.++..++  ||||+++++++...+..++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            366778999999999999998889999999997654433   56889999999996  5999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                       +.+++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++ ++.+||+|||++......
T Consensus       137 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          137 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             -CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             -cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence             568899999843    34788999999999999999999999   999999999999995 579999999999876544


Q ss_pred             CCceeeeccccCcccccccccccc---------ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          221 NDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      ..........||+.|+|||++.+.         ...++.++|||||||++|+|++|+.||......      ........
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~~~  281 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  281 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHH
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHHHh
Confidence            332233455699999999998641         125788999999999999999999999653221      11122222


Q ss_pred             hcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..........      ..+.++.+|+.+||+.||++|||+.|+++
T Consensus       282 ~~~~~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccCCCCc------cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            2211111111      12467899999999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-45  Score=320.32  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=202.5

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-------ChHHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      ....|.+.+.||+|+||.||+|... +++.+|+|++.....       ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3456788899999999999999876 788999999865432       35778999999999999999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC----ceEEec
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSD  210 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~----~~kl~D  210 (340)
                      .++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++    .+||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             EEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence            999999999999999983    235689999999999999999999999   999999999999998877    899999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      ||++........   .....+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......        ....
T Consensus       156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~  222 (283)
T 3bhy_A          156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQE--------TLTN  222 (283)
T ss_dssp             CTTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHH
T ss_pred             cccceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--------HHHH
Confidence            999986544332   2334589999999998764  67889999999999999999999997543211        1111


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +.....   ..........+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          223 ISAVNY---DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHTTCC---CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hHhccc---CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            111111   1112222345678999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=326.99  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=195.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcE----EEEEEccCC--CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGL----IAVKMLANS--KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~----vavK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      ..|.+.+.||+|+||.||+|.+. +++.    +|+|.+...  ....+.+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            34567789999999999999865 4544    577776543  334578999999999999999999999998765 789


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +++++++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999998432   35689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .............+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+..+..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  237 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER  237 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             cCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            544433333444578899999999875  77889999999999999999 999997654322        2222222222


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...      +...+.++.+++.+||+.||.+|||+.|+++.|+
T Consensus       238 ~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  274 (327)
T 3lzb_A          238 LPQ------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            211      1224567899999999999999999999999885

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=324.18  Aligned_cols=262  Identities=23%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC------CChHHHHHHHHHhcccC---CCceeeEeeEE
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK------FSGEEFINEVSTIGRIH---HVNVVQLLGFC  129 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~---h~~iv~~~~~~  129 (340)
                      .++...+|.+.+.||+|+||+||+|.+. +++.||+|++....      .....+.+|+.+++.++   ||||+++++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            3455667888899999999999999864 78899999986432      12356778888887774   99999999999


Q ss_pred             EcCC-----eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC
Q 044497          130 SEGS-----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (340)
Q Consensus       130 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~  204 (340)
                      ....     ..+++||++. ++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG  157 (308)
T ss_dssp             EECCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred             eccCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence            7755     4789999995 69999885432  34489999999999999999999999   999999999999999999


Q ss_pred             ceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh
Q 044497          205 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP  284 (340)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~  284 (340)
                      .+||+|||++........   .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||........    .
T Consensus       158 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~  228 (308)
T 3g33_A          158 TVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----L  228 (308)
T ss_dssp             CEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH----H
T ss_pred             CEEEeeCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence            999999999986544332   2445689999999999775  678899999999999999999999976443211    1


Q ss_pred             HHHHHHhhcCCCcc----------------ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 SWVYDQLNKGGDLE----------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+...........                ........+.++..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11111111000000                00001122345678899999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.6e-46  Score=343.21  Aligned_cols=254  Identities=19%  Similarity=0.197  Sum_probs=201.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++.+.    ....+.+.+|..++..++||||++++++|.+.+..|+|||
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E  154 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD  154 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence            3556689999999999999876 5788999998652    2223458899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       155 y~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          155 YYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             CCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             cCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            9999999999943   235689999999999999999999999   9999999999999999999999999999765443


Q ss_pred             CCceeeeccccCccccccccccc---cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          221 NDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ... ......||+.|+|||++..   ....++.++|||||||++|||++|+.||.......       ............
T Consensus       229 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~  300 (437)
T 4aw2_A          229 GTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHKERF  300 (437)
T ss_dssp             SCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTHHHHC
T ss_pred             CCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------HHHhhhhccccc
Confidence            322 2234579999999999862   12468889999999999999999999997644321       111111111001


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~evl~  336 (340)
                      ....   ....+++++.+|+.+||..+|++  ||+++|+++
T Consensus       301 ~~p~---~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 QFPT---QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCS---SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cCCc---ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1111   01124578999999999888888  999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-46  Score=334.59  Aligned_cols=260  Identities=24%  Similarity=0.430  Sum_probs=207.0

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEcC-C-----cEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLHT-G-----GLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  132 (340)
                      +....|.+.+.||+|+||.||+|.... +     ..||+|++......  .+.+.+|+.+++.+ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            334556677899999999999998652 2     37999999765432  35688999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKES----------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~  202 (340)
                      +..++||||+++|+|.+++.....          ....+++..+..++.|++.||+|||++   +++||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence            999999999999999998853211          134679999999999999999999999   9999999999999999


Q ss_pred             CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccccccc
Q 044497          203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKA  281 (340)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~  281 (340)
                      ++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|+| |..||.......   
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---  274 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---  274 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---
Confidence            999999999999865444433333445578899999998765  67889999999999999999 899987544321   


Q ss_pred             chhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                          ........+......      ...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       275 ----~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  322 (333)
T 2i1m_A          275 ----KFYKLVKDGYQMAQP------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ  322 (333)
T ss_dssp             ----HHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----HHHHHHhcCCCCCCC------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence                122222222221111      123467899999999999999999999999886

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-45  Score=342.16  Aligned_cols=263  Identities=19%  Similarity=0.228  Sum_probs=183.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEE-----cCCee
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCS-----EGSKR  135 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~  135 (340)
                      ..|.+.+.||+|+||+||+|.+. +++.||+|++......   .+.+.+|+.+++.++||||+++++++.     .....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            35677899999999999999865 7889999998764333   356889999999999999999999984     33568


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+|||++ +++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            9999998 678988883    345689999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCc-------------------------eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc----
Q 044497          216 FHPKENDF-------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG----  266 (340)
Q Consensus       216 ~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt----  266 (340)
                      ........                         .......||+.|+|||++... ..++.++|||||||++|||++    
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccc
Confidence            65432210                         122445689999999987443 368889999999999999999    


Q ss_pred             -------CCCCCCCCcccccccc----------------hhHHHHHHhhc--------------------CCCccccccc
Q 044497          267 -------GRRNSNMHATRSSKAY----------------FPSWVYDQLNK--------------------GGDLELRNVT  303 (340)
Q Consensus       267 -------g~~p~~~~~~~~~~~~----------------~~~~~~~~~~~--------------------~~~~~~~~~~  303 (340)
                             |+++|...........                ....+.+.+..                    ..........
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   5555544331100000                00000000000                    0000000111


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...+..++++.+|+.+||+.||++|||++|+++
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            122234678999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-45  Score=324.88  Aligned_cols=258  Identities=29%  Similarity=0.404  Sum_probs=194.7

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCC--
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGS--  133 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--  133 (340)
                      ....|.+.+.||+|+||.||+|...    ++..||+|++.......   +.+.+|+.+++.++||||+++++++...+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3455667789999999999999754    34479999997654443   56889999999999999999999997655  


Q ss_pred             ---eeEEEEEccCCCCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          134 ---KRALVYEYMPNGSLDRHIFPKE--SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       134 ---~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                         ..+++|||+++++|.+++....  .....+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence               3599999999999999884332  3346799999999999999999999999   9999999999999999999999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHH
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWV  287 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  287 (340)
                      +|||++................+++.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        .
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~  258 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------M  258 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------H
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------H
Confidence            999999865444332223344578899999999764  67889999999999999999 888887544322        1


Q ss_pred             HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          288 YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......+....      .+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       259 ~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  304 (313)
T 3brb_A          259 YDYLLHGHRLK------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE  304 (313)
T ss_dssp             HHHHHTTCCCC------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHcCCCCC------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            12222222111      11234578999999999999999999999999886

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=327.28  Aligned_cols=261  Identities=20%  Similarity=0.289  Sum_probs=197.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++.......   +.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            4567789999999999999876 68899999987655443   5678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           84 CDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999988873    345689999999999999999999999   99999999999999999999999999998655333


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH-------HHHHHhhc-
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS-------WVYDQLNK-  293 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~-  293 (340)
                      .  ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||..............       ........ 
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             c--ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            2  12344689999999998753 3678899999999999999999999976543221100000       00000000 


Q ss_pred             ----C-CCccccc---cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 ----G-GDLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ----~-~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          + .......   .....+.++..+.+|+.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                0 0000000   01111235677999999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.4e-45  Score=324.62  Aligned_cols=260  Identities=23%  Similarity=0.285  Sum_probs=196.7

Q ss_pred             hhhh-hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           67 NHFT-HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        67 ~~~~-~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      |.+. +.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus        14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   93 (316)
T 2ac3_A           14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM   93 (316)
T ss_dssp             CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence            4443 67999999999999855 788999999976543 357889999999885 7999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc---eEEecccCCccCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFGLAKFHPK  219 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~---~kl~Dfg~~~~~~~  219 (340)
                      ++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +||+|||++.....
T Consensus        94 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           94 RGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             CCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999843    35689999999999999999999999   9999999999999988766   99999999875533


Q ss_pred             CCCc-----eeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc----h---h
Q 044497          220 ENDF-----VSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY----F---P  284 (340)
Q Consensus       220 ~~~~-----~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~----~---~  284 (340)
                      ....     .......||+.|+|||.+.+.   ...++.++||||||+++|+|++|+.||...........    .   .
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            2211     112234599999999998641   12577899999999999999999999976543221100    0   1


Q ss_pred             HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......+..+.. ..  .......++..+.+|+.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~i~~~~~-~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKY-EF--PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCC-CC--CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCc-cc--CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            111222222211 11  11111235678999999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-45  Score=332.71  Aligned_cols=264  Identities=24%  Similarity=0.316  Sum_probs=187.9

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccC-CCceeeEeeEEEcCC--ee
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIH-HVNVVQLLGFCSEGS--KR  135 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~  135 (340)
                      ....|.+.+.||+|+||.||+|.+. +++.||+|++......   ...+.+|+.+++.+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            3456777899999999999999865 7899999998654333   356789999999997 999999999997544  68


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+||||++ ++|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999996 68988883     24688999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCC-------------------CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcc
Q 044497          216 FHPKEN-------------------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT  276 (340)
Q Consensus       216 ~~~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~  276 (340)
                      ......                   .........||+.|+|||++.+. ..++.++|||||||++|||++|++||...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            543211                   01122345699999999998763 3678899999999999999999999976543


Q ss_pred             cccccch-------------------hHHHHHHhhcCCCccccccch-h------------hHHHHHHHHHHHhhcccCC
Q 044497          277 RSSKAYF-------------------PSWVYDQLNKGGDLELRNVTE-I------------ESMIARKLCMIGLWCIQVK  324 (340)
Q Consensus       277 ~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~l~~l~~~cl~~~  324 (340)
                      ...-..+                   .......+............. +            ....++++.+|+.+||+.|
T Consensus       237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            2100000                   000000000000000000000 0            0023568999999999999


Q ss_pred             CCCCCCHHHHHH
Q 044497          325 AADRPSMTKVLE  336 (340)
Q Consensus       325 p~~Rps~~evl~  336 (340)
                      |++|||++|+++
T Consensus       317 P~~R~t~~e~l~  328 (388)
T 3oz6_A          317 PNKRISANDALK  328 (388)
T ss_dssp             GGGSCCHHHHTT
T ss_pred             cccCCCHHHHhC
Confidence            999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.9e-46  Score=330.89  Aligned_cols=266  Identities=23%  Similarity=0.311  Sum_probs=194.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHH--hcccCCCceeeEeeEEE-----cCCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVST--IGRIHHVNVVQLLGFCS-----EGSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~-----~~~~~~lv  138 (340)
                      .|.+.+.||+|+||.||+|.. +++.||+|++....  ...+..|.++  +..++||||+++++.+.     .....++|
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            456678999999999999976 58899999986543  2344444444  55689999999998553     23357899


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC------DVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~------~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      |||+++|+|.+++..     ...++..+..++.|++.||+|||+..      ..+++||||||+|||++.++.+||+|||
T Consensus        91 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            999999999999832     34588999999999999999999862      2389999999999999999999999999


Q ss_pred             CCccCCCCCC------ceeeeccccCccccccccccccc-----cccccccchhhHHHHHHHHHcCCCCCCCCcccc-cc
Q 044497          213 LAKFHPKEND------FVSISATRGTIGYIAPELISRNF-----GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS-SK  280 (340)
Q Consensus       213 ~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~  280 (340)
                      ++........      ........||+.|+|||.+.+..     ..++.++|||||||++|||++|..|+....... ..
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9986543221      11223446999999999987521     256678999999999999999977664433221 11


Q ss_pred             cc----------hhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          281 AY----------FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       281 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..          ...........................++++.+|+.+||+.||++|||++|+++.|+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            11          011111111112222222222233456778999999999999999999999999886

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.9e-45  Score=342.59  Aligned_cols=250  Identities=25%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccC---CCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLAN---SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ....|.+.+.||+|+||+||+|... +++.||+|++..   .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4567888999999999999999876 788999999864   234557899999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc---CCCceEEecccCCc
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAK  215 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~---~~~~~kl~Dfg~~~  215 (340)
                      |||+++++|.+.+..    ...+++..+..++.|++.||+|||++   +|+||||||+||+++   .++.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999988843    35689999999999999999999999   999999999999995   45679999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .......   .....||+.|+|||++.+   .++.++||||+||++|+|++|+.||......       . ....+..+.
T Consensus       173 ~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~~i~~~~  238 (486)
T 3mwu_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------D-ILKRVETGK  238 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTC
T ss_pred             ECCCCCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCC
Confidence            6544332   234569999999999875   5788999999999999999999999754321       1 122222221


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...   .......+++++.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          239 YAF---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CCS---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCC---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            110   11122345678999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-46  Score=352.31  Aligned_cols=256  Identities=29%  Similarity=0.444  Sum_probs=210.1

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +....+.+.+.||+|+||.||+|.+.++..||+|+++......+.+.+|+++|+.++||||+++++++.+ +..++||||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            4445567788999999999999999888889999998877777899999999999999999999999976 678999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++...  .+..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++......
T Consensus       343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            9999999999432  234588999999999999999999999   99999999999999999999999999998654321


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                       ........++..|+|||.+...  .++.++||||||+++|||++ |+.||......        .+...+..+..... 
T Consensus       418 -~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~-  485 (535)
T 2h8h_A          418 -YTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMPC-  485 (535)
T ss_dssp             -HHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--------HHHHHHHTTCCCCC-
T ss_pred             -eecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC-
Confidence             1111233467899999998764  78889999999999999999 89998754321        12233333322221 


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                           +..++..+.+|+.+||+.||++|||++++++.|+.
T Consensus       486 -----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  520 (535)
T 2h8h_A          486 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  520 (535)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                 12345788999999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.1e-45  Score=325.06  Aligned_cols=272  Identities=23%  Similarity=0.309  Sum_probs=210.8

Q ss_pred             CCCCCHHHHHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcc--cCCCceeeEeeEEEc
Q 044497           54 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGR--IHHVNVVQLLGFCSE  131 (340)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~  131 (340)
                      ...+...+.....|.+.+.||+|+||.||+|... ++.||+|++...  ..+.+.+|.+++..  ++||||+++++++..
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3445556777788899999999999999999874 889999998654  34567888888877  789999999999987


Q ss_pred             CC----eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeecCCCCCCee
Q 044497          132 GS----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH--------NGCDVCILHFDIKPHNIL  199 (340)
Q Consensus       132 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dik~~Nil  199 (340)
                      ..    ..++||||+++++|.+++..     ..+++..+..++.|++.||+|||        +.   +++||||||+||+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL  179 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence            76    78999999999999999832     46899999999999999999999        77   9999999999999


Q ss_pred             EcCCCceEEecccCCccCCCCCCce--eeeccccCcccccccccccccc----ccccccchhhHHHHHHHHHcC------
Q 044497          200 LDHNFIPKVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG------  267 (340)
Q Consensus       200 l~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~----~~~~~~DvwslG~~l~elltg------  267 (340)
                      ++.++.+||+|||++..........  ......||+.|+|||.+.+...    .++.++||||||+++|+|+||      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999997654443221  1234469999999999875311    234689999999999999999      


Q ss_pred             ----CCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          268 ----RRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       268 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                          ..||.......  .....+............... .......+..+.+|+.+||+.||++|||+.++++.|+
T Consensus       260 ~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCCCCTTTTTSCSS--CCHHHHHHHHTTSCCCCCCCG-GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             ccccccCccccCcCc--ccHHHHHHHHHHHHhCCCCcc-cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence                66765443321  111222222222222222221 1123356778999999999999999999999999886

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.8e-46  Score=343.68  Aligned_cols=245  Identities=22%  Similarity=0.290  Sum_probs=192.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++...    ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            4666789999999999999865 7889999998753    2233567889999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||+ +   +|+||||||+|||++.++.+||+|||+++....
T Consensus       229 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          229 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             CCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             eCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999883    34578999999999999999999998 8   999999999999999999999999999975433


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.......       ..........    
T Consensus       302 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~----  366 (446)
T 4ejn_A          302 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI----  366 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC----
T ss_pred             CCc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCCC----
Confidence            222  23456799999999999765  78899999999999999999999997543211       1111111111    


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                          ..+..+++++.+|+.+||+.||.+||     |++|+++
T Consensus       367 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 ----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                11223457899999999999999999     9999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-45  Score=320.43  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=201.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.......   +.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   86 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   86 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence            4566789999999999999876 68899999997655443   5678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc---eEEecccCCccCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFGLAKFHP  218 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~---~kl~Dfg~~~~~~  218 (340)
                      +++++|.+.+.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +||+|||++....
T Consensus        87 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           87 VTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999988883    335689999999999999999999999   9999999999999976655   9999999997655


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......        .......+....
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~  226 (284)
T 3kk8_A          160 DSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAYDY  226 (284)
T ss_dssp             SSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCC
T ss_pred             cCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchhH--------HHHHHHhccccC
Confidence            4332   2345689999999999775  67889999999999999999999996543221        112222211111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .   ......+++++.+++.+||+.||++|||+.|+++
T Consensus       227 ~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 P---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             C---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C---chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0   1111234578899999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-45  Score=317.55  Aligned_cols=250  Identities=25%  Similarity=0.402  Sum_probs=202.0

Q ss_pred             hhhhh-hcCCCCCeEEEEEEEc---CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           67 NHFTH-KLGQGGFGSVYKGQLH---TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        67 ~~~~~-~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      +.+.+ .||+|+||.||+|...   ++..||+|++.....  ..+.+.+|+++++.++||||+++++++. .+..++|||
T Consensus        11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e   89 (287)
T 1u59_A           11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVME   89 (287)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred             hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEE
Confidence            34444 8999999999999753   577899999987533  2357889999999999999999999994 556899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++......
T Consensus        90 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           90 MAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             CCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             eCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999842   345689999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          221 NDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       221 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .... ......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+..+....
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~i~~~~~~~  233 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRME  233 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCCC
T ss_pred             cceeeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHhcCCcCC
Confidence            3321 12233468899999999764  67889999999999999998 999997544321        222233322221


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            .+..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       234 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          234 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                  12244578999999999999999999999999885

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-45  Score=337.68  Aligned_cols=255  Identities=21%  Similarity=0.317  Sum_probs=194.6

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---------ChHHHHHHHHHhcccCCCceeeEeeEEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---------SGEEFINEVSTIGRIHHVNVVQLLGFCS  130 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~  130 (340)
                      ......|.+.+.||+|+||.||+|... +++.||+|++.....         ....+.+|+.+++.++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            445567788899999999999999865 688999999865321         1124789999999999999999999986


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC---ceE
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPK  207 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~---~~k  207 (340)
                      . +..++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++   .+|
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             c-CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence            5 45899999999999999883    345789999999999999999999999   999999999999997544   599


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~  286 (340)
                      |+|||+++......   ......||+.|+|||++.+ ....++.++||||||+++|+|++|+.||.......   .    
T Consensus       283 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~----  352 (419)
T 3i6u_A          283 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---S----  352 (419)
T ss_dssp             ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---C----
T ss_pred             EeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---H----
Confidence            99999998764432   2234569999999999854 22467889999999999999999999997543321   1    


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....+..+...   ........++..+.+|+.+||+.||++|||++|+++
T Consensus       353 ~~~~i~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 LKDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHHTTCCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcCCCC---CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11222222111   111222345678999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.9e-46  Score=329.85  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=193.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCCh----HHHHHHHHHhcccCCCceeeEeeEEEcCCe----e
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSK----R  135 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~  135 (340)
                      ..|.+.+.||+|+||.||+|.+ .+++.||+|++.......    ..+.+|+.+++.++||||+++++++.....    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            4567789999999999999986 478899999997654332    467899999999999999999999876543    4


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus        92 ~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             EEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            99999999999999984    235689999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          216 FHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       216 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ........ .......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       ..........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~  235 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVRED  235 (311)
T ss_dssp             -----------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCC
Confidence            65443221 122334589999999999775  6788999999999999999999999754431       1112222221


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...    .......++.++.+++.+||+.||.+||++.+++.
T Consensus       236 ~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          236 PIP----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             CCC----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CCC----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            111    11122235678999999999999999998777654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.8e-45  Score=344.83  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=201.1

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+.+.||+|+||.||+|... +++.||+|++.+.    ....+.+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus       188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~  267 (543)
T 3c4z_A          188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM  267 (543)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence            34467999999999999875 7899999999653    234467889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++|+|.+++.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++........
T Consensus       268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            99999999865554456799999999999999999999999   999999999999999999999999999986654332


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........   .. +...+.....      
T Consensus       345 --~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~-~~~~i~~~~~------  410 (543)
T 3c4z_A          345 --KTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KE-LKQRVLEQAV------  410 (543)
T ss_dssp             --CBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HH-HHHHHHHCCC------
T ss_pred             --ccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HH-HHHHHhhccc------
Confidence              12344799999999999875  7889999999999999999999999765432111   11 2222222111      


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSM  331 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  331 (340)
                       ..+..++..+.+|+.+||+.||++||++
T Consensus       411 -~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 -TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             -CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence             1223456789999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.7e-46  Score=334.53  Aligned_cols=245  Identities=26%  Similarity=0.313  Sum_probs=191.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHH-hcccCCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..|++.+.||+|+||.||+|... +++.||+|++.+...    ....+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            45677899999999999999876 678999999976432    22456667776 5778999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       118 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999883    335688999999999999999999999   99999999999999999999999999997533


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....  ......||+.|+|||++.+.  .++.++|+|||||++|||++|+.||......       ...........   
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~~---  256 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKPL---  256 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HHHHHHHHSCC---
T ss_pred             cCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHhccc---
Confidence            2221  23455799999999999875  6788999999999999999999999754321       11122222111   


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                           ..+..++..+.+|+.+||+.||.+||++.+.+
T Consensus       257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                 11123457889999999999999999985433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=333.96  Aligned_cols=264  Identities=19%  Similarity=0.289  Sum_probs=207.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCC--eeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e  140 (340)
                      .|.+.+.||+|+||+||+|.+. +++.||+|++....  ...+.+.+|+++++.++||||+++++++...+  ..++|||
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e   89 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence            4567789999999999999876 68899999997533  34567889999999999999999999998655  6799999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE----cCCCceEEecccCCcc
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  216 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill----~~~~~~kl~Dfg~~~~  216 (340)
                      |+++++|.+++.... ....+++..+..++.|++.||+|||++   +|+||||||+||++    +.++.+||+|||+++.
T Consensus        90 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             cCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            999999999985432 223489999999999999999999999   99999999999999    7778899999999986


Q ss_pred             CCCCCCceeeeccccCcccccccccccc------ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      ......   .....||+.|+|||.+.+.      ...++.++|||||||++|+|++|+.||.........   .......
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---~~~~~~~  239 (396)
T 4eut_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKI  239 (396)
T ss_dssp             CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---HHHHHHH
T ss_pred             ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---HHHHHHH
Confidence            544332   2344699999999998641      126778999999999999999999999754432211   1112222


Q ss_pred             hhcCCCc-----------------cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          291 LNKGGDL-----------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       291 ~~~~~~~-----------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .......                 ............+..+.+++.+||+.||++|||+.++++.++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence            2211100                 111122345678889999999999999999999999998764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.9e-45  Score=324.95  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGS  133 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  133 (340)
                      +....|.+.+.||+|+||.||+|.+.      +++.||+|++......  ...+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            33456777899999999999999754      4678999999764432  246889999999999999999999999999


Q ss_pred             eeEEEEEccCCCCcccccccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceE
Q 044497          134 KRALVYEYMPNGSLDRHIFPKE------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~k  207 (340)
                      ..++||||+++++|.+++....      .....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence            9999999999999999885321      1124578999999999999999999999   999999999999999999999


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  286 (340)
                      |+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------  248 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------  248 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--------
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--------
Confidence            9999999755433322222334568899999998765  67889999999999999999 888886543211        


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .......+.....      +..++..+.+++.+||+.||.+|||+.|+++.|+
T Consensus       249 ~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~  295 (322)
T 1p4o_A          249 VLRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  295 (322)
T ss_dssp             HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             HHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            2222222221111      1234577899999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.6e-45  Score=342.56  Aligned_cols=250  Identities=24%  Similarity=0.355  Sum_probs=200.3

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC---CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK---FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ....|.+.+.||+|+||+||+|... ++..+|+|++....   .....+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567888899999999999999876 78899999987643   2346789999999999999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCc
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAK  215 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~  215 (340)
                      |||+++|+|.+.+.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   ++.+||+|||++.
T Consensus       115 ~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999998883    335689999999999999999999999   9999999999999976   4559999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .......   .....||+.|+|||++.+   .++.++||||+||++|+|++|..||.......        ....+..+.
T Consensus       188 ~~~~~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~  253 (494)
T 3lij_A          188 VFENQKK---MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--------ILRKVEKGK  253 (494)
T ss_dssp             ECBTTBC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTC
T ss_pred             ECCCCcc---ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC
Confidence            6544322   234569999999999864   57889999999999999999999997644321        222222221


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...   .......+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       254 ~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          254 YTF---DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCC---CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC---CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            111   11112245678999999999999999999999885

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.1e-45  Score=343.81  Aligned_cols=249  Identities=25%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--------------CChHHHHHHHHHhcccCCCceeeEeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--------------FSGEEFINEVSTIGRIHHVNVVQLLGF  128 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~~  128 (340)
                      ...|.+.+.||+|+||+||+|... +++.+|+|++....              ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            345677899999999999999876 67899999987543              224678899999999999999999999


Q ss_pred             EEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC---c
Q 044497          129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---I  205 (340)
Q Consensus       129 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~---~  205 (340)
                      +.+....++||||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999998843    35689999999999999999999999   999999999999998775   6


Q ss_pred             eEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH
Q 044497          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS  285 (340)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~  285 (340)
                      +||+|||++........   .....||+.|+|||++.+   .++.++||||+||++|+|++|..||.......       
T Consensus       188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------  254 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------  254 (504)
T ss_dssp             EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred             EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------
Confidence            99999999986654432   234569999999999864   57889999999999999999999997644321       


Q ss_pred             HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ....+..+..   .........+++++.+|+.+||+.||.+|||++|+++
T Consensus       255 -~~~~i~~~~~---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          255 -IIKKVEKGKY---YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             -HHHHHHHCCC---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHcCCC---CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             2222222211   1111222345678999999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=330.04  Aligned_cols=251  Identities=28%  Similarity=0.402  Sum_probs=189.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc--CC--cEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEE-cCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH--TG--GLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~--~~--~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~  139 (340)
                      +.+.+.||+|+||.||+|...  ++  ..+|+|.++.....  .+.+.+|+.+++.++||||+++++++. ..+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            345688999999999999754  22  36899998754332  367899999999999999999999874 456789999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus       171 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          171 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             ECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999843   235678999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCc--eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          220 ENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       220 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ....  .......+|+.|+|||.+.+.  .++.++||||||+++|||+| |.+||.......        .......+..
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~~  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCCC
Confidence            3211  112334578899999999765  77889999999999999999 677776544322        1112222222


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...      +..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       315 ~~~------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          315 LLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111      1234567899999999999999999999999885

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.9e-45  Score=319.64  Aligned_cols=243  Identities=23%  Similarity=0.397  Sum_probs=197.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... ++..+|+|++....    ...+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   89 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence            3566789999999999999866 67789999986432    234678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++......
T Consensus        90 ~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           90 YAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999998832    35689999999999999999999999   9999999999999999999999999998654332


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .    .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......        ....+.....    
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~----  224 (279)
T 3fdn_A          163 R----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEF----  224 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCC----
T ss_pred             c----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--------HHHHHHhCCC----
Confidence            2    2344689999999998765  67889999999999999999999997543211        1122222111    


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ..+...+..+.+|+.+||+.||.+|||++|+++
T Consensus       225 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               111224567899999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.8e-45  Score=318.51  Aligned_cols=250  Identities=25%  Similarity=0.411  Sum_probs=199.2

Q ss_pred             Hhhhhh-hcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           66 TNHFTH-KLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        66 ~~~~~~-~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      .|.+.+ .||+|+||.||+|.+.   +++.||+|++......   .+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv   95 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV   95 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence            445555 8999999999999542   4678999999765432   36789999999999999999999999 55678999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        96 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            999999999999843    35689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          219 KENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       219 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ...... ......+++.|+|||.+.+.  .++.++||||||+++|+|++ |+.||......        .....+..+..
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~  238 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGER  238 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC
T ss_pred             cCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            544322 12233467899999999764  67889999999999999999 99998764432        12223333222


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      .+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       239 ~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          239 MG------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             CC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            21      12234578999999999999999999999999886

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=318.40  Aligned_cols=246  Identities=26%  Similarity=0.372  Sum_probs=182.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            3566789999999999999874 7889999998643    2234678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..   ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++......
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           92 MCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             CCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             cCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999843   235689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.........       .. ..   ...  
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~-~~---~~~--  228 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NK-VV---LAD--  228 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC---SSC--
T ss_pred             CC--cceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HH-Hh---hcc--
Confidence            22  11234589999999998765  6788999999999999999999999765432110       00 00   000  


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ...+..++.++.+++.+||+.||++|||++++++
T Consensus       229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              1112234578899999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-45  Score=344.09  Aligned_cols=251  Identities=25%  Similarity=0.326  Sum_probs=206.6

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      .....|.+.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34567888899999999999999876 7899999998653    334578999999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE---cCCCceEEecccC
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGL  213 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill---~~~~~~kl~Dfg~  213 (340)
                      +||||+.+++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||++   +.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          103 LVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            9999999999999884    345689999999999999999999999   99999999999999   5678999999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      +........   .....||+.|+|||++.+   .++.++||||+||++|+|++|+.||.......        ....+..
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~  241 (484)
T 3nyv_A          176 STHFEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--------ILKKVEK  241 (484)
T ss_dssp             HHHBCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHH
T ss_pred             eEEcccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHc
Confidence            986654432   234469999999999865   57889999999999999999999997644211        2222222


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +....   .......+++.+.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 GKYTF---ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCC---CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCC---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            21110   11122345678999999999999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-45  Score=345.72  Aligned_cols=249  Identities=27%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |.+.+.||+|+||.||+|... +++.||+|++...    ......+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            455688999999999999875 7899999998653    33456788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus       266 ~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          266 MNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            99999999885432  34589999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........    ..+...+....      
T Consensus       341 ~---~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~----~~i~~~i~~~~------  405 (576)
T 2acx_A          341 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEVP------  405 (576)
T ss_dssp             C---EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH----HHHHHHHHHCC------
T ss_pred             c---ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchhH----HHHHHHhhccc------
Confidence            2   2345799999999999875  6889999999999999999999999765432211    11222222211      


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                       ..++..+++++.+|+.+||+.||.+||     +++|+++
T Consensus       406 -~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 -EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             112234567899999999999999999     7788864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-45  Score=332.25  Aligned_cols=268  Identities=25%  Similarity=0.299  Sum_probs=205.7

Q ss_pred             CCCHHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-----CCceeeEeeEE
Q 044497           56 RYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-----HVNVVQLLGFC  129 (340)
Q Consensus        56 ~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~  129 (340)
                      .+...++....|.+.+.||+|+||+||+|... +++.||+|++.......+.+..|+.+++.++     ||||+++++++
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            44445555667888899999999999999874 7889999999765555567788999999986     99999999999


Q ss_pred             EcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-------
Q 044497          130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-------  202 (340)
Q Consensus       130 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-------  202 (340)
                      ...+..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.       
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence            9999999999999 999999985432  24589999999999999999999999   9999999999999975       


Q ss_pred             ------------------CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHH
Q 044497          203 ------------------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM  264 (340)
Q Consensus       203 ------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~el  264 (340)
                                        ++.+||+|||++.......     ....||+.|+|||++.+.  .++.++|||||||++|+|
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHH
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHH
Confidence                              7899999999998654332     244689999999999875  688999999999999999


Q ss_pred             HcCCCCCCCCcccccccc-------hhHHHHHHhhcCC--------C--cccccc--------------chhhHHHHHHH
Q 044497          265 AGGRRNSNMHATRSSKAY-------FPSWVYDQLNKGG--------D--LELRNV--------------TEIESMIARKL  313 (340)
Q Consensus       265 ltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~--------~--~~~~~~--------------~~~~~~~~~~l  313 (340)
                      ++|+.||...........       .+...........        .  ......              .......++.+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999999976443211000       0000000000000        0  000000              00111123678


Q ss_pred             HHHHhhcccCCCCCCCCHHHHHH
Q 044497          314 CMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       314 ~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+|+.+||+.||++|||++|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            89999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.8e-46  Score=334.52  Aligned_cols=263  Identities=17%  Similarity=0.188  Sum_probs=196.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcC------CcEEEEEEccCCCCC------------hHHHHHHHHHhcccCCCceeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHT------GGLIAVKMLANSKFS------------GEEFINEVSTIGRIHHVNVVQL  125 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~------~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~  125 (340)
                      ...|.+.+.||+|+||.||+|.+..      ++.||+|++......            ......|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3467788999999999999998764      468999998654321            1224456667777889999999


Q ss_pred             eeEEEcC----CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          126 LGFCSEG----SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       126 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                      ++++...    ...++||||+ +++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998664    4589999999 9999999843   235799999999999999999999999   999999999999998


Q ss_pred             --CCCceEEecccCCccCCCCCCce-----eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCC
Q 044497          202 --HNFIPKVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMH  274 (340)
Q Consensus       202 --~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~  274 (340)
                        .++.+||+|||+++.........     ......||+.|+|||.+.+.  .++.++|||||||++|+|+||+.||...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence              88999999999997654322111     11234599999999999875  6889999999999999999999999853


Q ss_pred             cccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          275 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .....   ............ ........-....++.++.+++.+||+.||.+|||+.++++.|+
T Consensus       265 ~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          265 LKDPK---YVRDSKIRYREN-IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             TTCHH---HHHHHHHHHHHC-HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             ccCHH---HHHHHHHHhhhh-HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence            32211   111111111000 00000000000123578999999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=332.97  Aligned_cols=267  Identities=16%  Similarity=0.165  Sum_probs=197.3

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCC------------hHHHHHHHHHhcccCCCcee
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFS------------GEEFINEVSTIGRIHHVNVV  123 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv  123 (340)
                      .++....|.+.+.||+|+||.||+|...    ++..+|+|+.......            ...+.+|+..+..++||||+
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            4445566788899999999999999875    5778999998765321            13466788889999999999


Q ss_pred             eEeeEEEc----CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCee
Q 044497          124 QLLGFCSE----GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL  199 (340)
Q Consensus       124 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nil  199 (340)
                      ++++++..    ....++||||+ +++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  183 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL  183 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence            99999977    78899999999 9999999843    33789999999999999999999999   9999999999999


Q ss_pred             EcCCC--ceEEecccCCccCCCCCCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCC
Q 044497          200 LDHNF--IPKVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (340)
Q Consensus       200 l~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~  272 (340)
                      ++.++  .+||+|||+++........     .......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~  261 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWE  261 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            98877  9999999999765432211     111344699999999999875  67889999999999999999999996


Q ss_pred             CCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          273 MHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      .......  .. ................. ......++.++.+++.+||+.||++|||++++++.|+.
T Consensus       262 ~~~~~~~--~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          262 QNLKDPV--AV-QTAKTNLLDELPQSVLK-WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             GGTTCHH--HH-HHHHHHHHHTTTHHHHH-HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             ccccccH--HH-HHHHHhhcccccHHHHh-hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            4322111  00 01111111100000000 00000345689999999999999999999999999873

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.8e-45  Score=324.90  Aligned_cols=246  Identities=25%  Similarity=0.353  Sum_probs=198.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCCh----HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..|...+.||+|+||+||+|.. .+++.||+|++.......    +.+.+|+++++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3456668899999999999986 478899999997654332    46889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+. |+|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9996 678777632   235789999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .      ....||+.|+|||++.+ ....++.++||||||+++|||++|+.||......       .......... ...
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~-~~~  272 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE-SPA  272 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-CCC
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcC-CCC
Confidence            2      23459999999999853 1246788999999999999999999998654321       1122222221 111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..     ....+..+.+++.+||+.||++|||++++++
T Consensus       273 ~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          273 LQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC-----CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            11     1123567899999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.8e-45  Score=321.02  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=201.9

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-----CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEc--CCeeEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALV  138 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  138 (340)
                      .+.+.||+|+||+||++...     +++.||+|++......  .+.+.+|+++++.++||||+++++++.+  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            67789999999999988642     6788999999865432  3568999999999999999999999987  4678999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999832     3489999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc-------ccchhHHHHHH
Q 044497          219 KENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS-------KAYFPSWVYDQ  290 (340)
Q Consensus       219 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-------~~~~~~~~~~~  290 (340)
                      ...... ......+|..|+|||.+.+.  .++.++||||||+++|+|++|+.||........       ...-.......
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            544322 22344578889999999775  678899999999999999999999865432100       00000111122


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ........      .+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       264 ~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          264 LERGERLP------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             HHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HhcccCCC------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            22222111      12234578999999999999999999999999886

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.3e-45  Score=338.62  Aligned_cols=256  Identities=21%  Similarity=0.212  Sum_probs=191.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcC------Cee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~  135 (340)
                      +|.+.+.||+|+||+||+|.+. +++.||+|++......   .+.+.+|+.+++.++||||+++++++...      ...
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            4566789999999999999865 7889999999764322   35688999999999999999999999654      457


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+||||+++ +|.+.+.      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       143 ~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          143 YLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             EEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            999999965 5666652      3488999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc-------------
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-------------  282 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------------  282 (340)
                      ......   ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+....-..             
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          213 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             ----CC---CC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCc---ccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            654432   22445699999999999875  788999999999999999999999976542110000             


Q ss_pred             --hhHHHHHHhhcCCCc------------cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          283 --FPSWVYDQLNKGGDL------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       283 --~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        +..............            ............++++.+|+.+||+.||++|||++|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              000000111110000            001112233344788999999999999999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-45  Score=347.36  Aligned_cols=245  Identities=25%  Similarity=0.411  Sum_probs=197.2

Q ss_pred             hcCCCCCeEEEEEEEc---CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           72 KLGQGGFGSVYKGQLH---TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      .||+|+||.||+|.+.   ++..||+|+++...  ...+.+.+|+++++.++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999764   45679999998643  345789999999999999999999999976 56899999999999


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce-e
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-S  225 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~  225 (340)
                      |.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......... .
T Consensus       422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999843   345689999999999999999999999   99999999999999999999999999998664432211 1


Q ss_pred             eeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       226 ~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                      .....+|+.|+|||++.+.  .++.++|||||||++|||++ |+.||......+        +...+..+.....     
T Consensus       496 ~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~~~-----  560 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRMEC-----  560 (613)
T ss_dssp             ------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------HHHHHHTTCCCCC-----
T ss_pred             ccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCCC-----
Confidence            1223467899999999764  78889999999999999998 999997654322        2233333332222     


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                       +..+++++.+++.+||+.||.+|||+.++++.|+
T Consensus       561 -p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          561 -PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             -CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             -CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             2235578999999999999999999999999886

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.5e-44  Score=315.67  Aligned_cols=244  Identities=26%  Similarity=0.377  Sum_probs=196.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEc----CCeeEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALV  138 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv  138 (340)
                      +.+.+.||+|+||.||+|... ++..||+|++.......   +.+.+|+.+++.++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            455678999999999999875 67889999987654433   568899999999999999999998865    4568999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeeEc-CCCceEEecccCCc
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLD-HNFIPKVSDFGLAK  215 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dik~~Nill~-~~~~~kl~Dfg~~~  215 (340)
                      |||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +  ++|+||||+||+++ +++.+||+|||++.
T Consensus       108 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          108 TELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999983    235688999999999999999999998   7  99999999999997 78999999999997


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .......    ....||+.|+|||.+.+   .++.++||||||+++|+|++|+.||......       .........+.
T Consensus       181 ~~~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~  246 (290)
T 1t4h_A          181 LKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGV  246 (290)
T ss_dssp             GCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTC
T ss_pred             ccccccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccC
Confidence            5544322    33458999999998864   5788999999999999999999999754321       11222222221


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..     ...+...++++.+++.+||+.||.+|||+.++++
T Consensus       247 ~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          247 KP-----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CC-----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cc-----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11     1122233467999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.7e-45  Score=318.70  Aligned_cols=251  Identities=28%  Similarity=0.413  Sum_probs=195.3

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcC----CcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEE-EcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~  139 (340)
                      |.+.+.||+|+||+||+|....    ...+|+|.+......  .+.+.+|+.++++++||||+++++++ ...+..+++|
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            5567899999999999997542    235899998764332  35688999999999999999999986 5566789999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       107 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          107 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             ECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             eCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999843   345688999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCc--eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          220 ENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       220 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ....  .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |.+||.......        .......+..
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~~~~~~  250 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  250 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------HHHHHHTTCC
T ss_pred             cchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhcCCC
Confidence            3211  122344578899999999775  67889999999999999999 555555433221        1111222211


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...      +..++..+.+++.+||+.||.+|||++++++.|+
T Consensus       251 ~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          251 LLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111      1123467899999999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=327.71  Aligned_cols=257  Identities=24%  Similarity=0.351  Sum_probs=193.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh--HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      +|.+.+.||+|+||+||+|... +++.||+|++.......  ..+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            3566789999999999999876 78899999987543222  24567999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      + ++|.+++..   .+..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........
T Consensus        83 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           83 D-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             S-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             c-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            6 588888743   235689999999999999999999999   999999999999999999999999999975443222


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc-----
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL-----  297 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  297 (340)
                        ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||........    ...+..........     
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ----LHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ---------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTG
T ss_pred             --ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHhchhh
Confidence              22344689999999998763 3678899999999999999999999976543211    11111111100000     


Q ss_pred             --------------cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 --------------ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 --------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                    ...........++.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                          000001122235678899999999999999999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7e-45  Score=320.80  Aligned_cols=257  Identities=23%  Similarity=0.346  Sum_probs=195.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++......    .+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            35677899999999999999864 7889999998753322    256889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++.........+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999998854433456789999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...  ......+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......     .. .............
T Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~  258 (310)
T 2wqm_A          189 KTT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEQCDYPPL  258 (310)
T ss_dssp             ------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-----HH-HHHHHHTTCSCCC
T ss_pred             CCc--cccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhH-----HH-HHHHhhcccCCCC
Confidence            322  12334589999999998764  67889999999999999999999986533211     11 1122222221111


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .     ...++.++.+++.+||+.||.+|||+.++++.|+
T Consensus       259 ~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~  293 (310)
T 2wqm_A          259 P-----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK  293 (310)
T ss_dssp             C-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             c-----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            1     1234568999999999999999999999999885

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-44  Score=329.18  Aligned_cols=245  Identities=23%  Similarity=0.282  Sum_probs=188.2

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcc-cCCCceeeEeeEEEc----CCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGR-IHHVNVVQLLGFCSE----GSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~  144 (340)
                      +.||+|+||+||+|... +++.||+|++..    ...+.+|++++.+ .+||||+++++++..    ....|+||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            68999999999999876 788999999863    2467788888744 589999999999865    5678999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCccCCCCC
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~~~~~~~  221 (340)
                      |+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   ++.+||+|||+++......
T Consensus       144 g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~  218 (400)
T 1nxk_A          144 GELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  218 (400)
T ss_dssp             EEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence            9999998542  234689999999999999999999999   9999999999999987   7899999999998654332


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                         ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||............    ...+..+... .. 
T Consensus       219 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~i~~~~~~-~~-  287 (400)
T 1nxk_A          219 ---SLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYE-FP-  287 (400)
T ss_dssp             -----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----HHHHHHTCCC-CC-
T ss_pred             ---ccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----HHHHHcCccc-CC-
Confidence               22345689999999999764  7888999999999999999999999765543222111    1111111110 00 


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ......++.++.+|+.+||+.||++|||+.|+++
T Consensus       288 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          288 -NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             -TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             1111235578999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-45  Score=323.79  Aligned_cols=253  Identities=19%  Similarity=0.266  Sum_probs=197.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++......    .+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            34667789999999999999876 7889999999764332    256889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus       114 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          114 RLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             ECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999842    35689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ... .......+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||......        ...........   
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~---  252 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIP---  252 (309)
T ss_dssp             -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCC---
T ss_pred             ccc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCC---
Confidence            321 122344689999999999765  6788999999999999999999999754321        12222222111   


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhc
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLE  339 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~evl~~L~  339 (340)
                       ........++..+.+++.+||+.||++|| |++++++.|+
T Consensus       253 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~  292 (309)
T 2h34_A          253 -RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH  292 (309)
T ss_dssp             -CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence             11122334567899999999999999999 9999999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.4e-45  Score=323.44  Aligned_cols=261  Identities=20%  Similarity=0.276  Sum_probs=206.4

Q ss_pred             CCCCHHHHHHHHhhhh-hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhccc-CCCceeeEeeE
Q 044497           55 KRYSYPEIIAVTNHFT-HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRI-HHVNVVQLLGF  128 (340)
Q Consensus        55 ~~~~~~~~~~~~~~~~-~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~  128 (340)
                      -.|...+.....|.+. +.||+|+||.||+|... +++.||+|++.....   ....+.+|+.++..+ +||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3566667777777776 88999999999999876 689999999876433   346789999999999 56999999999


Q ss_pred             EEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCc
Q 044497          129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFI  205 (340)
Q Consensus       129 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~  205 (340)
                      +.+.+..++||||+++++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||+++.   ++.
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence            99999999999999999999988432  346789999999999999999999999   9999999999999987   789


Q ss_pred             eEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH
Q 044497          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS  285 (340)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~  285 (340)
                      +||+|||++........   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       
T Consensus       173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------  240 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-------  240 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred             EEEeeCccccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------
Confidence            99999999986644322   2334699999999999765  67889999999999999999999997544321       


Q ss_pred             HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ............    .......++..+.+++.+||+.||.+|||++++++
T Consensus       241 ~~~~i~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          241 TYLNISQVNVDY----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHHTCCCC----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhccccc----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            111111111111    11122234578899999999999999999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.3e-45  Score=318.76  Aligned_cols=259  Identities=19%  Similarity=0.271  Sum_probs=200.6

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEE-EcCCeeEEEEEc
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEY  141 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~  141 (340)
                      ...|.+.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++.++|++++..+..+ ...+..+++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            34677789999999999999986 4788999998755432 24578999999999887766666554 777888999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE---cCCCceEEecccCCccCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill---~~~~~~kl~Dfg~~~~~~  218 (340)
                      + +++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||++   ++++.+||+|||++....
T Consensus        87 ~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           87 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             C-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             c-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9 9999999842   235689999999999999999999999   99999999999999   788999999999998654


Q ss_pred             CCCCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          219 KENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       219 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      .....     .......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||...........+..........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            43321     112345689999999999875  67889999999999999999999998755443322222211111111


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .       .......+++.+.+++.+||+.||++|||++++++.|+
T Consensus       238 ~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          238 P-------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             C-------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             h-------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            0       01111234578999999999999999999999999885

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-44  Score=322.21  Aligned_cols=254  Identities=26%  Similarity=0.439  Sum_probs=201.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcE--EEEEEccCC--CCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGL--IAVKMLANS--KFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~--vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l  137 (340)
                      ...|.+.+.||+|+||.||+|... ++..  +|+|.+...  ....+.+.+|+++++.+ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            345677899999999999999865 5554  489988653  22345789999999999 89999999999999999999


Q ss_pred             EEEccCCCCcccccccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc
Q 044497          138 VYEYMPNGSLDRHIFPKE------------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  205 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~  205 (340)
                      ||||+++++|.+++....            .....+++..++.++.|++.||+|||++   +++||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence            999999999999986543            2345789999999999999999999999   9999999999999999999


Q ss_pred             eEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchh
Q 044497          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFP  284 (340)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~  284 (340)
                      +||+|||++.......   ......+++.|+|||.+.+.  .++.++||||||+++|+|++ |+.||......       
T Consensus       181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------  248 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------  248 (327)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------
T ss_pred             EEEcccCcCccccccc---cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------
Confidence            9999999987432211   12233478899999998764  67889999999999999998 99999754321       


Q ss_pred             HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          285 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                       .....+..+.....      +..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       249 -~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  296 (327)
T 1fvr_A          249 -ELYEKLPQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  296 (327)
T ss_dssp             -HHHHHGGGTCCCCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHHhhcCCCCCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             12223333222111      1234578999999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-45  Score=320.31  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=202.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEE--cCCeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~  139 (340)
                      .|.+.+.||+|+||.||+|... +++.+|+|++.......   +.+.+|+.+++.++||||+++++++.  .....++||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            4567789999999999999876 78899999997654433   56889999999999999999999874  467899999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eeecCCCCCCeeEcCCCceEEecccCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC-----ILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-----ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      ||+++++|.+++.........+++..++.++.|++.||+|||+.   +     ++|+||||+||+++.++.+||+|||++
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            99999999999865444455699999999999999999999998   7     999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      .........  .....|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||......        .....+..+
T Consensus       164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~  231 (279)
T 2w5a_A          164 RILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREG  231 (279)
T ss_dssp             HHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT
T ss_pred             eeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHH--------HHHHHHhhc
Confidence            765443221  1234589999999999765  6788999999999999999999998765321        122223333


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .....      +..++.++.+++.+||+.||++|||+.|+++.+.
T Consensus       232 ~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          232 KFRRI------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ccccC------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            22211      1234578999999999999999999999998653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-45  Score=328.24  Aligned_cols=256  Identities=21%  Similarity=0.284  Sum_probs=192.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCC------ee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~  135 (340)
                      .|.+.+.||+|+||.||+|.+. +++.||+|++......   .+.+.+|+++++.++||||+++++++....      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            4566789999999999999875 7899999999654333   256789999999999999999999997653      46


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+||||+ +++|.+++..     ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++
T Consensus       106 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             EEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            9999999 8899998832     4688999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch-------hHHH-
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF-------PSWV-  287 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~~-  287 (340)
                      .....     .....+|+.|+|||++.+. ..++.++||||+||++|+|++|+.||........-..+       +... 
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            65432     2345689999999998763 36788999999999999999999999765431100000       0000 


Q ss_pred             --------HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          288 --------YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       288 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                              ...+..-...............++.+.+|+.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                    0000000000011111222344678999999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=336.26  Aligned_cols=253  Identities=20%  Similarity=0.185  Sum_probs=199.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++.+..    ...+.+.+|..++..++||||+++++++.+.+..|+|||
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE  141 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME  141 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence            4556689999999999999875 78999999996522    122457899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++...   +..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||++......
T Consensus       142 ~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          142 YYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             CCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            99999999998432   34789999999999999999999999   9999999999999999999999999999866543


Q ss_pred             CCceeeeccccCcccccccccccc-----ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          221 NDFVSISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .. .......||+.|+|||++...     ...++.++|||||||++|||++|+.||.......       ..........
T Consensus       216 ~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~  287 (412)
T 2vd5_A          216 GT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-------TYGKIVHYKE  287 (412)
T ss_dssp             SC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTHHH
T ss_pred             Cc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccc
Confidence            32 122345799999999998731     2367889999999999999999999997644321       1111111100


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCC---CCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADR---PSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~evl~  336 (340)
                      ....   ......++.++.+|+.+||+ +|.+|   |+++|+++
T Consensus       288 ~~~~---p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 HLSL---PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HCCC---C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CcCC---CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0000   11123456789999999999 99998   58988864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-45  Score=320.77  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=202.0

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...+|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3456778899999999999999876 788999999976433 34578899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE---cCCCceEEecccCCccC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill---~~~~~~kl~Dfg~~~~~  217 (340)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +++|+||||+||++   +.++.++|+|||++...
T Consensus        87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999998832    34689999999999999999999999   99999999999999   78899999999998754


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ....    .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......        .....+..+...
T Consensus       160 ~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~  225 (304)
T 2jam_A          160 QNGI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGYYE  225 (304)
T ss_dssp             CCBT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCCCC
T ss_pred             CCCc----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            3321    1234589999999999764  6788999999999999999999999754321        112222222111


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .   .......++..+.+++.+||+.||.+|||+.|+++
T Consensus       226 ~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 F---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             C---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             C---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0   11122345578999999999999999999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=322.95  Aligned_cols=253  Identities=30%  Similarity=0.466  Sum_probs=196.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcC-----CcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHT-----GGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      ..+.+.+.||+|+||.||+|....     +..||+|++......  ...+.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            344556899999999999997652     235999999764332  2468899999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus       124 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999843   235689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          218 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       218 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ...... .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||......        .....+..+.
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~  267 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGF  267 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTC
T ss_pred             ccccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHCCC
Confidence            443221 112233467899999999764  67889999999999999999 99998654321        1222333322


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....      +..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       268 ~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          268 RLPT------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILD  305 (333)
T ss_dssp             CCCC------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             cCCC------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            2111      1234567899999999999999999999999885

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-46  Score=333.16  Aligned_cols=254  Identities=22%  Similarity=0.261  Sum_probs=201.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE----cCCcEEEEEEccCCC-----CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCe
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLANSK-----FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  134 (340)
                      ..|.+.+.||+|+||.||+|..    .+++.||+|+++...     ...+.+.+|+.++..+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4567789999999999999987    378899999987532     2345677899999999 69999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~  214 (340)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999843    34689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      +........ ......||+.|+|||++.+....++.++|||||||++|+|++|+.||.........   .. +.......
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~-~~~~~~~~  281 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AE-ISRRILKS  281 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HH-HHHHHHHC
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HH-HHHHHhcc
Confidence            755332221 12345699999999999864346788999999999999999999999754432211   11 11111111


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  337 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~~  337 (340)
                      .       ...+..++..+.+|+.+||+.||.+||     |++|+++.
T Consensus       282 ~-------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 E-------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             C-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             C-------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            1       111223456789999999999999999     99998863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-44  Score=325.90  Aligned_cols=251  Identities=20%  Similarity=0.267  Sum_probs=201.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---------hHHHHHHHHHhccc-CCCceeeEeeEEEcCC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---------GEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  133 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  133 (340)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||++......         .+.+.+|+.+++.+ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            45666689999999999999876 7899999998764421         24578899999999 7999999999999999


Q ss_pred             eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      ..++||||+++++|.+++.    ....+++..+..++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||+
T Consensus       174 ~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCc
Confidence            9999999999999999984    335689999999999999999999999   999999999999999999999999999


Q ss_pred             CccCCCCCCceeeeccccCcccccccccccc----ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      +........   .....||+.|+|||++.+.    ...++.++||||||+++|+|++|+.||.......        ...
T Consensus       247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--------~~~  315 (365)
T 2y7j_A          247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--------MLR  315 (365)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH
T ss_pred             ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--------HHH
Confidence            986654332   2345699999999998642    1257789999999999999999999997543211        111


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+..+...   .........+..+.+++.+||+.||++|||+.++++
T Consensus       316 ~i~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 MIMEGQYQ---FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHTCCC---CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCC---CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111110   001111234567899999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-44  Score=314.90  Aligned_cols=251  Identities=26%  Similarity=0.384  Sum_probs=198.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcC----CcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..|.+.+.||+|+||.||+|.+..    +..||+|++.....  ..+.+.+|+.+++.++||||+++++++.+. ..+++
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence            356677899999999999997542    23599999876532  236788999999999999999999998754 57899


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        91 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           91 MELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999843   235689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ..... ......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+..+...
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~  233 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRL  233 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCC
T ss_pred             ccccc-ccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCC
Confidence            43221 22334578899999999764  67889999999999999998 999997544322        11222222221


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      +..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       234 ~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          234 PK------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence            11      1124567899999999999999999999999886

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=318.13  Aligned_cols=250  Identities=25%  Similarity=0.415  Sum_probs=193.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  145 (340)
                      .+.+.+.||+|+||.||+|... ++.||+|++... ...+.+.+|+++++.++||||+++++++.+  ..++||||++++
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~   84 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG   84 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred             HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence            4566789999999999999875 788999998643 234678999999999999999999998874  489999999999


Q ss_pred             CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc-eEEecccCCccCCCCCCce
Q 044497          146 SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       146 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~  224 (340)
                      +|.+++.... ....+++..+..++.|+++||+|||+....+++||||||+||+++.++. +||+|||++.......   
T Consensus        85 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---  160 (307)
T 2eva_A           85 SLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---  160 (307)
T ss_dssp             BHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence            9999985432 2235788999999999999999999932239999999999999988886 7999999997543321   


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccch
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE  304 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (340)
                        ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......     ..... ....+.....     
T Consensus       161 --~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~-~~~~~~~~~~-----  225 (307)
T 2eva_A          161 --TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMW-AVHNGTRPPL-----  225 (307)
T ss_dssp             ------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-----HHHHH-HHHTTCCCCC-----
T ss_pred             --ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-----HHHHH-HHhcCCCCCc-----
Confidence              234589999999999765  77889999999999999999999997543221     11111 1122221111     


Q ss_pred             hhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       305 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                       ...++..+.+++.+||+.||++|||++++++.|+
T Consensus       226 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             -BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence             1234567899999999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-45  Score=327.00  Aligned_cols=261  Identities=23%  Similarity=0.343  Sum_probs=197.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  105 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF  105 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence            4566789999999999999876 68899999987655443   4577999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.++..    ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus       106 ~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          106 VDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             CCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99988888762    345689999999999999999999999   99999999999999999999999999997654332


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------HHHHHHhhc-
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------SWVYDQLNK-  293 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~-  293 (340)
                      .  ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.............       ......... 
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  22344689999999998763 357889999999999999999999997654321100000       000000000 


Q ss_pred             ----C-CCccccc---cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 ----G-GDLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ----~-~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          + .......   .....+.++..+.+|+.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                0 0000111   11122245678999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-44  Score=314.63  Aligned_cols=246  Identities=22%  Similarity=0.358  Sum_probs=199.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ...|.+.+.||+|+||.||+|... +++.||+|++.....   ....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456777899999999999999876 789999999876432   235688999999999 999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC----------------
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----------------  202 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~----------------  202 (340)
                      |||+++++|.+++.........+++..+..++.|++.||+|||++   +++||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999955433346789999999999999999999999   9999999999999984                


Q ss_pred             ---CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc
Q 044497          203 ---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS  279 (340)
Q Consensus       203 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~  279 (340)
                         ...++|+|||.+.......      ...||+.|+|||.+.+. ..++.++||||||+++|+|++|.+|+.....   
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence               4479999999998665432      23489999999998764 3566799999999999999999877643211   


Q ss_pred             ccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          280 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                              ...+..+.....      +..++..+.+++.+||+.||++|||+.++++
T Consensus       237 --------~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 --------WHEIRQGRLPRI------PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             --------HHHHHTTCCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------HHHHHcCCCCCC------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                    112222222111      1234578999999999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-44  Score=317.20  Aligned_cols=257  Identities=19%  Similarity=0.276  Sum_probs=201.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEE-EcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~  143 (340)
                      .|.+.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ...+..+++|||+ 
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            456778999999999999986 4788999999876543 35788999999999988766655554 6777889999999 


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE---cCCCceEEecccCCccCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill---~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      +++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||++   ++++.+||+|||++......
T Consensus        88 ~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           88 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            9999999842   235689999999999999999999999   99999999999999   48889999999999865443


Q ss_pred             CCce-----eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          221 NDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       221 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ....     ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||...........+........... 
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  238 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-  238 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred             ccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence            3211     12345699999999999875  678899999999999999999999987554332222221111111110 


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            .......+++++.+++.+||+.||.+|||+.++++.|+
T Consensus       239 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          239 ------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             ------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             ------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence                  01122234578999999999999999999999999885

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.4e-45  Score=325.52  Aligned_cols=257  Identities=21%  Similarity=0.292  Sum_probs=191.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ..|.+.+.||+|+||+||+|... +++.||+|++......   .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE  113 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence            45677799999999999999865 7889999999754432   2467899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-----CCCceEEecccCCc
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-----HNFIPKVSDFGLAK  215 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-----~~~~~kl~Dfg~~~  215 (340)
                      |++ ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++     .++.+||+|||++.
T Consensus       114 ~~~-~~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          114 YAE-NDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             CCS-EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             cCC-CCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            996 59998883    344689999999999999999999999   999999999999994     45569999999997


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .......  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||........   + ...........
T Consensus       186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~-~~~~~~~~~~~  258 (329)
T 3gbz_A          186 AFGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---L-FKIFEVLGLPD  258 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-HHHHHHHCCCC
T ss_pred             ccCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---H-HHHHHHhCCCc
Confidence            6543221  22344589999999998764 3578899999999999999999999976443210   0 00111000000


Q ss_pred             C----------------ccccc---cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 D----------------LELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~----------------~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .                .....   .......++.++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0                00000   01122225578899999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=316.66  Aligned_cols=250  Identities=26%  Similarity=0.364  Sum_probs=196.6

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCc---EEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCee-EEEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGG---LIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-ALVYE  140 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~---~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e  140 (340)
                      ...+.||+|+||+||+|.+. ++.   .+|+|++......  .+.+.+|+.+++.++||||+++++++.+.+.. +++||
T Consensus        24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  103 (298)
T 3pls_A           24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP  103 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred             ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence            34578999999999999753 222   6999998764432  35788999999999999999999999766655 99999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+.+++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++......
T Consensus       104 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          104 YMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999843   245688999999999999999999999   9999999999999999999999999999755432


Q ss_pred             CCc--eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCC-CCcccccccchhHHHHHHhhcCCCc
Q 044497          221 NDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN-MHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       221 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ...  .......+|+.|+|||.+.+.  .++.++||||||+++|+|++|..|+. ......        ...........
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~~  247 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--------LTHFLAQGRRL  247 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--------HHHHHHTTCCC
T ss_pred             cccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--------HHHHhhcCCCC
Confidence            211  122344578899999999765  67889999999999999999655543 322211        22222222221


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      +...+..+.+++.+||+.||.+|||++++++.|+
T Consensus       248 ~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  283 (298)
T 3pls_A          248 PQ------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE  283 (298)
T ss_dssp             CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11      1223467899999999999999999999999886

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-45  Score=323.84  Aligned_cols=261  Identities=28%  Similarity=0.392  Sum_probs=205.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE-----cCCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEE--cCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~  136 (340)
                      ..|.+.+.||+|+||.||+|..     .+++.||+|++...... .+.+.+|+++++.++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4566778999999999999984     36789999998765332 356899999999999999999999886  456689


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence            999999999999998432   34689999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc-------ccchhHHHH
Q 044497          217 HPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS-------KAYFPSWVY  288 (340)
Q Consensus       217 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-------~~~~~~~~~  288 (340)
                      ........ ......+|..|+|||.+.+.  .++.++||||||+++|+|++|+.||........       .........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            65444322 22334578889999999775  678899999999999999999999865432110       000111122


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .....+....      .+..+++.+.+++.+||+.||++|||++++++.|+
T Consensus       255 ~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          255 ELLEEGQRLP------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             HHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhhcccCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            2222222111      12234578999999999999999999999999886

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.2e-46  Score=323.78  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=197.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CC-------cEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TG-------GLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~-------~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      ...|.+.+.||+|+||+||+|... ++       ..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            345677889999999999999755 33       469999986543 334678999999999999999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc--------e
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--------P  206 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~--------~  206 (340)
                      .++||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            99999999999999998432   23489999999999999999999999   9999999999999988877        9


Q ss_pred             EEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHH
Q 044497          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~  286 (340)
                      ||+|||++......      ....+|+.|+|||.+.+. ..++.++||||||+++|+|++|..|+.......       .
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------~  226 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------R  226 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------H
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchH-------H
Confidence            99999998754322      223478899999998763 367889999999999999999655443222111       0


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ............        ...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       227 ~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  272 (289)
T 4fvq_A          227 KLQFYEDRHQLP--------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNS  272 (289)
T ss_dssp             HHHHHHTTCCCC--------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHhhccCCCC--------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            111111111111        1123568899999999999999999999999863

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.2e-45  Score=315.41  Aligned_cols=247  Identities=29%  Similarity=0.460  Sum_probs=194.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcC-CeeEEEEEccC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEG-SKRALVYEYMP  143 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~  143 (340)
                      ..|.+.+.||+|+||.||+|... ++.||+|++.... ..+.+.+|+.+++.++||||+++++++... +..+++|||++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            45667789999999999999875 8899999997654 457889999999999999999999987544 57899999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.......  
T Consensus        99 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           99 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             TEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999984321  22378899999999999999999999   99999999999999999999999999987544322  


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                         ....+++.|+|||.+.+.  .++.++||||||+++|+|+| |+.||.......        .......+....    
T Consensus       172 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~----  234 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMD----  234 (278)
T ss_dssp             -------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCC----
T ss_pred             ---cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCC----
Confidence               233478899999998764  67889999999999999998 999987544321        122222222211    


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        .+..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       235 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  269 (278)
T 1byg_A          235 --APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  269 (278)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence              12234578999999999999999999999999886

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.5e-45  Score=323.03  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=201.9

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEE------cCCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcC
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  132 (340)
                      ++....|.+.+.||+|+||.||+|.+      .++..||+|++.....  ....+.+|+.+++.++||||+++++++...
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            34456677889999999999999973      2567899999965432  235688999999999999999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCce
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKES---RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIP  206 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~  206 (340)
                      ...++||||+++++|.+++.....   ....+++..++.++.|++.||+|||++   +++||||||+||+++.   +..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence            999999999999999999865432   224589999999999999999999999   9999999999999984   4569


Q ss_pred             EEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhH
Q 044497          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPS  285 (340)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~  285 (340)
                      ||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|+| |..||......        
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------  252 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------  252 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------
Confidence            99999998754333322223344578999999998764  67889999999999999998 99998754321        


Q ss_pred             HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          286 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ........+.....      +..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       253 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          253 EVLEFVTSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            12222222222211      1234568899999999999999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.7e-45  Score=316.23  Aligned_cols=243  Identities=21%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... ++..||+|++...    ....+.+.+|+++++.++||||+++++++.+.+..+++||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            4667789999999999999876 6778999998643    2334678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++......
T Consensus        95 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           95 FAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999998843    34689999999999999999999999   9999999999999999999999999998755432


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .    .....|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......        ....+.... .   
T Consensus       168 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~-~---  229 (284)
T 2vgo_A          168 R----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVNVD-L---  229 (284)
T ss_dssp             C----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-C---
T ss_pred             c----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhccc-c---
Confidence            2    2344689999999999875  67889999999999999999999997543211        111111111 1   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ..+..++..+.+++.+||+.||.+|||++++++
T Consensus       230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence               112234578899999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-45  Score=324.97  Aligned_cols=258  Identities=25%  Similarity=0.338  Sum_probs=196.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++......      .+.+.+|+++++.++||||+++++++...+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            45677789999999999999875 6889999999753221      2467899999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||+++ +|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        90 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999975 88887733   335688889999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      .....  ......+|+.|+|||.+.+. ..++.++|||||||++|+|++|.+||........   + ..+..........
T Consensus       163 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~-~~i~~~~~~~~~~  235 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---L-TRIFETLGTPTEE  235 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-HHHHHHHCCCCTT
T ss_pred             cCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---H-HHHHHHcCCCChh
Confidence            43322  22345689999999998653 3578899999999999999999999876542110   0 0011111000000


Q ss_pred             c------------cc-----ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 E------------LR-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~------------~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .            ..     .........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0            00     000112334578999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.1e-44  Score=314.86  Aligned_cols=245  Identities=23%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  102 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL  102 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence            3566789999999999999865 78899999987543  34478999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++.     ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++........
T Consensus       103 ~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          103 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             TTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999883     35689999999999999999999999   999999999999999999999999999976543321


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                        ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......        .............   
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~---  239 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMK--------VLFLIPKNNPPTL---  239 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCC---
T ss_pred             --ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--------HHHHhhcCCCCCC---
Confidence              12345689999999999765  67889999999999999999999987543211        1112222221111   


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ...++..+.+++.+||+.||.+|||+.++++
T Consensus       240 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          240 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             ---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               1233567899999999999999999999976

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6e-45  Score=349.23  Aligned_cols=245  Identities=25%  Similarity=0.419  Sum_probs=197.1

Q ss_pred             hhcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.||+|+||.||+|.+.   +++.||||+++.....   .+++.+|+++++.++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   4578999999764433   3689999999999999999999999975 458899999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc-
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-  223 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  223 (340)
                      |+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999993    345689999999999999999999999   9999999999999999999999999999866543322 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||......        .+...+..+.....   
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~---  593 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGC---  593 (635)
T ss_dssp             --------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCC---
T ss_pred             ccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC---
Confidence            122334467899999999764  78889999999999999998 99999765432        13333433332222   


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         +..++.++.+|+.+||+.||++|||+.++++.|+
T Consensus       594 ---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          594 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence               2234578999999999999999999999999886

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=320.18  Aligned_cols=262  Identities=27%  Similarity=0.422  Sum_probs=203.7

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEE-----cCCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEcCC--ee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KR  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~  135 (340)
                      ...+.+.+.||+|+||.||+|..     .+++.||+|++...... .+.+.+|+++++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            34466778999999999999973     36889999999764332 357899999999999999999999986544  68


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            9999999999999998532   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCcee-eeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccc--------ccccchhHH
Q 044497          216 FHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATR--------SSKAYFPSW  286 (340)
Q Consensus       216 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--------~~~~~~~~~  286 (340)
                      .......... .....++..|+|||.+.+.  .++.++||||||+++|+|+||..|+......        .........
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            7655443222 2233477789999999765  6788999999999999999999887643210        000000111


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....+.......      .+..++.++.+++.+||+.||++|||+.++++.|+
T Consensus       272 ~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~  318 (326)
T 2w1i_A          272 LIELLKNNGRLP------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD  318 (326)
T ss_dssp             HHHHHHTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhcCCCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            122222222211      12234578999999999999999999999999886

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-44  Score=315.51  Aligned_cols=249  Identities=24%  Similarity=0.400  Sum_probs=203.4

Q ss_pred             HHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEc------
Q 044497           59 YPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE------  131 (340)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------  131 (340)
                      ........|.+.+.||+|+||.||+|... +++.||+|++....   +.+.+|+++++.++||||+++++++..      
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            34556677888899999999999999876 78999999987543   467799999999999999999998854      


Q ss_pred             ----------CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          132 ----------GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       132 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                                ....+++|||+++++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||||+||+++
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV  156 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence                      44589999999999999998532  235789999999999999999999999   999999999999999


Q ss_pred             CCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc
Q 044497          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA  281 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~  281 (340)
                      +++.+||+|||++........   .....+|+.|+|||.+.+.  .++.++||||||+++|+|++|..|+....      
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~------  225 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETS------  225 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHHH------
T ss_pred             CCCCEEECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhHH------
Confidence            999999999999986654332   2334589999999999764  67889999999999999999988763211      


Q ss_pred             chhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         . ....+.....         +..++..+.+++.+||+.||.+|||+.|+++.|+
T Consensus       226 ---~-~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          226 ---K-FFTDLRDGII---------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             ---H-HHHHHHTTCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---H-HHHHhhcccc---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence               1 1112222111         1123467889999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-44  Score=322.78  Aligned_cols=256  Identities=21%  Similarity=0.292  Sum_probs=201.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh------------------HHHHHHHHHhcccCCCceeeEe
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG------------------EEFINEVSTIGRIHHVNVVQLL  126 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~------------------~~~~~e~~~l~~l~h~~iv~~~  126 (340)
                      ..|.+.+.||+|+||.||+|.. +++.||+|++.......                  +.+.+|+.+++.++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            3566778999999999999998 89999999986432111                  7899999999999999999999


Q ss_pred             eEEEcCCeeEEEEEccCCCCccccccc----CCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEc
Q 044497          127 GFCSEGSKRALVYEYMPNGSLDRHIFP----KESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       127 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~  201 (340)
                      +++.+.+..++||||+++++|.+++..    .......+++..+..++.|++.||+|||+ +   +++|+||||+||+++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence            999999999999999999999998321    12225679999999999999999999998 8   999999999999999


Q ss_pred             CCCceEEecccCCccCCCCCCceeeeccccCcccccccccccccccccc-ccchhhHHHHHHHHHcCCCCCCCCcccccc
Q 044497          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC-KSDVYGFGMVLLEMAGGRRNSNMHATRSSK  280 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~-~~DvwslG~~l~elltg~~p~~~~~~~~~~  280 (340)
                      .++.++|+|||.+......    ......||..|+|||.+.+. ..++. ++||||||+++|+|++|+.||.......  
T Consensus       187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  259 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--  259 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred             CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence            9999999999999865433    23455699999999998764 23444 8999999999999999999997654311  


Q ss_pred             cchhHHHHHHhhcCCCccccc------------cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          281 AYFPSWVYDQLNKGGDLELRN------------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          . ....+..+.......            .......++..+.+++.+||+.||.+|||+.|+++
T Consensus       260 ----~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 ----E-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ----H-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----H-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                1 111222211100000            00111345678999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-44  Score=317.42  Aligned_cols=245  Identities=23%  Similarity=0.314  Sum_probs=200.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... +++.+|+|++.....    ..+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   95 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE   95 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence            4566789999999999999876 678999999865432    23568899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        96 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           96 LCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             CCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             cCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999999873    235689999999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       .. ....... .   
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~-~~~~~~~-~---  232 (294)
T 2rku_A          169 GE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TY-LRIKKNE-Y---  232 (294)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HH-HHHHTTC-C---
T ss_pred             cc--ccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HH-HHHhhcc-C---
Confidence            22  12344689999999998764  67889999999999999999999997544211       11 1111111 1   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ..+...+..+.+++.+||+.||++|||++++++
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence               111234567899999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=316.25  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ....|.+.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            3455677789999999999999876 68899999997644 346789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++++|.+++..   ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus       106 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          106 CGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999998842   245789999999999999999999999   99999999999999999999999999997654332


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ......|++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       .. ............ 
T Consensus       180 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~-~~~~~~~~~~~~-  246 (314)
T 3com_A          180 A--KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------AI-FMIPTNPPPTFR-  246 (314)
T ss_dssp             S--CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HH-HHHHHSCCCCCS-
T ss_pred             c--ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHH-------HH-HHHhcCCCcccC-
Confidence            1  12344689999999998765  67889999999999999999999997543211       11 111111111111 


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         .+...+..+.+++.+||+.||.+|||+.++++
T Consensus       247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               12234578899999999999999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=314.69  Aligned_cols=250  Identities=23%  Similarity=0.280  Sum_probs=198.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC-----CCChHHHHHHHHHhcccCCCceeeEeeEE--EcCCeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS-----KFSGEEFINEVSTIGRIHHVNVVQLLGFC--SEGSKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~l  137 (340)
                      .|.+.+.||+|+||.||+|... +++.+|+|++...     ....+.+.+|+.+++.++||||+++++++  .+.+..++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            4667789999999999999875 7889999998753     22346789999999999999999999998  44567899


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||++++ |.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            99999776 66666432  245789999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      .............||+.|+|||.+.+.....+.++||||||+++|+|++|+.||......       . ....+..+.. 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~~i~~~~~-  230 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------K-LFENIGKGSY-  230 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------H-HHHHHHHCCC-
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------H-HHHHHhcCCC-
Confidence            543333334455699999999998764344577999999999999999999999754321       1 2222222211 


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .      .+..++..+.+++.+||+.||.+|||+.|+++
T Consensus       231 ~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          231 A------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             C------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             C------CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1      11234567889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=326.86  Aligned_cols=251  Identities=18%  Similarity=0.151  Sum_probs=199.8

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEE------EcCCcEEEEEEccCCCCChHHHHHHHHHhcccC---CCceeeEeeEEEcCC
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQ------LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH---HVNVVQLLGFCSEGS  133 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~  133 (340)
                      ....|.+.+.||+|+||+||+|.      ..+++.||+|++...  ...++..|++++..++   |+|++++++++...+
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            34556677899999999999993      447889999999654  4567788888888886   999999999999999


Q ss_pred             eeEEEEEccCCCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC----------
Q 044497          134 KRALVYEYMPNGSLDRHIFPKES-RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----------  202 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~----------  202 (340)
                      ..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++   +|+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999854222 346799999999999999999999999   9999999999999988          


Q ss_pred             -CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc
Q 044497          203 -NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA  281 (340)
Q Consensus       203 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~  281 (340)
                       ++.+||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+||+.||..........
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  295 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP  295 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCceee
Confidence             899999999999754433333344566799999999999875  68899999999999999999999986443321110


Q ss_pred             chhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHhc
Q 044497          282 YFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADR-PSMTKVLEMLE  339 (340)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-ps~~evl~~L~  339 (340)
                      .           ..   ... .    ..+..+.+++..|++.+|.+| |+++++.+.|+
T Consensus       296 ~-----------~~---~~~-~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          296 E-----------GL---FRR-L----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK  335 (365)
T ss_dssp             C-----------SC---CTT-C----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred             c-----------hh---ccc-c----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence            0           00   000 0    113567789999999999999 57777776664

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-44  Score=325.64  Aligned_cols=256  Identities=21%  Similarity=0.257  Sum_probs=181.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcC------Cee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~  135 (340)
                      +|.+.+.||+|+||.||+|.+. +++.||+|++......   .+.+.+|+.+++.++||||+++++++...      ...
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            4566789999999999999865 7889999999764333   35678999999999999999999998654      567


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++++|++ +++|.+++.     ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++
T Consensus       110 ~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          110 YLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             EEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             EEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            9999999 789988873     25689999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH----------
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS----------  285 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~----------  285 (340)
                      .....     .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........-..+..          
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            64332     2345689999999998763 3678899999999999999999999976543110000000          


Q ss_pred             ------HHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 ------WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            ........-...............++.+.+|+.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                  000000000000000111112234578999999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.6e-44  Score=320.47  Aligned_cols=260  Identities=20%  Similarity=0.253  Sum_probs=196.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEc--------C
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSE--------G  132 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~  132 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++.....   ....+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            35677899999999999999874 789999999865432   23578899999999999999999999876        4


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      +..++||||+++ +|.+.+..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            468999999965 77666632   234689999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCC--ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          213 LAKFHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       213 ~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      ++........  ........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........    ...+...
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~  244 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQL  244 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHH
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHH
Confidence            9986543221  1122445689999999998753 3578899999999999999999999976443211    0001110


Q ss_pred             hhcCCCc----------------cccccchhhH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          291 LNKGGDL----------------ELRNVTEIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       291 ~~~~~~~----------------~~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .......                ..........     ..++.+.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0000000                0000000111     12467899999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-44  Score=321.32  Aligned_cols=255  Identities=21%  Similarity=0.306  Sum_probs=199.4

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---------ChHHHHHHHHHhcccCCCceeeEeeEEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---------SGEEFINEVSTIGRIHHVNVVQLLGFCS  130 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~  130 (340)
                      ......|.+.+.||+|+||.||+|... +++.||+|++.....         ....+.+|+++++.++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            344567888899999999999999875 678999999865432         1234789999999999999999999997


Q ss_pred             cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc---eE
Q 044497          131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PK  207 (340)
Q Consensus       131 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~---~k  207 (340)
                      ..+ .++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +|
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred             CCc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence            765 899999999999999883    345789999999999999999999999   9999999999999987654   99


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW  286 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~  286 (340)
                      |+|||++........   .....||+.|+|||.+.+ ....++.++||||||+++|+|++|..||.......   .    
T Consensus       158 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~----  227 (322)
T 2ycf_A          158 ITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---S----  227 (322)
T ss_dssp             ECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---C----
T ss_pred             EccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---H----
Confidence            999999986543321   223458999999999742 12367889999999999999999999997544321   1    


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....+..+...   ........++..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 LKDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHHTCCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCccc---cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11122222111   011222345678999999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.6e-44  Score=322.74  Aligned_cols=256  Identities=21%  Similarity=0.213  Sum_probs=190.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCC------ee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGS------KR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~  135 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.......   +.+.+|+.+++.++||||+++++++...+      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            4566789999999999999865 78899999997644332   56789999999999999999999997655      78


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++||||++ ++|.+.+.      ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus       106 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          106 YIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             EEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            99999996 47877772      3488999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc--------c-----
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA--------Y-----  282 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--------~-----  282 (340)
                      ......   ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||........-.        .     
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -----------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccc---ccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            654322   12345689999999999875  67889999999999999999999997654311000        0     


Q ss_pred             --hhHHHHHHhhcCCC------------ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          283 --FPSWVYDQLNKGGD------------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       283 --~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        +.............            .............+.++.+|+.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence              00000011111000            0011112233455788999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-44  Score=323.03  Aligned_cols=246  Identities=23%  Similarity=0.306  Sum_probs=201.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..|.+.+.||+|+||.||++... +++.+|+|++.....    ..+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            34666789999999999999876 678999999875432    2356889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       121 e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          121 ELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             CCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999873    235689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       .. ........ . 
T Consensus       194 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~-~~~~~~~~-~-  259 (335)
T 2owb_A          194 DGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TY-LRIKKNEY-S-  259 (335)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HH-HHHHHTCC-C-
T ss_pred             Ccc--cccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HH-HHHhcCCC-C-
Confidence            322  12345689999999999765  67889999999999999999999997543211       11 11111111 1 


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           .+..++..+.+++.+||+.||++|||+.|+++
T Consensus       260 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 -----IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 11234467889999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-44  Score=325.26  Aligned_cols=261  Identities=18%  Similarity=0.224  Sum_probs=198.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcC-----CeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l  137 (340)
                      +|.+.+.||+|+||.||+|... ++..||+|++......  .+.+.+|+++++.++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            4667789999999999999866 7788999999754332  25788999999999999999999998654     36899


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +||++. ++|.+++.     ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          108 VQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            999996 58988883     24689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHH--------H-
Q 044497          218 PKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSW--------V-  287 (340)
Q Consensus       218 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~--------~-  287 (340)
                      ....... ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||...........+...        . 
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            4332211 12344699999999987653 35788999999999999999999999765432211100000        0 


Q ss_pred             -------HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          288 -------YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       288 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                             ......................+.++.+|+.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   0000000000000111122334678999999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-44  Score=312.66  Aligned_cols=245  Identities=23%  Similarity=0.356  Sum_probs=193.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4567789999999999999876 7899999998643    2344678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++......
T Consensus        92 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           92 YVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             ccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999843    34688999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..   .....+++.|+|||.+.+. ...+.++||||||+++|+|++|+.||......        .....+..+...   
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~---  229 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGGVFY---  229 (276)
T ss_dssp             ---------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC---
T ss_pred             cc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcCccc---
Confidence            21   2334589999999998764 23467999999999999999999998754321        122222222111   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          .+...+..+.+++.+||+.||.+|||+.++++
T Consensus       230 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          230 ----IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                11223467899999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-44  Score=347.24  Aligned_cols=245  Identities=23%  Similarity=0.272  Sum_probs=201.6

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..|++.+.||+|+||.||+|... +++.||+|++++.    ....+.+..|..++..+ +||+|+++++++.+.+..|+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            34566789999999999999876 6788999998752    33446788999999988 799999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       421 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999843    35689999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......       . ....+....   
T Consensus       494 ~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~~---  558 (674)
T 3pfq_A          494 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------E-LFQSIMEHN---  558 (674)
T ss_dssp             CTTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHSSC---
T ss_pred             cCCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHH-------H-HHHHHHhCC---
Confidence            3222  23456799999999999765  7889999999999999999999999764431       1 222222211   


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCH-----HHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSM-----TKVL  335 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~evl  335 (340)
                          ..++..++.++.+|+.+||+.||++||++     +|++
T Consensus       559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence                11223456789999999999999999997     6665

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-44  Score=330.19  Aligned_cols=199  Identities=25%  Similarity=0.321  Sum_probs=170.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc------CCCceeeEeeEEEcCCeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI------HHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~  136 (340)
                      ..+|.+.+.||+|+||.||+|... +++.||+|++.......+.+.+|+.+++.+      +|+||+++++++...+..+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            345677899999999999999766 688999999987654456778888888877      5779999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc--eEEecccCC
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLA  214 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~--~kl~Dfg~~  214 (340)
                      +|||++. ++|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.  +||+|||++
T Consensus       176 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            9999995 68988885432  34589999999999999999999999   9999999999999999887  999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCc
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHA  275 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~  275 (340)
                      .......     ....||+.|+|||++.+.  .++.++|||||||++|||++|++||....
T Consensus       250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQRV-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTCCC-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCcc-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            7544322     344689999999999875  67899999999999999999999997654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-45  Score=331.01  Aligned_cols=261  Identities=18%  Similarity=0.188  Sum_probs=194.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEc------------
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE------------  131 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------  131 (340)
                      .+|.+.+.||+|+||.||+|... +++.||+|++..+...   ..+|+.+++.++||||+++++++..            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            35667799999999999999864 7899999998755332   2379999999999999999999843            


Q ss_pred             --------------------------CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 044497          132 --------------------------GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD  185 (340)
Q Consensus       132 --------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~  185 (340)
                                                ....++||||++ ++|.+.+......+..+++..+..++.|++.||+|||++  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                      334889999997 587777644334456799999999999999999999999  


Q ss_pred             CCeeecCCCCCCeeEc-CCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHH
Q 044497          186 VCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM  264 (340)
Q Consensus       186 ~~ivH~dik~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~el  264 (340)
                       +++||||||+||+++ .++.+||+|||++........   .....+|+.|+|||.+.+. ..++.++||||+||++|+|
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHH
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHH
Confidence             999999999999997 688999999999986544332   2344589999999998764 3578899999999999999


Q ss_pred             HcCCCCCCCCcccccccch--------hHHHHHHhhcCCCcccc------ccchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 044497          265 AGGRRNSNMHATRSSKAYF--------PSWVYDQLNKGGDLELR------NVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (340)
Q Consensus       265 ltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  330 (340)
                      ++|+.||........-..+        .................      .....+...+.++.+|+.+||+.||++|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999765432110000        00000000000000000      001122335678999999999999999999


Q ss_pred             HHHHHH
Q 044497          331 MTKVLE  336 (340)
Q Consensus       331 ~~evl~  336 (340)
                      +.|+++
T Consensus       316 ~~e~l~  321 (383)
T 3eb0_A          316 PYEAMA  321 (383)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999984

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-44  Score=330.17  Aligned_cols=271  Identities=22%  Similarity=0.276  Sum_probs=207.3

Q ss_pred             CCCCCHHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC--------CCceee
Q 044497           54 PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH--------HVNVVQ  124 (340)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~  124 (340)
                      ...+...++....|.+.+.||+|+||+||+|... +++.||+|++.......+.+.+|+.+++.++        |+||++
T Consensus        26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            3455566666677888999999999999999865 6889999999866555577889999999985        788999


Q ss_pred             EeeEEE----cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE
Q 044497          125 LLGFCS----EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (340)
Q Consensus       125 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill  200 (340)
                      +++++.    .....++||||+ +++|.+.+...  ....+++..+..++.|++.||+|||+++  +|+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll  180 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL  180 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEE
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeE
Confidence            999987    566899999999 66776666432  2356899999999999999999999841  79999999999999


Q ss_pred             cCCC-------------------------------------------------ceEEecccCCccCCCCCCceeeecccc
Q 044497          201 DHNF-------------------------------------------------IPKVSDFGLAKFHPKENDFVSISATRG  231 (340)
Q Consensus       201 ~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g  231 (340)
                      +.++                                                 .+||+|||++.......     ....|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~g  255 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQ  255 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCS
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCC
Confidence            8775                                                 79999999998654332     33468


Q ss_pred             CccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh--HHHHHHhhc--------CCCc----
Q 044497          232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP--SWVYDQLNK--------GGDL----  297 (340)
Q Consensus       232 ~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~--------~~~~----  297 (340)
                      |+.|+|||++.+.  .++.++|||||||++|+|++|+.||.............  .........        +...    
T Consensus       256 t~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          256 TRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             CGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            9999999999875  67889999999999999999999998655433211100  000000000        0000    


Q ss_pred             -------cc------------cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 -------EL------------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 -------~~------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                             ..            ......+...+..+.+|+.+||+.||++|||++|+++
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                   00            0001234567788999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=329.69  Aligned_cols=260  Identities=16%  Similarity=0.126  Sum_probs=200.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcC---------CcEEEEEEccCCCCChHHHHHHHHHhcccCCCceee----------
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHT---------GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQ----------  124 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~----------  124 (340)
                      ...|.+.+.||+|+||.||+|....         ++.||+|++...    +.+.+|+++++.++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            3567788999999999999998763         789999998754    46789999999999999987          


Q ss_pred             -----EeeEEEc-CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          125 -----LLGFCSE-GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       125 -----~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                           +++++.. .+..++||||+ +++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI  190 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI  190 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence                 5667665 77899999999 99999999532  136799999999999999999999999   999999999999


Q ss_pred             eEcCCC--ceEEecccCCccCCCCCCce-----eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCC
Q 044497          199 LLDHNF--IPKVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  271 (340)
Q Consensus       199 ll~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~  271 (340)
                      +++.++  .+||+|||+++.........     ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999998  99999999997654322111     11334699999999999875  6788999999999999999999999


Q ss_pred             CCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          272 NMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .......  ..+....... .... ............++..+.+++.+||+.||++|||++++++.|+
T Consensus       269 ~~~~~~~--~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  332 (352)
T 2jii_A          269 TNCLPNT--EDIMKQKQKF-VDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE  332 (352)
T ss_dssp             GGGTTCH--HHHHHHHHHH-HHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             ccCCcCH--HHHHHHHHhc-cCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence            7654221  1111111111 1111 1111111111123578999999999999999999999999886

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=313.35  Aligned_cols=248  Identities=25%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      ..||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            48999999999999865 688999999876433 3467899999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccCCccCCCCCCceeee
Q 044497          149 RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSIS  227 (340)
Q Consensus       149 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (340)
                      +++.... ....+++..+..++.|++.||+|||++   +++|+||||+||+++. ++.+||+|||++........  ...
T Consensus       108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~  181 (295)
T 2clq_A          108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTE  181 (295)
T ss_dssp             HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred             HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--ccc
Confidence            9985432 234567899999999999999999999   9999999999999987 89999999999986543321  123


Q ss_pred             ccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhH
Q 044497          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES  307 (340)
Q Consensus       228 ~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (340)
                      ...||+.|+|||.+.+....++.++||||||+++|+|++|+.||.......      .............      ..+.
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~------~~~~  249 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMFKVHP------EIPE  249 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHHCCCC------CCCT
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhccccccc------cccc
Confidence            446899999999987643347889999999999999999999986433211      0011111111111      1222


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          308 MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       308 ~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .++.++.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            34578899999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.9e-45  Score=318.86  Aligned_cols=260  Identities=22%  Similarity=0.310  Sum_probs=184.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            34567789999999999999754 78899999987543  2346788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          142 MPNGSLDRHIFPK----ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       142 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +++++|.+++...    ......+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            9999999988431    12345689999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCc---eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          218 PKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       218 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      ......   .......||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.......       .........
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~  243 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQND  243 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTSS
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhccC
Confidence            433211   112334689999999998652 256889999999999999999999997654321       011111111


Q ss_pred             CCccccc---cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 GDLELRN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      . .....   .......++.++.+++.+||+.||.+|||+.++++
T Consensus       244 ~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 P-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             C-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             C-CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1 00000   01111234567899999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=324.01  Aligned_cols=260  Identities=26%  Similarity=0.331  Sum_probs=200.2

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEE----cCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv  138 (340)
                      ..|.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+++++.++||||+++++++.    .....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4567788999999999999987 478999999886533 23467889999999999999999999986    34578999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++++|.+++.........+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999999998865444457799999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCc-------eeeeccccCccccccccccccc-cccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          219 KENDF-------VSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       219 ~~~~~-------~~~~~~~g~~~y~aPE~~~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      .....       .......||+.|+|||.+.+.. ..++.++||||||+++|+|++|+.||........  .    ....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~----~~~~  259 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--S----VALA  259 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--C----HHHH
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--h----hhHH
Confidence            21110       0011234799999999986531 2467899999999999999999999864221110  0    1111


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ......  ...    ....+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       260 ~~~~~~--~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          260 VQNQLS--IPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             HHCC----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hhccCC--CCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            111111  111    1234568999999999999999999999999885

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.5e-44  Score=322.78  Aligned_cols=255  Identities=22%  Similarity=0.298  Sum_probs=194.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCee------
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKR------  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------  135 (340)
                      +|.+.+.||+|+||.||+|.+. +++.||+|++.......   +.+.+|+.+++.++||||+++++++...+..      
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            4556788999999999999865 78899999997654443   5688999999999999999999999877665      


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      ++||||+. ++|.+.+      ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus       123 ~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             EEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             EEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            99999996 6887776      23489999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-----------
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-----------  284 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-----------  284 (340)
                      .....     .....+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+.           
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            54332     2345689999999998763 367889999999999999999999997644211000000           


Q ss_pred             -----HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 -----SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           .........................++.+.+|+.+||+.||++|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                 0000000000001111111222334688999999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-44  Score=326.30  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...|.+.+.||+|+||.||+|... ++..||+|++......  .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            445677789999999999999876 7889999998765322  3578899999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+ +   +++||||||+||+++.++.+||+|||++.....
T Consensus       112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999832    3468999999999999999999998 5   799999999999999999999999999864322


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc-----------------
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-----------------  282 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-----------------  282 (340)
                      .    ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||...........                 
T Consensus       185 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          185 S----MANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             H----C----CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             c----cccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            1    12334689999999999875  678899999999999999999999976443211000                 


Q ss_pred             ------------------hhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          283 ------------------FPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       283 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                        ..... ...........     ....++.++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELL-DYIVNEPPPKL-----PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------------CCCHHHHH-HHHHHSCCCCC-----CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCcccccccCCCCcccchhhh-hHHhccCCCCC-----CcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                              00000 00111110000     01123568999999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.8e-44  Score=318.15  Aligned_cols=256  Identities=18%  Similarity=0.272  Sum_probs=198.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEc--CCeeEEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYE  140 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e  140 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++...  ..+.+.+|+.+++.++ ||||+++++++.+  ....+++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            45667789999999999999864 7889999998743  4578899999999997 9999999999987  667899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCccCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPK  219 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~~~  219 (340)
                      |+++++|.+++       ..+++..+..++.|++.||+|||++   +++||||||+|||++.++ .+||+|||++.....
T Consensus       114 ~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          114 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999887       2478899999999999999999999   999999999999999776 899999999986554


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch------hHHHHHHhhc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF------PSWVYDQLNK  293 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~------~~~~~~~~~~  293 (340)
                      ...   .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||............      .....+.+..
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            332   2344689999999998763 36788999999999999999999999543321100000      0000011111


Q ss_pred             CC---------------Cccc--cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 GG---------------DLEL--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ~~---------------~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..               ....  .........+++++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00               0000  0001112235678999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-45  Score=332.97  Aligned_cols=242  Identities=17%  Similarity=0.143  Sum_probs=184.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE-cCCcEEEEEEccCC----CCChHHHHHHHH---HhcccCCCceeeEe-------eEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANS----KFSGEEFINEVS---TIGRIHHVNVVQLL-------GFCS  130 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~---~l~~l~h~~iv~~~-------~~~~  130 (340)
                      .|.+.+.||+|+||.||+|.+ .+++.||+|++...    ....+.+.+|+.   .++.++||||++++       +++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            345568999999999999986 47899999999643    223367889994   55555899999998       6666


Q ss_pred             cCCe-----------------eEEEEEccCCCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 044497          131 EGSK-----------------RALVYEYMPNGSLDRHIFPKES---RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH  190 (340)
Q Consensus       131 ~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH  190 (340)
                      +.+.                 .+++|||+ +|+|.+++.....   ....+++..+..++.|++.||+|||++   +|+|
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  229 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  229 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            5532                 78999999 6899999853211   112344688889999999999999999   9999


Q ss_pred             cCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcccccccccccc---------ccccccccchhhHHHHH
Q 044497          191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVL  261 (340)
Q Consensus       191 ~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~~DvwslG~~l  261 (340)
                      |||||+|||++.++.+||+|||+++....     ......| +.|+|||.+.+.         ...++.++|||||||++
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            99999999999999999999999985332     2234457 999999998763         11578899999999999


Q ss_pred             HHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          262 LEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       262 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      |+|++|+.||...........        ....           ...+++++.+|+.+||+.||.+|||+.|+++
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~--------~~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEW--------IFRS-----------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHSSCCC------CCSGG--------GGSS-----------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHCCCCCcccccccchhh--------hhhh-----------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999975443221110        0000           0123468899999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.1e-44  Score=320.94  Aligned_cols=261  Identities=21%  Similarity=0.265  Sum_probs=195.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcC-----CeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l  137 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++......  ...+.+|+.+++.++||||+++++++...     ...++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   91 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI   91 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence            4566789999999999999876 7889999999754332  24678999999999999999999987654     67899


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      +|||+. ++|.+++..     ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        92 v~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           92 IQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            999996 689888732     4689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCce--------eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch------
Q 044497          218 PKENDFV--------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF------  283 (340)
Q Consensus       218 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~------  283 (340)
                      .......        ......||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            4322111        12234689999999987643 36788999999999999999999999765421100000      


Q ss_pred             -----------hHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          284 -----------PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       284 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                 .....+...................+++++.+|+.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                       00000000000000001111122345678999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=326.31  Aligned_cols=264  Identities=19%  Similarity=0.265  Sum_probs=181.4

Q ss_pred             hhh-hhhcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEE--cCCeeEEEEE
Q 044497           67 NHF-THKLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYE  140 (340)
Q Consensus        67 ~~~-~~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e  140 (340)
                      |.+ .++||+|+||+||+|...   +++.||+|++..... ...+.+|+.+++.++||||+++++++.  .....++|||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e  100 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD  100 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence            444 358999999999999865   578899999976543 357889999999999999999999994  4778999999


Q ss_pred             ccCCCCcccccccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE----cCCCceEEecc
Q 044497          141 YMPNGSLDRHIFPKE-----SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDF  211 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill----~~~~~~kl~Df  211 (340)
                      |+. ++|.+++....     .....+++..+..++.|++.||+|||++   +|+||||||+|||+    +.++.+||+||
T Consensus       101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A          101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            995 57777664211     1233589999999999999999999999   99999999999999    67889999999


Q ss_pred             cCCccCCCCCC-ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc--ccchhHHHH
Q 044497          212 GLAKFHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS--KAYFPSWVY  288 (340)
Q Consensus       212 g~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~--~~~~~~~~~  288 (340)
                      |+++....... ........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........  .......+.
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            99986643321 1223445689999999998764 3578899999999999999999999975543210  000001111


Q ss_pred             HHhhc---CCCcccc--------------------ccchhhH-------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 DQLNK---GGDLELR--------------------NVTEIES-------MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ~~~~~---~~~~~~~--------------------~~~~~~~-------~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..   .......                    .......       ..+..+.+|+.+||+.||.+|||++|+++
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11100   0000000                    0000000       01467889999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.8e-44  Score=315.49  Aligned_cols=252  Identities=24%  Similarity=0.306  Sum_probs=192.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEc------------
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE------------  131 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------------  131 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++.......+.+.+|+.+++.++||||+++++++.+            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            45677899999999999999875 78899999997655445678999999999999999999998754            


Q ss_pred             -CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEec
Q 044497          132 -GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       132 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~D  210 (340)
                       .+..++||||+++++|.+++..   ....+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence             4568999999999999999853   235678899999999999999999999   999999999999999999999999


Q ss_pred             ccCCccCCCCCC------------ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccc
Q 044497          211 FGLAKFHPKEND------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS  278 (340)
Q Consensus       211 fg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~  278 (340)
                      ||++........            ........||+.|+|||.+.+. +.++.++||||||+++|+|++   ||.....  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~--  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME--  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence            999986543211            1112344589999999998753 367889999999999999998   4432111  


Q ss_pred             cccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          279 SKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                           .......+..... .  .........+..+.+++.+||+.||.+|||+.++++
T Consensus       234 -----~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 -----RVNILKKLRSVSI-E--FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -----HHHHHHHHHSTTC-C--CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----HHHHHHhcccccc-c--cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                 0111112222111 1  111222344567899999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-44  Score=316.20  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=195.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEc------CCeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSE------GSKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~l  137 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.......+.+.+|+.+++.+ +||||+++++++..      .+..++
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            4566789999999999999875 788999999987766778899999999999 79999999999976      567899


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||+++++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            99999999999998543  235689999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG  294 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (340)
                      .....  ......||+.|+|||.+...   ...++.++||||||+++|+|++|+.||.......       ... .....
T Consensus       180 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~-~~~~~  249 (326)
T 2x7f_A          180 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALF-LIPRN  249 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHH-HHHHS
T ss_pred             CcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHH-HhhcC
Confidence            43221  12334689999999998631   2367889999999999999999999986543211       111 11111


Q ss_pred             CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......     ...++..+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          250 PAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCCCS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccCC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111     1123468899999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.6e-44  Score=313.72  Aligned_cols=251  Identities=20%  Similarity=0.218  Sum_probs=200.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----------ChHHHHHHHHHhcccC-CCceeeEeeEEEcC
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----------SGEEFINEVSTIGRIH-HVNVVQLLGFCSEG  132 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  132 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++.....          ..+.+.+|+.+++.+. ||||+++++++...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            34566789999999999999876 688999999875431          1245789999999995 99999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      +..++||||+++++|.+++..    ...+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999842    35689999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCcccccccccccc----ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHH
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY  288 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  288 (340)
                      ++........   .....+++.|+|||.+.+.    ...++.++||||||+++|+|++|+.||.......        ..
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~  238 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------ML  238 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HH
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--------HH
Confidence            9986554332   2344689999999998531    2357789999999999999999999996543211        11


Q ss_pred             HHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..+....   .......++..+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 RMIMSGNYQF---GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHTCCCC---CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCCccc---CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1222211110   01112235578999999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.2e-44  Score=322.33  Aligned_cols=265  Identities=25%  Similarity=0.238  Sum_probs=188.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCe-------e
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-------R  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------~  135 (340)
                      -..|.+.+.||+|+||.||+|... +++.||+|++..+........++++.+..++||||+++++++.....       .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            345667799999999999999875 78899999997766666677888999999999999999999865333       7


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeeecCCCCCCeeEcC-CCceEEeccc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH--NGCDVCILHFDIKPHNILLDH-NFIPKVSDFG  212 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg  212 (340)
                      ++||||+++ +|.+.+.........+++..+..++.|++.||+|||  ++   +++||||||+|||++. ++.+||+|||
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            899999965 555444322234567889999999999999999999  77   9999999999999996 8999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------H
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------S  285 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------~  285 (340)
                      ++........   .....||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+.       .
T Consensus       178 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          178 SAKKLSPSEP---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             TCBCCCTTSC---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             CceecCCCCC---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            9986654332   2344689999999998654 357889999999999999999999997654321100000       0


Q ss_pred             HHHHHhhc-CCCccccc--cc-------hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 WVYDQLNK-GGDLELRN--VT-------EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 ~~~~~~~~-~~~~~~~~--~~-------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ........ ........  ..       ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000000 00000000  00       011114678999999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-44  Score=323.81  Aligned_cols=260  Identities=20%  Similarity=0.217  Sum_probs=190.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC------------hHHHHHHHHHhcccCCCceeeEeeEEE---
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS------------GEEFINEVSTIGRIHHVNVVQLLGFCS---  130 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~~~---  130 (340)
                      .|.+.+.||+|+||.||+|...+++.||+|++......            .+.+.+|+++++.++||||+++++++.   
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE  102 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred             ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence            45567899999999999999888999999998653322            167899999999999999999999984   


Q ss_pred             --cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEE
Q 044497          131 --EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (340)
Q Consensus       131 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl  208 (340)
                        .....++||||++ ++|.+.+..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||
T Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A          103 EPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             TTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEE
Confidence              3346899999996 688877742   345789999999999999999999999   9999999999999999999999


Q ss_pred             ecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhH---
Q 044497          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS---  285 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~---  285 (340)
                      +|||++........   .....+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+..   
T Consensus       176 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (362)
T 3pg1_A          176 CDFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG  251 (362)
T ss_dssp             CCTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999975433322   2344689999999998763 3678899999999999999999999976542211000000   


Q ss_pred             -------------HHHHHhhcC-CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          286 -------------WVYDQLNKG-GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       286 -------------~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                   ......... ...............++.+.+|+.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                         000000000 000011111222334678999999999999999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-43  Score=309.88  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=193.0

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc--CCc--EEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCee
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH--TGG--LIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~--~~~--~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  135 (340)
                      ...|.+.+.||+|+||.||+|.+.  +++  .||+|++.....    ..+.+.+|+++++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            345677899999999999999753  233  689999876432    2357889999999999999999999998765 8


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +++|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            8999999999999998432   35689999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhc
Q 044497          216 FHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       216 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      ......... ......+|..|+|||.+.+.  .++.++||||||+++|+|++ |+.||......       .........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~  240 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKE  240 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTS
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------HHHHHHHcc
Confidence            765443322 22334578899999999765  67889999999999999999 99999754321       112222222


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .....      .+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       241 ~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          241 GERLP------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             CCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCC------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            11111      11234578999999999999999999999999886

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-43  Score=309.89  Aligned_cols=252  Identities=25%  Similarity=0.325  Sum_probs=203.5

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC---CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS---KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      .....+|.+.+.||+|+||.||+|... +++.||+|++...   ....+.+.+|+++++.++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            445567888899999999999999876 7889999998653   234578899999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC---CceEEecccC
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGL  213 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~---~~~kl~Dfg~  213 (340)
                      ++||++++++|.+++..    ...+++..+..++.|++.||+|||++   +++|+||||+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            99999999999988843    34689999999999999999999999   99999999999999754   4799999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      +........   .....+|+.|+|||.+.+   .++.++||||||+++|+|++|+.||......       . ....+..
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~~~~~~  236 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------D-ILKRVET  236 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHH
T ss_pred             ceeecCCCc---cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHc
Confidence            986544332   123358899999999865   4778999999999999999999999754321       1 1222222


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +....   .......++.++.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          237 GKYAF---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCCC---CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCC---CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            21110   01111234578999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.5e-45  Score=328.95  Aligned_cols=252  Identities=10%  Similarity=0.019  Sum_probs=178.8

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhccc--CCCceeeEe-------eEEEcC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRI--HHVNVVQLL-------GFCSEG  132 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l--~h~~iv~~~-------~~~~~~  132 (340)
                      |.+.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.++..+  +||||++++       +++...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            566789999999999999876 7889999999875542    24567785544444  699988755       444332


Q ss_pred             -----------------CeeEEEEEccCCCCcccccccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCee
Q 044497          133 -----------------SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKL------HEVALGTARGIEYLHNGCDVCIL  189 (340)
Q Consensus       133 -----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~i~~~i~~~l~~Lh~~~~~~iv  189 (340)
                                       ...++||||++ ++|.+++...   +..+.+..+      ..++.|++.||+|||++   +|+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv  216 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV  216 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence                             34799999998 8999998543   123344455      67889999999999999   999


Q ss_pred             ecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCC
Q 044497          190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  269 (340)
Q Consensus       190 H~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~  269 (340)
                      ||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||.+.+....++.++|||||||++|+|++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999865321     12445779999999997633478899999999999999999999


Q ss_pred             CCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          270 NSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       270 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ||..............    ...........  ......+++.+.+|+.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRP----SLRVPGTDSLA--FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCCBC----CTTSCCCCSCC--CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchhhh----hhhhccccccc--hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9987643321110000    00000000000  0111234678999999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-43  Score=328.56  Aligned_cols=257  Identities=19%  Similarity=0.256  Sum_probs=202.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCC-CceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|.+.+.||+|+||.||+|.+. +++.||||++..... ..++..|+++++.++| +++..+..++...+..++||||+ 
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            4667789999999999999864 788999998765443 2457899999999976 56666677778888899999999 


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE---cCCCceEEecccCCccCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill---~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      +++|.+++..   ....+++..++.++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        86 g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           86 GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            9999999843   245699999999999999999999999   99999999999999   68899999999999865543


Q ss_pred             CCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          221 NDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       221 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ...     .......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+..........  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~--  235 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT--  235 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS--
T ss_pred             ccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc--
Confidence            321     112345699999999999875  67889999999999999999999998755433222111111111110  


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           ........++.++.+++.+||+.+|++||++.+|++.|+
T Consensus       236 -----~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          236 -----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             -----CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             -----cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence                 011222334678999999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.6e-44  Score=328.66  Aligned_cols=261  Identities=21%  Similarity=0.213  Sum_probs=192.7

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCC------eeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv  138 (340)
                      .+|.+.+.||+|+||+||+|....+..+|+|++......   ..+|+++++.++||||+++++++....      ..++|
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            356778899999999999999877777999988654322   237999999999999999999985433      37899


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-CCCceEEecccCCccC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFH  217 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-~~~~~kl~Dfg~~~~~  217 (340)
                      |||++++ +.+.+.........+++..+..++.|++.||+|||++   +|+||||||+|||++ .++.+||+|||+++..
T Consensus       117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999764 4333322222356789999999999999999999999   999999999999999 7999999999999865


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh--------HHHHH
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP--------SWVYD  289 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~  289 (340)
                      .....   .....+|+.|+|||++.+. ..++.++||||+||++|+|++|+.||........-..+.        .....
T Consensus       193 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGEP---NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CTTCC---CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCCC---CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            44332   2344689999999998664 357889999999999999999999998654321100000        00000


Q ss_pred             HhhcCCCcccc--c----cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNKGGDLELR--N----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~~~~~~~~--~----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...........  .    ...+....++++.+|+.+||+.||.+|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            00000000000  0    01122235678999999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.6e-44  Score=314.34  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=196.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      ..|.+.+.||+|+||.||+|... +++.+|+|++.... ...+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            34667789999999999999876 68899999987543 34578899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++++|.+++..   ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++....... 
T Consensus        99 ~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           99 PGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            99999988743   235689999999999999999999999   99999999999999999999999999875321110 


Q ss_pred             ceeeeccccCccccccccccc---cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          223 FVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                       .......||+.|+|||.+..   ....++.++||||||+++|+|++|+.||......       ...... ........
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~-~~~~~~~~  242 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKI-AKSDPPTL  242 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHH-HHSCCCCC
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHH-hccCCccc
Confidence             01123458999999999842   1236778999999999999999999998754421       111111 11111111


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .    .+..++..+.+++.+||+.||.+|||+.++++
T Consensus       243 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 L----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             S----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             C----CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1    12234578899999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.3e-43  Score=309.82  Aligned_cols=252  Identities=20%  Similarity=0.287  Sum_probs=193.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCCh---HHHHHHHHHhcccC--CCceeeEeeEEEcCCeeEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ...|.+.+.||+|+||.||++...+++.||+|++.......   +.+.+|+.++..++  ||||+++++++...+..+++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            34466778999999999999998889999999997654433   56889999999997  59999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      || +.+++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||++++ +.+||+|||++....
T Consensus       107 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          107 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             Ee-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            99 558899999843    35789999999999999999999999   9999999999999965 899999999998665


Q ss_pred             CCCCceeeeccccCcccccccccccc---------ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH
Q 044497          219 KENDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      ............||+.|+|||.+.+.         ...++.++||||||+++|+|++|+.||......      ......
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~  251 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHA  251 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHH
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHHH
Confidence            44332223345689999999998641         125778999999999999999999999654321      111122


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...........      ...+.++.+++.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          252 IIDPNHEIEFP------DIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHCTTSCCCCC------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhcccccCCc------ccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            22221111111      112467899999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.2e-44  Score=317.47  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=201.2

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEE-c-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCc------eeeEeeEEEcCCe
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQL-H-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN------VVQLLGFCSEGSK  134 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~-~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~  134 (340)
                      ...+|.+.+.||+|+||.||+|.+ . +++.||+|++.......+.+.+|+.+++.++|++      ++++++++...+.
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            345677889999999999999986 3 6789999999765544567889999999987654      9999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC------------
Q 044497          135 RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH------------  202 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~------------  202 (340)
                      .++||||+ +++|.+++....  ..++++..+..++.|++.||+|||++   +++||||||+||+++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 889999885432  24688999999999999999999999   9999999999999987            


Q ss_pred             -------CCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCc
Q 044497          203 -------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHA  275 (340)
Q Consensus       203 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~  275 (340)
                             ++.+||+|||++.......     ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||....
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                   6689999999998654322     344689999999999865  67889999999999999999999997654


Q ss_pred             ccccccch-------hHHHHHHhhcCC----------------------CccccccchhhHHHHHHHHHHHhhcccCCCC
Q 044497          276 TRSSKAYF-------PSWVYDQLNKGG----------------------DLELRNVTEIESMIARKLCMIGLWCIQVKAA  326 (340)
Q Consensus       276 ~~~~~~~~-------~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~  326 (340)
                      .......+       +...........                      ..............++++.+|+.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            32110000       000000000000                      0000000111234567899999999999999


Q ss_pred             CCCCHHHHHH
Q 044497          327 DRPSMTKVLE  336 (340)
Q Consensus       327 ~Rps~~evl~  336 (340)
                      +|||+.|+++
T Consensus       319 ~Rpt~~ell~  328 (339)
T 1z57_A          319 KRITLREALK  328 (339)
T ss_dssp             TSCCHHHHTT
T ss_pred             cccCHHHHhc
Confidence            9999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=315.71  Aligned_cols=255  Identities=22%  Similarity=0.308  Sum_probs=192.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCe------e
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSK------R  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~  135 (340)
                      +|.+.+.||+|+||.||+|... +|+.||+|++.......   +.+.+|+.+++.++||||+++++++...+.      .
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            4556789999999999999875 78899999997654332   567899999999999999999999987654      4


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +++|||+. ++|.+++      ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus       105 ~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          105 YLVMPFMQ-TDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             EEEEECCS-EEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEecccc-CCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            99999996 6888777      23589999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch--------hHH-
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF--------PSW-  286 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------~~~-  286 (340)
                      .....     .....+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||........-..+        ..+ 
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            54332     2334689999999998763 36788999999999999999999999764421100000        000 


Q ss_pred             -------HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 -------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                             .......................+.++.+|+.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   00000000000000111222345678999999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.2e-43  Score=308.17  Aligned_cols=254  Identities=22%  Similarity=0.316  Sum_probs=186.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ..|.+.+.||+|+||.||+|... +++.||+|++.......   +.+.++...++.++||||+++++++.+.+..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            45667789999999999999874 78899999997654332   234455556888899999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |++ ++|.+++.........+++..+..++.|++.||+|||++  .+++||||||+||+++.++.+||+|||++......
T Consensus        87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            996 588777654334456799999999999999999999983  28999999999999999999999999999765443


Q ss_pred             CCceeeeccccCccccccccccc--cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          221 NDFVSISATRGTIGYIAPELISR--NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ..   .....||+.|+|||.+..  ....++.++||||||+++|+|++|+.||.......      ........... ..
T Consensus       164 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-~~  233 (290)
T 3fme_A          164 VA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEPS-PQ  233 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSCC-CC
T ss_pred             cc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccCC-CC
Confidence            22   233458999999999732  12367889999999999999999999997533211      11122222211 11


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..     ....+.++.+++.+||+.||++|||+.|+++
T Consensus       234 ~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 LP-----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cc-----cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11     1124578899999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=315.86  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=197.2

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...|.+.+.||+|+||.||+|..+.  .+|+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            3456677899999999999998753  599999875432   23567889999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++ ++.+||+|||++......
T Consensus       110 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          110 LCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             CCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             cccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999843   234688999999999999999999999   999999999999998 679999999998754322


Q ss_pred             CC---ceeeeccccCcccccccccccc-------ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          221 ND---FVSISATRGTIGYIAPELISRN-------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       221 ~~---~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      ..   ........|++.|+|||.+.+.       ...++.++||||||+++|+|++|+.||.......        ....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~  254 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--------IIWQ  254 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--------HHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHH
Confidence            11   1122334589999999998652       1346789999999999999999999997543211        1222


Q ss_pred             hhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                      ...+.......     ..++.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       255 ~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  299 (319)
T 2y4i_B          255 MGTGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK  299 (319)
T ss_dssp             HHTTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred             hccCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            22222222111     1234578899999999999999999999999873

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.9e-44  Score=328.02  Aligned_cols=257  Identities=23%  Similarity=0.275  Sum_probs=191.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEc------CCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv  138 (340)
                      .|.+.+.||+|+||.||+|.+. +++.||+|++.....   ...+|+++++.++||||+++++++..      ....++|
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            4566789999999999999876 689999999865432   23479999999999999999998843      2236789


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-CceEEecccCCccC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFH  217 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-~~~kl~Dfg~~~~~  217 (340)
                      |||+++ ++.+.+.........+++..+..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999965 66655533223456789999999999999999999999   99999999999999955 67899999999865


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHH---------
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVY---------  288 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~---------  288 (340)
                      .....   .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||........   +...+.         
T Consensus       208 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          208 VRGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred             ccCCC---ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence            44332   2334689999999998653 3678899999999999999999999976542210   111000         


Q ss_pred             -HHhhc-CCCccccc--cc----hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          289 -DQLNK-GGDLELRN--VT----EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       289 -~~~~~-~~~~~~~~--~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ..... .....+..  ..    .+....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence             00000 00000000  00    112234678999999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=319.54  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=181.0

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccC-CCceeeEeeEEE--------cC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIH-HVNVVQLLGFCS--------EG  132 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~  132 (340)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++..+. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            345677899999999999999865 788999998855432 2357889999999996 999999999983        34


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeeEcCCCceEEec
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dik~~Nill~~~~~~kl~D  210 (340)
                      ...+++|||+. |+|.+++.... ....+++..++.++.|++.||+|||++   +  ++||||||+||+++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            45889999995 78888874322 235699999999999999999999998   8  99999999999999999999999


Q ss_pred             ccCCccCCCCCCce----------eeeccccCccccccccccc-cccccccccchhhHHHHHHHHHcCCCCCCCCccccc
Q 044497          211 FGLAKFHPKENDFV----------SISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS  279 (340)
Q Consensus       211 fg~~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~  279 (340)
                      ||++..........          ......+|+.|+|||.+.. ....++.++||||||+++|+|++|+.||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99998665432211          1113458999999999832 12367889999999999999999999996533211 


Q ss_pred             ccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          280 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                                ..........      ....+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus       261 ----------~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          261 ----------IVNGKYSIPP------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ---------------CCCCT------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ----------hhcCcccCCc------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                      0111101000      0112245788999999999999999999999885

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=314.16  Aligned_cols=261  Identities=21%  Similarity=0.258  Sum_probs=189.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEE-------------
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCS-------------  130 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~-------------  130 (340)
                      +|.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++||||+++++++.             
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   91 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL   91 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence            4566789999999999999876 588999999865432 2367889999999999999999999873             


Q ss_pred             -cCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-CCCceEE
Q 044497          131 -EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKV  208 (340)
Q Consensus       131 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-~~~~~kl  208 (340)
                       .....++||||++ ++|.+++.     ...+++..+..++.|++.||+|||++   +++||||||+||+++ +++.+||
T Consensus        92 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           92 TELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence             4467899999996 69999883     35688999999999999999999999   999999999999997 5679999


Q ss_pred             ecccCCccCCCCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch----
Q 044497          209 SDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF----  283 (340)
Q Consensus       209 ~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~----  283 (340)
                      +|||++......... .......+|..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+    
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999865432211 122334578999999988653 36788999999999999999999999765431100000    


Q ss_pred             ---hHHHHHHhhcC--------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          284 ---PSWVYDQLNKG--------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       284 ---~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ...........        ..............++.++.+++.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence               00000000000        000000011122335678999999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.1e-43  Score=338.56  Aligned_cols=252  Identities=24%  Similarity=0.360  Sum_probs=199.1

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      ...+.+.+.||+|+||.||+|.+.    .+..+|+|.+......  .+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            445666788999999999999864    2457999998764332  2678899999999999999999999854 56899


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++...
T Consensus       468 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          468 IMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            9999999999999843   234689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ...... ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |..||.......        ....+..+..
T Consensus       542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~  610 (656)
T 2j0j_A          542 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGER  610 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHHTCC
T ss_pred             CCCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            443321 22334577899999999765  77889999999999999997 999987543221        2222222222


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...      +..+++.+.+++.+||+.||.+|||+.++++.|+
T Consensus       611 ~~~------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          611 LPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            221      2234578999999999999999999999999885

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.5e-43  Score=322.93  Aligned_cols=251  Identities=21%  Similarity=0.224  Sum_probs=185.3

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      .+.||+|+||+||.+...+|+.||||++....  .+.+.+|+.++..+ +||||+++++++.+.+..++||||+. |+|.
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            47899999999988777789999999986532  35678999999886 89999999999999999999999995 6999


Q ss_pred             cccccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC-------------CceEEeccc
Q 044497          149 RHIFPKESRGQS---FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-------------FIPKVSDFG  212 (340)
Q Consensus       149 ~~l~~~~~~~~~---~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~-------------~~~kl~Dfg  212 (340)
                      +++.........   ..+..+..++.|++.||+|||++   +|+||||||+|||++.+             +.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            998544322211   12334578999999999999999   99999999999999654             489999999


Q ss_pred             CCccCCCCCCce--eeeccccCcccccccccccc-----ccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchh
Q 044497          213 LAKFHPKENDFV--SISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFP  284 (340)
Q Consensus       213 ~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~  284 (340)
                      ++..........  ......||+.|+|||++.+.     ...++.++|||||||++|||+| |+.||.......      
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------  247 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------  247 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence            998765433211  12345699999999998652     2367889999999999999999 999986543211      


Q ss_pred             HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ............ ........++.++.+++.+||+.||.+|||+.++++
T Consensus       248 ---~~i~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ---SNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---HHHHHTCCCCCC-CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHhcCCCCccc-ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               111111111110 011123456788999999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.3e-44  Score=316.57  Aligned_cols=242  Identities=23%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC-------hHHHHHHHHHhcccC--CCceeeEeeEEEc
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS-------GEEFINEVSTIGRIH--HVNVVQLLGFCSE  131 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~iv~~~~~~~~  131 (340)
                      .....|.+.+.||+|+||.||+|... +++.||+|++......       .+.+.+|+.+++.++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34456777899999999999999865 7889999998764322       245678999999996  5999999999999


Q ss_pred             CCeeEEEEEccCC-CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-CCCceEEe
Q 044497          132 GSKRALVYEYMPN-GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVS  209 (340)
Q Consensus       132 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-~~~~~kl~  209 (340)
                      .+..+++||++.+ ++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++ +++.+||+
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999976 899998843    45689999999999999999999999   999999999999999 78999999


Q ss_pred             cccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH
Q 044497          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      |||++.......    .....||+.|+|||.+.+. ...+.++||||||+++|+|++|+.||.....             
T Consensus       193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------  254 (320)
T 3a99_A          193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------  254 (320)
T ss_dssp             CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred             eCcccccccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------
Confidence            999998665432    2334589999999998764 2346789999999999999999999864321             


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......  .      .+..++.++.+++.+||+.||++|||++++++
T Consensus       255 ~~~~~~--~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 IIRGQV--F------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHCCC--C------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhcccc--c------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111100  0      11123467899999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-43  Score=319.03  Aligned_cols=262  Identities=19%  Similarity=0.294  Sum_probs=197.5

Q ss_pred             HHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-----------CCceeeEeeEEE
Q 044497           63 IAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-----------HVNVVQLLGFCS  130 (340)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~  130 (340)
                      ....|.+.+.||+|+||+||+|... +++.||+|++..+....+.+.+|+.+++.++           ||||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            3456778899999999999999864 7889999999866555577889999999886           899999999987


Q ss_pred             cCC----eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-----
Q 044497          131 EGS----KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-----  201 (340)
Q Consensus       131 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-----  201 (340)
                      ..+    ..+++||++ +++|.+++....  ...+++..+..++.|++.||+|||++  .+++||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCC
Confidence            544    789999999 889999885432  34589999999999999999999983  1899999999999994     


Q ss_pred             -CCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccc
Q 044497          202 -HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK  280 (340)
Q Consensus       202 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~  280 (340)
                       ..+.+||+|||++.......     ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence             44589999999998654322     334689999999999875  6788999999999999999999999865432211


Q ss_pred             cchh--HHHHHHhhc--------C----------C------Ccc-------ccccchhhHHHHHHHHHHHhhcccCCCCC
Q 044497          281 AYFP--SWVYDQLNK--------G----------G------DLE-------LRNVTEIESMIARKLCMIGLWCIQVKAAD  327 (340)
Q Consensus       281 ~~~~--~~~~~~~~~--------~----------~------~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~  327 (340)
                      ....  ..+...+..        +          .      ...       .......+...+.++.+|+.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence            1000  000000000        0          0      000       00011234567889999999999999999


Q ss_pred             CCCHHHHHH
Q 044497          328 RPSMTKVLE  336 (340)
Q Consensus       328 Rps~~evl~  336 (340)
                      |||++|+++
T Consensus       325 Rpt~~ell~  333 (373)
T 1q8y_A          325 RADAGGLVN  333 (373)
T ss_dssp             CBCHHHHHT
T ss_pred             cCCHHHHhh
Confidence            999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.8e-43  Score=312.63  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=196.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEE--cCCcEEEEEEccCCCC---ChHHHHHHHHHhccc---CCCceeeEeeEEE-----cC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQL--HTGGLIAVKMLANSKF---SGEEFINEVSTIGRI---HHVNVVQLLGFCS-----EG  132 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~--~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~  132 (340)
                      .|.+.+.||+|+||.||+|..  .+++.||+|++.....   ....+.+|+.+++.+   +||||+++++++.     ..
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            466778999999999999987  3678899999865332   234567788877776   8999999999987     56


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      ...++||||++ ++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence            67899999996 69999885432  34589999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      ++.......   ......+|+.|+|||.+.+.  .++.++||||||+++|+|++|+.||........    ...+.....
T Consensus       166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~  236 (326)
T 1blx_A          166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LGKILDVIG  236 (326)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHC
T ss_pred             ccccccCCC---CccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHHcC
Confidence            997654322   12344689999999999765  678899999999999999999999976543210    011111100


Q ss_pred             cCCC----------------ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGD----------------LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~----------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....                ............++..+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000                0000111222345678899999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-42  Score=314.64  Aligned_cols=201  Identities=21%  Similarity=0.247  Sum_probs=168.3

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-CC-----ceeeEeeEEEcCCeeE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HV-----NVVQLLGFCSEGSKRA  136 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~  136 (340)
                      ...|.+.+.||+|+||+||+|... +++.||+|++.......+++..|+.+++.++ |+     +++++++++...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            346677899999999999999876 6789999999865544566778888888874 44     5999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc--CCCceEEecccCC
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLA  214 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~--~~~~~kl~Dfg~~  214 (340)
                      +||||++ ++|.+++....  ...+++..+..++.|++.||+|||++ +.+|+||||||+|||++  .++.+||+|||++
T Consensus       133 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999995 59999885432  24589999999999999999999952 23899999999999995  4788999999999


Q ss_pred             ccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCc
Q 044497          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHA  275 (340)
Q Consensus       215 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~  275 (340)
                      .......     ....||+.|+|||++.+.  .++.++|||||||++|+|+||+.||....
T Consensus       209 ~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          209 CQLGQRI-----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             EETTCCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eeccccc-----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            8664322     345689999999999875  68899999999999999999999998654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.3e-43  Score=314.29  Aligned_cols=264  Identities=21%  Similarity=0.297  Sum_probs=200.0

Q ss_pred             HHHHHHHhhhhhhcCCCCCeEEEEEEEc-CC-cEEEEEEccCCCCChHHHHHHHHHhcccCCCc------eeeEeeEEEc
Q 044497           60 PEIIAVTNHFTHKLGQGGFGSVYKGQLH-TG-GLIAVKMLANSKFSGEEFINEVSTIGRIHHVN------VVQLLGFCSE  131 (340)
Q Consensus        60 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~  131 (340)
                      .+.....|.+.+.||+|+||+||+|... ++ ..||+|++.......+.+.+|+.+++.++|++      ++.+++++..
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            3344556788899999999999999875 44 68999999765545567889999999997765      9999999999


Q ss_pred             CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE-----------
Q 044497          132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL-----------  200 (340)
Q Consensus       132 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill-----------  200 (340)
                      .+..++||||+ ++++.+++...  ....+++..+..++.|++.||+|||++   +++||||||+|||+           
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred             CCeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence            99999999999 66777776432  234689999999999999999999999   99999999999999           


Q ss_pred             --------cCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCC
Q 044497          201 --------DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (340)
Q Consensus       201 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~  272 (340)
                              +.++.+||+|||++.......     ....||+.|+|||++.+.  .++.++||||||+++|+|++|+.||.
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCC
Confidence                    567899999999998644332     334689999999999765  67889999999999999999999997


Q ss_pred             CCcccccccc-------hhHHHHHHhhcCCC----------------------ccccccchhhHHHHHHHHHHHhhcccC
Q 044497          273 MHATRSSKAY-------FPSWVYDQLNKGGD----------------------LELRNVTEIESMIARKLCMIGLWCIQV  323 (340)
Q Consensus       273 ~~~~~~~~~~-------~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~  323 (340)
                      ..........       .+............                      .............+.++.+|+.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            6543211000       00000000000000                      000000011123456899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 044497          324 KAADRPSMTKVLE  336 (340)
Q Consensus       324 ~p~~Rps~~evl~  336 (340)
                      ||++|||+.|+++
T Consensus       321 dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          321 DPAQRITLAEALL  333 (355)
T ss_dssp             STTTSCCHHHHTT
T ss_pred             ChhhCcCHHHHhc
Confidence            9999999999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-42  Score=309.75  Aligned_cols=250  Identities=20%  Similarity=0.256  Sum_probs=170.0

Q ss_pred             Hhhhh-hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEc----CCeeEEEE
Q 044497           66 TNHFT-HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVY  139 (340)
Q Consensus        66 ~~~~~-~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~  139 (340)
                      .|.+. +.||+|+||+||+|... +++.||+|++....   ....+....++.++||||+++++++..    ....++||
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  105 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM  105 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence            45554 46999999999999876 78999999986532   222233334566799999999999865    45589999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCcc
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKF  216 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~~  216 (340)
                      ||+++++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||+++.   ++.+||+|||++..
T Consensus       106 e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          106 ECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             ECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             eccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            999999999998543  235689999999999999999999999   9999999999999976   45599999999975


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .....    .....+|+.|+|||.+.+.  .++.++||||||+++|+|++|+.||............    ........ 
T Consensus       181 ~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~-  249 (336)
T 3fhr_A          181 TTQNA----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM----KRRIRLGQ-  249 (336)
T ss_dssp             C--------------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ccccc----cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH----HHhhhccc-
Confidence            54322    2344589999999998664  7788999999999999999999999765433211110    00000000 


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ..........++.++.+|+.+||+.||.+|||+.|+++
T Consensus       250 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          250 --YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              00001111234578999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=314.19  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=190.4

Q ss_pred             CHHHHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC-------hHHHHHHHHHhccc----CCCceeeE
Q 044497           58 SYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS-------GEEFINEVSTIGRI----HHVNVVQL  125 (340)
Q Consensus        58 ~~~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l----~h~~iv~~  125 (340)
                      ...+.....|.+.+.||+|+||.||+|... +++.||+|++......       ...+.+|+.++..+    +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            334556677888899999999999999864 7889999999764432       23456789999888    89999999


Q ss_pred             eeEEEcCCeeEEEEEc-cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc-CC
Q 044497          126 LGFCSEGSKRALVYEY-MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HN  203 (340)
Q Consensus       126 ~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~-~~  203 (340)
                      ++++...+..+++||+ +.+++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++ .+
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC
Confidence            9999999999999999 789999999843    34689999999999999999999999   999999999999999 88


Q ss_pred             CceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch
Q 044497          204 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF  283 (340)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~  283 (340)
                      +.+||+|||++.......    .....|+..|+|||.+.+. ...+.++||||||+++|+|++|+.||.....       
T Consensus       177 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------  244 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE-------  244 (312)
T ss_dssp             TEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred             CeEEEEEcchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH-------
Confidence            999999999998665432    2344589999999998764 2335589999999999999999999864221       


Q ss_pred             hHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          284 PSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            .....  .      ..+..++..+.+++.+||+.||++|||+.|+++
T Consensus       245 ------~~~~~--~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ------ILEAE--L------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ------HHHTC--C------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------Hhhhc--c------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  11110  0      111234567899999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=317.05  Aligned_cols=250  Identities=24%  Similarity=0.267  Sum_probs=184.8

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ++...+.||+|+||+|+.....+++.||||++.....  +.+.+|+.+++.+ +||||+++++++.+.+..++|||++. 
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            3455689999999997766666799999999865432  3456899999999 79999999999999999999999995 


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-----CCceEEecccCCccCCC
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-----~~~~kl~Dfg~~~~~~~  219 (340)
                      |+|.+++....   ....+..+..++.|++.||+|||++   +|+||||||+|||++.     ...+||+|||++.....
T Consensus       102 g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          102 ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            69999885433   2334445678999999999999999   9999999999999953     33578999999986644


Q ss_pred             CCC-ceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          220 END-FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       220 ~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ... ........||+.|+|||++.+. ...++.++|||||||++|+|++ |..||.......        . ........
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~-~~~~~~~~  246 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------A-NILLGACS  246 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------H-HHHTTCCC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------H-HHHhccCC
Confidence            321 1223445699999999998742 2356779999999999999999 888885432211        1 11111111


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ....   ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       247 ~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 LDCL---HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CTTS---CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccc---CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111   112234567889999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=300.93  Aligned_cols=250  Identities=22%  Similarity=0.278  Sum_probs=177.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.......   +.+.++..+++.++||||+++++++...+..++||||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~  105 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL  105 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence            4556789999999999999876 78899999997654332   2344555567888999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      + ++.+..+..   .....+++..+..++.|++.||+|||+ .   +++|+||||+||+++.++.+||+|||++......
T Consensus       106 ~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          106 M-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             C-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             c-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9 545544442   124578999999999999999999998 6   8999999999999999999999999999755433


Q ss_pred             CCceeeeccccCccccccccccc---cccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          221 NDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ..   .....+|+.|+|||.+..   ....++.++||||||+++|+|++|+.||......      ........ .....
T Consensus       179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~-~~~~~  248 (318)
T 2dyl_A          179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVL-QEEPP  248 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHH-HSCCC
T ss_pred             cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHh-ccCCC
Confidence            21   233458999999999853   1236778999999999999999999999753321      11122222 22211


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......    .++.++.+++.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 LLPGHM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccC----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111111    23467899999999999999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.4e-42  Score=298.17  Aligned_cols=235  Identities=13%  Similarity=0.072  Sum_probs=186.5

Q ss_pred             CCCHHH-HHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh----HHHHHHHHHhcccCCCceeeEeeEE
Q 044497           56 RYSYPE-IIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFC  129 (340)
Q Consensus        56 ~~~~~~-~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~  129 (340)
                      .+...+ +...+|.+.+.||+|+||.||+|.+. +++.||+|++.......    +.+.+|+..+..++||||+++++++
T Consensus        21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            344444 55567888899999999999999876 58899999998765433    6789999999999999999999999


Q ss_pred             EcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEe
Q 044497          130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (340)
Q Consensus       130 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~  209 (340)
                      ...+..|+||||+++++|.+++..     . .....+..++.|++.||+|||++   +++||||||+||++++++.+||+
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~  171 (286)
T 3uqc_A          101 HTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLA  171 (286)
T ss_dssp             EETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEEC
T ss_pred             EECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEE
Confidence            999999999999999999999821     1 35567889999999999999999   99999999999999999999998


Q ss_pred             cccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH
Q 044497          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      +++.                      ++         .++.++||||||+++|+|+||+.||........-...      
T Consensus       172 ~~~~----------------------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------  214 (286)
T 3uqc_A          172 YPAT----------------------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------  214 (286)
T ss_dssp             SCCC----------------------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------
T ss_pred             eccc----------------------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------
Confidence            5442                      22         3567899999999999999999999875543211000      


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                        .................++.++.+++.+||+.||++| |+.|+++.|+
T Consensus       215 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~  261 (286)
T 3uqc_A          215 --ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ  261 (286)
T ss_dssp             --CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred             --HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence              0000000111112333456789999999999999999 9999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.7e-42  Score=306.56  Aligned_cols=256  Identities=24%  Similarity=0.322  Sum_probs=175.1

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh--HHHHHHHH-HhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG--EEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.+.||+|+||.||+|... +++.||+|++.......  .++..|+. +++.++||||+++++++...+..++||||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~  102 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL  102 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence            3456789999999999999875 78899999997653322  34555655 77888999999999999999999999999


Q ss_pred             cCCCCcccccccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          142 MPNGSLDRHIFPK-ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       142 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      +++ +|.+++... ......+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||++......
T Consensus       103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            965 777766321 11246789999999999999999999983  28999999999999999999999999999765433


Q ss_pred             CCceeeeccccCcccccccccccc--ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          221 NDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ..   .....||+.|+|||.+...  ...++.++||||||+++|+|++|+.||.........      . .....+....
T Consensus       180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~-~~~~~~~~~~  249 (327)
T 3aln_A          180 IA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------L-TQVVKGDPPQ  249 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCC
T ss_pred             cc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------H-HHHhcCCCCC
Confidence            21   2233589999999998421  135788999999999999999999999754321100      0 0011111111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +.  ......++..+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 LS--NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CC--CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC--CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            11  1111234578999999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1e-41  Score=323.63  Aligned_cols=262  Identities=22%  Similarity=0.271  Sum_probs=195.4

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEc------CCee
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  135 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~  135 (340)
                      ..|.+.+.||+|+||.||+|.+. +++.||+|++......  .+.+.+|+++++.++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            56788899999999999999864 7889999998764322  3568899999999999999999998765      6778


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCc---eEEeccc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFG  212 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~---~kl~Dfg  212 (340)
                      ++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            99999999999999985433 234688899999999999999999999   9999999999999987664   8999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccc-ccchhHHHHHH-
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS-KAYFPSWVYDQ-  290 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~-  290 (340)
                      ++........   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|..||........ ........... 
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             cccccccccc---cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            9987654432   2345689999999999764  778899999999999999999999965321100 00000000000 


Q ss_pred             -----hhcCC--CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 044497          291 -----LNKGG--DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       291 -----~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                           .....  .............++..+.+++.+||+.||++|||+.+++
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence                 00000  0001111233445678999999999999999999998743

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-41  Score=329.14  Aligned_cols=240  Identities=20%  Similarity=0.240  Sum_probs=191.6

Q ss_pred             HHHHHHHHhhhhhhcCCCCCeEEEEEEEc--CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCe
Q 044497           59 YPEIIAVTNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        59 ~~~~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  134 (340)
                      ..++....|.+.+.||+|+||.||+|.+.  +++.||+|++......  .+.+.+|++++..++||||+++++++...+.
T Consensus        74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            34455567888899999999999999875  5889999998754322  2467899999999999999999999977655


Q ss_pred             -----eEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEe
Q 044497          135 -----RALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (340)
Q Consensus       135 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~  209 (340)
                           .|+||||+++++|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.+ .+||+
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEEC
T ss_pred             CCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEE
Confidence                 699999999999988762      2689999999999999999999999   99999999999999886 89999


Q ss_pred             cccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH
Q 044497          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      |||++......      ....||+.|+|||++.+.   ++.++||||||+++|+|++|..|+.........         
T Consensus       224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------  285 (681)
T 2pzi_A          224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------  285 (681)
T ss_dssp             CCTTCEETTCC------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------
T ss_pred             ecccchhcccC------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCccccccccc---------
Confidence            99999865443      334599999999998763   378999999999999999998887643221100         


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHHh
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLEML  338 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~evl~~L  338 (340)
                                 . .......++.+.+++.+||+.||.+||+ ++++...|
T Consensus       286 -----------~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          286 -----------E-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             -----------T-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             -----------c-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence                       0 0111234567899999999999999995 55555444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.8e-40  Score=291.11  Aligned_cols=228  Identities=21%  Similarity=0.230  Sum_probs=176.6

Q ss_pred             hhhh-hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHh-cccCCCceeeEeeEEEc----CCeeEEEE
Q 044497           67 NHFT-HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTI-GRIHHVNVVQLLGFCSE----GSKRALVY  139 (340)
Q Consensus        67 ~~~~-~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~  139 (340)
                      |.+. +.||+|+||.||+|... +++.||+|++..    ...+.+|+.++ +..+||||+++++++..    ....++||
T Consensus        19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~   94 (299)
T 3m2w_A           19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   94 (299)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence            3444 67999999999999874 788999999864    35677888888 55699999999999876    67789999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCcc
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKF  216 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~~  216 (340)
                      ||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+||+++.   ++.+||+|||++..
T Consensus        95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           95 ECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             CCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            9999999999985432  34689999999999999999999999   9999999999999998   78999999998863


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      ...                          ..++.++||||||+++|+|++|+.||............       ......
T Consensus       170 ~~~--------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~~~~~  216 (299)
T 3m2w_A          170 TTG--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIRM  216 (299)
T ss_dssp             CTT--------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CCSSCT
T ss_pred             ccc--------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HHHHhh
Confidence            221                          25677899999999999999999999754432111000       000000


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ............++.++.+++.+||+.||.+|||+.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0011111122345678999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.8e-41  Score=298.27  Aligned_cols=243  Identities=15%  Similarity=0.127  Sum_probs=186.3

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC---------ChHHHHHHHHHhcccC---------CCcee
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF---------SGEEFINEVSTIGRIH---------HVNVV  123 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~iv  123 (340)
                      +....|.+.+.||+|+||+||+|.+ +++.||+|++.....         ..+.+.+|+.+++.++         ||||+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3356788889999999999999987 689999999975432         2267889999998886         66666


Q ss_pred             eEeeE-----------------EEc-------------CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHH
Q 044497          124 QLLGF-----------------CSE-------------GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGT  173 (340)
Q Consensus       124 ~~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i  173 (340)
                      ++.+.                 +.+             .+..++||||+++|++.+.+.     ...+++..+..++.|+
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL  170 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence            66554                 332             678999999999998777662     2568999999999999


Q ss_pred             HHHHHHHH-cCCCCCeeecCCCCCCeeEcCCC--------------------ceEEecccCCccCCCCCCceeeeccccC
Q 044497          174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHNF--------------------IPKVSDFGLAKFHPKENDFVSISATRGT  232 (340)
Q Consensus       174 ~~~l~~Lh-~~~~~~ivH~dik~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~  232 (340)
                      +.||+||| ++   +|+||||||+|||++.++                    .+||+|||+++.....       ...||
T Consensus       171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt  240 (336)
T 2vuw_A          171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC  240 (336)
T ss_dssp             HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred             HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence            99999999 88   999999999999999887                    8999999999865432       23599


Q ss_pred             ccccccccccccccccccccchhhHHHH-HHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHH
Q 044497          233 IGYIAPELISRNFGTVSCKSDVYGFGMV-LLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIAR  311 (340)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~~~DvwslG~~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (340)
                      +.|+|||++.+.  . +.++||||+|++ .+++++|..||....       ......+.+.................+++
T Consensus       241 ~~y~aPE~~~g~--~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          241 DVSMDEDLFTGD--G-DYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMTFKTKCNTPAMKQIKR  310 (336)
T ss_dssp             CCTTCSGGGCCC--S-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred             ecccChhhhcCC--C-ccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhccCcccchhhhhhcCH
Confidence            999999999875  2 779999998777 777888988874210       00111112221111222222345667899


Q ss_pred             HHHHHHhhcccCCCCCCCCHHHHH
Q 044497          312 KLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       312 ~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                      ++.+|+.+||+.|     |++|++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            9999999999976     999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.6e-41  Score=307.06  Aligned_cols=240  Identities=15%  Similarity=0.117  Sum_probs=177.3

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC----ChHHHHHHHHHhcccCC-Cce---------eeEe------
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF----SGEEFINEVSTIGRIHH-VNV---------VQLL------  126 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h-~~i---------v~~~------  126 (340)
                      ...+.||+|+||.||+|.+. +++.||||++.....    ..+.+.+|+.+++.++| +|.         +...      
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  160 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  160 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence            34578999999999999855 789999999874322    24678999999999976 221         1111      


Q ss_pred             ------eEEEc-----CCeeEEEEEccCCCCcccccccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 044497          127 ------GFCSE-----GSKRALVYEYMPNGSLDRHIFPK---ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFD  192 (340)
Q Consensus       127 ------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d  192 (340)
                            .++..     ....+++|+.+ +++|.+++...   ......+++..+..++.|++.||+|||++   +|+|||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrD  236 (413)
T 3dzo_A          161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY  236 (413)
T ss_dssp             C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence                  11111     22356777776 78998887311   22345678889999999999999999999   999999


Q ss_pred             CCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccc--------cccccccccchhhHHHHHHHH
Q 044497          193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--------NFGTVSCKSDVYGFGMVLLEM  264 (340)
Q Consensus       193 ik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~~~DvwslG~~l~el  264 (340)
                      |||+|||++.++.+||+|||+++.....     .....| +.|+|||++..        ....++.++|||||||++|+|
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999998754332     344557 99999999832        113577899999999999999


Q ss_pred             HcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          265 AGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       265 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      +||+.||...........       .+..        ..    .++..+.+|+.+||+.||++|||+.++++
T Consensus       311 ltg~~Pf~~~~~~~~~~~-------~~~~--------~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEW-------IFRS--------CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGG-------GGSS--------CC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHCCCCCCCcchhhhHHH-------HHhh--------cc----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999976543221110       0100        01    23467999999999999999999888754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.5e-33  Score=265.15  Aligned_cols=183  Identities=15%  Similarity=0.134  Sum_probs=128.6

Q ss_pred             hcCCCCCeEEEEEE-EcCCcEEEEEEccCCCC-----------ChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEE
Q 044497           72 KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKF-----------SGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        72 ~ig~G~~g~v~~~~-~~~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..+.|++|....+. ...|+.+++|++.++..           +.+++.+|+++|+++ +|+||+++++++++.+..|+|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35666666666553 33688999999975422           124689999999999 799999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||++|++|.+++.    ..++++..   +|+.||+.||+|+|++   ||+||||||+|||+++++.+||+|||+|+...
T Consensus       321 MEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            99999999999994    34556654   5889999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCC
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  269 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~  269 (340)
                      ....  ......||+.|+|||++.+   .+..++|+||+|++++++.++..
T Consensus       391 ~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          391 QDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred             CCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccc
Confidence            4332  2344569999999999976   45568999999999887766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.8e-29  Score=237.46  Aligned_cols=184  Identities=15%  Similarity=0.164  Sum_probs=144.5

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .+.||+|+||.||+|.. .+..+++|+.......         .+.+.+|++++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999954 5788899986543222         2347899999999999999966666667778899999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..            +..++.|+++||+|||++   +|+||||||+|||+++  .+||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999832            458999999999999999   9999999999999998  9999999999876543


Q ss_pred             CCce-----eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCC
Q 044497          221 NDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  271 (340)
Q Consensus       221 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~  271 (340)
                      ....     ......||+.|+|||++......|+..+|+|+...-..+-..++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2211     11345699999999999874446778899999999988888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=3.7e-26  Score=197.81  Aligned_cols=141  Identities=17%  Similarity=0.121  Sum_probs=114.8

Q ss_pred             hhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC-------------------ChHHHHHHHHHhcccCCCceeeEeeEE
Q 044497           69 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF-------------------SGEEFINEVSTIGRIHHVNVVQLLGFC  129 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~iv~~~~~~  129 (340)
                      +.+.||+|+||.||+|.+.+++.||+|++.....                   ....+.+|+.+++.++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            3489999999999999887789999999965322                   1346889999999998  4 6666655


Q ss_pred             EcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEe
Q 044497          130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (340)
Q Consensus       130 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~  209 (340)
                      .. +..++||||+++++|.+ +..          .....++.|++.||+|||++   +++||||||+|||++ ++.+||+
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred             ec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence            43 56799999999999988 411          12446999999999999999   999999999999999 9999999


Q ss_pred             cccCCccCCCCCCceeeeccccCccccccccccc
Q 044497          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISR  243 (340)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  243 (340)
                      |||+++               .+..+.|||.+.+
T Consensus       235 DFG~a~---------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          235 DFPQSV---------------EVGEEGWREILER  253 (282)
T ss_dssp             CCTTCE---------------ETTSTTHHHHHHH
T ss_pred             ECCCCe---------------ECCCCCHHHHHHH
Confidence            999986               3445788998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=7.6e-22  Score=168.71  Aligned_cols=134  Identities=16%  Similarity=0.115  Sum_probs=103.2

Q ss_pred             hhhhhcCCCCCeEEEEEEE-cCCcE--EEEEEccCCCCC-------------------------hHHHHHHHHHhcccCC
Q 044497           68 HFTHKLGQGGFGSVYKGQL-HTGGL--IAVKMLANSKFS-------------------------GEEFINEVSTIGRIHH  119 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~h  119 (340)
                      .+.+.||+|+||.||+|.. .+|+.  ||+|+++.....                         ...+.+|+..+..++|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            3557899999999999987 67888  999997543211                         1257899999999988


Q ss_pred             Cce--eeEeeEEEcCCeeEEEEEccCC-C----CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeec
Q 044497          120 VNV--VQLLGFCSEGSKRALVYEYMPN-G----SLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH-NGCDVCILHF  191 (340)
Q Consensus       120 ~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH~  191 (340)
                      +++  +.+++.    +..++||||+.+ |    +|.+....       .++..+..++.|++.+|+||| +.   +++||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHr  195 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHA  195 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence            754  344432    357899999942 4    55544311       223467789999999999999 88   99999


Q ss_pred             CCCCCCeeEcCCCceEEecccCCccC
Q 044497          192 DIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       192 dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||+|||+++  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999988  9999999999743

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.3e-19  Score=159.47  Aligned_cols=135  Identities=13%  Similarity=0.094  Sum_probs=98.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC---------------ChHH--------HHHHHHHhcccCCCcee
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF---------------SGEE--------FINEVSTIGRIHHVNVV  123 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~e~~~l~~l~h~~iv  123 (340)
                      |.+.++||+|++|.||+|...+|+.||||+++....               ....        ..+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            456688999999999999988999999999754211               0111        23466666666544432


Q ss_pred             --eEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          124 --QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       124 --~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                        ..++.    ...++||||++|++|.++...          .....++.|++.+|.+||+.   |+|||||||.|||++
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR  239 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence              22222    224799999998888765411          12346789999999999999   999999999999998


Q ss_pred             CCC----------ceEEecccCCccCC
Q 044497          202 HNF----------IPKVSDFGLAKFHP  218 (340)
Q Consensus       202 ~~~----------~~kl~Dfg~~~~~~  218 (340)
                      +++          .+.|+||+-+....
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCCcccccccccceEEEEeCCcccCC
Confidence            776          38999999876443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=3.1e-13  Score=115.47  Aligned_cols=139  Identities=14%  Similarity=0.053  Sum_probs=108.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCC-CChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSK-FSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +.+...++.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+. +.+++++++++...+..++|||+++|
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   94 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG   94 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred             ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence            445567788888999999754 6899999986532 23346889999999884 67788999999988899999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC----------------------------------------  184 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------------  184 (340)
                      .+|.+.+..         ......++.+++++++.||+..                                        
T Consensus        95 ~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           95 VLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             EEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             eehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            998776411         1123467889999999999810                                        


Q ss_pred             ----------------CCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          185 ----------------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       185 ----------------~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                                      +..++|+|++|.||+++++..+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                            1358999999999999876666799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.34  E-value=3.8e-12  Score=108.35  Aligned_cols=130  Identities=16%  Similarity=0.143  Sum_probs=98.2

Q ss_pred             hcC-CCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCc--eeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           72 KLG-QGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        72 ~ig-~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      .++ .|..+.||++...+|+.+++|+....  ....+..|+.+++.+.+.+  +.+++++....+..+++|||++|.++.
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            344 55569999998777788999997654  2356788999999885434  566888888888899999999998884


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 044497          149 RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC--------------------------------------------  184 (340)
Q Consensus       149 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------------  184 (340)
                        ...       ..   ...++.+++..|+.||+..                                            
T Consensus       104 --~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A          104 --SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             --TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             --cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence              211       11   2256778888888888742                                            


Q ss_pred             -----------CCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          185 -----------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       185 -----------~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                                 +..++|+|++|+||+++++..+.|+||+.+.
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                       1139999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.30  E-value=1.4e-11  Score=110.01  Aligned_cols=139  Identities=16%  Similarity=0.184  Sum_probs=106.1

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEcc--CCC--CChHHHHHHHHHhcccC--CCceeeEeeEEEcC---CeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLA--NSK--FSGEEFINEVSTIGRIH--HVNVVQLLGFCSEG---SKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~e~  141 (340)
                      +.++.|.++.||+.... ++.+++|+..  ...  .....+.+|+.+++.+.  +..+++++.++.+.   +..++|||+
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            57899999999998765 4688899876  432  22356788999999986  45688889888776   458999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC-------------------------------------  184 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------------  184 (340)
                      ++|..+.+..      -..++......++.+++.+|+.||+..                                     
T Consensus       123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9988875432      134677888899999999999999731                                     


Q ss_pred             ------------------CCCeeecCCCCCCeeEcCCCc--eEEecccCCcc
Q 044497          185 ------------------DVCILHFDIKPHNILLDHNFI--PKVSDFGLAKF  216 (340)
Q Consensus       185 ------------------~~~ivH~dik~~Nill~~~~~--~kl~Dfg~~~~  216 (340)
                                        ...++|+|++|.||+++.++.  +.++||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              247999999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.16  E-value=1.5e-11  Score=107.21  Aligned_cols=187  Identities=20%  Similarity=0.262  Sum_probs=119.8

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCc--eeeEeeEEEcCC---eeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVN--VVQLLGFCSEGS---KRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~~~  144 (340)
                      +.++.|....||+..    +.+++|+.... .....+.+|..+++.+. +..  +.+++......+   ..|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            457889999999863    57889986533 23467889999998873 322  445555443333   35889999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG-----------------------------------------  183 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----------------------------------------  183 (340)
                      .++.+...      ..++......++.+++..++.||+.                                         
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            88865331      2456677778888888888888851                                         


Q ss_pred             --------------CCCCeeecCCCCCCeeEcC--CCceEEecccCCccCCCCCCceeeeccccCcccccccccc---cc
Q 044497          184 --------------CDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS---RN  244 (340)
Q Consensus       184 --------------~~~~ivH~dik~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~  244 (340)
                                    ....++|+|++|.||++++  +..+.++||+.+.......+.......  . .-..|+...   ..
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~--~-~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED--D-EEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT--T-TSCCHHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh--c-cccCHHHHHHHHHH
Confidence                          1135899999999999988  556789999998754332111000000  0 001222111   00


Q ss_pred             cc---------ccccccchhhHHHHHHHHHcCCCCC
Q 044497          245 FG---------TVSCKSDVYGFGMVLLEMAGGRRNS  271 (340)
Q Consensus       245 ~~---------~~~~~~DvwslG~~l~elltg~~p~  271 (340)
                      ++         ....-.+.|++|.++|.+.+|..++
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            00         1112358999999999999998554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=1.1e-07  Score=82.68  Aligned_cols=136  Identities=16%  Similarity=0.144  Sum_probs=93.2

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC---ceeeEeeEEE-cCCeeEEEEEccCCCC
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV---NVVQLLGFCS-EGSKRALVYEYMPNGS  146 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~~  146 (340)
                      +.++.|....||+.    ++.+++|+... ......+..|..+|+.+.+.   .+.+.+.+.. ..+..+++||+++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45778888899987    57788998532 12235788999999999642   3566777664 4556789999999988


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG-------------------------------------------  183 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------------------------------------------  183 (340)
                      +.+...      ..++......++.++...|+.||+.                                           
T Consensus       100 l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A          100 LGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             Cchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            865321      1223444445555555555555542                                           


Q ss_pred             --------------CCCCeeecCCCCCCeeEcC---CCc-eEEecccCCccC
Q 044497          184 --------------CDVCILHFDIKPHNILLDH---NFI-PKVSDFGLAKFH  217 (340)
Q Consensus       184 --------------~~~~ivH~dik~~Nill~~---~~~-~kl~Dfg~~~~~  217 (340)
                                    .+..++|+|++|.||+++.   ++. ..|+||+.+...
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2235799999999999987   455 489999988654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=1.4e-07  Score=80.51  Aligned_cols=134  Identities=14%  Similarity=0.125  Sum_probs=94.1

Q ss_pred             hcCCCCCe-EEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           72 KLGQGGFG-SVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        72 ~ig~G~~g-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      .+..|..| .||+.... ++..+++|+-...  ....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            34445544 68987655 4567899986433  2456788999998884 334778889999999999999999998776


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 044497          149 RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC--------------------------------------------  184 (340)
Q Consensus       149 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------------  184 (340)
                      +.....        ......+..+++..|+.||+..                                            
T Consensus       109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            544110        1122345556666666666421                                            


Q ss_pred             -----------CCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          185 -----------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       185 -----------~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                                 +..++|+|+.+.||++++++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1137999999999999988777899998775

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.57  E-value=2.2e-07  Score=82.66  Aligned_cols=79  Identities=8%  Similarity=0.042  Sum_probs=57.2

Q ss_pred             hhc-CCCCCeEEEEEEEc-------CCcEEEEEEccCCC---C-ChHHHHHHHHHhcccC-C--CceeeEeeEEEcC---
Q 044497           71 HKL-GQGGFGSVYKGQLH-------TGGLIAVKMLANSK---F-SGEEFINEVSTIGRIH-H--VNVVQLLGFCSEG---  132 (340)
Q Consensus        71 ~~i-g~G~~g~v~~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~---  132 (340)
                      +.| +.|....+|+....       +++.+++|+.....   . ....+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999998654       26689999876533   1 2356788999988884 2  3577788887655   


Q ss_pred             CeeEEEEEccCCCCccc
Q 044497          133 SKRALVYEYMPNGSLDR  149 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~  149 (340)
                      ...+++||+++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35789999999877764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.33  E-value=5.1e-06  Score=73.12  Aligned_cols=141  Identities=16%  Similarity=0.192  Sum_probs=81.0

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCC--CceeeEee------EEEcCCeeEEEEEcc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH--VNVVQLLG------FCSEGSKRALVYEYM  142 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv~e~~  142 (340)
                      +.|+.|..+.||+....+ +.+++|+...   ..+....|..+++.+..  -.+++++.      +....+..+++|+|+
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-GAVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETT-EEEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCC-CCEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            346667788999997754 4699998875   23455566666666631  12334443      123466789999999


Q ss_pred             CCCCccc-----------c---ccc--CCC--C-C-----CCCCHHH-------------------------------HH
Q 044497          143 PNGSLDR-----------H---IFP--KES--R-G-----QSFCWEK-------------------------------LH  167 (340)
Q Consensus       143 ~~~~L~~-----------~---l~~--~~~--~-~-----~~~~~~~-------------------------------~~  167 (340)
                      +|.++..           .   +..  ...  . .     ....|..                               +.
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            9866530           0   000  000  0 0     0012211                               11


Q ss_pred             HHHHHHHHHHHHHHc----------CCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          168 EVALGTARGIEYLHN----------GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       168 ~i~~~i~~~l~~Lh~----------~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      .+...+..++++|++          ..+..++|+|+++.||+++.++.+.++||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111223345666653          023489999999999999888889999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.30  E-value=3e-06  Score=76.45  Aligned_cols=73  Identities=14%  Similarity=0.088  Sum_probs=49.2

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC--------CChHHHHHHHHHhcccCC--C-ceeeEeeEEEcCCeeEEE
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK--------FSGEEFINEVSTIGRIHH--V-NVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~lv  138 (340)
                      +.||.|..+.||++... +++.+++|......        ...+.+..|.++++.+..  + .+++++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            57899999999999754 46789999864321        233567789999887742  3 34456544  34456899


Q ss_pred             EEccCCC
Q 044497          139 YEYMPNG  145 (340)
Q Consensus       139 ~e~~~~~  145 (340)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.20  E-value=1.5e-05  Score=69.21  Aligned_cols=138  Identities=15%  Similarity=0.144  Sum_probs=91.6

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccC---CCceeeEeeEEEcCCeeEEEEEccCCCCc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  147 (340)
                      +.|+.|....+|+... +++.+++|+....  ....+..|...|+.+.   ...+++++.+....+..+++||++++..+
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4688999999999876 4678999987543  3567889999998884   36788899988888889999999998765


Q ss_pred             ccc-----------cccCCC---C---------------CCCCCHHHHH---HHH----------------HHHHHHH-H
Q 044497          148 DRH-----------IFPKES---R---------------GQSFCWEKLH---EVA----------------LGTARGI-E  178 (340)
Q Consensus       148 ~~~-----------l~~~~~---~---------------~~~~~~~~~~---~i~----------------~~i~~~l-~  178 (340)
                      ...           +.....   .               ...-+|....   ++.                ..+++.+ .
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            310           111100   0               0012344322   111                1122222 2


Q ss_pred             HHHc-CCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          179 YLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       179 ~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      .|.. ..++.++|+|+.+.|++++.++ +.+.|+.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3321 2246899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.94  E-value=4.1e-05  Score=69.51  Aligned_cols=80  Identities=10%  Similarity=0.080  Sum_probs=46.8

Q ss_pred             CCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceeeeccccCcccccccccccccc-ccccccchhhHHHHHHHH
Q 044497          186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEM  264 (340)
Q Consensus       186 ~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~~DvwslG~~l~el  264 (340)
                      ..++|||++|.||+++.++ ++++||+.+.......+.... ...-...|.+|+....... ......++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            4899999999999998876 999999988754322111000 0001134556554421100 111234555777778877


Q ss_pred             HcC
Q 044497          265 AGG  267 (340)
Q Consensus       265 ltg  267 (340)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.86  E-value=6.6e-05  Score=66.92  Aligned_cols=141  Identities=16%  Similarity=0.154  Sum_probs=84.2

Q ss_pred             hhcCCCCCeEEEEEEEc--------CCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLH--------TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.+..|-...+|++...        +++.+++|+............+|..+++.+. +.-..++++.+.+    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            46777888899998764        2478999997554334566779999998884 2223566666644    289999


Q ss_pred             cCCCCcccc-cc----------------cCC-CCCCCC--CHHHHHHHHHHHHH-------------------HHHHHH-
Q 044497          142 MPNGSLDRH-IF----------------PKE-SRGQSF--CWEKLHEVALGTAR-------------------GIEYLH-  181 (340)
Q Consensus       142 ~~~~~L~~~-l~----------------~~~-~~~~~~--~~~~~~~i~~~i~~-------------------~l~~Lh-  181 (340)
                      ++|.+|..- +.                ... ..+...  .+.++.++..++..                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998666421 10                000 011122  24555555544322                   223332 


Q ss_pred             ---c-CCCCCeeecCCCCCCeeEcCC----CceEEecccCCc
Q 044497          182 ---N-GCDVCILHFDIKPHNILLDHN----FIPKVSDFGLAK  215 (340)
Q Consensus       182 ---~-~~~~~ivH~dik~~Nill~~~----~~~kl~Dfg~~~  215 (340)
                         . ..+..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               2 123469999999999999876    689999999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.86  E-value=7.8e-05  Score=64.95  Aligned_cols=143  Identities=11%  Similarity=0.151  Sum_probs=80.4

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCc--eeeEeeE------EEcCCeeEEEEEcc
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN--VVQLLGF------CSEGSKRALVYEYM  142 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e~~  142 (340)
                      +.|+.|....+|+....++ .+++|+.... ...+.+..|..++..+....  +.+++..      ....+..+++++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            4577788889999977644 7889988753 23346677888887774222  3333321      12345678999999


Q ss_pred             CCCCcccc--------------ccc--CC--CCC-CCC---CHHHHHH------------HHHHHHHHHHHHHcC----C
Q 044497          143 PNGSLDRH--------------IFP--KE--SRG-QSF---CWEKLHE------------VALGTARGIEYLHNG----C  184 (340)
Q Consensus       143 ~~~~L~~~--------------l~~--~~--~~~-~~~---~~~~~~~------------i~~~i~~~l~~Lh~~----~  184 (340)
                      +|..+...              +..  ..  ... ...   .|.....            +...+...++.+.+.    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            88665310              000  00  000 000   1211100            011134445555421    2


Q ss_pred             CCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       185 ~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +.+++|+|+.+.||+++++..+.++||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3479999999999999887666899998775

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.83  E-value=5.6e-05  Score=64.85  Aligned_cols=73  Identities=21%  Similarity=0.242  Sum_probs=53.9

Q ss_pred             hhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC-ChHHHHHHHHHhcccCC---CceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           71 HKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF-SGEEFINEVSTIGRIHH---VNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      +.+|.|..+.||+.+..+|+.+++|+...... ....+..|+..|+.+..   -.+++++++.    ..+++||+++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            56899999999999999999999998764432 33567889999888842   2345555542    3478999987765


Q ss_pred             c
Q 044497          147 L  147 (340)
Q Consensus       147 L  147 (340)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.82  E-value=5.5e-05  Score=65.32  Aligned_cols=72  Identities=13%  Similarity=0.123  Sum_probs=44.8

Q ss_pred             hhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCce-eeEeeEEEcCCeeEEEEEcc-CCCCc
Q 044497           70 THKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYM-PNGSL  147 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~~L  147 (340)
                      .+.|+.|....+|+.     +.+++|+........-....|..+++.+...++ .++++..  .+.-++++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            357888999999998     578899876532211223568777777742222 4555543  33457899999 66555


Q ss_pred             c
Q 044497          148 D  148 (340)
Q Consensus       148 ~  148 (340)
                      .
T Consensus        96 ~   96 (301)
T 3dxq_A           96 S   96 (301)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.81  E-value=0.00021  Score=62.35  Aligned_cols=143  Identities=14%  Similarity=0.081  Sum_probs=84.5

Q ss_pred             hcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCC--ceeeEeeE-----EEcCCeeEEEEEccCC
Q 044497           72 KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHV--NVVQLLGF-----CSEGSKRALVYEYMPN  144 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~-----~~~~~~~~lv~e~~~~  144 (340)
                      .++ |....||+....+|+.+++|+......+.+.+..|..++..+...  .+++++..     ....+..+++|++++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            355 777899988766677899999876555667788898888887422  23444443     2224556789999987


Q ss_pred             CCccc------------------ccccCC-CCCCCCCHHHH----------------------HHHHHHHHHHHHHHHc-
Q 044497          145 GSLDR------------------HIFPKE-SRGQSFCWEKL----------------------HEVALGTARGIEYLHN-  182 (340)
Q Consensus       145 ~~L~~------------------~l~~~~-~~~~~~~~~~~----------------------~~i~~~i~~~l~~Lh~-  182 (340)
                      ..+..                  ...... .......+...                      ...+..++..++-+-. 
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            55431                  000000 00111221111                      1111222222222211 


Q ss_pred             CCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       183 ~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ..+..++|+|+++.||+++ + .+.++||+.+...
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            1234789999999999998 4 8999999887643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.78  E-value=7.3e-05  Score=68.00  Aligned_cols=73  Identities=15%  Similarity=0.265  Sum_probs=50.5

Q ss_pred             hhcCCCCCeEEEEEEEcC--------CcEEEEEEccCCCCChHHHHHHHHHhcccCCCce-eeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLHT--------GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~  141 (340)
                      +.|+.|....+|++...+        ++.+++|+.... ...+.+..|..+++.+...++ +++++.+.+    .+++||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            467788889999998653        478999998432 222566789999988853333 566666543    289999


Q ss_pred             cCCCCcc
Q 044497          142 MPNGSLD  148 (340)
Q Consensus       142 ~~~~~L~  148 (340)
                      ++|.++.
T Consensus       154 l~G~~l~  160 (429)
T 1nw1_A          154 IPSRPLS  160 (429)
T ss_dssp             CCEEECC
T ss_pred             eCCcccC
Confidence            9875553

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.68  E-value=0.0002  Score=65.58  Aligned_cols=74  Identities=11%  Similarity=0.044  Sum_probs=47.7

Q ss_pred             hhcCCCCCeEEEEEEEcC-CcEEEEEEccCCCCChHHHHHHHHHhcccCCCce-eeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           71 HKLGQGGFGSVYKGQLHT-GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      +.|+.|-...+|+....+ +..+++|+........-.-..|..++..+...++ +++++.+.  +  .+||||++|.+|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l~  189 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYALS  189 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccCC
Confidence            467788889999998764 4789999875432111112578888888864443 56777663  2  2599999875553

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.67  E-value=8.1e-05  Score=60.02  Aligned_cols=100  Identities=11%  Similarity=-0.024  Sum_probs=63.8

Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      -+|.+.+.   ..+.+++++++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|.+...+ ..+.         
T Consensus        33 vSL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence            36677773   45689999999999999999988762210  112333467899999999987764 1110         


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHcC
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG  267 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg  267 (340)
                           .....+.|||...   ...+.+.=|||||+++|.-+-=
T Consensus        98 -----~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             --------------CCSS---SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             -----ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhc
Confidence                 0223567888763   1445678899999999998853

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.59  E-value=0.00037  Score=60.96  Aligned_cols=144  Identities=14%  Similarity=0.061  Sum_probs=73.3

Q ss_pred             hcCCCCCeE-EEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCC--CceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           72 KLGQGGFGS-VYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        72 ~ig~G~~g~-v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      .|+.|+... +|+....+++.+++|......  .+.+..|+.+++.+..  -.+.+++.+..+.  -+++||++.+..+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~  100 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT  100 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence            455554444 667665446778887654432  1234456777766632  2355666654333  37899998765554


Q ss_pred             cccccCC---------------------CC-CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---cC
Q 044497          149 RHIFPKE---------------------SR-GQSFCWEKLH-------E-------------VALGTARGIEYLH---NG  183 (340)
Q Consensus       149 ~~l~~~~---------------------~~-~~~~~~~~~~-------~-------------i~~~i~~~l~~Lh---~~  183 (340)
                      +.+....                     .. ...+......       .             ....+...++.+.   ..
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            3321100                     00 0112211110       0             0011112222221   11


Q ss_pred             CCCCeeecCCCCCCeeEcCC----CceEEecccCCccCCC
Q 044497          184 CDVCILHFDIKPHNILLDHN----FIPKVSDFGLAKFHPK  219 (340)
Q Consensus       184 ~~~~ivH~dik~~Nill~~~----~~~kl~Dfg~~~~~~~  219 (340)
                      .+..++|||+.++||+++.+    +.+.++||+.+.....
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            23479999999999999874    6789999998875433

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.50  E-value=0.00021  Score=63.63  Aligned_cols=73  Identities=12%  Similarity=0.118  Sum_probs=44.6

Q ss_pred             hhcCCCCCeEEEEEEEcC---------CcEEEEEEccCCCCChHHHHHHHHHhcccCCCc-eeeEeeEEEcCCeeEEEEE
Q 044497           71 HKLGQGGFGSVYKGQLHT---------GGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e  140 (340)
                      +.++.|....+|+....+         ++.+++|+.............|..+++.+...+ ..++++..  .  -+++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            467788888999997653         268999987653211112357888888774333 44566544  2  368999


Q ss_pred             ccCCCCc
Q 044497          141 YMPNGSL  147 (340)
Q Consensus       141 ~~~~~~L  147 (340)
                      |++|.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.43  E-value=0.00065  Score=59.67  Aligned_cols=68  Identities=10%  Similarity=0.080  Sum_probs=44.1

Q ss_pred             CCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCC---CceeeEeeE------EEcCCeeEEEEEccCC
Q 044497           74 GQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHH---VNVVQLLGF------CSEGSKRALVYEYMPN  144 (340)
Q Consensus        74 g~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~------~~~~~~~~lv~e~~~~  144 (340)
                      |.|....||+....++ .+++|+......     ..|+..+..+..   |++++++..      ....+..+++|+|++|
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            3344679999987666 999998766442     356666665531   224444432      2345678899999988


Q ss_pred             CCc
Q 044497          145 GSL  147 (340)
Q Consensus       145 ~~L  147 (340)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            766

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.81  E-value=0.0083  Score=54.14  Aligned_cols=141  Identities=9%  Similarity=0.107  Sum_probs=84.2

Q ss_pred             hhcCCCCCeEEEEEEEcC--------CcEEEEEEccCCCCChHHHHHHHHHhcccCC-CceeeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLHT--------GGLIAVKMLANSKFSGEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +.+..|-...+|+....+        ++.+++++........-+..+|..+++.+.. .-..++++.+.    -++|+||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence            467778888999998653        5789999975532222233578888888742 22345555432    2689999


Q ss_pred             cCCCCcccc-cc----------------c--C-----CC--CCCCCCHHHHHHHHHHH-------------------HHH
Q 044497          142 MPNGSLDRH-IF----------------P--K-----ES--RGQSFCWEKLHEVALGT-------------------ARG  176 (340)
Q Consensus       142 ~~~~~L~~~-l~----------------~--~-----~~--~~~~~~~~~~~~i~~~i-------------------~~~  176 (340)
                      ++|.+|..- +.                .  .     ..  ...+..+..+.++..++                   ...
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            998665311 00                0  0     00  11122344444443322                   222


Q ss_pred             HHHHHc---------------------CCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          177 IEYLHN---------------------GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       177 l~~Lh~---------------------~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +.+|.+                     ..+..++|+|+.+.|++ +.++.+.++||..+..
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            333321                     11346899999999999 7888999999998853

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.23  E-value=0.021  Score=51.17  Aligned_cols=30  Identities=27%  Similarity=0.356  Sum_probs=25.1

Q ss_pred             CeeecCCCCCCeeE------cCCCceEEecccCCcc
Q 044497          187 CILHFDIKPHNILL------DHNFIPKVSDFGLAKF  216 (340)
Q Consensus       187 ~ivH~dik~~Nill------~~~~~~kl~Dfg~~~~  216 (340)
                      .++|+|+.+.||++      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4466799999998853

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=92.82  E-value=0.13  Score=29.60  Aligned_cols=16  Identities=19%  Similarity=0.470  Sum_probs=9.4

Q ss_pred             EehhhHHHHHHHHHHH
Q 044497            8 LVDVPIIGRFILAPIV   23 (340)
Q Consensus         8 ~i~~~~~~~~~~~~~~   23 (340)
                      .|+..+++++++++++
T Consensus        12 ~IA~gVVgGv~~~~ii   27 (44)
T 2ks1_B           12 SIATGMVGALLLLLVV   27 (44)
T ss_dssp             SSTHHHHHHHHHHHHH
T ss_pred             eEEeehhHHHHHHHHH
Confidence            4666677766654443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=91.78  E-value=0.12  Score=29.63  Aligned_cols=27  Identities=7%  Similarity=0.263  Sum_probs=10.0

Q ss_pred             ehhhHHHHHHHHHHHHHHHHHHHHHhh
Q 044497            9 VDVPIIGRFILAPIVFLVFLIQRYRKS   35 (340)
Q Consensus         9 i~~~~~~~~~~~~~~~~~~~~~~~~~~   35 (340)
                      |+.++++.++++.+.+.++++.|+|+.
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence            344444422222233333444443433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=91.59  E-value=0.19  Score=28.89  Aligned_cols=27  Identities=15%  Similarity=0.242  Sum_probs=12.8

Q ss_pred             ehhhHHHHHHHHHH-HHHHHHHHHHHhh
Q 044497            9 VDVPIIGRFILAPI-VFLVFLIQRYRKS   35 (340)
Q Consensus         9 i~~~~~~~~~~~~~-~~~~~~~~~~~~~   35 (340)
                      |+..++++++++++ ++.+|++.|+|++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            55566665554443 3333444444333

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.79  E-value=0.51  Score=37.89  Aligned_cols=117  Identities=12%  Similarity=0.118  Sum_probs=76.6

Q ss_pred             CCCceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 044497          118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (340)
Q Consensus       118 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~N  197 (340)
                      .||++++. .+-.+.+.+.+.++.-+  +...+-     .-...+...+++++.+++....+++..     +|--+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            57888766 45566666555555433  222222     123567788999999999988666644     889999999


Q ss_pred             eeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCC
Q 044497          198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (340)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~  273 (340)
                      ++++.++.+++.--|+-.                   -++|.-       .+...=.-.+=+++..+++++..|..
T Consensus       110 L~f~~~~~p~i~~RGik~-------------------~l~P~~-------~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQN-------------------VVDPLP-------VSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EEECTTSCEEESCCEETT-------------------TBSCCC-------CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEEcCCCCEEEEEccCcc-------------------CCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999998655432                   122321       11112233566888999999877654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.47  E-value=0.56  Score=37.79  Aligned_cols=115  Identities=10%  Similarity=0.074  Sum_probs=73.2

Q ss_pred             CCCceeeEeeEEEcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeeecCCCCC
Q 044497          118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIE-YLHNGCDVCILHFDIKPH  196 (340)
Q Consensus       118 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~-~Lh~~~~~~ivH~dik~~  196 (340)
                      .||++  -..+-.+.+.+.+.++.-+++.=...+       ..++...+++++.+++.... +++.     -+|--+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57877  444446667666666654332222223       34667888999999888666 4543     488899999


Q ss_pred             CeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCC
Q 044497          197 NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (340)
Q Consensus       197 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~  272 (340)
                      |++++.++.+++.-.|.-.                   -++|.-+.       ...=.-++=+++..++.++..|.
T Consensus       114 NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~~-------ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKE-------------------SLPPDEWD-------DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETT-------------------TBSSCSCC-------HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcc-------------------cCCCCCCC-------HHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999998666432                   23332211       11112355678888888876654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.54  E-value=0.11  Score=47.50  Aligned_cols=59  Identities=5%  Similarity=0.025  Sum_probs=17.5

Q ss_pred             hhhhcCCCCCeEEEEEEEcC-CcEEEE------EEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEE
Q 044497           69 FTHKLGQGGFGSVYKGQLHT-GGLIAV------KMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCS  130 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~~-~~~vav------K~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~  130 (340)
                      +.+.||   ||.||+|.+.. ..+||+      |..+....+   ...+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345676   99999998763 467888      665542222   245788889999999999999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	340
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-50
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 8e-69
 Identities = 78/277 (28%), Positives = 141/277 (50%), Gaps = 24/277 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQ 124
               ++G G FG+VYKG+ H    +AVKML  +  +    + F NEV  + +  HVN++ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
            +G+ +   + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH   
Sbjct: 69  FMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS 124

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SR 243
              I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
           +    S +SDVY FG+VL E+  G+   SN++            +   + +G      ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRG--YLSPDL 231

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +++ S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-63
 Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 22/272 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
               +LG G FG V+ G  +    +AVK L     S + F+ E + + ++ H  +V+L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             ++     ++ EYM NGSL   +  K   G      KL ++A   A G+ ++       
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H D++  NIL+      K++DFGLA+    +N++ +    +  I + APE I  N+GT
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI--NYGT 186

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 307
            + KSDV+ FG++L E+    R      T          V   L +G  +          
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRM------VRPD 233

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +L  +   C + +  DRP+   +  +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 6e-63
 Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 22/272 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            F  +LG G FG V  G+      +A+KM+     S +EFI E   +  + H  +VQL G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
            C++     ++ EYM NG L  ++     R   F  ++L E+       +EYL +     
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK---Q 120

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++      
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY--SK 177

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 307
            S KSD++ FG+++ E+    +      T        S   + + +G  L          
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRL------YRPH 224

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           + + K+  I   C   KA +RP+   +L  + 
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-62
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 22/272 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
               KLGQG FG V+ G  +    +A+K L     S E F+ E   + ++ H  +VQL  
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             SE     +V EYM  GSL   +  +   G+     +L ++A   A G+ Y+     + 
Sbjct: 80  VVSEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MN 133

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H D++  NIL+  N + KV+DFGLA+    +N++ +    +  I + APE      G 
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY--GR 190

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIES 307
            + KSDV+ FG++L E+    R                 V DQ+ +G  +          
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRM------PCPP 237

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                L  +   C + +  +RP+   +   LE
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-62
 Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 22/271 (8%)

Query: 69  FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++    ++   F  E L  + L    G   +    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEG---MAYLEEACV 122

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   +    S   T+  + + +PE+   +F   
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVF--SFSRY 179

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM 308
           S KSDV+ FG+++ E+    +    + +        S V + ++ G  L          +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRL------YKPRL 226

Query: 309 IARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            +  +  I   C + +  DRP+ +++L  L 
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 5e-60
 Identities = 63/291 (21%), Positives = 117/291 (40%), Gaps = 30/291 (10%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE 131
            +G+G FG V++G+   G  +AVK+ ++ +        E+     + H N++  +   ++
Sbjct: 10  SIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 132 G----SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                ++  LV +Y  +GSL  ++        +   E + ++AL TA G+ +LH      
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 188 -----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPEL 240
                I H D+K  NIL+  N    ++D GLA  H    D + I+     GT  Y+APE+
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 241 ISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRS--------SKAYFPSWVY 288
           +  +          ++D+Y  G+V  E+A       +H            S         
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +     + N  +    + R +  I   C     A R +  ++ + L 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 1e-58
 Identities = 79/289 (27%), Positives = 124/289 (42%), Gaps = 24/289 (8%)

Query: 54  PKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINE 110
           P   +Y +        T  HKLG G +G VY+G        +AVK L       EEF+ E
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63

Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVA 170
            + +  I H N+VQLLG C+      ++ E+M  G+L  ++   E   Q      L  +A
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMA 121

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              +  +EYL        +H D+   N L+  N + KV+DFGL++    +      +  +
Sbjct: 122 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAK 177

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ 290
             I + APE ++      S KSDV+ FG++L E+A    +              S VY+ 
Sbjct: 178 FPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYEL 228

Query: 291 LNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           L K   +      E       K+  +   C Q   +DRPS  ++ +  E
Sbjct: 229 LEKDYRM------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (472), Expect = 2e-57
 Identities = 70/303 (23%), Positives = 127/303 (41%), Gaps = 41/303 (13%)

Query: 57  YSYPEIIAVTNHFT-----------HKLGQGGFGSVYKGQLHTGG----LIAVKMLANSK 101
           +++ +       F              +G G FG V  G L   G     +A+K L +  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 102 FSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQ 159
                 +F++E S +G+  H NV+ L G  ++ +   ++ E+M NGSLD  +   + +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124

Query: 160 SFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
            F   +L  +  G A G++YL +   +  +H D+   NIL++ N + KVSDFGL++F   
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 220 ENDFVSISAT---RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHAT 276
           +    + ++    +  I + APE I   +   +  SDV+ +G+V+ E+            
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGE------- 231

Query: 277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           R         V + + +   L               L  + L C Q     RP   +++ 
Sbjct: 232 RPYWDMTNQDVINAIEQDYRL------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 337 MLE 339
            L+
Sbjct: 286 TLD 288

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 5e-57
 Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 28/273 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G FG V  G  + G  +AVK + N   + + F+ E S + ++ H N+VQLLG
Sbjct: 10  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLG 67

Query: 128 FCSEGSKR-ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
              E      +V EYM  GSL  ++  +         + L + +L     +EYL      
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   N+L+  + + KVSDFGL K      D       +  + + APE +     
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALRE--K 175

Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 306
             S KSDV+ FG++L E+    R                 V  ++ KG  +      +  
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKM------DAP 222

Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 +  +   C  + AA RPS  ++ E LE
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (468), Expect = 9e-57
 Identities = 65/271 (23%), Positives = 106/271 (39%), Gaps = 32/271 (11%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + +    ++A+K ++ S     E     I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G         LV EY    + D          +     ++  V  G  +G+ YLH     
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDE 188

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 305
           G    K DV+  G+  +E+A  +              F       L      E   +   
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP-----------PLFNMNAMSALYHIAQNESPAL--Q 235

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
               +         C+Q    DRP+   +L+
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (460), Expect = 1e-55
 Identities = 63/300 (21%), Positives = 112/300 (37%), Gaps = 46/300 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHH 119
            +   +G+G FG V++ +           ++AVKML     +    +F  E + +    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIF--------------------PKESRGQ 159
            N+V+LLG C+ G    L++EYM  G L+  +                            
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 160 SFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
                +   +A   A G+ YL        +H D+   N L+  N + K++DFGL++    
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSS 279
            + + +       I ++ PE I  N    + +SDV+ +G+VL E+               
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 247

Query: 280 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                  V   +  G      N+         +L  +   C     ADRPS   +  +L+
Sbjct: 248 ----HEEVIYYVRDG------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-55
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 40/296 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSG--EEFINEVSTIGRI-H 118
            F   LG G FG V +   +          +AVKML  S      E  ++E+  +  + +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK--------------ESRGQSFCWE 164
           H+N+V LLG C+ G    ++ EY   G L   +  K              E    +   E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 165 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
            L   +   A+G+ +L +      +H D+   NILL H  I K+ DFGLA+    ++++V
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP 284
                R  + ++APE I       + +SDV+ +G+ L E+     +              
Sbjct: 203 VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------D 254

Query: 285 SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           S  Y  + +G  +              ++  I   C       RP+  ++++++E 
Sbjct: 255 SKFYKMIKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-54
 Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 26/277 (9%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE---FINEVSTIGRIHHVNVV 123
              + +G G +G   K +    G ++  K L     +  E    ++EV+ +  + H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 124 QLLGFCSEGSKRAL--VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +      + +   L  V EY   G L   I       Q    E +  V       ++  H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 182 --NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
             +     +LH D+KP N+ LD     K+ DFGLA+    +  F    A  GT  Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPE 184

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
            ++R   + + KSD++  G +L E+                A+    +  ++ +G     
Sbjct: 185 QMNR--MSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREG----- 229

Query: 300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                I    + +L  I    + +K   RPS+ ++LE
Sbjct: 230 -KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 8e-54
 Identities = 65/274 (23%), Positives = 115/274 (41%), Gaps = 28/274 (10%)

Query: 72  KLGQGGFGSVYKGQLH---TGGLIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G          +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G C +     LV E    G L + +     + +      + E+    + G++YL      
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE---K 128

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNF 245
             +H D+   N+LL +    K+SDFGL+K    ++ + +  SA +  + + APE I  NF
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 186

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 305
              S +SDV+ +G+ + E     +       +  K      V   + +G  +      E 
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQ-------KPYKKMKGPEVMAFIEQGKRM------EC 233

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 +L  +   C   K  DRP    V + + 
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 9e-54
 Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 33/277 (11%)

Query: 69  FTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQ 124
           F  ++G+G F +VYKG    T   +A   L + K +    + F  E   +  + H N+V+
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 125 LLGFCSEGSKR----ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
                    K      LV E M +G+L  ++     R +    + L        +G+++L
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 181 HNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           H      I+H D+K  NI +       K+ D GLA             A  GT  ++APE
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPE 183

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
           +    +       DVY FGM +LEMA             S+    + +Y ++  G     
Sbjct: 184 MYEEKYDE---SVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPA- 232

Query: 300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                 + +   ++  I   CI+    +R S+  +L 
Sbjct: 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 4e-53
 Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 30/275 (10%)

Query: 72  KLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG          +AVK+L N        +E + E + + ++ +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++     + +    + + E+    + G++YL     
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN- 127

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K    + ++       +  + + APE I+  
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY- 184

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE 304
               S KSDV+ FG+++ E     +               S V   L KG  +       
Sbjct: 185 -YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERM------G 230

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +   R++  +   C      +RP    V   L 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 4e-53
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 29/276 (10%)

Query: 73  LGQGGFGSVYKGQLHTGG-----LIAVKMLANSKFSGE--EFINEVSTIGRIHHVNVVQL 125
           +G G FG VYKG L T        +A+K L       +  +F+ E   +G+  H N+++L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
            G  S+     ++ EYM NG+LD+ +     +   F   +L  +  G A G++YL N   
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN--- 128

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRN 244
           +  +H D+   NIL++ N + KVSDFGL++    + +   + S  +  I + APE IS  
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY- 187

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE 304
               +  SDV+ FG+V+ E+           +          V   +N G  L       
Sbjct: 188 -RKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRL------P 233

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
                   +  + + C Q + A RP    ++ +L+ 
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-53
 Identities = 69/281 (24%), Positives = 108/281 (38%), Gaps = 30/281 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSGE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L          AVK L      GE  +F+ E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 122 VVQLLGFCSEGSKRA-LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
           V+ LLG C        +V  YM +G L   I        +   + L    L  A+G   +
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKG---M 143

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRGTIGYIAP 238
                   +H D+   N +LD  F  KV+DFGLA+     + +   + +  +  + ++A 
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E +       + KSDV+ FG++L E+                      +   L +G  L 
Sbjct: 204 ESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQGRRL- 253

Query: 299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                         L  + L C   KA  RPS ++++  + 
Sbjct: 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 7e-53
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 66  TNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHV 120
            + F    +LG G  G V+K     +G ++A K++          + I E+  +   +  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V   G      + ++  E+M  GSLD+ +     +      + L +V++   +G+ YL
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                  I+H D+KP NIL++     K+ DFG++            ++  GT  Y++PE 
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPER 174

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           +       S +SD++  G+ L+EMA GR 
Sbjct: 175 LQG--THYSVQSDIWSMGLSLVEMAVGRY 201

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 9e-53
 Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 30/281 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHH 119
               KLG G FG V +G+          +AVK L     S     ++FI EV+ +  + H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            N+++L G       + +V E  P GSL   +   +     F    L   A+  A G+ Y
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGY 126

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 238
           L +      +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E +     T S  SD + FG+ L EM    +   +           S +  +++K G+  
Sbjct: 184 ESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGE-- 232

Query: 299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                       + +  + + C   K  DRP+   + + L 
Sbjct: 233 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-52
 Identities = 69/299 (23%), Positives = 117/299 (39%), Gaps = 45/299 (15%)

Query: 69  FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSGE--EFINEVSTIGRI-HH 119
           F   LG G FG V     +          +AVKML     S E    ++E+  + ++  H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK-------------------ESRGQS 160
            N+V LLG C+      L++EY   G L  ++  K                   E     
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 161 FCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
             +E L   A   A+G+E+L        +H D+   N+L+ H  + K+ DFGLA+    +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSK 280
           +++V     R  + ++APE +    G  + KSDV+ +G++L E+     N          
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--- 272

Query: 281 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +  Y  +  G  +      +       ++ +I   C    +  RPS   +   L 
Sbjct: 273 ---DANFYKLIQNGFKM------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-52
 Identities = 61/270 (22%), Positives = 112/270 (41%), Gaps = 25/270 (9%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK Q   T  L A K++        E+++ E+  +    H N+V+LL   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
              +   ++ E+   G++D  +       +     ++  V   T   + YLH   D  I+
Sbjct: 79  YYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKII 132

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI---SRNFG 246
           H D+K  NIL   +   K++DFG++  + +        +  GT  ++APE++   +    
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIE 306
               K+DV+  G+ L+EMA                  P  V  ++ K     L   +   
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE--------PPHHELNPMRVLLKIAKSEPPTLAQPSRW- 241

Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           S   +        C++     R + +++L+
Sbjct: 242 SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 4e-52
 Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 39/290 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLHTGGL---IAVKML--ANSKFSGEEFINEVSTIGRI-HHVN 121
            F   +G+G FG V K ++   GL    A+K +    SK    +F  E+  + ++ HH N
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIF------------PKESRGQSFCWEKLHEV 169
           ++ LLG C       L  EY P+G+L   +                S   +   ++L   
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG++YL        +H D+   NIL+  N++ K++DFGL++       +V  +  
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMG 186

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD 289
           R  + ++A E +  N+   +  SDV+ +G++L E+           T        + +Y+
Sbjct: 187 RLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE 237

Query: 290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +L +G  L      E       ++  +   C + K  +RPS  ++L  L 
Sbjct: 238 KLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 8e-52
 Identities = 56/274 (20%), Positives = 110/274 (40%), Gaps = 33/274 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNV 122
                LG+G FG+VY  +   +  ++A+K+L  ++        +   EV     + H N+
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           ++L G+  + ++  L+ EY P G++ R +     +   F  ++        A  + Y H+
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS 124

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I 
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 177

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV 302
                   K D++  G++  E   G+             +  +   +   +   +E    
Sbjct: 178 G--RMHDEKVDLWSLGVLCYEFLVGKP-----------PFEANTYQETYKRISRVEF--- 221

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                 +      +    ++   + RP + +VLE
Sbjct: 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-50
 Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 29/275 (10%)

Query: 72  KLGQGGFGSVYKGQLHTGG-----LIAVKML--ANSKFSGEEFINEVSTIGRIHHVNVVQ 124
            LG G FG+VYKG     G      +A+K L  A S  + +E ++E   +  + + +V +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LLG C   + + L+ + MP G L  ++        +   + L    +  A+G+ YL +  
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 132 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH- 187

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE 304
               + +SDV+ +G+ + E+            +       S +   L KG  L       
Sbjct: 188 -RIYTHQSDVWSYGVTVWELMTFGS-------KPYDGIPASEISSILEKGERL------P 233

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              +    + MI + C  + A  RP   +++    
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-50
 Identities = 68/272 (25%), Positives = 100/272 (36%), Gaps = 23/272 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQ 124
                LG+G +G V       T   +AVK++   +     E    E+     ++H NVV+
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
             G   EG+ + L  EY   G L   I P                      G+ YLH   
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
            + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTE 304
               +   DV+  G+VL  M  G    +            S       K     L    +
Sbjct: 181 -EFHAEPVDVWSCGIVLTAMLAGELPWDQP--------SDSCQEYSDWKEKKTYLNPWKK 231

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           I       L       +    + R ++  + +
Sbjct: 232 I-DSAPLALLH---KILVENPSARITIPDIKK 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-50
 Identities = 64/287 (22%), Positives = 117/287 (40%), Gaps = 32/287 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSGE--EFINEVSTIGRIHH 119
             + +LGQG FG VY+G             +A+K +  +    E  EF+NE S +   + 
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK------ESRGQSFCWEKLHEVALGT 173
            +VV+LLG  S+G    ++ E M  G L  ++                   K+ ++A   
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         +
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK 293
            +++PE +    G  +  SDV+ FG+VL E+A           +  +      V   + +
Sbjct: 200 RWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAE-------QPYQGLSNEQVLRFVME 250

Query: 294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           GG L      +        L  +   C Q     RPS  +++  ++ 
Sbjct: 251 GGLL------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-48
 Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 39/294 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSGE--EFINEVSTIGRI-H 118
                LG+G FG V +          T   +AVKML       E    ++E+  +  I H
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 119 HVNVVQLLGFCSE-GSKRALVYEYMPNGSLDRHIF------------PKESRGQSFCWEK 165
           H+NVV LLG C++ G    ++ E+   G+L  ++             P++        E 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           L   +   A+G+E+L +      +H D+   NILL    + K+ DFGLA+   K+ D+V 
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS 285
               R  + ++APE I       + +SDV+ FG++L E+     +               
Sbjct: 193 KGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDE 244

Query: 286 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +L +G  +              ++    L C   + + RP+ ++++E L 
Sbjct: 245 EFCRRLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 2e-48
 Identities = 61/278 (21%), Positives = 106/278 (38%), Gaps = 29/278 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVN 121
                +G+G FG V++G           +A+K   N       E+F+ E  T+ +  H +
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +V+L+G  +E     ++ E    G L   +     R  S     L   A   +  + YL 
Sbjct: 70  IVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLE 125

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                  +H DI   N+L+  N   K+ DFGL+++      + + S  +  I ++APE I
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESI 181

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN 301
             NF   +  SDV+ FG+ + E+                    + V  ++  G  L    
Sbjct: 182 --NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERL---- 228

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              +       L  +   C     + RP  T++   L 
Sbjct: 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-48
 Identities = 66/267 (24%), Positives = 112/267 (41%), Gaps = 26/267 (9%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-FINEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+VY    + TG  +A++ +   +   +E  INE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  +V EY+  GSL   +             ++  V     + +E+LH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H DIK  NILL  +   K++DFG       E      S   GT  ++APE+++R      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTR--KAYG 194

Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMI 309
            K D++  G++ +EM  G                P      +   G  EL+N  ++ S I
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP--------YLNENPLRALYLIATNGTPELQNPEKL-SAI 245

Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLE 336
            R        C+ +    R S  ++L+
Sbjct: 246 FRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 2e-47
 Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 41/294 (13%)

Query: 69  FTHKLGQGGFGSVYKGQL--------HTGGLIAVKMLANSKFSGE--EFINEVSTIGRI- 117
               LG+G FG V   +         +    +AVKML +     +  + I+E+  +  I 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRG------------QSFCWEK 165
            H N++ LLG C++     ++ EY   G+L  ++  +   G            +    + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           L   A   ARG+EYL        +H D+   N+L+  + + K++DFGLA+     + +  
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPS 285
            +  R  + ++APE +       + +SDV+ FG++L E+     +               
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VE 244

Query: 286 WVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            ++  L +G  +      +  S    +L M+   C     + RP+  +++E L+
Sbjct: 245 ELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (399), Expect = 5e-46
 Identities = 54/278 (19%), Positives = 100/278 (35%), Gaps = 28/278 (10%)

Query: 65  VTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG-EEFINEVSTIGRIHHV 120
           V +H+    +LG G FG V++     TG   A K +     S  E    E+ T+  + H 
Sbjct: 24  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +V L     + ++  ++YE+M  G L   +            ++  E      +G+ ++
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 181 HNGCDVCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           H   +   +H D+KP NI+     +   K+ DFGL      +        T GT  + AP
Sbjct: 141 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAP 194

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E+       V   +D++  G++   +  G              +      + L      +
Sbjct: 195 EVAEG--KPVGYYTDMWSVGVLSYILLSGLS-----------PFGGENDDETLRNVKSCD 241

Query: 299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                   S I+          +      R ++ + LE
Sbjct: 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 4e-45
 Identities = 59/284 (20%), Positives = 104/284 (36%), Gaps = 43/284 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNV 122
            F   LG+G F +V   + L T    A+K+L       E        E   + R+ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
           V+L     +  K      Y  NG L ++I     +  SF           TA  +  L  
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDET---CTRFYTAEIVSALEY 123

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMHAT----RSSKAYFPSWVYDQLNKGG 295
               +    SD++  G ++ ++  G    R  N +         +  FP   +       
Sbjct: 184 E--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP------ 235

Query: 296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                   +   ++ +         + + A  R    ++     
Sbjct: 236 --------KARDLVEK--------LLVLDATKRLGCEEMEGYGP 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  151 bits (383), Expect = 1e-43
 Identities = 55/304 (18%), Positives = 116/304 (38%), Gaps = 28/304 (9%)

Query: 39  VDNVEKFLHNQQSWMPKRYSYPEIIAVTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVK 95
           +++ +KF  +       +    +  +V +++    +LG G FG V++     TG +   K
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60

Query: 96  MLANSKFSGEE-FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPK 154
            +       +    NE+S + ++HH  ++ L     +  +  L+ E++  G L   I   
Sbjct: 61  FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--- 117

Query: 155 ESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP--KVSDFG 212
            +        ++         G++++H   +  I+H DIKP NI+ +       K+ DFG
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFG 174

Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN 272
           LA     +        T  T  + APE++ R    V   +D++  G++   +  G     
Sbjct: 175 LATKLNPDEIVKV---TTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLS--- 226

Query: 273 MHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 332
                    +      + L      +     +  S ++ +        +Q +   R ++ 
Sbjct: 227 --------PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 278

Query: 333 KVLE 336
             LE
Sbjct: 279 DALE 282

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-42
 Identities = 43/268 (16%), Positives = 91/268 (33%), Gaps = 25/268 (9%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCS 130
            LG+G FG V++     +      K +            E+S +    H N++ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 131 EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILH 190
              +  +++E++    +   I    +        ++          +++LH      I H
Sbjct: 72  SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH---SHNIGH 125

Query: 191 FDIKPHNILLDH--NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           FDI+P NI+     +   K+ +FG A+     ++F           Y APE+       V
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQH--DVV 180

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESM 308
           S  +D++  G ++  +  G              +        +    + E     E    
Sbjct: 181 STATDMWSLGTLVYVLLSGIN-----------PFLAETNQQIIENIMNAEYTFDEEAFKE 229

Query: 309 IARKLCMIGLWCIQVKAADRPSMTKVLE 336
           I+ +        +  +   R + ++ L+
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (370), Expect = 4e-42
 Identities = 52/271 (19%), Positives = 94/271 (34%), Gaps = 23/271 (8%)

Query: 69  FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE--FINEVSTIGRIHHVNVVQL 125
           F   LG G F  V   +   T  L+A+K +A     G+E    NE++ + +I H N+V L
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCD 185
                 G    L+ + +  G L   I         +       +       ++YLH+   
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           V             LD +    +SDFGL+K     +   +     GT GY+APE++++  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---CGTPGYVAPEVLAQ-- 183

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI 305
              S   D +  G++   +  G              ++         +    E    +  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYP-----------PFYDENDAKLFEQILKAEYEFDSPY 232

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              I+          ++     R +  + L+
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 56/270 (20%), Positives = 104/270 (38%), Gaps = 32/270 (11%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE-------FINEVSTIGRIHHVNVV 123
            +G+GGFG VY  +   TG + A+K L   +   ++           +S +       +V
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            +        K + + + M  G L  H+    S+   F    +   A     G+E++H  
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMH-- 124

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            +  +++ D+KP NILLD +   ++SD GLA    K+        + GT GY+APE++ +
Sbjct: 125 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQK 179

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT 303
                   +D +  G +L ++  G      H T+         +   +            
Sbjct: 180 GVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------------ 226

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTK 333
           E+    + +L  +    +Q     R     
Sbjct: 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  141 bits (357), Expect = 1e-40
 Identities = 52/281 (18%), Positives = 102/281 (36%), Gaps = 37/281 (13%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG----------EEFINEVSTIGRIH-H 119
            LG+G    V +     T    AVK++  +              E  + EV  + ++  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            N++QL       +   LV++ M  G L  ++    +   +   ++  ++       I  
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           LH    + I+H D+KP NILLD +   K++DFG +           +    GT  Y+APE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 179

Query: 240 LIS----RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG 295
           +I      N      + D++  G+++  +  G              ++       L    
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP-----------PFWHRKQMLMLRMIM 228

Query: 296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
               +  +      +  +  +    + V+   R +  + L 
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  138 bits (349), Expect = 1e-39
 Identities = 55/282 (19%), Positives = 98/282 (34%), Gaps = 31/282 (10%)

Query: 69  FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNVV 123
               LG GG   V+  + L     +AVK+L             F  E      ++H  +V
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 124 QLLGFC----SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            +          G    +V EY+   +L   +            ++  EV     + + +
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 238
                   I+H D+KP NI++      KV DFG+A+      + V+ +A   GT  Y++P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE 298
           E       +V  +SDVY  G VL E+  G              +          +    +
Sbjct: 184 EQARG--DSVDARSDVYSLGCVLYEVLTGEP-----------PFTGDSPVSVAYQHVRED 230

Query: 299 LRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLE 339
               +     ++  L  + L  +     +R  +  ++   L 
Sbjct: 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (350), Expect = 2e-39
 Identities = 52/287 (18%), Positives = 99/287 (34%), Gaps = 29/287 (10%)

Query: 65  VTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN 121
           V N +    K+G G FG +Y G  +  G  +A+K+    K    +   E      +    
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGV 63

Query: 122 VVQLLGFC-SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            +  + +C +EG    +V E +     D   F      + F  + +  +A      IEY+
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYI 119

Query: 181 HNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSI-----SATRGT 232
           H       +H D+KP N L        +  + DFGLAK +        I         GT
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN 292
             Y +           S + D+   G VL+    G          + +  +      +++
Sbjct: 177 ARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234

Query: 293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              ++  +           +      +C  ++  D+P  + + ++  
Sbjct: 235 TPIEVLCKGYPS-------EFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-39
 Identities = 65/286 (22%), Positives = 107/286 (37%), Gaps = 30/286 (10%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG------EEFINEVSTIGRIHHVNVVQ 124
            LG+G F +VYK +  +T  ++A+K +     S          + E+  +  + H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC 184
           LL      S  +LV+++M                       +    L T +G+EYLH   
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              ILH D+KP+N+LLD N + K++DFGLAK     N   + +    T  Y APEL+   
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL-FG 174

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR-------------RNSNMHATRSSKAYFPSWVYDQL 291
                   D++  G +L E+                 R      T + + +         
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 292 NKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
                     +  I S     L  +           R + T+ L+M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-39
 Identities = 55/294 (18%), Positives = 108/294 (36%), Gaps = 27/294 (9%)

Query: 65  VTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG--EEFINEVSTIGRIHH 119
           V   +T    +G+G +G V           +A+K ++  +     +  + E+  + R  H
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            N++ +       +   +   Y+    +   ++ K  + Q    + +        RG++Y
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIGYIAP 238
           +H      +LH D+KP N+LL+     K+ DFGLA+   P  +    ++    T  Y AP
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMHATRSSKAYFPSWVYDQLNKG 294
           E++  + G  +   D++  G +L EM   R        +           S   + LN  
Sbjct: 182 EIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 295 GDLELRNV------------TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            +L+ RN               +      K   +    +      R  + + L 
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 9e-38
 Identities = 54/236 (22%), Positives = 91/236 (38%), Gaps = 24/236 (10%)

Query: 69  FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE----FINEVSTIGR-IHHVNV 122
               LG+G FG V+  +   T    A+K L       ++     + E   +     H  +
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
             +            V EY+  G L  HI         F   +    A     G+++L  
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFL-- 119

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I++ D+K  NILLD +   K++DFG+ K +   +     +   GT  YIAPE++ 
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILL 176

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMHATRSSKAYFPSWVYDQL 291
                 +   D + FG++L EM  G+            H+ R    ++P W+  + 
Sbjct: 177 G--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-37
 Identities = 58/277 (20%), Positives = 100/277 (36%), Gaps = 35/277 (12%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K +   TG   A K +   +          E+   EVS +  I H NV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L   +       +S   E+  E       G   ++  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNG---VYYL 129

Query: 184 CDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
             + I HFD+KP NI+L    +P    K+ DFGLA      N+F       GT  ++APE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
           ++  N+  +  ++D++  G++   +  G                       ++       
Sbjct: 187 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVNYEFE 236

Query: 300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                  S +A+         +      R ++   L+
Sbjct: 237 DEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  133 bits (336), Expect = 4e-37
 Identities = 55/232 (23%), Positives = 93/232 (40%), Gaps = 26/232 (11%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLL 126
            LG G FG V+  +  H G   A+K+L           E   +E   +  + H  ++++ 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
           G   +  +  ++ +Y+  G L   +   +            EV L        L      
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------ALEYLHSK 123

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+KP NILLD N   K++DFG AK+ P            GT  YIAPE++S    
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVST--K 176

Query: 247 TVSCKSDVYGFGMVLLEMAGGRR-------NSNMHATRSSKAYFPSWVYDQL 291
             +   D + FG+++ EM  G                 +++  FP +  + +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  131 bits (330), Expect = 1e-36
 Identities = 44/291 (15%), Positives = 95/291 (32%), Gaps = 31/291 (10%)

Query: 62  IIAVTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HH 119
           ++ V      ++G+G FG +++G  L     +A+K     +    +  +E  T   +   
Sbjct: 2   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGC 60

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
             +  +  F  EG    LV + +     D      +  G+ F  + +   A      ++ 
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIP-----KVSDFGLAKFHPKEND-----FVSISAT 229
           +H   +  +++ DIKP N L+            V DFG+ KF+          +      
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD 289
            GT  Y++           S + D+   G V +    G                 +    
Sbjct: 174 SGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQ--------GLKAATNKQ 223

Query: 290 QLNKGGDLELRN-VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +  + G+ +    + E+ +    +      +   +     P    +  +  
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 59/273 (21%), Positives = 106/273 (38%), Gaps = 30/273 (10%)

Query: 73  LGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFC- 129
           LG G  G V +     T    A+KML +      +   EV    R     ++V+++    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYE 75

Query: 130 ---SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDV 186
              +      +V E +  G L   I  ++   Q+F   +  E+       I+YLH    +
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 187 CILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            I H D+KP N+L      N I K++DFG AK     N   +   T     Y+APE++  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP---YYVAPEVLGP 187

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT 303
                    D++  G+++  +  G        +    A  P        + G  E  N  
Sbjct: 188 --EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMK--TRIRMGQYEFPN-- 238

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              S ++ ++ M+    ++ +   R ++T+ + 
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-36
 Identities = 55/283 (19%), Positives = 107/283 (37%), Gaps = 27/283 (9%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++         F   S         +        +G+ +        
Sbjct: 69  VIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         +      T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGC-KY 179

Query: 248 VSCKSDVYGFGMVLLEMAGGRR-------NSNMHATRSSKAYFPSWVYDQLNKGGDLEL- 299
            S   D++  G +  EM   R           +     +       V+  +    D +  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 300 ------RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                 ++ +++   +      +    +      R S    L 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-35
 Identities = 53/287 (18%), Positives = 112/287 (39%), Gaps = 30/287 (10%)

Query: 72  KLGQGGFGSVYKGQ--LHTGGLIAVKMLANSKFSGEE------FINEVSTIGRIHHVNVV 123
           ++G+G +G V+K +   + G  +A+K +                +  +  +    H NVV
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHI--FPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +L   C+           +    +D+ +  +  +        E + ++     RG+++LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                 ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y APE++
Sbjct: 134 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEVL 187

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMH--------ATRSSKAYFPSWVYD 289
            +   + +   D++  G +  EM   +     +S++              +  +P  V  
Sbjct: 188 LQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                     + + +  + I      + L C+    A R S    L 
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  128 bits (323), Expect = 1e-35
 Identities = 56/282 (19%), Positives = 99/282 (35%), Gaps = 27/282 (9%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGF 128
           K+G+G +G VYK Q + G   A+K +   K         I E+S +  + H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 129 CSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCI 188
                +  LV+E++           +                L    GI Y H   D  +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+KP N+L++     K++DFGLA+           +    T+ Y AP+++       
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVL-MGSKKY 178

Query: 249 SCKSDVYGFGMVLLEMAGGRR-------NSNMHATRSSKAYFPSWVYDQLNKGGDLELRN 301
           S   D++  G +  EM  G            +           S  +  + +    +   
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 302 VTEIESMIARKLCMIG-------LWCIQVKAADRPSMTKVLE 336
                      L  +           +++    R +  + LE
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-35
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 27/224 (12%)

Query: 54  PKRYSYPEIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVS 112
           P+  SY +           +G G FG VY+ +L  +G L+A+K +   K        E+ 
Sbjct: 17  PQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65

Query: 113 TIGRIHHVNVVQLLGFCSEGSKR------ALVYEYMPNGSLDRHIFPKESRGQSFCWEKL 166
            + ++ H N+V+L  F     ++       LV +Y+P     R         Q+     +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYV 124

Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVS 225
                   R + Y+H      I H DIKP N+LLD +  + K+ DFG AK   +    VS
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
              +R    Y APELI       +   DV+  G VL E+  G+ 
Sbjct: 182 YICSR---YYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQP 221

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 4e-35
 Identities = 54/276 (19%), Positives = 95/276 (34%), Gaps = 43/276 (15%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG-------EEFINEVSTIGRIH--HVN 121
            LG GGFGSVY G  +     +A+K +   + S             EV  + ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           V++LL +        L+ E               +   +   E            + +  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHC- 126

Query: 182 NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
              +  +LH DIK  NIL+D N    K+ DFG              +   GT  Y  PE 
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEW 180

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR 300
           I R        + V+  G++L +M  G                P    +++       +R
Sbjct: 181 I-RYHRYHGRSAAVWSLGILLYDMVCGD--------------IPFEHDEEI-------IR 218

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                   ++ +   +  WC+ ++ +DRP+  ++  
Sbjct: 219 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 3e-34
 Identities = 58/296 (19%), Positives = 101/296 (34%), Gaps = 39/296 (13%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG 127
           K+GQG FG V+K +   TG  +A+K +             + E+  +  + H NVV L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 128 FCSEGSKRA--------LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEY 179
            C   +           LV+++  +               S     +  +       +  
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-------LNG 129

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIA 237
           L+      ILH D+K  N+L+  + + K++DFGLA+     K +     +    T+ Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMHATRSSKAYFPSWVYDQLNK 293
           PEL+           D++G G ++ EM         N+  H          S   +    
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 294 GGDLELRNVTEIESMIARKLCMIGL-------------WCIQVKAADRPSMTKVLE 336
             + EL    E+     RK+                    + +  A R      L 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-33
 Identities = 48/207 (23%), Positives = 77/207 (37%), Gaps = 16/207 (7%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEE----FINEVSTIGRIHHVNV 122
            +   LG+G FG V   +   TG   A+K+L       ++     + E   +    H  +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN 182
             L        +   V EY   G L  H+                      A  +  L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFYGAEIVSALEY 120

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                +++ DIK  N++LD +   K++DFGL K    +   +      GT  Y+APE++ 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLE 178

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR 269
                     D +G G+V+ EM  GR 
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRL 203

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (311), Expect = 3e-33
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 22/238 (9%)

Query: 40  DNVEKFLHNQQSWMPKRYSYP-EIIAVTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVK 95
           ++V++FL   +    K++  P +  A  + F     LG G FG V   +   +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 96  MLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI 151
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R   F        A       EYLH    + +++ D+KP N+L+D     +V+DF
Sbjct: 133 R----RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           G AK        +      GT   +APE+I       +   D +  G+++ EMA G  
Sbjct: 186 GFAKRVKGRTWTL-----CGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYP 236

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-32
 Identities = 48/284 (16%), Positives = 102/284 (35%), Gaps = 29/284 (10%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G+V+K +   T  ++A+K +    + +      + E+  +  + H N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
                 K  LV+E+                           V     + ++ L       
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++ N   K+++FGLA+         S      T+ Y  P+++      
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA-KL 178

Query: 248 VSCKSDVYGFGMVLLEMAGGRR--------NSNMHATRSSKAYFPSWVYDQLNKGGDLEL 299
            S   D++  G +  E+A   R        +  +              +  + K  D + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 300 RNVTEIESMIARKLCMIG-------LWCIQVKAADRPSMTKVLE 336
             +    + +   +  +           ++     R S  + L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (294), Expect = 4e-31
 Identities = 52/297 (17%), Positives = 114/297 (38%), Gaps = 44/297 (14%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQL 125
               KLG+G +  V++   +     + VK+L   K   ++   E+  +  +    N++ L
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITL 95

Query: 126 LGFCSEGSKR--ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG 183
                +   R  ALV+E++ N    +         Q+     +        + ++Y H  
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH-- 146

Query: 184 CDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             + I+H D+KPHN+++DH +   ++ D+GLA+F+    ++   +    +  +  PEL+ 
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELL- 201

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR------RNSNMHATRSSKAYFPSWVYDQLNKGGD 296
            ++       D++  G +L  M   +       ++     R +K      +YD ++K   
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 297 LELRNVTEIESMIARKLCMIGL-----------------WCIQVKAADRPSMTKVLE 336
                  +I    +RK     +                   ++     R +  + +E
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 3e-30
 Identities = 53/285 (18%), Positives = 107/285 (37%), Gaps = 29/285 (10%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKML---ANSKFSGEEFINEVSTIGRIHHVNVVQLLG 127
            +G G +G+V       TG  +A+K L     S+   +    E+  +  + H NV+ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             +         ++            K  + +    +++  +     +G+ Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE+I  N+  
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI-LNWMR 195

Query: 248 VSCKSDVYGFGMVLLEMAGGRR-------NSNMHATRSSKAYFPSWVYDQLNKGG----- 295
            +   D++  G ++ EM  G+           +          P+    +L         
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 296 ----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
               +LE ++   I +  +     +    + + A  R +  + L 
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-29
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 18/208 (8%)

Query: 72  KLGQGGFGSVYKGQL----HTGGLIAVKMLANSKFSG-----EEFINEVSTIGRI-HHVN 121
            LG G +G V+  +      TG L A+K+L  +         E    E   +  I     
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
           +V L       +K  L+ +Y+  G L  H+  +E   +      + E+ L        L 
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA-------LE 143

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +   + I++ DIK  NILLD N    ++DFGL+K    +    +     GTI Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIV 202

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
                      D +  G+++ E+  G  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 5e-26
 Identities = 55/288 (19%), Positives = 102/288 (35%), Gaps = 35/288 (12%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG 127
            +G G +GSV       TG  +AVK L+    S    +    E+  +  + H NV+ LL 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 128 FCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC 187
             +         +      L         + Q    + +  +     RG++Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP N+ ++ +   K+ DFGLA+    E      +    T  Y APE++  N+  
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIM-LNWMH 195

Query: 248 VSCKSDVYGFGMVLLEMAGGRR-------------------NSNMHATRSSKAYFPSWVY 288
            +   D++  G ++ E+  GR                           +   +       
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 289 DQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
             L +   +   NV    + +A  L       + + +  R +  + L 
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (254), Expect = 3e-25
 Identities = 35/212 (16%), Positives = 80/212 (37%), Gaps = 18/212 (8%)

Query: 71  HKLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFC 129
            KLG G F +V+  + +     +A+K++   K   E   +E+  + R++  +  +     
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 130 SEGSKRALVYEYMPNGSLDRHIFPKE------------SRGQSFCWEKLHEVALGTARGI 177
           +    + L +      +    +   E               +      + +++     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +Y+H  C   I+H DIKP N+L++       +    +A            + +  T  Y 
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +PE++        C +D++    ++ E+  G 
Sbjct: 197 SPEVLLG--APWGCGADIWSTACLIFELITGD 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 5e-25
 Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 25/207 (12%)

Query: 72  KLGQGGFGSVYKGQ-LHTGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLG 127
            +G G  G V           +A+K L+    +    +    E+  +  ++H N++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 128 FCS------EGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLH 181
             +      E     LV E M            +        E++  +      GI++LH
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     I+H D+KP NI++  +   K+ DFGLA+           +    T  Y APE+I
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVI 190

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                      D++  G ++ EM   +
Sbjct: 191 LGM--GYKENVDIWSVGCIMGEMVRHK 215

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.1 bits (189), Expect = 2e-17
 Identities = 28/162 (17%), Positives = 46/162 (28%), Gaps = 22/162 (13%)

Query: 72  KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS-----------GEEFINEVSTIGRIHHV 120
            +G+G   +V+       G   VK       S              F        R    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYL 180
            + +L G          VY +  N  L   I  KE            EV       +   
Sbjct: 67  ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD--EVLDMILEEVAKF 119

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
           ++     I+H D+  +N+L+       + DF  +    +E  
Sbjct: 120 YH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	340
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.57
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.35
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.91
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.4
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.12

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=389.48  Aligned_cols=251  Identities=25%  Similarity=0.299  Sum_probs=203.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .|++.+.||+|+||+||+|.+. +++.||+|++.....  ..+.+.+|+++++.++||||+++++++.+.+..|+||||+
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            3567789999999999999875 789999999865432  2356899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++|+|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+|+.......
T Consensus        86 ~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          86 SGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             TTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999983    345799999999999999999999999   999999999999999999999999999987654443


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                      ........||+.|+|||++.+. ..++.++||||+||++|||+||+.||.......      .... ........     
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~-~~~~~~~~-----  225 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYS-DWKEKKTY-----  225 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHH-HHHTTCTT-----
T ss_pred             cccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHHH-HHhcCCCC-----
Confidence            3334556799999999999765 234678999999999999999999997544321      1111 11111111     


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......+++++.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1112234578889999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-57  Score=387.72  Aligned_cols=250  Identities=28%  Similarity=0.492  Sum_probs=199.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      +++.+.||+|+||+||+|.+.+++.||||+++.+....+++.+|++++++++||||++++|+|...+..++||||+++|+
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence            45678999999999999999888899999999888888899999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceee
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  226 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (340)
                      |.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++........ ..
T Consensus        87 L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~  159 (263)
T d1sm2a_          87 LSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SS  159 (263)
T ss_dssp             HHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             HHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-ee
Confidence            9998843   335688999999999999999999999   9999999999999999999999999999866443322 22


Q ss_pred             eccccCccccccccccccccccccccchhhHHHHHHHHHcC-CCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       227 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      ....||+.|+|||++.+.  .++.++|||||||++|||+|+ ++|+.....        ..+...+..+......     
T Consensus       160 ~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--------~~~~~~i~~~~~~~~p-----  224 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKP-----  224 (263)
T ss_dssp             -----CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--------HHHHHHHHHTCCCCCC-----
T ss_pred             cceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHhcCCCCCc-----
Confidence            345689999999999875  788999999999999999995 444443221        1122233333322221     


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                       ..+++++.+|+.+||+.||++|||++|+++.|+
T Consensus       225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~  257 (263)
T d1sm2a_         225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA  257 (263)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence             233568899999999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-57  Score=389.33  Aligned_cols=256  Identities=30%  Similarity=0.505  Sum_probs=200.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+.+.+.||+|+||+||+|+.+  +.||||+++....+   .+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~   85 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC   85 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence            3556789999999999999864  46999999754332   3678899999999999999999998865 5689999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++|+|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        86 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          86 EGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999998432   35689999999999999999999999   999999999999999999999999999987655444


Q ss_pred             ceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          223 FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      ........||+.|+|||++.+. ...++.++|||||||++|||+||+.||......       .........+....  .
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~p--~  230 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLSP--D  230 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSCCC--C
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCC--c
Confidence            3344556799999999998653 235788999999999999999999999754332       11222222222111  1


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ....+..+++++.+|+.+||+.||++|||++|+++.|+
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            12233345678999999999999999999999999886

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-57  Score=391.76  Aligned_cols=258  Identities=30%  Similarity=0.430  Sum_probs=214.5

Q ss_pred             HHHHHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           61 EIIAVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        61 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      |+....+++.+.||+|+||+||+|.+. +++.||||+++.+....+++.+|+++++.++||||++++++|.+.+..+++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            344456777899999999999999876 6889999999988888889999999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        93 E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          93 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             ecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            999999999998543  346789999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ... .......|++.|+|||++.+.  .++.++|||||||++|||++|..|+.....       ...+...+..+.....
T Consensus       168 ~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~~~i~~~~~~~~  237 (287)
T d1opja_         168 DTY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMER  237 (287)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHTTCCCCC
T ss_pred             CCc-eeeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHHHHHhcCCCCCC
Confidence            432 223445588999999999875  788999999999999999997776543222       1112333333332222


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                            +..+++++.+|+.+||+.||++|||++|+++.|+
T Consensus       238 ------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         238 ------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                  2234578999999999999999999999998875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-57  Score=386.00  Aligned_cols=243  Identities=23%  Similarity=0.393  Sum_probs=205.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccC----CCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|++.+.||+|+||+||+|... +++.||+|++.+    .....+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            3677899999999999999875 788999999864    23345678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||++......
T Consensus        87 y~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          87 YAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             ecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999983    345789999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .    .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......        .....+.....    
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~----  221 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVEF----  221 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCC----
T ss_pred             c----ccccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCC----
Confidence            2    2345699999999999875  6789999999999999999999999754321        12222222211    


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus       222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               122235678999999999999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-57  Score=389.12  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=208.7

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...+++.+.||+|+||+||+|.+++++.||||+++.+....+.+.+|++++++++|||||++++++.+ +..++||||++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            34567788999999999999999888899999998888788899999999999999999999998865 56799999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +|+|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+|+....... 
T Consensus        91 ~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          91 NGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            99999877332  234689999999999999999999999   999999999999999999999999999987654332 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      .......||+.|+|||++.+.  .++.++|||||||++|||+||..|+.....       .......+..+......   
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~~~~~~~p---  232 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRP---  232 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCC---
T ss_pred             ccccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCc---
Confidence            223445689999999999764  788999999999999999996655433221       11122333333322222   


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         ..+++++.+|+.+||+.||++|||++++++.|+
T Consensus       233 ---~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         233 ---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence               234578999999999999999999999999886

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=380.19  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=213.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCCCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  146 (340)
                      +++.++||+|+||+||+|++++++.||||+++.+....+++.+|++++++++||||++++|+|.+.+..++||||+++|+
T Consensus         6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence            35678999999999999999888899999999888888999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCceee
Q 044497          147 LDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  226 (340)
Q Consensus       147 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (340)
                      |.+++..   ....+++..+.+++.|+++||+|||++   +|+||||||+||++++++.+||+|||+++........ ..
T Consensus        86 l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~  158 (258)
T d1k2pa_          86 LLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS  158 (258)
T ss_dssp             HHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred             HHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence            9988733   335688999999999999999999999   9999999999999999999999999999865443322 23


Q ss_pred             eccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccchh
Q 044497          227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVTEI  305 (340)
Q Consensus       227 ~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (340)
                      ....+|+.|+|||.+.+.  .++.++||||||+++|||+| |+.||......+        +...+..+......     
T Consensus       159 ~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--------~~~~i~~~~~~~~p-----  223 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRP-----  223 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCCCCCC-----
T ss_pred             cccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCHHH--------HHHHHHhCCCCCCc-----
Confidence            345689999999999875  78889999999999999998 899987654321        23333343332222     


Q ss_pred             hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       306 ~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                       ...++++.+|+.+||+.||++|||++++++.|.+
T Consensus       224 -~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 -HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             2345789999999999999999999999998863

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=386.00  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=205.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      +|.+.+.||+|+||+||+|... +|+.||+|++.... ...+.+.+|+++++.++||||+++++++.+.+..|+||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            3567789999999999999864 78999999987543 345779999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +|+|.+++.     ...+++..+..++.|++.||+|||++   ||+||||||+|||++.++++||+|||+++....... 
T Consensus       101 gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            999998873     24689999999999999999999999   999999999999999999999999999987644332 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                       ......||+.|+|||++.+.  .++.++||||+||++|+|+||+.||......       .......... ....    
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~-~~~~----  236 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNG-TPEL----  236 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHC-SCCC----
T ss_pred             -cccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCC-CCCC----
Confidence             22455699999999999875  7789999999999999999999999754321       1122222221 1111    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            122345678999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=388.88  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=195.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEc--CCeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  139 (340)
                      .|++.+.||+|+||+||+|... +|+.||+|++.....+.   +.+.+|++++++++||||+++++++.+  .+.+|+||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            3667799999999999999875 78899999997765443   468899999999999999999999854  45689999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||+++|+|.+++.........+++..++.++.|++.||+|||++.  ..+|+||||||+|||+++++.+||+|||+++..
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            999999999998655445678999999999999999999999861  124999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      .....  ......||+.|+|||++.+.  .++.++|||||||++|||+||+.||......        .+...+..+...
T Consensus       165 ~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~~~~~i~~~~~~  232 (269)
T d2java1         165 NHDTS--FAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREGKFR  232 (269)
T ss_dssp             -------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCC
T ss_pred             ccCCC--ccccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            54332  22345699999999999775  7889999999999999999999999754321        122333333222


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..      +..+++++.+|+.+||+.||++|||++|+++
T Consensus       233 ~~------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 RI------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            22      2235678999999999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-56  Score=387.58  Aligned_cols=250  Identities=28%  Similarity=0.468  Sum_probs=192.1

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCc---EEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGG---LIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~---~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ++.+.||+|+||+||+|.+. +++   .||||.+......  .+.+.+|+++|++++|||||+++|++...+..++||||
T Consensus        29 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey  108 (299)
T d1jpaa_          29 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEF  108 (299)
T ss_dssp             EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEe
Confidence            34578999999999999865 332   5889988654433  35789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++..   ....+++..+..++.|+++||+|||++   +++||||||+|||+++++.+||+|||+++......
T Consensus       109 ~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         109 MENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             CTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             cCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999998743   235689999999999999999999999   99999999999999999999999999998665433


Q ss_pred             Cce---eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          222 DFV---SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       222 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ...   ......||+.|+|||.+.+.  .++.++|||||||++|||+| |+.||......        .+...+..+...
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~~  252 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVINAIEQDYRL  252 (299)
T ss_dssp             -------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCC
T ss_pred             CcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            221   12234578999999998764  78889999999999999998 89998754432        122333333322


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      +..++..+.+|+.+||+.||++|||+.|+++.|+
T Consensus       253 ~~------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~  288 (299)
T d1jpaa_         253 PP------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD  288 (299)
T ss_dssp             CC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CC------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            22      2234578899999999999999999999999885

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=377.95  Aligned_cols=243  Identities=26%  Similarity=0.382  Sum_probs=198.1

Q ss_pred             hhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEc----CCeeEEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVY  139 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~  139 (340)
                      ++.+.||+|+||+||+|.+. +++.||+|++.......   +.+.+|++++++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45678999999999999875 78899999987654433   568899999999999999999999864    45689999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCCeeEc-CCCceEEecccCCcc
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLD-HNFIPKVSDFGLAKF  216 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dik~~Nill~-~~~~~kl~Dfg~~~~  216 (340)
                      ||+++|+|.+++.    ....+++..+..++.|+++||+|||++   +  |+||||||+|||++ +++.+||+|||+++.
T Consensus        92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999999999983    345789999999999999999999998   7  99999999999996 578999999999986


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD  296 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (340)
                      .....    .....||+.|+|||++.+   .++.++|||||||++|||++|+.||......       ......+..+..
T Consensus       165 ~~~~~----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~~~~  230 (270)
T d1t4ha_         165 KRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK  230 (270)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred             ccCCc----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHcCCC
Confidence            44332    234579999999999865   5788999999999999999999999643321       112233333222


Q ss_pred             ccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 LELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .     ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       231 ~-----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 P-----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             C-----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C-----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1     1223334567899999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=387.17  Aligned_cols=246  Identities=23%  Similarity=0.302  Sum_probs=202.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccC----CCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|++.+.||+|+||+||+|... +++.||||++.+    .....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            3678899999999999999875 789999999864    23345679999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++|+|.+++.    ..+.+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        89 y~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          89 YAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999883    345799999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      ..........||+.|+|||++.+.  .++.++|||||||++|+|+||+.||......        .....+..+. .   
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~-~---  227 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------LIFQKIIKLE-Y---  227 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTTC-C---
T ss_pred             CcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCHH--------HHHHHHHcCC-C---
Confidence            443334456799999999999875  7788999999999999999999999754321        1222222221 1   


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl  335 (340)
                         .++..+++++.+|+.+||+.||++|||++|++
T Consensus       228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence               12223567899999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-56  Score=384.23  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=203.5

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC-CChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK-FSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      |++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            566789999999999999875 78899999987543 3346789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|.......  .
T Consensus        94 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~  165 (288)
T d2jfla1          94 GAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  165 (288)
T ss_dssp             EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence            999998743   245699999999999999999999999   99999999999999999999999999997543221  1


Q ss_pred             eeeccccCcccccccccccc---ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          225 SISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      ......||+.|+|||++...   ...++.++|||||||++|||+||+.||.......       ... ....+...... 
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~-~i~~~~~~~~~-  236 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLL-KIAKSEPPTLA-  236 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHH-HHHHSCCCCCS-
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHH-HHHcCCCCCCC-
Confidence            12345699999999998532   2357889999999999999999999997654321       111 22222221111 


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         .+..+++++.+|+.+||+.||++|||++|+++
T Consensus       237 ---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 ---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               22345678999999999999999999999976

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=379.58  Aligned_cols=245  Identities=25%  Similarity=0.419  Sum_probs=198.4

Q ss_pred             hhcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           71 HKLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      ++||+|+||+||+|.++   +++.||||+++....+   .+++.+|++++++++||||++++++|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999754   3467999999754333   35789999999999999999999999754 57899999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.........
T Consensus        92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999983    345799999999999999999999999   99999999999999999999999999998765544332


Q ss_pred             -eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          225 -SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       225 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                       ......||+.|+|||.+.+.  .++.++|||||||++|||+| |+.||......        .+...+..+.....   
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--------~~~~~i~~~~~~~~---  231 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGC---  231 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCC---
T ss_pred             ccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCHH--------HHHHHHHcCCCCCC---
Confidence             22345689999999999775  78899999999999999998 89999754321        13333444433322   


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         +..+++++.+|+.+||+.||++|||++++++.|+
T Consensus       232 ---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         232 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence               2235678999999999999999999999998875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=377.35  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=203.0

Q ss_pred             hhh-hcCCCCCeEEEEEEEc---CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           69 FTH-KLGQGGFGSVYKGQLH---TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        69 ~~~-~ig~G~~g~v~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      +.+ .||+|+||+||+|.++   ++..||||+++.....  .+++.+|+++|++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~   90 (285)
T d1u59a_          12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA   90 (285)
T ss_dssp             EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence            345 4999999999999754   3457999999764432  3578999999999999999999999975 4589999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      ++|+|.+++..   ....+++..+..++.|+++||+|||++   +++||||||+||+++.++.+||+|||+++.......
T Consensus        91 ~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          91 GGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             TTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            99999998732   345789999999999999999999999   999999999999999999999999999987655443


Q ss_pred             ce-eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          223 FV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       223 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .. ......||+.|+|||++.+.  .++.++|||||||++|||+| |+.||......+        +...+..+..... 
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------~~~~i~~~~~~~~-  233 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRMEC-  233 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCCCC-
T ss_pred             ccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC-
Confidence            22 22344689999999999765  78899999999999999998 899997644321        2333444443332 


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           ++.+++++.+|+.+||+.||++|||+.++++.|+
T Consensus       234 -----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         234 -----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             -----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                 2345678999999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-56  Score=385.65  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=190.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC--ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF--SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ..|++.+.||+|+||+||+|... +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            34677899999999999999875 788999999976433  235678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc---CCCceEEecccCCccCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~---~~~~~kl~Dfg~~~~~~  218 (340)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||++.   +++.+||+|||+++...
T Consensus        89 ~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          89 VSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             cCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999983    346799999999999999999999999   999999999999994   57899999999998654


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.......        ....+..+... 
T Consensus       162 ~~~~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~-  227 (307)
T d1a06a_         162 PGSV---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------LFEQILKAEYE-  227 (307)
T ss_dssp             --------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHTTCCC-
T ss_pred             CCCe---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCC-
Confidence            4332   2345699999999999875  68899999999999999999999997543211        12222222111 


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        ........+++++.+|+.+||+.||++|||++|+++
T Consensus       228 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         228 --FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             --CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              111223345678999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=386.68  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=208.5

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcC-C-----cEEEEEEccCCC--CChHHHHHHHHHhccc-CCCceeeEeeEEEcCCe
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHT-G-----GLIAVKMLANSK--FSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~-~-----~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  134 (340)
                      ...+.+.+.||+|+||+||+|++.. +     ..||+|.+....  .....+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3456778999999999999998652 2     269999986533  3346789999999998 89999999999999999


Q ss_pred             eEEEEEccCCCCcccccccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 044497          135 RALVYEYMPNGSLDRHIFPKES-------------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  195 (340)
Q Consensus       135 ~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~  195 (340)
                      .++||||+++|+|.+++.....                   ....+++..++.++.|+++||+|||++   +|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence            9999999999999999865432                   124589999999999999999999999   999999999


Q ss_pred             CCeeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCC
Q 044497          196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMH  274 (340)
Q Consensus       196 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~  274 (340)
                      +|||++.++.+||+|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999876555544444556689999999999875  78899999999999999998 89998754


Q ss_pred             cccccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          275 ATRSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ...       ..+...+..+.....      +..+++++.+|+.+||+.||++|||++||++.|.
T Consensus       271 ~~~-------~~~~~~~~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVD-------ANFYKLIQNGFKMDQ------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCS-------HHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHH-------HHHHHHHhcCCCCCC------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            432       112333444333222      2234578999999999999999999999999884

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-55  Score=382.69  Aligned_cols=246  Identities=25%  Similarity=0.337  Sum_probs=202.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh----HHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      ..|...+.||+|+||+||+|... +++.||||++.......    +.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            44667789999999999999865 78899999997655433    45889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      |||++|+|..++.    ...++++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||++.....
T Consensus        95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999999876652    346799999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeeccccCcccccccccccc-ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .      ....||+.|+|||++.+. ...++.++|||||||++|||++|+.||......       ......... ....
T Consensus       168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------~~~~~i~~~-~~~~  233 (309)
T d1u5ra_         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQN-ESPA  233 (309)
T ss_dssp             B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS-CCCC
T ss_pred             C------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhC-CCCC
Confidence            2      234699999999998653 246788999999999999999999999754321       112222222 2211


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..     +..+++++.+|+.+||+.||.+|||++|+++
T Consensus       234 ~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 LQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC-----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            11     1234578999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-56  Score=391.06  Aligned_cols=255  Identities=23%  Similarity=0.322  Sum_probs=200.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      ...|++.+.||+|+||+||+|... +|+.||+|+++.....  .+.+.+|+.+|+.++|||||+++++|.+.+..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            345667789999999999999875 7889999998764332  4678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      |+++|+|.+++.    +...+++..+..++.|++.||+|||+ +   +|+||||||+|||+++++.+||+|||+|.....
T Consensus        85 y~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999984    34568999999999999999999996 5   899999999999999999999999999985432


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHH------------
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWV------------  287 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~------------  287 (340)
                      ..    .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||................            
T Consensus       158 ~~----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         158 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HT----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             Cc----cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            21    2345799999999999875  78999999999999999999999997654321100000000            


Q ss_pred             ----------------------HHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          288 ----------------------YDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       288 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                            ............     .....+.++.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL-----PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCC-----CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                  000000000000     00113568999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=378.32  Aligned_cols=255  Identities=28%  Similarity=0.419  Sum_probs=204.4

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      ...+++.+.||+|+||+||+|.+++++.||||+++.+....+.+.+|+.++++++|||||++++++.+ +..++||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            34577889999999999999999888899999998888888899999999999999999999999855 56899999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCc
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  223 (340)
                      +|+|..++...  ....+++..++.++.|++.||+|||++   +++||||||+|||+++++++||+|||+++....... 
T Consensus        95 ~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          95 KGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            99999887432  234689999999999999999999999   999999999999999999999999999986543322 


Q ss_pred             eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       224 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                      .......||+.|+|||.+.+.  .++.++||||||+++|||+||..|+......       ......+..+...+.    
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~----  235 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPC----  235 (285)
T ss_dssp             -------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCC----
T ss_pred             eeeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCC----
Confidence            223345689999999999765  7888999999999999999977665543321       112233333322222    


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~~  340 (340)
                        +..+++++.+++.+||+.||++|||+++|++.|+.
T Consensus       236 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         236 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence              22345789999999999999999999999998863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=375.74  Aligned_cols=249  Identities=24%  Similarity=0.285  Sum_probs=205.8

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-------ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-------SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ..|++.+.||+|+||+||+|... +|+.||+|++++...       ..+.+.+|+.+|++++||||+++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            35677899999999999999875 789999999864322       3467899999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC----ceEEeccc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDFG  212 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~----~~kl~Dfg  212 (340)
                      +||||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++    .+|++|||
T Consensus        90 iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999983    345799999999999999999999999   999999999999998776    49999999


Q ss_pred             CCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      ++........   .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||......+        ....+.
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~  229 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVS  229 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHH
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--------HHHHHH
Confidence            9987654432   2345689999999999875  77899999999999999999999997543211        112222


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...   ..........++.++.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 AVN---YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTC---CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hcC---CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211   11112333456788999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-54  Score=384.07  Aligned_cols=249  Identities=20%  Similarity=0.291  Sum_probs=205.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC-hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS-GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|++.+.||+|+||+||+|... +|+.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            5788899999999999999875 7889999999764432 3568899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC--CCceEEecccCCccCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~--~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +|+|.+++..   ....+++..+..++.||+.||+|||++   +++||||||+|||++.  ++.+||+|||+++......
T Consensus       107 gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         107 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             SCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999998842   345699999999999999999999999   9999999999999964  6789999999998765544


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......       .............    
T Consensus       181 ~---~~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~----  244 (350)
T d1koaa2         181 S---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDWNM----  244 (350)
T ss_dssp             C---EEEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCS----
T ss_pred             c---cceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCC----
Confidence            3   2345699999999999875  6788999999999999999999999754321       1122222211111    


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .......+++++.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12222345678999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=373.51  Aligned_cols=252  Identities=29%  Similarity=0.459  Sum_probs=195.9

Q ss_pred             hhhhhhcCCCCCeEEEEEEEcCC-----cEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLHTG-----GLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~~~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      +.+.+.||+|+||+||+|.+++.     ..||||++......  ..++.+|++++++++|||||+++|++.+.+..+++|
T Consensus         9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~   88 (283)
T d1mqba_           9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT   88 (283)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence            45678999999999999986532     36999998754433  246889999999999999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+.++++.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        89 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          89 EYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             ECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999887733   335789999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      .... .......||+.|+|||++.+.  .++.++|||||||++|||++|..|+......       ..+...+..+....
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~~  233 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRLP  233 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCC
T ss_pred             CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCCCC
Confidence            3221 122344589999999999775  7888999999999999999976665432221       11333344443332


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      ..++..+.+|+.+||+.||++|||+.|+++.|+
T Consensus       234 ~~------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         234 TP------MDCPSAIYQLMMQCWQQERARRPKFADIVSILD  268 (283)
T ss_dssp             CC------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             Cc------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence            22      234577899999999999999999999999885

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.2e-54  Score=382.53  Aligned_cols=249  Identities=20%  Similarity=0.294  Sum_probs=205.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC-ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF-SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      .|++.+.||+|+||+||+|... +|+.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            4778899999999999999875 789999999876432 23567899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc--CCCceEEecccCCccCCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~--~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +|+|.+++.   ..+.++++..+..++.|++.||+|||++   ||+||||||+|||++  .++.+||+|||+|.......
T Consensus       110 gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         110 GGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999988773   2345799999999999999999999999   999999999999997  57899999999998765543


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|+|+||+.||.......        ....+..+...   .
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~---~  247 (352)
T d1koba_         184 I---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWE---F  247 (352)
T ss_dssp             C---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCC---C
T ss_pred             c---eeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCC---C
Confidence            2   2345699999999999875  78899999999999999999999997544221        11222222111   1


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .......+++++.+|+.+||+.||.+|||++|+++
T Consensus       248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11222345678999999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-54  Score=376.97  Aligned_cols=244  Identities=24%  Similarity=0.323  Sum_probs=205.0

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |++.+.||+|+||+||+|... +++.||+|++++.    ....+.+.+|+.+|+.++||||+++++++.+.+..|+||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            667899999999999999875 8999999999753    33457789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+......
T Consensus        87 ~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          87 ANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             CTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             cCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999883    345789999999999999999999999   99999999999999999999999999998654433


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                      .  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||...+...        +......+. .    
T Consensus       160 ~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------~~~~i~~~~-~----  222 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-I----  222 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-C----
T ss_pred             c--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHHH--------HHHHHhcCC-C----
Confidence            2  23456799999999999876  78899999999999999999999998654321        222222221 1    


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                        .++..+++++.+|+.+||+.||++||+     ++|+++
T Consensus       223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              122345678999999999999999995     777764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=374.25  Aligned_cols=249  Identities=16%  Similarity=0.226  Sum_probs=206.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEccCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  144 (340)
                      +|.+.+.||+|+||+||+|.+. +++.||+|+++........+.+|+++|+.++||||+++++++.+.+..|+|||||++
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            4677899999999999999875 788999999987765566788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCC--CceEEecccCCccCCCCCC
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN--FIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~--~~~kl~Dfg~~~~~~~~~~  222 (340)
                      |+|.+++..   .+..+++..+..++.|++.||+|||++   +|+||||||+|||++.+  ..+||+|||++........
T Consensus        86 g~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            999999832   234799999999999999999999999   99999999999999854  5899999999986654432


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccccc
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNV  302 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (340)
                         .....+|+.|+|||.+.+.  .++.++||||+||++|+|++|+.||.......        ....+..+.   ....
T Consensus       160 ---~~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--------~~~~i~~~~---~~~~  223 (321)
T d1tkia_         160 ---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--------IIENIMNAE---YTFD  223 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTC---CCCC
T ss_pred             ---ccccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC---CCCC
Confidence               2345689999999998775  78889999999999999999999997654321        122222211   1111


Q ss_pred             chhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       303 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......+++++.+|+.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2233345678999999999999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-53  Score=370.72  Aligned_cols=241  Identities=25%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccC----CCCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLAN----SKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      |++.+.||+|+||+||+|... +|+.||+|++.+    .....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            667899999999999999875 789999999864    233457889999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +++|+|..++    .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        86 ~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          86 IEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             CCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             cCCccccccc----cccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            9999999888    3456678899999999999999999999   99999999999999999999999999998764432


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccccc
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRN  301 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (340)
                           ....||+.|+|||++.+.  .++.++|||||||++|+|+||+.||......       . ....+..+..     
T Consensus       159 -----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~-~~~~i~~~~~-----  218 (316)
T d1fota_         159 -----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------K-TYEKILNAEL-----  218 (316)
T ss_dssp             -----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHHCCC-----
T ss_pred             -----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHH-------H-HHHHHHcCCC-----
Confidence                 345699999999999875  6888999999999999999999999754321       1 2222222211     


Q ss_pred             cchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          302 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       302 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                        ..+..+++++.+++.+||+.||.+||     |++++++
T Consensus       219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              12223457899999999999999996     8998875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=367.77  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=193.9

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEcC----CcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      ..|++.+.||+|+||.||+|.+..    +..||+|.++.....  .+.+.+|++++++++||||+++++++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            456778999999999999997642    346889988654333  356899999999999999999999996 4678999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +++||||||+||++++++.+||+|||+++...
T Consensus        86 ~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          86 MELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999988743   345789999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDL  297 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (340)
                      ..... ......||+.|+|||.+.+.  .++.++|||||||++|||+| |.+||......+        +...+..+...
T Consensus       160 ~~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~~~~~  228 (273)
T d1mp8a_         160 DSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERL  228 (273)
T ss_dssp             ------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCC
T ss_pred             CCcce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence            43322 22345689999999999875  78889999999999999998 888887654322        22333333332


Q ss_pred             cccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          298 ELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .      .+..+++++.+|+.+||+.||++|||++|+++.|+
T Consensus       229 ~------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         229 P------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            2      22345678999999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-53  Score=371.53  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=205.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      .+++.+.||+|+||+||+|+.+      +++.||||+++.....  .+++.+|++++++++||||+++++++...+..++
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~   93 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL   93 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence            3566789999999999999864      3468999999764433  3578999999999999999999999999999999


Q ss_pred             EEEccCCCCcccccccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 044497          138 VYEYMPNGSLDRHIFPKES--------------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~N  197 (340)
                      +|||+++|+|.+++.....                    ....+++..+..++.|++.||+|||++   +++||||||+|
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N  170 (301)
T d1lufa_          94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN  170 (301)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence            9999999999998853221                    133588999999999999999999999   99999999999


Q ss_pred             eeEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCC-CCCCCCcc
Q 044497          198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHAT  276 (340)
Q Consensus       198 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~  276 (340)
                      ||++.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++|||||||++|||++|. +||.....
T Consensus       171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999765444333333455688999999999875  7889999999999999999986 56654432


Q ss_pred             cccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          277 RSSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .        .+...+.++.....      +..+++++.+|+.+||+.||++|||+.||++.|+
T Consensus       249 ~--------e~~~~v~~~~~~~~------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         249 E--------EVIYYVRDGNILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             H--------HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H--------HHHHHHHcCCCCCC------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2        12233334333222      2234578899999999999999999999999886

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=362.27  Aligned_cols=246  Identities=29%  Similarity=0.463  Sum_probs=195.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEc-CCeeEEEEEccCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEYMPN  144 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~  144 (340)
                      .+++.+.||+|+||.||+|.++ |+.||||+++.+. ..+.+.+|++++++++||||++++|++.+ .+..++||||+++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~   85 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   85 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence            3457789999999999999985 7899999997654 44789999999999999999999999854 4668999999999


Q ss_pred             CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCCce
Q 044497          145 GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (340)
Q Consensus       145 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  224 (340)
                      |+|.+++...  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++......   
T Consensus        86 g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          86 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             EEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            9999998432  223589999999999999999999999   99999999999999999999999999998654322   


Q ss_pred             eeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCccccccc
Q 044497          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELRNVT  303 (340)
Q Consensus       225 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (340)
                        ....+|..|+|||.+.+.  .++.++||||||+++|||+| |+.||.......        +...+..+...+..   
T Consensus       158 --~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--------~~~~i~~~~~~~~~---  222 (262)
T d1byga_         158 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAP---  222 (262)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCCC---
T ss_pred             --ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCCCC---
Confidence              334588999999999775  78899999999999999998 677776543322        22333333333322   


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       304 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                         ...++++.+|+.+||+.||++|||+.++++.|+
T Consensus       223 ---~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~  255 (262)
T d1byga_         223 ---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  255 (262)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence               234578899999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=370.04  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=199.1

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCc----EEEEEEccCC--CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLANS--KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      |++.+.||+|+||+||+|.+. +|+    +||+|.++..  ....+++.+|++++++++||||++++++|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            567789999999999999865 443    5889988653  33457899999999999999999999999875 567888


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      |++.+++|.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        90 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          90 QLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             ECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            99999999988743   346789999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ...........||+.|+|||.+.+.  .++.++|||||||++|||+| |..||.......        +...+..+....
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~~  233 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERLP  233 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------HHHHHHHTCCCC
T ss_pred             ccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence            5444344455689999999999875  78899999999999999998 788887554322        233344443322


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      ..+++++.+|+.+||+.||.+|||+.|+++.|+
T Consensus       234 ~p------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         234 QP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             CC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            22      234578899999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.1e-53  Score=363.71  Aligned_cols=250  Identities=20%  Similarity=0.229  Sum_probs=204.7

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----------hHHHHHHHHHhcccC-CCceeeEeeEEEcCC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----------GEEFINEVSTIGRIH-HVNVVQLLGFCSEGS  133 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  133 (340)
                      .|++.+.||+|+||+||+|+.. +++.||+|++......          .+.+.+|+.++++++ ||||+++++++.+.+
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            4667899999999999999874 7889999998764322          135789999999997 999999999999999


Q ss_pred             eeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccC
Q 044497          134 KRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~  213 (340)
                      ..|+||||+++|+|.+++.    ...++++..+..++.||++||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999994    345799999999999999999999999   999999999999999999999999999


Q ss_pred             CccCCCCCCceeeeccccCcccccccccccc----ccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHH
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      ++.......   .....||+.|+|||.+.+.    ...++.++||||+||++|+|++|+.||......        ....
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--------~~~~  225 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LMLR  225 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--------HHHH
Confidence            987655432   2445699999999998642    235678999999999999999999999764421        1222


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .+..+...   ........+++++.+|+.+||+.||++|||++|+++
T Consensus       226 ~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         226 MIMSGNYQ---FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHTCCC---CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhCCCC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            22222111   111223346688999999999999999999999976

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-53  Score=361.84  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=193.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc--CC--cEEEEEEccCCCC----ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH--TG--GLIAVKMLANSKF----SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~--~~--~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  137 (340)
                      .|++.+.||+|+||.||+|..+  ++  ..||||+++....    ..+++.+|+++++.++||||++++|++.+ ...++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            3567789999999999999754  22  3689999876432    22578999999999999999999999976 46789


Q ss_pred             EEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccC
Q 044497          138 VYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (340)
Q Consensus       138 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~  217 (340)
                      ||||+++|++.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          88 VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999988743   235699999999999999999999999   9999999999999999999999999999976


Q ss_pred             CCCCCcee-eeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          218 PKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       218 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ........ .....+|..|+|||.+.+.  .++.++||||||+++|||+| |+.||......       .........+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~~~~~i~~~~~  232 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEGE  232 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------HHHHHHHhCCC
Confidence            55543322 2334578899999999875  78899999999999999998 89998754322       11222223322


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..+      .+..++..+.+|+.+||+.||++|||+.||++.|+
T Consensus       233 ~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         233 RLP------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             CCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            222      12234578999999999999999999999999886

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-52  Score=360.67  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=198.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC----hHHHHHHHHHhcccCCCceeeEeeEEEcCC----eeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS----GEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~  136 (340)
                      +|++.+.||+|+||+||+|... +++.||+|+++.+...    .+.+.+|+++++.++||||+++++++...+    ..|
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence            4677899999999999999864 7899999999765432    246889999999999999999999986543    378


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++..+++|||.+..
T Consensus        88 lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence            9999999999998873    345789999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCC-ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          217 HPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       217 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ...... ........||+.|+|||++.+.  .++.++|||||||++|+|+||+.||......       ...........
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~  231 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDP  231 (277)
T ss_dssp             CC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCC
T ss_pred             hccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCC
Confidence            433322 1223445699999999999775  7888999999999999999999999754321       22223333322


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~evl~~L~  339 (340)
                      ...    ......+++++.+++.+||+.||.+|| |+++++..|.
T Consensus       232 ~~~----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         232 IPP----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             CCG----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCC----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            211    122234567899999999999999999 8999888764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=363.27  Aligned_cols=267  Identities=23%  Similarity=0.281  Sum_probs=198.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEcCC----eeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~  141 (340)
                      ++.+.+.||+|+||.||+|+. +|+.||||++..+.........|+..+..++||||+++++++.+.+    ..++||||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            445678999999999999986 4889999999765432223344555666789999999999997543    57899999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNG-----CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      +++|+|.+++..     ..+++..+..++.|++.||+|||+.     .+.+|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999942     3689999999999999999999963     124999999999999999999999999999986


Q ss_pred             CCCCCCce--eeeccccCccccccccccccc----cccccccchhhHHHHHHHHHcCCCCCCCCccccccc-------ch
Q 044497          217 HPKENDFV--SISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA-------YF  283 (340)
Q Consensus       217 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~  283 (340)
                      ........  ......||+.|+|||++.+..    ..++.++|||||||++|||+||..|+..........       ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            65443322  224456999999999986531    136778999999999999999998875443221110       11


Q ss_pred             hHHHHHHhhc-CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          284 PSWVYDQLNK-GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       284 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .......... ...+.+.. ..........+.+|+.+||+.||++|||+.||++.|+
T Consensus       238 ~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~  293 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCc-ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            1222222222 22222222 1223345567999999999999999999999999885

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=368.43  Aligned_cols=250  Identities=22%  Similarity=0.255  Sum_probs=198.1

Q ss_pred             Hhhhh-hhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhccc-CCCceeeEeeEEEc----CCeeEEE
Q 044497           66 TNHFT-HKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRALV  138 (340)
Q Consensus        66 ~~~~~-~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv  138 (340)
                      .|.+. +.||+|+||+||+|.+. +++.||+|+++.    ...+.+|++++.++ +||||++++++|.+    ...+|+|
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            35555 46999999999999864 789999999864    35678899987654 89999999999865    4668999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCc
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAK  215 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~  215 (340)
                      ||||+||+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||+++   ++.+||+|||+++
T Consensus        88 mEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence            9999999999999532  235799999999999999999999999   9999999999999975   5679999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      .......   .....||+.|+|||++.+.  .++.++|||||||++|+|+||+.||...........    ..   ....
T Consensus       163 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~----~~---~~i~  230 (335)
T d2ozaa1         163 ETTSHNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MK---TRIR  230 (335)
T ss_dssp             ECCCCCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCC
T ss_pred             eccCCCc---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH----HH---HHHh
Confidence            6654432   2455699999999999875  788999999999999999999999975543221110    11   1111


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      .............+++++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111222334567789999999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.4e-52  Score=370.06  Aligned_cols=246  Identities=24%  Similarity=0.323  Sum_probs=197.6

Q ss_pred             hhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCC----CChHHHHH---HHHHhcccCCCceeeEeeEEEcCCeeEEE
Q 044497           67 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSK----FSGEEFIN---EVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        67 ~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  138 (340)
                      |.+.+.||+|+||.||+|... +|+.||+|++.+..    .....+.+   ++.+++.++||||+++++++.+.+..|+|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            567789999999999999875 78999999986422    22233444   46777888999999999999999999999


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      |||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+|+...
T Consensus        86 mE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          86 LDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             ECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999983    345688999999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       219 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ...    .....||+.|+|||++... ..++.++|||||||++|||+||+.||........     ..+....   ....
T Consensus       159 ~~~----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~---~~~~  225 (364)
T d1omwa3         159 KKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT---LTMA  225 (364)
T ss_dssp             SSC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHS---SSCC
T ss_pred             CCc----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhc---ccCC
Confidence            433    2345699999999998643 3678899999999999999999999976543221     1111111   1111


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                          ...+..+++++.+|+.+||+.||++|||     ++|+++
T Consensus       226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                1122235678999999999999999999     678764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=366.28  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=196.6

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEc-CC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSE-GS  133 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~  133 (340)
                      ...|++.+.||+|+||.||+|.+.      +++.||+|+++.....  .+.+.+|...+.++ +|+||+.+++++.. ..
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            345677899999999999999754      2457999999754432  34677888888777 68999999998865 45


Q ss_pred             eeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEc
Q 044497          134 KRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (340)
Q Consensus       134 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~  201 (340)
                      ..+++|||+++|+|.+++.....            ....+++..+..++.|++.||+|||++   +|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence            68999999999999999854322            234589999999999999999999999   999999999999999


Q ss_pred             CCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCC-CCCCCCcccccc
Q 044497          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATRSSK  280 (340)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~~  280 (340)
                      +++.+||+|||+|+...............||+.|+|||.+.+.  .++.++|||||||++|||+||. +||......   
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~---  243 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---  243 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHH---
Confidence            9999999999999866554443334456799999999999875  7889999999999999999975 566543321   


Q ss_pred             cchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          281 AYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                          ..+...+..+......      ..+++++.+++.+||+.||++|||++|+++.|+
T Consensus       244 ----~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         244 ----EEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             ----HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----HHHHHHHhcCCCCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                2233344444333322      234578999999999999999999999999886

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=364.83  Aligned_cols=253  Identities=25%  Similarity=0.322  Sum_probs=195.4

Q ss_pred             hhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC------hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           70 THKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS------GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        70 ~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+.||+|+||+||+|.+. +|+.||||+++.....      .+.+.+|+++++.++||||+++++++.+.+..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            368999999999999865 7899999999754322      246889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      .++++....    .....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            887776655    3456788899999999999999999999   999999999999999999999999999986554332


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCC------
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGD------  296 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  296 (340)
                        ......||+.|+|||++.+. ..++.++||||+||++|||+||..||......+.    ...+.+.......      
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~----l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCTTTSSST
T ss_pred             --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH----HHHHHHhcCCCChhhccch
Confidence              22345699999999998653 3578899999999999999999999975443210    0001111000000      


Q ss_pred             ------c---cc--cccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          297 ------L---EL--RNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       297 ------~---~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                            .   ..  ..........++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                  0   00  0001122234678999999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-52  Score=370.28  Aligned_cols=242  Identities=24%  Similarity=0.283  Sum_probs=203.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  140 (340)
                      .|++.+.||+|+||.||+|.+. +|+.||+|++.+.    ....+.+.+|+++|+.++||||+++++++.+....++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            5777899999999999999875 7999999998642    3344678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+.+|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus       122 ~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         122 YVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             CCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999883    335689999999999999999999999   9999999999999999999999999999866433


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcccc
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLELR  300 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (340)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|+|+||+.||......        .....+..+..    
T Consensus       195 ~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~----  255 (350)
T d1rdqe_         195 T-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIVSGKV----  255 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC----
T ss_pred             c-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCHH--------HHHHHHhcCCC----
Confidence            2     345699999999999875  6789999999999999999999999754321        12222222211    


Q ss_pred             ccchhhHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 044497          301 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (340)
Q Consensus       301 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~evl~  336 (340)
                         ..+..+++++.+|+.+||+.||.+|+     |++++++
T Consensus       256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               11223567899999999999999994     8999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=361.41  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             HHHhhhhhhcCCCCCeEEEEEEEcC--------CcEEEEEEccCCCCCh--HHHHHHHHHhccc-CCCceeeEeeEEEcC
Q 044497           64 AVTNHFTHKLGQGGFGSVYKGQLHT--------GGLIAVKMLANSKFSG--EEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (340)
Q Consensus        64 ~~~~~~~~~ig~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  132 (340)
                      ...|++.+.||+|+||.||+|+..+        +..||||+++.+....  .++.+|...+.++ +||||++++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3466778999999999999997532        2379999997755433  5788899999888 799999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeE
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKES------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill  200 (340)
                      +..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||++   +++||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            999999999999999999965432            235689999999999999999999999   99999999999999


Q ss_pred             cCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHc-CCCCCCCCccccc
Q 044497          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMHATRSS  279 (340)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~  279 (340)
                      +.++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |.+||.....   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---  243 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  243 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence            99999999999999866554443344556689999999999775  78999999999999999998 6888764332   


Q ss_pred             ccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          280 KAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           ..+...+..+......      ..+++++.+|+.+||+.||.+|||+.|+++.|+
T Consensus       244 -----~~~~~~i~~~~~~~~p------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~  292 (299)
T d1fgka_         244 -----EELFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  292 (299)
T ss_dssp             -----HHHHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----HHHHHHHHcCCCCCCC------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence                 2233444444433332      234578999999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=367.86  Aligned_cols=244  Identities=22%  Similarity=0.293  Sum_probs=201.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCC----CCChHHHHHHHHHhc-ccCCCceeeEeeEEEcCCeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANS----KFSGEEFINEVSTIG-RIHHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .|.+.+.||+|+||+||+|... +++.||+|++.++    ....+.+..|..++. .++||||+++++++.+.+..|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            3667899999999999999875 7899999999653    334456677777765 689999999999999999999999


Q ss_pred             EccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCC
Q 044497          140 EYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~  219 (340)
                      ||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++....
T Consensus        83 Ey~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          83 EYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             eecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999983    345689999999999999999999999   999999999999999999999999999986544


Q ss_pred             CCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCccc
Q 044497          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLEL  299 (340)
Q Consensus       220 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (340)
                      ...  ......||+.|+|||++.+.  .++.++||||+||++|+|+||+.||......        .+...+..+..   
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~---  220 (320)
T d1xjda_         156 GDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNP---  220 (320)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC---
T ss_pred             ccc--cccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC---
Confidence            332  23445799999999999875  7889999999999999999999999754432        12222222211   


Q ss_pred             cccchhhHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 044497          300 RNVTEIESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (340)
Q Consensus       300 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-evl  335 (340)
                          ..+..+++++.+|+.+||+.||++|||+. +++
T Consensus       221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                12224567899999999999999999995 664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=363.26  Aligned_cols=260  Identities=26%  Similarity=0.410  Sum_probs=211.0

Q ss_pred             HHHHHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCC--hHHHHHHHHHhccc-CCCceeeEeeEEEcC
Q 044497           62 IIAVTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFS--GEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (340)
Q Consensus        62 ~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~  132 (340)
                      +....+++.++||+|+||.||+|++.      +++.||||+++.....  ...+.+|+.++..+ +||||+++++++.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            44456778899999999999999752      4568999999765433  24688999999999 699999999999999


Q ss_pred             CeeEEEEEccCCCCcccccccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCe
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKES--------------RGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Ni  198 (340)
                      +..+++|||+++|+|.+++.....              ....+++..+..++.||+.||+|||++   +++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence            999999999999999998854321              234689999999999999999999999   999999999999


Q ss_pred             eEcCCCceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcC-CCCCCCCccc
Q 044497          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMHATR  277 (340)
Q Consensus       199 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~  277 (340)
                      +++.++.+|++|||.++...............||+.|+|||.+.+.  .++.++|||||||++|||+|+ .+|+......
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999977666555555566799999999999764  788999999999999999995 5545433321


Q ss_pred             ccccchhHHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          278 SSKAYFPSWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                             ..+...+..+......      ...+..+.+|+.+||+.||++|||+.|+++.|+
T Consensus       255 -------~~~~~~i~~~~~~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         255 -------SKFYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             -------HHHHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHHHHHHhcCCCCCCc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                   1123333343332222      234578999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=361.33  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=201.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCc--EEEEEEccCC--CCChHHHHHHHHHhccc-CCCceeeEeeEEEcCCeeEEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGG--LIAVKMLANS--KFSGEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  139 (340)
                      .+++.+.||+|+||+||+|.++ ++.  .||||.+...  ....+.+.+|+++|.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~   90 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   90 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence            3456789999999999999875 444  4777877543  22346799999999999 7999999999999999999999


Q ss_pred             EccCCCCcccccccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceE
Q 044497          140 EYMPNGSLDRHIFPKE------------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (340)
Q Consensus       140 e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~k  207 (340)
                      ||+++|+|.+++....            .....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+|
T Consensus        91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred             EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceE
Confidence            9999999999986542            3456799999999999999999999999   999999999999999999999


Q ss_pred             EecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCC-CCCCCcccccccchhHH
Q 044497          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMHATRSSKAYFPSW  286 (340)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~-p~~~~~~~~~~~~~~~~  286 (340)
                      |+|||+++.......   .....||..|+|||.+.+.  .++.++|||||||++|||++|.. ||.....        ..
T Consensus       168 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------~~  234 (309)
T d1fvra_         168 IADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE  234 (309)
T ss_dssp             ECCTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred             Ecccccccccccccc---ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCCH--------HH
Confidence            999999975443222   2344589999999999775  78899999999999999999765 5544322        22


Q ss_pred             HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          287 VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      +...+..+.....      +..+++++.+|+.+||+.||++|||++|+++.|+
T Consensus       235 ~~~~i~~~~~~~~------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~  281 (309)
T d1fvra_         235 LYEKLPQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  281 (309)
T ss_dssp             HHHHGGGTCCCCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHhcCCCCC------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            3333444333222      2234578999999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=359.52  Aligned_cols=251  Identities=27%  Similarity=0.387  Sum_probs=198.3

Q ss_pred             hhhhhcCCCCCeEEEEEEEcCC----cEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEc-CCeeEEEEE
Q 044497           68 HFTHKLGQGGFGSVYKGQLHTG----GLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYE  140 (340)
Q Consensus        68 ~~~~~ig~G~~g~v~~~~~~~~----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  140 (340)
                      +|.++||+|+||+||+|.+..+    ..||||+++.....  .+++.+|++++++++||||++++|++.. ....++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4567899999999999986432    25899998753322  3679999999999999999999999865 568999999


Q ss_pred             ccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCC
Q 044497          141 YMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       141 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~  220 (340)
                      |+++++|.+++..   .....++..+.+++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       110 ~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         110 YMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             CCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999998843   345677889999999999999999999   9999999999999999999999999999866543


Q ss_pred             CCce--eeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCCCcc
Q 044497          221 NDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGGDLE  298 (340)
Q Consensus       221 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (340)
                      ....  ......||+.|+|||.+.+.  .++.++||||||+++|||+||+.||.......   .    ....+..+....
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~----~~~~i~~g~~~~  254 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---D----ITVYLLQGRRLL  254 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCC
T ss_pred             ccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---H----HHHHHHcCCCCC
Confidence            3221  22334689999999998765  78899999999999999999888876433211   1    112222333222


Q ss_pred             ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          299 LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       299 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      ..      ..+++++.+|+.+||+.||++|||+.||++.|+
T Consensus       255 ~p------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~  289 (311)
T d1r0pa_         255 QP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  289 (311)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             Cc------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            21      234568999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-52  Score=361.92  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=207.5

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc------CCcEEEEEEccCCCCCh--HHHHHHHHHhcccCCCceeeEeeEEEcCCeeE
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLANSKFSG--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  136 (340)
                      ..+++.+.||+|+||+||+|.++      ++..||||+++......  ..+.+|++++++++||||+++++++...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            45667799999999999999763      35689999997654333  35889999999999999999999999999999


Q ss_pred             EEEEccCCCCcccccccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEec
Q 044497          137 LVYEYMPNGSLDRHIFPKE------SRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~D  210 (340)
                      +||||+++|+|.+++....      .....+++..+..++.|+++||+|||++   +|+||||||+|||+++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence            9999999999999874321      1224578999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCC-CCCCCCcccccccchhHHHHH
Q 044497          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMHATRSSKAYFPSWVYD  289 (340)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~  289 (340)
                      ||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||+||. .||......       . ...
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-------~-~~~  246 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------Q-VLR  246 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------H-HHH
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCHH-------H-HHH
Confidence            9999866554443334445689999999999875  7788999999999999999985 666543321       1 223


Q ss_pred             HhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          290 QLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .+.++......      ..+++.+.+++.+||+.||.+|||++++++.|+
T Consensus       247 ~i~~~~~~~~p------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  290 (308)
T d1p4oa_         247 FVMEGGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  290 (308)
T ss_dssp             HHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             HHHhCCCCCCc------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            33333332222      234578999999999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=359.63  Aligned_cols=258  Identities=21%  Similarity=0.310  Sum_probs=197.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      .|.+.++||+|+||+||+|.+. +++.||+|+++....   ..+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            3566789999999999999875 789999999965432   246789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +.++ +.+++..  .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.|+......
T Consensus        83 ~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          83 LHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             cCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9654 4444422  2345699999999999999999999999   99999999999999999999999999997654433


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC------
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG------  295 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  295 (340)
                      .  ......||+.|+|||.+... ..++.++||||+||++|+|++|+.||........   +.. .........      
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~-i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFR-IFRTLGTPDEVVWPG  229 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HHHHHCCCCTTTSTT
T ss_pred             c--cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHH-HHHhcCCCchhhccc
Confidence            2  22345699999999987664 3567899999999999999999999975432110   000 000000000      


Q ss_pred             ------------CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          296 ------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       296 ------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                                  ..............++++.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                        00000001122234578999999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=360.56  Aligned_cols=238  Identities=23%  Similarity=0.323  Sum_probs=194.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC-------hHHHHHHHHHhcccC--CCceeeEeeEEEcCCee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS-------GEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~  135 (340)
                      +|++.+.||+|+||+||+|... +++.||+|++......       ..++.+|+.++++++  ||||+++++++.+.+..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            5677899999999999999875 7899999998754322       234678999999996  89999999999999999


Q ss_pred             EEEEEccCC-CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-CCceEEecccC
Q 044497          136 ALVYEYMPN-GSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGL  213 (340)
Q Consensus       136 ~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-~~~~kl~Dfg~  213 (340)
                      ++||||+.+ +++.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+|||++. ++.+||+|||+
T Consensus        85 ~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            999999976 56777763    345789999999999999999999999   9999999999999985 57999999999


Q ss_pred             CccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhc
Q 044497          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNK  293 (340)
Q Consensus       214 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (340)
                      +.......    .....||+.|+|||++.+. ..++.++||||+||++|+|+||+.||.....             ....
T Consensus       158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~  219 (273)
T d1xwsa_         158 GALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRG  219 (273)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHC
T ss_pred             ceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhc
Confidence            98654332    2445699999999999764 2446789999999999999999999964321             1111


Q ss_pred             CCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 GGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ..        ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus       220 ~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         220 QV--------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc--------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            10        111234578999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.7e-51  Score=354.59  Aligned_cols=257  Identities=22%  Similarity=0.262  Sum_probs=199.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEcc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      +|++.++||+|+||+||+|.+++++.||+|++.....   ..+.+.+|+.+|++++||||+++++++...+..+++||++
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            4566789999999999999999999999999865432   2468999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCCC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~~  222 (340)
                      .++.+..+.    .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.+........
T Consensus        83 ~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          83 DQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             SEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             hhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            877666665    3346799999999999999999999999   999999999999999999999999999986544322


Q ss_pred             ceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh----------
Q 044497          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN----------  292 (340)
Q Consensus       223 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  292 (340)
                        ......+++.|+|||.+.+. ..++.++||||+||++|||++|+.||........   +.. +.....          
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~-i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMR-IFRILGTPNSKNWPNV  228 (286)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HHHHHCCCCTTTSTTG
T ss_pred             --ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHH-HHHhhCCCChhhccch
Confidence              22344589999999998764 4678899999999999999999999975432110   000 000000          


Q ss_pred             -cCC-------CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          293 -KGG-------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       293 -~~~-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ...       ..............++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000       00000011222345678999999999999999999999984

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=352.44  Aligned_cols=256  Identities=21%  Similarity=0.277  Sum_probs=192.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcCC------ee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEGS------KR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~  135 (340)
                      +|.+.+.||+|+||+||+|.+. +|+.||||+++....+.   +.+.+|+++|+.++||||++++++|...+      ..
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            4566789999999999999875 78999999998654443   46889999999999999999999997654      46


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+||||+ +.+|....     ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||+++
T Consensus        99 ~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             EEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence            9999999 66777665     235699999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc-------hhHH--
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-------FPSW--  286 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~~~~--  286 (340)
                      ......     ....||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||........-..       .+..  
T Consensus       170 ~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccCCcc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            654432     345699999999998764 3568899999999999999999999976542110000       0000  


Q ss_pred             -------HHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          287 -------VYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       287 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                             .......................++++.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   00000000111111112222345678899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=351.78  Aligned_cols=257  Identities=22%  Similarity=0.318  Sum_probs=194.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-C-CcEEEEEEccCCCC---ChHHHHHHHHHhccc---CCCceeeEeeEEEc-----
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-T-GGLIAVKMLANSKF---SGEEFINEVSTIGRI---HHVNVVQLLGFCSE-----  131 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~-~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----  131 (340)
                      ..|++.+.||+|+||+||+|.+. + ++.||+|+++....   ....+.+|+.+++.+   +||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            35677889999999999999874 4 56799999865322   234567888887776   79999999999853     


Q ss_pred             CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecc
Q 044497          132 GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (340)
Q Consensus       132 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Df  211 (340)
                      ....+++||++.++++.....   .....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence            346899999998876654432   2346689999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHh
Q 044497          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQL  291 (340)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  291 (340)
                      |++.......   ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||........   + ..+....
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~-~~i~~~~  231 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---L-GKILDVI  231 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-HHHHHHH
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---H-HHHHHhh
Confidence            9987543332   23455799999999999875  788999999999999999999999976543210   0 0000100


Q ss_pred             hcC----------------CCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          292 NKG----------------GDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       292 ~~~----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ...                ...............++.+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000                000000111223345678899999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=350.65  Aligned_cols=262  Identities=18%  Similarity=0.209  Sum_probs=193.5

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC--hHHHHHHHHHhcccCCCceeeEeeEEEcCC----eeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS--GEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv  138 (340)
                      +|++.+.||+|+||+||+|... +++.||||++......  .+.+.+|+++|+.++||||+++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            4667789999999999999864 8999999999764432  357889999999999999999999986543    23445


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~  218 (340)
                      ++++.+|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||++....
T Consensus        89 ~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          89 VTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            55666999999983     24689999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCc-eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh-------------
Q 044497          219 KENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP-------------  284 (340)
Q Consensus       219 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-------------  284 (340)
                      ..... .......||+.|+|||++... ..++.++||||+||++|+|++|+.||.............             
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            43221 122445699999999998654 366889999999999999999999997654211000000             


Q ss_pred             ---HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 ---SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                         ......................+..++++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000000000000000111222334578999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=352.15  Aligned_cols=260  Identities=22%  Similarity=0.248  Sum_probs=193.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCceeeEeeEEEc------CCeeEEE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRALV  138 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv  138 (340)
                      +|+..++||+|+||+||+|++. +++.||||++..+...   ..+|+++|++++||||++++++|..      ....++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            4666789999999999999875 7899999999765433   2479999999999999999999843      3357899


Q ss_pred             EEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCccC
Q 044497          139 YEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  217 (340)
Q Consensus       139 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~  217 (340)
                      |||++++.+ +.+.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||++...
T Consensus        98 ~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          98 LDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999976533 33322223456799999999999999999999999   999999999999999775 8999999999866


Q ss_pred             CCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc--------hhHHHHH
Q 044497          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY--------FPSWVYD  289 (340)
Q Consensus       218 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~--------~~~~~~~  289 (340)
                      .....   .....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||........-..        .......
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            44332   2345699999999988654 3678999999999999999999999976543211000        0011111


Q ss_pred             HhhcCCCccccc------cchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          290 QLNKGGDLELRN------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       290 ~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ............      ........++++.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111100000000      01112235678999999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=340.66  Aligned_cols=260  Identities=21%  Similarity=0.249  Sum_probs=193.3

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCC---ChHHHHHHHHHhcccCCCceeeEeeEEEc--------C
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKF---SGEEFINEVSTIGRIHHVNVVQLLGFCSE--------G  132 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~  132 (340)
                      .+|.+.+.||+|+||+||+|.+. +|+.||||++.....   ...++.+|+++|+.++|||++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            35677889999999999999875 789999999865432   33678899999999999999999998855        3


Q ss_pred             CeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEeccc
Q 044497          133 SKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (340)
Q Consensus       133 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg  212 (340)
                      +..+++||++.++.+....    .....+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+|++|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            4588999999877665544    3456788999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCc--eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHH
Q 044497          213 LAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQ  290 (340)
Q Consensus       213 ~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  290 (340)
                      ++.........  .......||+.|+|||++.+. ..++.++||||+||++|||++|+.||..........    .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~----~i~~~  237 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA----LISQL  237 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHH
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH----HHHHh
Confidence            99765433221  122334699999999998764 367889999999999999999999997543211100    01111


Q ss_pred             hhcCCC----------------ccccccchh-----hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          291 LNKGGD----------------LELRNVTEI-----ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       291 ~~~~~~----------------~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                      ......                .........     ....++++.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            100000                000000011     1122467889999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=339.20  Aligned_cols=258  Identities=19%  Similarity=0.257  Sum_probs=201.6

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCC---hHHHHHHHHHhcccCCCceeeEeeEEEcCCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFS---GEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      +|++.+.||+|+||+||+|++. +++.||||+++.....   ..++.+|+.+++.++||||+++++++.+....++++++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            3567789999999999999875 7889999998654332   36789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCccCCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~~~~~~  221 (340)
                      +.++++..++.    ....+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||.++......
T Consensus        83 ~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          83 CDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99988887773    346788999999999999999999999   99999999999999999999999999998665443


Q ss_pred             CceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcC-------
Q 044497          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKG-------  294 (340)
Q Consensus       222 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  294 (340)
                      ..  .....+++.|+|||.+.+. ..++.++||||+||++|||++|+.||.........  + ..+.......       
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--L-KRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--H-HHHHHHHCCCCTTTCTT
T ss_pred             cc--ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--H-HHHHhhcCCCChhhhhh
Confidence            21  2334577899999988764 34688999999999999999999997543321100  0 0010000000       


Q ss_pred             -------C----CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          295 -------G----DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       295 -------~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                             .    ..............++.+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0    00001112233345678899999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-48  Score=337.79  Aligned_cols=257  Identities=18%  Similarity=0.245  Sum_probs=196.0

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCCCc-eeeEeeEEEcCCeeEEEEEccC
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYMP  143 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~  143 (340)
                      +|.+.+.||+|+||+||+|.+. +++.||||++..... .+++..|+++++.++|+| |+.+.+++.+.+..++||||+ 
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            4677899999999999999865 788999999876433 346789999999997665 555566668888899999999 


Q ss_pred             CCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC---CCceEEecccCCccCCCC
Q 044497          144 NGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKE  220 (340)
Q Consensus       144 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~---~~~~kl~Dfg~~~~~~~~  220 (340)
                      ++++.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..++|+|||+|+.....
T Consensus        86 ~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          86 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            5666665532   345789999999999999999999999   9999999999999853   557999999999876443


Q ss_pred             CCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          221 NDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       221 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ...     .......||+.|+|||.+.+.  .++.++|||||||++|||+||+.||......................  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--  235 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  235 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--
Confidence            321     122445699999999999875  68899999999999999999999998655433222211111111110  


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                           ........+++++.+++.+||+.||++||+++++.+.|+
T Consensus       236 -----~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         236 -----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             -----CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             -----ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence                 011222345678999999999999999999999888765

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.6e-48  Score=340.08  Aligned_cols=255  Identities=18%  Similarity=0.285  Sum_probs=197.3

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEc--CCeeEEEEEc
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYEY  141 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~  141 (340)
                      .|++.+.||+|+||+||+|+.. +++.||+|+++..  ..+++.+|+++|+.++ ||||+++++++..  ....++||||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence            5778899999999999999875 7889999998653  3578899999999995 9999999999974  4568999999


Q ss_pred             cCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCC-ceEEecccCCccCCCC
Q 044497          142 MPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKE  220 (340)
Q Consensus       142 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~-~~kl~Dfg~~~~~~~~  220 (340)
                      +.+++|....       ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|......
T Consensus       114 ~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         114 VNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             CCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             cCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999997764       4689999999999999999999999   999999999999998655 6899999999866544


Q ss_pred             CCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccc-hh-----HHHHHHhhc-
Q 044497          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAY-FP-----SWVYDQLNK-  293 (340)
Q Consensus       221 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-~~-----~~~~~~~~~-  293 (340)
                      ..   .....+|+.|+|||.+.+. ..++.++||||+||++|+|++|+.||........... +.     ......... 
T Consensus       184 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         184 QE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             Cc---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            32   2445689999999998764 3568899999999999999999999876543211000 00     000000000 


Q ss_pred             --CCCcc--------------ccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          294 --GGDLE--------------LRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       294 --~~~~~--------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                        .....              ..........+++++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00000              00011122345678999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=345.99  Aligned_cols=252  Identities=22%  Similarity=0.261  Sum_probs=201.4

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc----CCcEEEEEEccCC-----CCChHHHHHHHHHhcccCC-CceeeEeeEEEcCCee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLANS-----KFSGEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~----~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~  135 (340)
                      .|++.+.||+|+||+||+|...    +|+.||+|+++..     ....+.+.+|++++++++| |||+++++++.+....
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            3778899999999999999752    5789999998643     2234678899999999966 8999999999999999


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      +++|||+.+|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++
T Consensus       105 ~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         105 HLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999983    345678899999999999999999999   99999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhhcCC
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLNKGG  295 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (340)
                      ........ ......|++.|+|||.+.+....++.++|||||||++|+|++|+.||.........    ..+........
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~~~  252 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSE  252 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHCC
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcccCC
Confidence            65433222 22345699999999999776556788999999999999999999999766543321    11222111111


Q ss_pred             CccccccchhhHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 044497          296 DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (340)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~evl~  336 (340)
                             ...+..+++++.+|+.+||+.||++|||     ++|+++
T Consensus       253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                   1122345688999999999999999994     788875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-47  Score=333.12  Aligned_cols=258  Identities=17%  Similarity=0.254  Sum_probs=202.1

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccCC-CceeeEeeEEEcCCeeEEEEEcc
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEYM  142 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~  142 (340)
                      .+|.+.+.||+|+||+||+|.+. +++.||+|++.... ..+.+.+|++.+..++| +|++.+++++......++||||+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            35678899999999999999865 78899999886543 33467789999999965 89999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcC-----CCceEEecccCCccC
Q 044497          143 PNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFH  217 (340)
Q Consensus       143 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~-----~~~~kl~Dfg~~~~~  217 (340)
                       +++|.+++..   .+..+++.++..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+|+..
T Consensus        84 -~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          84 -GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence             7899888743   335689999999999999999999999   9999999999999964     578999999999865


Q ss_pred             CCCCCc-----eeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchhHHHHHHhh
Q 044497          218 PKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFPSWVYDQLN  292 (340)
Q Consensus       218 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  292 (340)
                      ......     .......||+.|+|||.+.+.  .++.++||||||+++|||+||+.||............. .+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~-~i~~~~~  233 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-RIGEKKQ  233 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH-HHHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH-HHHhccC
Confidence            433211     122345699999999999875  78899999999999999999999997654432211111 1111100


Q ss_pred             cCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 044497          293 KGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (340)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~~L~  339 (340)
                      .      ....+....+++++.+++..|++.+|++||+++.+.+.|+
T Consensus       234 ~------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         234 S------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             H------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             C------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            0      1112222345678999999999999999999988877664

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=339.28  Aligned_cols=256  Identities=21%  Similarity=0.203  Sum_probs=189.2

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEc------CCee
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  135 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~  135 (340)
                      +|++.+.||+|+||+||+|.+. +|+.||||++.....+.   ..+.+|+.++++++||||++++++|..      ...+
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            3566789999999999999876 79999999997655443   457899999999999999999999953      4678


Q ss_pred             EEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          136 ALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       136 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      |+||||+.++.+ +.+      ...+++..+..++.|++.||+|||++   ||+||||||+|||++.++.++++|||+++
T Consensus        98 ~iv~Ey~~~~l~-~~~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          98 YLVMELMDANLC-QVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEECCSEEHH-HHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEeccchHHH-Hhh------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence            999999966544 444      24588999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCccccccc--------------
Q 044497          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKA--------------  281 (340)
Q Consensus       216 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--------------  281 (340)
                      ......   ......+|+.|+|||.+.+.  .++.++||||+||++|+|++|+.||..........              
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             ----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccc---ccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            554433   23445689999999999875  77889999999999999999999997544211000              


Q ss_pred             -chhHHHHHHhhcCC------------CccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          282 -YFPSWVYDQLNKGG------------DLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       282 -~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                       ..............            ..............++++.+|+.+||+.||++|||++|+|+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             00000111111110            00111122345567889999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=340.98  Aligned_cols=257  Identities=19%  Similarity=0.235  Sum_probs=192.9

Q ss_pred             HhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCCh---HHHHHHHHHhcccCCCceeeEeeEEEcC-----CeeE
Q 044497           66 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSG---EEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  136 (340)
Q Consensus        66 ~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  136 (340)
                      +|++.+.||+|+||+||+|.+. +|+.||||++.....+.   +.+.+|+++|+.++|||++++++++...     ...+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            4667789999999999999865 79999999998655443   4678999999999999999999998643     3346


Q ss_pred             EEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          137 LVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       137 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      ++++++.+|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++..
T Consensus        99 ~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             EEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             EEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence            6677778999999882     34699999999999999999999999   999999999999999999999999999975


Q ss_pred             CCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccchh------------
Q 044497          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYFP------------  284 (340)
Q Consensus       217 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~------------  284 (340)
                      ....     .....||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||...+.......+.            
T Consensus       171 ~~~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CTGG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cCcc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            4332     2345689999999987664 356789999999999999999999997554221100000            


Q ss_pred             ----HHHHHHhhcCCCccccccchhhHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 044497          285 ----SWVYDQLNKGGDLELRNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (340)
Q Consensus       285 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~evl~  336 (340)
                          .........................++++.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                0000000000000000111112234678899999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.7e-42  Score=308.68  Aligned_cols=261  Identities=18%  Similarity=0.244  Sum_probs=189.0

Q ss_pred             HHhhhhhhcCCCCCeEEEEEEEc-CCcEEEEEEccCCCCChHHHHHHHHHhcccC-----------CCceeeEeeEEEc-
Q 044497           65 VTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLANSKFSGEEFINEVSTIGRIH-----------HVNVVQLLGFCSE-  131 (340)
Q Consensus        65 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~-  131 (340)
                      .+|.+.+.||+|+||+||+|+.. +|+.||||+++++....+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            34788899999999999999875 7899999999876655577888999988875           5789999988753 


Q ss_pred             -CCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCeeEcCCC-----
Q 044497          132 -GSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNF-----  204 (340)
Q Consensus       132 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dik~~Nill~~~~-----  204 (340)
                       ....+++++++..+....... .......+++..+..++.|++.||+|||+ .   ||+||||||+|||++.++     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             cccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence             455667777765444332221 12345678899999999999999999997 6   999999999999997654     


Q ss_pred             -ceEEecccCCccCCCCCCceeeeccccCccccccccccccccccccccchhhHHHHHHHHHcCCCCCCCCcccccccch
Q 044497          205 -IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMHATRSSKAYF  283 (340)
Q Consensus       205 -~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~  283 (340)
                       .++++|||.+.......     ....||+.|+|||.+.+.  .++.++|+||+||++++|++|+.||............
T Consensus       169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             ceeeEeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence             38999999997554322     345699999999998865  6788999999999999999999999765432111100


Q ss_pred             hHHHH----------HHhhcCC----------------Cccc-------cccchhhHHHHHHHHHHHhhcccCCCCCCCC
Q 044497          284 PSWVY----------DQLNKGG----------------DLEL-------RNVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (340)
Q Consensus       284 ~~~~~----------~~~~~~~----------------~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  330 (340)
                      .....          .......                ....       ..........++++.+|+.+||+.||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            00000          0000000                0000       0011233567789999999999999999999


Q ss_pred             HHHHHH
Q 044497          331 MTKVLE  336 (340)
Q Consensus       331 ~~evl~  336 (340)
                      ++|+|+
T Consensus       322 a~e~L~  327 (362)
T d1q8ya_         322 AGGLVN  327 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.4e-26  Score=185.79  Aligned_cols=161  Identities=17%  Similarity=0.113  Sum_probs=118.1

Q ss_pred             hhhhcCCCCCeEEEEEEEcCCcEEEEEEccCCCCC-------------------hHHHHHHHHHhcccCCCceeeEeeEE
Q 044497           69 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLANSKFS-------------------GEEFINEVSTIGRIHHVNVVQLLGFC  129 (340)
Q Consensus        69 ~~~~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~iv~~~~~~  129 (340)
                      +.++||+|+||+||+|.+.+|+.||||+++.+..+                   ......|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            56899999999999999888999999987532111                   12245688889999999999887653


Q ss_pred             EcCCeeEEEEEccCCCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCeeEcCCCceEEe
Q 044497          130 SEGSKRALVYEYMPNGSLDRHIFPKESRGQSFCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (340)
Q Consensus       130 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dik~~Nill~~~~~~kl~  209 (340)
                          ..+++||++++..+.+.           +......++.|++.+++|||++   +++||||||+|||++++ .++|+
T Consensus        84 ----~~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 ----GNAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ----TTEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             ----CCEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence                23799999987555432           2233567899999999999999   99999999999999865 48999


Q ss_pred             cccCCccCCCCCCceeeeccccCccccc------cccccccccccccccchhhHHHHH
Q 044497          210 DFGLAKFHPKENDFVSISATRGTIGYIA------PELISRNFGTVSCKSDVYGFGMVL  261 (340)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~g~~~y~a------PE~~~~~~~~~~~~~DvwslG~~l  261 (340)
                      |||.|.........          .|..      .+.+.   ..++.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIITYFS---RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHHHHc---CCCCCcccHHHHHHHH
Confidence            99999755433211          1111      12222   2567889999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.57  E-value=1.5e-07  Score=77.79  Aligned_cols=132  Identities=15%  Similarity=0.075  Sum_probs=90.0

Q ss_pred             CCCCCeEEEEEEEcCCcEEEEEEccCC-CCChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEccCCCCccccc
Q 044497           74 GQGGFGSVYKGQLHTGGLIAVKMLANS-KFSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHI  151 (340)
Q Consensus        74 g~G~~g~v~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  151 (340)
                      +.++.+.||+... +++.+++|+.... ......+.+|...+..+. +-.+.+++.+....+..++||++++|.++.+..
T Consensus        23 ~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          23 EGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             CCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred             CCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence            3344578998864 4667888887543 233445778888887774 444677888888888999999999988876544


Q ss_pred             ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------------
Q 044497          152 FPKESRGQSFCWEKLHEVALGTARGIEYLHNGC-----------------------------------------------  184 (340)
Q Consensus       152 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----------------------------------------------  184 (340)
                      ...      .   ....++.+++..++.||+..                                               
T Consensus       102 ~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (263)
T d1j7la_         102 EDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD  172 (263)
T ss_dssp             TTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred             ccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence            111      1   12234455555555565321                                               


Q ss_pred             ---------CCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          185 ---------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       185 ---------~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                               ...++|+|+.|.||++++++...|+||+.+.
T Consensus       173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                     1137999999999999987767799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.35  E-value=9.7e-07  Score=72.35  Aligned_cols=130  Identities=18%  Similarity=0.173  Sum_probs=86.9

Q ss_pred             hcCCCC-CeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccC--CCceeeEeeEEEcCCeeEEEEEccCCCCcc
Q 044497           72 KLGQGG-FGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (340)
Q Consensus        72 ~ig~G~-~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  148 (340)
                      .+..|. .+.||+....++..+++|......  ...+..|...++.+.  .-.+.+++.+..+.+..+++|++++|.++.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344444 368999988878888999865443  345678888887774  334677888888888899999999887664


Q ss_pred             cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc----------------------------------------------
Q 044497          149 RHIFPKESRGQSFCWEKLHEVALGTARGIEYLHN----------------------------------------------  182 (340)
Q Consensus       149 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~----------------------------------------------  182 (340)
                      +..         ....   ..+.++...|+-||+                                              
T Consensus        95 ~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          95 SSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            321         0001   112233333333332                                              


Q ss_pred             -----CC----CCCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          183 -----GC----DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       183 -----~~----~~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                           ..    +..++|+|+.|.||+++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 11    1237999999999999987667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.91  E-value=1.9e-05  Score=68.90  Aligned_cols=75  Identities=15%  Similarity=0.131  Sum_probs=49.2

Q ss_pred             hhcCCCCCeEEEEEEEc-CCcEEEEEEccC------C--CCChHHHHHHHHHhcccC-C--CceeeEeeEEEcCCeeEEE
Q 044497           71 HKLGQGGFGSVYKGQLH-TGGLIAVKMLAN------S--KFSGEEFINEVSTIGRIH-H--VNVVQLLGFCSEGSKRALV  138 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~-~~~~vavK~~~~------~--~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv  138 (340)
                      +.||.|....||+.... +++.+++|.-..      .  ..+.++...|.+.|+.+. +  ..+++++.+  +....+++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999765 467899996432      1  123355667888887763 2  345666654  44556899


Q ss_pred             EEccCCCCc
Q 044497          139 YEYMPNGSL  147 (340)
Q Consensus       139 ~e~~~~~~L  147 (340)
                      ||++.+..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999976443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.90  E-value=2.2e-05  Score=66.66  Aligned_cols=136  Identities=13%  Similarity=0.099  Sum_probs=83.6

Q ss_pred             eEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCce--eeEe-----eEEEcCCeeEEEEEccCCCCcccc-
Q 044497           79 GSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVNV--VQLL-----GFCSEGSKRALVYEYMPNGSLDRH-  150 (340)
Q Consensus        79 g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~~L~~~-  150 (340)
                      -.||+++..+|+.+++|+......+.+++..|...+..|....+  +..+     ..+......+.++++++|..+... 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            47999998889999999998888888889999998888742221  1111     123456668889999976544210 


Q ss_pred             -----------------cccCC-CCCCCCCH----------------------HHHHHHHHHHHHHHHHH-HcCCCCCee
Q 044497          151 -----------------IFPKE-SRGQSFCW----------------------EKLHEVALGTARGIEYL-HNGCDVCIL  189 (340)
Q Consensus       151 -----------------l~~~~-~~~~~~~~----------------------~~~~~i~~~i~~~l~~L-h~~~~~~iv  189 (340)
                                       ..... ........                      ......+.++...+.-. .+..+.+++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence                             00000 00011111                      12222333333333322 122345799


Q ss_pred             ecCCCCCCeeEcCCCceEEecccCCcc
Q 044497          190 HFDIKPHNILLDHNFIPKVSDFGLAKF  216 (340)
Q Consensus       190 H~dik~~Nill~~~~~~kl~Dfg~~~~  216 (340)
                      |+|+.+.|||++++  ..++||+.+..
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCCCcccEEEeCC--ceEEechhccc
Confidence            99999999999754  45899998874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.40  E-value=0.00031  Score=61.01  Aligned_cols=73  Identities=15%  Similarity=0.219  Sum_probs=50.6

Q ss_pred             hhcCCCCCeEEEEEEEcC--------CcEEEEEEccCCCCChHHHHHHHHHhcccC-CCceeeEeeEEEcCCeeEEEEEc
Q 044497           71 HKLGQGGFGSVYKGQLHT--------GGLIAVKMLANSKFSGEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY  141 (340)
Q Consensus        71 ~~ig~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  141 (340)
                      ++|+.|-.-.+|+....+        ...+.+++... ........+|..+++.+. +.-.+++++++.+    .+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            568888889999997643        34677887763 333445678999988885 3334567777653    588999


Q ss_pred             cCCCCcc
Q 044497          142 MPNGSLD  148 (340)
Q Consensus       142 ~~~~~L~  148 (340)
                      ++|.++.
T Consensus       123 i~g~~l~  129 (395)
T d1nw1a_         123 IPSRPLS  129 (395)
T ss_dssp             CCEEECC
T ss_pred             eccccCC
Confidence            9875553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.12  E-value=0.001  Score=55.50  Aligned_cols=142  Identities=9%  Similarity=0.028  Sum_probs=75.8

Q ss_pred             hcCCCCCeEEEEEEEcCCcEEEEEEccCCCCChHHHHHHHHHhcccCCCc--eeeEee------EEEcCCeeEEEEEccC
Q 044497           72 KLGQGGFGSVYKGQLHTGGLIAVKMLANSKFSGEEFINEVSTIGRIHHVN--VVQLLG------FCSEGSKRALVYEYMP  143 (340)
Q Consensus        72 ~ig~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~------~~~~~~~~~lv~e~~~  143 (340)
                      .|..|---+.|+.+..+| .+++|+.... .+.+++..|++++..+...+  +...+.      +.........++.+..
T Consensus        25 ~i~~G~~N~ny~v~t~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~  102 (316)
T d2ppqa1          25 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  102 (316)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             cCCCCcccCeEEEEECCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence            456677778899887654 6999998653 23456677888888874322  211111      1223445666777766


Q ss_pred             CCCcccccc------------------c--CCCCCCC-----------------CCHHHHHHHHHHHHHHHHHHHc-CCC
Q 044497          144 NGSLDRHIF------------------P--KESRGQS-----------------FCWEKLHEVALGTARGIEYLHN-GCD  185 (340)
Q Consensus       144 ~~~L~~~l~------------------~--~~~~~~~-----------------~~~~~~~~i~~~i~~~l~~Lh~-~~~  185 (340)
                      +......-.                  .  .......                 .........+......+.-.+. ..+
T Consensus       103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~  182 (316)
T d2ppqa1         103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  182 (316)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence            544321100                  0  0000000                 0001111222223333333322 234


Q ss_pred             CCeeecCCCCCCeeEcCCCceEEecccCCc
Q 044497          186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (340)
Q Consensus       186 ~~ivH~dik~~Nill~~~~~~kl~Dfg~~~  215 (340)
                      .+++|+|+.++|++++.+...-+.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            589999999999999988777899999875